data_1d1n_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1d1n _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.665 0.269 . . . . 0.0 110.938 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 17.0 t -61.69 141.06 18.12 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.595 0 CA-C-O 121.25 0.548 . . . . 0.0 111.53 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.475 HD12 HG23 ' A' ' 148' ' ' ILE . 0.3 OUTLIER -126.54 2.17 4.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.632 177.48 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 175.83 74.29 0.05 OUTLIER Glycine 0 C--N 1.341 0.847 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.356 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.71 132.86 36.08 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -151.88 174.16 13.93 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-O 121.466 0.65 . . . . 0.0 112.438 -178.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.426 ' HA ' ' HA ' ' A' ' 229' ' ' VAL . 50.4 mt-10 -118.71 122.75 43.22 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.274 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.436 ' CG1' ' HA ' ' A' ' 226' ' ' GLU . 2.4 p -52.1 132.26 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 121.257 0.551 . . . . 0.0 112.436 -178.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . 0.41 ' O ' ' HB3' ' A' ' 226' ' ' GLU . 4.7 mmp_? -89.33 -61.48 1.69 Allowed 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 175.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.38 -163.83 0.96 Allowed 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 113.624 -1.625 . . . . 0.0 109.479 174.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.5 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 12.2 p -143.82 173.57 11.57 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 177.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.6 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 9.2 m-85 -125.5 75.5 1.48 Allowed 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -178.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -86.2 63.14 7.85 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 177.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 66.5 t -91.71 156.02 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 CA-C-N 113.603 -1.635 . . . . 0.0 110.343 -178.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 49.1 p -91.36 34.71 0.94 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.217 0.532 . . . . 0.0 109.845 178.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 1.6 mttt -150.84 -32.15 0.17 Allowed 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.358 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 91.9 t -102.11 -103.31 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -159.04 -100.44 0.16 Allowed Glycine 0 N--CA 1.451 -0.317 0 N-CA-C 111.438 -0.665 . . . . 0.0 111.438 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' THR . . . . . 0.437 ' CG2' ' CG2' ' A' ' 224' ' ' ILE . 0.0 OUTLIER -153.87 35.11 0.44 Allowed 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 114.209 -0.996 . . . . 0.0 108.709 178.266 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.6 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 4.2 mt -42.13 95.57 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.567 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.5 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . -88.07 119.01 28.03 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.744 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -88.07 146.82 19.94 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 178.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -147.17 135.28 21.49 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 117.248 0.524 . . . . 0.0 110.833 -178.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -86.85 124.12 32.73 Favored 'General case' 0 C--O 1.223 -0.301 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 177.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 26.9 t -85.53 147.13 5.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 -175.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.2 p -139.86 14.26 2.48 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.924 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -150.85 -144.66 0.16 Allowed 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -40.3 -105.16 0.01 OUTLIER Glycine 0 CA--C 1.534 1.246 0 N-CA-C 115.208 0.843 . . . . 0.0 115.208 -179.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 6.8 mttt -151.04 143.25 24.1 Favored 'General case' 0 CA--C 1.517 -0.315 0 O-C-N 122.557 -0.378 . . . . 0.0 111.764 -178.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 14.6 mm -95.36 78.94 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 176.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 0.0 OUTLIER -97.97 171.06 8.51 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -176.834 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.34 -39.54 74.63 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.28 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -88.58 55.14 3.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.815 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -150.18 159.65 44.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.603 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . 0.423 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 0.0 OUTLIER -89.06 -178.49 5.7 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 179.238 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 3.3 m -149.64 146.24 17.1 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.615 0 CA-C-O 121.599 0.714 . . . . 0.0 112.028 179.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 231' ' ' GLU . 7.8 ttt180 -154.54 101.93 2.37 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.748 -1.114 . . . . 0.0 112.198 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.477 ' CB ' ' HA ' ' A' ' 230' ' ' ILE . 0.3 OUTLIER -97.46 170.54 8.98 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.636 179.234 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.421 ' O ' ' HB3' ' A' ' 228' ' ' ASP . 5.3 mp -152.08 141.32 14.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.021 -177.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.424 ' N ' HG21 ' A' ' 190' ' ' VAL . 3.6 ttm180 -86.37 -156.22 0.29 Allowed 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 178.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -93.62 26.5 3.03 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.915 179.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -154.07 -43.68 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.062 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.423 ' CG2' ' N ' ' A' ' 189' ' ' VAL . 0.4 OUTLIER -150.4 -159.74 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -178.001 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.423 ' N ' ' CG2' ' A' ' 188' ' ' ILE . 22.4 t -84.86 133.68 28.75 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 CA-C-O 121.572 0.701 . . . . 0.0 110.137 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . 0.462 HG23 ' HG ' ' A' ' 183' ' ' LEU . 0.2 OUTLIER -88.32 -38.38 11.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 114.678 -1.147 . . . . 0.0 109.223 -179.213 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . 1.666 ' HE1' ' CE2' ' A' ' 191' ' ' TYR . 19.1 t80 -169.62 162.39 9.83 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.201 178.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -150.1 157.97 43.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.041 0.448 . . . . 0.0 111.056 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 146.27 -126.42 2.49 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.077 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . 0.423 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 3.9 pt-20 -139.92 -176.9 4.75 Favored 'General case' 0 CA--C 1.498 -1.038 0 CA-C-O 121.152 0.501 . . . . 0.0 111.3 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 3.1 mp -86.85 141.44 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.39 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.351 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.08 -47.48 8.07 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 40.4 m -151.24 163.42 38.92 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.086 179.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.38 108.84 8.4 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 121.099 0.476 . . . . 0.0 111.073 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 3.3 mtpm? -150.1 118.61 6.49 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.682 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.527 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.946 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 . . . . . 0 N--CA 1.454 -0.275 0 CA-C-O 121.002 0.43 . . . . 0.0 110.334 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 32.6 m -64.38 154.83 6.61 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.905 0 CA-C-O 121.501 0.667 . . . . 0.0 112.038 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . 0.446 ' O ' ' HA ' ' A' ' 176' ' ' THR . 4.3 ttm-85 -89.62 -29.7 18.66 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 114.868 -1.06 . . . . 0.0 112.052 -178.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -142.93 178.17 7.85 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.123 0.487 . . . . 0.0 111.078 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -151.18 75.83 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.882 179.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -98.24 172.81 7.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.053 0.454 . . . . 0.0 112.195 -178.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 83.94 -73.49 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.957 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 178.45 37.71 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.328 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . 1.671 ' HE1' ' CE2' ' A' ' 212' ' ' TYR . 4.6 m-85 -102.23 142.98 32.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.863 0.363 . . . . 0.0 111.237 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -100.17 131.72 45.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.337 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 48.6 t -133.85 148.19 51.26 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.384 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -88.54 111.47 3.79 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.016 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.73 144.76 46.06 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 120.946 0.403 . . . . 0.0 111.281 -179.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.37 149.0 27.94 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 1.7 mp -113.96 88.2 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 -179.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 2.3 tttt 45.51 -144.72 0.19 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.931 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -87.08 61.35 6.72 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 120.957 0.408 . . . . 0.0 110.889 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . 0.456 ' CE1' ' HB2' ' A' ' 191' ' ' TYR . 0.1 OUTLIER -55.23 118.85 4.74 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 179.081 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 21.8 t30 -81.56 -47.46 13.05 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 114.804 -1.089 . . . . 0.0 108.571 176.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . 0.424 ' O ' ' CD1' ' A' ' 221' ' ' PHE . 0.0 OUTLIER -83.62 139.25 32.94 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.204 177.966 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.437 ' CG2' ' CG2' ' A' ' 164' ' ' THR . 0.2 OUTLIER -132.27 179.35 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 CA-C-O 121.276 0.56 . . . . 0.0 112.28 -179.542 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . 0.403 ' O ' ' C ' ' A' ' 226' ' ' GLU . 0.3 OUTLIER 58.01 115.87 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.677 -178.756 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . 0.436 ' HA ' ' CG1' ' A' ' 153' ' ' VAL . 2.6 pt-20 3.64 66.62 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 124.812 1.245 . . . . 0.0 113.931 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -63.35 -62.56 5.27 Favored Glycine 0 N--CA 1.43 -1.745 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.855 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . 0.421 ' HB3' ' O ' ' A' ' 184' ' ' ILE . 0.8 OUTLIER -164.95 -148.38 0.11 Allowed 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -179.891 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . 0.454 ' O ' ' HB2' ' A' ' 183' ' ' LEU . 96.4 t -90.37 132.23 35.54 Favored 'Isoleucine or valine' 0 C--N 1.347 0.46 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . 0.477 ' HA ' ' CB ' ' A' ' 183' ' ' LEU . 4.6 mp -98.61 158.8 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 O-C-N 123.477 0.486 . . . . 0.0 111.572 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' GLU . . . . . 0.44 ' O ' ' N ' ' A' ' 182' ' ' ARG . 7.8 tt0 -145.89 109.55 4.79 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.12 126.86 35.34 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.516 178.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' TYR . . . . . 1.612 ' HE1' ' CE2' ' A' ' 233' ' ' TYR . 5.1 p90 -132.57 140.08 48.11 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.107 -178.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.538 0.508 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.937 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 12.7 tttt . . . . . 0 N--CA 1.461 0.079 0 CA-C-O 120.874 0.369 . . . . 0.0 111.159 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 15.1 t -59.0 140.81 16.81 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.595 0 CA-C-O 121.209 0.528 . . . . 0.0 111.485 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.96 -0.85 4.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.819 177.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -176.66 72.95 0.08 OUTLIER Glycine 0 C--N 1.341 0.848 0 C-N-CA 121.109 -0.567 . . . . 0.0 111.817 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.416 ' HA ' ' HA ' ' A' ' 231' ' ' GLU . 0.0 OUTLIER -91.97 132.3 36.62 Favored 'General case' 0 CA--C 1.511 -0.532 0 O-C-N 122.514 -0.403 . . . . 0.0 110.217 179.899 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.405 ' CB ' ' HB2' ' A' ' 168' ' ' CYS . . . -152.22 177.51 10.46 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -178.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 229' ' ' VAL . 2.1 mm-40 -123.66 125.09 44.16 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.566 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.436 ' CG1' ' HA ' ' A' ' 226' ' ' GLU . 1.4 p -49.82 132.43 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -179.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . 0.511 ' O ' ' HB3' ' A' ' 226' ' ' GLU . 4.3 mmp_? -89.58 -61.88 1.6 Allowed 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 105.232 -2.136 . . . . 0.0 105.232 175.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.29 -159.05 0.46 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 113.555 -1.657 . . . . 0.0 108.945 175.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 17.4 p -146.04 175.16 10.67 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 110.34 -0.245 . . . . 0.0 110.34 177.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.593 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 12.0 m-85 -129.06 73.25 1.5 Allowed 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -179.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 163' ' ' GLY . 4.6 ptmt -85.81 64.38 8.57 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.2 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 57.0 t -93.22 156.87 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 CA-C-N 113.294 -1.775 . . . . 0.0 110.527 -178.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 92.0 p -91.95 35.91 0.97 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.221 0.534 . . . . 0.0 109.584 178.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -150.85 -34.04 0.16 Allowed 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.165 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 89.5 t -102.18 -102.04 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 158' ' ' LYS . . . -158.54 -102.0 0.18 Allowed Glycine 0 C--O 1.226 -0.384 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' THR . . . . . 0.414 ' HA ' ' C ' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -153.37 34.46 0.46 Allowed 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 124.482 1.113 . . . . 0.0 108.145 177.795 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.593 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 1.6 mp -42.15 95.2 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 CA-C-N 115.063 -0.971 . . . . 0.0 112.143 -178.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.494 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . -87.8 117.89 26.95 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.416 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -87.9 149.51 21.63 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.157 -1.02 . . . . 0.0 110.761 179.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . 0.405 ' HB2' ' CB ' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -144.7 135.06 24.34 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.929 0.365 . . . . 0.0 110.537 -178.69 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -86.94 124.69 33.43 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 177.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 25.0 t -85.06 143.53 11.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -175.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -136.44 14.75 3.21 Favored 'General case' 0 CA--C 1.526 0.053 0 CA-C-N 114.475 -1.239 . . . . 0.0 111.851 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -150.36 -144.28 0.15 Allowed 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -42.06 -105.06 0.01 OUTLIER Glycine 0 CA--C 1.532 1.107 0 N-CA-C 115.055 0.782 . . . . 0.0 115.055 -179.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 17.8 mttt -150.83 143.8 24.65 Favored 'General case' 0 N--CA 1.465 0.312 0 O-C-N 122.585 -0.362 . . . . 0.0 111.582 -178.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 13.2 mm -94.96 81.64 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 176.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 0.1 OUTLIER -95.47 169.23 10.2 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -177.028 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 24.7 mtm105 -65.5 -44.46 86.98 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.977 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.16 60.59 5.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.128 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 23.8 m -149.98 161.49 42.22 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.682 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . 0.458 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 13.5 mttt -91.46 -169.72 2.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.077 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 1.2 m -150.34 158.1 5.58 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.451 0 CA-C-O 121.235 0.541 . . . . 0.0 111.633 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . 0.443 ' N ' ' O ' ' A' ' 231' ' ' GLU . 1.6 ttt85 -152.73 100.53 2.54 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.377 -0.829 . . . . 0.0 112.88 -179.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.516 ' HB3' HG23 ' A' ' 190' ' ' VAL . 0.3 OUTLIER -85.99 156.32 20.5 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-O 121.793 0.806 . . . . 0.0 113.149 -179.608 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 28.4 mm -154.3 123.96 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 114.254 -1.339 . . . . 0.0 111.296 178.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.419 ' N ' HG21 ' A' ' 190' ' ' VAL . 0.2 OUTLIER -85.74 -150.85 0.14 Allowed 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 177.976 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.84 25.74 3.48 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 118.531 0.605 . . . . 0.0 110.81 178.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -155.03 -68.11 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.478 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -120.61 -156.68 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 115.327 -0.437 . . . . 0.0 110.901 -178.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 59.0 t -87.22 135.85 24.35 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-O 121.303 0.573 . . . . 0.0 111.506 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . 0.516 HG23 ' HB3' ' A' ' 183' ' ' LEU . 0.1 OUTLIER -89.37 -33.95 6.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.165 -0.925 . . . . 0.0 108.911 178.764 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . 1.636 ' HE1' ' CE2' ' A' ' 191' ' ' TYR . 15.8 t80 -162.71 159.31 24.14 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.45 178.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -150.17 158.08 43.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.862 178.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 133.02 -119.49 2.39 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.24 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . 0.458 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 12.2 pt-20 -150.61 -175.17 5.0 Favored 'General case' 0 CA--C 1.5 -0.971 0 CA-C-O 121.179 0.514 . . . . 0.0 111.345 -179.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 4.9 mp -88.86 143.76 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.409 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.91 -53.9 4.38 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -151.72 142.71 23.08 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.783 179.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.407 ' HA ' ' HB3' ' A' ' 216' ' ' LEU . 32.3 tp -115.73 117.51 30.44 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 121.466 0.65 . . . . 0.0 111.922 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 25.6 mttt -150.36 120.94 7.45 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.952 179.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 4.5 ttm180 . . . . . 0 C--N 1.322 -0.591 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.991 -179.666 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 . . . . . 0 N--CA 1.453 -0.299 0 CA-C-O 120.905 0.383 . . . . 0.0 110.061 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 28.3 m -60.96 157.77 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.884 0 CA-C-O 121.596 0.712 . . . . 0.0 112.376 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . 0.414 ' O ' ' HA ' ' A' ' 176' ' ' THR . 0.1 OUTLIER -89.31 -35.26 16.22 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 114.616 -1.175 . . . . 0.0 111.454 -178.741 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -144.32 178.49 7.88 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.9 0.381 . . . . 0.0 110.878 179.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 1.3 t -150.93 77.0 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.109 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -96.85 170.84 8.89 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -178.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 85.77 -75.5 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.233 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 177.89 37.15 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.334 -0.936 . . . . 0.0 112.432 179.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . 1.625 ' HD2' ' CD1' ' A' ' 212' ' ' TYR . 1.4 m-85 -95.27 150.03 20.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.901 0.381 . . . . 0.0 111.333 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -89.76 159.53 17.0 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.215 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 5.1 p -150.71 -175.48 5.13 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.265 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -144.02 96.97 0.19 Allowed Glycine 0 N--CA 1.451 -0.335 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 179.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.407 ' HB3' ' HA ' ' A' ' 198' ' ' LEU . 0.4 OUTLIER -131.71 142.01 49.7 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 120.932 0.396 . . . . 0.0 111.992 -178.367 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -79.14 132.98 36.74 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 176.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . 0.475 ' CG2' ' CD2' ' A' ' 191' ' ' TYR . 1.4 mp -98.35 97.49 6.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.459 -177.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 6.5 tttp 42.5 -144.33 0.08 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.978 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -87.66 64.14 7.88 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 120.871 0.367 . . . . 0.0 110.738 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . 0.479 ' CZ ' ' CD1' ' A' ' 183' ' ' LEU . 0.1 OUTLIER -54.81 118.51 4.31 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 179.075 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -82.76 -43.82 16.31 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 114.691 -1.14 . . . . 0.0 108.548 176.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . 0.412 ' O ' ' CD1' ' A' ' 221' ' ' PHE . 0.0 OUTLIER -89.57 130.7 35.85 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 178.171 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.406 HG22 HD11 ' A' ' 224' ' ' ILE . 0.2 OUTLIER -114.96 175.89 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 CA-C-O 121.263 0.554 . . . . 0.0 111.511 179.562 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . 0.469 ' O ' ' N ' ' A' ' 227' ' ' GLY . 5.9 mtmt 63.53 147.74 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.84 -1.073 . . . . 0.0 108.992 -178.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . 0.511 ' HB3' ' O ' ' A' ' 154' ' ' ARG . 3.3 pt-20 -36.58 87.98 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.931 0.872 . . . . 0.0 112.855 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 225' ' ' LYS . . . -81.46 -57.62 2.73 Favored Glycine 0 N--CA 1.427 -1.902 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.873 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . 0.404 ' CG ' ' HA ' ' A' ' 185' ' ' ARG . 1.0 OUTLIER -163.71 -146.91 0.11 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 179.365 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . 0.413 ' HA ' ' HA ' ' A' ' 152' ' ' GLU . 61.6 t -93.64 147.4 5.54 Favored 'Isoleucine or valine' 0 C--N 1.342 0.278 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.62 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 2.8 mp -118.6 154.58 20.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.187 -179.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' GLU . . . . . 0.443 ' O ' ' N ' ' A' ' 182' ' ' ARG . 10.2 tt0 -142.49 112.26 6.85 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.421 0.629 . . . . 0.0 111.965 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -86.9 129.81 34.72 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.195 178.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' TYR . . . . . 1.58 ' HE2' ' CE1' ' A' ' 233' ' ' TYR . 6.0 p90 -130.2 144.0 51.11 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.289 -178.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.674 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 2.8 tttp . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.634 0.254 . . . . 0.0 110.548 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 14.4 t -61.72 139.27 20.93 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.628 0 CA-C-O 121.357 0.599 . . . . 0.0 111.226 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.1 pt -117.64 -11.87 11.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.145 178.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -177.64 77.91 0.07 OUTLIER Glycine 0 C--N 1.34 0.799 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -91.29 137.94 31.97 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 120.704 0.288 . . . . 0.0 110.56 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -152.01 178.13 9.75 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -178.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.405 ' HA ' ' HA ' ' A' ' 229' ' ' VAL . 40.4 mt-10 -124.34 124.93 43.45 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.334 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.458 ' CG1' ' HA ' ' A' ' 226' ' ' GLU . 2.2 p -51.04 133.84 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -89.52 -63.39 1.29 Allowed 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 104.943 -2.243 . . . . 0.0 104.943 175.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.4 -162.29 0.8 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 113.664 -1.607 . . . . 0.0 108.839 174.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 4.9 p -147.19 143.95 28.58 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 177.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.455 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 0.4 OUTLIER -89.96 83.51 6.13 Favored 'General case' 0 CA--C 1.51 -0.583 0 N-CA-C 113.969 1.099 . . . . 0.0 113.969 -177.598 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 10.2 tttp -86.82 62.18 7.24 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 177.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.421 HG23 ' CD2' ' A' ' 157' ' ' PHE . 40.9 t -93.32 156.02 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 CA-C-N 113.694 -1.593 . . . . 0.0 110.306 -178.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 12.4 t -90.15 35.68 0.86 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.13 0.491 . . . . 0.0 109.954 178.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -150.41 -32.4 0.18 Allowed 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.343 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 93.5 t -102.85 -103.23 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.226 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -159.07 -99.07 0.15 Allowed Glycine 0 N--CA 1.452 -0.25 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 178.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' THR . . . . . 0.406 ' CG2' ' CG2' ' A' ' 224' ' ' ILE . 0.0 OUTLIER -153.49 34.65 0.45 Allowed 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.282 1.033 . . . . 0.0 108.275 177.72 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.455 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 1.1 mm -40.86 98.11 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.587 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.459 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . -85.78 119.47 26.13 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.914 -1.039 . . . . 0.0 112.368 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -88.32 151.65 22.86 Favored Glycine 0 N--CA 1.443 -0.892 0 N-CA-C 110.159 -1.176 . . . . 0.0 110.159 178.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -145.62 133.74 21.56 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 117.181 0.491 . . . . 0.0 110.724 -178.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . 1.64 ' HE1' ' CE2' ' A' ' 169' ' ' TYR . 10.9 t80 -87.33 127.33 35.19 Favored 'General case' 0 C--O 1.221 -0.429 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 177.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 44.2 t -85.23 143.29 11.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -176.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -135.99 15.35 3.3 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 114.563 -1.199 . . . . 0.0 111.99 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -150.07 -146.42 0.2 Allowed 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -42.7 -105.11 0.01 OUTLIER Glycine 0 CA--C 1.531 1.071 0 N-CA-C 114.986 0.754 . . . . 0.0 114.986 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.05 135.56 17.04 Favored 'General case' 0 CA--C 1.513 -0.465 0 O-C-N 122.637 -0.331 . . . . 0.0 111.207 -178.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -95.51 112.13 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 176.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 0.1 OUTLIER -120.93 169.12 10.77 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.468 0.652 . . . . 0.0 112.219 -176.8 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.92 -43.58 98.41 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.931 179.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -89.73 61.16 5.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.964 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 57.9 m -148.06 159.23 44.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.819 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 0.0 OUTLIER -89.08 -176.95 5.31 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.344 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.4 ' CG1' ' CD1' ' A' ' 195' ' ' ILE . 1.4 m -146.15 156.75 12.06 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 CA-C-O 121.466 0.65 . . . . 0.0 112.278 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . 0.436 ' N ' ' O ' ' A' ' 231' ' ' GLU . 4.1 ttt180 -153.49 102.65 2.59 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.081 -0.963 . . . . 0.0 113.051 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.483 ' CD1' ' CZ ' ' A' ' 221' ' ' PHE . 0.3 OUTLIER -86.03 159.55 19.56 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-O 122.143 0.973 . . . . 0.0 113.255 -179.758 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.506 ' N ' HG23 ' A' ' 190' ' ' VAL . 16.2 mt -153.82 122.59 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 113.838 -1.528 . . . . 0.0 112.311 178.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.418 ' N ' HG21 ' A' ' 190' ' ' VAL . 0.2 OUTLIER -87.05 -147.93 0.14 Allowed 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 177.848 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 21.0 mm100 -95.47 27.36 3.41 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 118.651 0.659 . . . . 0.0 110.745 178.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -154.57 -80.24 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.755 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -112.41 -155.37 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 115.342 -0.429 . . . . 0.0 110.716 -179.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 41.2 t -87.04 135.62 24.8 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.096 0 CA-C-O 121.45 0.643 . . . . 0.0 111.576 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . 0.506 HG23 ' N ' ' A' ' 184' ' ' ILE . 0.2 OUTLIER -89.88 -32.25 5.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.203 178.687 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . 1.614 ' HD1' ' CD2' ' A' ' 191' ' ' TYR . 17.4 t80 -160.06 158.35 30.26 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.496 178.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -150.81 154.05 36.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.072 178.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 135.29 -119.75 2.18 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.054 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . 0.459 ' CG ' ' N ' ' A' ' 195' ' ' ILE . 0.0 OUTLIER -148.43 -178.47 6.34 Favored 'General case' 0 CA--C 1.501 -0.904 0 CA-C-O 121.523 0.678 . . . . 0.0 111.663 -179.446 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.459 ' N ' ' CG ' ' A' ' 194' ' ' GLU . 0.0 OUTLIER -88.75 147.77 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 CA-C-N 114.64 -1.163 . . . . 0.0 110.257 -178.674 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.68 -54.68 3.96 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 179.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 64.2 p -150.93 160.05 44.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.5 179.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.404 ' CD1' ' CD2' ' A' ' 216' ' ' LEU . 27.2 tp -133.44 110.71 10.18 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.384 0.611 . . . . 0.0 111.205 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 9.7 ptmt -149.8 123.89 9.44 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.414 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 2.6 ttm-85 . . . . . 0 C--N 1.322 -0.589 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.896 -179.938 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 . . . . . 0 N--CA 1.453 -0.294 0 CA-C-O 120.996 0.427 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 33.3 m -58.68 161.3 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.949 0 CA-C-O 121.55 0.69 . . . . 0.0 112.21 -179.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . 0.411 ' O ' ' HA ' ' A' ' 176' ' ' THR . 4.4 ttp180 -89.39 -38.17 14.31 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 114.625 -1.17 . . . . 0.0 111.461 -178.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -138.01 177.06 8.16 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.132 0.492 . . . . 0.0 111.332 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -151.05 81.78 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.544 178.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -101.7 172.52 6.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.102 0.477 . . . . 0.0 112.281 -178.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 2.8 tp-100 83.9 -72.98 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.983 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 178.09 37.95 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.371 -0.918 . . . . 0.0 112.44 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -97.99 143.22 28.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.979 0.419 . . . . 0.0 111.471 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -89.63 158.13 17.73 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.352 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -150.48 -171.09 3.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.015 0.436 . . . . 0.0 111.289 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -137.98 106.36 0.53 Allowed Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 178.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.407 ' CD1' ' CD1' ' A' ' 195' ' ' ILE . 0.1 OUTLIER -135.17 147.84 49.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.452 0.644 . . . . 0.0 112.602 -177.377 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.31 142.77 27.64 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 177.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . 0.469 ' CG2' ' CD2' ' A' ' 191' ' ' TYR . 1.5 mp -100.52 81.11 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.915 0.388 . . . . 0.0 110.817 -178.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 4.0 ttpt 42.34 -88.94 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.721 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' ASN . . . . . 0.401 ' N ' ' O ' ' A' ' 218' ' ' ILE . 13.0 t-20 -132.6 62.59 1.65 Allowed 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.118 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . 0.483 ' CZ ' ' CD1' ' A' ' 183' ' ' LEU . 0.1 OUTLIER -59.23 119.55 7.58 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 179.443 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -81.58 -42.51 19.99 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 175.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . 0.439 ' O ' ' CD1' ' A' ' 221' ' ' PHE . 0.0 OUTLIER -92.81 143.44 26.28 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.339 177.693 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.42 ' CD1' ' N ' ' A' ' 224' ' ' ILE . 0.2 OUTLIER -135.94 178.14 5.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -179.183 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . 0.412 ' O ' ' C ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER 57.68 119.31 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 114.543 -1.208 . . . . 0.0 110.009 -178.953 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . 0.458 ' HA ' ' CG1' ' A' ' 153' ' ' VAL . 5.3 tt0 5.95 65.81 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 124.455 1.102 . . . . 0.0 113.62 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -66.34 -63.74 3.76 Favored Glycine 0 N--CA 1.429 -1.802 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.236 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . 0.428 ' O ' ' HB ' ' A' ' 153' ' ' VAL . 1.0 OUTLIER -165.05 -147.17 0.1 Allowed 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 179.259 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 152' ' ' GLU . 52.6 t -89.8 146.92 5.59 Favored 'Isoleucine or valine' 0 C--N 1.34 0.181 0 CA-C-N 116.71 -0.223 . . . . 0.0 110.412 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 4.4 mp -116.63 153.57 18.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.024 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' GLU . . . . . 0.436 ' O ' ' N ' ' A' ' 182' ' ' ARG . 0.1 OUTLIER -142.09 110.74 6.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.281 0.562 . . . . 0.0 111.949 -179.052 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.93 127.97 35.37 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.312 178.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' TYR . . . . . 1.592 ' HE2' ' CE1' ' A' ' 233' ' ' TYR . 6.8 p90 -129.3 139.41 51.78 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.349 -178.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.535 0.396 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.881 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 5.3 mmtm . . . . . 0 CA--C 1.529 0.143 0 CA-C-O 120.441 0.162 . . . . 0.0 110.605 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 11.9 t -102.46 137.22 31.26 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.712 0 CA-C-O 121.36 0.6 . . . . 0.0 110.988 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.405 HG12 ' N ' ' A' ' 234' ' ' VAL . 2.7 pp -131.9 6.85 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.245 178.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 171.77 73.91 0.04 OUTLIER Glycine 0 C--N 1.341 0.841 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.125 179.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.445 ' HA ' ' HA ' ' A' ' 231' ' ' GLU . 0.5 OUTLIER -93.04 132.09 37.46 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 122.551 -0.381 . . . . 0.0 110.613 -179.683 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -151.22 172.92 15.08 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 121.377 0.608 . . . . 0.0 112.564 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -121.6 126.21 48.54 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.438 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.481 ' CG1' ' HA ' ' A' ' 226' ' ' GLU . 1.9 p -52.39 131.32 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-O 121.344 0.592 . . . . 0.0 112.309 -179.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . 0.461 ' O ' ' HB3' ' A' ' 226' ' ' GLU . 0.0 OUTLIER -90.47 -60.34 1.95 Allowed 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 105.142 -2.17 . . . . 0.0 105.142 175.444 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.49 -159.88 0.49 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 114.206 -1.361 . . . . 0.0 109.915 174.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.501 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 12.7 p -150.13 148.2 28.68 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.5 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 0.2 OUTLIER -90.72 82.47 5.75 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -177.723 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.6 tttt -86.44 62.29 7.33 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 177.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.415 HG23 ' CD1' ' A' ' 157' ' ' PHE . 54.0 t -91.28 156.08 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 CA-C-N 113.771 -1.559 . . . . 0.0 110.059 -178.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 80.0 p -90.41 34.2 0.88 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.122 0.487 . . . . 0.0 110.161 178.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.75 -32.32 0.17 Allowed 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.471 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 87.4 t -100.17 -102.68 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.15 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -159.28 -101.51 0.17 Allowed Glycine 0 N--CA 1.451 -0.344 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' THR . . . . . 0.411 ' CG2' ' CG2' ' A' ' 224' ' ' ILE . 0.0 OUTLIER -153.5 36.46 0.46 Allowed 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 177.822 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.5 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 0.9 OUTLIER -42.31 95.3 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.26 -179.416 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.501 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . -82.08 118.68 23.22 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 114.495 -1.229 . . . . 0.0 112.482 -178.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -91.22 143.99 16.94 Favored Glycine 0 N--CA 1.442 -0.965 0 N-CA-C 111.001 -0.839 . . . . 0.0 111.001 178.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -137.73 132.95 33.56 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . 1.671 ' HD1' ' CD2' ' A' ' 169' ' ' TYR . 7.4 t80 -85.03 128.16 34.51 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 178.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 44.4 t -85.96 147.79 5.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -176.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.6 p -140.78 14.83 2.31 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-N 114.474 -1.239 . . . . 0.0 111.841 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -150.8 -144.46 0.15 Allowed 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 -179.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -40.15 -104.22 0.01 OUTLIER Glycine 0 CA--C 1.532 1.11 0 N-CA-C 115.209 0.844 . . . . 0.0 115.209 -179.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 20.2 mttp -151.13 134.73 16.33 Favored 'General case' 0 CA--C 1.514 -0.427 0 O-C-N 122.517 -0.402 . . . . 0.0 111.839 -178.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 4.6 mm -91.2 83.87 2.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 176.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 0.0 OUTLIER -98.62 -178.16 3.9 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -176.704 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.59 -45.59 21.33 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-N 114.854 -1.066 . . . . 0.0 111.166 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -88.67 61.39 6.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.393 0.616 . . . . 0.0 110.338 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 16.4 m -149.32 157.74 43.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.986 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -89.06 -178.17 5.62 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 1.9 m -142.71 161.79 18.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.336 0.589 . . . . 0.0 111.845 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . 0.428 ' N ' ' O ' ' A' ' 231' ' ' GLU . 15.1 ttt180 -151.74 98.95 2.54 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.113 -0.948 . . . . 0.0 112.323 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.49 ' CD1' ' HB3' ' A' ' 191' ' ' TYR . 5.4 mp -89.08 146.14 25.02 Favored 'General case' 0 CA--C 1.497 -1.09 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -178.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.419 ' N ' HG23 ' A' ' 190' ' ' VAL . 17.8 mt -156.57 128.18 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-N 113.168 -1.833 . . . . 0.0 111.772 179.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.403 ' N ' ' CG2' ' A' ' 190' ' ' VAL . 0.1 OUTLIER -88.87 -148.44 0.17 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 177.943 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -94.94 29.69 2.32 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 118.604 0.638 . . . . 0.0 110.998 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -153.6 -83.34 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.869 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -111.6 -158.7 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 CA-C-N 115.455 -0.372 . . . . 0.0 110.621 -179.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 43.4 t -87.13 134.85 26.58 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 CA-C-O 121.68 0.752 . . . . 0.0 110.992 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . 0.419 HG23 ' N ' ' A' ' 184' ' ' ILE . 0.2 OUTLIER -94.79 -34.84 5.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 114.416 -1.265 . . . . 0.0 109.525 -179.909 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . 1.656 ' HD1' ' CD2' ' A' ' 191' ' ' TYR . 27.0 t80 -170.1 156.14 5.82 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.102 -0.953 . . . . 0.0 112.446 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -151.13 162.12 41.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.634 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 134.76 -114.88 1.33 Allowed Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.558 -0.829 . . . . 0.0 112.343 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . 0.463 ' CG ' ' N ' ' A' ' 195' ' ' ILE . 0.0 OUTLIER -150.47 -178.43 6.53 Favored 'General case' 0 CA--C 1.503 -0.865 0 CA-C-O 121.323 0.583 . . . . 0.0 110.901 -179.407 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.463 ' N ' ' CG ' ' A' ' 194' ' ' GLU . 0.0 OUTLIER -89.76 154.65 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.921 -179.431 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -89.8 -66.79 0.89 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 178.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -151.63 146.72 26.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.248 179.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.409 ' HA ' ' HB3' ' A' ' 216' ' ' LEU . 2.4 tt -110.96 119.52 39.34 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.519 0.676 . . . . 0.0 112.487 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -151.55 116.52 5.22 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.491 178.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.325 -0.463 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 5.1 t70 . . . . . 0 N--CA 1.453 -0.276 0 CA-C-O 120.96 0.41 . . . . 0.0 110.417 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 34.2 m -66.14 162.39 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.958 0 CA-C-O 121.414 0.626 . . . . 0.0 112.062 -179.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . 0.418 ' O ' ' HA ' ' A' ' 176' ' ' THR . 5.3 mtp180 -89.15 -37.32 15.14 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.565 -178.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -141.38 178.35 7.49 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.27 0.557 . . . . 0.0 111.746 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -151.05 80.59 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.588 179.034 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -96.47 172.02 8.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.072 0.463 . . . . 0.0 112.038 -178.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 84.83 -73.88 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.055 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 177.87 37.34 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.29 -0.957 . . . . 0.0 112.623 179.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . 1.604 ' HD1' ' CD2' ' A' ' 212' ' ' TYR . 2.0 m-85 -99.51 145.23 27.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.939 0.399 . . . . 0.0 111.568 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -89.77 161.38 16.06 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.528 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 27.1 p -150.55 -170.03 3.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.967 0.413 . . . . 0.0 111.209 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -139.74 98.68 0.24 Allowed Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 179.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.409 ' HB3' ' HA ' ' A' ' 198' ' ' LEU . 0.2 OUTLIER -129.3 151.11 50.32 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 121.06 0.457 . . . . 0.0 110.782 -178.997 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.91 141.06 28.88 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 177.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . 0.438 ' HB ' ' CD2' ' A' ' 221' ' ' PHE . 16.6 mm -98.2 74.39 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.77 -178.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 46.43 -136.0 0.8 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.295 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -87.03 58.07 4.86 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 120.793 0.33 . . . . 0.0 111.609 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . 0.486 ' CE1' ' HB2' ' A' ' 191' ' ' TYR . 0.1 OUTLIER -56.25 120.0 6.88 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 178.1 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -80.01 -45.23 18.76 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 176.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . 0.426 ' O ' ' CD1' ' A' ' 221' ' ' PHE . 0.0 OUTLIER -91.35 131.44 36.84 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.761 178.109 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.411 ' CG2' ' CG2' ' A' ' 164' ' ' THR . 0.1 OUTLIER -121.29 177.61 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-O 121.17 0.51 . . . . 0.0 111.929 -179.877 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . 0.473 ' O ' ' N ' ' A' ' 227' ' ' GLY . 2.3 mtpp 62.92 152.32 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.136 -178.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . 0.481 ' HA ' ' CG1' ' A' ' 153' ' ' VAL . 0.4 OUTLIER -38.45 90.14 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 CA-C-O 122.186 0.993 . . . . 0.0 112.258 -179.947 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 225' ' ' LYS . . . -106.45 -39.28 2.1 Favored Glycine 0 N--CA 1.43 -1.741 0 CA-C-N 114.429 -1.26 . . . . 0.0 112.152 -178.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . 0.438 ' O ' ' HB ' ' A' ' 153' ' ' VAL . 2.9 p30 -158.23 -164.85 1.57 Allowed 'General case' 0 C--O 1.22 -0.466 0 N-CA-C 115.292 1.59 . . . . 0.0 115.292 -178.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 89.3 t -102.25 144.66 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 177.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 3.7 mp -114.79 153.61 16.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.217 0.532 . . . . 0.0 112.103 -178.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' GLU . . . . . 0.445 ' HA ' ' HA ' ' A' ' 150' ' ' GLN . 20.3 tt0 -140.85 111.88 7.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.374 0.606 . . . . 0.0 111.476 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.78 128.7 35.32 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.896 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -130.81 142.81 50.41 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.916 -179.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.405 ' N ' HG12 ' A' ' 148' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.111 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 5.9 mmtm . . . . . 0 C--O 1.23 0.078 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 18.9 t -97.39 136.91 26.56 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.631 0 CA-C-O 121.17 0.509 . . . . 0.0 110.527 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 2.7 pp -128.94 6.31 2.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.326 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 171.21 75.43 0.04 OUTLIER Glycine 0 C--N 1.341 0.843 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.003 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.422 ' HA ' ' HA ' ' A' ' 231' ' ' GLU . 0.7 OUTLIER -95.14 130.3 41.9 Favored 'General case' 0 CA--C 1.517 -0.317 0 O-C-N 122.551 -0.382 . . . . 0.0 110.419 -179.826 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.403 ' HA ' ' O ' ' A' ' 169' ' ' TYR . . . -151.04 171.21 17.69 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 120.32 -0.552 . . . . 0.0 112.25 -178.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -119.01 128.0 53.97 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.536 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.499 ' CG1' ' HA ' ' A' ' 226' ' ' GLU . 2.0 p -49.65 142.61 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -178.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -100.77 -63.01 1.17 Allowed 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 104.379 -2.452 . . . . 0.0 104.379 174.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.92 -165.65 1.29 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 113.735 -1.575 . . . . 0.0 109.368 174.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 8.1 p -147.11 163.29 36.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.553 0.216 . . . . 0.0 110.425 177.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.477 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 0.2 OUTLIER -115.48 76.26 0.99 Allowed 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -179.475 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 7.2 tmtm? -86.27 62.97 7.75 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 177.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.421 HG12 ' N ' ' A' ' 160' ' ' SER . 98.3 t -92.94 158.59 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 CA-C-N 113.589 -1.642 . . . . 0.0 110.538 -178.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' SER . . . . . 0.421 ' N ' HG12 ' A' ' 159' ' ' VAL . 19.7 m -93.28 34.57 1.13 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.317 0.58 . . . . 0.0 109.552 177.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -151.49 -34.77 0.14 Allowed 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.164 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 86.0 t -97.65 -102.7 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 N-CA-C 109.703 -0.481 . . . . 0.0 109.703 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -159.46 -102.47 0.18 Allowed Glycine 0 N--CA 1.451 -0.326 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' THR . . . . . 0.432 ' CG2' ' CG2' ' A' ' 224' ' ' ILE . 0.0 OUTLIER -154.21 32.61 0.43 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 113.976 -1.112 . . . . 0.0 108.543 177.611 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.477 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 1.8 mt -42.53 95.42 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.481 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.482 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . -90.45 122.94 33.75 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.82 -1.082 . . . . 0.0 112.052 -179.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' A' ' 153' ' ' VAL . . . -88.29 146.03 19.38 Favored Glycine 0 N--CA 1.44 -1.053 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 178.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -143.76 131.4 21.24 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 117.164 0.482 . . . . 0.0 110.072 -179.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . 1.643 ' HE1' ' CE2' ' A' ' 169' ' ' TYR . 17.2 t80 -86.94 122.39 30.74 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 178.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 38.7 t -85.38 145.17 8.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -176.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 2.0 p -138.19 14.92 2.82 Favored 'General case' 0 N--CA 1.457 -0.113 0 CA-C-N 114.662 -1.154 . . . . 0.0 111.912 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -150.62 -144.36 0.15 Allowed 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -179.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -40.48 -105.52 0.01 OUTLIER Glycine 0 CA--C 1.532 1.103 0 N-CA-C 115.13 0.812 . . . . 0.0 115.13 -178.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 7.1 mttt -151.4 134.85 16.17 Favored 'General case' 0 CA--C 1.514 -0.417 0 O-C-N 122.526 -0.397 . . . . 0.0 111.957 -178.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 6.0 mm -91.81 83.23 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 176.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 0.1 OUTLIER -98.59 176.22 5.73 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.54 0.686 . . . . 0.0 112.415 -177.557 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -71.58 -44.67 64.06 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.969 -1.014 . . . . 0.0 111.386 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -88.99 61.83 6.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.249 0.547 . . . . 0.0 110.756 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 20.3 m -150.09 157.95 43.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.048 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 2.1 mptt -88.68 177.27 6.79 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 2.0 m -141.68 163.71 19.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.399 0.619 . . . . 0.0 111.956 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . 0.43 ' N ' ' O ' ' A' ' 231' ' ' GLU . 7.4 ttt180 -151.51 100.09 2.68 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.037 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.474 ' CD1' ' HB3' ' A' ' 191' ' ' TYR . 5.4 mp -89.2 144.49 26.07 Favored 'General case' 0 CA--C 1.494 -1.184 0 CA-C-O 122.476 1.131 . . . . 0.0 113.868 -178.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.408 ' N ' HG23 ' A' ' 190' ' ' VAL . 18.1 mt -156.65 129.28 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-N 113.007 -1.906 . . . . 0.0 111.754 179.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.413 ' N ' ' CG2' ' A' ' 190' ' ' VAL . 0.1 OUTLIER -88.54 -148.45 0.17 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.028 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -95.46 29.53 2.54 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 118.526 0.603 . . . . 0.0 110.818 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -153.23 -82.39 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.904 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -113.06 -158.26 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 115.519 -0.34 . . . . 0.0 110.704 -179.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 40.0 t -87.08 137.02 21.7 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 CA-C-O 121.741 0.781 . . . . 0.0 111.05 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . 0.414 HG22 ' CB ' ' A' ' 228' ' ' ASP . 0.2 OUTLIER -98.88 -35.78 5.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 114.272 -1.331 . . . . 0.0 109.484 -179.462 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . 1.601 ' HE1' ' CE2' ' A' ' 191' ' ' TYR . 14.7 t80 -169.04 157.72 8.07 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.012 -0.994 . . . . 0.0 112.38 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -151.5 162.06 41.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.748 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 135.38 -116.98 1.62 Allowed Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.169 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 17.0 pt-20 -149.98 -176.3 5.38 Favored 'General case' 0 CA--C 1.497 -1.085 0 CA-C-O 121.336 0.589 . . . . 0.0 111.432 -179.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.484 HD11 HG23 ' A' ' 195' ' ' ILE . 49.1 mt -89.43 146.99 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.352 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.552 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -89.14 -59.87 2.11 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.87 0.366 . . . . 0.0 110.033 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 1.3 m -151.32 159.08 44.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.87 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.54 122.86 34.4 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 121.435 0.636 . . . . 0.0 112.093 -179.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 13.2 mtmm -150.61 118.15 6.11 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.96 179.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 7.5 ttp180 . . . . . 0 C--N 1.324 -0.503 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.309 -179.592 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 9.8 t70 . . . . . 0 N--CA 1.453 -0.287 0 CA-C-O 121.049 0.452 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 32.6 m -57.71 158.62 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.961 0 CA-C-O 121.511 0.672 . . . . 0.0 112.179 -179.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . 0.418 ' O ' ' HA ' ' A' ' 176' ' ' THR . 1.7 ttp180 -89.44 -35.36 16.05 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 114.769 -1.105 . . . . 0.0 112.225 -178.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -140.11 177.55 7.9 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.343 0.592 . . . . 0.0 111.898 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -151.07 77.86 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.167 178.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -98.55 174.35 6.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.168 0.508 . . . . 0.0 112.366 -178.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 81.75 -70.08 0.07 Allowed 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.867 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 178.2 37.23 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 120.431 -0.89 . . . . 0.0 112.248 179.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . 1.655 ' HD2' ' CD1' ' A' ' 212' ' ' TYR . 1.2 m-85 -104.11 140.49 37.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.966 0.412 . . . . 0.0 111.215 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -95.48 148.61 22.3 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.404 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 45.5 t -150.51 146.14 26.42 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.371 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -88.11 112.49 3.89 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.943 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -138.56 143.3 39.36 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 120.864 0.364 . . . . 0.0 111.149 -179.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.48 142.42 30.95 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 177.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . 0.405 ' O ' ' CG2' ' A' ' 218' ' ' ILE . 1.6 mp -106.84 92.36 2.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 -178.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 2.5 tttp 45.77 -146.98 0.13 Allowed 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.511 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 -87.54 62.46 7.11 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-O 120.857 0.36 . . . . 0.0 110.984 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . 0.46 ' CE1' ' HB2' ' A' ' 191' ' ' TYR . 0.1 OUTLIER -54.71 119.86 5.93 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 179.31 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -84.19 -47.6 10.67 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 114.771 -1.104 . . . . 0.0 108.368 176.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 223' ' ' ASP . 0.0 OUTLIER -84.78 130.27 34.7 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 178.026 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.432 ' CG2' ' CG2' ' A' ' 164' ' ' THR . 1.2 pt -126.46 176.48 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -179.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . 0.432 ' O ' ' N ' ' A' ' 227' ' ' GLY . 0.0 OUTLIER 61.12 129.47 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.102 -179.057 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . 0.499 ' HA ' ' CG1' ' A' ' 153' ' ' VAL . 3.6 tt0 -11.67 77.97 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 124.249 1.02 . . . . 0.0 113.341 -179.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 225' ' ' LYS . . . -98.26 -40.16 3.55 Favored Glycine 0 N--CA 1.43 -1.759 0 CA-C-N 114.564 -1.198 . . . . 0.0 112.626 -178.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . 0.431 ' O ' ' HB ' ' A' ' 153' ' ' VAL . 2.7 p30 -159.03 -160.98 0.9 Allowed 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 115.375 1.62 . . . . 0.0 115.375 -177.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 91.9 t -108.3 143.88 17.9 Favored 'Isoleucine or valine' 0 C--N 1.343 0.292 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 177.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 3.7 mp -111.43 153.32 13.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.252 0.548 . . . . 0.0 112.097 -178.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' GLU . . . . . 0.43 ' O ' ' N ' ' A' ' 182' ' ' ARG . 15.1 tt0 -141.05 111.32 6.75 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.437 0.637 . . . . 0.0 111.598 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.34 134.21 33.6 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.412 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' TYR . . . . . 1.657 ' HE1' ' CE2' ' A' ' 233' ' ' TYR . 2.7 p90 -138.58 139.27 38.56 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.081 -178.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.534 0.355 0 CA-C-O 120.938 0.399 . . . . 0.0 111.881 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 6.3 tptt . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.762 0.315 . . . . 0.0 110.776 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 5.8 t -61.0 141.0 17.93 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.683 0 CA-C-O 121.294 0.569 . . . . 0.0 111.181 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.56 -5.65 7.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.871 178.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -174.38 74.41 0.08 OUTLIER Glycine 0 C--N 1.342 0.869 0 N-CA-C 111.683 -0.567 . . . . 0.0 111.683 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.49 136.11 33.22 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.424 ' CB ' ' HB2' ' A' ' 168' ' ' CYS . . . -151.93 173.2 15.12 Favored 'General case' 0 N--CA 1.435 -1.176 0 C-N-CA 120.009 -0.677 . . . . 0.0 112.478 -178.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -122.32 121.1 35.94 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.081 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.451 ' CG1' ' HA ' ' A' ' 226' ' ' GLU . 2.2 p -49.71 132.55 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -178.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -90.17 -61.56 1.66 Allowed 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 104.941 -2.244 . . . . 0.0 104.941 175.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.28 -163.49 0.93 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 113.76 -1.563 . . . . 0.0 109.405 174.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.509 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 6.9 p -145.42 156.97 44.09 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 120.845 0.355 . . . . 0.0 110.079 177.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.63 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 2.4 m-85 -103.98 73.22 1.14 Allowed 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -177.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.95 63.93 8.31 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.418 HG12 ' N ' ' A' ' 160' ' ' SER . 88.2 t -91.4 157.87 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 CA-C-N 113.611 -1.631 . . . . 0.0 110.075 -179.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' SER . . . . . 0.418 ' N ' HG12 ' A' ' 159' ' ' VAL . 3.8 t -92.67 34.4 1.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.145 0.498 . . . . 0.0 109.784 178.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -151.45 -33.03 0.15 Allowed 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.445 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 90.4 t -100.07 -101.95 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.169 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -158.74 -103.69 0.2 Allowed Glycine 0 N--CA 1.451 -0.366 0 N-CA-C 111.706 -0.558 . . . . 0.0 111.706 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' THR . . . . . 0.431 ' CG2' ' CG2' ' A' ' 224' ' ' ILE . 0.0 OUTLIER -153.63 34.82 0.45 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 114.406 -0.897 . . . . 0.0 108.932 178.483 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.63 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 2.9 mm -42.88 95.44 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.496 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.509 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . -86.19 119.17 26.18 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.706 -1.133 . . . . 0.0 111.247 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -87.95 150.63 22.37 Favored Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 178.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . 0.424 ' HB2' ' CB ' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -148.25 136.43 21.19 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 117.364 0.582 . . . . 0.0 111.102 -178.236 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -87.66 129.96 34.96 Favored 'General case' 0 C--O 1.221 -0.402 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 177.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 38.3 t -85.67 145.09 8.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -176.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.2 p -138.25 13.18 2.82 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 114.788 -1.096 . . . . 0.0 112.164 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -149.98 -141.04 0.1 Allowed 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -48.67 -109.59 0.01 OUTLIER Glycine 0 CA--C 1.531 1.033 0 N-CA-C 114.527 0.571 . . . . 0.0 114.527 -179.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 5.6 mtmt -150.59 138.84 20.29 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 122.397 -0.472 . . . . 0.0 110.603 -179.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -94.38 112.29 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 C-N-CA 119.528 -0.869 . . . . 0.0 109.536 177.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.461 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 0.2 OUTLIER -120.36 173.05 7.38 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.654 0.74 . . . . 0.0 112.99 -177.009 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.02 -43.67 86.93 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 114.521 -1.218 . . . . 0.0 109.95 178.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -89.25 56.5 3.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.696 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 5.4 m -150.33 161.39 42.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.86 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 7.6 tptt -89.32 177.62 6.55 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.036 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 1.5 m -146.13 146.9 18.73 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.548 0 CA-C-O 121.347 0.594 . . . . 0.0 111.04 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . 0.46 ' N ' ' O ' ' A' ' 231' ' ' GLU . 5.2 ttm-85 -155.37 99.34 2.05 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.177 -0.92 . . . . 0.0 112.539 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.474 ' HA ' ' HA ' ' A' ' 230' ' ' ILE . 0.3 OUTLIER -97.51 166.59 11.45 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 120.186 -0.606 . . . . 0.0 110.908 179.302 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 4.4 mp -151.87 140.08 14.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.143 -0.48 . . . . 0.0 112.057 -177.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -87.08 -152.67 0.19 Allowed 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.371 -0.832 . . . . 0.0 108.906 178.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -94.64 29.04 2.42 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 118.19 0.45 . . . . 0.0 111.489 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -153.23 -76.12 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.39 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -117.9 -155.86 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 115.373 -0.414 . . . . 0.0 110.216 -179.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 35.1 t -85.95 139.53 17.26 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 CA-C-O 121.573 0.701 . . . . 0.0 110.758 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . 0.416 HG23 ' HG ' ' A' ' 183' ' ' LEU . 0.7 OUTLIER -87.41 -40.76 14.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 114.693 -1.14 . . . . 0.0 108.409 179.898 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . 1.66 ' HD1' ' CD2' ' A' ' 191' ' ' TYR . 0.6 OUTLIER -171.91 150.21 2.56 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.606 -1.179 . . . . 0.0 111.131 179.322 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -135.53 164.45 27.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.081 0.467 . . . . 0.0 111.19 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 135.87 -160.26 24.52 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . 0.411 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 3.3 pt-20 -108.69 -178.1 3.5 Favored 'General case' 0 CA--C 1.498 -1.052 0 CA-C-N 117.656 0.728 . . . . 0.0 110.723 179.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -88.39 148.92 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.881 -177.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -88.92 -54.94 3.9 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -151.47 152.86 33.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.088 179.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.01 103.42 8.8 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.882 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.96 122.72 21.11 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.428 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.323 -0.567 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.096 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 . . . . . 0 N--CA 1.453 -0.316 0 CA-C-O 120.97 0.414 . . . . 0.0 110.37 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 35.5 m -62.29 165.23 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.063 0 CA-C-O 121.538 0.685 . . . . 0.0 112.088 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . 0.461 ' O ' ' HA ' ' A' ' 176' ' ' THR . 1.6 ttm180 -89.18 -41.7 12.09 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-N 114.726 -1.125 . . . . 0.0 111.368 -178.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -136.2 178.6 6.94 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.249 0.547 . . . . 0.0 111.963 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -150.96 94.67 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.701 179.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -118.27 178.09 4.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.215 0.531 . . . . 0.0 112.36 -178.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 80.91 -71.8 0.07 Allowed 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.794 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 178.62 37.31 0.06 OUTLIER Glycine 0 N--CA 1.442 -0.933 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.2 179.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -104.48 139.11 39.87 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.962 0.41 . . . . 0.0 111.089 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.74 150.92 22.09 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.039 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 7.5 t -150.15 146.13 26.71 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.679 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -89.1 115.41 4.47 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.043 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.18 141.48 49.1 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 120.975 0.417 . . . . 0.0 110.742 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 1.6 m -105.67 140.08 39.29 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 177.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . 0.463 ' HB ' ' HB2' ' A' ' 221' ' ' PHE . 18.9 mm -89.19 144.32 9.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 120.449 -0.5 . . . . 0.0 109.747 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.78 -10.74 4.11 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -176.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' ASN . . . . . 0.453 ' O ' ' CE2' ' A' ' 191' ' ' TYR . 58.2 t30 -153.23 21.1 0.56 Allowed 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . 0.463 ' HB2' ' HB ' ' A' ' 218' ' ' ILE . 0.1 OUTLIER -57.95 123.76 16.93 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 -179.681 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -96.59 -47.76 5.8 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 114.347 -1.297 . . . . 0.0 108.367 176.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . 0.456 ' O ' ' CD1' ' A' ' 221' ' ' PHE . 0.0 OUTLIER -75.66 150.25 37.98 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.095 177.422 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.431 ' CG2' ' CG2' ' A' ' 164' ' ' THR . 0.2 OUTLIER -143.14 177.78 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -179.209 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . 0.424 ' O ' ' C ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER 56.56 116.25 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 114.443 -1.253 . . . . 0.0 110.073 -179.046 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . 0.451 ' HA ' ' CG1' ' A' ' 153' ' ' VAL . 3.2 tt0 8.78 63.88 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.523 1.129 . . . . 0.0 113.517 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -61.61 -65.48 3.22 Favored Glycine 0 N--CA 1.432 -1.613 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.4 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -165.38 -147.48 0.1 Allowed 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 114.236 1.199 . . . . 0.0 114.236 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 91.7 t -89.17 135.09 26.75 Favored 'Isoleucine or valine' 0 C--N 1.346 0.437 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . 0.474 ' HA ' ' HA ' ' A' ' 183' ' ' LEU . 2.7 mp -102.93 159.04 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 O-C-N 123.378 0.424 . . . . 0.0 110.859 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' GLU . . . . . 0.46 ' O ' ' N ' ' A' ' 182' ' ' ARG . 5.7 tt0 -149.46 108.43 3.89 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.274 0.559 . . . . 0.0 112.348 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.56 131.67 34.31 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.022 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' TYR . . . . . 1.638 ' HE1' ' CE2' ' A' ' 233' ' ' TYR . 4.6 p90 -134.33 163.46 29.6 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.577 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 1.9 p . . . . . 0 CA--C 1.536 0.412 0 CA-C-O 120.77 0.319 . . . . 0.0 111.489 179.925 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.472 0.649 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.454 HG13 ' HG3' ' A' ' 150' ' ' GLN . 29.1 t -89.45 138.44 19.29 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.732 0 CA-C-O 121.287 0.565 . . . . 0.0 110.193 178.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.42 ' O ' ' O ' ' A' ' 174' ' ' LYS . 3.7 tp -121.5 -14.96 7.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.257 177.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 165.11 88.56 0.07 OUTLIER Glycine 0 C--N 1.345 1.071 0 C-N-CA 120.131 -1.033 . . . . 0.0 112.864 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.454 ' HG3' HG13 ' A' ' 147' ' ' VAL . 3.0 mt-30 -90.05 142.22 27.91 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.416 ' CB ' ' HB2' ' A' ' 168' ' ' CYS . . . -150.93 174.99 12.47 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 120.107 -0.637 . . . . 0.0 112.148 -179.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 229' ' ' VAL . 0.0 OUTLIER -120.42 123.72 43.72 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.054 179.81 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.459 HG12 ' HA ' ' A' ' 226' ' ' GLU . 2.4 p -55.79 127.77 15.14 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 CA-C-O 121.377 0.608 . . . . 0.0 111.522 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . 0.416 ' CA ' ' NE ' ' A' ' 154' ' ' ARG . 0.0 OUTLIER -89.56 -57.49 2.86 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 105.025 -2.213 . . . . 0.0 105.025 176.209 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.76 -163.61 0.9 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.257 -1.338 . . . . 0.0 110.262 174.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.538 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 16.7 p -144.42 158.92 43.51 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 177.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.615 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 2.4 m-85 -99.98 76.08 1.91 Allowed 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -176.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 7.7 tttt -85.93 63.58 8.11 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 122.071 0.938 . . . . 0.0 108.809 178.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 55.0 t -89.89 155.53 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 CA-C-N 113.77 -1.559 . . . . 0.0 109.867 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 3.9 t -90.7 33.58 0.92 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.126 0.489 . . . . 0.0 110.153 178.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 3.6 mttt -151.02 -29.67 0.19 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.712 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 88.2 t -103.19 -101.79 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 O-C-N 122.195 -0.316 . . . . 0.0 110.275 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -158.5 -103.39 0.19 Allowed Glycine 0 N--CA 1.451 -0.363 0 N-CA-C 111.661 -0.576 . . . . 0.0 111.661 179.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' THR . . . . . 0.415 ' CG2' ' CG2' ' A' ' 224' ' ' ILE . 0.0 OUTLIER -153.14 36.24 0.48 Allowed 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 114.362 -0.919 . . . . 0.0 108.968 178.458 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.615 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 4.9 mt -42.55 101.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.925 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.538 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . -83.62 121.88 27.85 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.004 -0.998 . . . . 0.0 112.871 -178.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -89.1 136.08 13.38 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 178.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . 0.416 ' HB2' ' CB ' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -138.14 131.49 30.52 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.898 0.349 . . . . 0.0 110.531 -178.523 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -85.94 126.42 34.09 Favored 'General case' 0 C--O 1.219 -0.502 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 178.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 45.3 t -85.22 145.37 8.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -175.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -133.9 10.52 3.93 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 114.646 -1.161 . . . . 0.0 112.337 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . 0.428 ' O ' ' O ' ' A' ' 173' ' ' GLY . 3.0 t70 -150.12 -145.76 0.18 Allowed 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 118.91 -0.567 . . . . 0.0 109.613 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 172' ' ' ASP . . . -37.68 -108.11 0.0 OUTLIER Glycine 0 CA--C 1.537 1.444 0 N-CA-C 115.338 0.895 . . . . 0.0 115.338 -179.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.42 ' O ' ' O ' ' A' ' 148' ' ' ILE . 1.7 mtmm -151.51 135.52 16.58 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 122.311 -0.523 . . . . 0.0 111.84 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 2.6 mm -88.44 86.9 2.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 177.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 0.0 OUTLIER -98.26 170.41 8.9 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.17 -177.767 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -69.02 -39.41 79.26 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.269 179.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -89.29 51.85 2.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.97 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -142.94 159.49 42.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.75 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 2.8 mptp? -89.6 177.71 6.47 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 2.8 m -149.43 148.69 15.4 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.509 0 CA-C-O 121.535 0.683 . . . . 0.0 112.237 179.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 231' ' ' GLU . 23.0 ttp180 -153.83 102.45 2.52 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.671 -1.15 . . . . 0.0 111.678 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.472 ' HA ' ' O ' ' A' ' 229' ' ' VAL . 0.3 OUTLIER -98.16 169.13 9.81 Favored 'General case' 0 N--CA 1.438 -1.064 0 C-N-CA 120.564 -0.455 . . . . 0.0 111.246 179.869 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 4.0 mp -151.01 139.83 14.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.048 -178.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.406 ' N ' HG21 ' A' ' 190' ' ' VAL . 0.0 OUTLIER -88.04 -150.73 0.18 Allowed 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.156 -0.929 . . . . 0.0 108.749 178.241 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -94.72 27.75 2.94 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 118.461 0.573 . . . . 0.0 111.454 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -153.11 -77.78 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.688 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -116.69 -154.34 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-N 115.514 -0.343 . . . . 0.0 110.43 -179.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 23.0 t -85.67 138.45 19.05 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 CA-C-O 121.517 0.675 . . . . 0.0 110.803 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . 0.436 HG23 ' HG ' ' A' ' 183' ' ' LEU . 0.7 OUTLIER -87.86 -39.24 12.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 114.739 -1.119 . . . . 0.0 109.0 -179.86 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . 1.601 ' HD1' ' CD2' ' A' ' 191' ' ' TYR . 1.0 OUTLIER -172.17 157.67 4.32 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.63 -1.168 . . . . 0.0 110.411 -179.935 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -144.79 157.16 44.28 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.205 0.526 . . . . 0.0 111.182 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 148.9 -129.82 3.19 Favored Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.524 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . 0.417 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 12.7 pt-20 -138.97 -175.78 4.27 Favored 'General case' 0 CA--C 1.497 -1.061 0 CA-C-O 121.292 0.567 . . . . 0.0 111.584 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 3.0 mp -88.13 143.35 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.379 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.405 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.02 -56.92 3.09 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 3.0 m -151.61 150.54 30.4 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.942 179.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.3 tt -120.56 111.56 17.82 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 121.379 0.609 . . . . 0.0 111.169 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 62.2 mttt -150.62 122.55 8.17 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.286 179.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.602 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.509 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 . . . . . 0 N--CA 1.454 -0.27 0 CA-C-O 120.725 0.298 . . . . 0.0 110.652 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 33.9 m -82.87 163.82 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.916 0 CA-C-O 121.481 0.658 . . . . 0.0 112.152 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . 0.419 ' O ' ' HA ' ' A' ' 176' ' ' THR . 0.2 OUTLIER -89.11 -36.79 15.53 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.939 -178.53 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -141.73 -178.08 5.49 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.343 0.592 . . . . 0.0 111.993 -179.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -151.08 91.73 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.681 178.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -112.89 165.87 11.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.022 0.439 . . . . 0.0 112.028 -179.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 34.1 tp60 82.26 -69.36 0.07 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.035 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 178.41 37.78 0.06 OUTLIER Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.355 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -97.45 136.05 38.45 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.863 0.363 . . . . 0.0 111.199 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -91.54 146.48 23.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.349 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 1.8 m -150.95 142.7 23.74 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.532 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -89.64 103.77 3.04 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.608 -0.806 . . . . 0.0 111.978 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.86 143.16 50.83 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.078 0.466 . . . . 0.0 111.467 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 1.2 m -83.93 143.49 29.81 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 177.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . 0.402 ' O ' ' CG2' ' A' ' 218' ' ' ILE . 1.5 mp -106.16 92.09 2.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.943 0.401 . . . . 0.0 110.247 -178.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 4.3 tttp 45.06 -144.24 0.17 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.894 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -87.18 61.33 6.66 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 121.024 0.44 . . . . 0.0 110.817 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . 0.455 ' CE1' ' HB2' ' A' ' 191' ' ' TYR . 0.1 OUTLIER -55.92 120.62 7.7 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 114.722 1.379 . . . . 0.0 114.722 179.128 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 21.4 t30 -82.32 -48.55 11.05 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 114.815 -1.084 . . . . 0.0 108.346 176.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . 0.439 ' O ' ' CD1' ' A' ' 221' ' ' PHE . 0.0 OUTLIER -82.01 137.88 35.0 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 177.668 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.426 ' CD1' ' N ' ' A' ' 224' ' ' ILE . 0.2 OUTLIER -133.85 179.13 4.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -178.951 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . 0.417 ' N ' ' OG1' ' A' ' 156' ' ' THR . 0.1 OUTLIER 57.09 117.28 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.107 -179.114 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . 0.459 ' HA ' HG12 ' A' ' 153' ' ' VAL . 38.9 tt0 7.71 63.28 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 124.484 1.114 . . . . 0.0 113.758 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -63.49 -66.43 2.54 Favored Glycine 0 N--CA 1.431 -1.655 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.932 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -164.17 -150.2 0.14 Allowed 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 69.2 t -88.49 130.68 37.59 Favored 'Isoleucine or valine' 0 C--N 1.345 0.38 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.208 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . 0.459 ' HA ' ' CB ' ' A' ' 183' ' ' LEU . 5.1 mp -100.37 157.72 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 O-C-N 123.618 0.574 . . . . 0.0 110.961 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' GLU . . . . . 0.44 ' O ' ' N ' ' A' ' 182' ' ' ARG . 33.6 tt0 -146.94 112.32 5.55 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 120.246 -0.582 . . . . 0.0 112.427 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.18 133.91 33.91 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.008 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' TYR . . . . . 1.648 ' HE1' ' CE2' ' A' ' 233' ' ' TYR . 2.9 p90 -136.04 120.3 17.88 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.803 -178.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.405 ' CG2' ' O ' ' A' ' 233' ' ' TYR . 62.6 t . . . . . 0 N--CA 1.464 0.229 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.863 179.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? . . . . . 0 CA--C 1.529 0.169 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 6.7 t -99.5 140.71 18.23 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.758 0 CA-C-O 121.245 0.545 . . . . 0.0 110.699 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.416 ' O ' ' O ' ' A' ' 174' ' ' LYS . 0.0 OUTLIER -131.33 -2.32 2.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.009 178.784 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -178.43 73.59 0.07 OUTLIER Glycine 0 C--N 1.342 0.889 0 C-N-CA 120.81 -0.71 . . . . 0.0 111.931 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.411 ' CG ' ' CG ' ' A' ' 231' ' ' GLU . 0.4 OUTLIER -91.67 134.77 34.41 Favored 'General case' 0 CA--C 1.505 -0.769 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.749 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -151.62 175.03 12.76 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-O 121.52 0.676 . . . . 0.0 112.511 -178.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -120.37 127.02 51.91 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.107 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.489 HG12 ' HA ' ' A' ' 226' ' ' GLU . 2.6 p -57.68 128.22 17.92 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.354 0 CA-C-O 121.643 0.735 . . . . 0.0 111.887 -179.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . 0.404 ' CA ' ' NE ' ' A' ' 154' ' ' ARG . 0.0 OUTLIER -90.17 -57.25 2.91 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 104.789 -2.3 . . . . 0.0 104.789 175.617 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.3 -166.16 1.2 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.094 -1.412 . . . . 0.0 110.363 174.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.495 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 18.8 p -151.17 149.88 29.97 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.191 177.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.579 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 5.8 m-30 -94.83 72.11 3.51 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -178.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? -86.48 61.4 6.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.894 0.854 . . . . 0.0 108.924 178.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.44 HG12 ' N ' ' A' ' 160' ' ' SER . 49.0 t -89.77 155.59 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-N 114.095 -1.411 . . . . 0.0 109.789 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' SER . . . . . 0.44 ' N ' HG12 ' A' ' 159' ' ' VAL . 0.3 OUTLIER -89.75 22.01 3.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.905 0.383 . . . . 0.0 111.177 178.741 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 6.5 mttt -150.9 6.98 0.53 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.982 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 58.4 t -130.81 -99.6 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 CA-C-N 118.374 0.534 . . . . 0.0 110.017 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -158.46 -112.76 0.34 Allowed Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' THR . . . . . 0.426 ' CG2' ' CG2' ' A' ' 224' ' ' ILE . 0.0 OUTLIER -153.7 32.08 0.45 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.401 -0.899 . . . . 0.0 109.18 178.173 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.579 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 1.9 mm -41.09 94.32 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.473 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.495 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . -86.48 113.93 22.81 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.689 -1.141 . . . . 0.0 111.993 -179.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -88.3 126.38 8.08 Favored Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 178.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -129.79 134.48 47.6 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.83 0.315 . . . . 0.0 110.471 -178.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . 1.634 ' HE1' ' CE2' ' A' ' 169' ' ' TYR . 15.0 t80 -86.27 130.34 34.55 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.081 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 42.3 t -85.78 148.57 4.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 113.404 0.891 . . . . 0.0 113.404 -175.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -141.87 15.79 2.12 Favored 'General case' 0 CA--C 1.527 0.076 0 CA-C-N 114.562 -1.199 . . . . 0.0 111.898 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -150.24 -142.64 0.12 Allowed 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -45.73 -109.89 0.01 OUTLIER Glycine 0 CA--C 1.533 1.193 0 N-CA-C 115.009 0.764 . . . . 0.0 115.009 -178.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.416 ' O ' ' O ' ' A' ' 148' ' ' ILE . 3.8 mttm -151.13 127.01 10.32 Favored 'General case' 0 CA--C 1.512 -0.496 0 O-C-N 122.451 -0.441 . . . . 0.0 111.107 -178.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -89.03 113.85 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 C-N-CA 119.199 -1.0 . . . . 0.0 109.431 177.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.422 ' HB ' ' O ' ' A' ' 206' ' ' ARG . 0.1 OUTLIER -124.97 169.26 12.27 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.95 -177.376 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.34 -38.74 88.01 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.299 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -89.28 52.74 2.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.156 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 29.4 m -150.46 157.04 42.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.341 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 0.0 OUTLIER -89.35 176.78 6.79 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.553 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 2.5 m -145.65 149.21 16.7 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.579 0 CA-C-O 121.473 0.654 . . . . 0.0 112.203 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . 0.436 ' N ' ' O ' ' A' ' 231' ' ' GLU . 26.8 ttm180 -154.36 102.34 2.43 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.851 -1.068 . . . . 0.0 112.236 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.515 ' CB ' ' HA ' ' A' ' 230' ' ' ILE . 0.3 OUTLIER -99.61 170.67 8.42 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-O 120.932 0.396 . . . . 0.0 110.649 179.363 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.429 ' O ' ' HB3' ' A' ' 228' ' ' ASP . 36.5 mt -155.5 139.94 9.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.855 -178.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.405 ' N ' HG21 ' A' ' 184' ' ' ILE . 6.9 ttm-85 -87.33 -152.64 0.2 Allowed 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.9 178.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 18.7 mp0 -94.69 28.67 2.57 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 118.141 0.428 . . . . 0.0 111.32 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -152.72 -79.14 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.487 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -114.4 -157.22 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 115.536 -0.332 . . . . 0.0 110.227 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 22.3 t -86.22 139.54 17.22 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 CA-C-O 121.457 0.646 . . . . 0.0 110.739 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . 0.461 HG23 ' HG ' ' A' ' 183' ' ' LEU . 0.4 OUTLIER -87.89 -35.53 8.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.13 -179.93 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . 1.671 ' HE1' ' CE2' ' A' ' 191' ' ' TYR . 22.5 t80 -178.54 146.4 0.36 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.901 179.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -135.46 158.08 45.27 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.015 0.436 . . . . 0.0 110.858 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 147.23 -124.6 1.98 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.736 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 13.7 pt-20 -144.15 -174.95 4.43 Favored 'General case' 0 CA--C 1.497 -1.087 0 CA-C-O 121.202 0.525 . . . . 0.0 111.437 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 3.8 mp -87.72 142.92 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.602 -179.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.03 -52.37 5.12 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 1.2 m -151.47 145.62 25.33 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.724 178.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 4.5 tt -124.06 114.15 19.34 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.394 0.616 . . . . 0.0 111.613 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 56.6 mttt -150.17 121.19 7.69 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.096 -0.957 . . . . 0.0 109.86 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.323 -0.573 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.285 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 22.0 p30 . . . . . 0 N--CA 1.451 -0.401 0 CA-C-O 121.088 0.471 . . . . 0.0 110.043 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 33.9 m -55.12 164.02 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.04 0 CA-C-O 121.47 0.652 . . . . 0.0 112.304 -179.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . 0.422 ' O ' ' HB ' ' A' ' 176' ' ' THR . 1.6 mtm180 -89.44 -41.34 12.14 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-N 114.715 -1.13 . . . . 0.0 111.34 -178.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -129.72 -178.59 4.76 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.458 0.647 . . . . 0.0 112.37 -179.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -151.17 81.44 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.269 178.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -100.76 171.79 7.47 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -178.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 8.9 tm0? 83.49 -72.67 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.016 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 177.93 37.18 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.345 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -98.21 141.61 30.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.925 0.393 . . . . 0.0 111.303 -179.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.5 131.15 43.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.339 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 52.5 t -133.17 143.96 49.56 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.676 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -88.5 109.62 3.56 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.978 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -135.75 141.77 44.88 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 120.924 0.393 . . . . 0.0 111.478 -179.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.43 146.97 36.22 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 177.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . 0.412 ' O ' ' CG2' ' A' ' 218' ' ' ILE . 1.6 mp -112.61 87.83 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.144 0.497 . . . . 0.0 109.755 -179.126 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 6.5 tttp 46.71 -144.85 0.26 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.759 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -87.33 61.09 6.45 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 121.009 0.433 . . . . 0.0 111.135 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . 0.458 ' CE1' ' HB2' ' A' ' 191' ' ' TYR . 0.1 OUTLIER -55.49 121.42 8.97 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 178.973 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 14.4 t30 -88.63 -45.15 10.08 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.483 176.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 223' ' ' ASP . 0.0 OUTLIER -81.72 134.7 35.48 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.215 177.604 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.426 ' CG2' ' CG2' ' A' ' 164' ' ' THR . 0.2 OUTLIER -133.82 -179.64 3.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -179.067 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . 0.422 ' O ' ' C ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER 57.07 114.33 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.698 -178.367 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . 0.489 ' HA ' HG12 ' A' ' 153' ' ' VAL . 3.0 tt0 8.66 64.22 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 124.633 1.173 . . . . 0.0 113.555 -179.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -61.48 -66.86 2.39 Favored Glycine 0 N--CA 1.432 -1.59 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.468 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . 0.429 ' HB3' ' O ' ' A' ' 184' ' ' ILE . 0.9 OUTLIER -164.9 -147.99 0.11 Allowed 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 179.435 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . 0.453 ' O ' ' HB2' ' A' ' 183' ' ' LEU . 98.4 t -89.24 132.16 34.69 Favored 'Isoleucine or valine' 0 C--N 1.347 0.462 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . 0.515 ' HA ' ' CB ' ' A' ' 183' ' ' LEU . 4.5 mp -99.2 157.23 3.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 O-C-N 123.499 0.499 . . . . 0.0 111.196 -179.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' GLU . . . . . 0.436 ' O ' ' N ' ' A' ' 182' ' ' ARG . 1.9 tm-20 -147.63 110.24 4.68 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 120.159 -0.616 . . . . 0.0 112.633 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.8 134.39 33.69 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.472 178.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' TYR . . . . . 1.6 ' HE2' ' CE1' ' A' ' 233' ' ' TYR . 6.3 p90 -131.58 147.07 52.5 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.935 0.398 . . . . 0.0 111.703 -179.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.536 0.41 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.417 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 1.1 tptp . . . . . 0 CA--C 1.53 0.181 0 N-CA-C 110.529 -0.174 . . . . 0.0 110.529 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 5.8 t -58.62 142.42 14.32 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 CA-C-O 121.333 0.587 . . . . 0.0 111.381 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 11.6 mm -134.41 13.16 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.57 178.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 175.46 65.68 0.06 OUTLIER Glycine 0 C--N 1.343 0.945 0 C-N-CA 121.329 -0.462 . . . . 0.0 112.181 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.61 131.19 35.74 Favored 'General case' 0 CA--C 1.507 -0.679 0 O-C-N 122.506 -0.408 . . . . 0.0 110.481 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.403 ' HA ' ' O ' ' A' ' 169' ' ' TYR . . . -152.18 174.21 14.02 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-O 121.42 0.629 . . . . 0.0 112.448 -178.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.415 ' HA ' ' HA ' ' A' ' 229' ' ' VAL . 7.2 mt-10 -120.63 121.73 38.97 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.487 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.495 HG12 ' HA ' ' A' ' 226' ' ' GLU . 3.1 p -51.45 131.07 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -90.07 -59.27 2.24 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 175.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.416 ' HA ' ' H ' ' A' ' 226' ' ' GLU . 0.3 OUTLIER -162.3 -164.32 1.03 Allowed 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 113.75 -1.568 . . . . 0.0 109.751 175.449 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.491 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 7.0 p -150.47 162.51 40.45 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 177.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.484 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 0.2 OUTLIER -115.53 78.41 1.17 Allowed 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -179.123 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 8.6 tttm -86.47 62.57 7.5 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 177.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 71.3 t -93.04 156.19 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 CA-C-N 113.606 -1.633 . . . . 0.0 110.488 -178.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 46.0 p -91.29 34.64 0.94 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.234 0.54 . . . . 0.0 109.71 178.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.76 -32.92 0.17 Allowed 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.206 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 84.3 t -100.67 -103.05 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -159.35 -101.19 0.17 Allowed Glycine 0 N--CA 1.451 -0.353 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 178.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' THR . . . . . 0.437 ' CG2' ' CG2' ' A' ' 224' ' ' ILE . 0.0 OUTLIER -154.14 33.94 0.43 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 114.115 -1.042 . . . . 0.0 108.51 177.812 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.484 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 1.5 mp -42.91 95.26 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.522 -179.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.491 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . -89.93 120.51 31.21 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.722 -1.126 . . . . 0.0 112.179 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -88.15 148.0 20.55 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 178.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -147.73 134.64 20.19 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 117.366 0.583 . . . . 0.0 110.694 -178.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . 0.403 ' O ' ' HA ' ' A' ' 151' ' ' ALA . 78.4 t80 -86.53 124.47 32.87 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 177.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 22.7 t -85.42 144.3 9.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 113.14 0.792 . . . . 0.0 113.14 -176.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.1 p -137.2 14.17 3.04 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 114.779 -1.1 . . . . 0.0 112.078 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -150.56 -144.68 0.16 Allowed 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -40.27 -105.0 0.01 OUTLIER Glycine 0 CA--C 1.533 1.16 0 N-CA-C 115.264 0.865 . . . . 0.0 115.264 -178.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.406 ' HB2' ' HB3' ' A' ' 207' ' ' GLU . 0.0 OUTLIER -150.93 150.9 31.39 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.061 0.458 . . . . 0.0 111.442 -178.416 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 16.1 mm -103.67 82.72 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 176.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 0.0 OUTLIER -95.58 172.89 7.78 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.78 1.029 . . . . 0.0 113.78 -176.569 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 7.8 ttp180 -69.42 -48.68 60.28 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 114.1 -1.409 . . . . 0.0 110.792 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -89.45 61.61 5.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.28 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 1.8 m -148.3 157.62 43.6 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.343 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 1.1 mptt -88.56 173.7 8.5 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 2.9 m -142.49 150.35 18.54 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.568 0 CA-C-O 121.483 0.659 . . . . 0.0 112.595 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . 0.421 ' N ' ' O ' ' A' ' 231' ' ' GLU . 43.5 ttp180 -154.83 102.09 2.33 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.847 -1.069 . . . . 0.0 112.479 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.511 ' CB ' ' HA ' ' A' ' 230' ' ' ILE . 0.3 OUTLIER -100.56 170.57 8.29 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 120.426 -0.51 . . . . 0.0 111.004 179.235 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.406 ' O ' ' HB3' ' A' ' 228' ' ' ASP . 26.6 mt -154.18 140.15 11.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -178.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -87.17 -154.18 0.24 Allowed 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.012 -0.995 . . . . 0.0 108.774 178.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -94.7 28.74 2.54 Favored 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 122.02 -0.425 . . . . 0.0 111.184 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -152.98 -75.81 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.45 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -117.75 -156.75 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 115.441 -0.379 . . . . 0.0 110.296 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.402 ' CG1' ' HG3' ' A' ' 192' ' ' GLU . 21.3 t -86.48 139.49 17.28 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.393 0 CA-C-O 121.399 0.619 . . . . 0.0 110.916 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . 0.469 HG23 ' HG ' ' A' ' 183' ' ' LEU . 0.3 OUTLIER -88.58 -35.84 8.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.468 -179.841 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . 1.652 ' HD1' ' CD2' ' A' ' 191' ' ' TYR . 31.1 t80 -178.34 144.31 0.3 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.997 179.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . 0.402 ' HG3' ' CG1' ' A' ' 189' ' ' VAL . 0.3 OUTLIER -131.87 159.03 39.77 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.937 0.398 . . . . 0.0 110.801 179.293 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 146.16 -126.05 2.41 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.852 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . 0.451 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 11.0 pt-20 -143.07 -176.37 4.89 Favored 'General case' 0 CA--C 1.499 -1.011 0 CA-C-O 121.289 0.566 . . . . 0.0 111.667 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 12.3 mm -87.42 143.41 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.485 -179.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.78 -57.1 3.03 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 1.2 m -151.59 152.94 33.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.282 178.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -134.87 119.05 17.62 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.694 0.759 . . . . 0.0 112.014 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.28 125.31 9.94 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 114.445 -1.252 . . . . 0.0 109.431 178.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 1.2 ptp85 . . . . . 0 C--N 1.316 -0.859 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.244 -179.661 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 . . . . . 0 N--CA 1.452 -0.35 0 CA-C-O 121.243 0.544 . . . . 0.0 110.066 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 35.3 m -56.55 158.16 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.962 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.796 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . 0.474 ' O ' ' HA ' ' A' ' 176' ' ' THR . 2.5 ttp-105 -89.07 -27.82 20.54 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.716 -178.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.406 ' HB3' ' HB2' ' A' ' 174' ' ' LYS . 1.5 mp0 -139.99 178.36 7.32 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.092 0.472 . . . . 0.0 111.162 179.15 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -151.02 75.74 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.854 179.121 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -97.27 175.18 6.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.081 0.467 . . . . 0.0 112.223 -178.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 83.88 -75.46 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.858 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 178.26 36.89 0.06 OUTLIER Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.372 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -98.32 144.06 28.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.901 0.382 . . . . 0.0 111.171 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.62 131.32 44.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.021 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 50.8 t -134.22 149.86 51.01 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.753 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -88.99 116.54 4.69 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.568 -0.825 . . . . 0.0 111.621 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -143.68 145.65 32.61 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 121.113 0.482 . . . . 0.0 111.386 -178.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.44 146.48 26.41 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . 0.42 ' O ' ' CG2' ' A' ' 218' ' ' ILE . 1.6 mp -110.36 87.91 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 1.4 tttt 45.93 -144.44 0.23 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.018 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -87.17 62.03 7.06 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 121.097 0.475 . . . . 0.0 111.016 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . 0.45 ' CE1' ' HB2' ' A' ' 191' ' ' TYR . 0.1 OUTLIER -55.59 122.23 10.86 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 114.423 1.268 . . . . 0.0 114.423 179.034 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -87.92 -45.69 10.03 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 114.899 -1.046 . . . . 0.0 108.422 176.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . 0.454 ' OD1' ' N ' ' A' ' 223' ' ' ASP . 0.0 OUTLIER -81.65 135.14 35.54 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.994 177.588 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.437 ' CG2' ' CG2' ' A' ' 164' ' ' THR . 0.2 OUTLIER -134.67 179.65 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.718 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . 0.411 ' O ' ' C ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER 57.33 114.44 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 114.479 -1.237 . . . . 0.0 110.052 -178.96 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . 0.495 ' HA ' HG12 ' A' ' 153' ' ' VAL . 5.2 tm-20 11.41 61.1 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 124.671 1.232 . . . . 0.0 112.919 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -60.19 -68.02 1.88 Allowed Glycine 0 N--CA 1.433 -1.541 0 CA-C-N 114.695 -1.139 . . . . 0.0 111.736 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . 0.406 ' HB3' ' O ' ' A' ' 184' ' ' ILE . 0.8 OUTLIER -164.8 -148.93 0.12 Allowed 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 179.631 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 92.1 t -88.44 129.61 39.32 Favored 'Isoleucine or valine' 0 C--N 1.346 0.453 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.517 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . 0.511 ' HA ' ' CB ' ' A' ' 183' ' ' LEU . 17.4 mt -98.94 157.17 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 O-C-N 123.689 0.618 . . . . 0.0 111.564 -179.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' GLU . . . . . 0.421 ' O ' ' N ' ' A' ' 182' ' ' ARG . 0.0 OUTLIER -146.46 109.97 4.82 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -179.673 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.96 131.14 35.29 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.397 178.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' TYR . . . . . 1.618 ' HD1' ' CD2' ' A' ' 233' ' ' TYR . 11.8 p90 -128.95 142.83 50.8 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.724 0.297 . . . . 0.0 110.962 -179.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.536 0.431 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.607 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 17.4 tptt . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.584 0.23 . . . . 0.0 111.099 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 13.6 t -122.64 142.73 38.03 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.555 0 CA-C-O 121.507 0.67 . . . . 0.0 111.706 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.423 ' O ' ' O ' ' A' ' 174' ' ' LYS . 3.9 tp -118.01 -20.05 5.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.084 178.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -178.02 85.17 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.445 -179.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.72 132.98 37.56 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.419 ' CB ' ' HB2' ' A' ' 168' ' ' CYS . . . -152.14 175.88 12.12 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 119.736 -0.786 . . . . 0.0 113.059 -177.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.406 ' HA ' ' HA ' ' A' ' 229' ' ' VAL . 13.1 mt-10 -120.47 124.09 44.56 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.445 -1.252 . . . . 0.0 110.046 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.446 ' CG1' ' HA ' ' A' ' 226' ' ' GLU . 3.6 p -50.52 134.46 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -178.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -89.46 -61.35 1.72 Allowed 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 175.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.411 ' HA ' ' H ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER -161.13 -160.46 0.73 Allowed 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 113.711 -1.586 . . . . 0.0 109.651 175.595 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.452 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 4.3 p -147.99 168.24 22.83 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 177.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.624 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 6.4 m-85 -118.11 75.58 1.02 Allowed 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -178.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.05 63.28 7.94 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 122.121 0.962 . . . . 0.0 108.481 178.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.424 HG12 ' N ' ' A' ' 160' ' ' SER . 83.9 t -90.9 157.75 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 CA-C-N 113.709 -1.587 . . . . 0.0 110.229 -178.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' SER . . . . . 0.424 ' N ' HG12 ' A' ' 159' ' ' VAL . 1.2 m -92.5 34.57 1.05 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.217 0.532 . . . . 0.0 109.849 178.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 9.8 mttt -151.67 -32.97 0.15 Allowed 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.442 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 84.0 t -99.83 -103.21 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.278 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -159.12 -101.56 0.17 Allowed Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 111.481 -0.648 . . . . 0.0 111.481 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' THR . . . . . 0.402 ' CG2' ' CG2' ' A' ' 224' ' ' ILE . 0.0 OUTLIER -153.83 36.18 0.44 Allowed 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 114.152 -1.024 . . . . 0.0 108.49 178.25 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.624 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 3.8 mt -42.14 98.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.441 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.452 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . -91.71 121.05 33.0 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.006 -0.997 . . . . 0.0 112.298 -179.057 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -88.73 150.96 22.01 Favored Glycine 0 N--CA 1.441 -0.969 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 178.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . 0.419 ' HB2' ' CB ' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -145.92 136.05 23.74 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 117.377 0.588 . . . . 0.0 110.776 -178.409 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . 1.644 ' HE1' ' CE2' ' A' ' 169' ' ' TYR . 31.4 t80 -87.2 123.56 32.36 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 177.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 38.8 t -85.13 148.08 5.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -175.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -138.86 16.86 2.67 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-N 114.298 -1.319 . . . . 0.0 111.81 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -150.19 -147.42 0.23 Allowed 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -179.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -44.39 -104.47 0.01 OUTLIER Glycine 0 CA--C 1.53 1.025 0 N-CA-C 114.685 0.634 . . . . 0.0 114.685 -179.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.423 ' O ' ' O ' ' A' ' 148' ' ' ILE . 0.0 OUTLIER -151.1 126.61 10.11 Favored 'General case' 0 CA--C 1.513 -0.449 0 O-C-N 122.608 -0.348 . . . . 0.0 111.458 -179.04 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 1.5 tp -88.82 83.76 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 CA-C-O 122.035 0.922 . . . . 0.0 109.238 177.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.18 -177.91 5.53 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.384 -1.28 . . . . 0.0 112.932 -177.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 37.7 mtm180 -74.71 -44.11 51.71 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 114.669 -1.151 . . . . 0.0 110.839 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -89.04 57.68 4.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.75 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 3.3 m -148.22 163.33 37.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.401 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 2.7 mptm? -93.77 176.48 6.34 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.104 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.418 ' HA ' ' HA ' ' A' ' 232' ' ' ALA . 1.1 m -151.14 149.99 13.69 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.476 0 CA-C-O 121.598 0.713 . . . . 0.0 111.952 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . 0.449 ' N ' ' O ' ' A' ' 231' ' ' GLU . 41.3 ttp180 -153.39 104.36 2.75 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.108 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.485 ' HB2' ' O ' ' A' ' 229' ' ' VAL . 0.3 OUTLIER -99.49 170.88 8.31 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-O 120.976 0.417 . . . . 0.0 111.008 -179.75 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.428 ' O ' ' HB3' ' A' ' 228' ' ' ASP . 48.4 mt -152.92 141.64 14.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.194 -177.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.412 ' N ' HG21 ' A' ' 190' ' ' VAL . 7.1 ttp180 -86.49 -157.38 0.35 Allowed 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -94.17 27.14 2.97 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.724 178.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -154.25 -43.59 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.862 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.434 ' CG2' ' N ' ' A' ' 189' ' ' VAL . 0.4 OUTLIER -150.24 -160.52 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -178.098 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.434 ' N ' ' CG2' ' A' ' 188' ' ' ILE . 35.5 t -85.41 134.98 25.87 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.397 0 CA-C-O 121.439 0.638 . . . . 0.0 110.386 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . 0.453 ' HB ' HD12 ' A' ' 183' ' ' LEU . 0.2 OUTLIER -88.79 -32.54 5.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.619 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . 1.647 ' HE1' ' CE2' ' A' ' 191' ' ' TYR . 79.8 t80 179.9 158.41 0.72 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.673 178.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -143.87 154.28 43.21 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.969 0.414 . . . . 0.0 110.443 178.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 148.5 -129.33 3.08 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.843 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . 0.449 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 13.3 pt-20 -139.38 -174.38 3.86 Favored 'General case' 0 CA--C 1.498 -1.039 0 CA-C-O 121.27 0.557 . . . . 0.0 111.393 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 4.2 mp -88.0 143.84 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.009 -178.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -89.24 -53.29 4.63 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 18.3 p -151.2 143.22 23.95 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.308 178.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -119.67 114.42 22.16 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.329 0.585 . . . . 0.0 111.681 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 26.9 tttt -150.48 122.15 8.04 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.137 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.323 -0.563 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.968 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 4.4 t70 . . . . . 0 N--CA 1.453 -0.292 0 CA-C-O 120.959 0.409 . . . . 0.0 110.189 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 32.9 m -61.07 160.06 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 CA-C-O 121.521 0.677 . . . . 0.0 112.242 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -89.43 -36.74 15.28 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 114.735 -1.121 . . . . 0.0 111.607 -178.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -137.53 177.23 8.02 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.301 0.572 . . . . 0.0 111.895 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.86 82.64 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.074 -0.967 . . . . 0.0 109.46 179.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -101.5 171.67 7.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.093 0.473 . . . . 0.0 112.182 -178.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 83.22 -72.55 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.998 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 178.0 37.89 0.06 OUTLIER Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.404 179.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -98.09 142.93 29.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.95 0.405 . . . . 0.0 111.565 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.67 160.71 16.47 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.482 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -150.41 -164.97 2.14 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.863 0.363 . . . . 0.0 111.04 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -148.64 96.23 0.17 Allowed Glycine 0 N--CA 1.451 -0.316 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 179.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -131.17 143.6 50.73 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -177.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.0 143.79 37.25 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 176.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 1.6 mp -108.26 88.14 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.709 -178.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 9.8 tttt 47.16 -141.91 0.44 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.663 179.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -86.42 55.73 3.68 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.091 0.472 . . . . 0.0 110.99 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . 0.522 ' CE1' ' CB ' ' A' ' 191' ' ' TYR . 0.1 OUTLIER -57.51 132.0 51.85 Favored 'General case' 0 C--N 1.339 0.126 0 N-CA-C 116.086 1.884 . . . . 0.0 116.086 178.964 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.42 -42.3 8.55 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 114.35 -1.296 . . . . 0.0 108.658 175.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . 0.518 ' HB3' ' CE1' ' A' ' 221' ' ' PHE . 0.0 OUTLIER -64.96 164.12 13.27 Favored 'General case' 0 C--N 1.351 0.65 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.794 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.402 ' CG2' ' CG2' ' A' ' 164' ' ' THR . 0.2 OUTLIER -155.36 -177.11 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 114.897 -1.047 . . . . 0.0 111.988 176.39 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 34.12 103.92 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.752 1.221 . . . . 0.0 112.345 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . 0.446 ' HA ' ' CG1' ' A' ' 153' ' ' VAL . 18.5 tt0 20.35 59.49 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.228 0 O-C-N 124.487 1.117 . . . . 0.0 113.224 179.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -61.65 -61.73 6.5 Favored Glycine 0 N--CA 1.432 -1.574 0 CA-C-N 114.869 -1.06 . . . . 0.0 112.482 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . 0.428 ' HB3' ' O ' ' A' ' 184' ' ' ILE . 0.6 OUTLIER -164.06 -152.02 0.18 Allowed 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -179.544 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . 0.485 ' O ' ' HB2' ' A' ' 183' ' ' LEU . 92.2 t -90.02 134.41 29.13 Favored 'Isoleucine or valine' 0 C--N 1.35 0.604 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.945 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . 0.479 ' HA ' ' CB ' ' A' ' 183' ' ' LEU . 2.7 mp -103.39 158.69 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 O-C-N 123.544 0.528 . . . . 0.0 111.228 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' GLU . . . . . 0.449 ' O ' ' N ' ' A' ' 182' ' ' ARG . 9.2 tt0 -147.79 111.32 4.98 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . 0.418 ' HA ' ' HA ' ' A' ' 181' ' ' VAL . . . -87.7 139.68 30.28 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.683 179.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' TYR . . . . . 0.413 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 30.3 p90 -139.03 135.01 33.79 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.146 -179.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.54 0.593 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.668 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.814 0.34 . . . . 0.0 110.952 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 20.7 t -58.68 143.22 13.33 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.449 0 CA-C-O 121.415 0.626 . . . . 0.0 111.424 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 16.1 mm -129.7 6.98 2.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.843 178.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 173.9 72.88 0.05 OUTLIER Glycine 0 C--N 1.343 0.936 0 C-N-CA 121.127 -0.559 . . . . 0.0 111.904 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.71 131.5 38.98 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 116.871 0.335 . . . . 0.0 110.305 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -151.65 176.47 11.33 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -178.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.424 ' HA ' ' HA ' ' A' ' 229' ' ' VAL . 1.9 mt-10 -123.69 125.82 45.45 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.746 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.419 HG12 ' HA ' ' A' ' 226' ' ' GLU . 1.8 p -55.16 127.21 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-O 121.569 0.699 . . . . 0.0 112.196 -179.221 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . 0.446 ' O ' ' HB3' ' A' ' 226' ' ' GLU . 0.0 OUTLIER -89.87 -55.16 3.74 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 105.056 -2.201 . . . . 0.0 105.056 175.736 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.83 -164.07 0.86 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.861 174.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.518 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 26.3 p -143.41 -175.9 4.73 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 178.253 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.6 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 21.7 m-85 -144.11 76.53 1.51 Allowed 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.432 ' HG2' HG13 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -86.52 62.64 7.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 122.428 1.109 . . . . 0.0 108.498 178.285 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 45.8 t -89.85 154.73 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 CA-C-N 113.236 -1.802 . . . . 0.0 110.226 -178.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 26.3 t -89.83 36.74 0.86 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.057 0.456 . . . . 0.0 110.006 178.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -150.6 -34.18 0.16 Allowed 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.213 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 84.9 t -101.65 -101.81 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 158' ' ' LYS . . . -158.79 -101.74 0.18 Allowed Glycine 0 C--O 1.224 -0.498 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 178.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -152.32 37.07 0.53 Allowed 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 177.48 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.6 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 2.2 mm -40.28 93.21 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.338 0.095 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.773 -179.175 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.518 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . -84.98 116.47 23.4 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.457 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -87.49 134.4 12.44 Favored Glycine 0 N--CA 1.438 -1.181 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 178.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -136.46 131.21 33.73 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.859 0.329 . . . . 0.0 110.374 -178.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . 1.637 ' HD2' ' CD1' ' A' ' 169' ' ' TYR . 41.1 t80 -85.64 126.8 34.2 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 177.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 45.4 t -85.73 146.36 6.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -175.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.2 p -138.44 14.19 2.77 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 114.402 -1.272 . . . . 0.0 111.807 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -150.46 -142.58 0.12 Allowed 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -44.54 -105.36 0.01 OUTLIER Glycine 0 CA--C 1.53 1.015 0 N-CA-C 114.455 0.542 . . . . 0.0 114.455 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 10.7 mttm -151.8 143.13 23.39 Favored 'General case' 0 CA--C 1.516 -0.347 0 O-C-N 122.301 -0.529 . . . . 0.0 111.995 -179.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 11.2 mm -93.23 90.52 3.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 176.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 0.1 OUTLIER -106.13 174.7 5.77 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.488 0.661 . . . . 0.0 112.677 -177.495 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.407 ' HG3' ' HB2' ' A' ' 198' ' ' LEU . 0.1 OUTLIER -72.96 -42.59 63.22 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.208 179.351 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -88.28 56.22 3.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.141 -179.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -150.2 161.51 42.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.418 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 0.0 OUTLIER -89.18 -177.45 5.41 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.5 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 1.4 m -146.07 157.29 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 CA-C-O 121.227 0.537 . . . . 0.0 111.638 179.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . 0.418 ' N ' ' O ' ' A' ' 231' ' ' GLU . 6.0 ttt85 -152.78 102.54 2.7 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.312 -0.858 . . . . 0.0 113.196 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.478 ' CD1' ' CZ ' ' A' ' 221' ' ' PHE . 0.3 OUTLIER -86.36 154.12 21.43 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-O 121.701 0.763 . . . . 0.0 113.034 -179.937 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.472 ' N ' HG23 ' A' ' 190' ' ' VAL . 3.2 mp -148.5 121.24 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 113.989 -1.46 . . . . 0.0 112.27 178.124 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.41 ' N ' HG21 ' A' ' 190' ' ' VAL . 1.3 ttm180 -85.99 -150.44 0.14 Allowed 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 177.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -93.99 27.48 2.78 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 118.78 0.718 . . . . 0.0 110.766 178.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -154.81 -77.54 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.835 -0.697 . . . . 0.0 112.673 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -115.44 -155.28 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 115.277 -0.462 . . . . 0.0 110.734 -179.136 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 44.2 t -87.08 135.44 25.21 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.102 0 CA-C-O 121.565 0.698 . . . . 0.0 111.74 -179.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . 0.472 HG23 ' N ' ' A' ' 184' ' ' ILE . 0.2 OUTLIER -89.58 -34.51 6.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 114.665 -1.152 . . . . 0.0 108.961 178.637 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . 1.638 ' HD1' ' CD2' ' A' ' 191' ' ' TYR . 16.6 t80 -158.33 158.79 35.0 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.35 178.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -150.33 155.81 40.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.112 178.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 134.7 -119.34 2.15 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.257 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . 0.448 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 17.6 pt-20 -150.32 -175.01 4.91 Favored 'General case' 0 CA--C 1.496 -1.097 0 CA-C-O 121.357 0.599 . . . . 0.0 111.675 -179.111 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 4.3 mp -88.48 143.38 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.322 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.93 -57.47 2.89 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 35.2 t -151.53 153.03 33.78 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.222 179.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.407 ' HB2' ' HG3' ' A' ' 177' ' ' ARG . 0.1 OUTLIER -123.0 119.22 29.73 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-O 121.37 0.605 . . . . 0.0 111.484 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.34 118.7 6.42 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.126 179.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 4.6 ptm85 . . . . . 0 C--N 1.321 -0.653 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.177 179.844 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 19.4 t70 . . . . . 0 N--CA 1.454 -0.26 0 CA-C-O 120.978 0.418 . . . . 0.0 110.078 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 36.0 m -72.12 166.33 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.921 0 CA-C-O 121.618 0.723 . . . . 0.0 112.562 -178.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . 0.439 ' O ' ' HA ' ' A' ' 176' ' ' THR . 16.6 ttp180 -89.07 -41.1 12.51 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 114.483 -1.235 . . . . 0.0 111.556 -178.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -138.09 -177.18 4.71 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.135 0.493 . . . . 0.0 111.684 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -150.88 81.56 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.801 179.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -99.74 175.28 5.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.056 0.455 . . . . 0.0 112.154 -178.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 82.59 -75.0 0.03 OUTLIER 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.697 -179.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 178.47 37.31 0.06 OUTLIER Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.376 -0.916 . . . . 0.0 112.362 179.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . 1.603 ' HE1' ' CE2' ' A' ' 212' ' ' TYR . 0.5 OUTLIER -99.22 145.28 27.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.963 0.411 . . . . 0.0 111.196 -179.407 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.4 131.79 46.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.453 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 50.0 t -134.96 144.45 47.42 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.399 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -88.58 108.15 3.42 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.494 -0.86 . . . . 0.0 111.995 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.406 ' HB3' ' HA ' ' A' ' 198' ' ' LEU . 0.3 OUTLIER -132.54 140.51 48.33 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 120.97 0.414 . . . . 0.0 111.436 -179.264 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.73 138.8 38.42 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 177.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . 0.463 ' CG2' ' CD2' ' A' ' 191' ' ' TYR . 1.4 mp -105.79 95.4 3.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 -178.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 44.04 -145.53 0.11 Allowed 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.928 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 -88.16 63.83 7.42 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-O 120.85 0.357 . . . . 0.0 111.2 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . 0.478 ' CZ ' ' CD1' ' A' ' 183' ' ' LEU . 0.1 OUTLIER -54.4 118.44 4.13 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 179.002 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -84.14 -43.43 15.01 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.755 176.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -87.74 132.26 34.2 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.97 178.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.432 HG13 ' HG2' ' A' ' 158' ' ' LYS . 0.1 OUTLIER -116.61 179.56 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 CA-C-O 121.09 0.471 . . . . 0.0 112.003 -179.646 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . 0.421 ' O ' ' N ' ' A' ' 227' ' ' GLY . 0.0 OUTLIER 55.67 120.88 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.543 179.853 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . 0.446 ' HB3' ' O ' ' A' ' 154' ' ' ARG . 3.3 pt-20 -3.97 71.73 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 225' ' ' LYS . . . -64.48 -63.42 4.3 Favored Glycine 0 N--CA 1.43 -1.722 0 CA-C-N 114.7 -1.136 . . . . 0.0 111.616 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . 0.416 ' O ' ' HB ' ' A' ' 153' ' ' VAL . 1.0 OUTLIER -164.76 -148.49 0.11 Allowed 'General case' 0 C--O 1.22 -0.491 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 179.585 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . 0.424 ' HA ' ' HA ' ' A' ' 152' ' ' GLU . 61.9 t -89.47 145.76 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.225 0 O-C-N 122.091 -0.381 . . . . 0.0 110.494 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . 0.405 HG13 ' CD2' ' A' ' 183' ' ' LEU . 2.6 mp -117.01 154.4 18.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.156 -179.231 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' GLU . . . . . 0.418 ' O ' ' N ' ' A' ' 182' ' ' ARG . 7.5 tt0 -143.27 113.96 7.56 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.403 0.62 . . . . 0.0 111.948 -179.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.45 128.45 35.53 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.497 178.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' TYR . . . . . 1.615 ' HE2' ' CE1' ' A' ' 233' ' ' TYR . 6.1 p90 -130.5 129.48 42.95 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.869 -178.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 4.3 t . . . . . 0 C--N 1.328 -0.349 0 CA-C-O 120.982 0.42 . . . . 0.0 111.762 -179.835 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 2.0 tttm . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.663 0.268 . . . . 0.0 110.527 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 14.9 t -59.53 140.9 17.04 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.637 0 CA-C-O 121.308 0.575 . . . . 0.0 111.315 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.8 pp -124.97 -1.78 5.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.048 178.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 179.51 73.95 0.06 OUTLIER Glycine 0 C--N 1.34 0.791 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.165 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.99 132.8 35.76 Favored 'General case' 0 CA--C 1.509 -0.61 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.249 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -151.57 174.71 13.12 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 121.457 0.646 . . . . 0.0 112.458 -178.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.429 ' HA ' ' HA ' ' A' ' 229' ' ' VAL . 0.8 OUTLIER -119.98 122.14 40.52 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.021 179.691 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.428 ' CG1' ' HA ' ' A' ' 226' ' ' GLU . 2.6 p -50.05 134.13 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -89.29 -63.31 1.31 Allowed 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 175.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.51 -162.03 0.85 Allowed 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 113.826 -1.534 . . . . 0.0 109.198 175.206 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 7.5 p -145.89 157.3 43.91 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 120.829 0.347 . . . . 0.0 110.392 177.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.625 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 2.3 m-85 -104.21 72.13 1.06 Allowed 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -177.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 16.7 tttt -85.67 63.72 8.22 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 122.125 0.964 . . . . 0.0 108.826 178.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.419 HG12 ' N ' ' A' ' 160' ' ' SER . 95.8 t -89.9 158.21 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 CA-C-N 113.673 -1.603 . . . . 0.0 109.906 -179.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' SER . . . . . 0.419 ' N ' HG12 ' A' ' 159' ' ' VAL . 25.2 p -92.62 32.97 1.16 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.224 0.535 . . . . 0.0 110.036 178.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 3.2 mtmt -152.02 -31.54 0.15 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.644 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 98.5 t -98.98 -101.19 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 O-C-N 122.171 -0.331 . . . . 0.0 110.234 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -158.72 -105.95 0.22 Allowed Glycine 0 N--CA 1.451 -0.361 0 N-CA-C 111.644 -0.583 . . . . 0.0 111.644 179.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' THR . . . . . 0.427 ' CG2' ' CG2' ' A' ' 224' ' ' ILE . 0.0 OUTLIER -153.7 34.85 0.45 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.378 -0.911 . . . . 0.0 108.944 178.391 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.625 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 3.8 mm -42.45 94.87 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.577 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.482 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . -87.77 117.8 26.85 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 114.748 -1.114 . . . . 0.0 111.189 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -88.39 153.97 24.72 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 179.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -148.29 136.12 20.88 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.922 0.361 . . . . 0.0 110.81 -178.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . 1.634 ' HD2' ' CD1' ' A' ' 169' ' ' TYR . 33.3 t80 -87.39 124.96 33.95 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 177.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 24.5 t -85.08 144.51 9.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -175.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -136.41 14.3 3.23 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-N 114.544 -1.207 . . . . 0.0 112.013 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -150.52 -144.16 0.15 Allowed 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -179.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -41.32 -106.0 0.01 OUTLIER Glycine 0 CA--C 1.533 1.188 0 N-CA-C 115.197 0.839 . . . . 0.0 115.197 -178.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.69 146.74 26.66 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.014 0.435 . . . . 0.0 111.619 -178.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 10.6 mm -99.39 83.23 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 176.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 0.1 OUTLIER -95.88 168.5 10.6 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -177.177 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 33.8 mtm180 -64.58 -45.07 88.58 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 114.546 -1.206 . . . . 0.0 110.743 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -89.4 59.99 5.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.743 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 58.9 m -149.13 156.04 41.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.756 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -89.18 -179.33 5.86 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.696 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 1.1 m -150.86 150.12 13.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.493 0.663 . . . . 0.0 111.953 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . 0.439 ' N ' ' O ' ' A' ' 231' ' ' GLU . 11.5 ttt85 -153.25 102.43 2.61 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.463 179.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.482 ' CB ' ' HA ' ' A' ' 230' ' ' ILE . 0.3 OUTLIER -100.58 167.67 10.2 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-O 120.947 0.403 . . . . 0.0 111.382 -179.829 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.409 ' O ' ' HB3' ' A' ' 228' ' ' ASP . 4.7 mp -151.56 139.98 14.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.944 -177.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.404 ' N ' HG21 ' A' ' 190' ' ' VAL . 0.1 OUTLIER -87.16 -153.19 0.21 Allowed 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.022 -0.99 . . . . 0.0 108.86 178.117 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -94.71 28.02 2.83 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 118.092 0.405 . . . . 0.0 111.296 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -152.96 -76.75 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.556 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -116.12 -156.57 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 115.525 -0.338 . . . . 0.0 110.319 -179.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 31.0 t -86.16 138.84 18.32 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 CA-C-O 121.476 0.655 . . . . 0.0 110.702 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . 0.408 ' HB ' ' CD1' ' A' ' 183' ' ' LEU . 0.6 OUTLIER -87.68 -37.11 10.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 114.913 -1.04 . . . . 0.0 108.89 179.847 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . 1.637 ' HE2' ' CE1' ' A' ' 191' ' ' TYR . 0.5 OUTLIER -178.69 150.49 0.52 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.354 179.617 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -137.13 158.35 44.63 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.935 179.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 144.53 -132.73 4.9 Favored Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.556 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -143.58 -179.34 6.37 Favored 'General case' 0 CA--C 1.498 -1.023 0 CA-C-O 121.186 0.517 . . . . 0.0 111.051 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 4.5 mp -88.73 143.05 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.877 -178.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -91.81 -43.79 9.33 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 48.8 m -151.29 145.56 25.43 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.09 179.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.404 ' CD1' ' CD2' ' A' ' 216' ' ' LEU . 16.7 tp -119.39 113.82 21.39 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.075 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 19.7 mtmm -149.56 122.86 8.98 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.368 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.322 -0.594 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.833 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 . . . . . 0 N--CA 1.453 -0.308 0 CA-C-O 120.919 0.39 . . . . 0.0 110.317 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 33.1 m -64.52 159.45 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.878 0 CA-C-O 121.583 0.706 . . . . 0.0 112.313 -179.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . 0.451 ' O ' ' HA ' ' A' ' 176' ' ' THR . 1.9 ttt180 -89.3 -34.54 16.54 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.875 -178.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -142.03 -179.01 5.97 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.156 0.503 . . . . 0.0 111.527 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 1.9 t -150.79 73.03 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.848 179.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -96.25 171.01 8.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.087 0.47 . . . . 0.0 112.206 -178.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 83.11 -76.32 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.766 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 178.31 37.46 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.299 -0.953 . . . . 0.0 112.656 179.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -95.83 154.71 17.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.894 0.378 . . . . 0.0 111.2 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -89.55 162.43 15.68 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.355 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 29.8 p -150.49 -171.65 3.98 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.874 0.369 . . . . 0.0 111.42 -179.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -150.2 98.58 0.19 Allowed Glycine 0 N--CA 1.451 -0.343 0 N-CA-C 111.505 -0.638 . . . . 0.0 111.505 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.405 ' O ' ' N ' ' A' ' 166' ' ' ALA . 0.5 OUTLIER -126.27 140.63 52.37 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-O 121.18 0.514 . . . . 0.0 112.242 -179.113 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -100.6 115.19 29.6 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.314 -0.857 . . . . 0.0 108.738 177.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . 0.466 ' HB ' ' HB2' ' A' ' 221' ' ' PHE . 15.6 mm -63.39 140.59 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-O 121.27 0.557 . . . . 0.0 110.626 -178.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 6.1 ptmt -42.45 -28.64 0.22 Allowed 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 -177.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' ASN . . . . . 0.433 ' O ' ' CE2' ' A' ' 191' ' ' TYR . 6.1 t-20 -152.36 34.4 0.51 Allowed 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 -178.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . 0.466 ' HB2' ' HB ' ' A' ' 218' ' ' ILE . 0.1 OUTLIER -58.25 121.41 10.68 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 178.872 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -89.52 -48.68 7.15 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 114.888 -1.051 . . . . 0.0 108.377 176.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . 0.463 ' OD1' ' N ' ' A' ' 223' ' ' ASP . 0.0 OUTLIER -77.14 140.22 40.16 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.292 177.496 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.427 ' CG2' ' CG2' ' A' ' 164' ' ' THR . 0.2 OUTLIER -134.67 178.01 6.06 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -178.85 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . 0.413 ' O ' ' C ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER 56.61 115.54 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 114.391 -1.277 . . . . 0.0 110.182 -179.147 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . 0.428 ' HA ' ' CG1' ' A' ' 153' ' ' VAL . 6.5 tt0 7.5 64.28 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 124.65 1.18 . . . . 0.0 113.55 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -61.18 -65.78 3.07 Favored Glycine 0 N--CA 1.431 -1.635 0 CA-C-N 114.694 -1.139 . . . . 0.0 111.764 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . 0.409 ' HB3' ' O ' ' A' ' 184' ' ' ILE . 0.9 OUTLIER -164.98 -147.67 0.1 Allowed 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 179.859 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 76.4 t -89.32 131.51 36.42 Favored 'Isoleucine or valine' 0 C--N 1.348 0.536 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.063 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . 0.482 ' HA ' ' CB ' ' A' ' 183' ' ' LEU . 3.7 mt -102.31 159.23 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 O-C-N 123.494 0.496 . . . . 0.0 111.487 -179.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' GLU . . . . . 0.439 ' O ' ' N ' ' A' ' 182' ' ' ARG . 7.2 tt0 -145.25 110.42 5.22 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.26 129.5 35.35 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.668 178.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' TYR . . . . . 1.575 ' HE2' ' CE1' ' A' ' 233' ' ' TYR . 5.4 p90 -130.82 141.5 50.34 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.803 -178.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.535 0.38 0 CA-C-O 120.804 0.335 . . . . 0.0 111.135 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 11.6 mmtp . . . . . 0 CA--C 1.528 0.118 0 CA-C-O 120.667 0.27 . . . . 0.0 110.751 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 20.1 t -56.71 137.59 18.42 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.541 0 CA-C-O 121.135 0.493 . . . . 0.0 111.522 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.405 ' O ' ' O ' ' A' ' 174' ' ' LYS . 25.7 mm -121.81 -4.31 8.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.27 178.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -176.72 72.15 0.08 OUTLIER Glycine 0 C--N 1.343 0.926 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.044 179.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.406 ' HA ' ' HA ' ' A' ' 231' ' ' GLU . 2.3 tt0 -90.49 135.15 33.88 Favored 'General case' 0 CA--C 1.512 -0.501 0 O-C-N 122.678 -0.307 . . . . 0.0 110.369 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.416 ' HA ' ' O ' ' A' ' 169' ' ' TYR . . . -152.56 171.08 18.68 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 120.095 -0.642 . . . . 0.0 112.674 -178.1 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -119.84 124.09 45.25 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.031 179.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.446 ' CG1' ' HA ' ' A' ' 226' ' ' GLU . 3.9 p -52.01 133.26 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -178.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -89.29 -60.28 1.99 Allowed 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 104.827 -2.286 . . . . 0.0 104.827 175.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.41 ' HA ' ' H ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER -161.28 -161.94 0.85 Allowed 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 113.04 -1.891 . . . . 0.0 108.773 175.252 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.485 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 1.6 p -150.96 155.56 39.35 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 176.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.646 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 2.8 m-85 -104.62 76.38 1.28 Allowed 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -178.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -86.07 62.99 7.77 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 54.7 t -89.97 155.35 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 CA-C-N 113.749 -1.569 . . . . 0.0 110.12 -178.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 28.6 t -90.79 34.78 0.9 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.203 0.525 . . . . 0.0 109.973 178.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -150.71 -31.67 0.18 Allowed 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.316 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 90.5 t -102.71 -102.78 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . 0.402 ' O ' ' O ' ' A' ' 157' ' ' PHE . . . -158.95 -105.9 0.22 Allowed Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 179.084 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' THR . . . . . 0.434 ' CG2' ' CG2' ' A' ' 224' ' ' ILE . 0.0 OUTLIER -156.03 54.4 0.58 Allowed 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 178.124 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.646 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 0.1 OUTLIER -34.38 -27.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.214 -0.812 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 -177.003 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.485 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . 36.78 97.52 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 178.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 153' ' ' VAL . . . -86.39 149.67 22.95 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 109.881 -1.287 . . . . 0.0 109.881 178.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . 0.408 ' HB2' ' CB ' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -144.81 135.33 24.44 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 117.216 0.508 . . . . 0.0 110.467 -178.18 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . 0.416 ' O ' ' HA ' ' A' ' 151' ' ' ALA . 1.9 t80 -87.96 124.8 34.07 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 177.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 41.0 t -85.16 137.92 19.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.635 0.731 . . . . 0.0 112.849 -176.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.3 p -129.42 12.0 5.9 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 114.627 -1.169 . . . . 0.0 112.096 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -145.76 -139.21 0.1 Allowed 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -50.84 -110.73 0.01 OUTLIER Glycine 0 CA--C 1.53 1.013 0 C-N-CA 121.058 -0.592 . . . . 0.0 114.151 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.405 ' O ' ' O ' ' A' ' 148' ' ' ILE . 0.0 OUTLIER -144.7 137.26 26.43 Favored 'General case' 0 CA--C 1.514 -0.423 0 O-C-N 122.349 -0.501 . . . . 0.0 110.834 -179.272 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -94.43 112.18 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 C-N-CA 119.556 -0.858 . . . . 0.0 109.165 177.371 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.441 ' HB ' ' O ' ' A' ' 206' ' ' ARG . 0.3 OUTLIER -125.03 177.76 5.89 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.37 0.605 . . . . 0.0 112.09 -177.373 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.413 ' N ' HD11 ' A' ' 198' ' ' LEU . 0.0 OUTLIER -74.8 -36.81 62.47 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.032 -0.986 . . . . 0.0 109.525 179.241 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -88.94 52.04 2.31 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.054 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -150.72 159.59 44.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.987 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 0.0 OUTLIER -88.98 -177.84 5.56 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.172 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 2.3 m -142.13 160.39 20.22 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 CA-C-O 121.335 0.588 . . . . 0.0 111.82 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . 0.445 ' N ' ' O ' ' A' ' 231' ' ' GLU . 4.4 ttt-85 -152.66 97.81 2.28 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.099 -0.955 . . . . 0.0 112.806 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.495 HD12 ' CZ ' ' A' ' 221' ' ' PHE . 0.3 OUTLIER -86.25 153.79 21.75 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-O 121.748 0.785 . . . . 0.0 112.58 179.991 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 17.8 mt -158.23 131.73 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 114.171 -1.377 . . . . 0.0 112.581 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.0 -151.74 0.22 Allowed 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.024 -1.472 . . . . 0.0 107.024 176.253 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -95.93 27.54 3.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 118.521 0.601 . . . . 0.0 110.516 178.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -153.96 -43.33 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.679 -0.772 . . . . 0.0 113.405 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.428 ' CG2' ' N ' ' A' ' 189' ' ' VAL . 0.4 OUTLIER -150.15 -158.33 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -177.953 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.428 ' N ' ' CG2' ' A' ' 188' ' ' ILE . 48.0 t -87.34 138.11 19.7 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 CA-C-O 121.624 0.726 . . . . 0.0 111.204 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . 0.452 HG23 ' HB3' ' A' ' 183' ' ' LEU . 0.1 OUTLIER -98.12 -34.21 4.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 114.645 -1.161 . . . . 0.0 108.864 179.264 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . 1.664 ' HD2' ' CD1' ' A' ' 191' ' ' TYR . 19.1 t80 -158.58 159.75 35.83 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.18 179.096 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -150.34 155.11 39.02 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.61 178.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 135.13 -121.48 2.59 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.485 -0.864 . . . . 0.0 112.382 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . 0.472 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 12.4 pt-20 -150.01 -176.57 5.5 Favored 'General case' 0 CA--C 1.495 -1.143 0 CA-C-O 121.447 0.642 . . . . 0.0 112.031 -178.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 4.5 mp -89.06 150.28 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 CA-C-N 115.175 -0.921 . . . . 0.0 109.37 -179.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -88.73 -67.98 0.8 Allowed 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.061 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -151.99 154.62 36.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.455 178.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.413 HD11 ' N ' ' A' ' 177' ' ' ARG . 0.2 OUTLIER -107.61 127.85 54.02 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.319 0.581 . . . . 0.0 111.711 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 43.8 tttt -150.63 113.46 4.75 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.388 179.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.516 0 CA-C-N 116.081 -0.508 . . . . 0.0 109.823 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 . . . . . 0 N--CA 1.454 -0.267 0 CA-C-O 120.673 0.273 . . . . 0.0 110.44 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 35.0 m -74.34 176.66 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -0.986 0 CA-C-O 121.576 0.703 . . . . 0.0 112.366 -179.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . 0.441 ' O ' ' HB ' ' A' ' 176' ' ' THR . 2.1 ttt180 -103.74 -42.24 5.69 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 114.616 -1.175 . . . . 0.0 111.796 -179.01 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -131.03 -177.02 4.19 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.207 0.527 . . . . 0.0 112.052 -179.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -151.42 71.26 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.848 178.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -91.65 171.68 9.0 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.094 0.473 . . . . 0.0 112.174 -178.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 83.67 -76.87 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.9 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . 0.4 ' O ' ' CE1' ' A' ' 169' ' ' TYR . . . 178.04 36.95 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.338 -0.934 . . . . 0.0 112.563 179.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -100.45 153.01 19.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.023 0.439 . . . . 0.0 111.239 -179.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.2 133.05 45.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.971 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 1.8 t -135.73 146.08 47.31 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.976 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -89.66 112.27 3.99 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.868 179.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -139.95 131.67 27.37 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-O 120.937 0.398 . . . . 0.0 111.012 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.72 142.96 54.85 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.267 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . 0.451 ' CG2' ' CD2' ' A' ' 191' ' ' TYR . 1.7 mp -108.81 87.42 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 -178.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . 0.424 ' HB2' ' O ' ' A' ' 194' ' ' GLU . 2.7 tttt 45.3 -143.47 0.22 Allowed 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.519 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -88.44 63.69 7.18 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-O 120.732 0.301 . . . . 0.0 111.317 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . 0.495 ' CZ ' HD12 ' A' ' 183' ' ' LEU . 0.1 OUTLIER -54.91 119.04 4.82 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 178.705 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -82.75 -45.44 14.4 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.651 176.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . 0.406 ' O ' ' CD1' ' A' ' 221' ' ' PHE . 0.0 OUTLIER -88.16 146.33 25.45 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.031 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.434 ' CG2' ' CG2' ' A' ' 164' ' ' THR . 0.2 OUTLIER -141.46 -179.18 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.146 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -178.527 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . 0.409 ' O ' ' C ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER 54.87 111.1 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 114.184 -1.371 . . . . 0.0 110.376 -179.127 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . 0.446 ' HA ' ' CG1' ' A' ' 153' ' ' VAL . 21.9 tt0 14.81 56.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 124.685 1.24 . . . . 0.0 112.504 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -67.45 -56.63 11.06 Favored Glycine 0 N--CA 1.422 -2.262 0 CA-C-N 114.224 -1.353 . . . . 0.0 113.323 -178.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . 0.428 ' CB ' HG22 ' A' ' 190' ' ' VAL . 4.3 m-20 -161.25 -164.12 1.11 Allowed 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 115.124 1.527 . . . . 0.0 115.124 -177.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 63.9 t -88.07 140.87 15.12 Favored 'Isoleucine or valine' 0 C--N 1.346 0.429 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 2.7 mp -112.92 154.55 14.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.958 0.408 . . . . 0.0 111.372 -178.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' GLU . . . . . 0.445 ' O ' ' N ' ' A' ' 182' ' ' ARG . 5.0 tt0 -144.5 109.5 5.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.328 0.585 . . . . 0.0 111.684 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.01 128.5 35.08 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.965 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' TYR . . . . . 0.423 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 8.8 p90 -131.63 141.22 49.58 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.551 -179.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 4.4 p . . . . . 0 C--N 1.329 -0.317 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -179.809 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.629 0.252 . . . . 0.0 110.479 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 15.7 t -55.38 144.77 6.26 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.526 0 CA-C-O 121.441 0.638 . . . . 0.0 111.483 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 2.7 pp -124.63 -6.64 6.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.04 178.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -179.32 76.99 0.06 OUTLIER Glycine 0 C--N 1.343 0.964 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.043 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.401 ' HA ' ' HA ' ' A' ' 231' ' ' GLU . 0.1 OUTLIER -89.9 135.21 33.77 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 179.715 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.43 ' HA ' ' O ' ' A' ' 169' ' ' TYR . . . -151.35 167.68 27.16 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 120.102 -0.639 . . . . 0.0 112.522 -178.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -120.42 124.51 45.65 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.407 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.484 ' HB ' ' O ' ' A' ' 228' ' ' ASP . 3.1 p -51.17 132.63 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -178.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -89.44 -60.16 2.02 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 104.416 -2.439 . . . . 0.0 104.416 175.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.45 -163.71 1.03 Allowed 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 113.025 -1.898 . . . . 0.0 108.613 174.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.479 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 1.5 p -151.91 143.02 23.21 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 176.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.598 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 5.7 m-30 -91.04 75.37 6.29 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.043 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.66 63.72 8.12 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.967 0.889 . . . . 0.0 108.847 178.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 49.2 t -89.25 154.85 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-N 113.944 -1.48 . . . . 0.0 109.707 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 47.4 t -89.74 33.49 0.85 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.074 0.464 . . . . 0.0 110.406 178.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -150.93 -29.3 0.2 Allowed 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.597 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 97.7 t -103.52 -101.53 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 O-C-N 122.132 -0.355 . . . . 0.0 110.15 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -158.51 -110.34 0.29 Allowed Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 111.543 -0.623 . . . . 0.0 111.543 179.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' THR . . . . . 0.435 ' CG2' ' CG2' ' A' ' 224' ' ' ILE . 0.0 OUTLIER -155.15 58.96 0.65 Allowed 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 178.253 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.598 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 0.3 OUTLIER -38.7 -22.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.219 -0.54 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 -177.243 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.479 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . 31.02 98.36 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 178.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -87.59 150.76 22.72 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 178.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . 0.402 ' HB2' ' CB ' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -145.07 136.48 25.18 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 117.353 0.577 . . . . 0.0 110.725 -178.482 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . 0.43 ' O ' ' HA ' ' A' ' 151' ' ' ALA . 71.9 t80 -87.74 131.05 34.63 Favored 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 106.965 -1.495 . . . . 0.0 106.965 177.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 4.7 p -86.25 144.84 8.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -176.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.4 p -138.53 11.91 2.74 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.416 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -151.48 -147.51 0.23 Allowed 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 119.52 -0.276 . . . . 0.0 110.263 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -39.53 -104.56 0.01 OUTLIER Glycine 0 CA--C 1.531 1.047 0 N-CA-C 115.188 0.835 . . . . 0.0 115.188 -178.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.75 143.89 24.78 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.092 0.472 . . . . 0.0 111.88 -178.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 7.4 mm -99.68 87.15 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 N-CA-C 108.498 -0.926 . . . . 0.0 108.498 176.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 0.2 OUTLIER -100.93 172.82 6.8 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.517 0.675 . . . . 0.0 112.106 -178.061 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -69.2 -43.02 74.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.711 -1.131 . . . . 0.0 111.067 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -88.56 58.59 4.74 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.17 -179.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 1.1 m -149.08 162.69 39.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.797 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 26.4 mttp -89.0 -170.81 3.04 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 2.4 m -150.23 160.79 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.539 0 CA-C-O 121.398 0.618 . . . . 0.0 111.711 179.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . 0.458 ' N ' ' O ' ' A' ' 231' ' ' GLU . 43.3 ttm180 -153.58 98.75 2.26 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.136 -0.938 . . . . 0.0 113.215 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.498 ' HB3' HG23 ' A' ' 190' ' ' VAL . 0.2 OUTLIER -86.68 148.33 25.5 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-O 121.745 0.783 . . . . 0.0 112.22 179.721 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 22.2 mt -157.87 130.14 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 114.311 -1.313 . . . . 0.0 111.485 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -88.52 -151.94 0.21 Allowed 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 177.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -94.71 29.84 2.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 118.354 0.525 . . . . 0.0 110.533 179.05 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -154.04 -45.94 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.668 -0.777 . . . . 0.0 113.182 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.42 ' CG2' ' N ' ' A' ' 189' ' ' VAL . 0.4 OUTLIER -150.11 -160.56 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -178.106 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.42 ' N ' ' CG2' ' A' ' 188' ' ' ILE . 96.1 t -87.09 135.76 24.51 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 CA-C-O 121.684 0.754 . . . . 0.0 110.845 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . 0.498 HG23 ' HB3' ' A' ' 183' ' ' LEU . 0.0 OUTLIER -97.67 -35.44 5.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 114.562 -1.199 . . . . 0.0 108.959 179.343 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . 1.644 ' HE2' ' CE1' ' A' ' 191' ' ' TYR . 5.0 t80 -157.51 156.13 31.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.569 179.115 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -151.0 155.39 38.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.218 178.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 134.85 -113.15 1.1 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.573 -0.823 . . . . 0.0 112.363 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . 0.49 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 0.0 OUTLIER -150.77 -176.16 5.4 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-O 121.303 0.573 . . . . 0.0 111.161 -179.051 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.473 ' N ' ' CG ' ' A' ' 194' ' ' GLU . 0.3 OUTLIER -99.13 155.07 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.178 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.495 -179.074 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -89.42 -67.64 0.83 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 1.3 m -150.91 154.45 37.19 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.949 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -107.46 117.8 35.05 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.962 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 18.1 ttmt -138.13 115.14 10.85 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.812 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 7.6 ttm180 . . . . . 0 C--N 1.325 -0.493 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.846 179.688 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 16.4 t70 . . . . . 0 N--CA 1.453 -0.293 0 CA-C-O 120.931 0.396 . . . . 0.0 110.279 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 32.7 m -59.28 159.86 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.934 0 CA-C-O 121.603 0.716 . . . . 0.0 112.317 -179.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . 0.467 ' O ' ' HA ' ' A' ' 176' ' ' THR . 7.6 ttm-85 -89.44 -36.51 15.4 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 114.651 -1.159 . . . . 0.0 111.795 -178.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -141.31 179.42 6.78 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.221 0.534 . . . . 0.0 111.682 -179.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -151.12 70.95 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.729 178.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -97.46 178.47 5.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.138 -178.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 81.97 -75.45 0.03 OUTLIER 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.538 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 178.41 38.12 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.401 -0.904 . . . . 0.0 112.286 179.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -107.43 150.09 27.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.159 0.504 . . . . 0.0 112.025 -179.118 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -96.57 152.78 18.31 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.076 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 18.5 t -150.64 154.34 37.31 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.004 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -89.53 110.24 3.7 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.116 179.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.404 ' O ' ' O ' ' A' ' 165' ' ' ILE . 0.2 OUTLIER -134.44 131.36 38.04 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 121.298 0.571 . . . . 0.0 111.59 -179.026 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.35 130.38 34.8 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.93 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . 0.457 ' CG2' ' CD2' ' A' ' 191' ' ' TYR . 1.5 mp -90.84 79.27 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 34.75 -85.99 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.998 0 O-C-N 124.134 0.896 . . . . 0.0 112.835 -178.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' ASN . . . . . 0.439 ' N ' ' O ' ' A' ' 218' ' ' ILE . 5.9 p30 -129.73 65.67 1.48 Allowed 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.589 -179.427 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . 0.487 ' CZ ' HD12 ' A' ' 183' ' ' LEU . 0.1 OUTLIER -58.58 119.38 6.94 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 177.883 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -77.91 -44.51 26.79 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 176.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . 0.402 ' O ' ' CG ' ' A' ' 221' ' ' PHE . 0.0 OUTLIER -92.74 143.19 26.55 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.236 177.713 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.435 ' CG2' ' CG2' ' A' ' 164' ' ' THR . 0.2 OUTLIER -140.48 -179.4 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -178.706 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . 0.414 ' O ' ' C ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER 55.26 110.56 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 114.319 -1.31 . . . . 0.0 110.067 -178.881 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . 0.471 ' HA ' ' CG1' ' A' ' 153' ' ' VAL . 18.2 tt0 10.95 60.5 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 124.747 1.28 . . . . 0.0 112.948 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -71.59 -58.13 5.58 Favored Glycine 0 N--CA 1.421 -2.348 0 CA-C-N 114.115 -1.402 . . . . 0.0 113.144 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . 0.484 ' O ' ' HB ' ' A' ' 153' ' ' VAL . 25.8 m-20 -158.48 -160.62 0.9 Allowed 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -178.019 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 42.9 t -88.65 152.98 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 CA-C-O 120.769 0.318 . . . . 0.0 110.15 178.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 3.0 mp -120.92 153.93 24.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.753 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' GLU . . . . . 0.458 ' O ' ' N ' ' A' ' 182' ' ' ARG . 20.1 tt0 -147.12 111.58 5.23 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 119.839 -0.744 . . . . 0.0 112.676 -179.385 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.17 135.58 33.24 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.17 178.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' TYR . . . . . 1.614 ' HE1' ' CE2' ' A' ' 233' ' ' TYR . 3.5 p90 -137.64 156.75 47.7 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.062 -178.45 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.536 0.435 0 CA-C-O 121.15 0.5 . . . . 0.0 110.743 179.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 4.5 ptpt . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.553 0.216 . . . . 0.0 110.767 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 12.1 t -58.58 139.99 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.611 0 CA-C-O 121.297 0.57 . . . . 0.0 111.506 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.406 HG12 ' N ' ' A' ' 234' ' ' VAL . 2.7 pp -127.06 -1.82 4.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.35 178.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 178.08 75.34 0.06 OUTLIER Glycine 0 C--N 1.342 0.897 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.912 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.438 ' HA ' ' HA ' ' A' ' 231' ' ' GLU . 0.0 OUTLIER -89.97 136.41 33.06 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 122.721 -0.282 . . . . 0.0 110.336 -179.969 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -151.17 179.59 8.16 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-O 121.63 0.729 . . . . 0.0 112.871 -178.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -126.96 120.37 28.94 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.814 -1.084 . . . . 0.0 110.445 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.453 ' CG1' ' HA ' ' A' ' 226' ' ' GLU . 2.2 p -48.13 137.97 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -179.37 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . 0.474 ' O ' ' HB3' ' A' ' 226' ' ' GLU . 3.2 mmp_? -97.44 -61.03 1.45 Allowed 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 105.963 -1.865 . . . . 0.0 105.963 176.093 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.75 -160.53 0.46 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 113.739 -1.573 . . . . 0.0 109.157 175.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 5.9 p -150.92 149.0 29.11 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 177.275 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.559 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 5.6 m-30 -92.6 72.1 5.03 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -178.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 15.6 tttt -85.95 62.21 7.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 122.002 0.906 . . . . 0.0 109.071 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.449 HG12 ' N ' ' A' ' 160' ' ' SER . 55.2 t -89.64 155.78 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 CA-C-N 113.919 -1.492 . . . . 0.0 109.535 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' SER . . . . . 0.449 ' N ' HG12 ' A' ' 159' ' ' VAL . 9.0 m -89.72 22.41 3.09 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.049 178.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.71 5.66 0.52 Allowed 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.188 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 57.8 t -129.98 -99.17 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 CA-C-N 118.483 0.583 . . . . 0.0 110.14 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -158.02 -113.51 0.38 Allowed Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' THR . . . . . 0.415 ' CG2' ' CG2' ' A' ' 224' ' ' ILE . 0.0 OUTLIER -153.98 32.9 0.44 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.462 -0.869 . . . . 0.0 109.098 178.157 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.559 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 1.9 mm -40.27 93.78 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.715 -179.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.445 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . -88.25 118.45 27.85 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 114.729 -1.123 . . . . 0.0 111.967 -179.203 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -89.59 151.21 21.69 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.49 179.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -147.58 133.45 19.08 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -179.349 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . 1.613 ' HE1' ' CE2' ' A' ' 169' ' ' TYR . 11.1 t80 -86.8 131.28 34.17 Favored 'General case' 0 C--O 1.219 -0.512 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 178.279 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.404 ' O ' ' CE1' ' A' ' 169' ' ' TYR . 5.7 p -85.64 147.01 5.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -175.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.1 p -141.87 13.12 2.07 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.04 -0.982 . . . . 0.0 112.359 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -151.27 -145.87 0.18 Allowed 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -38.96 -103.53 0.01 OUTLIER Glycine 0 CA--C 1.531 1.05 0 N-CA-C 115.275 0.87 . . . . 0.0 115.275 -178.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 21.9 mttm -150.47 134.94 17.25 Favored 'General case' 0 CA--C 1.515 -0.402 0 O-C-N 122.591 -0.358 . . . . 0.0 111.871 -178.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 3.5 mm -93.37 86.89 2.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 176.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 0.1 OUTLIER -100.79 172.24 7.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.523 -177.265 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -69.25 -42.1 76.05 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.347 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -88.75 56.32 3.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.415 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 29.7 m -145.97 157.34 43.88 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.428 -179.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 0.0 OUTLIER -89.25 -172.93 3.83 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.44 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -150.1 156.76 6.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.385 0.612 . . . . 0.0 111.473 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . 0.425 ' N ' ' O ' ' A' ' 231' ' ' GLU . 60.2 ttt180 -152.03 101.83 2.76 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.113 -0.948 . . . . 0.0 112.581 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.473 ' CD1' ' CZ ' ' A' ' 221' ' ' PHE . 0.3 OUTLIER -86.16 157.41 20.01 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-O 121.862 0.839 . . . . 0.0 112.918 -179.669 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.493 ' N ' HG23 ' A' ' 190' ' ' VAL . 3.1 mp -151.01 121.36 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 113.885 -1.507 . . . . 0.0 111.935 177.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.41 ' HA ' ' CG ' ' A' ' 228' ' ' ASP . 0.0 OUTLIER -85.45 -151.76 0.15 Allowed 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 177.504 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -93.97 28.57 2.38 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 118.539 0.608 . . . . 0.0 110.829 178.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -154.62 -76.96 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.619 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -116.47 -156.54 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 115.34 -0.43 . . . . 0.0 110.718 -179.039 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 46.3 t -87.37 133.96 28.9 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.101 0 CA-C-O 121.518 0.675 . . . . 0.0 111.771 -179.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . 0.493 HG23 ' N ' ' A' ' 184' ' ' ILE . 0.2 OUTLIER -89.61 -34.21 6.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 114.778 -1.101 . . . . 0.0 108.884 178.503 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . 1.656 ' HD2' ' CD1' ' A' ' 191' ' ' TYR . 41.5 t80 -157.6 155.87 30.88 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 178.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . 0.458 ' N ' ' CD2' ' A' ' 191' ' ' TYR . 14.4 mt-10 -150.14 148.83 29.43 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.287 177.342 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 133.05 -127.75 4.85 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.068 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . 0.462 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 4.5 pt-20 -145.38 -178.88 6.3 Favored 'General case' 0 CA--C 1.499 -0.986 0 CA-C-O 121.662 0.744 . . . . 0.0 112.631 -178.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 4.7 mp -89.67 153.42 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.115 -179.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -93.95 -52.19 4.53 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 4.6 m -151.38 144.92 24.91 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.858 178.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 2.8 tt -120.49 118.01 29.14 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.427 0.632 . . . . 0.0 111.647 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 10.7 tttm -148.83 122.52 9.23 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.672 179.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 8.4 ttp85 . . . . . 0 C--N 1.321 -0.637 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.314 -179.52 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 . . . . . 0 N--CA 1.451 -0.402 0 CA-C-O 121.025 0.441 . . . . 0.0 110.107 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 28.3 m -56.29 156.94 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.931 0 CA-C-O 121.515 0.674 . . . . 0.0 112.23 -179.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . 0.401 ' O ' ' HA ' ' A' ' 176' ' ' THR . 0.1 OUTLIER -89.51 -34.07 16.54 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.899 -178.447 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -141.26 175.75 9.39 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.03 0.443 . . . . 0.0 111.161 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -150.8 83.25 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.782 178.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -101.85 174.05 6.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.787 -179.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 80.63 -68.76 0.1 Allowed 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.725 -179.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 178.95 36.75 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.49 179.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . 1.606 ' HD2' ' CD1' ' A' ' 212' ' ' TYR . 2.7 m-85 -100.27 135.01 42.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.022 0.439 . . . . 0.0 111.747 -179.167 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -89.73 152.25 21.42 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.22 179.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -150.57 139.89 21.33 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.095 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -89.08 115.92 4.57 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.662 -0.78 . . . . 0.0 111.733 179.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -135.47 141.6 45.38 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 121.119 0.485 . . . . 0.0 111.609 -179.28 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 1.4 m -89.17 133.1 34.54 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . 0.478 ' CG2' ' CZ ' ' A' ' 191' ' ' TYR . 1.6 mp -86.16 134.4 27.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 -179.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 5.5 ptmt -39.24 -31.75 0.09 Allowed 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 114.406 1.262 . . . . 0.0 114.406 -177.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -153.08 40.38 0.54 Allowed 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 -178.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . 0.473 ' CZ ' ' CD1' ' A' ' 183' ' ' LEU . 0.1 OUTLIER -59.16 115.98 3.55 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 178.626 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -83.67 -42.56 16.51 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.12 -0.946 . . . . 0.0 108.481 176.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . 0.417 ' O ' ' CD1' ' A' ' 221' ' ' PHE . 0.0 OUTLIER -90.53 141.95 28.24 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.893 178.201 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.415 ' CG2' ' CG2' ' A' ' 164' ' ' THR . 2.5 pp -122.49 -177.97 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.36 0.6 . . . . 0.0 112.423 -179.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . 0.461 ' O ' ' N ' ' A' ' 227' ' ' GLY . 11.4 mtpt 59.37 172.76 0.08 Allowed 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.289 -177.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . 0.474 ' HB3' ' O ' ' A' ' 154' ' ' ARG . 0.3 OUTLIER -58.61 84.09 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.036 0.446 . . . . 0.0 110.831 179.683 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 225' ' ' LYS . . . -71.65 -61.54 3.79 Favored Glycine 0 N--CA 1.427 -1.911 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 178.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . 0.41 ' CG ' ' HA ' ' A' ' 185' ' ' ARG . 0.9 OUTLIER -164.6 -148.3 0.11 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 178.669 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 59.4 t -89.48 145.33 7.53 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 O-C-N 122.331 -0.231 . . . . 0.0 110.606 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 2.9 mt -116.16 153.07 17.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.205 -179.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' GLU . . . . . 0.438 ' HA ' ' HA ' ' A' ' 150' ' ' GLN . 23.9 tt0 -142.1 111.73 6.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.33 0.586 . . . . 0.0 112.369 -179.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.89 127.92 35.65 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.942 179.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -128.36 144.44 51.13 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.945 -179.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.406 ' N ' HG12 ' A' ' 148' ' ' ILE . 0.3 OUTLIER . . . . . 0 CA--C 1.535 0.368 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.881 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 12.2 mttp . . . . . 0 CA--C 1.529 0.135 0 N-CA-C 110.417 -0.216 . . . . 0.0 110.417 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 6.4 t -115.85 137.59 49.01 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.79 0 CA-C-O 121.356 0.598 . . . . 0.0 110.804 179.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 31.0 mm -129.45 -3.93 3.01 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.693 178.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -171.97 70.77 0.11 Allowed Glycine 0 C--N 1.341 0.806 0 N-CA-C 111.344 -0.703 . . . . 0.0 111.344 179.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.414 ' HA ' ' HA ' ' A' ' 231' ' ' GLU . 0.8 OUTLIER -91.31 136.25 33.23 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-O 120.734 0.302 . . . . 0.0 110.639 -179.643 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.406 ' HA ' ' O ' ' A' ' 169' ' ' TYR . . . -151.76 175.79 12.06 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 121.537 0.684 . . . . 0.0 112.761 -178.293 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -126.15 121.64 33.4 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.5 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.426 ' CG1' ' HA ' ' A' ' 226' ' ' GLU . 1.6 p -47.31 144.42 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 121.37 0.605 . . . . 0.0 112.595 -179.108 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . 0.477 ' O ' ' HB3' ' A' ' 226' ' ' GLU . 3.8 mmp_? -109.86 -57.32 2.2 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 176.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.55 -162.88 0.61 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 113.755 -1.566 . . . . 0.0 109.776 175.34 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.491 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 8.0 p -150.79 163.88 37.55 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 177.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.485 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 0.2 OUTLIER -116.05 80.08 1.4 Allowed 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -179.033 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 6.5 tttt -86.53 62.77 7.61 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.438 HG12 ' N ' ' A' ' 160' ' ' SER . 71.7 t -92.9 157.32 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 CA-C-N 113.659 -1.61 . . . . 0.0 110.528 -178.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' SER . . . . . 0.438 ' N ' HG12 ' A' ' 159' ' ' VAL . 28.9 t -92.33 35.89 1.0 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 177.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.37 -35.22 0.14 Allowed 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.092 -179.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 88.7 t -98.96 -103.7 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -159.51 -99.99 0.16 Allowed Glycine 0 N--CA 1.452 -0.271 0 N-CA-C 111.194 -0.763 . . . . 0.0 111.194 178.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' THR . . . . . 0.414 ' CG2' ' CG2' ' A' ' 224' ' ' ILE . 0.0 OUTLIER -153.72 33.83 0.45 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 113.958 -1.121 . . . . 0.0 108.278 177.732 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.485 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 3.6 mt -41.98 95.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.461 0.086 0 CA-C-N 115.155 -0.929 . . . . 0.0 111.664 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.491 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . -87.12 125.23 34.01 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.735 -1.12 . . . . 0.0 112.27 -179.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -88.99 144.39 18.02 Favored Glycine 0 N--CA 1.442 -0.951 0 N-CA-C 110.534 -1.027 . . . . 0.0 110.534 178.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -145.69 132.36 19.93 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 117.204 0.502 . . . . 0.0 110.271 -178.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . 0.406 ' O ' ' HA ' ' A' ' 151' ' ' ALA . 5.6 t80 -87.3 127.37 35.18 Favored 'General case' 0 C--O 1.222 -0.39 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 177.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 44.3 t -85.44 142.16 13.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 -176.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.4 p -135.38 12.61 3.51 Favored 'General case' 0 C--O 1.231 0.084 0 CA-C-N 114.833 -1.076 . . . . 0.0 112.3 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -146.87 -144.01 0.15 Allowed 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -45.2 -107.03 0.01 OUTLIER Glycine 0 CA--C 1.532 1.149 0 N-CA-C 114.792 0.677 . . . . 0.0 114.792 -178.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.76 135.0 16.94 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 122.562 -0.375 . . . . 0.0 111.039 -178.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -92.31 111.45 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 176.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.436 ' HB ' ' O ' ' A' ' 206' ' ' ARG . 0.1 OUTLIER -118.54 169.47 9.76 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.458 0.647 . . . . 0.0 112.481 -176.327 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.4 ' HA ' HG23 ' A' ' 195' ' ' ILE . 0.5 OUTLIER -61.13 -40.86 95.41 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.478 179.667 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -95.91 63.64 2.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.251 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 4.8 m -148.8 161.43 41.82 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.92 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . 0.429 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 0.0 OUTLIER -88.93 -175.29 4.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.722 179.493 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 1.6 m -147.93 156.09 9.58 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.478 0 CA-C-O 121.247 0.546 . . . . 0.0 111.731 179.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . 0.445 ' N ' ' O ' ' A' ' 231' ' ' GLU . 17.9 ttt180 -152.96 100.67 2.52 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.313 -0.858 . . . . 0.0 113.305 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.524 ' HB3' HG23 ' A' ' 190' ' ' VAL . 0.3 OUTLIER -86.88 156.1 19.98 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-O 121.7 0.762 . . . . 0.0 112.839 -179.869 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.406 ' N ' HG23 ' A' ' 190' ' ' VAL . 28.9 mm -154.01 123.93 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 114.487 -1.233 . . . . 0.0 111.345 178.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.424 ' N ' HG21 ' A' ' 190' ' ' VAL . 4.6 ttp180 -85.68 -151.3 0.15 Allowed 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 177.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -93.84 25.8 3.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 118.509 0.595 . . . . 0.0 110.892 178.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -155.12 -67.57 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.498 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -121.16 -156.34 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-N 115.297 -0.452 . . . . 0.0 110.84 -178.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 58.3 t -87.39 136.28 23.41 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 CA-C-O 121.287 0.565 . . . . 0.0 111.632 -179.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . 0.524 HG23 ' HB3' ' A' ' 183' ' ' LEU . 0.1 OUTLIER -89.57 -33.86 6.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.099 -0.955 . . . . 0.0 108.914 178.614 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . 1.627 ' HE1' ' CE2' ' A' ' 191' ' ' TYR . 16.0 t80 -162.5 157.04 21.73 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.386 -0.825 . . . . 0.0 112.273 178.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -149.94 160.08 43.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.902 178.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 133.46 -115.4 1.52 Allowed Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.519 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . 0.429 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 17.1 pt-20 -150.4 -174.87 4.88 Favored 'General case' 0 CA--C 1.496 -1.1 0 CA-C-O 121.247 0.546 . . . . 0.0 111.342 -178.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.424 ' CD1' ' HB2' ' A' ' 216' ' ' LEU . 0.4 OUTLIER -88.52 142.84 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.024 -178.921 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.75 -55.35 3.74 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.03 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 17.2 p -152.6 164.68 37.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.051 178.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 21.2 tp -135.16 110.25 8.87 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.417 0.627 . . . . 0.0 111.419 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 45.4 mttt -137.79 126.91 24.36 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.308 179.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 27.8 ttm180 . . . . . 0 C--N 1.32 -0.71 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.274 -179.937 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 . . . . . 0 N--CA 1.452 -0.337 0 CA-C-O 120.741 0.305 . . . . 0.0 110.338 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 28.4 m -59.32 158.7 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -1.011 0 CA-C-O 121.554 0.692 . . . . 0.0 112.001 -179.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . 0.436 ' O ' ' HB ' ' A' ' 176' ' ' THR . 4.0 ttp180 -89.43 -38.03 14.38 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.505 -178.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -141.2 177.46 8.07 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.073 0.463 . . . . 0.0 111.418 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -151.28 79.78 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.462 178.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -104.49 173.34 6.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.065 0.459 . . . . 0.0 112.204 -178.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 84.22 -71.61 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.104 -179.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 178.05 37.6 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.394 179.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -104.51 140.56 37.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.983 0.421 . . . . 0.0 111.233 -179.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -93.26 152.75 18.99 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.28 179.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 2.3 m -150.54 145.55 26.02 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.767 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -88.26 106.35 3.23 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.484 -0.865 . . . . 0.0 110.998 179.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.424 ' HB2' ' CD1' ' A' ' 195' ' ' ILE . 0.2 OUTLIER -133.53 145.34 50.04 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 120.993 0.425 . . . . 0.0 111.789 -178.055 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.64 140.79 29.48 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . 0.467 ' CG2' ' CD2' ' A' ' 191' ' ' TYR . 1.6 mp -108.5 94.03 2.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 121.028 -0.269 . . . . 0.0 110.427 -179.158 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 6.1 tttp 42.16 -143.7 0.08 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.133 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 32.1 t30 -87.87 63.71 7.54 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 120.901 0.381 . . . . 0.0 110.9 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . 0.48 ' CZ ' ' CD1' ' A' ' 183' ' ' LEU . 0.1 OUTLIER -54.98 118.01 3.93 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 114.595 1.332 . . . . 0.0 114.595 178.835 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -83.07 -43.55 16.16 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.586 176.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . 0.409 ' O ' ' CD1' ' A' ' 221' ' ' PHE . 0.0 OUTLIER -89.73 129.97 36.06 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.023 178.264 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.414 ' CG2' ' CG2' ' A' ' 164' ' ' THR . 2.0 pt -114.67 178.95 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 CA-C-O 121.191 0.519 . . . . 0.0 111.551 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . 0.47 ' O ' ' N ' ' A' ' 227' ' ' GLY . 11.2 mtpt 62.38 155.63 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.098 -178.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . 0.477 ' HB3' ' O ' ' A' ' 154' ' ' ARG . 0.6 OUTLIER -45.08 90.35 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 121.199 0.523 . . . . 0.0 111.77 -179.461 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 225' ' ' LYS . . . -83.35 -57.97 2.39 Favored Glycine 0 N--CA 1.428 -1.885 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 178.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . 0.413 ' CG ' ' HA ' ' A' ' 185' ' ' ARG . 1.0 OUTLIER -163.83 -148.89 0.13 Allowed 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 179.014 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 46.1 t -90.33 149.38 4.07 Favored 'Isoleucine or valine' 0 C--N 1.341 0.218 0 CA-C-O 120.75 0.31 . . . . 0.0 110.771 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 2.7 mp -120.17 153.41 23.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.77 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' GLU . . . . . 0.445 ' O ' ' N ' ' A' ' 182' ' ' ARG . 0.0 OUTLIER -144.14 109.97 5.31 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.357 0.598 . . . . 0.0 112.559 -179.053 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.65 127.46 35.57 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.598 178.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' TYR . . . . . 1.663 ' HE2' ' CE1' ' A' ' 233' ' ' TYR . 26.1 p90 -123.02 140.59 52.87 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.013 0.435 . . . . 0.0 111.403 -178.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.538 0.496 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.04 179.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.132 0 CA-C-O 120.608 0.242 . . . . 0.0 110.583 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.412 HG11 ' HG3' ' A' ' 150' ' ' GLN . 19.5 t -58.77 141.53 15.62 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.559 0 CA-C-O 121.394 0.616 . . . . 0.0 111.559 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.412 HG12 ' N ' ' A' ' 234' ' ' VAL . 1.3 pt -123.7 -8.38 7.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.074 178.247 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -174.63 74.56 0.08 OUTLIER Glycine 0 C--N 1.344 0.981 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.114 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.412 ' HG3' HG11 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -89.38 136.8 32.82 Favored 'General case' 0 CA--C 1.506 -0.725 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.255 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.411 ' CB ' ' HB2' ' A' ' 168' ' ' CYS . . . -151.35 169.15 22.69 Favored 'General case' 0 N--CA 1.435 -1.176 0 C-N-CA 120.164 -0.615 . . . . 0.0 112.387 -178.03 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -119.85 124.98 47.4 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.024 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.487 HG12 ' HA ' ' A' ' 226' ' ' GLU . 4.0 p -55.9 128.15 15.79 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 CA-C-O 121.325 0.583 . . . . 0.0 111.771 -179.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . 0.414 ' CA ' ' NE ' ' A' ' 154' ' ' ARG . 0.0 OUTLIER -89.99 -53.54 4.44 Favored 'General case' 0 N--CA 1.429 -1.521 0 N-CA-C 105.175 -2.158 . . . . 0.0 105.175 175.982 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.425 ' HA ' ' H ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER -162.33 -163.36 0.91 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 114.016 -1.447 . . . . 0.0 110.482 175.233 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.541 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 6.0 p -148.09 -179.57 7.02 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 177.28 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.473 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 0.2 OUTLIER -133.29 79.41 1.83 Allowed 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -179.911 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? -86.34 62.25 7.31 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 177.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.419 HG23 ' CD1' ' A' ' 157' ' ' PHE . 54.6 t -92.31 156.05 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 CA-C-N 113.633 -1.622 . . . . 0.0 110.455 -178.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 52.3 m -90.86 34.81 0.9 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.125 0.488 . . . . 0.0 109.797 178.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.51 -32.76 0.18 Allowed 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.291 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 89.9 t -101.53 -104.02 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.26 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -159.7 -98.27 0.13 Allowed Glycine 0 N--CA 1.451 -0.347 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 178.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.92 34.83 0.44 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 113.996 -1.102 . . . . 0.0 108.246 177.692 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.473 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 1.8 mm -41.56 94.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.44 -179.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.541 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . -84.06 117.57 23.51 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 114.767 -1.106 . . . . 0.0 112.416 -179.189 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -88.29 136.95 14.08 Favored Glycine 0 N--CA 1.439 -1.109 0 N-CA-C 109.934 -1.267 . . . . 0.0 109.934 178.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . 0.411 ' HB2' ' CB ' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -138.43 132.66 31.71 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.938 0.369 . . . . 0.0 110.838 -178.023 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . 1.647 ' HD1' ' CD2' ' A' ' 169' ' ' TYR . 11.7 t80 -86.8 133.37 33.65 Favored 'General case' 0 C--O 1.222 -0.368 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 177.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 44.2 t -85.73 143.55 11.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -176.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.1 p -135.28 13.57 3.53 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 114.719 -1.128 . . . . 0.0 112.041 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -150.01 -146.71 0.21 Allowed 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -179.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -42.12 -102.5 0.01 OUTLIER Glycine 0 CA--C 1.532 1.117 0 N-CA-C 114.777 0.671 . . . . 0.0 114.777 -179.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.404 ' O ' ' O ' ' A' ' 148' ' ' ILE . 6.3 mttt -150.75 134.61 16.65 Favored 'General case' 0 CA--C 1.514 -0.407 0 O-C-N 122.696 -0.297 . . . . 0.0 111.19 -178.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . 0.409 ' O ' ' CG2' ' A' ' 175' ' ' ILE . 1.1 tp -95.18 83.51 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-O 122.195 0.997 . . . . 0.0 108.948 177.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 0.0 OUTLIER -90.97 -177.61 4.98 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.501 -1.227 . . . . 0.0 113.144 -176.565 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 46.9 mtm180 -76.58 -45.57 29.79 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 114.572 -1.194 . . . . 0.0 111.206 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -88.96 60.64 5.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.104 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 74.7 m -147.81 160.08 43.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.828 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 0.0 OUTLIER -88.55 178.69 6.45 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.171 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 2.9 m -146.73 149.17 16.11 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.539 0 CA-C-O 121.449 0.642 . . . . 0.0 112.165 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . 0.457 ' N ' ' O ' ' A' ' 231' ' ' GLU . 2.7 ttt180 -154.11 100.28 2.31 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.822 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.492 ' CB ' ' HA ' ' A' ' 230' ' ' ILE . 0.6 OUTLIER -99.54 165.79 11.46 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-O 121.21 0.528 . . . . 0.0 110.8 179.767 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.435 ' N ' HG23 ' A' ' 190' ' ' VAL . 42.8 mt -157.5 141.32 7.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.467 -178.272 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 30.8 ptt180 -87.75 -157.2 0.39 Allowed 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 177.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -93.72 30.6 1.75 Allowed 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.004 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -153.45 -45.47 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.7 -0.762 . . . . 0.0 113.053 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.43 ' CG2' ' N ' ' A' ' 189' ' ' VAL . 0.2 OUTLIER -150.49 -162.95 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-O 120.945 0.402 . . . . 0.0 112.022 -178.035 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.43 ' N ' ' CG2' ' A' ' 188' ' ' ILE . 21.9 t -85.85 133.2 30.17 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.531 0 CA-C-O 121.505 0.669 . . . . 0.0 109.842 179.011 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . 0.454 HG23 ' HG ' ' A' ' 183' ' ' LEU . 0.5 OUTLIER -88.38 -35.08 7.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.738 -179.187 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . 1.627 ' HD1' ' CD2' ' A' ' 191' ' ' TYR . 0.4 OUTLIER -176.94 166.5 2.48 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.544 179.735 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -151.11 158.5 44.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.924 0.392 . . . . 0.0 111.072 179.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 143.95 -131.47 4.45 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.917 -0.658 . . . . 0.0 111.687 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . 0.415 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 4.4 pt-20 -133.27 -177.6 4.6 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-O 121.237 0.541 . . . . 0.0 111.003 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 1.1 tt -88.08 149.07 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.293 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.959 -178.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.48 -60.35 1.97 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 179.029 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 9.7 t -152.02 151.1 30.72 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.532 178.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 10.9 tp -125.93 118.63 25.82 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.481 0.658 . . . . 0.0 111.644 -179.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -150.23 121.09 7.6 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.593 179.009 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . 0.432 ' NH1' ' CD1' ' A' ' 212' ' ' TYR . 3.5 ttm180 . . . . . 0 C--N 1.323 -0.578 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.342 -179.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 23.9 p30 . . . . . 0 N--CA 1.452 -0.331 0 CA-C-O 121.188 0.518 . . . . 0.0 109.817 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 33.1 m -55.45 160.8 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.925 0 CA-C-O 121.595 0.712 . . . . 0.0 112.549 -178.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . 0.417 ' O ' ' HA ' ' A' ' 176' ' ' THR . 4.8 ttm180 -89.3 -37.26 15.06 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 114.642 -1.163 . . . . 0.0 111.524 -178.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -138.04 179.41 6.45 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.159 0.504 . . . . 0.0 111.512 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -150.94 78.4 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.842 179.283 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -97.44 170.31 9.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.052 0.453 . . . . 0.0 112.151 -178.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 85.89 -74.99 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.155 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . 0.403 ' O ' ' CE2' ' A' ' 169' ' ' TYR . . . 177.86 37.7 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.219 -0.991 . . . . 0.0 112.494 179.11 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . 0.432 ' CD1' ' NH1' ' A' ' 200' ' ' ARG . 1.6 m-85 -95.17 148.62 22.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.966 0.413 . . . . 0.0 111.414 -179.343 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -89.54 159.12 17.37 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.095 179.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 10.3 p -150.95 -177.88 6.27 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.182 0.515 . . . . 0.0 111.642 -179.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -136.71 105.83 0.53 Allowed Glycine 0 N--CA 1.452 -0.3 0 N-CA-C 110.086 -1.205 . . . . 0.0 110.086 178.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -138.86 144.68 39.32 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -177.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.39 -179.06 6.58 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 176.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 49.8 mm -141.11 81.66 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 120.024 -0.67 . . . . 0.0 112.737 -178.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 13.7 tttt 44.08 -134.95 0.57 Allowed 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 121.177 -0.209 . . . . 0.0 110.695 177.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -87.7 53.62 2.84 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.088 0.47 . . . . 0.0 110.645 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . 1.662 ' HE1' ' CE2' ' A' ' 221' ' ' PHE . 1.2 t80 -56.96 153.52 11.07 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 117.332 2.345 . . . . 0.0 117.332 179.336 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . 0.432 ' HB2' ' CE1' ' A' ' 191' ' ' TYR . 7.8 t-20 -122.52 -49.34 2.02 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 112.957 -1.928 . . . . 0.0 111.481 178.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . 0.454 ' OD1' ' N ' ' A' ' 224' ' ' ILE . 0.0 OUTLIER -61.28 163.82 6.05 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 -178.463 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.454 ' N ' ' OD1' ' A' ' 223' ' ' ASP . 17.4 pt -154.13 -178.31 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 176.4 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 34.4 100.65 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 114.466 -1.243 . . . . 0.0 111.926 -179.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . 0.487 ' HA ' HG12 ' A' ' 153' ' ' VAL . 38.1 tt0 25.95 57.44 0.06 Allowed 'General case' 0 N--CA 1.482 1.169 0 O-C-N 124.294 0.996 . . . . 0.0 112.277 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . 0.411 ' HA3' ' OD1' ' A' ' 223' ' ' ASP . . . -57.83 -69.83 1.16 Allowed Glycine 0 N--CA 1.429 -1.775 0 CA-C-N 114.411 -1.268 . . . . 0.0 113.14 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . 0.4 ' O ' ' HB ' ' A' ' 153' ' ' VAL . 8.3 m-20 -157.58 -159.67 0.86 Allowed 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 -178.233 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . 0.447 ' O ' ' HB2' ' A' ' 183' ' ' LEU . 69.7 t -88.21 136.09 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 O-C-N 122.142 -0.349 . . . . 0.0 110.308 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . 0.492 ' HA ' ' CB ' ' A' ' 183' ' ' LEU . 5.3 mp -102.64 158.52 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 O-C-N 123.639 0.587 . . . . 0.0 111.257 -179.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' GLU . . . . . 0.457 ' O ' ' N ' ' A' ' 182' ' ' ARG . 5.2 tm-20 -147.14 109.57 4.56 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.41 130.05 34.81 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.474 178.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' TYR . . . . . 1.625 ' HE2' ' CE1' ' A' ' 233' ' ' TYR . 5.7 p90 -132.81 141.96 48.74 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.047 -178.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.412 ' N ' HG12 ' A' ' 148' ' ' ILE . 0.3 OUTLIER . . . . . 0 CA--C 1.535 0.382 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.746 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 17.3 tttt . . . . . 0 N--CA 1.462 0.158 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 3.5 t -60.05 140.24 18.39 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.871 0 CA-C-O 121.254 0.55 . . . . 0.0 111.209 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.459 ' O ' ' O ' ' A' ' 174' ' ' LYS . 3.3 tp -132.61 -3.05 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.225 177.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -165.77 66.71 0.21 Allowed Glycine 0 C--N 1.341 0.825 0 C-N-CA 119.982 -1.104 . . . . 0.0 112.496 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.44 ' HA ' ' HA ' ' A' ' 231' ' ' GLU . 1.3 mt-30 -90.0 132.48 35.33 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.41 ' CB ' ' HB2' ' A' ' 168' ' ' CYS . . . -152.54 178.33 9.69 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 -177.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.7 124.18 42.17 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.693 -1.14 . . . . 0.0 110.373 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.489 ' CG1' ' HA ' ' A' ' 226' ' ' GLU . 2.7 p -49.5 133.06 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -179.209 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . 0.473 ' O ' ' HB3' ' A' ' 226' ' ' GLU . 4.3 mmp_? -89.56 -62.16 1.54 Allowed 'General case' 0 N--CA 1.434 -1.248 0 N-CA-C 105.08 -2.193 . . . . 0.0 105.08 175.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.51 -160.08 0.5 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 113.671 -1.604 . . . . 0.0 108.698 174.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.496 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 7.6 p -148.97 159.3 44.33 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.871 0.367 . . . . 0.0 110.232 177.342 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.61 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 2.6 m-85 -104.42 73.95 1.14 Allowed 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -177.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -85.9 63.42 8.03 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 122.08 0.943 . . . . 0.0 108.794 178.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.419 HG12 ' N ' ' A' ' 160' ' ' SER . 93.1 t -90.09 158.1 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-N 113.752 -1.567 . . . . 0.0 110.02 -179.37 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' SER . . . . . 0.419 ' N ' HG12 ' A' ' 159' ' ' VAL . 13.9 m -92.52 33.32 1.12 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.132 0.491 . . . . 0.0 110.004 178.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -151.84 -31.78 0.15 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.639 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 93.0 t -99.47 -101.94 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.203 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -158.79 -104.33 0.2 Allowed Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 111.728 -0.549 . . . . 0.0 111.728 179.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' THR . . . . . 0.421 ' CG2' ' CG2' ' A' ' 224' ' ' ILE . 0.0 OUTLIER -153.78 35.63 0.44 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 114.299 -0.95 . . . . 0.0 108.771 178.355 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.61 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 1.7 mp -42.8 95.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-N 115.327 -0.852 . . . . 0.0 111.342 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.496 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . -87.19 120.79 28.84 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 114.649 -1.16 . . . . 0.0 111.859 -179.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -89.46 149.91 20.92 Favored Glycine 0 N--CA 1.442 -0.93 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 178.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . 0.41 ' HB2' ' CB ' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -144.55 133.78 22.96 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 117.061 0.431 . . . . 0.0 110.21 -179.279 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . 1.655 ' HD1' ' CD2' ' A' ' 169' ' ' TYR . 1.1 t80 -86.94 127.51 35.07 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 178.262 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 36.7 t -85.21 142.97 12.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -175.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -132.76 9.16 4.21 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 114.289 -1.323 . . . . 0.0 111.921 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -142.67 -142.42 0.14 Allowed 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -179.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -48.26 -104.84 0.01 OUTLIER Glycine 0 CA--C 1.535 1.294 0 C-N-CA 120.636 -0.792 . . . . 0.0 114.387 -179.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.459 ' O ' ' O ' ' A' ' 148' ' ' ILE . 0.0 OUTLIER -145.45 133.91 21.94 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.003 0.521 . . . . 0.0 110.849 -179.276 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 9.0 tp -88.5 84.12 2.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 122.26 1.029 . . . . 0.0 109.425 178.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 0.6 OUTLIER -85.99 -174.42 5.09 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.327 -1.306 . . . . 0.0 113.924 -176.585 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -84.71 -45.99 11.89 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 114.417 -1.265 . . . . 0.0 111.439 -179.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -88.72 52.89 2.54 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.589 -178.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -139.66 161.24 38.0 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.882 179.15 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 1.1 mptt -88.65 -172.21 3.64 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 3.0 m -141.35 161.03 22.22 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.647 0 CA-C-O 121.4 0.619 . . . . 0.0 111.883 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . 0.434 ' HB3' ' HB3' ' A' ' 231' ' ' GLU . 8.4 ttt85 -152.09 92.8 1.75 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.04 -0.982 . . . . 0.0 112.099 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.479 ' CD2' ' CZ ' ' A' ' 221' ' ' PHE . 5.7 mp -88.37 142.33 27.82 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -178.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 17.3 mm -150.56 128.73 2.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 113.05 -1.886 . . . . 0.0 111.36 179.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.405 ' N ' ' CG2' ' A' ' 190' ' ' VAL . 4.0 ttp180 -88.83 -148.09 0.17 Allowed 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 177.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -95.79 28.33 3.11 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 118.473 0.579 . . . . 0.0 110.726 178.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -153.87 -83.6 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.792 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -110.22 -157.78 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 115.427 -0.387 . . . . 0.0 110.657 -179.204 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 41.4 t -87.41 135.62 24.92 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 CA-C-O 121.751 0.786 . . . . 0.0 111.262 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . 0.417 HG22 ' CB ' ' A' ' 228' ' ' ASP . 0.1 OUTLIER -97.3 -34.04 4.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 114.426 -1.261 . . . . 0.0 109.411 179.76 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . 0.497 ' HB2' ' CE1' ' A' ' 221' ' ' PHE . 41.8 t80 -167.86 154.0 7.54 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.327 -0.852 . . . . 0.0 112.453 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . 0.471 ' N ' ' CD1' ' A' ' 191' ' ' TYR . 50.7 mt-10 -150.16 158.28 43.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.067 178.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 133.97 -120.48 2.51 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.427 -0.892 . . . . 0.0 112.761 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . 0.449 ' CG ' ' N ' ' A' ' 195' ' ' ILE . 0.0 OUTLIER -147.92 179.53 7.66 Favored 'General case' 0 CA--C 1.503 -0.857 0 CA-C-O 121.706 0.765 . . . . 0.0 111.797 -179.04 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.449 ' N ' ' CG ' ' A' ' 194' ' ' GLU . 32.9 mm -92.57 153.06 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.308 0 CA-C-N 114.35 -1.295 . . . . 0.0 110.186 -179.186 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -89.97 -58.52 2.48 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 36.4 p -150.6 156.73 41.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.85 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.405 ' CD1' ' CD2' ' A' ' 216' ' ' LEU . 5.9 tp -127.88 115.78 19.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.172 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 5.1 ptpt -150.09 120.0 7.13 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.195 -0.912 . . . . 0.0 109.564 179.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.523 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.328 -179.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 22.7 t70 . . . . . 0 N--CA 1.453 -0.324 0 CA-C-O 121.247 0.546 . . . . 0.0 110.022 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 31.9 m -53.91 160.87 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.969 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.352 -179.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . 0.435 ' O ' ' HA ' ' A' ' 176' ' ' THR . 0.0 OUTLIER -88.86 -36.73 15.83 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.321 -178.859 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.419 ' HA ' ' HA ' ' A' ' 176' ' ' THR . 0.6 OUTLIER -133.71 176.78 8.24 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.268 0.556 . . . . 0.0 111.821 179.926 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -150.38 84.24 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.759 179.129 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -99.99 178.82 4.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.096 0.474 . . . . 0.0 112.086 -178.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 81.9 -75.01 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.698 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . 0.405 ' O ' ' CE1' ' A' ' 169' ' ' TYR . . . 178.42 37.65 0.06 OUTLIER Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.347 179.033 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . 1.634 ' HD1' ' CD2' ' A' ' 212' ' ' TYR . 1.1 m-85 -101.75 143.2 31.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.917 0.389 . . . . 0.0 111.372 -179.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . 0.425 ' CG ' ' CD2' ' A' ' 169' ' ' TYR . 0.0 OUTLIER -98.56 131.5 44.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.454 179.943 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 34.6 t -125.84 145.52 50.2 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.333 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -88.38 113.81 4.12 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.148 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.405 ' CD2' ' CD1' ' A' ' 198' ' ' LEU . 0.5 OUTLIER -133.81 147.35 51.23 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 120.839 0.352 . . . . 0.0 111.073 -179.26 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.01 138.45 31.97 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 177.038 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . 0.445 HG23 ' CD1' ' A' ' 191' ' ' TYR . 19.1 mm -91.33 52.61 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.086 0.469 . . . . 0.0 112.193 -177.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 4.6 tptm 61.48 -72.08 0.04 OUTLIER 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.642 178.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' ASN . . . . . 0.426 ' N ' ' O ' ' A' ' 218' ' ' ILE . 5.0 p-10 -145.43 51.45 1.2 Allowed 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.253 -179.089 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . 0.497 ' CE1' ' HB2' ' A' ' 191' ' ' TYR . 0.1 OUTLIER -57.3 118.49 5.16 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 178.33 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -77.84 -46.3 21.88 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 176.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . 0.438 ' O ' ' CD1' ' A' ' 221' ' ' PHE . 0.0 OUTLIER -88.09 130.39 35.02 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 177.48 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.421 ' CG2' ' CG2' ' A' ' 164' ' ' THR . 0.2 OUTLIER -117.31 176.77 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 CA-C-O 121.438 0.637 . . . . 0.0 112.466 -179.283 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . 0.463 ' O ' ' N ' ' A' ' 227' ' ' GLY . 10.4 mtmt 62.06 154.28 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.231 -178.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . 0.489 ' HA ' ' CG1' ' A' ' 153' ' ' VAL . 0.2 OUTLIER -39.99 90.77 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 122.235 1.017 . . . . 0.0 111.845 179.939 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 225' ' ' LYS . . . -106.66 -38.85 2.14 Favored Glycine 0 N--CA 1.429 -1.805 0 CA-C-N 114.356 -1.293 . . . . 0.0 112.207 -178.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . 0.417 ' CB ' HG22 ' A' ' 190' ' ' VAL . 2.9 p30 -157.95 -166.7 2.03 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 115.736 1.754 . . . . 0.0 115.736 -178.166 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 40.6 t -97.98 142.48 14.4 Favored 'Isoleucine or valine' 0 C--N 1.343 0.326 0 CA-C-N 114.441 -1.254 . . . . 0.0 108.075 177.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 3.9 mp -115.48 150.89 17.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.091 0.472 . . . . 0.0 111.831 -178.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' GLU . . . . . 0.44 ' HA ' ' HA ' ' A' ' 150' ' ' GLN . 7.4 tt0 -137.69 108.73 6.75 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.271 0.558 . . . . 0.0 110.731 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.8 124.19 33.36 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.808 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -123.62 166.97 14.57 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.709 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 9.8 p . . . . . 0 C--N 1.326 -0.444 0 C-N-CA 121.076 -0.249 . . . . 0.0 110.98 -179.627 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.632 0.253 . . . . 0.0 110.57 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 15.0 t -60.13 139.84 19.03 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 CA-C-O 121.463 0.649 . . . . 0.0 111.356 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.406 ' O ' ' O ' ' A' ' 174' ' ' LYS . 6.9 tp -114.13 -18.97 7.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.231 178.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 178.97 85.9 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.339 -179.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.44 135.05 34.12 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -150.78 173.14 14.55 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 -177.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.437 ' HA ' ' HA ' ' A' ' 229' ' ' VAL . 0.4 OUTLIER -117.51 122.82 44.75 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.091 179.715 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.438 HG12 ' HA ' ' A' ' 226' ' ' GLU . 2.7 p -55.65 128.92 16.52 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.338 0 CA-C-O 121.326 0.584 . . . . 0.0 111.65 -179.42 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . 0.419 ' CA ' ' NE ' ' A' ' 154' ' ' ARG . 0.0 OUTLIER -89.2 -58.38 2.56 Favored 'General case' 0 N--CA 1.427 -1.606 0 N-CA-C 105.288 -2.115 . . . . 0.0 105.288 176.203 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.404 ' HA ' ' HB3' ' A' ' 226' ' ' GLU . 0.0 OUTLIER -163.1 -163.23 0.83 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.691 174.906 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.543 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 7.0 p -147.57 149.01 31.76 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 1.662 ' HD1' ' CD2' ' A' ' 157' ' ' PHE . 0.2 OUTLIER -94.4 80.3 3.92 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -177.984 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 13.8 tttm -85.88 63.69 8.18 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.415 HG12 ' N ' ' A' ' 160' ' ' SER . 69.9 t -93.21 157.06 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-N 113.652 -1.613 . . . . 0.0 110.231 -178.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' SER . . . . . 0.415 ' N ' HG12 ' A' ' 159' ' ' VAL . 1.0 OUTLIER -92.07 35.45 0.99 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.208 0.528 . . . . 0.0 109.655 178.129 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 5.0 mttt -151.47 -35.32 0.14 Allowed 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.084 -179.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 95.5 t -97.85 -102.24 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -159.33 -102.8 0.18 Allowed Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 178.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' THR . . . . . 0.416 ' CG2' ' CG2' ' A' ' 224' ' ' ILE . 0.0 OUTLIER -153.68 35.2 0.45 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.087 -1.056 . . . . 0.0 108.271 177.404 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.493 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 1.5 mp -42.92 96.02 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.541 -179.448 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.543 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . -80.39 118.67 22.23 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.697 -1.138 . . . . 0.0 112.194 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -88.75 141.86 16.73 Favored Glycine 0 N--CA 1.441 -1.022 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 178.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -141.01 132.39 26.76 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.879 0.339 . . . . 0.0 110.488 -178.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . 1.664 ' HD2' ' CD1' ' A' ' 169' ' ' TYR . 47.5 t80 -85.59 129.36 34.84 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.247 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 31.8 t -85.73 149.28 4.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -175.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -140.09 15.12 2.44 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 114.427 -1.261 . . . . 0.0 111.826 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -150.6 -145.26 0.17 Allowed 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -43.48 -105.18 0.01 OUTLIER Glycine 0 CA--C 1.53 0.997 0 N-CA-C 114.84 0.696 . . . . 0.0 114.84 -179.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.406 ' O ' ' O ' ' A' ' 148' ' ' ILE . 7.6 mttt -151.44 144.28 24.44 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.999 0.428 . . . . 0.0 112.013 -178.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 10.3 mm -89.91 87.34 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 176.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -98.1 165.7 11.77 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -176.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 20.6 mtm105 -64.85 -44.45 89.75 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 114.55 -1.204 . . . . 0.0 111.083 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -89.3 60.15 5.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.752 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 46.6 m -149.2 159.54 44.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.652 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . 0.498 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 14.9 mttp -89.62 -172.28 3.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.483 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.41 ' CG1' ' CD1' ' A' ' 195' ' ' ILE . 3.0 m -149.47 146.32 17.16 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.607 0 CA-C-O 121.554 0.692 . . . . 0.0 111.861 179.326 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . 0.448 ' N ' ' O ' ' A' ' 231' ' ' GLU . 6.0 ttm180 -154.45 98.83 2.14 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.722 -1.126 . . . . 0.0 112.002 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.494 ' CB ' ' HA ' ' A' ' 230' ' ' ILE . 0.3 OUTLIER -100.88 168.53 9.58 Favored 'General case' 0 N--CA 1.437 -1.093 0 C-N-CA 120.358 -0.537 . . . . 0.0 111.026 179.597 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.429 ' O ' ' HB3' ' A' ' 228' ' ' ASP . 5.3 mp -151.15 140.07 14.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.156 -177.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.47 ' N ' HG21 ' A' ' 190' ' ' VAL . 8.0 ptp180 -87.16 -155.77 0.3 Allowed 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.172 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -93.6 27.23 2.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 118.327 0.512 . . . . 0.0 111.385 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -154.4 -43.87 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.966 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.428 ' CG2' ' N ' ' A' ' 189' ' ' VAL . 0.4 OUTLIER -150.14 -159.34 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 120.679 0.276 . . . . 0.0 111.711 -177.969 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.428 ' N ' ' CG2' ' A' ' 188' ' ' ILE . 39.8 t -85.13 135.13 25.49 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 CA-C-O 121.564 0.697 . . . . 0.0 110.349 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . 0.47 HG21 ' N ' ' A' ' 185' ' ' ARG . 0.3 OUTLIER -87.99 -35.04 7.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.347 -179.848 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . 1.615 ' HE2' ' CE1' ' A' ' 191' ' ' TYR . 0.6 OUTLIER -176.66 155.3 1.31 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.042 -179.994 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -141.7 161.14 38.67 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.884 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 141.28 -137.31 8.03 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 111.377 -0.689 . . . . 0.0 111.377 -179.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 7.2 pt-20 -131.97 -176.07 3.94 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-O 121.011 0.434 . . . . 0.0 111.169 179.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.41 ' CD1' ' CG1' ' A' ' 181' ' ' VAL . 5.8 mm -87.21 159.11 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.687 -178.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -103.16 -56.98 2.12 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 18.1 p -151.58 155.01 37.58 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.543 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.412 ' CD2' ' HB3' ' A' ' 216' ' ' LEU . 13.6 mt -117.11 128.22 54.92 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.927 179.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 10.8 ptpt -151.09 118.45 6.0 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.473 178.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 6.6 ttp180 . . . . . 0 C--N 1.321 -0.668 0 CA-C-O 121.433 0.635 . . . . 0.0 111.525 -178.778 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 . . . . . 0 N--CA 1.452 -0.341 0 CA-C-O 120.739 0.304 . . . . 0.0 110.731 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 27.6 m -66.48 155.42 7.19 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.915 0 CA-C-O 121.332 0.587 . . . . 0.0 111.671 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 2.7 mtp180 -89.37 -32.74 17.16 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.388 -178.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -150.06 179.0 8.42 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.921 0.391 . . . . 0.0 110.713 179.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 1.8 t -151.07 80.34 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.828 178.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -102.68 174.53 5.85 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 83.11 -74.33 0.03 OUTLIER 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.09 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 178.11 37.21 0.06 OUTLIER Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.392 -0.909 . . . . 0.0 112.385 179.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . 1.629 ' HD1' ' CD2' ' A' ' 212' ' ' TYR . 0.5 OUTLIER -98.17 144.69 27.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.919 0.39 . . . . 0.0 111.274 -179.428 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -96.77 130.11 44.08 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.872 179.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 33.6 t -128.75 144.93 51.28 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.775 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -88.77 110.64 3.69 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.634 -0.793 . . . . 0.0 111.761 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.412 ' HB3' ' CD2' ' A' ' 198' ' ' LEU . 0.1 OUTLIER -129.0 144.37 51.16 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.116 0.484 . . . . 0.0 111.111 -179.229 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -107.09 141.69 37.92 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 178.147 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . 0.479 ' HB ' ' HB2' ' A' ' 221' ' ' PHE . 18.4 mm -90.72 140.45 15.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.241 0.544 . . . . 0.0 110.571 -179.344 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt -42.0 -30.1 0.26 Allowed 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -177.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 220' ' ' ASN . . . . . 0.425 ' O ' ' CE2' ' A' ' 191' ' ' TYR . 5.0 t30 -152.46 35.08 0.51 Allowed 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -178.335 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . 0.479 ' HB2' ' HB ' ' A' ' 218' ' ' ILE . 0.1 OUTLIER -58.84 120.09 8.37 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 178.891 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -88.11 -46.97 8.85 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 176.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . 0.464 ' OD1' ' N ' ' A' ' 223' ' ' ASP . 0.0 OUTLIER -79.54 136.25 36.83 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.063 177.403 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.416 ' CG2' ' CG2' ' A' ' 164' ' ' THR . 0.2 OUTLIER -133.28 178.9 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -178.859 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . 0.412 ' O ' ' C ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER 57.46 116.8 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.853 -178.862 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . 0.438 ' HA ' HG12 ' A' ' 153' ' ' VAL . 0.5 OUTLIER 6.91 63.95 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 124.51 1.124 . . . . 0.0 113.814 -179.545 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -61.39 -66.73 2.48 Favored Glycine 0 N--CA 1.434 -1.497 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.739 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . 0.429 ' HB3' ' O ' ' A' ' 184' ' ' ILE . 0.8 OUTLIER -165.07 -148.21 0.11 Allowed 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 114.279 1.215 . . . . 0.0 114.279 179.686 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 73.0 t -89.14 130.2 38.89 Favored 'Isoleucine or valine' 0 C--N 1.345 0.381 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . 0.494 ' HA ' ' CB ' ' A' ' 183' ' ' LEU . 22.6 mt -101.04 158.32 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.119 0 O-C-N 123.66 0.6 . . . . 0.0 111.332 -179.118 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 231' ' ' GLU . . . . . 0.448 ' O ' ' N ' ' A' ' 182' ' ' ARG . 16.1 tt0 -144.85 111.0 5.51 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.3 0.572 . . . . 0.0 112.522 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.67 122.83 31.85 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.948 178.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' TYR . . . . . 1.66 ' HD2' ' CD1' ' A' ' 233' ' ' TYR . 11.1 p90 -123.84 141.27 52.18 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.022 -179.113 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.54 0.593 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.017 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 33.2 mttp . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.665 0.269 . . . . 0.0 110.302 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 4.3 t -108.43 141.96 22.32 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.739 0 CA-C-O 121.435 0.636 . . . . 0.0 110.727 179.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.412 HG13 ' HA ' ' A' ' 233' ' ' TYR . 2.6 pp -128.99 -8.85 3.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.635 179.203 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -174.04 75.0 0.09 OUTLIER Glycine 0 C--N 1.341 0.817 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.831 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.414 ' CG ' ' CG ' ' A' ' 231' ' ' GLU . 0.0 OUTLIER -90.39 137.99 31.9 Favored 'General case' 0 CA--C 1.506 -0.728 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.852 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.406 ' HA ' ' O ' ' A' ' 169' ' ' TYR . . . -151.66 174.85 12.99 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 120.093 -0.643 . . . . 0.0 112.339 -178.105 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -125.12 119.37 28.4 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.507 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.429 ' CG1' ' HA ' ' A' ' 226' ' ' GLU . 1.1 p -49.07 131.23 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -178.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . 0.514 ' O ' ' HB3' ' A' ' 226' ' ' GLU . 4.0 mmp_? -91.48 -60.17 1.95 Allowed 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 105.249 -2.13 . . . . 0.0 105.249 175.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.73 -159.18 0.44 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 113.743 -1.571 . . . . 0.0 109.422 175.044 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.504 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 9.5 p -148.92 163.17 38.24 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 120.821 0.343 . . . . 0.0 110.647 177.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.608 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 3.7 m-85 -110.13 73.04 0.82 Allowed 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -178.34 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 8.2 tmtm? -85.94 64.36 8.55 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.426 HG12 ' N ' ' A' ' 160' ' ' SER . 92.4 t -92.25 158.22 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 CA-C-N 113.549 -1.66 . . . . 0.0 110.258 -178.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' SER . . . . . 0.426 ' N ' HG12 ' A' ' 159' ' ' VAL . 71.5 m -93.06 34.46 1.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.225 0.535 . . . . 0.0 109.761 178.308 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.63 -33.09 0.15 Allowed 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.386 -179.667 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 89.0 t -99.82 -102.19 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.19 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -158.85 -103.4 0.19 Allowed Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 111.522 -0.631 . . . . 0.0 111.522 179.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' THR . . . . . 0.434 ' CG2' ' CG2' ' A' ' 224' ' ' ILE . 0.0 OUTLIER -153.64 34.61 0.45 Allowed 'General case' 0 C--O 1.232 0.148 0 CA-C-N 114.311 -0.944 . . . . 0.0 108.801 178.259 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.608 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 1.6 mp -43.3 98.09 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.527 0.096 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.424 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.504 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . -87.08 122.89 31.52 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.854 -1.067 . . . . 0.0 111.698 -179.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -87.73 146.54 20.02 Favored Glycine 0 N--CA 1.442 -0.921 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 178.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . 0.403 ' HB2' ' CB ' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -147.66 134.37 19.98 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 117.279 0.539 . . . . 0.0 110.771 -178.338 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . 1.666 ' HE1' ' CE2' ' A' ' 169' ' ' TYR . 22.9 t80 -86.84 134.34 33.55 Favored 'General case' 0 C--O 1.221 -0.414 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 177.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.401 ' O ' ' CE1' ' A' ' 169' ' ' TYR . 9.2 p -86.43 146.63 6.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -176.258 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.2 p -140.95 12.01 2.23 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.557 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -150.79 -148.14 0.25 Allowed 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -41.48 -104.51 0.01 OUTLIER Glycine 0 CA--C 1.532 1.119 0 N-CA-C 115.09 0.796 . . . . 0.0 115.09 -178.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.64 128.89 11.98 Favored 'General case' 0 CA--C 1.513 -0.457 0 O-C-N 122.722 -0.281 . . . . 0.0 111.368 -178.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 1.1 tp -89.54 76.78 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 CA-C-O 122.27 1.033 . . . . 0.0 108.981 177.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.456 ' HA ' ' HA ' ' A' ' 207' ' ' GLU . 0.2 OUTLIER -84.03 173.01 11.49 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.015 -1.448 . . . . 0.0 113.543 -176.796 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 43.0 ttp85 -59.96 -51.6 68.98 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 114.2 -1.364 . . . . 0.0 111.536 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -89.55 61.92 5.72 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.68 -178.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -142.68 160.4 40.38 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.443 179.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 11.9 mttt -89.08 -174.39 4.43 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.451 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 2.4 m -150.7 145.51 16.77 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 CA-C-O 121.573 0.702 . . . . 0.0 112.111 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . 0.465 ' N ' ' O ' ' A' ' 231' ' ' GLU . 16.9 ttt180 -154.87 100.52 2.21 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.725 -1.125 . . . . 0.0 112.051 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.495 ' CB ' ' HA ' ' A' ' 230' ' ' ILE . 0.3 OUTLIER -100.15 168.83 9.57 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 120.616 -0.433 . . . . 0.0 110.878 179.551 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.453 ' O ' ' HB3' ' A' ' 228' ' ' ASP . 27.2 mt -155.5 139.55 8.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.333 -0.394 . . . . 0.0 112.017 -178.069 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.402 ' HA ' ' CG ' ' A' ' 228' ' ' ASP . 0.0 OUTLIER -86.57 -154.02 0.22 Allowed 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.081 178.174 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -94.27 29.11 2.29 Favored 'General case' 0 N--CA 1.455 -0.191 0 O-C-N 122.023 -0.423 . . . . 0.0 111.51 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -152.91 -77.41 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.319 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -115.49 -157.68 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-N 115.464 -0.368 . . . . 0.0 110.094 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 23.4 t -86.83 139.97 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 CA-C-O 121.425 0.631 . . . . 0.0 110.889 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . 0.446 HG23 ' HG ' ' A' ' 183' ' ' LEU . 0.4 OUTLIER -88.22 -35.44 8.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.011 179.883 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . 1.64 ' HD1' ' CD2' ' A' ' 191' ' ' TYR . 9.9 t80 -178.91 151.33 0.52 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.014 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -143.47 159.34 42.59 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.68 179.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 150.33 -122.9 1.46 Allowed Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.825 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . 0.482 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 8.8 pt-20 -139.31 -177.98 5.16 Favored 'General case' 0 CA--C 1.497 -1.065 0 CA-C-O 121.288 0.566 . . . . 0.0 111.207 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -88.27 142.62 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.145 -178.485 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -88.7 -61.69 1.65 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -151.94 166.05 32.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.529 178.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -139.3 122.41 16.86 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.69 0.757 . . . . 0.0 112.149 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -146.83 127.82 14.55 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 114.406 -1.27 . . . . 0.0 108.719 178.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 3.1 ttp85 . . . . . 0 C--N 1.32 -0.709 0 CA-C-O 121.51 0.671 . . . . 0.0 111.82 -178.321 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.45 -0.468 0 CA-C-O 120.695 0.283 . . . . 0.0 110.644 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 30.4 m -56.15 173.47 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.068 0 CA-C-O 120.972 0.415 . . . . 0.0 111.361 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . 0.405 ' O ' ' HB ' ' A' ' 176' ' ' THR . 2.6 ttp180 -97.34 -40.07 8.91 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.787 -178.587 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.456 ' HA ' ' HA ' ' A' ' 176' ' ' THR . 1.1 mp0 -143.12 178.12 7.92 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.29 0.567 . . . . 0.0 111.938 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -150.74 81.23 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.743 179.478 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -105.32 177.5 4.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.999 0.428 . . . . 0.0 112.043 -178.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 83.24 -72.06 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.942 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 178.63 36.88 0.06 OUTLIER Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.537 -0.839 . . . . 0.0 112.369 179.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . 1.615 ' HE1' ' CE2' ' A' ' 212' ' ' TYR . 0.5 OUTLIER -104.54 144.45 31.67 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.071 0.463 . . . . 0.0 111.746 -179.232 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -99.56 151.11 21.54 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.933 179.546 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 53.9 t -146.66 148.2 31.8 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.845 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -88.23 108.72 3.45 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.394 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -138.27 147.6 43.81 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 121.12 0.486 . . . . 0.0 112.06 -178.208 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.1 143.86 26.83 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.025 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . 0.413 ' O ' ' CG2' ' A' ' 218' ' ' ILE . 1.5 mp -109.42 92.15 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 -179.335 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 1.8 ttpp 44.43 -146.1 0.11 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.852 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -87.67 62.66 7.14 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-O 121.319 0.58 . . . . 0.0 110.808 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . 0.456 ' CD1' ' O ' ' A' ' 223' ' ' ASP . 0.1 OUTLIER -54.37 121.6 8.63 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 179.14 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -84.06 -48.66 9.67 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.287 176.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 223' ' ' ASP . 0.0 OUTLIER -81.0 125.37 30.08 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.122 177.68 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.434 ' CG2' ' CG2' ' A' ' 164' ' ' THR . 1.7 pt -115.89 176.86 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.603 0 CA-C-O 121.469 0.652 . . . . 0.0 111.884 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . 0.501 ' O ' ' N ' ' A' ' 227' ' ' GLY . 0.1 OUTLIER 63.88 149.46 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.757 -1.111 . . . . 0.0 108.635 -178.627 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . 0.514 ' HB3' ' O ' ' A' ' 154' ' ' ARG . 5.5 pt-20 -36.92 86.5 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 121.986 0.898 . . . . 0.0 112.89 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 225' ' ' LYS . . . -78.5 -60.17 2.71 Favored Glycine 0 N--CA 1.426 -2.006 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.502 179.452 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . 0.453 ' HB3' ' O ' ' A' ' 184' ' ' ILE . 1.1 t70 -165.21 -144.94 0.08 Allowed 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . 0.465 ' O ' ' HB2' ' A' ' 183' ' ' LEU . 80.2 t -89.65 134.21 29.48 Favored 'Isoleucine or valine' 0 C--N 1.349 0.555 0 C-N-CA 122.937 0.495 . . . . 0.0 109.881 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . 0.495 ' HA ' ' CB ' ' A' ' 183' ' ' LEU . 5.5 mt -103.26 158.04 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 O-C-N 123.435 0.459 . . . . 0.0 110.951 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 231' ' ' GLU . . . . . 0.465 ' O ' ' N ' ' A' ' 182' ' ' ARG . 1.4 tm-20 -148.89 109.88 4.33 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.59 128.25 35.27 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' TYR . . . . . 1.651 ' HD2' ' CD1' ' A' ' 233' ' ' TYR . 11.5 p90 -124.97 143.17 51.03 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.625 -178.164 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.4 ' CG1' HG12 ' A' ' 148' ' ' ILE . 0.3 OUTLIER . . . . . 0 CA--C 1.534 0.332 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.855 178.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 1.646 ' HE1' ' CE2' ' A' ' 143' ' ' TYR . 8.7 p90 . . . . . 0 N--CA 1.487 1.424 0 CA-C-O 120.892 0.377 . . . . 0.0 111.194 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -101.25 157.8 16.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.849 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -88.25 59.21 5.13 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.807 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -59.17 -169.13 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.938 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 17.0 t -61.69 141.06 18.12 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.595 0 CA-C-O 121.25 0.548 . . . . 0.0 111.53 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.475 HD12 HG23 ' A' ' 148' ' ' ILE . 0.3 OUTLIER -126.54 2.17 4.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.632 177.48 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 175.83 74.29 0.05 OUTLIER Glycine 0 C--N 1.341 0.847 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.356 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.71 132.86 36.08 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -151.88 174.16 13.93 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-O 121.466 0.65 . . . . 0.0 112.438 -178.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.426 ' HA ' ' HA ' ' A' ' 229' ' ' VAL . 50.4 mt-10 -118.71 122.75 43.22 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.274 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.436 ' CG1' ' HA ' ' A' ' 226' ' ' GLU . 2.4 p -52.1 132.26 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 121.257 0.551 . . . . 0.0 112.436 -178.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.41 ' O ' ' HB3' ' A' ' 226' ' ' GLU . 4.7 mmp_? -89.33 -61.48 1.69 Allowed 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 175.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.38 -163.83 0.96 Allowed 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 113.624 -1.625 . . . . 0.0 109.479 174.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.5 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 12.2 p -143.82 173.57 11.57 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 177.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.6 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 9.2 m-85 -125.5 75.5 1.48 Allowed 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -178.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -86.2 63.14 7.85 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 177.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 66.5 t -91.71 156.02 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 CA-C-N 113.603 -1.635 . . . . 0.0 110.343 -178.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 49.1 p -91.36 34.71 0.94 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.217 0.532 . . . . 0.0 109.845 178.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 1.6 mttt -150.84 -32.15 0.17 Allowed 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.358 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 91.9 t -102.11 -103.31 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -159.04 -100.44 0.16 Allowed Glycine 0 N--CA 1.451 -0.317 0 N-CA-C 111.438 -0.665 . . . . 0.0 111.438 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.437 ' CG2' ' CG2' ' A' ' 224' ' ' ILE . 0.0 OUTLIER -153.87 35.11 0.44 Allowed 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 114.209 -0.996 . . . . 0.0 108.709 178.266 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.6 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 4.2 mt -42.13 95.57 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.567 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.5 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . -88.07 119.01 28.03 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.744 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -88.07 146.82 19.94 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 178.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -147.17 135.28 21.49 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 117.248 0.524 . . . . 0.0 110.833 -178.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -86.85 124.12 32.73 Favored 'General case' 0 C--O 1.223 -0.301 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 177.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 26.9 t -85.53 147.13 5.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 -175.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.2 p -139.86 14.26 2.48 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.924 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -150.85 -144.66 0.16 Allowed 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -40.3 -105.16 0.01 OUTLIER Glycine 0 CA--C 1.534 1.246 0 N-CA-C 115.208 0.843 . . . . 0.0 115.208 -179.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 6.8 mttt -151.04 143.25 24.1 Favored 'General case' 0 CA--C 1.517 -0.315 0 O-C-N 122.557 -0.378 . . . . 0.0 111.764 -178.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 14.6 mm -95.36 78.94 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 176.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 0.0 OUTLIER -97.97 171.06 8.51 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -176.834 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.34 -39.54 74.63 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.28 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -88.58 55.14 3.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.815 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -150.18 159.65 44.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.603 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.423 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 0.0 OUTLIER -89.06 -178.49 5.7 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 179.238 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 3.3 m -149.64 146.24 17.1 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.615 0 CA-C-O 121.599 0.714 . . . . 0.0 112.028 179.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 231' ' ' GLU . 7.8 ttt180 -154.54 101.93 2.37 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.748 -1.114 . . . . 0.0 112.198 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.477 ' CB ' ' HA ' ' A' ' 230' ' ' ILE . 0.3 OUTLIER -97.46 170.54 8.98 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.636 179.234 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.421 ' O ' ' HB3' ' A' ' 228' ' ' ASP . 5.3 mp -152.08 141.32 14.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.021 -177.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.424 ' N ' HG21 ' A' ' 190' ' ' VAL . 3.6 ttm180 -86.37 -156.22 0.29 Allowed 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 178.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -93.62 26.5 3.03 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.915 179.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -154.07 -43.68 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.062 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.423 ' CG2' ' N ' ' A' ' 189' ' ' VAL . 0.4 OUTLIER -150.4 -159.74 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -178.001 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.423 ' N ' ' CG2' ' A' ' 188' ' ' ILE . 22.4 t -84.86 133.68 28.75 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 CA-C-O 121.572 0.701 . . . . 0.0 110.137 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . 0.462 HG23 ' HG ' ' A' ' 183' ' ' LEU . 0.2 OUTLIER -88.32 -38.38 11.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 114.678 -1.147 . . . . 0.0 109.223 -179.213 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . 1.666 ' HE1' ' CE2' ' A' ' 191' ' ' TYR . 19.1 t80 -169.62 162.39 9.83 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.201 178.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -150.1 157.97 43.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.041 0.448 . . . . 0.0 111.056 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 146.27 -126.42 2.49 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.077 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . 0.423 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 3.9 pt-20 -139.92 -176.9 4.75 Favored 'General case' 0 CA--C 1.498 -1.038 0 CA-C-O 121.152 0.501 . . . . 0.0 111.3 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 3.1 mp -86.85 141.44 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.39 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.351 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.08 -47.48 8.07 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 40.4 m -151.24 163.42 38.92 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.086 179.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.38 108.84 8.4 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 121.099 0.476 . . . . 0.0 111.073 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 3.3 mtpm? -150.1 118.61 6.49 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.682 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.21 -160.5 0.64 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.946 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -87.35 -9.81 53.84 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 121.243 -0.183 . . . . 0.0 111.169 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.45 -57.7 2.03 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-O 120.632 0.253 . . . . 0.0 111.142 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 26.2 p-10 -152.32 -170.62 3.69 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 120.807 0.337 . . . . 0.0 111.049 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -89.71 72.62 7.69 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.334 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 32.6 m -64.38 154.83 6.61 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.905 0 CA-C-O 121.501 0.667 . . . . 0.0 112.038 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . 0.446 ' O ' ' HA ' ' A' ' 176' ' ' THR . 4.3 ttm-85 -89.62 -29.7 18.66 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 114.868 -1.06 . . . . 0.0 112.052 -178.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -142.93 178.17 7.85 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.123 0.487 . . . . 0.0 111.078 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -151.18 75.83 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.882 179.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -98.24 172.81 7.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.053 0.454 . . . . 0.0 112.195 -178.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 83.94 -73.49 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.957 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 178.45 37.71 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.328 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . 1.671 ' HE1' ' CE2' ' A' ' 212' ' ' TYR . 4.6 m-85 -102.23 142.98 32.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.863 0.363 . . . . 0.0 111.237 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -100.17 131.72 45.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.337 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 48.6 t -133.85 148.19 51.26 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.384 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -88.54 111.47 3.79 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.016 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.73 144.76 46.06 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 120.946 0.403 . . . . 0.0 111.281 -179.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.37 149.0 27.94 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 1.7 mp -113.96 88.2 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 -179.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 2.3 tttt 45.51 -144.72 0.19 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.931 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -87.08 61.35 6.72 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 120.957 0.408 . . . . 0.0 110.889 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.456 ' CE1' ' HB2' ' A' ' 191' ' ' TYR . 0.1 OUTLIER -55.23 118.85 4.74 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 179.081 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 21.8 t30 -81.56 -47.46 13.05 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 114.804 -1.089 . . . . 0.0 108.571 176.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . 0.424 ' O ' ' CD1' ' A' ' 221' ' ' PHE . 0.0 OUTLIER -83.62 139.25 32.94 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.204 177.966 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.437 ' CG2' ' CG2' ' A' ' 164' ' ' THR . 0.2 OUTLIER -132.27 179.35 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 CA-C-O 121.276 0.56 . . . . 0.0 112.28 -179.542 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.403 ' O ' ' C ' ' A' ' 226' ' ' GLU . 0.3 OUTLIER 58.01 115.87 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.677 -178.756 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . 0.436 ' HA ' ' CG1' ' A' ' 153' ' ' VAL . 2.6 pt-20 3.64 66.62 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 124.812 1.245 . . . . 0.0 113.931 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -63.35 -62.56 5.27 Favored Glycine 0 N--CA 1.43 -1.745 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.855 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.421 ' HB3' ' O ' ' A' ' 184' ' ' ILE . 0.8 OUTLIER -164.95 -148.38 0.11 Allowed 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -179.891 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . 0.454 ' O ' ' HB2' ' A' ' 183' ' ' LEU . 96.4 t -90.37 132.23 35.54 Favored 'Isoleucine or valine' 0 C--N 1.347 0.46 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . 0.477 ' HA ' ' CB ' ' A' ' 183' ' ' LEU . 4.6 mp -98.61 158.8 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 O-C-N 123.477 0.486 . . . . 0.0 111.572 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' GLU . . . . . 0.44 ' O ' ' N ' ' A' ' 182' ' ' ARG . 7.8 tt0 -145.89 109.55 4.79 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.12 126.86 35.34 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.516 178.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' TYR . . . . . 1.612 ' HE1' ' CE2' ' A' ' 233' ' ' TYR . 5.1 p90 -132.57 140.08 48.11 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.107 -178.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.413 ' CG1' ' CG2' ' A' ' 238' ' ' VAL . 0.4 OUTLIER -176.64 -162.33 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.937 179.807 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.46 -163.49 1.01 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.691 0.281 . . . . 0.0 110.63 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -96.48 36.82 1.32 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.911 0.386 . . . . 0.0 111.366 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -125.78 44.66 2.78 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.904 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.414 ' CG2' HG13 ' A' ' 148' ' ' ILE . 11.6 t -101.93 159.4 4.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.256 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . 70.53 -62.73 0.43 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.354 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 3.4 ttp180 -89.19 -3.42 58.59 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.313 -1.015 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.11 179.983 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.808 0.337 . . . . 0.0 111.129 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -145.22 153.38 41.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.969 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.74 -72.57 0.55 Allowed 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 121.567 0.699 . . . . 0.0 111.147 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 12.7 tttt 64.57 168.14 0.17 Allowed 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.159 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 15.1 t -59.0 140.81 16.81 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.595 0 CA-C-O 121.209 0.528 . . . . 0.0 111.485 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.96 -0.85 4.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.819 177.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -176.66 72.95 0.08 OUTLIER Glycine 0 C--N 1.341 0.848 0 C-N-CA 121.109 -0.567 . . . . 0.0 111.817 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.416 ' HA ' ' HA ' ' A' ' 231' ' ' GLU . 0.0 OUTLIER -91.97 132.3 36.62 Favored 'General case' 0 CA--C 1.511 -0.532 0 O-C-N 122.514 -0.403 . . . . 0.0 110.217 179.899 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.405 ' CB ' ' HB2' ' A' ' 168' ' ' CYS . . . -152.22 177.51 10.46 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -178.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 229' ' ' VAL . 2.1 mm-40 -123.66 125.09 44.16 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.566 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.436 ' CG1' ' HA ' ' A' ' 226' ' ' GLU . 1.4 p -49.82 132.43 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -179.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.511 ' O ' ' HB3' ' A' ' 226' ' ' GLU . 4.3 mmp_? -89.58 -61.88 1.6 Allowed 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 105.232 -2.136 . . . . 0.0 105.232 175.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.29 -159.05 0.46 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 113.555 -1.657 . . . . 0.0 108.945 175.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 17.4 p -146.04 175.16 10.67 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 110.34 -0.245 . . . . 0.0 110.34 177.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.593 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 12.0 m-85 -129.06 73.25 1.5 Allowed 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -179.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 163' ' ' GLY . 4.6 ptmt -85.81 64.38 8.57 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.2 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 57.0 t -93.22 156.87 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 CA-C-N 113.294 -1.775 . . . . 0.0 110.527 -178.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 92.0 p -91.95 35.91 0.97 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.221 0.534 . . . . 0.0 109.584 178.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -150.85 -34.04 0.16 Allowed 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.165 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 89.5 t -102.18 -102.04 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 158' ' ' LYS . . . -158.54 -102.0 0.18 Allowed Glycine 0 C--O 1.226 -0.384 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.414 ' HA ' ' C ' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -153.37 34.46 0.46 Allowed 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 124.482 1.113 . . . . 0.0 108.145 177.795 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.593 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 1.6 mp -42.15 95.2 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 CA-C-N 115.063 -0.971 . . . . 0.0 112.143 -178.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.494 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . -87.8 117.89 26.95 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.416 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -87.9 149.51 21.63 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.157 -1.02 . . . . 0.0 110.761 179.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . 0.405 ' HB2' ' CB ' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -144.7 135.06 24.34 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.929 0.365 . . . . 0.0 110.537 -178.69 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -86.94 124.69 33.43 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 177.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 25.0 t -85.06 143.53 11.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -175.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -136.44 14.75 3.21 Favored 'General case' 0 CA--C 1.526 0.053 0 CA-C-N 114.475 -1.239 . . . . 0.0 111.851 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -150.36 -144.28 0.15 Allowed 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -42.06 -105.06 0.01 OUTLIER Glycine 0 CA--C 1.532 1.107 0 N-CA-C 115.055 0.782 . . . . 0.0 115.055 -179.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 17.8 mttt -150.83 143.8 24.65 Favored 'General case' 0 N--CA 1.465 0.312 0 O-C-N 122.585 -0.362 . . . . 0.0 111.582 -178.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 13.2 mm -94.96 81.64 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 176.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 0.1 OUTLIER -95.47 169.23 10.2 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -177.028 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 24.7 mtm105 -65.5 -44.46 86.98 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.977 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.16 60.59 5.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.128 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 23.8 m -149.98 161.49 42.22 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.682 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.458 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 13.5 mttt -91.46 -169.72 2.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.077 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 1.2 m -150.34 158.1 5.58 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.451 0 CA-C-O 121.235 0.541 . . . . 0.0 111.633 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . 0.443 ' N ' ' O ' ' A' ' 231' ' ' GLU . 1.6 ttt85 -152.73 100.53 2.54 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.377 -0.829 . . . . 0.0 112.88 -179.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.516 ' HB3' HG23 ' A' ' 190' ' ' VAL . 0.3 OUTLIER -85.99 156.32 20.5 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-O 121.793 0.806 . . . . 0.0 113.149 -179.608 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 28.4 mm -154.3 123.96 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 114.254 -1.339 . . . . 0.0 111.296 178.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.419 ' N ' HG21 ' A' ' 190' ' ' VAL . 0.2 OUTLIER -85.74 -150.85 0.14 Allowed 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 177.976 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.84 25.74 3.48 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 118.531 0.605 . . . . 0.0 110.81 178.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -155.03 -68.11 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.478 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -120.61 -156.68 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 115.327 -0.437 . . . . 0.0 110.901 -178.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 59.0 t -87.22 135.85 24.35 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-O 121.303 0.573 . . . . 0.0 111.506 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . 0.516 HG23 ' HB3' ' A' ' 183' ' ' LEU . 0.1 OUTLIER -89.37 -33.95 6.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.165 -0.925 . . . . 0.0 108.911 178.764 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . 1.636 ' HE1' ' CE2' ' A' ' 191' ' ' TYR . 15.8 t80 -162.71 159.31 24.14 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.45 178.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -150.17 158.08 43.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.862 178.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 133.02 -119.49 2.39 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.24 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . 0.458 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 12.2 pt-20 -150.61 -175.17 5.0 Favored 'General case' 0 CA--C 1.5 -0.971 0 CA-C-O 121.179 0.514 . . . . 0.0 111.345 -179.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 4.9 mp -88.86 143.76 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.409 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.91 -53.9 4.38 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -151.72 142.71 23.08 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.783 179.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.407 ' HA ' ' HB3' ' A' ' 216' ' ' LEU . 32.3 tp -115.73 117.51 30.44 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 121.466 0.65 . . . . 0.0 111.922 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 25.6 mttt -150.36 120.94 7.45 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.952 179.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 4.5 ttm180 -87.96 -157.99 0.44 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.991 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 1.666 ' HD1' ' CD2' ' A' ' 201' ' ' TYR . 33.9 p90 -86.44 -16.02 38.44 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.606 0.241 . . . . 0.0 110.919 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.51 -60.77 1.64 Allowed 'General case' 0 N--CA 1.441 -0.898 0 CA-C-O 120.594 0.235 . . . . 0.0 110.973 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.86 -164.52 1.96 Allowed 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 120.808 0.337 . . . . 0.0 110.983 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -89.68 73.16 7.68 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.061 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 28.3 m -60.96 157.77 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.884 0 CA-C-O 121.596 0.712 . . . . 0.0 112.376 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . 0.414 ' O ' ' HA ' ' A' ' 176' ' ' THR . 0.1 OUTLIER -89.31 -35.26 16.22 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 114.616 -1.175 . . . . 0.0 111.454 -178.741 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -144.32 178.49 7.88 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.9 0.381 . . . . 0.0 110.878 179.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 1.3 t -150.93 77.0 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.109 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -96.85 170.84 8.89 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -178.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 85.77 -75.5 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.233 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 177.89 37.15 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.334 -0.936 . . . . 0.0 112.432 179.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . 1.625 ' HD2' ' CD1' ' A' ' 212' ' ' TYR . 1.4 m-85 -95.27 150.03 20.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.901 0.381 . . . . 0.0 111.333 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -89.76 159.53 17.0 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.215 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 5.1 p -150.71 -175.48 5.13 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.265 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -144.02 96.97 0.19 Allowed Glycine 0 N--CA 1.451 -0.335 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 179.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.407 ' HB3' ' HA ' ' A' ' 198' ' ' LEU . 0.4 OUTLIER -131.71 142.01 49.7 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 120.932 0.396 . . . . 0.0 111.992 -178.367 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -79.14 132.98 36.74 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 176.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . 0.475 ' CG2' ' CD2' ' A' ' 191' ' ' TYR . 1.4 mp -98.35 97.49 6.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.459 -177.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 6.5 tttp 42.5 -144.33 0.08 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.978 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -87.66 64.14 7.88 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 120.871 0.367 . . . . 0.0 110.738 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.479 ' CZ ' ' CD1' ' A' ' 183' ' ' LEU . 0.1 OUTLIER -54.81 118.51 4.31 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 179.075 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -82.76 -43.82 16.31 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 114.691 -1.14 . . . . 0.0 108.548 176.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . 0.412 ' O ' ' CD1' ' A' ' 221' ' ' PHE . 0.0 OUTLIER -89.57 130.7 35.85 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 178.171 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.406 HG22 HD11 ' A' ' 224' ' ' ILE . 0.2 OUTLIER -114.96 175.89 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 CA-C-O 121.263 0.554 . . . . 0.0 111.511 179.562 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.469 ' O ' ' N ' ' A' ' 227' ' ' GLY . 5.9 mtmt 63.53 147.74 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.84 -1.073 . . . . 0.0 108.992 -178.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . 0.511 ' HB3' ' O ' ' A' ' 154' ' ' ARG . 3.3 pt-20 -36.58 87.98 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.931 0.872 . . . . 0.0 112.855 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 225' ' ' LYS . . . -81.46 -57.62 2.73 Favored Glycine 0 N--CA 1.427 -1.902 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.873 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.404 ' CG ' ' HA ' ' A' ' 185' ' ' ARG . 1.0 OUTLIER -163.71 -146.91 0.11 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 179.365 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . 0.413 ' HA ' ' HA ' ' A' ' 152' ' ' GLU . 61.6 t -93.64 147.4 5.54 Favored 'Isoleucine or valine' 0 C--N 1.342 0.278 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.62 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 2.8 mp -118.6 154.58 20.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.187 -179.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' GLU . . . . . 0.443 ' O ' ' N ' ' A' ' 182' ' ' ARG . 10.2 tt0 -142.49 112.26 6.85 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.421 0.629 . . . . 0.0 111.965 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -86.9 129.81 34.72 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.195 178.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' TYR . . . . . 1.58 ' HE2' ' CE1' ' A' ' 233' ' ' TYR . 6.0 p90 -130.2 144.0 51.11 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.289 -178.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER 178.46 -169.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.674 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -96.96 -162.85 0.99 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.068 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 29.2 mm100 -89.23 77.01 7.56 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.142 0.496 . . . . 0.0 110.784 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 -150.61 40.16 0.74 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.142 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -104.46 163.44 4.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.014 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . 71.25 -62.38 0.46 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.271 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.23 -3.76 58.44 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.312 -1.05 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.041 179.968 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.868 0.366 . . . . 0.0 111.15 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -75.18 -168.5 0.79 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.928 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -89.64 50.87 1.97 Allowed 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.236 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 2.8 tttp -71.35 -168.05 0.29 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.548 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 14.4 t -61.72 139.27 20.93 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.628 0 CA-C-O 121.357 0.599 . . . . 0.0 111.226 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.1 pt -117.64 -11.87 11.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.145 178.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -177.64 77.91 0.07 OUTLIER Glycine 0 C--N 1.34 0.799 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -91.29 137.94 31.97 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 120.704 0.288 . . . . 0.0 110.56 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -152.01 178.13 9.75 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -178.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.405 ' HA ' ' HA ' ' A' ' 229' ' ' VAL . 40.4 mt-10 -124.34 124.93 43.45 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.334 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.458 ' CG1' ' HA ' ' A' ' 226' ' ' GLU . 2.2 p -51.04 133.84 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -89.52 -63.39 1.29 Allowed 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 104.943 -2.243 . . . . 0.0 104.943 175.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.4 -162.29 0.8 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 113.664 -1.607 . . . . 0.0 108.839 174.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 4.9 p -147.19 143.95 28.58 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 177.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.455 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 0.4 OUTLIER -89.96 83.51 6.13 Favored 'General case' 0 CA--C 1.51 -0.583 0 N-CA-C 113.969 1.099 . . . . 0.0 113.969 -177.598 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 10.2 tttp -86.82 62.18 7.24 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 177.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.421 HG23 ' CD2' ' A' ' 157' ' ' PHE . 40.9 t -93.32 156.02 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 CA-C-N 113.694 -1.593 . . . . 0.0 110.306 -178.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 12.4 t -90.15 35.68 0.86 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.13 0.491 . . . . 0.0 109.954 178.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -150.41 -32.4 0.18 Allowed 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.343 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 93.5 t -102.85 -103.23 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.226 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -159.07 -99.07 0.15 Allowed Glycine 0 N--CA 1.452 -0.25 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 178.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.406 ' CG2' ' CG2' ' A' ' 224' ' ' ILE . 0.0 OUTLIER -153.49 34.65 0.45 Allowed 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.282 1.033 . . . . 0.0 108.275 177.72 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.455 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 1.1 mm -40.86 98.11 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.587 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.459 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . -85.78 119.47 26.13 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.914 -1.039 . . . . 0.0 112.368 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -88.32 151.65 22.86 Favored Glycine 0 N--CA 1.443 -0.892 0 N-CA-C 110.159 -1.176 . . . . 0.0 110.159 178.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -145.62 133.74 21.56 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 117.181 0.491 . . . . 0.0 110.724 -178.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . 1.64 ' HE1' ' CE2' ' A' ' 169' ' ' TYR . 10.9 t80 -87.33 127.33 35.19 Favored 'General case' 0 C--O 1.221 -0.429 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 177.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 44.2 t -85.23 143.29 11.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -176.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -135.99 15.35 3.3 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 114.563 -1.199 . . . . 0.0 111.99 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -150.07 -146.42 0.2 Allowed 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -42.7 -105.11 0.01 OUTLIER Glycine 0 CA--C 1.531 1.071 0 N-CA-C 114.986 0.754 . . . . 0.0 114.986 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.05 135.56 17.04 Favored 'General case' 0 CA--C 1.513 -0.465 0 O-C-N 122.637 -0.331 . . . . 0.0 111.207 -178.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -95.51 112.13 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 176.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 0.1 OUTLIER -120.93 169.12 10.77 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.468 0.652 . . . . 0.0 112.219 -176.8 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.92 -43.58 98.41 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.931 179.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -89.73 61.16 5.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.964 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 57.9 m -148.06 159.23 44.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.819 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 0.0 OUTLIER -89.08 -176.95 5.31 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.344 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.4 ' CG1' ' CD1' ' A' ' 195' ' ' ILE . 1.4 m -146.15 156.75 12.06 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 CA-C-O 121.466 0.65 . . . . 0.0 112.278 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . 0.436 ' N ' ' O ' ' A' ' 231' ' ' GLU . 4.1 ttt180 -153.49 102.65 2.59 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.081 -0.963 . . . . 0.0 113.051 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.483 ' CD1' ' CZ ' ' A' ' 221' ' ' PHE . 0.3 OUTLIER -86.03 159.55 19.56 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-O 122.143 0.973 . . . . 0.0 113.255 -179.758 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.506 ' N ' HG23 ' A' ' 190' ' ' VAL . 16.2 mt -153.82 122.59 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 113.838 -1.528 . . . . 0.0 112.311 178.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.418 ' N ' HG21 ' A' ' 190' ' ' VAL . 0.2 OUTLIER -87.05 -147.93 0.14 Allowed 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 177.848 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 21.0 mm100 -95.47 27.36 3.41 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 118.651 0.659 . . . . 0.0 110.745 178.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -154.57 -80.24 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.755 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -112.41 -155.37 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 115.342 -0.429 . . . . 0.0 110.716 -179.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 41.2 t -87.04 135.62 24.8 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.096 0 CA-C-O 121.45 0.643 . . . . 0.0 111.576 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . 0.506 HG23 ' N ' ' A' ' 184' ' ' ILE . 0.2 OUTLIER -89.88 -32.25 5.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.203 178.687 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . 1.614 ' HD1' ' CD2' ' A' ' 191' ' ' TYR . 17.4 t80 -160.06 158.35 30.26 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.496 178.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -150.81 154.05 36.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.072 178.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 135.29 -119.75 2.18 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.054 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . 0.459 ' CG ' ' N ' ' A' ' 195' ' ' ILE . 0.0 OUTLIER -148.43 -178.47 6.34 Favored 'General case' 0 CA--C 1.501 -0.904 0 CA-C-O 121.523 0.678 . . . . 0.0 111.663 -179.446 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.459 ' N ' ' CG ' ' A' ' 194' ' ' GLU . 0.0 OUTLIER -88.75 147.77 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 CA-C-N 114.64 -1.163 . . . . 0.0 110.257 -178.674 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.68 -54.68 3.96 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 179.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 64.2 p -150.93 160.05 44.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.5 179.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.404 ' CD1' ' CD2' ' A' ' 216' ' ' LEU . 27.2 tp -133.44 110.71 10.18 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.384 0.611 . . . . 0.0 111.205 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 9.7 ptmt -149.8 123.89 9.44 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.414 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 2.6 ttm-85 -87.98 -160.17 0.6 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.896 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -87.1 -12.21 47.82 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.46 0.172 . . . . 0.0 110.988 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.03 -59.13 1.91 Allowed 'General case' 0 N--CA 1.441 -0.916 0 CA-C-O 120.651 0.263 . . . . 0.0 110.876 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -152.49 -174.79 5.02 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 120.88 0.371 . . . . 0.0 111.171 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -89.98 66.61 6.9 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.239 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 33.3 m -58.68 161.3 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.949 0 CA-C-O 121.55 0.69 . . . . 0.0 112.21 -179.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . 0.411 ' O ' ' HA ' ' A' ' 176' ' ' THR . 4.4 ttp180 -89.39 -38.17 14.31 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 114.625 -1.17 . . . . 0.0 111.461 -178.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -138.01 177.06 8.16 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.132 0.492 . . . . 0.0 111.332 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -151.05 81.78 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.544 178.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -101.7 172.52 6.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.102 0.477 . . . . 0.0 112.281 -178.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 2.8 tp-100 83.9 -72.98 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.983 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 178.09 37.95 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.371 -0.918 . . . . 0.0 112.44 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -97.99 143.22 28.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.979 0.419 . . . . 0.0 111.471 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -89.63 158.13 17.73 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.352 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -150.48 -171.09 3.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.015 0.436 . . . . 0.0 111.289 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -137.98 106.36 0.53 Allowed Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 178.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.407 ' CD1' ' CD1' ' A' ' 195' ' ' ILE . 0.1 OUTLIER -135.17 147.84 49.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.452 0.644 . . . . 0.0 112.602 -177.377 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.31 142.77 27.64 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 177.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . 0.469 ' CG2' ' CD2' ' A' ' 191' ' ' TYR . 1.5 mp -100.52 81.11 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.915 0.388 . . . . 0.0 110.817 -178.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 4.0 ttpt 42.34 -88.94 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.721 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . 0.401 ' N ' ' O ' ' A' ' 218' ' ' ILE . 13.0 t-20 -132.6 62.59 1.65 Allowed 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.118 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.483 ' CZ ' ' CD1' ' A' ' 183' ' ' LEU . 0.1 OUTLIER -59.23 119.55 7.58 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 179.443 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -81.58 -42.51 19.99 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 175.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . 0.439 ' O ' ' CD1' ' A' ' 221' ' ' PHE . 0.0 OUTLIER -92.81 143.44 26.28 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.339 177.693 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.42 ' CD1' ' N ' ' A' ' 224' ' ' ILE . 0.2 OUTLIER -135.94 178.14 5.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -179.183 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.412 ' O ' ' C ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER 57.68 119.31 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 114.543 -1.208 . . . . 0.0 110.009 -178.953 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . 0.458 ' HA ' ' CG1' ' A' ' 153' ' ' VAL . 5.3 tt0 5.95 65.81 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 124.455 1.102 . . . . 0.0 113.62 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -66.34 -63.74 3.76 Favored Glycine 0 N--CA 1.429 -1.802 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.236 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.428 ' O ' ' HB ' ' A' ' 153' ' ' VAL . 1.0 OUTLIER -165.05 -147.17 0.1 Allowed 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 179.259 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 152' ' ' GLU . 52.6 t -89.8 146.92 5.59 Favored 'Isoleucine or valine' 0 C--N 1.34 0.181 0 CA-C-N 116.71 -0.223 . . . . 0.0 110.412 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 4.4 mp -116.63 153.57 18.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.024 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' GLU . . . . . 0.436 ' O ' ' N ' ' A' ' 182' ' ' ARG . 0.1 OUTLIER -142.09 110.74 6.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.281 0.562 . . . . 0.0 111.949 -179.052 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.93 127.97 35.37 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.312 178.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' TYR . . . . . 1.592 ' HE2' ' CE1' ' A' ' 233' ' ' TYR . 6.8 p90 -129.3 139.41 51.78 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.349 -178.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -177.56 -175.6 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.881 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 1.3 mtm -89.13 -163.51 1.0 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.634 0.254 . . . . 0.0 110.709 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -90.22 66.64 6.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.433 0.635 . . . . 0.0 110.707 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -150.97 56.28 0.9 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.091 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.51 174.85 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.793 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . 73.13 -61.05 0.52 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.44 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.34 -5.09 57.79 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.313 -0.984 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.043 179.978 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.772 0.32 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 63.34 127.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.088 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -95.16 39.21 1.12 Allowed 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.26 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 5.3 mmtm -112.55 -82.95 0.59 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.605 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 11.9 t -102.46 137.22 31.26 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.712 0 CA-C-O 121.36 0.6 . . . . 0.0 110.988 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.405 HG12 ' N ' ' A' ' 234' ' ' VAL . 2.7 pp -131.9 6.85 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.245 178.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 171.77 73.91 0.04 OUTLIER Glycine 0 C--N 1.341 0.841 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.125 179.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.445 ' HA ' ' HA ' ' A' ' 231' ' ' GLU . 0.5 OUTLIER -93.04 132.09 37.46 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 122.551 -0.381 . . . . 0.0 110.613 -179.683 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -151.22 172.92 15.08 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 121.377 0.608 . . . . 0.0 112.564 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -121.6 126.21 48.54 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.438 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.481 ' CG1' ' HA ' ' A' ' 226' ' ' GLU . 1.9 p -52.39 131.32 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-O 121.344 0.592 . . . . 0.0 112.309 -179.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.461 ' O ' ' HB3' ' A' ' 226' ' ' GLU . 0.0 OUTLIER -90.47 -60.34 1.95 Allowed 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 105.142 -2.17 . . . . 0.0 105.142 175.444 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.49 -159.88 0.49 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 114.206 -1.361 . . . . 0.0 109.915 174.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.501 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 12.7 p -150.13 148.2 28.68 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.5 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 0.2 OUTLIER -90.72 82.47 5.75 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -177.723 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.6 tttt -86.44 62.29 7.33 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 177.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.415 HG23 ' CD1' ' A' ' 157' ' ' PHE . 54.0 t -91.28 156.08 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 CA-C-N 113.771 -1.559 . . . . 0.0 110.059 -178.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 80.0 p -90.41 34.2 0.88 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.122 0.487 . . . . 0.0 110.161 178.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.75 -32.32 0.17 Allowed 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.471 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 87.4 t -100.17 -102.68 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.15 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -159.28 -101.51 0.17 Allowed Glycine 0 N--CA 1.451 -0.344 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.411 ' CG2' ' CG2' ' A' ' 224' ' ' ILE . 0.0 OUTLIER -153.5 36.46 0.46 Allowed 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 177.822 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.5 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 0.9 OUTLIER -42.31 95.3 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.26 -179.416 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.501 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . -82.08 118.68 23.22 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 114.495 -1.229 . . . . 0.0 112.482 -178.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -91.22 143.99 16.94 Favored Glycine 0 N--CA 1.442 -0.965 0 N-CA-C 111.001 -0.839 . . . . 0.0 111.001 178.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -137.73 132.95 33.56 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . 1.671 ' HD1' ' CD2' ' A' ' 169' ' ' TYR . 7.4 t80 -85.03 128.16 34.51 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 178.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 44.4 t -85.96 147.79 5.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -176.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.6 p -140.78 14.83 2.31 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-N 114.474 -1.239 . . . . 0.0 111.841 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -150.8 -144.46 0.15 Allowed 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 -179.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -40.15 -104.22 0.01 OUTLIER Glycine 0 CA--C 1.532 1.11 0 N-CA-C 115.209 0.844 . . . . 0.0 115.209 -179.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 20.2 mttp -151.13 134.73 16.33 Favored 'General case' 0 CA--C 1.514 -0.427 0 O-C-N 122.517 -0.402 . . . . 0.0 111.839 -178.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 4.6 mm -91.2 83.87 2.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 176.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 0.0 OUTLIER -98.62 -178.16 3.9 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -176.704 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.59 -45.59 21.33 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-N 114.854 -1.066 . . . . 0.0 111.166 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -88.67 61.39 6.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.393 0.616 . . . . 0.0 110.338 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 16.4 m -149.32 157.74 43.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.986 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -89.06 -178.17 5.62 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 1.9 m -142.71 161.79 18.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.336 0.589 . . . . 0.0 111.845 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . 0.428 ' N ' ' O ' ' A' ' 231' ' ' GLU . 15.1 ttt180 -151.74 98.95 2.54 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.113 -0.948 . . . . 0.0 112.323 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.49 ' CD1' ' HB3' ' A' ' 191' ' ' TYR . 5.4 mp -89.08 146.14 25.02 Favored 'General case' 0 CA--C 1.497 -1.09 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -178.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.419 ' N ' HG23 ' A' ' 190' ' ' VAL . 17.8 mt -156.57 128.18 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-N 113.168 -1.833 . . . . 0.0 111.772 179.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.403 ' N ' ' CG2' ' A' ' 190' ' ' VAL . 0.1 OUTLIER -88.87 -148.44 0.17 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 177.943 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -94.94 29.69 2.32 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 118.604 0.638 . . . . 0.0 110.998 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -153.6 -83.34 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.869 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -111.6 -158.7 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 CA-C-N 115.455 -0.372 . . . . 0.0 110.621 -179.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 43.4 t -87.13 134.85 26.58 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 CA-C-O 121.68 0.752 . . . . 0.0 110.992 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . 0.419 HG23 ' N ' ' A' ' 184' ' ' ILE . 0.2 OUTLIER -94.79 -34.84 5.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 114.416 -1.265 . . . . 0.0 109.525 -179.909 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . 1.656 ' HD1' ' CD2' ' A' ' 191' ' ' TYR . 27.0 t80 -170.1 156.14 5.82 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.102 -0.953 . . . . 0.0 112.446 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -151.13 162.12 41.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.634 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 134.76 -114.88 1.33 Allowed Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.558 -0.829 . . . . 0.0 112.343 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . 0.463 ' CG ' ' N ' ' A' ' 195' ' ' ILE . 0.0 OUTLIER -150.47 -178.43 6.53 Favored 'General case' 0 CA--C 1.503 -0.865 0 CA-C-O 121.323 0.583 . . . . 0.0 110.901 -179.407 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.463 ' N ' ' CG ' ' A' ' 194' ' ' GLU . 0.0 OUTLIER -89.76 154.65 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.921 -179.431 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -89.8 -66.79 0.89 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 178.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -151.63 146.72 26.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.248 179.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.409 ' HA ' ' HB3' ' A' ' 216' ' ' LEU . 2.4 tt -110.96 119.52 39.34 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.519 0.676 . . . . 0.0 112.487 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -151.55 116.52 5.22 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.491 178.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -88.06 -159.71 0.56 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -87.95 13.0 11.82 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.35 -62.11 1.46 Allowed 'General case' 0 N--CA 1.438 -1.04 0 CA-C-O 120.943 0.402 . . . . 0.0 110.384 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -151.97 -172.79 4.33 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.763 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -90.72 71.86 6.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.417 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 34.2 m -66.14 162.39 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.958 0 CA-C-O 121.414 0.626 . . . . 0.0 112.062 -179.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . 0.418 ' O ' ' HA ' ' A' ' 176' ' ' THR . 5.3 mtp180 -89.15 -37.32 15.14 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.565 -178.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.401 ' CG ' ' CB ' ' A' ' 239' ' ' ALA . 0.5 OUTLIER -141.38 178.35 7.49 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.27 0.557 . . . . 0.0 111.746 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -151.05 80.59 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.588 179.034 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -96.47 172.02 8.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.072 0.463 . . . . 0.0 112.038 -178.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 84.83 -73.88 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.055 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 177.87 37.34 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.29 -0.957 . . . . 0.0 112.623 179.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . 1.604 ' HD1' ' CD2' ' A' ' 212' ' ' TYR . 2.0 m-85 -99.51 145.23 27.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.939 0.399 . . . . 0.0 111.568 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -89.77 161.38 16.06 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.528 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 27.1 p -150.55 -170.03 3.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.967 0.413 . . . . 0.0 111.209 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -139.74 98.68 0.24 Allowed Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 179.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.409 ' HB3' ' HA ' ' A' ' 198' ' ' LEU . 0.2 OUTLIER -129.3 151.11 50.32 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 121.06 0.457 . . . . 0.0 110.782 -178.997 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.91 141.06 28.88 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 177.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . 0.438 ' HB ' ' CD2' ' A' ' 221' ' ' PHE . 16.6 mm -98.2 74.39 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.77 -178.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 46.43 -136.0 0.8 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.295 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -87.03 58.07 4.86 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 120.793 0.33 . . . . 0.0 111.609 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.486 ' CE1' ' HB2' ' A' ' 191' ' ' TYR . 0.1 OUTLIER -56.25 120.0 6.88 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 178.1 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -80.01 -45.23 18.76 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 176.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . 0.426 ' O ' ' CD1' ' A' ' 221' ' ' PHE . 0.0 OUTLIER -91.35 131.44 36.84 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.761 178.109 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.411 ' CG2' ' CG2' ' A' ' 164' ' ' THR . 0.1 OUTLIER -121.29 177.61 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-O 121.17 0.51 . . . . 0.0 111.929 -179.877 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.473 ' O ' ' N ' ' A' ' 227' ' ' GLY . 2.3 mtpp 62.92 152.32 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.136 -178.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . 0.481 ' HA ' ' CG1' ' A' ' 153' ' ' VAL . 0.4 OUTLIER -38.45 90.14 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 CA-C-O 122.186 0.993 . . . . 0.0 112.258 -179.947 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 225' ' ' LYS . . . -106.45 -39.28 2.1 Favored Glycine 0 N--CA 1.43 -1.741 0 CA-C-N 114.429 -1.26 . . . . 0.0 112.152 -178.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.438 ' O ' ' HB ' ' A' ' 153' ' ' VAL . 2.9 p30 -158.23 -164.85 1.57 Allowed 'General case' 0 C--O 1.22 -0.466 0 N-CA-C 115.292 1.59 . . . . 0.0 115.292 -178.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 89.3 t -102.25 144.66 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 177.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 3.7 mp -114.79 153.61 16.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.217 0.532 . . . . 0.0 112.103 -178.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' GLU . . . . . 0.445 ' HA ' ' HA ' ' A' ' 150' ' ' GLN . 20.3 tt0 -140.85 111.88 7.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.374 0.606 . . . . 0.0 111.476 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.78 128.7 35.32 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.896 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -130.81 142.81 50.41 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.916 -179.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.405 ' N ' HG12 ' A' ' 148' ' ' ILE . 0.3 OUTLIER -178.12 -177.36 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.111 -179.762 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -89.7 -157.71 0.48 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.976 179.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -88.26 70.82 9.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.442 0.639 . . . . 0.0 110.819 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -150.66 58.73 0.94 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.544 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.404 ' CG1' ' CG2' ' A' ' 176' ' ' THR . 0.2 OUTLIER -92.44 -164.35 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.727 -179.438 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . 0.401 ' CB ' ' CG ' ' A' ' 207' ' ' GLU . . . -49.62 -71.77 0.06 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.028 0.442 . . . . 0.0 111.243 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -89.83 -6.47 55.85 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.036 179.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.316 -0.85 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.168 179.961 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.819 0.342 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -119.66 119.59 34.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.972 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.83 36.03 1.46 Allowed 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.187 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 5.9 mmtm -147.48 -80.39 0.14 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.243 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 18.9 t -97.39 136.91 26.56 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.631 0 CA-C-O 121.17 0.509 . . . . 0.0 110.527 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 2.7 pp -128.94 6.31 2.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.326 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 171.21 75.43 0.04 OUTLIER Glycine 0 C--N 1.341 0.843 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.003 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.422 ' HA ' ' HA ' ' A' ' 231' ' ' GLU . 0.7 OUTLIER -95.14 130.3 41.9 Favored 'General case' 0 CA--C 1.517 -0.317 0 O-C-N 122.551 -0.382 . . . . 0.0 110.419 -179.826 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.403 ' HA ' ' O ' ' A' ' 169' ' ' TYR . . . -151.04 171.21 17.69 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 120.32 -0.552 . . . . 0.0 112.25 -178.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -119.01 128.0 53.97 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.536 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.499 ' CG1' ' HA ' ' A' ' 226' ' ' GLU . 2.0 p -49.65 142.61 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -178.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -100.77 -63.01 1.17 Allowed 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 104.379 -2.452 . . . . 0.0 104.379 174.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.92 -165.65 1.29 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 113.735 -1.575 . . . . 0.0 109.368 174.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 8.1 p -147.11 163.29 36.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.553 0.216 . . . . 0.0 110.425 177.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.477 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 0.2 OUTLIER -115.48 76.26 0.99 Allowed 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -179.475 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 7.2 tmtm? -86.27 62.97 7.75 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 177.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.421 HG12 ' N ' ' A' ' 160' ' ' SER . 98.3 t -92.94 158.59 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 CA-C-N 113.589 -1.642 . . . . 0.0 110.538 -178.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.421 ' N ' HG12 ' A' ' 159' ' ' VAL . 19.7 m -93.28 34.57 1.13 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.317 0.58 . . . . 0.0 109.552 177.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -151.49 -34.77 0.14 Allowed 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.164 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 86.0 t -97.65 -102.7 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 N-CA-C 109.703 -0.481 . . . . 0.0 109.703 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -159.46 -102.47 0.18 Allowed Glycine 0 N--CA 1.451 -0.326 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.432 ' CG2' ' CG2' ' A' ' 224' ' ' ILE . 0.0 OUTLIER -154.21 32.61 0.43 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 113.976 -1.112 . . . . 0.0 108.543 177.611 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.477 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 1.8 mt -42.53 95.42 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.481 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.482 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . -90.45 122.94 33.75 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.82 -1.082 . . . . 0.0 112.052 -179.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' A' ' 153' ' ' VAL . . . -88.29 146.03 19.38 Favored Glycine 0 N--CA 1.44 -1.053 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 178.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -143.76 131.4 21.24 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 117.164 0.482 . . . . 0.0 110.072 -179.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . 1.643 ' HE1' ' CE2' ' A' ' 169' ' ' TYR . 17.2 t80 -86.94 122.39 30.74 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 178.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 38.7 t -85.38 145.17 8.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -176.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 2.0 p -138.19 14.92 2.82 Favored 'General case' 0 N--CA 1.457 -0.113 0 CA-C-N 114.662 -1.154 . . . . 0.0 111.912 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -150.62 -144.36 0.15 Allowed 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -179.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -40.48 -105.52 0.01 OUTLIER Glycine 0 CA--C 1.532 1.103 0 N-CA-C 115.13 0.812 . . . . 0.0 115.13 -178.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 7.1 mttt -151.4 134.85 16.17 Favored 'General case' 0 CA--C 1.514 -0.417 0 O-C-N 122.526 -0.397 . . . . 0.0 111.957 -178.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 6.0 mm -91.81 83.23 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 176.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 0.1 OUTLIER -98.59 176.22 5.73 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.54 0.686 . . . . 0.0 112.415 -177.557 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -71.58 -44.67 64.06 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.969 -1.014 . . . . 0.0 111.386 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -88.99 61.83 6.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.249 0.547 . . . . 0.0 110.756 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 20.3 m -150.09 157.95 43.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.048 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 2.1 mptt -88.68 177.27 6.79 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 2.0 m -141.68 163.71 19.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.399 0.619 . . . . 0.0 111.956 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . 0.43 ' N ' ' O ' ' A' ' 231' ' ' GLU . 7.4 ttt180 -151.51 100.09 2.68 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.037 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.474 ' CD1' ' HB3' ' A' ' 191' ' ' TYR . 5.4 mp -89.2 144.49 26.07 Favored 'General case' 0 CA--C 1.494 -1.184 0 CA-C-O 122.476 1.131 . . . . 0.0 113.868 -178.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.408 ' N ' HG23 ' A' ' 190' ' ' VAL . 18.1 mt -156.65 129.28 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-N 113.007 -1.906 . . . . 0.0 111.754 179.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.413 ' N ' ' CG2' ' A' ' 190' ' ' VAL . 0.1 OUTLIER -88.54 -148.45 0.17 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.028 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -95.46 29.53 2.54 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 118.526 0.603 . . . . 0.0 110.818 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -153.23 -82.39 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.904 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -113.06 -158.26 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 115.519 -0.34 . . . . 0.0 110.704 -179.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 40.0 t -87.08 137.02 21.7 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 CA-C-O 121.741 0.781 . . . . 0.0 111.05 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . 0.414 HG22 ' CB ' ' A' ' 228' ' ' ASP . 0.2 OUTLIER -98.88 -35.78 5.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 114.272 -1.331 . . . . 0.0 109.484 -179.462 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . 1.601 ' HE1' ' CE2' ' A' ' 191' ' ' TYR . 14.7 t80 -169.04 157.72 8.07 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.012 -0.994 . . . . 0.0 112.38 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -151.5 162.06 41.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.748 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 135.38 -116.98 1.62 Allowed Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.169 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 17.0 pt-20 -149.98 -176.3 5.38 Favored 'General case' 0 CA--C 1.497 -1.085 0 CA-C-O 121.336 0.589 . . . . 0.0 111.432 -179.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.484 HD11 HG23 ' A' ' 195' ' ' ILE . 49.1 mt -89.43 146.99 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.352 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.552 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -89.14 -59.87 2.11 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.87 0.366 . . . . 0.0 110.033 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 1.3 m -151.32 159.08 44.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.87 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.54 122.86 34.4 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 121.435 0.636 . . . . 0.0 112.093 -179.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 13.2 mtmm -150.61 118.15 6.11 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.96 179.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 7.5 ttp180 -88.15 -160.35 0.62 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.309 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -87.11 -13.92 42.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.775 -0.193 . . . . 0.0 110.889 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -97.18 -57.63 2.22 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-O 120.659 0.266 . . . . 0.0 111.024 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -152.46 -166.5 2.49 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 120.706 0.289 . . . . 0.0 110.854 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -89.72 64.41 6.49 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 121.049 0.452 . . . . 0.0 110.209 179.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 32.6 m -57.71 158.62 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.961 0 CA-C-O 121.511 0.672 . . . . 0.0 112.179 -179.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . 0.418 ' O ' ' HA ' ' A' ' 176' ' ' THR . 1.7 ttp180 -89.44 -35.36 16.05 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 114.769 -1.105 . . . . 0.0 112.225 -178.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.403 ' HG2' ' CB ' ' A' ' 239' ' ' ALA . 0.3 OUTLIER -140.11 177.55 7.9 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.343 0.592 . . . . 0.0 111.898 -179.456 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -151.07 77.86 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.167 178.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -98.55 174.35 6.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.168 0.508 . . . . 0.0 112.366 -178.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 81.75 -70.08 0.07 Allowed 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.867 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 178.2 37.23 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 120.431 -0.89 . . . . 0.0 112.248 179.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . 1.655 ' HD2' ' CD1' ' A' ' 212' ' ' TYR . 1.2 m-85 -104.11 140.49 37.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.966 0.412 . . . . 0.0 111.215 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -95.48 148.61 22.3 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.404 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 45.5 t -150.51 146.14 26.42 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.371 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -88.11 112.49 3.89 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.943 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -138.56 143.3 39.36 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 120.864 0.364 . . . . 0.0 111.149 -179.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.48 142.42 30.95 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 177.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . 0.405 ' O ' ' CG2' ' A' ' 218' ' ' ILE . 1.6 mp -106.84 92.36 2.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 -178.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 2.5 tttp 45.77 -146.98 0.13 Allowed 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.511 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 -87.54 62.46 7.11 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-O 120.857 0.36 . . . . 0.0 110.984 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.46 ' CE1' ' HB2' ' A' ' 191' ' ' TYR . 0.1 OUTLIER -54.71 119.86 5.93 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 179.31 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -84.19 -47.6 10.67 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 114.771 -1.104 . . . . 0.0 108.368 176.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 223' ' ' ASP . 0.0 OUTLIER -84.78 130.27 34.7 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 178.026 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.432 ' CG2' ' CG2' ' A' ' 164' ' ' THR . 1.2 pt -126.46 176.48 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -179.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.432 ' O ' ' N ' ' A' ' 227' ' ' GLY . 0.0 OUTLIER 61.12 129.47 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.102 -179.057 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . 0.499 ' HA ' ' CG1' ' A' ' 153' ' ' VAL . 3.6 tt0 -11.67 77.97 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 124.249 1.02 . . . . 0.0 113.341 -179.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 225' ' ' LYS . . . -98.26 -40.16 3.55 Favored Glycine 0 N--CA 1.43 -1.759 0 CA-C-N 114.564 -1.198 . . . . 0.0 112.626 -178.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.431 ' O ' ' HB ' ' A' ' 153' ' ' VAL . 2.7 p30 -159.03 -160.98 0.9 Allowed 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 115.375 1.62 . . . . 0.0 115.375 -177.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 91.9 t -108.3 143.88 17.9 Favored 'Isoleucine or valine' 0 C--N 1.343 0.292 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 177.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 3.7 mp -111.43 153.32 13.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.252 0.548 . . . . 0.0 112.097 -178.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' GLU . . . . . 0.43 ' O ' ' N ' ' A' ' 182' ' ' ARG . 15.1 tt0 -141.05 111.32 6.75 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.437 0.637 . . . . 0.0 111.598 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.34 134.21 33.6 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.412 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' TYR . . . . . 1.657 ' HE1' ' CE2' ' A' ' 233' ' ' TYR . 2.7 p90 -138.58 139.27 38.56 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.081 -178.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -177.39 131.09 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-O 120.938 0.399 . . . . 0.0 111.881 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 1.8 mpp? -89.5 56.69 3.67 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -127.48 -152.0 0.5 Allowed 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.67 -178.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -136.86 69.78 1.41 Allowed 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 4.6 t -83.65 161.07 3.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.216 -178.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . 0.403 ' CB ' ' HG2' ' A' ' 207' ' ' GLU . . . 80.74 -56.64 0.32 Allowed 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.182 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 1.6 ttp85 -89.48 -5.42 57.34 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.312 -1.034 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.12 -179.997 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 12.2 p90 . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 120.653 0.263 . . . . 0.0 111.409 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 60.83 169.37 0.09 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.836 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.06 42.17 1.09 Allowed 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.406 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 6.3 tptt -97.37 -173.29 2.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.776 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 5.8 t -61.0 141.0 17.93 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.683 0 CA-C-O 121.294 0.569 . . . . 0.0 111.181 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.56 -5.65 7.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.871 178.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -174.38 74.41 0.08 OUTLIER Glycine 0 C--N 1.342 0.869 0 N-CA-C 111.683 -0.567 . . . . 0.0 111.683 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.49 136.11 33.22 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.424 ' CB ' ' HB2' ' A' ' 168' ' ' CYS . . . -151.93 173.2 15.12 Favored 'General case' 0 N--CA 1.435 -1.176 0 C-N-CA 120.009 -0.677 . . . . 0.0 112.478 -178.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -122.32 121.1 35.94 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.081 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.451 ' CG1' ' HA ' ' A' ' 226' ' ' GLU . 2.2 p -49.71 132.55 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -178.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -90.17 -61.56 1.66 Allowed 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 104.941 -2.244 . . . . 0.0 104.941 175.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.28 -163.49 0.93 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 113.76 -1.563 . . . . 0.0 109.405 174.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.509 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 6.9 p -145.42 156.97 44.09 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 120.845 0.355 . . . . 0.0 110.079 177.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.63 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 2.4 m-85 -103.98 73.22 1.14 Allowed 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -177.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.95 63.93 8.31 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.418 HG12 ' N ' ' A' ' 160' ' ' SER . 88.2 t -91.4 157.87 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 CA-C-N 113.611 -1.631 . . . . 0.0 110.075 -179.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.418 ' N ' HG12 ' A' ' 159' ' ' VAL . 3.8 t -92.67 34.4 1.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.145 0.498 . . . . 0.0 109.784 178.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -151.45 -33.03 0.15 Allowed 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.445 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 90.4 t -100.07 -101.95 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.169 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -158.74 -103.69 0.2 Allowed Glycine 0 N--CA 1.451 -0.366 0 N-CA-C 111.706 -0.558 . . . . 0.0 111.706 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.431 ' CG2' ' CG2' ' A' ' 224' ' ' ILE . 0.0 OUTLIER -153.63 34.82 0.45 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 114.406 -0.897 . . . . 0.0 108.932 178.483 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.63 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 2.9 mm -42.88 95.44 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.496 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.509 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . -86.19 119.17 26.18 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.706 -1.133 . . . . 0.0 111.247 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -87.95 150.63 22.37 Favored Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 178.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . 0.424 ' HB2' ' CB ' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -148.25 136.43 21.19 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 117.364 0.582 . . . . 0.0 111.102 -178.236 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -87.66 129.96 34.96 Favored 'General case' 0 C--O 1.221 -0.402 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 177.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 38.3 t -85.67 145.09 8.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -176.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.2 p -138.25 13.18 2.82 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 114.788 -1.096 . . . . 0.0 112.164 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -149.98 -141.04 0.1 Allowed 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -48.67 -109.59 0.01 OUTLIER Glycine 0 CA--C 1.531 1.033 0 N-CA-C 114.527 0.571 . . . . 0.0 114.527 -179.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 5.6 mtmt -150.59 138.84 20.29 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 122.397 -0.472 . . . . 0.0 110.603 -179.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -94.38 112.29 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 C-N-CA 119.528 -0.869 . . . . 0.0 109.536 177.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.461 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 0.2 OUTLIER -120.36 173.05 7.38 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.654 0.74 . . . . 0.0 112.99 -177.009 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.02 -43.67 86.93 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 114.521 -1.218 . . . . 0.0 109.95 178.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -89.25 56.5 3.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.696 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 5.4 m -150.33 161.39 42.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.86 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 7.6 tptt -89.32 177.62 6.55 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.036 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 1.5 m -146.13 146.9 18.73 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.548 0 CA-C-O 121.347 0.594 . . . . 0.0 111.04 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . 0.46 ' N ' ' O ' ' A' ' 231' ' ' GLU . 5.2 ttm-85 -155.37 99.34 2.05 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.177 -0.92 . . . . 0.0 112.539 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.474 ' HA ' ' HA ' ' A' ' 230' ' ' ILE . 0.3 OUTLIER -97.51 166.59 11.45 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 120.186 -0.606 . . . . 0.0 110.908 179.302 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 4.4 mp -151.87 140.08 14.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.143 -0.48 . . . . 0.0 112.057 -177.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -87.08 -152.67 0.19 Allowed 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.371 -0.832 . . . . 0.0 108.906 178.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -94.64 29.04 2.42 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 118.19 0.45 . . . . 0.0 111.489 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -153.23 -76.12 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.39 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -117.9 -155.86 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 115.373 -0.414 . . . . 0.0 110.216 -179.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 35.1 t -85.95 139.53 17.26 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 CA-C-O 121.573 0.701 . . . . 0.0 110.758 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . 0.416 HG23 ' HG ' ' A' ' 183' ' ' LEU . 0.7 OUTLIER -87.41 -40.76 14.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 114.693 -1.14 . . . . 0.0 108.409 179.898 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . 1.66 ' HD1' ' CD2' ' A' ' 191' ' ' TYR . 0.6 OUTLIER -171.91 150.21 2.56 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.606 -1.179 . . . . 0.0 111.131 179.322 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -135.53 164.45 27.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.081 0.467 . . . . 0.0 111.19 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 135.87 -160.26 24.52 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . 0.411 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 3.3 pt-20 -108.69 -178.1 3.5 Favored 'General case' 0 CA--C 1.498 -1.052 0 CA-C-N 117.656 0.728 . . . . 0.0 110.723 179.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -88.39 148.92 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.881 -177.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -88.92 -54.94 3.9 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -151.47 152.86 33.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.088 179.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.01 103.42 8.8 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.882 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.96 122.72 21.11 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.428 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -88.37 -159.26 0.53 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.096 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -87.03 -10.81 52.15 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 121.295 -0.162 . . . . 0.0 111.101 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.72 -59.44 1.72 Allowed 'General case' 0 N--CA 1.441 -0.909 0 CA-C-O 120.699 0.285 . . . . 0.0 111.01 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -152.27 -169.34 3.32 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 120.804 0.335 . . . . 0.0 110.991 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -90.16 70.07 7.24 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.37 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 35.5 m -62.29 165.23 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.063 0 CA-C-O 121.538 0.685 . . . . 0.0 112.088 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . 0.461 ' O ' ' HA ' ' A' ' 176' ' ' THR . 1.6 ttm180 -89.18 -41.7 12.09 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-N 114.726 -1.125 . . . . 0.0 111.368 -178.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -136.2 178.6 6.94 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.249 0.547 . . . . 0.0 111.963 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -150.96 94.67 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.701 179.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -118.27 178.09 4.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.215 0.531 . . . . 0.0 112.36 -178.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 80.91 -71.8 0.07 Allowed 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.794 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 178.62 37.31 0.06 OUTLIER Glycine 0 N--CA 1.442 -0.933 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.2 179.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -104.48 139.11 39.87 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.962 0.41 . . . . 0.0 111.089 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.74 150.92 22.09 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.039 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 7.5 t -150.15 146.13 26.71 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.679 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -89.1 115.41 4.47 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.043 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.18 141.48 49.1 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 120.975 0.417 . . . . 0.0 110.742 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 1.6 m -105.67 140.08 39.29 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 177.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . 0.463 ' HB ' ' HB2' ' A' ' 221' ' ' PHE . 18.9 mm -89.19 144.32 9.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 120.449 -0.5 . . . . 0.0 109.747 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.78 -10.74 4.11 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -176.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . 0.453 ' O ' ' CE2' ' A' ' 191' ' ' TYR . 58.2 t30 -153.23 21.1 0.56 Allowed 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.463 ' HB2' ' HB ' ' A' ' 218' ' ' ILE . 0.1 OUTLIER -57.95 123.76 16.93 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 -179.681 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -96.59 -47.76 5.8 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 114.347 -1.297 . . . . 0.0 108.367 176.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . 0.456 ' O ' ' CD1' ' A' ' 221' ' ' PHE . 0.0 OUTLIER -75.66 150.25 37.98 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.095 177.422 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.431 ' CG2' ' CG2' ' A' ' 164' ' ' THR . 0.2 OUTLIER -143.14 177.78 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -179.209 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.424 ' O ' ' C ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER 56.56 116.25 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 114.443 -1.253 . . . . 0.0 110.073 -179.046 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . 0.451 ' HA ' ' CG1' ' A' ' 153' ' ' VAL . 3.2 tt0 8.78 63.88 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.523 1.129 . . . . 0.0 113.517 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -61.61 -65.48 3.22 Favored Glycine 0 N--CA 1.432 -1.613 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.4 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -165.38 -147.48 0.1 Allowed 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 114.236 1.199 . . . . 0.0 114.236 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 91.7 t -89.17 135.09 26.75 Favored 'Isoleucine or valine' 0 C--N 1.346 0.437 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . 0.474 ' HA ' ' HA ' ' A' ' 183' ' ' LEU . 2.7 mp -102.93 159.04 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 O-C-N 123.378 0.424 . . . . 0.0 110.859 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' GLU . . . . . 0.46 ' O ' ' N ' ' A' ' 182' ' ' ARG . 5.7 tt0 -149.46 108.43 3.89 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.274 0.559 . . . . 0.0 112.348 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.56 131.67 34.31 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.022 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' TYR . . . . . 1.638 ' HE1' ' CE2' ' A' ' 233' ' ' TYR . 4.6 p90 -134.33 163.46 29.6 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.577 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 1.9 p -175.07 171.32 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-O 120.77 0.319 . . . . 0.0 111.489 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 3.2 mtm -99.52 34.55 2.18 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.293 0.568 . . . . 0.0 110.631 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . 0.401 ' CB ' ' CB ' ' A' ' 241' ' ' ALA . 1.0 OUTLIER -150.53 -158.91 0.96 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.827 -179.957 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -98.82 -90.45 0.29 Allowed 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 120.838 0.352 . . . . 0.0 110.331 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.4 ' CG1' ' CG2' ' A' ' 176' ' ' THR . 0.1 OUTLIER -154.2 -176.11 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.644 179.78 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . 66.61 -72.3 0.09 Allowed 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.998 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.53 -1.23 57.97 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.153 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . 0.401 ' CB ' ' CB ' ' A' ' 236' ' ' GLN . . . . . . . . 0 C--N 1.317 -0.824 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.061 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.415 0 CA-C-O 120.778 0.323 . . . . 0.0 111.14 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 59.36 89.48 0.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.967 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.439 ' CA ' ' HA ' ' A' ' 235' ' ' MET . 0.6 OUTLIER -90.43 65.92 6.28 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-O 121.226 0.536 . . . . 0.0 111.773 -179.826 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -39.66 -65.6 0.37 Allowed 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.68 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.454 HG13 ' HG3' ' A' ' 150' ' ' GLN . 29.1 t -89.45 138.44 19.29 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.732 0 CA-C-O 121.287 0.565 . . . . 0.0 110.193 178.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.42 ' O ' ' O ' ' A' ' 174' ' ' LYS . 3.7 tp -121.5 -14.96 7.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.257 177.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 165.11 88.56 0.07 OUTLIER Glycine 0 C--N 1.345 1.071 0 C-N-CA 120.131 -1.033 . . . . 0.0 112.864 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.454 ' HG3' HG13 ' A' ' 147' ' ' VAL . 3.0 mt-30 -90.05 142.22 27.91 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.416 ' CB ' ' HB2' ' A' ' 168' ' ' CYS . . . -150.93 174.99 12.47 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 120.107 -0.637 . . . . 0.0 112.148 -179.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 229' ' ' VAL . 0.0 OUTLIER -120.42 123.72 43.72 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.054 179.81 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.459 HG12 ' HA ' ' A' ' 226' ' ' GLU . 2.4 p -55.79 127.77 15.14 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 CA-C-O 121.377 0.608 . . . . 0.0 111.522 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.416 ' CA ' ' NE ' ' A' ' 154' ' ' ARG . 0.0 OUTLIER -89.56 -57.49 2.86 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 105.025 -2.213 . . . . 0.0 105.025 176.209 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.76 -163.61 0.9 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.257 -1.338 . . . . 0.0 110.262 174.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.538 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 16.7 p -144.42 158.92 43.51 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 177.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.615 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 2.4 m-85 -99.98 76.08 1.91 Allowed 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -176.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 7.7 tttt -85.93 63.58 8.11 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 122.071 0.938 . . . . 0.0 108.809 178.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 55.0 t -89.89 155.53 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 CA-C-N 113.77 -1.559 . . . . 0.0 109.867 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 3.9 t -90.7 33.58 0.92 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.126 0.489 . . . . 0.0 110.153 178.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 3.6 mttt -151.02 -29.67 0.19 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.712 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 88.2 t -103.19 -101.79 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 O-C-N 122.195 -0.316 . . . . 0.0 110.275 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -158.5 -103.39 0.19 Allowed Glycine 0 N--CA 1.451 -0.363 0 N-CA-C 111.661 -0.576 . . . . 0.0 111.661 179.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.415 ' CG2' ' CG2' ' A' ' 224' ' ' ILE . 0.0 OUTLIER -153.14 36.24 0.48 Allowed 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 114.362 -0.919 . . . . 0.0 108.968 178.458 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.615 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 4.9 mt -42.55 101.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.925 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.538 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . -83.62 121.88 27.85 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.004 -0.998 . . . . 0.0 112.871 -178.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -89.1 136.08 13.38 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 178.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . 0.416 ' HB2' ' CB ' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -138.14 131.49 30.52 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.898 0.349 . . . . 0.0 110.531 -178.523 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -85.94 126.42 34.09 Favored 'General case' 0 C--O 1.219 -0.502 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 178.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 45.3 t -85.22 145.37 8.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -175.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -133.9 10.52 3.93 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 114.646 -1.161 . . . . 0.0 112.337 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.428 ' O ' ' O ' ' A' ' 173' ' ' GLY . 3.0 t70 -150.12 -145.76 0.18 Allowed 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 118.91 -0.567 . . . . 0.0 109.613 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 172' ' ' ASP . . . -37.68 -108.11 0.0 OUTLIER Glycine 0 CA--C 1.537 1.444 0 N-CA-C 115.338 0.895 . . . . 0.0 115.338 -179.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.42 ' O ' ' O ' ' A' ' 148' ' ' ILE . 1.7 mtmm -151.51 135.52 16.58 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 122.311 -0.523 . . . . 0.0 111.84 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 2.6 mm -88.44 86.9 2.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 177.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 0.0 OUTLIER -98.26 170.41 8.9 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.17 -177.767 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -69.02 -39.41 79.26 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.269 179.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -89.29 51.85 2.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.97 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -142.94 159.49 42.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.75 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 2.8 mptp? -89.6 177.71 6.47 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 2.8 m -149.43 148.69 15.4 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.509 0 CA-C-O 121.535 0.683 . . . . 0.0 112.237 179.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 231' ' ' GLU . 23.0 ttp180 -153.83 102.45 2.52 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.671 -1.15 . . . . 0.0 111.678 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.472 ' HA ' ' O ' ' A' ' 229' ' ' VAL . 0.3 OUTLIER -98.16 169.13 9.81 Favored 'General case' 0 N--CA 1.438 -1.064 0 C-N-CA 120.564 -0.455 . . . . 0.0 111.246 179.869 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 4.0 mp -151.01 139.83 14.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.048 -178.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.406 ' N ' HG21 ' A' ' 190' ' ' VAL . 0.0 OUTLIER -88.04 -150.73 0.18 Allowed 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.156 -0.929 . . . . 0.0 108.749 178.241 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -94.72 27.75 2.94 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 118.461 0.573 . . . . 0.0 111.454 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -153.11 -77.78 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.688 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -116.69 -154.34 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-N 115.514 -0.343 . . . . 0.0 110.43 -179.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 23.0 t -85.67 138.45 19.05 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 CA-C-O 121.517 0.675 . . . . 0.0 110.803 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . 0.436 HG23 ' HG ' ' A' ' 183' ' ' LEU . 0.7 OUTLIER -87.86 -39.24 12.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 114.739 -1.119 . . . . 0.0 109.0 -179.86 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . 1.601 ' HD1' ' CD2' ' A' ' 191' ' ' TYR . 1.0 OUTLIER -172.17 157.67 4.32 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.63 -1.168 . . . . 0.0 110.411 -179.935 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -144.79 157.16 44.28 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.205 0.526 . . . . 0.0 111.182 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 148.9 -129.82 3.19 Favored Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.524 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . 0.417 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 12.7 pt-20 -138.97 -175.78 4.27 Favored 'General case' 0 CA--C 1.497 -1.061 0 CA-C-O 121.292 0.567 . . . . 0.0 111.584 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 3.0 mp -88.13 143.35 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.379 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.405 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.02 -56.92 3.09 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 3.0 m -151.61 150.54 30.4 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.942 179.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.3 tt -120.56 111.56 17.82 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 121.379 0.609 . . . . 0.0 111.169 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 62.2 mttt -150.62 122.55 8.17 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.286 179.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.57 -160.8 0.64 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.509 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 1.63 ' HD1' ' CD2' ' A' ' 201' ' ' TYR . 0.2 OUTLIER -87.27 -8.15 57.08 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 121.23 -0.188 . . . . 0.0 111.04 179.587 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.52 -58.74 1.82 Allowed 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 120.628 0.251 . . . . 0.0 111.006 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -152.23 -175.11 5.12 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-O 120.876 0.37 . . . . 0.0 111.095 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -94.84 92.06 6.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.652 179.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 33.9 m -82.87 163.82 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.916 0 CA-C-O 121.481 0.658 . . . . 0.0 112.152 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . 0.419 ' O ' ' HA ' ' A' ' 176' ' ' THR . 0.2 OUTLIER -89.11 -36.79 15.53 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.939 -178.53 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.4 ' HG2' ' CB ' ' A' ' 239' ' ' ALA . 1.9 mp0 -141.73 -178.08 5.49 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.343 0.592 . . . . 0.0 111.993 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -151.08 91.73 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.681 178.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -112.89 165.87 11.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.022 0.439 . . . . 0.0 112.028 -179.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 34.1 tp60 82.26 -69.36 0.07 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.035 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 178.41 37.78 0.06 OUTLIER Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.355 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -97.45 136.05 38.45 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.863 0.363 . . . . 0.0 111.199 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -91.54 146.48 23.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.349 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 1.8 m -150.95 142.7 23.74 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.532 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -89.64 103.77 3.04 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.608 -0.806 . . . . 0.0 111.978 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.86 143.16 50.83 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.078 0.466 . . . . 0.0 111.467 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 1.2 m -83.93 143.49 29.81 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 177.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . 0.402 ' O ' ' CG2' ' A' ' 218' ' ' ILE . 1.5 mp -106.16 92.09 2.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.943 0.401 . . . . 0.0 110.247 -178.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 4.3 tttp 45.06 -144.24 0.17 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.894 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -87.18 61.33 6.66 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 121.024 0.44 . . . . 0.0 110.817 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.455 ' CE1' ' HB2' ' A' ' 191' ' ' TYR . 0.1 OUTLIER -55.92 120.62 7.7 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 114.722 1.379 . . . . 0.0 114.722 179.128 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 21.4 t30 -82.32 -48.55 11.05 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 114.815 -1.084 . . . . 0.0 108.346 176.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . 0.439 ' O ' ' CD1' ' A' ' 221' ' ' PHE . 0.0 OUTLIER -82.01 137.88 35.0 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 177.668 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.426 ' CD1' ' N ' ' A' ' 224' ' ' ILE . 0.2 OUTLIER -133.85 179.13 4.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -178.951 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.417 ' N ' ' OG1' ' A' ' 156' ' ' THR . 0.1 OUTLIER 57.09 117.28 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.107 -179.114 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . 0.459 ' HA ' HG12 ' A' ' 153' ' ' VAL . 38.9 tt0 7.71 63.28 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 124.484 1.114 . . . . 0.0 113.758 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -63.49 -66.43 2.54 Favored Glycine 0 N--CA 1.431 -1.655 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.932 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -164.17 -150.2 0.14 Allowed 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 69.2 t -88.49 130.68 37.59 Favored 'Isoleucine or valine' 0 C--N 1.345 0.38 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.208 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . 0.459 ' HA ' ' CB ' ' A' ' 183' ' ' LEU . 5.1 mp -100.37 157.72 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 O-C-N 123.618 0.574 . . . . 0.0 110.961 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' GLU . . . . . 0.44 ' O ' ' N ' ' A' ' 182' ' ' ARG . 33.6 tt0 -146.94 112.32 5.55 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 120.246 -0.582 . . . . 0.0 112.427 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.18 133.91 33.91 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.008 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' TYR . . . . . 1.648 ' HE1' ' CE2' ' A' ' 233' ' ' TYR . 2.9 p90 -136.04 120.3 17.88 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.803 -178.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.405 ' CG2' ' O ' ' A' ' 233' ' ' TYR . 62.6 t -159.97 111.17 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.863 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' MET . . . . . 0.439 ' HA ' ' CA ' ' A' ' 145' ' ' GLU . 18.5 mtm -86.88 59.36 5.59 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 19.6 mm100 -132.06 -145.2 0.26 Allowed 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.426 -0.807 . . . . 0.0 111.485 -177.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -126.49 66.04 1.24 Allowed 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.559 0.695 . . . . 0.0 109.318 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 12.5 t -83.43 160.46 3.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.81 -178.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . 0.4 ' CB ' ' HG2' ' A' ' 207' ' ' GLU . . . 80.64 -56.24 0.33 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 122.854 0.461 . . . . 0.0 111.215 -179.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.87 -6.2 56.06 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.312 -1.03 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.064 -179.992 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 . . . . . 0 N--CA 1.485 1.312 0 CA-C-O 120.756 0.312 . . . . 0.0 111.202 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -147.23 140.2 25.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.951 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.98 37.39 1.23 Allowed 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.35 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -135.17 -82.68 0.42 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.251 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 6.7 t -99.5 140.71 18.23 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.758 0 CA-C-O 121.245 0.545 . . . . 0.0 110.699 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.416 ' O ' ' O ' ' A' ' 174' ' ' LYS . 0.0 OUTLIER -131.33 -2.32 2.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.009 178.784 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -178.43 73.59 0.07 OUTLIER Glycine 0 C--N 1.342 0.889 0 C-N-CA 120.81 -0.71 . . . . 0.0 111.931 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.411 ' CG ' ' CG ' ' A' ' 231' ' ' GLU . 0.4 OUTLIER -91.67 134.77 34.41 Favored 'General case' 0 CA--C 1.505 -0.769 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.749 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -151.62 175.03 12.76 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-O 121.52 0.676 . . . . 0.0 112.511 -178.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -120.37 127.02 51.91 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.107 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.489 HG12 ' HA ' ' A' ' 226' ' ' GLU . 2.6 p -57.68 128.22 17.92 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.354 0 CA-C-O 121.643 0.735 . . . . 0.0 111.887 -179.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.404 ' CA ' ' NE ' ' A' ' 154' ' ' ARG . 0.0 OUTLIER -90.17 -57.25 2.91 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 104.789 -2.3 . . . . 0.0 104.789 175.617 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.3 -166.16 1.2 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.094 -1.412 . . . . 0.0 110.363 174.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.495 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 18.8 p -151.17 149.88 29.97 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.191 177.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.579 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 5.8 m-30 -94.83 72.11 3.51 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -178.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? -86.48 61.4 6.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.894 0.854 . . . . 0.0 108.924 178.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.44 HG12 ' N ' ' A' ' 160' ' ' SER . 49.0 t -89.77 155.59 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-N 114.095 -1.411 . . . . 0.0 109.789 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.44 ' N ' HG12 ' A' ' 159' ' ' VAL . 0.3 OUTLIER -89.75 22.01 3.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.905 0.383 . . . . 0.0 111.177 178.741 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 6.5 mttt -150.9 6.98 0.53 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.982 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 58.4 t -130.81 -99.6 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 CA-C-N 118.374 0.534 . . . . 0.0 110.017 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -158.46 -112.76 0.34 Allowed Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.426 ' CG2' ' CG2' ' A' ' 224' ' ' ILE . 0.0 OUTLIER -153.7 32.08 0.45 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.401 -0.899 . . . . 0.0 109.18 178.173 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.579 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 1.9 mm -41.09 94.32 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.473 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.495 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . -86.48 113.93 22.81 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.689 -1.141 . . . . 0.0 111.993 -179.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -88.3 126.38 8.08 Favored Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 178.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -129.79 134.48 47.6 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.83 0.315 . . . . 0.0 110.471 -178.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . 1.634 ' HE1' ' CE2' ' A' ' 169' ' ' TYR . 15.0 t80 -86.27 130.34 34.55 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.081 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 42.3 t -85.78 148.57 4.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 113.404 0.891 . . . . 0.0 113.404 -175.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -141.87 15.79 2.12 Favored 'General case' 0 CA--C 1.527 0.076 0 CA-C-N 114.562 -1.199 . . . . 0.0 111.898 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -150.24 -142.64 0.12 Allowed 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -45.73 -109.89 0.01 OUTLIER Glycine 0 CA--C 1.533 1.193 0 N-CA-C 115.009 0.764 . . . . 0.0 115.009 -178.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.416 ' O ' ' O ' ' A' ' 148' ' ' ILE . 3.8 mttm -151.13 127.01 10.32 Favored 'General case' 0 CA--C 1.512 -0.496 0 O-C-N 122.451 -0.441 . . . . 0.0 111.107 -178.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -89.03 113.85 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 C-N-CA 119.199 -1.0 . . . . 0.0 109.431 177.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.422 ' HB ' ' O ' ' A' ' 206' ' ' ARG . 0.1 OUTLIER -124.97 169.26 12.27 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.95 -177.376 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.34 -38.74 88.01 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.299 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -89.28 52.74 2.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.156 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 29.4 m -150.46 157.04 42.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.341 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 0.0 OUTLIER -89.35 176.78 6.79 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.553 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 2.5 m -145.65 149.21 16.7 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.579 0 CA-C-O 121.473 0.654 . . . . 0.0 112.203 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . 0.436 ' N ' ' O ' ' A' ' 231' ' ' GLU . 26.8 ttm180 -154.36 102.34 2.43 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.851 -1.068 . . . . 0.0 112.236 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.515 ' CB ' ' HA ' ' A' ' 230' ' ' ILE . 0.3 OUTLIER -99.61 170.67 8.42 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-O 120.932 0.396 . . . . 0.0 110.649 179.363 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.429 ' O ' ' HB3' ' A' ' 228' ' ' ASP . 36.5 mt -155.5 139.94 9.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.855 -178.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.405 ' N ' HG21 ' A' ' 184' ' ' ILE . 6.9 ttm-85 -87.33 -152.64 0.2 Allowed 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.9 178.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 18.7 mp0 -94.69 28.67 2.57 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 118.141 0.428 . . . . 0.0 111.32 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -152.72 -79.14 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.487 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -114.4 -157.22 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 115.536 -0.332 . . . . 0.0 110.227 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 22.3 t -86.22 139.54 17.22 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 CA-C-O 121.457 0.646 . . . . 0.0 110.739 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . 0.461 HG23 ' HG ' ' A' ' 183' ' ' LEU . 0.4 OUTLIER -87.89 -35.53 8.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.13 -179.93 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . 1.671 ' HE1' ' CE2' ' A' ' 191' ' ' TYR . 22.5 t80 -178.54 146.4 0.36 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.901 179.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -135.46 158.08 45.27 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.015 0.436 . . . . 0.0 110.858 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 147.23 -124.6 1.98 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.736 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 13.7 pt-20 -144.15 -174.95 4.43 Favored 'General case' 0 CA--C 1.497 -1.087 0 CA-C-O 121.202 0.525 . . . . 0.0 111.437 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 3.8 mp -87.72 142.92 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.602 -179.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.03 -52.37 5.12 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 1.2 m -151.47 145.62 25.33 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.724 178.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 4.5 tt -124.06 114.15 19.34 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.394 0.616 . . . . 0.0 111.613 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 56.6 mttt -150.17 121.19 7.69 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.096 -0.957 . . . . 0.0 109.86 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.19 -160.03 0.6 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.285 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 1.649 ' HE1' ' CE2' ' A' ' 201' ' ' TYR . 1.1 t80 -86.74 -16.64 35.79 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.528 0.204 . . . . 0.0 110.778 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.96 -59.67 2.14 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-O 120.655 0.264 . . . . 0.0 110.617 179.15 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -152.96 -171.09 3.82 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 120.964 0.411 . . . . 0.0 111.083 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 22.0 p30 -89.95 57.83 3.96 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.043 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 33.9 m -55.12 164.02 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.04 0 CA-C-O 121.47 0.652 . . . . 0.0 112.304 -179.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . 0.422 ' O ' ' HB ' ' A' ' 176' ' ' THR . 1.6 mtm180 -89.44 -41.34 12.14 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-N 114.715 -1.13 . . . . 0.0 111.34 -178.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -129.72 -178.59 4.76 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.458 0.647 . . . . 0.0 112.37 -179.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -151.17 81.44 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.269 178.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -100.76 171.79 7.47 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -178.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 8.9 tm0? 83.49 -72.67 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.016 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 177.93 37.18 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.345 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -98.21 141.61 30.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.925 0.393 . . . . 0.0 111.303 -179.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.5 131.15 43.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.339 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 52.5 t -133.17 143.96 49.56 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.676 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -88.5 109.62 3.56 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.978 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -135.75 141.77 44.88 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 120.924 0.393 . . . . 0.0 111.478 -179.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.43 146.97 36.22 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 177.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . 0.412 ' O ' ' CG2' ' A' ' 218' ' ' ILE . 1.6 mp -112.61 87.83 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.144 0.497 . . . . 0.0 109.755 -179.126 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 6.5 tttp 46.71 -144.85 0.26 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.759 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -87.33 61.09 6.45 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 121.009 0.433 . . . . 0.0 111.135 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.458 ' CE1' ' HB2' ' A' ' 191' ' ' TYR . 0.1 OUTLIER -55.49 121.42 8.97 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 178.973 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 14.4 t30 -88.63 -45.15 10.08 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.483 176.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 223' ' ' ASP . 0.0 OUTLIER -81.72 134.7 35.48 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.215 177.604 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.426 ' CG2' ' CG2' ' A' ' 164' ' ' THR . 0.2 OUTLIER -133.82 -179.64 3.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -179.067 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.422 ' O ' ' C ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER 57.07 114.33 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.698 -178.367 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . 0.489 ' HA ' HG12 ' A' ' 153' ' ' VAL . 3.0 tt0 8.66 64.22 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 124.633 1.173 . . . . 0.0 113.555 -179.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -61.48 -66.86 2.39 Favored Glycine 0 N--CA 1.432 -1.59 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.468 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.429 ' HB3' ' O ' ' A' ' 184' ' ' ILE . 0.9 OUTLIER -164.9 -147.99 0.11 Allowed 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 179.435 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . 0.453 ' O ' ' HB2' ' A' ' 183' ' ' LEU . 98.4 t -89.24 132.16 34.69 Favored 'Isoleucine or valine' 0 C--N 1.347 0.462 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . 0.515 ' HA ' ' CB ' ' A' ' 183' ' ' LEU . 4.5 mp -99.2 157.23 3.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 O-C-N 123.499 0.499 . . . . 0.0 111.196 -179.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' GLU . . . . . 0.436 ' O ' ' N ' ' A' ' 182' ' ' ARG . 1.9 tm-20 -147.63 110.24 4.68 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 120.159 -0.616 . . . . 0.0 112.633 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.8 134.39 33.69 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.472 178.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' TYR . . . . . 1.6 ' HE2' ' CE1' ' A' ' 233' ' ' TYR . 6.3 p90 -131.58 147.07 52.5 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.935 0.398 . . . . 0.0 111.703 -179.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.411 ' CG1' ' N ' ' A' ' 235' ' ' MET . 0.9 OUTLIER -179.77 167.28 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.417 179.959 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' MET . . . . . 0.411 ' N ' ' CG1' ' A' ' 234' ' ' VAL . 1.9 mtm -88.88 -73.54 0.5 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.565 0.698 . . . . 0.0 110.527 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -150.03 73.2 1.15 Allowed 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.896 179.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -150.94 57.97 0.91 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.788 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -94.96 -165.52 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.682 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -55.05 -73.23 0.05 Allowed 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.942 0.401 . . . . 0.0 111.038 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.83 -5.49 58.0 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.261 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.313 -0.995 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.076 -179.946 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 1.635 ' HE2' ' CE1' ' A' ' 143' ' ' TYR . 87.6 t80 . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.859 0.361 . . . . 0.0 111.204 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 59.96 28.92 18.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.018 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -89.86 49.39 1.71 Allowed 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.442 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 1.1 tptp -83.11 -162.68 0.63 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.529 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 5.8 t -58.62 142.42 14.32 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 CA-C-O 121.333 0.587 . . . . 0.0 111.381 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 11.6 mm -134.41 13.16 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.57 178.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 175.46 65.68 0.06 OUTLIER Glycine 0 C--N 1.343 0.945 0 C-N-CA 121.329 -0.462 . . . . 0.0 112.181 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.61 131.19 35.74 Favored 'General case' 0 CA--C 1.507 -0.679 0 O-C-N 122.506 -0.408 . . . . 0.0 110.481 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.403 ' HA ' ' O ' ' A' ' 169' ' ' TYR . . . -152.18 174.21 14.02 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-O 121.42 0.629 . . . . 0.0 112.448 -178.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.415 ' HA ' ' HA ' ' A' ' 229' ' ' VAL . 7.2 mt-10 -120.63 121.73 38.97 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.487 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.495 HG12 ' HA ' ' A' ' 226' ' ' GLU . 3.1 p -51.45 131.07 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -90.07 -59.27 2.24 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 175.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.416 ' HA ' ' H ' ' A' ' 226' ' ' GLU . 0.3 OUTLIER -162.3 -164.32 1.03 Allowed 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 113.75 -1.568 . . . . 0.0 109.751 175.449 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.491 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 7.0 p -150.47 162.51 40.45 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 177.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.484 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 0.2 OUTLIER -115.53 78.41 1.17 Allowed 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -179.123 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 8.6 tttm -86.47 62.57 7.5 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 177.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 71.3 t -93.04 156.19 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 CA-C-N 113.606 -1.633 . . . . 0.0 110.488 -178.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 46.0 p -91.29 34.64 0.94 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.234 0.54 . . . . 0.0 109.71 178.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.76 -32.92 0.17 Allowed 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.206 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 84.3 t -100.67 -103.05 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -159.35 -101.19 0.17 Allowed Glycine 0 N--CA 1.451 -0.353 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 178.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.437 ' CG2' ' CG2' ' A' ' 224' ' ' ILE . 0.0 OUTLIER -154.14 33.94 0.43 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 114.115 -1.042 . . . . 0.0 108.51 177.812 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.484 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 1.5 mp -42.91 95.26 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.522 -179.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.491 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . -89.93 120.51 31.21 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.722 -1.126 . . . . 0.0 112.179 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -88.15 148.0 20.55 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 178.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -147.73 134.64 20.19 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 117.366 0.583 . . . . 0.0 110.694 -178.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . 0.403 ' O ' ' HA ' ' A' ' 151' ' ' ALA . 78.4 t80 -86.53 124.47 32.87 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 177.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 22.7 t -85.42 144.3 9.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 113.14 0.792 . . . . 0.0 113.14 -176.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.1 p -137.2 14.17 3.04 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 114.779 -1.1 . . . . 0.0 112.078 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -150.56 -144.68 0.16 Allowed 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -40.27 -105.0 0.01 OUTLIER Glycine 0 CA--C 1.533 1.16 0 N-CA-C 115.264 0.865 . . . . 0.0 115.264 -178.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.406 ' HB2' ' HB3' ' A' ' 207' ' ' GLU . 0.0 OUTLIER -150.93 150.9 31.39 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.061 0.458 . . . . 0.0 111.442 -178.416 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 16.1 mm -103.67 82.72 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 176.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 0.0 OUTLIER -95.58 172.89 7.78 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.78 1.029 . . . . 0.0 113.78 -176.569 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 7.8 ttp180 -69.42 -48.68 60.28 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 114.1 -1.409 . . . . 0.0 110.792 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -89.45 61.61 5.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.28 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 1.8 m -148.3 157.62 43.6 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.343 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 1.1 mptt -88.56 173.7 8.5 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 2.9 m -142.49 150.35 18.54 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.568 0 CA-C-O 121.483 0.659 . . . . 0.0 112.595 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . 0.421 ' N ' ' O ' ' A' ' 231' ' ' GLU . 43.5 ttp180 -154.83 102.09 2.33 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.847 -1.069 . . . . 0.0 112.479 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.511 ' CB ' ' HA ' ' A' ' 230' ' ' ILE . 0.3 OUTLIER -100.56 170.57 8.29 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 120.426 -0.51 . . . . 0.0 111.004 179.235 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.406 ' O ' ' HB3' ' A' ' 228' ' ' ASP . 26.6 mt -154.18 140.15 11.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -178.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -87.17 -154.18 0.24 Allowed 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.012 -0.995 . . . . 0.0 108.774 178.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -94.7 28.74 2.54 Favored 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 122.02 -0.425 . . . . 0.0 111.184 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -152.98 -75.81 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.45 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -117.75 -156.75 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 115.441 -0.379 . . . . 0.0 110.296 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.402 ' CG1' ' HG3' ' A' ' 192' ' ' GLU . 21.3 t -86.48 139.49 17.28 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.393 0 CA-C-O 121.399 0.619 . . . . 0.0 110.916 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . 0.469 HG23 ' HG ' ' A' ' 183' ' ' LEU . 0.3 OUTLIER -88.58 -35.84 8.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.468 -179.841 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . 1.652 ' HD1' ' CD2' ' A' ' 191' ' ' TYR . 31.1 t80 -178.34 144.31 0.3 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.997 179.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . 0.402 ' HG3' ' CG1' ' A' ' 189' ' ' VAL . 0.3 OUTLIER -131.87 159.03 39.77 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.937 0.398 . . . . 0.0 110.801 179.293 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 146.16 -126.05 2.41 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.852 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . 0.451 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 11.0 pt-20 -143.07 -176.37 4.89 Favored 'General case' 0 CA--C 1.499 -1.011 0 CA-C-O 121.289 0.566 . . . . 0.0 111.667 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 12.3 mm -87.42 143.41 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.485 -179.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.78 -57.1 3.03 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 1.2 m -151.59 152.94 33.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.282 178.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -134.87 119.05 17.62 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.694 0.759 . . . . 0.0 112.014 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.28 125.31 9.94 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 114.445 -1.252 . . . . 0.0 109.431 178.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 1.2 ptp85 -86.88 -145.98 0.12 Allowed 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.244 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -84.5 108.57 17.36 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 54.13 29.38 10.32 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.501 -179.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -150.61 116.43 5.54 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 120.933 0.397 . . . . 0.0 111.342 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -89.49 55.2 3.15 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.066 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 35.3 m -56.55 158.16 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.962 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.796 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . 0.474 ' O ' ' HA ' ' A' ' 176' ' ' THR . 2.5 ttp-105 -89.07 -27.82 20.54 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.716 -178.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.406 ' HB3' ' HB2' ' A' ' 174' ' ' LYS . 1.5 mp0 -139.99 178.36 7.32 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.092 0.472 . . . . 0.0 111.162 179.15 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -151.02 75.74 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.854 179.121 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -97.27 175.18 6.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.081 0.467 . . . . 0.0 112.223 -178.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 83.88 -75.46 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.858 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 178.26 36.89 0.06 OUTLIER Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.372 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -98.32 144.06 28.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.901 0.382 . . . . 0.0 111.171 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.62 131.32 44.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.021 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 50.8 t -134.22 149.86 51.01 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.753 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -88.99 116.54 4.69 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.568 -0.825 . . . . 0.0 111.621 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -143.68 145.65 32.61 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 121.113 0.482 . . . . 0.0 111.386 -178.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.44 146.48 26.41 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . 0.42 ' O ' ' CG2' ' A' ' 218' ' ' ILE . 1.6 mp -110.36 87.91 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 1.4 tttt 45.93 -144.44 0.23 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.018 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -87.17 62.03 7.06 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 121.097 0.475 . . . . 0.0 111.016 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.45 ' CE1' ' HB2' ' A' ' 191' ' ' TYR . 0.1 OUTLIER -55.59 122.23 10.86 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 114.423 1.268 . . . . 0.0 114.423 179.034 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -87.92 -45.69 10.03 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 114.899 -1.046 . . . . 0.0 108.422 176.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . 0.454 ' OD1' ' N ' ' A' ' 223' ' ' ASP . 0.0 OUTLIER -81.65 135.14 35.54 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.994 177.588 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.437 ' CG2' ' CG2' ' A' ' 164' ' ' THR . 0.2 OUTLIER -134.67 179.65 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.718 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.411 ' O ' ' C ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER 57.33 114.44 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 114.479 -1.237 . . . . 0.0 110.052 -178.96 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . 0.495 ' HA ' HG12 ' A' ' 153' ' ' VAL . 5.2 tm-20 11.41 61.1 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 124.671 1.232 . . . . 0.0 112.919 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -60.19 -68.02 1.88 Allowed Glycine 0 N--CA 1.433 -1.541 0 CA-C-N 114.695 -1.139 . . . . 0.0 111.736 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.406 ' HB3' ' O ' ' A' ' 184' ' ' ILE . 0.8 OUTLIER -164.8 -148.93 0.12 Allowed 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 179.631 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 92.1 t -88.44 129.61 39.32 Favored 'Isoleucine or valine' 0 C--N 1.346 0.453 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.517 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . 0.511 ' HA ' ' CB ' ' A' ' 183' ' ' LEU . 17.4 mt -98.94 157.17 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 O-C-N 123.689 0.618 . . . . 0.0 111.564 -179.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' GLU . . . . . 0.421 ' O ' ' N ' ' A' ' 182' ' ' ARG . 0.0 OUTLIER -146.46 109.97 4.82 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -179.673 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.96 131.14 35.29 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.397 178.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' TYR . . . . . 1.618 ' HD1' ' CD2' ' A' ' 233' ' ' TYR . 11.8 p90 -128.95 142.83 50.8 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.724 0.297 . . . . 0.0 110.962 -179.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.401 ' CG1' ' CG2' ' A' ' 238' ' ' VAL . 0.9 OUTLIER -175.62 -172.64 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.607 -179.906 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 7.8 mtm -88.68 -162.74 0.88 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.671 0.272 . . . . 0.0 110.842 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 68.9 mm-40 -95.56 37.83 1.18 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.934 0.397 . . . . 0.0 111.361 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -131.58 46.31 2.67 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.79 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.401 ' CG2' ' CG1' ' A' ' 234' ' ' VAL . 2.8 t -93.46 161.95 2.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.986 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . 72.86 -60.86 0.52 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.517 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -89.19 -4.36 58.26 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.312 -1.065 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.01 179.903 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.836 0.351 . . . . 0.0 111.307 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 59.25 85.61 0.1 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.033 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.56 40.69 1.15 Allowed 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.091 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 17.4 tptt -94.73 -76.59 0.48 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.099 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 13.6 t -122.64 142.73 38.03 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.555 0 CA-C-O 121.507 0.67 . . . . 0.0 111.706 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.426 HG12 HG22 ' A' ' 238' ' ' VAL . 3.9 tp -118.01 -20.05 5.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.084 178.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -178.02 85.17 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.445 -179.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.72 132.98 37.56 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.419 ' CB ' ' HB2' ' A' ' 168' ' ' CYS . . . -152.14 175.88 12.12 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 119.736 -0.786 . . . . 0.0 113.059 -177.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.406 ' HA ' ' HA ' ' A' ' 229' ' ' VAL . 13.1 mt-10 -120.47 124.09 44.56 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.445 -1.252 . . . . 0.0 110.046 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.446 ' CG1' ' HA ' ' A' ' 226' ' ' GLU . 3.6 p -50.52 134.46 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -178.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -89.46 -61.35 1.72 Allowed 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 175.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.411 ' HA ' ' H ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER -161.13 -160.46 0.73 Allowed 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 113.711 -1.586 . . . . 0.0 109.651 175.595 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.452 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 4.3 p -147.99 168.24 22.83 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 177.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.624 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 6.4 m-85 -118.11 75.58 1.02 Allowed 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -178.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.05 63.28 7.94 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 122.121 0.962 . . . . 0.0 108.481 178.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.424 HG12 ' N ' ' A' ' 160' ' ' SER . 83.9 t -90.9 157.75 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 CA-C-N 113.709 -1.587 . . . . 0.0 110.229 -178.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.424 ' N ' HG12 ' A' ' 159' ' ' VAL . 1.2 m -92.5 34.57 1.05 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.217 0.532 . . . . 0.0 109.849 178.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 9.8 mttt -151.67 -32.97 0.15 Allowed 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.442 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 84.0 t -99.83 -103.21 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.278 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -159.12 -101.56 0.17 Allowed Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 111.481 -0.648 . . . . 0.0 111.481 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.402 ' CG2' ' CG2' ' A' ' 224' ' ' ILE . 0.0 OUTLIER -153.83 36.18 0.44 Allowed 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 114.152 -1.024 . . . . 0.0 108.49 178.25 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.624 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 3.8 mt -42.14 98.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.441 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.452 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . -91.71 121.05 33.0 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.006 -0.997 . . . . 0.0 112.298 -179.057 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -88.73 150.96 22.01 Favored Glycine 0 N--CA 1.441 -0.969 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 178.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . 0.419 ' HB2' ' CB ' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -145.92 136.05 23.74 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 117.377 0.588 . . . . 0.0 110.776 -178.409 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . 1.644 ' HE1' ' CE2' ' A' ' 169' ' ' TYR . 31.4 t80 -87.2 123.56 32.36 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 177.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 38.8 t -85.13 148.08 5.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -175.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -138.86 16.86 2.67 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-N 114.298 -1.319 . . . . 0.0 111.81 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -150.19 -147.42 0.23 Allowed 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -179.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -44.39 -104.47 0.01 OUTLIER Glycine 0 CA--C 1.53 1.025 0 N-CA-C 114.685 0.634 . . . . 0.0 114.685 -179.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.423 ' O ' ' O ' ' A' ' 148' ' ' ILE . 0.0 OUTLIER -151.1 126.61 10.11 Favored 'General case' 0 CA--C 1.513 -0.449 0 O-C-N 122.608 -0.348 . . . . 0.0 111.458 -179.04 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 1.5 tp -88.82 83.76 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 CA-C-O 122.035 0.922 . . . . 0.0 109.238 177.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.18 -177.91 5.53 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.384 -1.28 . . . . 0.0 112.932 -177.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 37.7 mtm180 -74.71 -44.11 51.71 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 114.669 -1.151 . . . . 0.0 110.839 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -89.04 57.68 4.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.75 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 3.3 m -148.22 163.33 37.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.401 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 2.7 mptm? -93.77 176.48 6.34 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.104 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.418 ' HA ' ' HA ' ' A' ' 232' ' ' ALA . 1.1 m -151.14 149.99 13.69 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.476 0 CA-C-O 121.598 0.713 . . . . 0.0 111.952 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . 0.449 ' N ' ' O ' ' A' ' 231' ' ' GLU . 41.3 ttp180 -153.39 104.36 2.75 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.108 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.485 ' HB2' ' O ' ' A' ' 229' ' ' VAL . 0.3 OUTLIER -99.49 170.88 8.31 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-O 120.976 0.417 . . . . 0.0 111.008 -179.75 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.428 ' O ' ' HB3' ' A' ' 228' ' ' ASP . 48.4 mt -152.92 141.64 14.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.194 -177.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.412 ' N ' HG21 ' A' ' 190' ' ' VAL . 7.1 ttp180 -86.49 -157.38 0.35 Allowed 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -94.17 27.14 2.97 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.724 178.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -154.25 -43.59 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.862 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.434 ' CG2' ' N ' ' A' ' 189' ' ' VAL . 0.4 OUTLIER -150.24 -160.52 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -178.098 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.434 ' N ' ' CG2' ' A' ' 188' ' ' ILE . 35.5 t -85.41 134.98 25.87 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.397 0 CA-C-O 121.439 0.638 . . . . 0.0 110.386 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . 0.453 ' HB ' HD12 ' A' ' 183' ' ' LEU . 0.2 OUTLIER -88.79 -32.54 5.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.619 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . 1.647 ' HE1' ' CE2' ' A' ' 191' ' ' TYR . 79.8 t80 179.9 158.41 0.72 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.673 178.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -143.87 154.28 43.21 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.969 0.414 . . . . 0.0 110.443 178.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 148.5 -129.33 3.08 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.843 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . 0.449 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 13.3 pt-20 -139.38 -174.38 3.86 Favored 'General case' 0 CA--C 1.498 -1.039 0 CA-C-O 121.27 0.557 . . . . 0.0 111.393 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 4.2 mp -88.0 143.84 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.009 -178.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -89.24 -53.29 4.63 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 18.3 p -151.2 143.22 23.95 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.308 178.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -119.67 114.42 22.16 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.329 0.585 . . . . 0.0 111.681 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 26.9 tttt -150.48 122.15 8.04 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.137 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -88.04 -160.16 0.6 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.968 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -87.03 -12.76 46.37 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.489 0.185 . . . . 0.0 110.931 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.97 -59.28 1.94 Allowed 'General case' 0 N--CA 1.44 -0.952 0 CA-C-O 120.633 0.254 . . . . 0.0 110.775 179.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -152.54 -169.29 3.3 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 120.907 0.384 . . . . 0.0 111.01 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -93.07 66.31 4.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.189 179.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 32.9 m -61.07 160.06 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 CA-C-O 121.521 0.677 . . . . 0.0 112.242 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -89.43 -36.74 15.28 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 114.735 -1.121 . . . . 0.0 111.607 -178.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -137.53 177.23 8.02 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.301 0.572 . . . . 0.0 111.895 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.86 82.64 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.074 -0.967 . . . . 0.0 109.46 179.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -101.5 171.67 7.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.093 0.473 . . . . 0.0 112.182 -178.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 83.22 -72.55 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.998 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 178.0 37.89 0.06 OUTLIER Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.404 179.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -98.09 142.93 29.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.95 0.405 . . . . 0.0 111.565 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.67 160.71 16.47 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.482 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -150.41 -164.97 2.14 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.863 0.363 . . . . 0.0 111.04 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -148.64 96.23 0.17 Allowed Glycine 0 N--CA 1.451 -0.316 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 179.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -131.17 143.6 50.73 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -177.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.0 143.79 37.25 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 176.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 1.6 mp -108.26 88.14 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.709 -178.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 9.8 tttt 47.16 -141.91 0.44 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.663 179.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -86.42 55.73 3.68 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.091 0.472 . . . . 0.0 110.99 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.522 ' CE1' ' CB ' ' A' ' 191' ' ' TYR . 0.1 OUTLIER -57.51 132.0 51.85 Favored 'General case' 0 C--N 1.339 0.126 0 N-CA-C 116.086 1.884 . . . . 0.0 116.086 178.964 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.42 -42.3 8.55 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 114.35 -1.296 . . . . 0.0 108.658 175.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . 0.518 ' HB3' ' CE1' ' A' ' 221' ' ' PHE . 0.0 OUTLIER -64.96 164.12 13.27 Favored 'General case' 0 C--N 1.351 0.65 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.794 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.402 ' CG2' ' CG2' ' A' ' 164' ' ' THR . 0.2 OUTLIER -155.36 -177.11 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 114.897 -1.047 . . . . 0.0 111.988 176.39 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 34.12 103.92 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.752 1.221 . . . . 0.0 112.345 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . 0.446 ' HA ' ' CG1' ' A' ' 153' ' ' VAL . 18.5 tt0 20.35 59.49 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.228 0 O-C-N 124.487 1.117 . . . . 0.0 113.224 179.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -61.65 -61.73 6.5 Favored Glycine 0 N--CA 1.432 -1.574 0 CA-C-N 114.869 -1.06 . . . . 0.0 112.482 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.428 ' HB3' ' O ' ' A' ' 184' ' ' ILE . 0.6 OUTLIER -164.06 -152.02 0.18 Allowed 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -179.544 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . 0.485 ' O ' ' HB2' ' A' ' 183' ' ' LEU . 92.2 t -90.02 134.41 29.13 Favored 'Isoleucine or valine' 0 C--N 1.35 0.604 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.945 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . 0.479 ' HA ' ' CB ' ' A' ' 183' ' ' LEU . 2.7 mp -103.39 158.69 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 O-C-N 123.544 0.528 . . . . 0.0 111.228 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' GLU . . . . . 0.449 ' O ' ' N ' ' A' ' 182' ' ' ARG . 9.2 tt0 -147.79 111.32 4.98 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . 0.418 ' HA ' ' HA ' ' A' ' 181' ' ' VAL . . . -87.7 139.68 30.28 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.683 179.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' TYR . . . . . 0.413 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 30.3 p90 -139.03 135.01 33.79 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.146 -179.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.409 ' CG1' ' N ' ' A' ' 235' ' ' MET . 0.5 OUTLIER -176.93 -161.05 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.668 179.716 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' MET . . . . . 0.409 ' N ' ' CG1' ' A' ' 234' ' ' VAL . 0.0 OUTLIER -95.94 -167.54 1.61 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.795 0.331 . . . . 0.0 110.687 -179.892 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.91 32.7 2.55 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.092 0.472 . . . . 0.0 111.334 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -118.84 43.04 2.65 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.023 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.426 HG22 HG12 ' A' ' 148' ' ' ILE . 0.6 OUTLIER -108.44 168.38 3.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.075 -179.137 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . 69.84 -64.87 0.33 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.885 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.67 -3.95 57.99 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.313 -0.987 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.059 -179.995 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 1.597 ' HE1' ' CE2' ' A' ' 143' ' ' TYR . 35.5 m-85 . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.765 0.317 . . . . 0.0 111.215 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -67.98 139.65 56.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.972 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -93.84 42.23 1.09 Allowed 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.389 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -94.3 -178.51 4.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.952 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 20.7 t -58.68 143.22 13.33 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.449 0 CA-C-O 121.415 0.626 . . . . 0.0 111.424 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 16.1 mm -129.7 6.98 2.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.843 178.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 173.9 72.88 0.05 OUTLIER Glycine 0 C--N 1.343 0.936 0 C-N-CA 121.127 -0.559 . . . . 0.0 111.904 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.71 131.5 38.98 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 116.871 0.335 . . . . 0.0 110.305 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -151.65 176.47 11.33 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -178.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.424 ' HA ' ' HA ' ' A' ' 229' ' ' VAL . 1.9 mt-10 -123.69 125.82 45.45 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.746 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.419 HG12 ' HA ' ' A' ' 226' ' ' GLU . 1.8 p -55.16 127.21 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-O 121.569 0.699 . . . . 0.0 112.196 -179.221 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.446 ' O ' ' HB3' ' A' ' 226' ' ' GLU . 0.0 OUTLIER -89.87 -55.16 3.74 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 105.056 -2.201 . . . . 0.0 105.056 175.736 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.83 -164.07 0.86 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.861 174.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.518 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 26.3 p -143.41 -175.9 4.73 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 178.253 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.6 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 21.7 m-85 -144.11 76.53 1.51 Allowed 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.432 ' HG2' HG13 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -86.52 62.64 7.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 122.428 1.109 . . . . 0.0 108.498 178.285 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 45.8 t -89.85 154.73 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 CA-C-N 113.236 -1.802 . . . . 0.0 110.226 -178.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 26.3 t -89.83 36.74 0.86 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.057 0.456 . . . . 0.0 110.006 178.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -150.6 -34.18 0.16 Allowed 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.213 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 84.9 t -101.65 -101.81 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 158' ' ' LYS . . . -158.79 -101.74 0.18 Allowed Glycine 0 C--O 1.224 -0.498 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 178.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -152.32 37.07 0.53 Allowed 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 177.48 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.6 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 2.2 mm -40.28 93.21 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.338 0.095 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.773 -179.175 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.518 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . -84.98 116.47 23.4 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.457 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -87.49 134.4 12.44 Favored Glycine 0 N--CA 1.438 -1.181 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 178.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -136.46 131.21 33.73 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.859 0.329 . . . . 0.0 110.374 -178.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . 1.637 ' HD2' ' CD1' ' A' ' 169' ' ' TYR . 41.1 t80 -85.64 126.8 34.2 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 177.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 45.4 t -85.73 146.36 6.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -175.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.2 p -138.44 14.19 2.77 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 114.402 -1.272 . . . . 0.0 111.807 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -150.46 -142.58 0.12 Allowed 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -44.54 -105.36 0.01 OUTLIER Glycine 0 CA--C 1.53 1.015 0 N-CA-C 114.455 0.542 . . . . 0.0 114.455 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 10.7 mttm -151.8 143.13 23.39 Favored 'General case' 0 CA--C 1.516 -0.347 0 O-C-N 122.301 -0.529 . . . . 0.0 111.995 -179.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 11.2 mm -93.23 90.52 3.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 176.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 0.1 OUTLIER -106.13 174.7 5.77 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.488 0.661 . . . . 0.0 112.677 -177.495 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.407 ' HG3' ' HB2' ' A' ' 198' ' ' LEU . 0.1 OUTLIER -72.96 -42.59 63.22 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.208 179.351 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -88.28 56.22 3.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.141 -179.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -150.2 161.51 42.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.418 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 0.0 OUTLIER -89.18 -177.45 5.41 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.5 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 1.4 m -146.07 157.29 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 CA-C-O 121.227 0.537 . . . . 0.0 111.638 179.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . 0.418 ' N ' ' O ' ' A' ' 231' ' ' GLU . 6.0 ttt85 -152.78 102.54 2.7 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.312 -0.858 . . . . 0.0 113.196 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.478 ' CD1' ' CZ ' ' A' ' 221' ' ' PHE . 0.3 OUTLIER -86.36 154.12 21.43 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-O 121.701 0.763 . . . . 0.0 113.034 -179.937 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.472 ' N ' HG23 ' A' ' 190' ' ' VAL . 3.2 mp -148.5 121.24 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 113.989 -1.46 . . . . 0.0 112.27 178.124 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.41 ' N ' HG21 ' A' ' 190' ' ' VAL . 1.3 ttm180 -85.99 -150.44 0.14 Allowed 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 177.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -93.99 27.48 2.78 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 118.78 0.718 . . . . 0.0 110.766 178.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -154.81 -77.54 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.835 -0.697 . . . . 0.0 112.673 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -115.44 -155.28 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 115.277 -0.462 . . . . 0.0 110.734 -179.136 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 44.2 t -87.08 135.44 25.21 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.102 0 CA-C-O 121.565 0.698 . . . . 0.0 111.74 -179.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . 0.472 HG23 ' N ' ' A' ' 184' ' ' ILE . 0.2 OUTLIER -89.58 -34.51 6.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 114.665 -1.152 . . . . 0.0 108.961 178.637 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . 1.638 ' HD1' ' CD2' ' A' ' 191' ' ' TYR . 16.6 t80 -158.33 158.79 35.0 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.35 178.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -150.33 155.81 40.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.112 178.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 134.7 -119.34 2.15 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.257 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . 0.448 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 17.6 pt-20 -150.32 -175.01 4.91 Favored 'General case' 0 CA--C 1.496 -1.097 0 CA-C-O 121.357 0.599 . . . . 0.0 111.675 -179.111 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 4.3 mp -88.48 143.38 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.322 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.93 -57.47 2.89 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 35.2 t -151.53 153.03 33.78 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.222 179.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.407 ' HB2' ' HG3' ' A' ' 177' ' ' ARG . 0.1 OUTLIER -123.0 119.22 29.73 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-O 121.37 0.605 . . . . 0.0 111.484 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.34 118.7 6.42 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.126 179.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 4.6 ptm85 -87.86 -144.27 0.13 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.177 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -84.57 109.32 17.87 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 53.0 29.25 7.65 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.767 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -150.85 130.31 12.94 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 120.947 0.403 . . . . 0.0 111.316 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -98.34 71.42 2.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.078 179.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 36.0 m -72.12 166.33 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.921 0 CA-C-O 121.618 0.723 . . . . 0.0 112.562 -178.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . 0.439 ' O ' ' HA ' ' A' ' 176' ' ' THR . 16.6 ttp180 -89.07 -41.1 12.51 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 114.483 -1.235 . . . . 0.0 111.556 -178.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -138.09 -177.18 4.71 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.135 0.493 . . . . 0.0 111.684 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -150.88 81.56 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.801 179.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -99.74 175.28 5.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.056 0.455 . . . . 0.0 112.154 -178.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 82.59 -75.0 0.03 OUTLIER 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.697 -179.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 178.47 37.31 0.06 OUTLIER Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.376 -0.916 . . . . 0.0 112.362 179.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . 1.603 ' HE1' ' CE2' ' A' ' 212' ' ' TYR . 0.5 OUTLIER -99.22 145.28 27.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.963 0.411 . . . . 0.0 111.196 -179.407 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.4 131.79 46.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.453 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 50.0 t -134.96 144.45 47.42 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.399 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -88.58 108.15 3.42 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.494 -0.86 . . . . 0.0 111.995 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.406 ' HB3' ' HA ' ' A' ' 198' ' ' LEU . 0.3 OUTLIER -132.54 140.51 48.33 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 120.97 0.414 . . . . 0.0 111.436 -179.264 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.73 138.8 38.42 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 177.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . 0.463 ' CG2' ' CD2' ' A' ' 191' ' ' TYR . 1.4 mp -105.79 95.4 3.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 -178.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 44.04 -145.53 0.11 Allowed 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.928 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 -88.16 63.83 7.42 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-O 120.85 0.357 . . . . 0.0 111.2 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.478 ' CZ ' ' CD1' ' A' ' 183' ' ' LEU . 0.1 OUTLIER -54.4 118.44 4.13 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 179.002 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -84.14 -43.43 15.01 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.755 176.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -87.74 132.26 34.2 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.97 178.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.432 HG13 ' HG2' ' A' ' 158' ' ' LYS . 0.1 OUTLIER -116.61 179.56 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 CA-C-O 121.09 0.471 . . . . 0.0 112.003 -179.646 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.421 ' O ' ' N ' ' A' ' 227' ' ' GLY . 0.0 OUTLIER 55.67 120.88 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.543 179.853 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . 0.446 ' HB3' ' O ' ' A' ' 154' ' ' ARG . 3.3 pt-20 -3.97 71.73 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 225' ' ' LYS . . . -64.48 -63.42 4.3 Favored Glycine 0 N--CA 1.43 -1.722 0 CA-C-N 114.7 -1.136 . . . . 0.0 111.616 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.416 ' O ' ' HB ' ' A' ' 153' ' ' VAL . 1.0 OUTLIER -164.76 -148.49 0.11 Allowed 'General case' 0 C--O 1.22 -0.491 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 179.585 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . 0.424 ' HA ' ' HA ' ' A' ' 152' ' ' GLU . 61.9 t -89.47 145.76 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.225 0 O-C-N 122.091 -0.381 . . . . 0.0 110.494 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . 0.405 HG13 ' CD2' ' A' ' 183' ' ' LEU . 2.6 mp -117.01 154.4 18.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.156 -179.231 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' GLU . . . . . 0.418 ' O ' ' N ' ' A' ' 182' ' ' ARG . 7.5 tt0 -143.27 113.96 7.56 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.403 0.62 . . . . 0.0 111.948 -179.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.45 128.45 35.53 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.497 178.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' TYR . . . . . 1.615 ' HE2' ' CE1' ' A' ' 233' ' ' TYR . 6.1 p90 -130.5 129.48 42.95 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.869 -178.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 4.3 t -153.98 139.4 10.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.982 0.42 . . . . 0.0 111.762 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.59 37.25 1.96 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 178.432 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -120.08 -143.54 0.35 Allowed 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.316 -178.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -137.31 72.77 1.42 Allowed 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.1 t -82.72 160.64 3.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.862 -178.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . 78.62 -59.77 0.41 Allowed 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.842 -179.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.8 -7.66 53.87 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.312 -1.031 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.038 179.998 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 1.647 ' HE2' ' CE1' ' A' ' 143' ' ' TYR . 2.8 t80 . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.888 0.375 . . . . 0.0 111.251 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 60.64 -175.47 0.11 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.97 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -93.7 42.46 1.1 Allowed 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.453 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 2.0 tttm -76.26 -166.33 0.6 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.527 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 14.9 t -59.53 140.9 17.04 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.637 0 CA-C-O 121.308 0.575 . . . . 0.0 111.315 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.8 pp -124.97 -1.78 5.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.048 178.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 179.51 73.95 0.06 OUTLIER Glycine 0 C--N 1.34 0.791 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.165 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.99 132.8 35.76 Favored 'General case' 0 CA--C 1.509 -0.61 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.249 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -151.57 174.71 13.12 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 121.457 0.646 . . . . 0.0 112.458 -178.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.429 ' HA ' ' HA ' ' A' ' 229' ' ' VAL . 0.8 OUTLIER -119.98 122.14 40.52 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.021 179.691 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.428 ' CG1' ' HA ' ' A' ' 226' ' ' GLU . 2.6 p -50.05 134.13 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -89.29 -63.31 1.31 Allowed 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 175.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.51 -162.03 0.85 Allowed 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 113.826 -1.534 . . . . 0.0 109.198 175.206 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 7.5 p -145.89 157.3 43.91 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 120.829 0.347 . . . . 0.0 110.392 177.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.625 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 2.3 m-85 -104.21 72.13 1.06 Allowed 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -177.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 16.7 tttt -85.67 63.72 8.22 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 122.125 0.964 . . . . 0.0 108.826 178.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.419 HG12 ' N ' ' A' ' 160' ' ' SER . 95.8 t -89.9 158.21 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 CA-C-N 113.673 -1.603 . . . . 0.0 109.906 -179.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.419 ' N ' HG12 ' A' ' 159' ' ' VAL . 25.2 p -92.62 32.97 1.16 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.224 0.535 . . . . 0.0 110.036 178.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 3.2 mtmt -152.02 -31.54 0.15 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.644 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 98.5 t -98.98 -101.19 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 O-C-N 122.171 -0.331 . . . . 0.0 110.234 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -158.72 -105.95 0.22 Allowed Glycine 0 N--CA 1.451 -0.361 0 N-CA-C 111.644 -0.583 . . . . 0.0 111.644 179.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.427 ' CG2' ' CG2' ' A' ' 224' ' ' ILE . 0.0 OUTLIER -153.7 34.85 0.45 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.378 -0.911 . . . . 0.0 108.944 178.391 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.625 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 3.8 mm -42.45 94.87 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.577 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.482 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . -87.77 117.8 26.85 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 114.748 -1.114 . . . . 0.0 111.189 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -88.39 153.97 24.72 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 179.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -148.29 136.12 20.88 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.922 0.361 . . . . 0.0 110.81 -178.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . 1.634 ' HD2' ' CD1' ' A' ' 169' ' ' TYR . 33.3 t80 -87.39 124.96 33.95 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 177.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 24.5 t -85.08 144.51 9.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -175.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -136.41 14.3 3.23 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-N 114.544 -1.207 . . . . 0.0 112.013 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -150.52 -144.16 0.15 Allowed 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -179.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -41.32 -106.0 0.01 OUTLIER Glycine 0 CA--C 1.533 1.188 0 N-CA-C 115.197 0.839 . . . . 0.0 115.197 -178.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.69 146.74 26.66 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.014 0.435 . . . . 0.0 111.619 -178.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 10.6 mm -99.39 83.23 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 176.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 0.1 OUTLIER -95.88 168.5 10.6 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -177.177 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 33.8 mtm180 -64.58 -45.07 88.58 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 114.546 -1.206 . . . . 0.0 110.743 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -89.4 59.99 5.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.743 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 58.9 m -149.13 156.04 41.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.756 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -89.18 -179.33 5.86 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.696 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 1.1 m -150.86 150.12 13.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.493 0.663 . . . . 0.0 111.953 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . 0.439 ' N ' ' O ' ' A' ' 231' ' ' GLU . 11.5 ttt85 -153.25 102.43 2.61 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.463 179.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.482 ' CB ' ' HA ' ' A' ' 230' ' ' ILE . 0.3 OUTLIER -100.58 167.67 10.2 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-O 120.947 0.403 . . . . 0.0 111.382 -179.829 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.409 ' O ' ' HB3' ' A' ' 228' ' ' ASP . 4.7 mp -151.56 139.98 14.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.944 -177.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.404 ' N ' HG21 ' A' ' 190' ' ' VAL . 0.1 OUTLIER -87.16 -153.19 0.21 Allowed 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.022 -0.99 . . . . 0.0 108.86 178.117 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -94.71 28.02 2.83 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 118.092 0.405 . . . . 0.0 111.296 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -152.96 -76.75 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.556 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -116.12 -156.57 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 115.525 -0.338 . . . . 0.0 110.319 -179.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 31.0 t -86.16 138.84 18.32 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 CA-C-O 121.476 0.655 . . . . 0.0 110.702 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . 0.408 ' HB ' ' CD1' ' A' ' 183' ' ' LEU . 0.6 OUTLIER -87.68 -37.11 10.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 114.913 -1.04 . . . . 0.0 108.89 179.847 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . 1.637 ' HE2' ' CE1' ' A' ' 191' ' ' TYR . 0.5 OUTLIER -178.69 150.49 0.52 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.354 179.617 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -137.13 158.35 44.63 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.935 179.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 144.53 -132.73 4.9 Favored Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.556 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -143.58 -179.34 6.37 Favored 'General case' 0 CA--C 1.498 -1.023 0 CA-C-O 121.186 0.517 . . . . 0.0 111.051 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 4.5 mp -88.73 143.05 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.877 -178.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -91.81 -43.79 9.33 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 48.8 m -151.29 145.56 25.43 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.09 179.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.404 ' CD1' ' CD2' ' A' ' 216' ' ' LEU . 16.7 tp -119.39 113.82 21.39 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.075 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 19.7 mtmm -149.56 122.86 8.98 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.368 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -87.76 -159.77 0.56 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.833 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -87.17 -7.77 57.61 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 121.097 -0.241 . . . . 0.0 111.295 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 10.4 tptt -102.86 -59.41 1.71 Allowed 'General case' 0 N--CA 1.441 -0.902 0 CA-C-O 120.712 0.291 . . . . 0.0 110.975 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 -152.46 -171.07 3.82 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 120.764 0.316 . . . . 0.0 111.021 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -89.61 75.07 7.53 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.317 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 33.1 m -64.52 159.45 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.878 0 CA-C-O 121.583 0.706 . . . . 0.0 112.313 -179.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . 0.451 ' O ' ' HA ' ' A' ' 176' ' ' THR . 1.9 ttt180 -89.3 -34.54 16.54 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.875 -178.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -142.03 -179.01 5.97 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.156 0.503 . . . . 0.0 111.527 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 1.9 t -150.79 73.03 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.848 179.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -96.25 171.01 8.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.087 0.47 . . . . 0.0 112.206 -178.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 83.11 -76.32 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.766 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 178.31 37.46 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.299 -0.953 . . . . 0.0 112.656 179.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -95.83 154.71 17.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.894 0.378 . . . . 0.0 111.2 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -89.55 162.43 15.68 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.355 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 29.8 p -150.49 -171.65 3.98 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.874 0.369 . . . . 0.0 111.42 -179.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -150.2 98.58 0.19 Allowed Glycine 0 N--CA 1.451 -0.343 0 N-CA-C 111.505 -0.638 . . . . 0.0 111.505 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.405 ' O ' ' N ' ' A' ' 166' ' ' ALA . 0.5 OUTLIER -126.27 140.63 52.37 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-O 121.18 0.514 . . . . 0.0 112.242 -179.113 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -100.6 115.19 29.6 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.314 -0.857 . . . . 0.0 108.738 177.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . 0.466 ' HB ' ' HB2' ' A' ' 221' ' ' PHE . 15.6 mm -63.39 140.59 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-O 121.27 0.557 . . . . 0.0 110.626 -178.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 6.1 ptmt -42.45 -28.64 0.22 Allowed 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 -177.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . 0.433 ' O ' ' CE2' ' A' ' 191' ' ' TYR . 6.1 t-20 -152.36 34.4 0.51 Allowed 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 -178.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.466 ' HB2' ' HB ' ' A' ' 218' ' ' ILE . 0.1 OUTLIER -58.25 121.41 10.68 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 178.872 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -89.52 -48.68 7.15 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 114.888 -1.051 . . . . 0.0 108.377 176.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . 0.463 ' OD1' ' N ' ' A' ' 223' ' ' ASP . 0.0 OUTLIER -77.14 140.22 40.16 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.292 177.496 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.427 ' CG2' ' CG2' ' A' ' 164' ' ' THR . 0.2 OUTLIER -134.67 178.01 6.06 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -178.85 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.413 ' O ' ' C ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER 56.61 115.54 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 114.391 -1.277 . . . . 0.0 110.182 -179.147 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . 0.428 ' HA ' ' CG1' ' A' ' 153' ' ' VAL . 6.5 tt0 7.5 64.28 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 124.65 1.18 . . . . 0.0 113.55 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -61.18 -65.78 3.07 Favored Glycine 0 N--CA 1.431 -1.635 0 CA-C-N 114.694 -1.139 . . . . 0.0 111.764 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.409 ' HB3' ' O ' ' A' ' 184' ' ' ILE . 0.9 OUTLIER -164.98 -147.67 0.1 Allowed 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 179.859 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 76.4 t -89.32 131.51 36.42 Favored 'Isoleucine or valine' 0 C--N 1.348 0.536 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.063 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . 0.482 ' HA ' ' CB ' ' A' ' 183' ' ' LEU . 3.7 mt -102.31 159.23 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 O-C-N 123.494 0.496 . . . . 0.0 111.487 -179.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' GLU . . . . . 0.439 ' O ' ' N ' ' A' ' 182' ' ' ARG . 7.2 tt0 -145.25 110.42 5.22 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.26 129.5 35.35 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.668 178.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' TYR . . . . . 1.575 ' HE2' ' CE1' ' A' ' 233' ' ' TYR . 5.4 p90 -130.82 141.5 50.34 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.803 -178.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -178.81 -173.78 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-O 120.804 0.335 . . . . 0.0 111.135 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.65 -163.73 1.05 Allowed 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.21 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 6.0 pm0 -90.06 77.25 6.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.107 0.479 . . . . 0.0 110.71 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -150.84 39.35 0.7 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.007 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 3.0 m -109.64 148.01 13.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.555 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . 69.67 -63.65 0.38 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.168 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.4 -3.88 58.26 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 121.147 0.499 . . . . 0.0 112.326 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.314 -0.959 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.145 179.932 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.811 0.339 . . . . 0.0 111.202 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -131.12 126.27 35.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.885 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.54 40.63 1.09 Allowed 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.391 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 11.6 mmtp -123.79 -165.62 1.37 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.751 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 20.1 t -56.71 137.59 18.42 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.541 0 CA-C-O 121.135 0.493 . . . . 0.0 111.522 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.405 ' O ' ' O ' ' A' ' 174' ' ' LYS . 25.7 mm -121.81 -4.31 8.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.27 178.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -176.72 72.15 0.08 OUTLIER Glycine 0 C--N 1.343 0.926 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.044 179.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.406 ' HA ' ' HA ' ' A' ' 231' ' ' GLU . 2.3 tt0 -90.49 135.15 33.88 Favored 'General case' 0 CA--C 1.512 -0.501 0 O-C-N 122.678 -0.307 . . . . 0.0 110.369 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.416 ' HA ' ' O ' ' A' ' 169' ' ' TYR . . . -152.56 171.08 18.68 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 120.095 -0.642 . . . . 0.0 112.674 -178.1 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -119.84 124.09 45.25 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.031 179.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.446 ' CG1' ' HA ' ' A' ' 226' ' ' GLU . 3.9 p -52.01 133.26 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -178.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -89.29 -60.28 1.99 Allowed 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 104.827 -2.286 . . . . 0.0 104.827 175.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.41 ' HA ' ' H ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER -161.28 -161.94 0.85 Allowed 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 113.04 -1.891 . . . . 0.0 108.773 175.252 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.485 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 1.6 p -150.96 155.56 39.35 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 176.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.646 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 2.8 m-85 -104.62 76.38 1.28 Allowed 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -178.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -86.07 62.99 7.77 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 54.7 t -89.97 155.35 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 CA-C-N 113.749 -1.569 . . . . 0.0 110.12 -178.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 28.6 t -90.79 34.78 0.9 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.203 0.525 . . . . 0.0 109.973 178.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -150.71 -31.67 0.18 Allowed 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.316 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 90.5 t -102.71 -102.78 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . 0.402 ' O ' ' O ' ' A' ' 157' ' ' PHE . . . -158.95 -105.9 0.22 Allowed Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 179.084 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.434 ' CG2' ' CG2' ' A' ' 224' ' ' ILE . 0.0 OUTLIER -156.03 54.4 0.58 Allowed 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 178.124 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.646 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 0.1 OUTLIER -34.38 -27.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.214 -0.812 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 -177.003 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.485 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . 36.78 97.52 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 178.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 153' ' ' VAL . . . -86.39 149.67 22.95 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 109.881 -1.287 . . . . 0.0 109.881 178.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . 0.408 ' HB2' ' CB ' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -144.81 135.33 24.44 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 117.216 0.508 . . . . 0.0 110.467 -178.18 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . 0.416 ' O ' ' HA ' ' A' ' 151' ' ' ALA . 1.9 t80 -87.96 124.8 34.07 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 177.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 41.0 t -85.16 137.92 19.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.635 0.731 . . . . 0.0 112.849 -176.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.3 p -129.42 12.0 5.9 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 114.627 -1.169 . . . . 0.0 112.096 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -145.76 -139.21 0.1 Allowed 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -50.84 -110.73 0.01 OUTLIER Glycine 0 CA--C 1.53 1.013 0 C-N-CA 121.058 -0.592 . . . . 0.0 114.151 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.405 ' O ' ' O ' ' A' ' 148' ' ' ILE . 0.0 OUTLIER -144.7 137.26 26.43 Favored 'General case' 0 CA--C 1.514 -0.423 0 O-C-N 122.349 -0.501 . . . . 0.0 110.834 -179.272 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -94.43 112.18 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 C-N-CA 119.556 -0.858 . . . . 0.0 109.165 177.371 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.441 ' HB ' ' O ' ' A' ' 206' ' ' ARG . 0.3 OUTLIER -125.03 177.76 5.89 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.37 0.605 . . . . 0.0 112.09 -177.373 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.413 ' N ' HD11 ' A' ' 198' ' ' LEU . 0.0 OUTLIER -74.8 -36.81 62.47 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.032 -0.986 . . . . 0.0 109.525 179.241 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -88.94 52.04 2.31 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.054 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -150.72 159.59 44.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.987 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 0.0 OUTLIER -88.98 -177.84 5.56 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.172 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 2.3 m -142.13 160.39 20.22 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 CA-C-O 121.335 0.588 . . . . 0.0 111.82 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . 0.445 ' N ' ' O ' ' A' ' 231' ' ' GLU . 4.4 ttt-85 -152.66 97.81 2.28 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.099 -0.955 . . . . 0.0 112.806 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.495 HD12 ' CZ ' ' A' ' 221' ' ' PHE . 0.3 OUTLIER -86.25 153.79 21.75 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-O 121.748 0.785 . . . . 0.0 112.58 179.991 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 17.8 mt -158.23 131.73 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 114.171 -1.377 . . . . 0.0 112.581 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.0 -151.74 0.22 Allowed 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.024 -1.472 . . . . 0.0 107.024 176.253 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -95.93 27.54 3.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 118.521 0.601 . . . . 0.0 110.516 178.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -153.96 -43.33 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.679 -0.772 . . . . 0.0 113.405 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.428 ' CG2' ' N ' ' A' ' 189' ' ' VAL . 0.4 OUTLIER -150.15 -158.33 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -177.953 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.428 ' N ' ' CG2' ' A' ' 188' ' ' ILE . 48.0 t -87.34 138.11 19.7 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 CA-C-O 121.624 0.726 . . . . 0.0 111.204 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . 0.452 HG23 ' HB3' ' A' ' 183' ' ' LEU . 0.1 OUTLIER -98.12 -34.21 4.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 114.645 -1.161 . . . . 0.0 108.864 179.264 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . 1.664 ' HD2' ' CD1' ' A' ' 191' ' ' TYR . 19.1 t80 -158.58 159.75 35.83 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.18 179.096 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -150.34 155.11 39.02 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.61 178.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 135.13 -121.48 2.59 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.485 -0.864 . . . . 0.0 112.382 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . 0.472 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 12.4 pt-20 -150.01 -176.57 5.5 Favored 'General case' 0 CA--C 1.495 -1.143 0 CA-C-O 121.447 0.642 . . . . 0.0 112.031 -178.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 4.5 mp -89.06 150.28 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 CA-C-N 115.175 -0.921 . . . . 0.0 109.37 -179.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -88.73 -67.98 0.8 Allowed 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.061 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -151.99 154.62 36.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.455 178.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.413 HD11 ' N ' ' A' ' 177' ' ' ARG . 0.2 OUTLIER -107.61 127.85 54.02 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.319 0.581 . . . . 0.0 111.711 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 43.8 tttt -150.63 113.46 4.75 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.388 179.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.18 -161.66 0.75 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.081 -0.508 . . . . 0.0 109.823 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -87.76 -13.23 42.91 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.474 0.178 . . . . 0.0 110.972 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.85 -55.07 2.74 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 120.569 0.223 . . . . 0.0 111.229 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -152.38 -173.41 4.54 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 120.858 0.361 . . . . 0.0 111.234 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -89.96 82.2 6.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.44 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 35.0 m -74.34 176.66 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -0.986 0 CA-C-O 121.576 0.703 . . . . 0.0 112.366 -179.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . 0.441 ' O ' ' HB ' ' A' ' 176' ' ' THR . 2.1 ttt180 -103.74 -42.24 5.69 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 114.616 -1.175 . . . . 0.0 111.796 -179.01 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -131.03 -177.02 4.19 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.207 0.527 . . . . 0.0 112.052 -179.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -151.42 71.26 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.848 178.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -91.65 171.68 9.0 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.094 0.473 . . . . 0.0 112.174 -178.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 83.67 -76.87 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.9 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . 0.4 ' O ' ' CE1' ' A' ' 169' ' ' TYR . . . 178.04 36.95 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.338 -0.934 . . . . 0.0 112.563 179.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -100.45 153.01 19.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.023 0.439 . . . . 0.0 111.239 -179.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.2 133.05 45.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.971 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 1.8 t -135.73 146.08 47.31 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.976 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -89.66 112.27 3.99 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.868 179.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -139.95 131.67 27.37 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-O 120.937 0.398 . . . . 0.0 111.012 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.72 142.96 54.85 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.267 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . 0.451 ' CG2' ' CD2' ' A' ' 191' ' ' TYR . 1.7 mp -108.81 87.42 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 -178.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . 0.424 ' HB2' ' O ' ' A' ' 194' ' ' GLU . 2.7 tttt 45.3 -143.47 0.22 Allowed 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.519 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -88.44 63.69 7.18 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-O 120.732 0.301 . . . . 0.0 111.317 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.495 ' CZ ' HD12 ' A' ' 183' ' ' LEU . 0.1 OUTLIER -54.91 119.04 4.82 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 178.705 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -82.75 -45.44 14.4 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.651 176.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . 0.406 ' O ' ' CD1' ' A' ' 221' ' ' PHE . 0.0 OUTLIER -88.16 146.33 25.45 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.031 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.434 ' CG2' ' CG2' ' A' ' 164' ' ' THR . 0.2 OUTLIER -141.46 -179.18 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.146 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -178.527 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.409 ' O ' ' C ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER 54.87 111.1 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 114.184 -1.371 . . . . 0.0 110.376 -179.127 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . 0.446 ' HA ' ' CG1' ' A' ' 153' ' ' VAL . 21.9 tt0 14.81 56.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 124.685 1.24 . . . . 0.0 112.504 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -67.45 -56.63 11.06 Favored Glycine 0 N--CA 1.422 -2.262 0 CA-C-N 114.224 -1.353 . . . . 0.0 113.323 -178.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.428 ' CB ' HG22 ' A' ' 190' ' ' VAL . 4.3 m-20 -161.25 -164.12 1.11 Allowed 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 115.124 1.527 . . . . 0.0 115.124 -177.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 63.9 t -88.07 140.87 15.12 Favored 'Isoleucine or valine' 0 C--N 1.346 0.429 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 2.7 mp -112.92 154.55 14.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.958 0.408 . . . . 0.0 111.372 -178.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' GLU . . . . . 0.445 ' O ' ' N ' ' A' ' 182' ' ' ARG . 5.0 tt0 -144.5 109.5 5.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.328 0.585 . . . . 0.0 111.684 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.01 128.5 35.08 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.965 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' TYR . . . . . 0.423 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 8.8 p90 -131.63 141.22 49.58 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.551 -179.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 4.4 p -175.97 137.76 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.29 67.31 1.56 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -142.79 -146.99 0.2 Allowed 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.741 -178.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -135.09 74.71 1.53 Allowed 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.2 t -82.45 161.19 3.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.796 -178.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . 81.22 -56.66 0.28 Allowed 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.944 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.82 -7.87 53.35 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.312 -1.022 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.153 179.951 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 120.881 0.372 . . . . 0.0 111.22 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -140.22 127.22 20.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.88 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -93.84 40.49 1.08 Allowed 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.592 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -127.55 -169.91 2.13 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.479 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 15.7 t -55.38 144.77 6.26 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.526 0 CA-C-O 121.441 0.638 . . . . 0.0 111.483 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 2.7 pp -124.63 -6.64 6.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.04 178.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -179.32 76.99 0.06 OUTLIER Glycine 0 C--N 1.343 0.964 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.043 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.401 ' HA ' ' HA ' ' A' ' 231' ' ' GLU . 0.1 OUTLIER -89.9 135.21 33.77 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 179.715 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.43 ' HA ' ' O ' ' A' ' 169' ' ' TYR . . . -151.35 167.68 27.16 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 120.102 -0.639 . . . . 0.0 112.522 -178.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -120.42 124.51 45.65 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.407 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.484 ' HB ' ' O ' ' A' ' 228' ' ' ASP . 3.1 p -51.17 132.63 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -178.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -89.44 -60.16 2.02 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 104.416 -2.439 . . . . 0.0 104.416 175.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.45 -163.71 1.03 Allowed 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 113.025 -1.898 . . . . 0.0 108.613 174.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.479 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 1.5 p -151.91 143.02 23.21 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 176.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.598 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 5.7 m-30 -91.04 75.37 6.29 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.043 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.66 63.72 8.12 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.967 0.889 . . . . 0.0 108.847 178.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 49.2 t -89.25 154.85 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-N 113.944 -1.48 . . . . 0.0 109.707 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 47.4 t -89.74 33.49 0.85 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.074 0.464 . . . . 0.0 110.406 178.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -150.93 -29.3 0.2 Allowed 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.597 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 97.7 t -103.52 -101.53 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 O-C-N 122.132 -0.355 . . . . 0.0 110.15 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -158.51 -110.34 0.29 Allowed Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 111.543 -0.623 . . . . 0.0 111.543 179.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.435 ' CG2' ' CG2' ' A' ' 224' ' ' ILE . 0.0 OUTLIER -155.15 58.96 0.65 Allowed 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 178.253 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.598 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 0.3 OUTLIER -38.7 -22.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.219 -0.54 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 -177.243 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.479 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . 31.02 98.36 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 178.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -87.59 150.76 22.72 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 178.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . 0.402 ' HB2' ' CB ' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -145.07 136.48 25.18 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 117.353 0.577 . . . . 0.0 110.725 -178.482 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . 0.43 ' O ' ' HA ' ' A' ' 151' ' ' ALA . 71.9 t80 -87.74 131.05 34.63 Favored 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 106.965 -1.495 . . . . 0.0 106.965 177.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 4.7 p -86.25 144.84 8.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -176.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.4 p -138.53 11.91 2.74 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.416 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -151.48 -147.51 0.23 Allowed 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 119.52 -0.276 . . . . 0.0 110.263 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -39.53 -104.56 0.01 OUTLIER Glycine 0 CA--C 1.531 1.047 0 N-CA-C 115.188 0.835 . . . . 0.0 115.188 -178.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.75 143.89 24.78 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.092 0.472 . . . . 0.0 111.88 -178.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 7.4 mm -99.68 87.15 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 N-CA-C 108.498 -0.926 . . . . 0.0 108.498 176.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 0.2 OUTLIER -100.93 172.82 6.8 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.517 0.675 . . . . 0.0 112.106 -178.061 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -69.2 -43.02 74.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.711 -1.131 . . . . 0.0 111.067 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -88.56 58.59 4.74 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.17 -179.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 1.1 m -149.08 162.69 39.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.797 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 26.4 mttp -89.0 -170.81 3.04 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 2.4 m -150.23 160.79 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.539 0 CA-C-O 121.398 0.618 . . . . 0.0 111.711 179.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . 0.458 ' N ' ' O ' ' A' ' 231' ' ' GLU . 43.3 ttm180 -153.58 98.75 2.26 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.136 -0.938 . . . . 0.0 113.215 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.498 ' HB3' HG23 ' A' ' 190' ' ' VAL . 0.2 OUTLIER -86.68 148.33 25.5 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-O 121.745 0.783 . . . . 0.0 112.22 179.721 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 22.2 mt -157.87 130.14 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 114.311 -1.313 . . . . 0.0 111.485 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -88.52 -151.94 0.21 Allowed 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 177.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -94.71 29.84 2.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 118.354 0.525 . . . . 0.0 110.533 179.05 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -154.04 -45.94 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.668 -0.777 . . . . 0.0 113.182 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.42 ' CG2' ' N ' ' A' ' 189' ' ' VAL . 0.4 OUTLIER -150.11 -160.56 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -178.106 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.42 ' N ' ' CG2' ' A' ' 188' ' ' ILE . 96.1 t -87.09 135.76 24.51 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 CA-C-O 121.684 0.754 . . . . 0.0 110.845 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . 0.498 HG23 ' HB3' ' A' ' 183' ' ' LEU . 0.0 OUTLIER -97.67 -35.44 5.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 114.562 -1.199 . . . . 0.0 108.959 179.343 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . 1.644 ' HE2' ' CE1' ' A' ' 191' ' ' TYR . 5.0 t80 -157.51 156.13 31.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.569 179.115 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -151.0 155.39 38.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.218 178.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 134.85 -113.15 1.1 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.573 -0.823 . . . . 0.0 112.363 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . 0.49 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 0.0 OUTLIER -150.77 -176.16 5.4 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-O 121.303 0.573 . . . . 0.0 111.161 -179.051 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.473 ' N ' ' CG ' ' A' ' 194' ' ' GLU . 0.3 OUTLIER -99.13 155.07 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.178 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.495 -179.074 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -89.42 -67.64 0.83 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 1.3 m -150.91 154.45 37.19 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.949 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -107.46 117.8 35.05 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.962 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 18.1 ttmt -138.13 115.14 10.85 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.812 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 7.6 ttm180 -88.83 -158.7 0.51 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.846 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -87.11 -6.75 58.56 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 121.227 -0.189 . . . . 0.0 111.35 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -105.54 -59.71 1.73 Allowed 'General case' 0 N--CA 1.442 -0.87 0 CA-C-O 120.708 0.29 . . . . 0.0 111.154 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -151.82 -163.39 1.73 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.72 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -89.06 75.4 7.94 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 120.931 0.396 . . . . 0.0 110.279 179.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 32.7 m -59.28 159.86 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.934 0 CA-C-O 121.603 0.716 . . . . 0.0 112.317 -179.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . 0.467 ' O ' ' HA ' ' A' ' 176' ' ' THR . 7.6 ttm-85 -89.44 -36.51 15.4 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 114.651 -1.159 . . . . 0.0 111.795 -178.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -141.31 179.42 6.78 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.221 0.534 . . . . 0.0 111.682 -179.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -151.12 70.95 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.729 178.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -97.46 178.47 5.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.138 -178.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 81.97 -75.45 0.03 OUTLIER 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.538 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 178.41 38.12 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.401 -0.904 . . . . 0.0 112.286 179.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -107.43 150.09 27.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.159 0.504 . . . . 0.0 112.025 -179.118 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -96.57 152.78 18.31 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.076 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 18.5 t -150.64 154.34 37.31 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.004 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -89.53 110.24 3.7 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.116 179.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.404 ' O ' ' O ' ' A' ' 165' ' ' ILE . 0.2 OUTLIER -134.44 131.36 38.04 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 121.298 0.571 . . . . 0.0 111.59 -179.026 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.35 130.38 34.8 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.93 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . 0.457 ' CG2' ' CD2' ' A' ' 191' ' ' TYR . 1.5 mp -90.84 79.27 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 34.75 -85.99 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.998 0 O-C-N 124.134 0.896 . . . . 0.0 112.835 -178.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . 0.439 ' N ' ' O ' ' A' ' 218' ' ' ILE . 5.9 p30 -129.73 65.67 1.48 Allowed 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.589 -179.427 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.487 ' CZ ' HD12 ' A' ' 183' ' ' LEU . 0.1 OUTLIER -58.58 119.38 6.94 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 177.883 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -77.91 -44.51 26.79 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 176.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . 0.402 ' O ' ' CG ' ' A' ' 221' ' ' PHE . 0.0 OUTLIER -92.74 143.19 26.55 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.236 177.713 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.435 ' CG2' ' CG2' ' A' ' 164' ' ' THR . 0.2 OUTLIER -140.48 -179.4 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -178.706 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.414 ' O ' ' C ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER 55.26 110.56 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 114.319 -1.31 . . . . 0.0 110.067 -178.881 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . 0.471 ' HA ' ' CG1' ' A' ' 153' ' ' VAL . 18.2 tt0 10.95 60.5 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 124.747 1.28 . . . . 0.0 112.948 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -71.59 -58.13 5.58 Favored Glycine 0 N--CA 1.421 -2.348 0 CA-C-N 114.115 -1.402 . . . . 0.0 113.144 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.484 ' O ' ' HB ' ' A' ' 153' ' ' VAL . 25.8 m-20 -158.48 -160.62 0.9 Allowed 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -178.019 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 42.9 t -88.65 152.98 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 CA-C-O 120.769 0.318 . . . . 0.0 110.15 178.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 3.0 mp -120.92 153.93 24.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.753 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' GLU . . . . . 0.458 ' O ' ' N ' ' A' ' 182' ' ' ARG . 20.1 tt0 -147.12 111.58 5.23 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 119.839 -0.744 . . . . 0.0 112.676 -179.385 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.17 135.58 33.24 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.17 178.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' TYR . . . . . 1.614 ' HE1' ' CE2' ' A' ' 233' ' ' TYR . 3.5 p90 -137.64 156.75 47.7 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.062 -178.45 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER 171.55 149.68 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-O 121.15 0.5 . . . . 0.0 110.743 179.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.15 45.74 1.15 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.557 178.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -133.15 -154.1 0.59 Allowed 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.216 -0.447 . . . . 0.0 112.158 -177.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -142.7 75.43 1.49 Allowed 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.408 ' O ' ' CB ' ' A' ' 239' ' ' ALA . 2.4 t -83.08 142.18 13.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 114.67 -1.15 . . . . 0.0 112.422 -176.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . 0.408 ' CB ' ' O ' ' A' ' 238' ' ' VAL . . . 152.74 -51.28 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 114.443 -1.253 . . . . 0.0 110.292 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.84 -7.51 54.13 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.312 -1.047 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.042 -179.977 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.847 0.356 . . . . 0.0 111.234 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -129.53 -167.64 1.83 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.856 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -93.48 42.21 1.09 Allowed 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.456 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 4.5 ptpt -61.6 -171.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.767 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 12.1 t -58.58 139.99 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.611 0 CA-C-O 121.297 0.57 . . . . 0.0 111.506 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.406 HG12 ' N ' ' A' ' 234' ' ' VAL . 2.7 pp -127.06 -1.82 4.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.35 178.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 178.08 75.34 0.06 OUTLIER Glycine 0 C--N 1.342 0.897 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.912 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.438 ' HA ' ' HA ' ' A' ' 231' ' ' GLU . 0.0 OUTLIER -89.97 136.41 33.06 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 122.721 -0.282 . . . . 0.0 110.336 -179.969 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -151.17 179.59 8.16 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-O 121.63 0.729 . . . . 0.0 112.871 -178.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -126.96 120.37 28.94 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.814 -1.084 . . . . 0.0 110.445 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.453 ' CG1' ' HA ' ' A' ' 226' ' ' GLU . 2.2 p -48.13 137.97 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -179.37 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.474 ' O ' ' HB3' ' A' ' 226' ' ' GLU . 3.2 mmp_? -97.44 -61.03 1.45 Allowed 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 105.963 -1.865 . . . . 0.0 105.963 176.093 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.75 -160.53 0.46 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 113.739 -1.573 . . . . 0.0 109.157 175.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 5.9 p -150.92 149.0 29.11 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 177.275 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.559 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 5.6 m-30 -92.6 72.1 5.03 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -178.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 15.6 tttt -85.95 62.21 7.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 122.002 0.906 . . . . 0.0 109.071 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.449 HG12 ' N ' ' A' ' 160' ' ' SER . 55.2 t -89.64 155.78 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 CA-C-N 113.919 -1.492 . . . . 0.0 109.535 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.449 ' N ' HG12 ' A' ' 159' ' ' VAL . 9.0 m -89.72 22.41 3.09 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.049 178.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.71 5.66 0.52 Allowed 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.188 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 57.8 t -129.98 -99.17 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 CA-C-N 118.483 0.583 . . . . 0.0 110.14 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -158.02 -113.51 0.38 Allowed Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.415 ' CG2' ' CG2' ' A' ' 224' ' ' ILE . 0.0 OUTLIER -153.98 32.9 0.44 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.462 -0.869 . . . . 0.0 109.098 178.157 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.559 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 1.9 mm -40.27 93.78 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.715 -179.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.445 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . -88.25 118.45 27.85 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 114.729 -1.123 . . . . 0.0 111.967 -179.203 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -89.59 151.21 21.69 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.49 179.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -147.58 133.45 19.08 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -179.349 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . 1.613 ' HE1' ' CE2' ' A' ' 169' ' ' TYR . 11.1 t80 -86.8 131.28 34.17 Favored 'General case' 0 C--O 1.219 -0.512 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 178.279 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.404 ' O ' ' CE1' ' A' ' 169' ' ' TYR . 5.7 p -85.64 147.01 5.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -175.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.1 p -141.87 13.12 2.07 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.04 -0.982 . . . . 0.0 112.359 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -151.27 -145.87 0.18 Allowed 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -38.96 -103.53 0.01 OUTLIER Glycine 0 CA--C 1.531 1.05 0 N-CA-C 115.275 0.87 . . . . 0.0 115.275 -178.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 21.9 mttm -150.47 134.94 17.25 Favored 'General case' 0 CA--C 1.515 -0.402 0 O-C-N 122.591 -0.358 . . . . 0.0 111.871 -178.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 3.5 mm -93.37 86.89 2.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 176.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 0.1 OUTLIER -100.79 172.24 7.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.523 -177.265 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -69.25 -42.1 76.05 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.347 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -88.75 56.32 3.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.415 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 29.7 m -145.97 157.34 43.88 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.428 -179.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 0.0 OUTLIER -89.25 -172.93 3.83 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.44 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -150.1 156.76 6.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.385 0.612 . . . . 0.0 111.473 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . 0.425 ' N ' ' O ' ' A' ' 231' ' ' GLU . 60.2 ttt180 -152.03 101.83 2.76 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.113 -0.948 . . . . 0.0 112.581 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.473 ' CD1' ' CZ ' ' A' ' 221' ' ' PHE . 0.3 OUTLIER -86.16 157.41 20.01 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-O 121.862 0.839 . . . . 0.0 112.918 -179.669 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.493 ' N ' HG23 ' A' ' 190' ' ' VAL . 3.1 mp -151.01 121.36 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 113.885 -1.507 . . . . 0.0 111.935 177.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.41 ' HA ' ' CG ' ' A' ' 228' ' ' ASP . 0.0 OUTLIER -85.45 -151.76 0.15 Allowed 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 177.504 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -93.97 28.57 2.38 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 118.539 0.608 . . . . 0.0 110.829 178.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -154.62 -76.96 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.619 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -116.47 -156.54 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 115.34 -0.43 . . . . 0.0 110.718 -179.039 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 46.3 t -87.37 133.96 28.9 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.101 0 CA-C-O 121.518 0.675 . . . . 0.0 111.771 -179.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . 0.493 HG23 ' N ' ' A' ' 184' ' ' ILE . 0.2 OUTLIER -89.61 -34.21 6.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 114.778 -1.101 . . . . 0.0 108.884 178.503 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . 1.656 ' HD2' ' CD1' ' A' ' 191' ' ' TYR . 41.5 t80 -157.6 155.87 30.88 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 178.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . 0.458 ' N ' ' CD2' ' A' ' 191' ' ' TYR . 14.4 mt-10 -150.14 148.83 29.43 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.287 177.342 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 133.05 -127.75 4.85 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.068 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . 0.462 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 4.5 pt-20 -145.38 -178.88 6.3 Favored 'General case' 0 CA--C 1.499 -0.986 0 CA-C-O 121.662 0.744 . . . . 0.0 112.631 -178.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 4.7 mp -89.67 153.42 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.115 -179.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -93.95 -52.19 4.53 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 4.6 m -151.38 144.92 24.91 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.858 178.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 2.8 tt -120.49 118.01 29.14 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.427 0.632 . . . . 0.0 111.647 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 10.7 tttm -148.83 122.52 9.23 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.672 179.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 8.4 ttp85 -87.81 -160.38 0.61 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.314 -179.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 1.65 ' HD2' ' CD1' ' A' ' 201' ' ' TYR . 11.3 m-85 -86.89 -15.1 40.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.522 0.201 . . . . 0.0 110.902 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -93.56 -58.73 2.19 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-O 120.633 0.254 . . . . 0.0 110.698 179.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -152.83 -170.54 3.66 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 120.863 0.363 . . . . 0.0 111.164 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -90.0 63.35 5.91 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.107 179.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 28.3 m -56.29 156.94 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.931 0 CA-C-O 121.515 0.674 . . . . 0.0 112.23 -179.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . 0.401 ' O ' ' HA ' ' A' ' 176' ' ' THR . 0.1 OUTLIER -89.51 -34.07 16.54 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.899 -178.447 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -141.26 175.75 9.39 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.03 0.443 . . . . 0.0 111.161 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -150.8 83.25 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.782 178.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -101.85 174.05 6.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.787 -179.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 80.63 -68.76 0.1 Allowed 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.725 -179.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 178.95 36.75 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.49 179.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . 1.606 ' HD2' ' CD1' ' A' ' 212' ' ' TYR . 2.7 m-85 -100.27 135.01 42.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.022 0.439 . . . . 0.0 111.747 -179.167 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -89.73 152.25 21.42 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.22 179.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -150.57 139.89 21.33 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.095 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -89.08 115.92 4.57 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.662 -0.78 . . . . 0.0 111.733 179.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -135.47 141.6 45.38 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 121.119 0.485 . . . . 0.0 111.609 -179.28 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 1.4 m -89.17 133.1 34.54 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . 0.478 ' CG2' ' CZ ' ' A' ' 191' ' ' TYR . 1.6 mp -86.16 134.4 27.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 -179.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 5.5 ptmt -39.24 -31.75 0.09 Allowed 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 114.406 1.262 . . . . 0.0 114.406 -177.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -153.08 40.38 0.54 Allowed 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 -178.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.473 ' CZ ' ' CD1' ' A' ' 183' ' ' LEU . 0.1 OUTLIER -59.16 115.98 3.55 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 178.626 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -83.67 -42.56 16.51 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.12 -0.946 . . . . 0.0 108.481 176.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . 0.417 ' O ' ' CD1' ' A' ' 221' ' ' PHE . 0.0 OUTLIER -90.53 141.95 28.24 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.893 178.201 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.415 ' CG2' ' CG2' ' A' ' 164' ' ' THR . 2.5 pp -122.49 -177.97 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.36 0.6 . . . . 0.0 112.423 -179.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.461 ' O ' ' N ' ' A' ' 227' ' ' GLY . 11.4 mtpt 59.37 172.76 0.08 Allowed 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.289 -177.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . 0.474 ' HB3' ' O ' ' A' ' 154' ' ' ARG . 0.3 OUTLIER -58.61 84.09 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.036 0.446 . . . . 0.0 110.831 179.683 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 225' ' ' LYS . . . -71.65 -61.54 3.79 Favored Glycine 0 N--CA 1.427 -1.911 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 178.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.41 ' CG ' ' HA ' ' A' ' 185' ' ' ARG . 0.9 OUTLIER -164.6 -148.3 0.11 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 178.669 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 59.4 t -89.48 145.33 7.53 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 O-C-N 122.331 -0.231 . . . . 0.0 110.606 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 2.9 mt -116.16 153.07 17.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.205 -179.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' GLU . . . . . 0.438 ' HA ' ' HA ' ' A' ' 150' ' ' GLN . 23.9 tt0 -142.1 111.73 6.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.33 0.586 . . . . 0.0 112.369 -179.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.89 127.92 35.65 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.942 179.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -128.36 144.44 51.13 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.945 -179.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.406 ' N ' HG12 ' A' ' 148' ' ' ILE . 0.3 OUTLIER -178.95 -166.99 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.881 -179.891 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.58 -164.23 1.11 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.141 179.304 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 -89.72 75.27 7.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.152 0.501 . . . . 0.0 110.694 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -150.64 39.23 0.71 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.099 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -108.1 167.69 3.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.102 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . 70.91 -63.34 0.42 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.104 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -89.4 -4.26 58.1 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.313 -1.003 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.061 179.971 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 120.819 0.342 . . . . 0.0 111.13 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 60.34 99.6 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.903 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -94.95 38.86 1.11 Allowed 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.452 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 12.2 mttp -94.6 -83.5 0.34 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.417 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 6.4 t -115.85 137.59 49.01 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.79 0 CA-C-O 121.356 0.598 . . . . 0.0 110.804 179.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 31.0 mm -129.45 -3.93 3.01 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.693 178.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -171.97 70.77 0.11 Allowed Glycine 0 C--N 1.341 0.806 0 N-CA-C 111.344 -0.703 . . . . 0.0 111.344 179.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.414 ' HA ' ' HA ' ' A' ' 231' ' ' GLU . 0.8 OUTLIER -91.31 136.25 33.23 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-O 120.734 0.302 . . . . 0.0 110.639 -179.643 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.406 ' HA ' ' O ' ' A' ' 169' ' ' TYR . . . -151.76 175.79 12.06 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 121.537 0.684 . . . . 0.0 112.761 -178.293 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -126.15 121.64 33.4 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.5 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.426 ' CG1' ' HA ' ' A' ' 226' ' ' GLU . 1.6 p -47.31 144.42 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 121.37 0.605 . . . . 0.0 112.595 -179.108 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.477 ' O ' ' HB3' ' A' ' 226' ' ' GLU . 3.8 mmp_? -109.86 -57.32 2.2 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 176.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.55 -162.88 0.61 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 113.755 -1.566 . . . . 0.0 109.776 175.34 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.491 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 8.0 p -150.79 163.88 37.55 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 177.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.485 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 0.2 OUTLIER -116.05 80.08 1.4 Allowed 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -179.033 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 6.5 tttt -86.53 62.77 7.61 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.438 HG12 ' N ' ' A' ' 160' ' ' SER . 71.7 t -92.9 157.32 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 CA-C-N 113.659 -1.61 . . . . 0.0 110.528 -178.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.438 ' N ' HG12 ' A' ' 159' ' ' VAL . 28.9 t -92.33 35.89 1.0 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 177.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.37 -35.22 0.14 Allowed 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.092 -179.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 88.7 t -98.96 -103.7 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -159.51 -99.99 0.16 Allowed Glycine 0 N--CA 1.452 -0.271 0 N-CA-C 111.194 -0.763 . . . . 0.0 111.194 178.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.414 ' CG2' ' CG2' ' A' ' 224' ' ' ILE . 0.0 OUTLIER -153.72 33.83 0.45 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 113.958 -1.121 . . . . 0.0 108.278 177.732 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.485 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 3.6 mt -41.98 95.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.461 0.086 0 CA-C-N 115.155 -0.929 . . . . 0.0 111.664 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.491 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . -87.12 125.23 34.01 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.735 -1.12 . . . . 0.0 112.27 -179.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -88.99 144.39 18.02 Favored Glycine 0 N--CA 1.442 -0.951 0 N-CA-C 110.534 -1.027 . . . . 0.0 110.534 178.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -145.69 132.36 19.93 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 117.204 0.502 . . . . 0.0 110.271 -178.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . 0.406 ' O ' ' HA ' ' A' ' 151' ' ' ALA . 5.6 t80 -87.3 127.37 35.18 Favored 'General case' 0 C--O 1.222 -0.39 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 177.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 44.3 t -85.44 142.16 13.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 -176.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.4 p -135.38 12.61 3.51 Favored 'General case' 0 C--O 1.231 0.084 0 CA-C-N 114.833 -1.076 . . . . 0.0 112.3 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -146.87 -144.01 0.15 Allowed 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -45.2 -107.03 0.01 OUTLIER Glycine 0 CA--C 1.532 1.149 0 N-CA-C 114.792 0.677 . . . . 0.0 114.792 -178.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.76 135.0 16.94 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 122.562 -0.375 . . . . 0.0 111.039 -178.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -92.31 111.45 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 176.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.436 ' HB ' ' O ' ' A' ' 206' ' ' ARG . 0.1 OUTLIER -118.54 169.47 9.76 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.458 0.647 . . . . 0.0 112.481 -176.327 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.4 ' HA ' HG23 ' A' ' 195' ' ' ILE . 0.5 OUTLIER -61.13 -40.86 95.41 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.478 179.667 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -95.91 63.64 2.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.251 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 4.8 m -148.8 161.43 41.82 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.92 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.429 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 0.0 OUTLIER -88.93 -175.29 4.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.722 179.493 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 1.6 m -147.93 156.09 9.58 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.478 0 CA-C-O 121.247 0.546 . . . . 0.0 111.731 179.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . 0.445 ' N ' ' O ' ' A' ' 231' ' ' GLU . 17.9 ttt180 -152.96 100.67 2.52 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.313 -0.858 . . . . 0.0 113.305 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.524 ' HB3' HG23 ' A' ' 190' ' ' VAL . 0.3 OUTLIER -86.88 156.1 19.98 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-O 121.7 0.762 . . . . 0.0 112.839 -179.869 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.406 ' N ' HG23 ' A' ' 190' ' ' VAL . 28.9 mm -154.01 123.93 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 114.487 -1.233 . . . . 0.0 111.345 178.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.424 ' N ' HG21 ' A' ' 190' ' ' VAL . 4.6 ttp180 -85.68 -151.3 0.15 Allowed 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 177.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -93.84 25.8 3.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 118.509 0.595 . . . . 0.0 110.892 178.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -155.12 -67.57 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.498 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -121.16 -156.34 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-N 115.297 -0.452 . . . . 0.0 110.84 -178.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 58.3 t -87.39 136.28 23.41 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 CA-C-O 121.287 0.565 . . . . 0.0 111.632 -179.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . 0.524 HG23 ' HB3' ' A' ' 183' ' ' LEU . 0.1 OUTLIER -89.57 -33.86 6.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.099 -0.955 . . . . 0.0 108.914 178.614 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . 1.627 ' HE1' ' CE2' ' A' ' 191' ' ' TYR . 16.0 t80 -162.5 157.04 21.73 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.386 -0.825 . . . . 0.0 112.273 178.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -149.94 160.08 43.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.902 178.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 133.46 -115.4 1.52 Allowed Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.519 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . 0.429 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 17.1 pt-20 -150.4 -174.87 4.88 Favored 'General case' 0 CA--C 1.496 -1.1 0 CA-C-O 121.247 0.546 . . . . 0.0 111.342 -178.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.424 ' CD1' ' HB2' ' A' ' 216' ' ' LEU . 0.4 OUTLIER -88.52 142.84 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.024 -178.921 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.75 -55.35 3.74 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.03 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 17.2 p -152.6 164.68 37.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.051 178.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 21.2 tp -135.16 110.25 8.87 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.417 0.627 . . . . 0.0 111.419 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 45.4 mttt -137.79 126.91 24.36 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.308 179.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 27.8 ttm180 -87.56 -112.66 0.06 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.274 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -88.37 -79.23 0.31 Allowed 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 117.939 0.336 . . . . 0.0 110.463 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -115.31 20.78 14.63 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 111.728 0.27 . . . . 0.0 111.728 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -151.22 153.33 34.71 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 120.969 0.414 . . . . 0.0 111.612 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -89.86 79.34 6.67 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.338 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 28.4 m -59.32 158.7 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -1.011 0 CA-C-O 121.554 0.692 . . . . 0.0 112.001 -179.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . 0.436 ' O ' ' HB ' ' A' ' 176' ' ' THR . 4.0 ttp180 -89.43 -38.03 14.38 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.505 -178.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -141.2 177.46 8.07 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.073 0.463 . . . . 0.0 111.418 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -151.28 79.78 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.462 178.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -104.49 173.34 6.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.065 0.459 . . . . 0.0 112.204 -178.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 84.22 -71.61 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.104 -179.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 178.05 37.6 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.394 179.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -104.51 140.56 37.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.983 0.421 . . . . 0.0 111.233 -179.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -93.26 152.75 18.99 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.28 179.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 2.3 m -150.54 145.55 26.02 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.767 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -88.26 106.35 3.23 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.484 -0.865 . . . . 0.0 110.998 179.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.424 ' HB2' ' CD1' ' A' ' 195' ' ' ILE . 0.2 OUTLIER -133.53 145.34 50.04 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 120.993 0.425 . . . . 0.0 111.789 -178.055 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.64 140.79 29.48 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . 0.467 ' CG2' ' CD2' ' A' ' 191' ' ' TYR . 1.6 mp -108.5 94.03 2.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 121.028 -0.269 . . . . 0.0 110.427 -179.158 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 6.1 tttp 42.16 -143.7 0.08 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.133 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 32.1 t30 -87.87 63.71 7.54 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 120.901 0.381 . . . . 0.0 110.9 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.48 ' CZ ' ' CD1' ' A' ' 183' ' ' LEU . 0.1 OUTLIER -54.98 118.01 3.93 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 114.595 1.332 . . . . 0.0 114.595 178.835 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -83.07 -43.55 16.16 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.586 176.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . 0.409 ' O ' ' CD1' ' A' ' 221' ' ' PHE . 0.0 OUTLIER -89.73 129.97 36.06 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.023 178.264 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.414 ' CG2' ' CG2' ' A' ' 164' ' ' THR . 2.0 pt -114.67 178.95 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 CA-C-O 121.191 0.519 . . . . 0.0 111.551 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.47 ' O ' ' N ' ' A' ' 227' ' ' GLY . 11.2 mtpt 62.38 155.63 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.098 -178.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . 0.477 ' HB3' ' O ' ' A' ' 154' ' ' ARG . 0.6 OUTLIER -45.08 90.35 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 121.199 0.523 . . . . 0.0 111.77 -179.461 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 225' ' ' LYS . . . -83.35 -57.97 2.39 Favored Glycine 0 N--CA 1.428 -1.885 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 178.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.413 ' CG ' ' HA ' ' A' ' 185' ' ' ARG . 1.0 OUTLIER -163.83 -148.89 0.13 Allowed 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 179.014 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 46.1 t -90.33 149.38 4.07 Favored 'Isoleucine or valine' 0 C--N 1.341 0.218 0 CA-C-O 120.75 0.31 . . . . 0.0 110.771 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 2.7 mp -120.17 153.41 23.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.77 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' GLU . . . . . 0.445 ' O ' ' N ' ' A' ' 182' ' ' ARG . 0.0 OUTLIER -144.14 109.97 5.31 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.357 0.598 . . . . 0.0 112.559 -179.053 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.65 127.46 35.57 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.598 178.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' TYR . . . . . 1.663 ' HE2' ' CE1' ' A' ' 233' ' ' TYR . 26.1 p90 -123.02 140.59 52.87 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.013 0.435 . . . . 0.0 111.403 -178.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.402 HG13 ' N ' ' A' ' 235' ' ' MET . 0.9 OUTLIER -176.14 -163.07 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.04 179.716 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' MET . . . . . 0.402 ' N ' HG13 ' A' ' 234' ' ' VAL . 0.0 OUTLIER -89.41 -171.12 3.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.708 0.289 . . . . 0.0 110.742 179.945 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -96.27 37.53 1.25 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.885 0.374 . . . . 0.0 111.364 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -137.67 50.33 1.95 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.047 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -105.35 137.65 33.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.755 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . 167.52 -81.03 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.738 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.98 -8.56 45.79 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.312 -1.041 0 CA-C-N 115.635 -0.712 . . . . 0.0 111.09 -179.962 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 1.637 ' HE1' ' CE2' ' A' ' 143' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.798 0.332 . . . . 0.0 111.068 . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -75.91 89.95 2.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.986 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.87 40.07 1.13 Allowed 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.24 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.55 -164.01 1.03 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.583 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.412 HG11 ' HG3' ' A' ' 150' ' ' GLN . 19.5 t -58.77 141.53 15.62 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.559 0 CA-C-O 121.394 0.616 . . . . 0.0 111.559 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.412 HG12 ' N ' ' A' ' 234' ' ' VAL . 1.3 pt -123.7 -8.38 7.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.074 178.247 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -174.63 74.56 0.08 OUTLIER Glycine 0 C--N 1.344 0.981 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.114 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.412 ' HG3' HG11 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -89.38 136.8 32.82 Favored 'General case' 0 CA--C 1.506 -0.725 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.255 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.411 ' CB ' ' HB2' ' A' ' 168' ' ' CYS . . . -151.35 169.15 22.69 Favored 'General case' 0 N--CA 1.435 -1.176 0 C-N-CA 120.164 -0.615 . . . . 0.0 112.387 -178.03 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -119.85 124.98 47.4 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.024 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.487 HG12 ' HA ' ' A' ' 226' ' ' GLU . 4.0 p -55.9 128.15 15.79 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 CA-C-O 121.325 0.583 . . . . 0.0 111.771 -179.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.414 ' CA ' ' NE ' ' A' ' 154' ' ' ARG . 0.0 OUTLIER -89.99 -53.54 4.44 Favored 'General case' 0 N--CA 1.429 -1.521 0 N-CA-C 105.175 -2.158 . . . . 0.0 105.175 175.982 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.425 ' HA ' ' H ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER -162.33 -163.36 0.91 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 114.016 -1.447 . . . . 0.0 110.482 175.233 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.541 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 6.0 p -148.09 -179.57 7.02 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 177.28 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.473 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 0.2 OUTLIER -133.29 79.41 1.83 Allowed 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -179.911 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? -86.34 62.25 7.31 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 177.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.419 HG23 ' CD1' ' A' ' 157' ' ' PHE . 54.6 t -92.31 156.05 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 CA-C-N 113.633 -1.622 . . . . 0.0 110.455 -178.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 52.3 m -90.86 34.81 0.9 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.125 0.488 . . . . 0.0 109.797 178.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.51 -32.76 0.18 Allowed 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.291 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 89.9 t -101.53 -104.02 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.26 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -159.7 -98.27 0.13 Allowed Glycine 0 N--CA 1.451 -0.347 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 178.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.92 34.83 0.44 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 113.996 -1.102 . . . . 0.0 108.246 177.692 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.473 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 1.8 mm -41.56 94.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.44 -179.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.541 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . -84.06 117.57 23.51 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 114.767 -1.106 . . . . 0.0 112.416 -179.189 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -88.29 136.95 14.08 Favored Glycine 0 N--CA 1.439 -1.109 0 N-CA-C 109.934 -1.267 . . . . 0.0 109.934 178.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . 0.411 ' HB2' ' CB ' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -138.43 132.66 31.71 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.938 0.369 . . . . 0.0 110.838 -178.023 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . 1.647 ' HD1' ' CD2' ' A' ' 169' ' ' TYR . 11.7 t80 -86.8 133.37 33.65 Favored 'General case' 0 C--O 1.222 -0.368 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 177.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 44.2 t -85.73 143.55 11.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -176.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.1 p -135.28 13.57 3.53 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 114.719 -1.128 . . . . 0.0 112.041 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -150.01 -146.71 0.21 Allowed 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -179.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -42.12 -102.5 0.01 OUTLIER Glycine 0 CA--C 1.532 1.117 0 N-CA-C 114.777 0.671 . . . . 0.0 114.777 -179.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.404 ' O ' ' O ' ' A' ' 148' ' ' ILE . 6.3 mttt -150.75 134.61 16.65 Favored 'General case' 0 CA--C 1.514 -0.407 0 O-C-N 122.696 -0.297 . . . . 0.0 111.19 -178.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . 0.409 ' O ' ' CG2' ' A' ' 175' ' ' ILE . 1.1 tp -95.18 83.51 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-O 122.195 0.997 . . . . 0.0 108.948 177.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 0.0 OUTLIER -90.97 -177.61 4.98 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.501 -1.227 . . . . 0.0 113.144 -176.565 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 46.9 mtm180 -76.58 -45.57 29.79 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 114.572 -1.194 . . . . 0.0 111.206 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -88.96 60.64 5.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.104 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 74.7 m -147.81 160.08 43.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.828 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 0.0 OUTLIER -88.55 178.69 6.45 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.171 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 2.9 m -146.73 149.17 16.11 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.539 0 CA-C-O 121.449 0.642 . . . . 0.0 112.165 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . 0.457 ' N ' ' O ' ' A' ' 231' ' ' GLU . 2.7 ttt180 -154.11 100.28 2.31 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.822 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.492 ' CB ' ' HA ' ' A' ' 230' ' ' ILE . 0.6 OUTLIER -99.54 165.79 11.46 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-O 121.21 0.528 . . . . 0.0 110.8 179.767 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.435 ' N ' HG23 ' A' ' 190' ' ' VAL . 42.8 mt -157.5 141.32 7.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.467 -178.272 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 30.8 ptt180 -87.75 -157.2 0.39 Allowed 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 177.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -93.72 30.6 1.75 Allowed 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.004 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -153.45 -45.47 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.7 -0.762 . . . . 0.0 113.053 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.43 ' CG2' ' N ' ' A' ' 189' ' ' VAL . 0.2 OUTLIER -150.49 -162.95 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-O 120.945 0.402 . . . . 0.0 112.022 -178.035 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.43 ' N ' ' CG2' ' A' ' 188' ' ' ILE . 21.9 t -85.85 133.2 30.17 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.531 0 CA-C-O 121.505 0.669 . . . . 0.0 109.842 179.011 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . 0.454 HG23 ' HG ' ' A' ' 183' ' ' LEU . 0.5 OUTLIER -88.38 -35.08 7.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.738 -179.187 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . 1.627 ' HD1' ' CD2' ' A' ' 191' ' ' TYR . 0.4 OUTLIER -176.94 166.5 2.48 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.544 179.735 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -151.11 158.5 44.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.924 0.392 . . . . 0.0 111.072 179.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 143.95 -131.47 4.45 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.917 -0.658 . . . . 0.0 111.687 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . 0.415 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 4.4 pt-20 -133.27 -177.6 4.6 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-O 121.237 0.541 . . . . 0.0 111.003 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 1.1 tt -88.08 149.07 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.293 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.959 -178.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.48 -60.35 1.97 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 179.029 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 9.7 t -152.02 151.1 30.72 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.532 178.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 10.9 tp -125.93 118.63 25.82 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.481 0.658 . . . . 0.0 111.644 -179.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -150.23 121.09 7.6 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.593 179.009 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . 0.432 ' NH1' ' CD1' ' A' ' 212' ' ' TYR . 3.5 ttm180 -87.77 -159.88 0.57 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.342 -179.361 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -86.75 -11.66 50.44 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.475 0.178 . . . . 0.0 111.093 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.76 -60.34 1.67 Allowed 'General case' 0 N--CA 1.44 -0.94 0 CA-C-O 120.67 0.272 . . . . 0.0 110.641 179.338 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -152.8 -170.82 3.74 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.779 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 23.9 p30 -89.61 63.07 6.11 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.188 0.518 . . . . 0.0 109.817 179.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 33.1 m -55.45 160.8 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.925 0 CA-C-O 121.595 0.712 . . . . 0.0 112.549 -178.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . 0.417 ' O ' ' HA ' ' A' ' 176' ' ' THR . 4.8 ttm180 -89.3 -37.26 15.06 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 114.642 -1.163 . . . . 0.0 111.524 -178.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -138.04 179.41 6.45 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.159 0.504 . . . . 0.0 111.512 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -150.94 78.4 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.842 179.283 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -97.44 170.31 9.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.052 0.453 . . . . 0.0 112.151 -178.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 85.89 -74.99 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.155 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . 0.403 ' O ' ' CE2' ' A' ' 169' ' ' TYR . . . 177.86 37.7 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.219 -0.991 . . . . 0.0 112.494 179.11 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . 0.432 ' CD1' ' NH1' ' A' ' 200' ' ' ARG . 1.6 m-85 -95.17 148.62 22.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.966 0.413 . . . . 0.0 111.414 -179.343 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -89.54 159.12 17.37 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.095 179.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 10.3 p -150.95 -177.88 6.27 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.182 0.515 . . . . 0.0 111.642 -179.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -136.71 105.83 0.53 Allowed Glycine 0 N--CA 1.452 -0.3 0 N-CA-C 110.086 -1.205 . . . . 0.0 110.086 178.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -138.86 144.68 39.32 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -177.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.39 -179.06 6.58 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 176.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 49.8 mm -141.11 81.66 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 120.024 -0.67 . . . . 0.0 112.737 -178.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 13.7 tttt 44.08 -134.95 0.57 Allowed 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 121.177 -0.209 . . . . 0.0 110.695 177.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -87.7 53.62 2.84 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.088 0.47 . . . . 0.0 110.645 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 1.662 ' HE1' ' CE2' ' A' ' 221' ' ' PHE . 1.2 t80 -56.96 153.52 11.07 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 117.332 2.345 . . . . 0.0 117.332 179.336 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . 0.432 ' HB2' ' CE1' ' A' ' 191' ' ' TYR . 7.8 t-20 -122.52 -49.34 2.02 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 112.957 -1.928 . . . . 0.0 111.481 178.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . 0.454 ' OD1' ' N ' ' A' ' 224' ' ' ILE . 0.0 OUTLIER -61.28 163.82 6.05 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 -178.463 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.454 ' N ' ' OD1' ' A' ' 223' ' ' ASP . 17.4 pt -154.13 -178.31 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 176.4 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 34.4 100.65 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 114.466 -1.243 . . . . 0.0 111.926 -179.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . 0.487 ' HA ' HG12 ' A' ' 153' ' ' VAL . 38.1 tt0 25.95 57.44 0.06 Allowed 'General case' 0 N--CA 1.482 1.169 0 O-C-N 124.294 0.996 . . . . 0.0 112.277 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . 0.411 ' HA3' ' OD1' ' A' ' 223' ' ' ASP . . . -57.83 -69.83 1.16 Allowed Glycine 0 N--CA 1.429 -1.775 0 CA-C-N 114.411 -1.268 . . . . 0.0 113.14 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.4 ' O ' ' HB ' ' A' ' 153' ' ' VAL . 8.3 m-20 -157.58 -159.67 0.86 Allowed 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 -178.233 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . 0.447 ' O ' ' HB2' ' A' ' 183' ' ' LEU . 69.7 t -88.21 136.09 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 O-C-N 122.142 -0.349 . . . . 0.0 110.308 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . 0.492 ' HA ' ' CB ' ' A' ' 183' ' ' LEU . 5.3 mp -102.64 158.52 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 O-C-N 123.639 0.587 . . . . 0.0 111.257 -179.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' GLU . . . . . 0.457 ' O ' ' N ' ' A' ' 182' ' ' ARG . 5.2 tm-20 -147.14 109.57 4.56 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.41 130.05 34.81 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.474 178.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' TYR . . . . . 1.625 ' HE2' ' CE1' ' A' ' 233' ' ' TYR . 5.7 p90 -132.81 141.96 48.74 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.047 -178.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.412 ' N ' HG12 ' A' ' 148' ' ' ILE . 0.3 OUTLIER -179.6 -167.14 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.746 -179.832 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' MET . . . . . 0.4 ' N ' ' CG1' ' A' ' 234' ' ' VAL . 1.5 ttm -97.3 -163.47 1.05 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.009 179.13 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -89.5 77.26 7.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.157 0.503 . . . . 0.0 110.808 179.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -150.87 38.75 0.68 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.116 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.0 m -106.14 161.14 5.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.266 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . 70.02 -64.39 0.36 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.023 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.73 -3.52 58.14 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.314 -0.966 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.046 179.957 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.842 0.353 . . . . 0.0 111.15 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -177.13 136.14 0.21 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.877 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.467 ' HB2' ' HA ' ' A' ' 235' ' ' MET . 0.0 OUTLIER -98.66 34.6 2.01 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.437 179.775 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 17.3 tttt 68.06 166.94 0.25 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -178.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 3.5 t -60.05 140.24 18.39 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.871 0 CA-C-O 121.254 0.55 . . . . 0.0 111.209 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.468 HG12 HG22 ' A' ' 238' ' ' VAL . 3.3 tp -132.61 -3.05 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.225 177.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -165.77 66.71 0.21 Allowed Glycine 0 C--N 1.341 0.825 0 C-N-CA 119.982 -1.104 . . . . 0.0 112.496 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.44 ' HA ' ' HA ' ' A' ' 231' ' ' GLU . 1.3 mt-30 -90.0 132.48 35.33 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.41 ' CB ' ' HB2' ' A' ' 168' ' ' CYS . . . -152.54 178.33 9.69 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 -177.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.7 124.18 42.17 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.693 -1.14 . . . . 0.0 110.373 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.489 ' CG1' ' HA ' ' A' ' 226' ' ' GLU . 2.7 p -49.5 133.06 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -179.209 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.473 ' O ' ' HB3' ' A' ' 226' ' ' GLU . 4.3 mmp_? -89.56 -62.16 1.54 Allowed 'General case' 0 N--CA 1.434 -1.248 0 N-CA-C 105.08 -2.193 . . . . 0.0 105.08 175.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.51 -160.08 0.5 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 113.671 -1.604 . . . . 0.0 108.698 174.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.496 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 7.6 p -148.97 159.3 44.33 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.871 0.367 . . . . 0.0 110.232 177.342 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.61 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 2.6 m-85 -104.42 73.95 1.14 Allowed 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -177.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -85.9 63.42 8.03 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 122.08 0.943 . . . . 0.0 108.794 178.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.419 HG12 ' N ' ' A' ' 160' ' ' SER . 93.1 t -90.09 158.1 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-N 113.752 -1.567 . . . . 0.0 110.02 -179.37 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.419 ' N ' HG12 ' A' ' 159' ' ' VAL . 13.9 m -92.52 33.32 1.12 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.132 0.491 . . . . 0.0 110.004 178.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -151.84 -31.78 0.15 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.639 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 93.0 t -99.47 -101.94 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.203 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -158.79 -104.33 0.2 Allowed Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 111.728 -0.549 . . . . 0.0 111.728 179.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.421 ' CG2' ' CG2' ' A' ' 224' ' ' ILE . 0.0 OUTLIER -153.78 35.63 0.44 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 114.299 -0.95 . . . . 0.0 108.771 178.355 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.61 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 1.7 mp -42.8 95.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-N 115.327 -0.852 . . . . 0.0 111.342 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.496 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . -87.19 120.79 28.84 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 114.649 -1.16 . . . . 0.0 111.859 -179.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -89.46 149.91 20.92 Favored Glycine 0 N--CA 1.442 -0.93 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 178.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . 0.41 ' HB2' ' CB ' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -144.55 133.78 22.96 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 117.061 0.431 . . . . 0.0 110.21 -179.279 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . 1.655 ' HD1' ' CD2' ' A' ' 169' ' ' TYR . 1.1 t80 -86.94 127.51 35.07 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 178.262 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 36.7 t -85.21 142.97 12.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -175.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -132.76 9.16 4.21 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 114.289 -1.323 . . . . 0.0 111.921 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -142.67 -142.42 0.14 Allowed 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -179.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -48.26 -104.84 0.01 OUTLIER Glycine 0 CA--C 1.535 1.294 0 C-N-CA 120.636 -0.792 . . . . 0.0 114.387 -179.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.459 ' O ' ' O ' ' A' ' 148' ' ' ILE . 0.0 OUTLIER -145.45 133.91 21.94 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.003 0.521 . . . . 0.0 110.849 -179.276 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 9.0 tp -88.5 84.12 2.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 122.26 1.029 . . . . 0.0 109.425 178.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 0.6 OUTLIER -85.99 -174.42 5.09 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.327 -1.306 . . . . 0.0 113.924 -176.585 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -84.71 -45.99 11.89 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 114.417 -1.265 . . . . 0.0 111.439 -179.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -88.72 52.89 2.54 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.589 -178.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -139.66 161.24 38.0 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.882 179.15 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 1.1 mptt -88.65 -172.21 3.64 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 3.0 m -141.35 161.03 22.22 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.647 0 CA-C-O 121.4 0.619 . . . . 0.0 111.883 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . 0.434 ' HB3' ' HB3' ' A' ' 231' ' ' GLU . 8.4 ttt85 -152.09 92.8 1.75 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.04 -0.982 . . . . 0.0 112.099 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.479 ' CD2' ' CZ ' ' A' ' 221' ' ' PHE . 5.7 mp -88.37 142.33 27.82 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -178.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 17.3 mm -150.56 128.73 2.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 113.05 -1.886 . . . . 0.0 111.36 179.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.405 ' N ' ' CG2' ' A' ' 190' ' ' VAL . 4.0 ttp180 -88.83 -148.09 0.17 Allowed 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 177.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -95.79 28.33 3.11 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 118.473 0.579 . . . . 0.0 110.726 178.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -153.87 -83.6 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.792 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -110.22 -157.78 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 115.427 -0.387 . . . . 0.0 110.657 -179.204 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 41.4 t -87.41 135.62 24.92 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 CA-C-O 121.751 0.786 . . . . 0.0 111.262 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . 0.417 HG22 ' CB ' ' A' ' 228' ' ' ASP . 0.1 OUTLIER -97.3 -34.04 4.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 114.426 -1.261 . . . . 0.0 109.411 179.76 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . 0.497 ' HB2' ' CE1' ' A' ' 221' ' ' PHE . 41.8 t80 -167.86 154.0 7.54 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.327 -0.852 . . . . 0.0 112.453 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . 0.471 ' N ' ' CD1' ' A' ' 191' ' ' TYR . 50.7 mt-10 -150.16 158.28 43.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.067 178.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 133.97 -120.48 2.51 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.427 -0.892 . . . . 0.0 112.761 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . 0.449 ' CG ' ' N ' ' A' ' 195' ' ' ILE . 0.0 OUTLIER -147.92 179.53 7.66 Favored 'General case' 0 CA--C 1.503 -0.857 0 CA-C-O 121.706 0.765 . . . . 0.0 111.797 -179.04 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.449 ' N ' ' CG ' ' A' ' 194' ' ' GLU . 32.9 mm -92.57 153.06 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.308 0 CA-C-N 114.35 -1.295 . . . . 0.0 110.186 -179.186 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -89.97 -58.52 2.48 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 36.4 p -150.6 156.73 41.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.85 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.405 ' CD1' ' CD2' ' A' ' 216' ' ' LEU . 5.9 tp -127.88 115.78 19.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.172 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 5.1 ptpt -150.09 120.0 7.13 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.195 -0.912 . . . . 0.0 109.564 179.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.88 -159.79 0.56 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.328 -179.249 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -86.62 -11.09 52.4 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 120.533 0.206 . . . . 0.0 111.101 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -94.48 -60.39 1.73 Allowed 'General case' 0 N--CA 1.439 -0.993 0 CA-C-O 120.739 0.304 . . . . 0.0 110.641 179.218 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -152.66 -174.3 4.86 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.085 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -89.61 56.1 3.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.247 0.546 . . . . 0.0 110.022 179.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 31.9 m -53.91 160.87 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.969 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.352 -179.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . 0.435 ' O ' ' HA ' ' A' ' 176' ' ' THR . 0.0 OUTLIER -88.86 -36.73 15.83 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.321 -178.859 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.419 ' HA ' ' HA ' ' A' ' 176' ' ' THR . 0.6 OUTLIER -133.71 176.78 8.24 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.268 0.556 . . . . 0.0 111.821 179.926 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -150.38 84.24 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.759 179.129 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -99.99 178.82 4.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.096 0.474 . . . . 0.0 112.086 -178.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 81.9 -75.01 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.698 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . 0.405 ' O ' ' CE1' ' A' ' 169' ' ' TYR . . . 178.42 37.65 0.06 OUTLIER Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.347 179.033 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . 1.634 ' HD1' ' CD2' ' A' ' 212' ' ' TYR . 1.1 m-85 -101.75 143.2 31.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.917 0.389 . . . . 0.0 111.372 -179.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . 0.425 ' CG ' ' CD2' ' A' ' 169' ' ' TYR . 0.0 OUTLIER -98.56 131.5 44.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.454 179.943 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 34.6 t -125.84 145.52 50.2 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.333 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -88.38 113.81 4.12 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.148 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.405 ' CD2' ' CD1' ' A' ' 198' ' ' LEU . 0.5 OUTLIER -133.81 147.35 51.23 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 120.839 0.352 . . . . 0.0 111.073 -179.26 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.01 138.45 31.97 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 177.038 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . 0.445 HG23 ' CD1' ' A' ' 191' ' ' TYR . 19.1 mm -91.33 52.61 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.086 0.469 . . . . 0.0 112.193 -177.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 4.6 tptm 61.48 -72.08 0.04 OUTLIER 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.642 178.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . 0.426 ' N ' ' O ' ' A' ' 218' ' ' ILE . 5.0 p-10 -145.43 51.45 1.2 Allowed 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.253 -179.089 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.497 ' CE1' ' HB2' ' A' ' 191' ' ' TYR . 0.1 OUTLIER -57.3 118.49 5.16 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 178.33 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -77.84 -46.3 21.88 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 176.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . 0.438 ' O ' ' CD1' ' A' ' 221' ' ' PHE . 0.0 OUTLIER -88.09 130.39 35.02 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 177.48 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.421 ' CG2' ' CG2' ' A' ' 164' ' ' THR . 0.2 OUTLIER -117.31 176.77 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 CA-C-O 121.438 0.637 . . . . 0.0 112.466 -179.283 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.463 ' O ' ' N ' ' A' ' 227' ' ' GLY . 10.4 mtmt 62.06 154.28 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.231 -178.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . 0.489 ' HA ' ' CG1' ' A' ' 153' ' ' VAL . 0.2 OUTLIER -39.99 90.77 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 122.235 1.017 . . . . 0.0 111.845 179.939 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 225' ' ' LYS . . . -106.66 -38.85 2.14 Favored Glycine 0 N--CA 1.429 -1.805 0 CA-C-N 114.356 -1.293 . . . . 0.0 112.207 -178.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.417 ' CB ' HG22 ' A' ' 190' ' ' VAL . 2.9 p30 -157.95 -166.7 2.03 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 115.736 1.754 . . . . 0.0 115.736 -178.166 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 40.6 t -97.98 142.48 14.4 Favored 'Isoleucine or valine' 0 C--N 1.343 0.326 0 CA-C-N 114.441 -1.254 . . . . 0.0 108.075 177.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 3.9 mp -115.48 150.89 17.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.091 0.472 . . . . 0.0 111.831 -178.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' GLU . . . . . 0.44 ' HA ' ' HA ' ' A' ' 150' ' ' GLN . 7.4 tt0 -137.69 108.73 6.75 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.271 0.558 . . . . 0.0 110.731 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.8 124.19 33.36 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.808 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -123.62 166.97 14.57 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.709 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.403 ' O ' ' N ' ' A' ' 145' ' ' GLU . 9.8 p -176.19 150.49 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 121.076 -0.249 . . . . 0.0 110.98 -179.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' MET . . . . . 0.467 ' HA ' ' HB2' ' A' ' 145' ' ' GLU . 0.0 OUTLIER -97.06 30.94 2.55 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.123 0.487 . . . . 0.0 109.695 178.798 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -133.72 -155.88 0.7 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -98.56 -99.57 0.21 Allowed 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 179.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.468 HG22 HG12 ' A' ' 148' ' ' ILE . 0.6 OUTLIER -154.47 -158.05 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.159 -179.883 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -47.36 -78.62 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 122.97 0.508 . . . . 0.0 111.318 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -90.68 -5.22 56.07 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.953 179.273 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.314 -0.951 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.072 179.994 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 1.67 ' HD1' ' CD2' ' A' ' 143' ' ' TYR . 70.2 m-85 . . . . . 0 N--CA 1.487 1.424 0 N-CA-C 111.714 0.264 . . . . 0.0 111.714 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 179.46 138.76 0.11 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.768 0.318 . . . . 0.0 110.673 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.3 39.5 1.12 Allowed 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.392 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -76.91 -179.21 5.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.57 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 15.0 t -60.13 139.84 19.03 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 CA-C-O 121.463 0.649 . . . . 0.0 111.356 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.432 HG12 HG23 ' A' ' 238' ' ' VAL . 6.9 tp -114.13 -18.97 7.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.231 178.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 178.97 85.9 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.339 -179.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.44 135.05 34.12 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -150.78 173.14 14.55 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 -177.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.437 ' HA ' ' HA ' ' A' ' 229' ' ' VAL . 0.4 OUTLIER -117.51 122.82 44.75 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.091 179.715 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.438 HG12 ' HA ' ' A' ' 226' ' ' GLU . 2.7 p -55.65 128.92 16.52 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.338 0 CA-C-O 121.326 0.584 . . . . 0.0 111.65 -179.42 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.419 ' CA ' ' NE ' ' A' ' 154' ' ' ARG . 0.0 OUTLIER -89.2 -58.38 2.56 Favored 'General case' 0 N--CA 1.427 -1.606 0 N-CA-C 105.288 -2.115 . . . . 0.0 105.288 176.203 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.404 ' HA ' ' HB3' ' A' ' 226' ' ' GLU . 0.0 OUTLIER -163.1 -163.23 0.83 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.691 174.906 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.543 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 7.0 p -147.57 149.01 31.76 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 1.662 ' HD1' ' CD2' ' A' ' 157' ' ' PHE . 0.2 OUTLIER -94.4 80.3 3.92 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -177.984 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 13.8 tttm -85.88 63.69 8.18 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.415 HG12 ' N ' ' A' ' 160' ' ' SER . 69.9 t -93.21 157.06 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-N 113.652 -1.613 . . . . 0.0 110.231 -178.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.415 ' N ' HG12 ' A' ' 159' ' ' VAL . 1.0 OUTLIER -92.07 35.45 0.99 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.208 0.528 . . . . 0.0 109.655 178.129 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 5.0 mttt -151.47 -35.32 0.14 Allowed 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.084 -179.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 95.5 t -97.85 -102.24 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -159.33 -102.8 0.18 Allowed Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 178.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.416 ' CG2' ' CG2' ' A' ' 224' ' ' ILE . 0.0 OUTLIER -153.68 35.2 0.45 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.087 -1.056 . . . . 0.0 108.271 177.404 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.493 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 1.5 mp -42.92 96.02 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.541 -179.448 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.543 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . -80.39 118.67 22.23 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.697 -1.138 . . . . 0.0 112.194 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -88.75 141.86 16.73 Favored Glycine 0 N--CA 1.441 -1.022 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 178.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -141.01 132.39 26.76 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.879 0.339 . . . . 0.0 110.488 -178.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . 1.664 ' HD2' ' CD1' ' A' ' 169' ' ' TYR . 47.5 t80 -85.59 129.36 34.84 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.247 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 31.8 t -85.73 149.28 4.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -175.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -140.09 15.12 2.44 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 114.427 -1.261 . . . . 0.0 111.826 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -150.6 -145.26 0.17 Allowed 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -43.48 -105.18 0.01 OUTLIER Glycine 0 CA--C 1.53 0.997 0 N-CA-C 114.84 0.696 . . . . 0.0 114.84 -179.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.406 ' O ' ' O ' ' A' ' 148' ' ' ILE . 7.6 mttt -151.44 144.28 24.44 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.999 0.428 . . . . 0.0 112.013 -178.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 10.3 mm -89.91 87.34 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 176.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -98.1 165.7 11.77 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -176.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 20.6 mtm105 -64.85 -44.45 89.75 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 114.55 -1.204 . . . . 0.0 111.083 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -89.3 60.15 5.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.752 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 46.6 m -149.2 159.54 44.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.652 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.498 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 14.9 mttp -89.62 -172.28 3.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.483 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.41 ' CG1' ' CD1' ' A' ' 195' ' ' ILE . 3.0 m -149.47 146.32 17.16 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.607 0 CA-C-O 121.554 0.692 . . . . 0.0 111.861 179.326 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . 0.448 ' N ' ' O ' ' A' ' 231' ' ' GLU . 6.0 ttm180 -154.45 98.83 2.14 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.722 -1.126 . . . . 0.0 112.002 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.494 ' CB ' ' HA ' ' A' ' 230' ' ' ILE . 0.3 OUTLIER -100.88 168.53 9.58 Favored 'General case' 0 N--CA 1.437 -1.093 0 C-N-CA 120.358 -0.537 . . . . 0.0 111.026 179.597 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.429 ' O ' ' HB3' ' A' ' 228' ' ' ASP . 5.3 mp -151.15 140.07 14.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.156 -177.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.47 ' N ' HG21 ' A' ' 190' ' ' VAL . 8.0 ptp180 -87.16 -155.77 0.3 Allowed 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.172 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -93.6 27.23 2.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 118.327 0.512 . . . . 0.0 111.385 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -154.4 -43.87 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.966 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.428 ' CG2' ' N ' ' A' ' 189' ' ' VAL . 0.4 OUTLIER -150.14 -159.34 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 120.679 0.276 . . . . 0.0 111.711 -177.969 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.428 ' N ' ' CG2' ' A' ' 188' ' ' ILE . 39.8 t -85.13 135.13 25.49 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 CA-C-O 121.564 0.697 . . . . 0.0 110.349 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . 0.47 HG21 ' N ' ' A' ' 185' ' ' ARG . 0.3 OUTLIER -87.99 -35.04 7.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.347 -179.848 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . 1.615 ' HE2' ' CE1' ' A' ' 191' ' ' TYR . 0.6 OUTLIER -176.66 155.3 1.31 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.042 -179.994 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -141.7 161.14 38.67 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.884 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 141.28 -137.31 8.03 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 111.377 -0.689 . . . . 0.0 111.377 -179.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 7.2 pt-20 -131.97 -176.07 3.94 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-O 121.011 0.434 . . . . 0.0 111.169 179.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.41 ' CD1' ' CG1' ' A' ' 181' ' ' VAL . 5.8 mm -87.21 159.11 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.687 -178.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -103.16 -56.98 2.12 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 18.1 p -151.58 155.01 37.58 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.543 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.412 ' CD2' ' HB3' ' A' ' 216' ' ' LEU . 13.6 mt -117.11 128.22 54.92 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.927 179.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 10.8 ptpt -151.09 118.45 6.0 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.473 178.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 6.6 ttp180 -88.74 -39.11 14.19 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.433 0.635 . . . . 0.0 111.525 -178.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -151.61 -86.4 0.07 Allowed 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 114.979 -1.009 . . . . 0.0 110.782 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.19 22.76 11.68 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 116.733 -0.212 . . . . 0.0 111.154 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -150.49 155.37 39.38 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 120.896 0.379 . . . . 0.0 110.938 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -89.83 90.7 8.3 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.731 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 27.6 m -66.48 155.42 7.19 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.915 0 CA-C-O 121.332 0.587 . . . . 0.0 111.671 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 2.7 mtp180 -89.37 -32.74 17.16 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.388 -178.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -150.06 179.0 8.42 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.921 0.391 . . . . 0.0 110.713 179.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 1.8 t -151.07 80.34 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.828 178.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -102.68 174.53 5.85 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 83.11 -74.33 0.03 OUTLIER 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.09 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 178.11 37.21 0.06 OUTLIER Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.392 -0.909 . . . . 0.0 112.385 179.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . 1.629 ' HD1' ' CD2' ' A' ' 212' ' ' TYR . 0.5 OUTLIER -98.17 144.69 27.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.919 0.39 . . . . 0.0 111.274 -179.428 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -96.77 130.11 44.08 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.872 179.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 33.6 t -128.75 144.93 51.28 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.775 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -88.77 110.64 3.69 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.634 -0.793 . . . . 0.0 111.761 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.412 ' HB3' ' CD2' ' A' ' 198' ' ' LEU . 0.1 OUTLIER -129.0 144.37 51.16 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.116 0.484 . . . . 0.0 111.111 -179.229 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -107.09 141.69 37.92 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 178.147 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . 0.479 ' HB ' ' HB2' ' A' ' 221' ' ' PHE . 18.4 mm -90.72 140.45 15.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.241 0.544 . . . . 0.0 110.571 -179.344 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt -42.0 -30.1 0.26 Allowed 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -177.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . 0.425 ' O ' ' CE2' ' A' ' 191' ' ' TYR . 5.0 t30 -152.46 35.08 0.51 Allowed 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -178.335 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.479 ' HB2' ' HB ' ' A' ' 218' ' ' ILE . 0.1 OUTLIER -58.84 120.09 8.37 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 178.891 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -88.11 -46.97 8.85 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 176.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . 0.464 ' OD1' ' N ' ' A' ' 223' ' ' ASP . 0.0 OUTLIER -79.54 136.25 36.83 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.063 177.403 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.416 ' CG2' ' CG2' ' A' ' 164' ' ' THR . 0.2 OUTLIER -133.28 178.9 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -178.859 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.412 ' O ' ' C ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER 57.46 116.8 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.853 -178.862 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . 0.438 ' HA ' HG12 ' A' ' 153' ' ' VAL . 0.5 OUTLIER 6.91 63.95 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 124.51 1.124 . . . . 0.0 113.814 -179.545 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -61.39 -66.73 2.48 Favored Glycine 0 N--CA 1.434 -1.497 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.739 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.429 ' HB3' ' O ' ' A' ' 184' ' ' ILE . 0.8 OUTLIER -165.07 -148.21 0.11 Allowed 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 114.279 1.215 . . . . 0.0 114.279 179.686 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 183' ' ' LEU . 73.0 t -89.14 130.2 38.89 Favored 'Isoleucine or valine' 0 C--N 1.345 0.381 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . 0.494 ' HA ' ' CB ' ' A' ' 183' ' ' LEU . 22.6 mt -101.04 158.32 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.119 0 O-C-N 123.66 0.6 . . . . 0.0 111.332 -179.118 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' GLU . . . . . 0.448 ' O ' ' N ' ' A' ' 182' ' ' ARG . 16.1 tt0 -144.85 111.0 5.51 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.3 0.572 . . . . 0.0 112.522 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.67 122.83 31.85 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.948 178.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' TYR . . . . . 1.66 ' HD2' ' CD1' ' A' ' 233' ' ' TYR . 11.1 p90 -123.84 141.27 52.18 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.022 -179.113 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -175.99 -175.71 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.017 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -89.43 -162.64 0.89 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.657 0.265 . . . . 0.0 111.106 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.78 38.09 1.07 Allowed 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.874 0.369 . . . . 0.0 111.885 -179.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -123.62 46.41 2.23 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.167 0.508 . . . . 0.0 110.057 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.432 HG23 HG12 ' A' ' 148' ' ' ILE . 1.4 t -108.24 168.35 3.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.298 -178.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . 69.71 -64.68 0.34 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.052 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.62 -3.21 58.37 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.314 -0.938 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.978 -179.994 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 1.657 ' HE1' ' CE2' ' A' ' 143' ' ' TYR . 25.4 m-85 . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.822 0.344 . . . . 0.0 111.24 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -140.81 179.16 6.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.867 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.11 37.08 1.26 Allowed 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.303 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 33.2 mttp -119.17 -80.26 0.61 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.302 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 4.3 t -108.43 141.96 22.32 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.739 0 CA-C-O 121.435 0.636 . . . . 0.0 110.727 179.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.412 HG13 ' HA ' ' A' ' 233' ' ' TYR . 2.6 pp -128.99 -8.85 3.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.635 179.203 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -174.04 75.0 0.09 OUTLIER Glycine 0 C--N 1.341 0.817 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.831 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.414 ' CG ' ' CG ' ' A' ' 231' ' ' GLU . 0.0 OUTLIER -90.39 137.99 31.9 Favored 'General case' 0 CA--C 1.506 -0.728 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.852 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.406 ' HA ' ' O ' ' A' ' 169' ' ' TYR . . . -151.66 174.85 12.99 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 120.093 -0.643 . . . . 0.0 112.339 -178.105 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -125.12 119.37 28.4 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.507 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.429 ' CG1' ' HA ' ' A' ' 226' ' ' GLU . 1.1 p -49.07 131.23 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -178.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.514 ' O ' ' HB3' ' A' ' 226' ' ' GLU . 4.0 mmp_? -91.48 -60.17 1.95 Allowed 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 105.249 -2.13 . . . . 0.0 105.249 175.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.73 -159.18 0.44 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 113.743 -1.571 . . . . 0.0 109.422 175.044 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.504 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 9.5 p -148.92 163.17 38.24 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 120.821 0.343 . . . . 0.0 110.647 177.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.608 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 3.7 m-85 -110.13 73.04 0.82 Allowed 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -178.34 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 8.2 tmtm? -85.94 64.36 8.55 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.426 HG12 ' N ' ' A' ' 160' ' ' SER . 92.4 t -92.25 158.22 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 CA-C-N 113.549 -1.66 . . . . 0.0 110.258 -178.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.426 ' N ' HG12 ' A' ' 159' ' ' VAL . 71.5 m -93.06 34.46 1.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.225 0.535 . . . . 0.0 109.761 178.308 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.63 -33.09 0.15 Allowed 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.386 -179.667 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 89.0 t -99.82 -102.19 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.19 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -158.85 -103.4 0.19 Allowed Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 111.522 -0.631 . . . . 0.0 111.522 179.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.434 ' CG2' ' CG2' ' A' ' 224' ' ' ILE . 0.0 OUTLIER -153.64 34.61 0.45 Allowed 'General case' 0 C--O 1.232 0.148 0 CA-C-N 114.311 -0.944 . . . . 0.0 108.801 178.259 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.608 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 1.6 mp -43.3 98.09 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.527 0.096 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.424 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.504 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . -87.08 122.89 31.52 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.854 -1.067 . . . . 0.0 111.698 -179.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -87.73 146.54 20.02 Favored Glycine 0 N--CA 1.442 -0.921 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 178.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . 0.403 ' HB2' ' CB ' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -147.66 134.37 19.98 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 117.279 0.539 . . . . 0.0 110.771 -178.338 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . 1.666 ' HE1' ' CE2' ' A' ' 169' ' ' TYR . 22.9 t80 -86.84 134.34 33.55 Favored 'General case' 0 C--O 1.221 -0.414 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 177.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.401 ' O ' ' CE1' ' A' ' 169' ' ' TYR . 9.2 p -86.43 146.63 6.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -176.258 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.2 p -140.95 12.01 2.23 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.557 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -150.79 -148.14 0.25 Allowed 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -41.48 -104.51 0.01 OUTLIER Glycine 0 CA--C 1.532 1.119 0 N-CA-C 115.09 0.796 . . . . 0.0 115.09 -178.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.64 128.89 11.98 Favored 'General case' 0 CA--C 1.513 -0.457 0 O-C-N 122.722 -0.281 . . . . 0.0 111.368 -178.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 1.1 tp -89.54 76.78 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 CA-C-O 122.27 1.033 . . . . 0.0 108.981 177.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.456 ' HA ' ' HA ' ' A' ' 207' ' ' GLU . 0.2 OUTLIER -84.03 173.01 11.49 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.015 -1.448 . . . . 0.0 113.543 -176.796 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 43.0 ttp85 -59.96 -51.6 68.98 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 114.2 -1.364 . . . . 0.0 111.536 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -89.55 61.92 5.72 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.68 -178.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -142.68 160.4 40.38 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.443 179.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 11.9 mttt -89.08 -174.39 4.43 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.451 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 2.4 m -150.7 145.51 16.77 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 CA-C-O 121.573 0.702 . . . . 0.0 112.111 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . 0.465 ' N ' ' O ' ' A' ' 231' ' ' GLU . 16.9 ttt180 -154.87 100.52 2.21 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.725 -1.125 . . . . 0.0 112.051 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.495 ' CB ' ' HA ' ' A' ' 230' ' ' ILE . 0.3 OUTLIER -100.15 168.83 9.57 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 120.616 -0.433 . . . . 0.0 110.878 179.551 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.453 ' O ' ' HB3' ' A' ' 228' ' ' ASP . 27.2 mt -155.5 139.55 8.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.333 -0.394 . . . . 0.0 112.017 -178.069 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.402 ' HA ' ' CG ' ' A' ' 228' ' ' ASP . 0.0 OUTLIER -86.57 -154.02 0.22 Allowed 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.081 178.174 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -94.27 29.11 2.29 Favored 'General case' 0 N--CA 1.455 -0.191 0 O-C-N 122.023 -0.423 . . . . 0.0 111.51 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -152.91 -77.41 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.319 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -115.49 -157.68 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-N 115.464 -0.368 . . . . 0.0 110.094 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 23.4 t -86.83 139.97 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 CA-C-O 121.425 0.631 . . . . 0.0 110.889 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . 0.446 HG23 ' HG ' ' A' ' 183' ' ' LEU . 0.4 OUTLIER -88.22 -35.44 8.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.011 179.883 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . 1.64 ' HD1' ' CD2' ' A' ' 191' ' ' TYR . 9.9 t80 -178.91 151.33 0.52 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.014 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -143.47 159.34 42.59 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.68 179.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 150.33 -122.9 1.46 Allowed Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.825 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . 0.482 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 8.8 pt-20 -139.31 -177.98 5.16 Favored 'General case' 0 CA--C 1.497 -1.065 0 CA-C-O 121.288 0.566 . . . . 0.0 111.207 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -88.27 142.62 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.145 -178.485 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -88.7 -61.69 1.65 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -151.94 166.05 32.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.529 178.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -139.3 122.41 16.86 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.69 0.757 . . . . 0.0 112.149 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -146.83 127.82 14.55 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 114.406 -1.27 . . . . 0.0 108.719 178.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 3.1 ttp85 -88.8 -38.19 14.83 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.51 0.671 . . . . 0.0 111.82 -178.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.459 ' CD1' ' N ' ' A' ' 201' ' ' TYR . 0.0 OUTLIER -151.52 -96.32 0.06 Allowed 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.139 179.504 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 5.3 tttp -107.07 20.63 18.74 Favored 'General case' 0 N--CA 1.44 -0.97 0 O-C-N 122.33 -0.231 . . . . 0.0 110.908 179.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -150.82 144.11 24.85 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 120.864 0.364 . . . . 0.0 110.828 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.67 82.32 6.33 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.644 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 30.4 m -56.15 173.47 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.068 0 CA-C-O 120.972 0.415 . . . . 0.0 111.361 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . 0.405 ' O ' ' HB ' ' A' ' 176' ' ' THR . 2.6 ttp180 -97.34 -40.07 8.91 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.787 -178.587 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.456 ' HA ' ' HA ' ' A' ' 176' ' ' THR . 1.1 mp0 -143.12 178.12 7.92 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.29 0.567 . . . . 0.0 111.938 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -150.74 81.23 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.743 179.478 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -105.32 177.5 4.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.999 0.428 . . . . 0.0 112.043 -178.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 83.24 -72.06 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.942 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 178.63 36.88 0.06 OUTLIER Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.537 -0.839 . . . . 0.0 112.369 179.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . 1.615 ' HE1' ' CE2' ' A' ' 212' ' ' TYR . 0.5 OUTLIER -104.54 144.45 31.67 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.071 0.463 . . . . 0.0 111.746 -179.232 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -99.56 151.11 21.54 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.933 179.546 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 53.9 t -146.66 148.2 31.8 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.845 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -88.23 108.72 3.45 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.394 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -138.27 147.6 43.81 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 121.12 0.486 . . . . 0.0 112.06 -178.208 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.1 143.86 26.83 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.025 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . 0.413 ' O ' ' CG2' ' A' ' 218' ' ' ILE . 1.5 mp -109.42 92.15 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 -179.335 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 1.8 ttpp 44.43 -146.1 0.11 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.852 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -87.67 62.66 7.14 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-O 121.319 0.58 . . . . 0.0 110.808 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.456 ' CD1' ' O ' ' A' ' 223' ' ' ASP . 0.1 OUTLIER -54.37 121.6 8.63 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 179.14 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -84.06 -48.66 9.67 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.287 176.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 223' ' ' ASP . 0.0 OUTLIER -81.0 125.37 30.08 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.122 177.68 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.434 ' CG2' ' CG2' ' A' ' 164' ' ' THR . 1.7 pt -115.89 176.86 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.603 0 CA-C-O 121.469 0.652 . . . . 0.0 111.884 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.501 ' O ' ' N ' ' A' ' 227' ' ' GLY . 0.1 OUTLIER 63.88 149.46 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.757 -1.111 . . . . 0.0 108.635 -178.627 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . 0.514 ' HB3' ' O ' ' A' ' 154' ' ' ARG . 5.5 pt-20 -36.92 86.5 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 121.986 0.898 . . . . 0.0 112.89 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 225' ' ' LYS . . . -78.5 -60.17 2.71 Favored Glycine 0 N--CA 1.426 -2.006 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.502 179.452 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.453 ' HB3' ' O ' ' A' ' 184' ' ' ILE . 1.1 t70 -165.21 -144.94 0.08 Allowed 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . 0.465 ' O ' ' HB2' ' A' ' 183' ' ' LEU . 80.2 t -89.65 134.21 29.48 Favored 'Isoleucine or valine' 0 C--N 1.349 0.555 0 C-N-CA 122.937 0.495 . . . . 0.0 109.881 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . 0.495 ' HA ' ' CB ' ' A' ' 183' ' ' LEU . 5.5 mt -103.26 158.04 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 O-C-N 123.435 0.459 . . . . 0.0 110.951 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' GLU . . . . . 0.465 ' O ' ' N ' ' A' ' 182' ' ' ARG . 1.4 tm-20 -148.89 109.88 4.33 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.59 128.25 35.27 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' TYR . . . . . 1.651 ' HD2' ' CD1' ' A' ' 233' ' ' TYR . 11.5 p90 -124.97 143.17 51.03 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.625 -178.164 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.4 ' CG1' HG12 ' A' ' 148' ' ' ILE . 0.3 OUTLIER 179.97 -173.83 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.855 178.909 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 3.6 mmt -89.87 -162.38 0.88 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.437 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -89.52 53.64 2.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.243 0.544 . . . . 0.0 110.9 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -133.64 44.56 2.76 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.111 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.7 m -104.05 166.91 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.98 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . 69.92 -64.54 0.35 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.923 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 3.5 ttp180 -89.68 -3.65 58.12 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.313 -1.012 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.114 179.967 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.665 0.269 . . . . 0.0 110.938 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.661 HG11 ' HB2' ' A' ' 150' ' ' GLN . 17.0 t -61.69 141.06 18.12 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.595 0 CA-C-O 121.25 0.548 . . . . 0.0 111.53 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.735 HG21 HG12 ' A' ' 234' ' ' VAL . 0.3 OUTLIER -126.54 2.17 4.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.632 177.48 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 149' ' ' GLY . . . . . 0.587 ' CA ' ' HB3' ' A' ' 232' ' ' ALA . . . 175.83 74.29 0.05 OUTLIER Glycine 0 C--N 1.341 0.847 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.356 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.661 ' HB2' HG11 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -91.71 132.86 36.08 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.177 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.424 ' O ' HG13 ' A' ' 229' ' ' VAL . . . -151.88 174.16 13.93 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-O 121.466 0.65 . . . . 0.0 112.438 -178.464 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.681 ' HG2' HG22 ' A' ' 229' ' ' VAL . 50.4 mt-10 -118.71 122.75 43.22 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.274 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.731 ' HB ' HD11 ' A' ' 230' ' ' ILE . 2.4 p -52.1 132.26 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 121.257 0.551 . . . . 0.0 112.436 -178.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.445 ' O ' ' HB3' ' A' ' 226' ' ' GLU . 4.7 mmp_? -89.33 -61.48 1.69 Allowed 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 175.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.435 ' HA ' ' H ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER -162.38 -163.83 0.96 Allowed 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 113.624 -1.625 . . . . 0.0 109.479 174.789 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.553 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 12.2 p -143.82 173.57 11.57 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 177.434 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.654 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 9.2 m-85 -125.5 75.5 1.48 Allowed 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -178.565 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -86.2 63.14 7.85 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 177.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.47 HG12 ' N ' ' A' ' 161' ' ' LYS . 66.5 t -91.71 156.02 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 CA-C-N 113.603 -1.635 . . . . 0.0 110.343 -178.601 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 49.1 p -91.36 34.71 0.94 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.217 0.532 . . . . 0.0 109.845 178.137 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.47 ' N ' HG12 ' A' ' 159' ' ' VAL . 1.6 mttt -150.84 -32.15 0.17 Allowed 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.358 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.792 HG11 HD12 ' A' ' 165' ' ' ILE . 91.9 t -102.11 -103.31 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' GLY . . . . . 0.512 ' N ' HG12 ' A' ' 162' ' ' VAL . . . -159.04 -100.44 0.16 Allowed Glycine 0 N--CA 1.451 -0.317 0 N-CA-C 111.438 -0.665 . . . . 0.0 111.438 179.157 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.437 ' CG2' ' CG2' ' A' ' 224' ' ' ILE . 0.0 OUTLIER -153.87 35.11 0.44 Allowed 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 114.209 -0.996 . . . . 0.0 108.709 178.266 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.792 HD12 HG11 ' A' ' 162' ' ' VAL . 4.2 mt -42.13 95.57 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.567 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.553 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . -88.07 119.01 28.03 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.744 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -88.07 146.82 19.94 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 178.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.639 ' HB3' HD13 ' A' ' 230' ' ' ILE . 0.0 OUTLIER -147.17 135.28 21.49 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 117.248 0.524 . . . . 0.0 110.833 -178.416 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 169' ' ' TYR . . . . . 0.4 ' O ' ' HA ' ' A' ' 151' ' ' ALA . 5.3 t80 -86.85 124.12 32.73 Favored 'General case' 0 C--O 1.223 -0.301 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 177.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.787 HG21 ' O ' ' A' ' 208' ' ' VAL . 26.9 t -85.53 147.13 5.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 -175.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.2 p -139.86 14.26 2.48 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.924 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.437 ' H ' HG12 ' A' ' 170' ' ' VAL . 3.9 t70 -150.85 -144.66 0.16 Allowed 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -40.3 -105.16 0.01 OUTLIER Glycine 0 CA--C 1.534 1.246 0 N-CA-C 115.208 0.843 . . . . 0.0 115.208 -179.004 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.817 ' HG2' ' HB2' ' A' ' 209' ' ' ALA . 6.8 mttt -151.04 143.25 24.1 Favored 'General case' 0 CA--C 1.517 -0.315 0 O-C-N 122.557 -0.378 . . . . 0.0 111.764 -178.543 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.628 HG13 HG22 ' A' ' 170' ' ' VAL . 14.6 mm -95.36 78.94 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 176.615 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.853 ' O ' HD13 ' A' ' 195' ' ' ILE . 0.0 OUTLIER -97.97 171.06 8.51 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -176.834 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.34 -39.54 74.63 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.28 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -88.58 55.14 3.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.815 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' SER . . . . . 0.812 ' O ' HD12 ' A' ' 195' ' ' ILE . 0.9 OUTLIER -150.18 159.65 44.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.603 -179.973 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 0.0 OUTLIER -89.06 -178.49 5.7 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 179.238 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.697 HG21 HG23 ' A' ' 218' ' ' ILE . 3.3 m -149.64 146.24 17.1 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.615 0 CA-C-O 121.599 0.714 . . . . 0.0 112.028 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 231' ' ' GLU . 7.8 ttt180 -154.54 101.93 2.37 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.748 -1.114 . . . . 0.0 112.198 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.643 ' C ' HD12 ' A' ' 184' ' ' ILE . 0.3 OUTLIER -97.46 170.54 8.98 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.636 179.234 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.791 HG23 ' O ' ' A' ' 188' ' ' ILE . 5.3 mp -152.08 141.32 14.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.021 -177.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.486 ' N ' HG22 ' A' ' 190' ' ' VAL . 3.6 ttm180 -86.37 -156.22 0.29 Allowed 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 178.196 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -93.62 26.5 3.03 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.915 179.071 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -154.07 -43.68 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.062 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.791 ' O ' HG23 ' A' ' 184' ' ' ILE . 0.4 OUTLIER -150.4 -159.74 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -178.001 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.663 ' N ' HG23 ' A' ' 188' ' ' ILE . 22.4 t -84.86 133.68 28.75 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 CA-C-O 121.572 0.701 . . . . 0.0 110.137 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.875 HG12 ' OD2' ' A' ' 223' ' ' ASP . 0.2 OUTLIER -88.32 -38.38 11.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 114.678 -1.147 . . . . 0.0 109.223 -179.213 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 191' ' ' TYR . . . . . 0.479 ' HB2' ' CE1' ' A' ' 221' ' ' PHE . 19.1 t80 -169.62 162.39 9.83 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.201 178.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 192' ' ' GLU . . . . . 0.654 ' CG ' HG11 ' A' ' 189' ' ' VAL . 28.1 mt-10 -150.1 157.97 43.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.041 0.448 . . . . 0.0 111.056 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 146.27 -126.42 2.49 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.077 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' GLU . . . . . 0.597 ' CA ' HG22 ' A' ' 181' ' ' VAL . 3.9 pt-20 -139.92 -176.9 4.75 Favored 'General case' 0 CA--C 1.498 -1.038 0 CA-C-O 121.152 0.501 . . . . 0.0 111.3 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.853 HD13 ' O ' ' A' ' 176' ' ' THR . 3.1 mp -86.85 141.44 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.39 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.351 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.08 -47.48 8.07 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 40.4 m -151.24 163.42 38.92 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.086 179.147 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.69 HD22 ' HB3' ' A' ' 216' ' ' LEU . 0.1 OUTLIER -134.38 108.84 8.4 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 121.099 0.476 . . . . 0.0 111.073 -179.947 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 199' ' ' LYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 3.3 mtpm? -150.1 118.61 6.49 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.682 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 200' ' ' ARG . . . . . 0.551 HH12 HG11 ' A' ' 205' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.527 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.946 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 204' ' ' ASP . . . . . 0.401 ' HA ' ' HA ' ' A' ' 199' ' ' LYS . 4.1 m-20 . . . . . 0 N--CA 1.454 -0.275 0 CA-C-O 121.002 0.43 . . . . 0.0 110.334 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.551 HG11 HH12 ' A' ' 200' ' ' ARG . 32.6 m -64.38 154.83 6.61 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.905 0 CA-C-O 121.501 0.667 . . . . 0.0 112.038 -179.273 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 206' ' ' ARG . . . . . 0.456 ' O ' ' HB ' ' A' ' 176' ' ' THR . 4.3 ttm-85 -89.62 -29.7 18.66 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 114.868 -1.06 . . . . 0.0 112.052 -178.624 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.699 ' HB3' HG22 ' A' ' 176' ' ' THR . 1.5 mp0 -142.93 178.17 7.85 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.123 0.487 . . . . 0.0 111.078 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.787 ' O ' HG21 ' A' ' 170' ' ' VAL . 0.2 OUTLIER -151.18 75.83 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.882 179.054 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.817 ' HB2' ' HG2' ' A' ' 174' ' ' LYS . . . -98.24 172.81 7.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.053 0.454 . . . . 0.0 112.195 -178.783 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 83.94 -73.49 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.957 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 178.45 37.71 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.328 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -102.23 142.98 32.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.863 0.363 . . . . 0.0 111.237 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -100.17 131.72 45.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.337 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 214' ' ' CYS . . . . . 0.569 ' HB3' HG21 ' A' ' 208' ' ' VAL . 48.6 t -133.85 148.19 51.26 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.384 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -88.54 111.47 3.79 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.016 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.69 ' HB3' HD22 ' A' ' 198' ' ' LEU . 0.2 OUTLIER -135.73 144.76 46.06 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 120.946 0.403 . . . . 0.0 111.281 -179.141 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 217' ' ' THR . . . . . 0.543 ' C ' HD12 ' A' ' 218' ' ' ILE . 0.2 OUTLIER -82.37 149.0 27.94 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.189 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 218' ' ' ILE . . . . . 0.697 HG23 HG21 ' A' ' 181' ' ' VAL . 1.7 mp -113.96 88.2 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 -179.074 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 2.3 tttt 45.51 -144.72 0.19 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.931 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -87.08 61.35 6.72 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 120.957 0.408 . . . . 0.0 110.889 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' PHE . . . . . 0.523 ' CZ ' HD21 ' A' ' 183' ' ' LEU . 0.1 OUTLIER -55.23 118.85 4.74 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 179.081 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 21.8 t30 -81.56 -47.46 13.05 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 114.804 -1.089 . . . . 0.0 108.571 176.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 223' ' ' ASP . . . . . 0.875 ' OD2' HG12 ' A' ' 190' ' ' VAL . 0.0 OUTLIER -83.62 139.25 32.94 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.204 177.966 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.636 HD13 ' N ' ' A' ' 224' ' ' ILE . 0.2 OUTLIER -132.27 179.35 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 CA-C-O 121.276 0.56 . . . . 0.0 112.28 -179.542 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.403 ' O ' ' C ' ' A' ' 226' ' ' GLU . 0.3 OUTLIER 58.01 115.87 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.677 -178.756 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 226' ' ' GLU . . . . . 0.445 ' HB3' ' O ' ' A' ' 154' ' ' ARG . 2.6 pt-20 3.64 66.62 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 124.812 1.245 . . . . 0.0 113.931 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -63.35 -62.56 5.27 Favored Glycine 0 N--CA 1.43 -1.745 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.855 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.451 ' O ' HG12 ' A' ' 153' ' ' VAL . 0.8 OUTLIER -164.95 -148.38 0.11 Allowed 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -179.891 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 229' ' ' VAL . . . . . 0.681 HG22 ' HG2' ' A' ' 152' ' ' GLU . 96.4 t -90.37 132.23 35.54 Favored 'Isoleucine or valine' 0 C--N 1.347 0.46 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 230' ' ' ILE . . . . . 0.731 HD11 ' HB ' ' A' ' 153' ' ' VAL . 4.6 mp -98.61 158.8 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 O-C-N 123.477 0.486 . . . . 0.0 111.572 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 231' ' ' GLU . . . . . 0.44 ' O ' ' N ' ' A' ' 182' ' ' ARG . 7.8 tt0 -145.89 109.55 4.79 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.587 ' HB3' ' CA ' ' A' ' 149' ' ' GLY . . . -88.12 126.86 35.34 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.516 178.685 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -132.57 140.08 48.11 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.107 -178.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.735 HG12 HG21 ' A' ' 148' ' ' ILE . 0.4 OUTLIER . . . . . 0 CA--C 1.538 0.508 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.937 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 12.7 tttt . . . . . 0 N--CA 1.461 0.079 0 CA-C-O 120.874 0.369 . . . . 0.0 111.159 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.711 HG11 ' HB2' ' A' ' 150' ' ' GLN . 15.1 t -59.0 140.81 16.81 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.595 0 CA-C-O 121.209 0.528 . . . . 0.0 111.485 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.666 HG13 HG12 ' A' ' 234' ' ' VAL . 0.1 OUTLIER -125.96 -0.85 4.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.819 177.872 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 149' ' ' GLY . . . . . 0.551 ' CA ' ' HB3' ' A' ' 232' ' ' ALA . . . -176.66 72.95 0.08 OUTLIER Glycine 0 C--N 1.341 0.848 0 C-N-CA 121.109 -0.567 . . . . 0.0 111.817 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.711 ' HB2' HG11 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -91.97 132.3 36.62 Favored 'General case' 0 CA--C 1.511 -0.532 0 O-C-N 122.514 -0.403 . . . . 0.0 110.217 179.899 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.493 ' O ' HG13 ' A' ' 229' ' ' VAL . . . -152.22 177.51 10.46 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -178.184 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.504 ' CD ' HG22 ' A' ' 229' ' ' VAL . 2.1 mm-40 -123.66 125.09 44.16 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.566 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.447 HG12 ' O ' ' A' ' 228' ' ' ASP . 1.4 p -49.82 132.43 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -179.088 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.554 ' O ' ' HB3' ' A' ' 226' ' ' GLU . 4.3 mmp_? -89.58 -61.88 1.6 Allowed 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 105.232 -2.136 . . . . 0.0 105.232 175.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.29 -159.05 0.46 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 113.555 -1.657 . . . . 0.0 108.945 175.113 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.525 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 17.4 p -146.04 175.16 10.67 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 110.34 -0.245 . . . . 0.0 110.34 177.547 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.662 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 12.0 m-85 -129.06 73.25 1.5 Allowed 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -179.068 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 163' ' ' GLY . 4.6 ptmt -85.81 64.38 8.57 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.2 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.491 HG12 ' N ' ' A' ' 161' ' ' LYS . 57.0 t -93.22 156.87 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 CA-C-N 113.294 -1.775 . . . . 0.0 110.527 -178.261 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 92.0 p -91.95 35.91 0.97 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.221 0.534 . . . . 0.0 109.584 178.011 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.491 ' N ' HG12 ' A' ' 159' ' ' VAL . 0.2 OUTLIER -150.85 -34.04 0.16 Allowed 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.165 -179.576 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.617 HG12 HD13 ' A' ' 165' ' ' ILE . 89.5 t -102.18 -102.04 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' GLY . . . . . 0.511 ' N ' HG12 ' A' ' 162' ' ' VAL . . . -158.54 -102.0 0.18 Allowed Glycine 0 C--O 1.226 -0.384 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.461 HG22 HG22 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -153.37 34.46 0.46 Allowed 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 124.482 1.113 . . . . 0.0 108.145 177.795 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.662 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 1.6 mp -42.15 95.2 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 CA-C-N 115.063 -0.971 . . . . 0.0 112.143 -178.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.525 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . -87.8 117.89 26.95 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.416 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -87.9 149.51 21.63 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.157 -1.02 . . . . 0.0 110.761 179.174 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.427 ' HB2' ' CB ' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -144.7 135.06 24.34 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.929 0.365 . . . . 0.0 110.537 -178.69 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 169' ' ' TYR . . . . . 0.408 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 91.0 t80 -86.94 124.69 33.43 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 177.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.716 HG21 ' O ' ' A' ' 208' ' ' VAL . 25.0 t -85.06 143.53 11.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -175.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -136.44 14.75 3.21 Favored 'General case' 0 CA--C 1.526 0.053 0 CA-C-N 114.475 -1.239 . . . . 0.0 111.851 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.421 ' H ' HG12 ' A' ' 170' ' ' VAL . 5.0 t0 -150.36 -144.28 0.15 Allowed 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -179.534 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -42.06 -105.06 0.01 OUTLIER Glycine 0 CA--C 1.532 1.107 0 N-CA-C 115.055 0.782 . . . . 0.0 115.055 -179.018 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.779 ' HG2' ' HB2' ' A' ' 209' ' ' ALA . 17.8 mttt -150.83 143.8 24.65 Favored 'General case' 0 N--CA 1.465 0.312 0 O-C-N 122.585 -0.362 . . . . 0.0 111.582 -178.525 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.61 ' CG1' HG22 ' A' ' 170' ' ' VAL . 13.2 mm -94.96 81.64 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 176.525 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.707 HG22 ' HB3' ' A' ' 207' ' ' GLU . 0.1 OUTLIER -95.47 169.23 10.2 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -177.028 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.406 ' CG ' ' HB3' ' A' ' 198' ' ' LEU . 24.7 mtm105 -65.5 -44.46 86.98 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.977 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.16 60.59 5.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.128 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' SER . . . . . 0.49 ' O ' HD12 ' A' ' 195' ' ' ILE . 23.8 m -149.98 161.49 42.22 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.682 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 13.5 mttt -91.46 -169.72 2.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.077 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.552 HG22 ' CA ' ' A' ' 194' ' ' GLU . 1.2 m -150.34 158.1 5.58 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.451 0 CA-C-O 121.235 0.541 . . . . 0.0 111.633 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' ARG . . . . . 0.632 ' NH1' HD11 ' A' ' 184' ' ' ILE . 1.6 ttt85 -152.73 100.53 2.54 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.377 -0.829 . . . . 0.0 112.88 -179.581 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.673 HD12 ' HB3' ' A' ' 191' ' ' TYR . 0.3 OUTLIER -85.99 156.32 20.5 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-O 121.793 0.806 . . . . 0.0 113.149 -179.608 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.699 ' N ' HG23 ' A' ' 190' ' ' VAL . 28.4 mm -154.3 123.96 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 114.254 -1.339 . . . . 0.0 111.296 178.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.571 ' N ' HG22 ' A' ' 190' ' ' VAL . 0.2 OUTLIER -85.74 -150.85 0.14 Allowed 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 177.976 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.84 25.74 3.48 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 118.531 0.605 . . . . 0.0 110.81 178.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -155.03 -68.11 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.478 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -120.61 -156.68 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 115.327 -0.437 . . . . 0.0 110.901 -178.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.761 HG11 ' CG ' ' A' ' 192' ' ' GLU . 59.0 t -87.22 135.85 24.35 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-O 121.303 0.573 . . . . 0.0 111.506 -179.277 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.781 HG12 ' OD2' ' A' ' 223' ' ' ASP . 0.1 OUTLIER -89.37 -33.95 6.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.165 -0.925 . . . . 0.0 108.911 178.764 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 191' ' ' TYR . . . . . 0.673 ' HB3' HD12 ' A' ' 183' ' ' LEU . 15.8 t80 -162.71 159.31 24.14 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.45 178.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 192' ' ' GLU . . . . . 0.761 ' CG ' HG11 ' A' ' 189' ' ' VAL . 19.8 mt-10 -150.17 158.08 43.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.862 178.473 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 133.02 -119.49 2.39 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.24 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' GLU . . . . . 0.552 ' CA ' HG22 ' A' ' 181' ' ' VAL . 12.2 pt-20 -150.61 -175.17 5.0 Favored 'General case' 0 CA--C 1.5 -0.971 0 CA-C-O 121.179 0.514 . . . . 0.0 111.345 -179.143 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.49 HD12 ' O ' ' A' ' 179' ' ' SER . 4.9 mp -88.86 143.76 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.409 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 196' ' ' ASP . . . . . 0.57 ' HB3' HG23 ' A' ' 217' ' ' THR . 0.6 OUTLIER -88.91 -53.9 4.38 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.5 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -151.72 142.71 23.08 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.783 179.096 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.781 ' CD1' HD22 ' A' ' 216' ' ' LEU . 32.3 tp -115.73 117.51 30.44 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 121.466 0.65 . . . . 0.0 111.922 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 199' ' ' LYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 25.6 mttt -150.36 120.94 7.45 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.952 179.165 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 4.5 ttm180 . . . . . 0 C--N 1.322 -0.591 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.991 -179.666 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 204' ' ' ASP . . . . . 0.412 ' HA ' ' HA ' ' A' ' 199' ' ' LYS . 7.2 p-10 . . . . . 0 N--CA 1.453 -0.299 0 CA-C-O 120.905 0.383 . . . . 0.0 110.061 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 28.3 m -60.96 157.77 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.884 0 CA-C-O 121.596 0.712 . . . . 0.0 112.376 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 206' ' ' ARG . . . . . 0.47 ' O ' ' HB ' ' A' ' 176' ' ' THR . 0.1 OUTLIER -89.31 -35.26 16.22 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 114.616 -1.175 . . . . 0.0 111.454 -178.741 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.707 ' HB3' HG22 ' A' ' 176' ' ' THR . 2.2 mp0 -144.32 178.49 7.88 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.9 0.381 . . . . 0.0 110.878 179.285 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.716 ' O ' HG21 ' A' ' 170' ' ' VAL . 1.3 t -150.93 77.0 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.109 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.779 ' HB2' ' HG2' ' A' ' 174' ' ' LYS . . . -96.85 170.84 8.89 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -178.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 85.77 -75.5 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.233 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 177.89 37.15 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.334 -0.936 . . . . 0.0 112.432 179.077 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -95.27 150.03 20.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.901 0.381 . . . . 0.0 111.333 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -89.76 159.53 17.0 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.215 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 5.1 p -150.71 -175.48 5.13 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.265 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 215' ' ' GLY . . . . . 0.448 ' C ' HG23 ' A' ' 165' ' ' ILE . . . -144.02 96.97 0.19 Allowed Glycine 0 N--CA 1.451 -0.335 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 179.342 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.781 HD22 ' CD1' ' A' ' 198' ' ' LEU . 0.4 OUTLIER -131.71 142.01 49.7 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 120.932 0.396 . . . . 0.0 111.992 -178.367 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 217' ' ' THR . . . . . 0.57 HG23 ' HB3' ' A' ' 196' ' ' ASP . 0.1 OUTLIER -79.14 132.98 36.74 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 176.877 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 218' ' ' ILE . . . . . 0.578 HG22 ' O ' ' A' ' 218' ' ' ILE . 1.4 mp -98.35 97.49 6.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.459 -177.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 6.5 tttp 42.5 -144.33 0.08 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.978 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -87.66 64.14 7.88 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 120.871 0.367 . . . . 0.0 110.738 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 221' ' ' PHE . . . . . 0.646 ' CZ ' HD13 ' A' ' 183' ' ' LEU . 0.1 OUTLIER -54.81 118.51 4.31 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 179.075 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -82.76 -43.82 16.31 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 114.691 -1.14 . . . . 0.0 108.548 176.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 223' ' ' ASP . . . . . 0.781 ' OD2' HG12 ' A' ' 190' ' ' VAL . 0.0 OUTLIER -89.57 130.7 35.85 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 178.171 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.617 HD13 ' H ' ' A' ' 224' ' ' ILE . 0.2 OUTLIER -114.96 175.89 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 CA-C-O 121.263 0.554 . . . . 0.0 111.511 179.562 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.469 ' O ' ' N ' ' A' ' 227' ' ' GLY . 5.9 mtmt 63.53 147.74 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.84 -1.073 . . . . 0.0 108.992 -178.724 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 226' ' ' GLU . . . . . 0.554 ' HB3' ' O ' ' A' ' 154' ' ' ARG . 3.3 pt-20 -36.58 87.98 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.931 0.872 . . . . 0.0 112.855 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 227' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 225' ' ' LYS . . . -81.46 -57.62 2.73 Favored Glycine 0 N--CA 1.427 -1.902 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.873 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.447 ' O ' HG12 ' A' ' 153' ' ' VAL . 1.0 OUTLIER -163.71 -146.91 0.11 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 179.365 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 229' ' ' VAL . . . . . 0.504 HG22 ' CD ' ' A' ' 152' ' ' GLU . 61.6 t -93.64 147.4 5.54 Favored 'Isoleucine or valine' 0 C--N 1.342 0.278 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.62 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 230' ' ' ILE . . . . . 0.409 HG13 ' HG ' ' A' ' 183' ' ' LEU . 2.8 mp -118.6 154.58 20.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.187 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 231' ' ' GLU . . . . . 0.46 ' HA ' ' HA ' ' A' ' 150' ' ' GLN . 10.2 tt0 -142.49 112.26 6.85 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.421 0.629 . . . . 0.0 111.965 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.551 ' HB3' ' CA ' ' A' ' 149' ' ' GLY . . . -86.9 129.81 34.72 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.195 178.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 233' ' ' TYR . . . . . 0.61 ' C ' HD12 ' A' ' 148' ' ' ILE . 6.0 p90 -130.2 144.0 51.11 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.289 -178.787 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.666 HG12 HG13 ' A' ' 148' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.674 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 2.8 tttp . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.634 0.254 . . . . 0.0 110.548 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.81 HG11 ' HB2' ' A' ' 150' ' ' GLN . 14.4 t -61.72 139.27 20.93 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.628 0 CA-C-O 121.357 0.599 . . . . 0.0 111.226 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.727 HG21 HG12 ' A' ' 234' ' ' VAL . 1.1 pt -117.64 -11.87 11.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.145 178.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' GLY . . . . . 0.527 ' O ' ' HB3' ' A' ' 232' ' ' ALA . . . -177.64 77.91 0.07 OUTLIER Glycine 0 C--N 1.34 0.799 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.81 ' HB2' HG11 ' A' ' 147' ' ' VAL . 0.7 OUTLIER -91.29 137.94 31.97 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 120.704 0.288 . . . . 0.0 110.56 -179.65 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.468 ' O ' HG13 ' A' ' 229' ' ' VAL . . . -152.01 178.13 9.75 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -178.288 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.724 ' HG2' HG22 ' A' ' 229' ' ' VAL . 40.4 mt-10 -124.34 124.93 43.45 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.334 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.543 ' HB ' HD11 ' A' ' 230' ' ' ILE . 2.2 p -51.04 133.84 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.098 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.403 ' HD2' ' HB2' ' A' ' 169' ' ' TYR . 4.2 mmp_? -89.52 -63.39 1.29 Allowed 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 104.943 -2.243 . . . . 0.0 104.943 175.319 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.418 ' HA ' ' H ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER -162.4 -162.29 0.8 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 113.664 -1.607 . . . . 0.0 108.839 174.721 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 4.9 p -147.19 143.95 28.58 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 177.194 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.527 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 0.4 OUTLIER -89.96 83.51 6.13 Favored 'General case' 0 CA--C 1.51 -0.583 0 N-CA-C 113.969 1.099 . . . . 0.0 113.969 -177.598 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 10.2 tttp -86.82 62.18 7.24 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 177.144 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.518 HG12 ' N ' ' A' ' 161' ' ' LYS . 40.9 t -93.32 156.02 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 CA-C-N 113.694 -1.593 . . . . 0.0 110.306 -178.423 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 12.4 t -90.15 35.68 0.86 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.13 0.491 . . . . 0.0 109.954 178.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.518 ' N ' HG12 ' A' ' 159' ' ' VAL . 0.9 OUTLIER -150.41 -32.4 0.18 Allowed 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.343 -179.671 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.523 HG12 ' N ' ' A' ' 163' ' ' GLY . 93.5 t -102.85 -103.23 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.226 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' GLY . . . . . 0.523 ' N ' HG12 ' A' ' 162' ' ' VAL . . . -159.07 -99.07 0.15 Allowed Glycine 0 N--CA 1.452 -0.25 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 178.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' THR . . . . . 1.118 HG21 HG21 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -153.49 34.65 0.45 Allowed 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.282 1.033 . . . . 0.0 108.275 177.72 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.529 HG22 ' O ' ' A' ' 165' ' ' ILE . 1.1 mm -40.86 98.11 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.587 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.672 ' HB3' HD13 ' A' ' 218' ' ' ILE . . . -85.78 119.47 26.13 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.914 -1.039 . . . . 0.0 112.368 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -88.32 151.65 22.86 Favored Glycine 0 N--CA 1.443 -0.892 0 N-CA-C 110.159 -1.176 . . . . 0.0 110.159 178.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.55 ' HB3' HD13 ' A' ' 230' ' ' ILE . 0.0 OUTLIER -145.62 133.74 21.56 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 117.181 0.491 . . . . 0.0 110.724 -178.563 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 169' ' ' TYR . . . . . 0.432 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 10.9 t80 -87.33 127.33 35.19 Favored 'General case' 0 C--O 1.221 -0.429 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 177.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.812 HG21 ' O ' ' A' ' 208' ' ' VAL . 44.2 t -85.23 143.29 11.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -176.211 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -135.99 15.35 3.3 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 114.563 -1.199 . . . . 0.0 111.99 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -150.07 -146.42 0.2 Allowed 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -42.7 -105.11 0.01 OUTLIER Glycine 0 CA--C 1.531 1.071 0 N-CA-C 114.986 0.754 . . . . 0.0 114.986 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.745 ' HG3' ' HB2' ' A' ' 209' ' ' ALA . 0.0 OUTLIER -151.05 135.56 17.04 Favored 'General case' 0 CA--C 1.513 -0.465 0 O-C-N 122.637 -0.331 . . . . 0.0 111.207 -178.864 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.61 ' CG2' HG23 ' A' ' 208' ' ' VAL . 0.5 OUTLIER -95.51 112.13 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 176.909 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.48 ' HB ' ' O ' ' A' ' 206' ' ' ARG . 0.1 OUTLIER -120.93 169.12 10.77 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.468 0.652 . . . . 0.0 112.219 -176.8 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.92 -43.58 98.41 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.931 179.237 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -89.73 61.16 5.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.964 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' SER . . . . . 0.702 ' HB3' HD11 ' A' ' 148' ' ' ILE . 57.9 m -148.06 159.23 44.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.819 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 0.0 OUTLIER -89.08 -176.95 5.31 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.344 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.886 ' CG1' HD12 ' A' ' 195' ' ' ILE . 1.4 m -146.15 156.75 12.06 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 CA-C-O 121.466 0.65 . . . . 0.0 112.278 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' ARG . . . . . 0.436 ' N ' ' O ' ' A' ' 231' ' ' GLU . 4.1 ttt180 -153.49 102.65 2.59 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.081 -0.963 . . . . 0.0 113.051 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.738 HD13 ' CZ ' ' A' ' 221' ' ' PHE . 0.3 OUTLIER -86.03 159.55 19.56 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-O 122.143 0.973 . . . . 0.0 113.255 -179.758 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.531 ' N ' HG23 ' A' ' 190' ' ' VAL . 16.2 mt -153.82 122.59 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 113.838 -1.528 . . . . 0.0 112.311 178.13 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.431 ' N ' HG22 ' A' ' 190' ' ' VAL . 0.2 OUTLIER -87.05 -147.93 0.14 Allowed 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 177.848 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 21.0 mm100 -95.47 27.36 3.41 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 118.651 0.659 . . . . 0.0 110.745 178.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.419 ' C ' HD13 ' A' ' 188' ' ' ILE . . . -154.57 -80.24 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.755 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.419 HD13 ' C ' ' A' ' 187' ' ' GLY . 0.3 OUTLIER -112.41 -155.37 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 115.342 -0.429 . . . . 0.0 110.716 -179.107 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.777 HG11 ' CG ' ' A' ' 192' ' ' GLU . 41.2 t -87.04 135.62 24.8 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.096 0 CA-C-O 121.45 0.643 . . . . 0.0 111.576 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.897 HG12 ' OD2' ' A' ' 223' ' ' ASP . 0.2 OUTLIER -89.88 -32.25 5.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.203 178.687 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 191' ' ' TYR . . . . . 0.698 ' HB3' HD12 ' A' ' 183' ' ' LEU . 17.4 t80 -160.06 158.35 30.26 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.496 178.494 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 192' ' ' GLU . . . . . 0.777 ' CG ' HG11 ' A' ' 189' ' ' VAL . 22.3 mt-10 -150.81 154.05 36.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.072 178.178 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 135.29 -119.75 2.18 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.054 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' GLU . . . . . 0.624 ' CA ' HG22 ' A' ' 181' ' ' VAL . 0.0 OUTLIER -148.43 -178.47 6.34 Favored 'General case' 0 CA--C 1.501 -0.904 0 CA-C-O 121.523 0.678 . . . . 0.0 111.663 -179.446 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.886 HD12 ' CG1' ' A' ' 181' ' ' VAL . 0.0 OUTLIER -88.75 147.77 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 CA-C-N 114.64 -1.163 . . . . 0.0 110.257 -178.674 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.68 -54.68 3.96 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 179.157 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 64.2 p -150.93 160.05 44.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.5 179.104 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.895 ' CD1' HD22 ' A' ' 216' ' ' LEU . 27.2 tp -133.44 110.71 10.18 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.384 0.611 . . . . 0.0 111.205 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 9.7 ptmt -149.8 123.89 9.44 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.414 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 2.6 ttm-85 . . . . . 0 C--N 1.322 -0.589 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.896 -179.938 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 . . . . . 0 N--CA 1.453 -0.294 0 CA-C-O 120.996 0.427 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 33.3 m -58.68 161.3 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.949 0 CA-C-O 121.55 0.69 . . . . 0.0 112.21 -179.229 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' ARG . . . . . 0.48 ' O ' ' HB ' ' A' ' 176' ' ' THR . 4.4 ttp180 -89.39 -38.17 14.31 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 114.625 -1.17 . . . . 0.0 111.461 -178.659 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -138.01 177.06 8.16 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.132 0.492 . . . . 0.0 111.332 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.812 ' O ' HG21 ' A' ' 170' ' ' VAL . 0.0 OUTLIER -151.05 81.78 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.544 178.98 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.745 ' HB2' ' HG3' ' A' ' 174' ' ' LYS . . . -101.7 172.52 6.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.102 0.477 . . . . 0.0 112.281 -178.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 2.8 tp-100 83.9 -72.98 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.983 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 178.09 37.95 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.371 -0.918 . . . . 0.0 112.44 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -97.99 143.22 28.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.979 0.419 . . . . 0.0 111.471 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -89.63 158.13 17.73 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.352 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -150.48 -171.09 3.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.015 0.436 . . . . 0.0 111.289 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -137.98 106.36 0.53 Allowed Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 178.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.895 HD22 ' CD1' ' A' ' 198' ' ' LEU . 0.1 OUTLIER -135.17 147.84 49.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.452 0.644 . . . . 0.0 112.602 -177.377 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 217' ' ' THR . . . . . 0.485 ' C ' HD12 ' A' ' 218' ' ' ILE . 0.0 OUTLIER -87.31 142.77 27.64 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 177.355 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 218' ' ' ILE . . . . . 0.672 HD13 ' HB3' ' A' ' 166' ' ' ALA . 1.5 mp -100.52 81.11 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.915 0.388 . . . . 0.0 110.817 -178.557 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 4.0 ttpt 42.34 -88.94 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.721 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 220' ' ' ASN . . . . . 0.401 ' N ' ' O ' ' A' ' 218' ' ' ILE . 13.0 t-20 -132.6 62.59 1.65 Allowed 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.118 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 221' ' ' PHE . . . . . 0.738 ' CZ ' HD13 ' A' ' 183' ' ' LEU . 0.1 OUTLIER -59.23 119.55 7.58 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 179.443 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -81.58 -42.51 19.99 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 175.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 223' ' ' ASP . . . . . 0.897 ' OD2' HG12 ' A' ' 190' ' ' VAL . 0.0 OUTLIER -92.81 143.44 26.28 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.339 177.693 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 1.118 HG21 HG21 ' A' ' 164' ' ' THR . 0.2 OUTLIER -135.94 178.14 5.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -179.183 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.412 ' O ' ' C ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER 57.68 119.31 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 114.543 -1.208 . . . . 0.0 110.009 -178.953 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 226' ' ' GLU . . . . . 0.453 ' HA ' ' CG1' ' A' ' 153' ' ' VAL . 5.3 tt0 5.95 65.81 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 124.455 1.102 . . . . 0.0 113.62 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -66.34 -63.74 3.76 Favored Glycine 0 N--CA 1.429 -1.802 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.236 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.441 ' O ' ' HB ' ' A' ' 153' ' ' VAL . 1.0 OUTLIER -165.05 -147.17 0.1 Allowed 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 179.259 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 229' ' ' VAL . . . . . 0.724 HG22 ' HG2' ' A' ' 152' ' ' GLU . 52.6 t -89.8 146.92 5.59 Favored 'Isoleucine or valine' 0 C--N 1.34 0.181 0 CA-C-N 116.71 -0.223 . . . . 0.0 110.412 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 230' ' ' ILE . . . . . 0.55 HD13 ' HB3' ' A' ' 168' ' ' CYS . 4.4 mp -116.63 153.57 18.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.024 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 231' ' ' GLU . . . . . 0.436 ' O ' ' N ' ' A' ' 182' ' ' ARG . 0.1 OUTLIER -142.09 110.74 6.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.281 0.562 . . . . 0.0 111.949 -179.052 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.527 ' HB3' ' O ' ' A' ' 149' ' ' GLY . . . -87.93 127.97 35.37 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.312 178.73 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -129.3 139.41 51.78 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.349 -178.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.727 HG12 HG21 ' A' ' 148' ' ' ILE . 0.5 OUTLIER . . . . . 0 CA--C 1.535 0.396 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.881 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 5.3 mmtm . . . . . 0 CA--C 1.529 0.143 0 CA-C-O 120.441 0.162 . . . . 0.0 110.605 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 11.9 t -102.46 137.22 31.26 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.712 0 CA-C-O 121.36 0.6 . . . . 0.0 110.988 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.598 HG21 HG12 ' A' ' 234' ' ' VAL . 2.7 pp -131.9 6.85 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.245 178.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' GLY . . . . . 0.547 ' CA ' ' HB3' ' A' ' 232' ' ' ALA . . . 171.77 73.91 0.04 OUTLIER Glycine 0 C--N 1.341 0.841 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.125 179.412 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.486 ' HA ' ' HA ' ' A' ' 231' ' ' GLU . 0.5 OUTLIER -93.04 132.09 37.46 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 122.551 -0.381 . . . . 0.0 110.613 -179.683 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.483 ' O ' HG13 ' A' ' 229' ' ' VAL . . . -151.22 172.92 15.08 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 121.377 0.608 . . . . 0.0 112.564 -178.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.43 ' HA ' ' HA ' ' A' ' 229' ' ' VAL . 1.8 mm-40 -121.6 126.21 48.54 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.438 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.48 ' CG1' ' HA ' ' A' ' 226' ' ' GLU . 1.9 p -52.39 131.32 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-O 121.344 0.592 . . . . 0.0 112.309 -179.296 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.497 ' O ' ' HB3' ' A' ' 226' ' ' GLU . 0.0 OUTLIER -90.47 -60.34 1.95 Allowed 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 105.142 -2.17 . . . . 0.0 105.142 175.444 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.49 -159.88 0.49 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 114.206 -1.361 . . . . 0.0 109.915 174.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.547 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 12.7 p -150.13 148.2 28.68 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.375 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.574 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 0.2 OUTLIER -90.72 82.47 5.75 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -177.723 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.401 ' CD ' HG13 ' A' ' 224' ' ' ILE . 1.6 tttt -86.44 62.29 7.33 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 177.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.478 HG12 ' N ' ' A' ' 161' ' ' LYS . 54.0 t -91.28 156.08 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 CA-C-N 113.771 -1.559 . . . . 0.0 110.059 -178.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 80.0 p -90.41 34.2 0.88 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.122 0.487 . . . . 0.0 110.161 178.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.478 ' N ' HG12 ' A' ' 159' ' ' VAL . 0.0 OUTLIER -150.75 -32.32 0.17 Allowed 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.471 -179.862 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.494 HG12 ' N ' ' A' ' 163' ' ' GLY . 87.4 t -100.17 -102.68 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.15 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' GLY . . . . . 0.494 ' N ' HG12 ' A' ' 162' ' ' VAL . . . -159.28 -101.51 0.17 Allowed Glycine 0 N--CA 1.451 -0.344 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 178.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' THR . . . . . 1.039 HG21 HG21 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -153.5 36.46 0.46 Allowed 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 177.822 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.696 HD12 ' O ' ' A' ' 215' ' ' GLY . 0.9 OUTLIER -42.31 95.3 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.26 -179.416 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.877 ' O ' HD12 ' A' ' 216' ' ' LEU . . . -82.08 118.68 23.22 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 114.495 -1.229 . . . . 0.0 112.482 -178.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -91.22 143.99 16.94 Favored Glycine 0 N--CA 1.442 -0.965 0 N-CA-C 111.001 -0.839 . . . . 0.0 111.001 178.522 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.656 ' SG ' HD11 ' A' ' 216' ' ' LEU . 0.0 OUTLIER -137.73 132.95 33.56 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 -179.728 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 169' ' ' TYR . . . . . 0.432 ' HB2' ' HD3' ' A' ' 154' ' ' ARG . 7.4 t80 -85.03 128.16 34.51 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 178.272 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.581 HG21 ' O ' ' A' ' 208' ' ' VAL . 44.4 t -85.96 147.79 5.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -176.084 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.6 p -140.78 14.83 2.31 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-N 114.474 -1.239 . . . . 0.0 111.841 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.406 ' CB ' ' HB2' ' A' ' 150' ' ' GLN . 11.3 t0 -150.8 -144.46 0.15 Allowed 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 -179.183 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -40.15 -104.22 0.01 OUTLIER Glycine 0 CA--C 1.532 1.11 0 N-CA-C 115.209 0.844 . . . . 0.0 115.209 -179.031 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.671 ' HG2' ' HB2' ' A' ' 209' ' ' ALA . 20.2 mttp -151.13 134.73 16.33 Favored 'General case' 0 CA--C 1.514 -0.427 0 O-C-N 122.517 -0.402 . . . . 0.0 111.839 -178.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.839 ' CG2' HD21 ' A' ' 216' ' ' LEU . 4.6 mm -91.2 83.87 2.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 176.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.706 HG22 ' HB3' ' A' ' 207' ' ' GLU . 0.0 OUTLIER -98.62 -178.16 3.9 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -176.704 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.59 -45.59 21.33 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-N 114.854 -1.066 . . . . 0.0 111.166 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -88.67 61.39 6.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.393 0.616 . . . . 0.0 110.338 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' SER . . . . . 0.533 ' HB3' HD11 ' A' ' 148' ' ' ILE . 16.4 m -149.32 157.74 43.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.986 -179.268 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 1.7 mptt -89.06 -178.17 5.62 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.655 HG22 ' CA ' ' A' ' 194' ' ' GLU . 1.9 m -142.71 161.79 18.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.336 0.589 . . . . 0.0 111.845 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' ARG . . . . . 0.428 ' N ' ' O ' ' A' ' 231' ' ' GLU . 15.1 ttt180 -151.74 98.95 2.54 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.113 -0.948 . . . . 0.0 112.323 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.89 HD13 ' HB3' ' A' ' 191' ' ' TYR . 5.4 mp -89.08 146.14 25.02 Favored 'General case' 0 CA--C 1.497 -1.09 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -178.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.465 ' CA ' HG23 ' A' ' 190' ' ' VAL . 17.8 mt -156.57 128.18 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-N 113.168 -1.833 . . . . 0.0 111.772 179.15 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.403 ' N ' ' CG2' ' A' ' 190' ' ' VAL . 0.1 OUTLIER -88.87 -148.44 0.17 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 177.943 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -94.94 29.69 2.32 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 118.604 0.638 . . . . 0.0 110.998 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -153.6 -83.34 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.869 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.47 ' H ' HD12 ' A' ' 188' ' ' ILE . 0.1 OUTLIER -111.6 -158.7 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 CA-C-N 115.455 -0.372 . . . . 0.0 110.621 -179.252 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.536 HG11 ' CG ' ' A' ' 192' ' ' GLU . 43.4 t -87.13 134.85 26.58 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 CA-C-O 121.68 0.752 . . . . 0.0 110.992 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.895 HG12 ' OD2' ' A' ' 223' ' ' ASP . 0.2 OUTLIER -94.79 -34.84 5.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 114.416 -1.265 . . . . 0.0 109.525 -179.909 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 191' ' ' TYR . . . . . 0.89 ' HB3' HD13 ' A' ' 183' ' ' LEU . 27.0 t80 -170.1 156.14 5.82 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.102 -0.953 . . . . 0.0 112.446 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 192' ' ' GLU . . . . . 0.536 ' CG ' HG11 ' A' ' 189' ' ' VAL . 32.2 mt-10 -151.13 162.12 41.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.634 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 134.76 -114.88 1.33 Allowed Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.558 -0.829 . . . . 0.0 112.343 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' GLU . . . . . 0.655 ' CA ' HG22 ' A' ' 181' ' ' VAL . 0.0 OUTLIER -150.47 -178.43 6.53 Favored 'General case' 0 CA--C 1.503 -0.865 0 CA-C-O 121.323 0.583 . . . . 0.0 110.901 -179.407 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.683 ' CD1' HD22 ' A' ' 216' ' ' LEU . 0.0 OUTLIER -89.76 154.65 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.921 -179.431 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 196' ' ' ASP . . . . . 0.402 ' HB3' ' CB ' ' A' ' 217' ' ' THR . 26.3 t70 -89.8 -66.79 0.89 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 178.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -151.63 146.72 26.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.248 179.04 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.853 ' HG ' HD23 ' A' ' 216' ' ' LEU . 2.4 tt -110.96 119.52 39.34 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.519 0.676 . . . . 0.0 112.487 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 199' ' ' LYS . . . . . 0.558 ' N ' HD23 ' A' ' 198' ' ' LEU . 0.7 OUTLIER -151.55 116.52 5.22 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.491 178.55 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.325 -0.463 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 5.1 t70 . . . . . 0 N--CA 1.453 -0.276 0 CA-C-O 120.96 0.41 . . . . 0.0 110.417 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 34.2 m -66.14 162.39 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.958 0 CA-C-O 121.414 0.626 . . . . 0.0 112.062 -179.257 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' ARG . . . . . 0.468 ' O ' ' HB ' ' A' ' 176' ' ' THR . 5.3 mtp180 -89.15 -37.32 15.14 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.565 -178.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.706 ' HB3' HG22 ' A' ' 176' ' ' THR . 0.5 OUTLIER -141.38 178.35 7.49 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.27 0.557 . . . . 0.0 111.746 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.581 ' O ' HG21 ' A' ' 170' ' ' VAL . 0.0 OUTLIER -151.05 80.59 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.588 179.034 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.671 ' HB2' ' HG2' ' A' ' 174' ' ' LYS . . . -96.47 172.02 8.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.072 0.463 . . . . 0.0 112.038 -178.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 84.83 -73.88 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.055 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 177.87 37.34 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.29 -0.957 . . . . 0.0 112.623 179.068 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -99.51 145.23 27.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.939 0.399 . . . . 0.0 111.568 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -89.77 161.38 16.06 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.528 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 27.1 p -150.55 -170.03 3.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.967 0.413 . . . . 0.0 111.209 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 215' ' ' GLY . . . . . 0.696 ' O ' HD12 ' A' ' 165' ' ' ILE . . . -139.74 98.68 0.24 Allowed Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 179.028 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.877 HD12 ' O ' ' A' ' 166' ' ' ALA . 0.2 OUTLIER -129.3 151.11 50.32 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 121.06 0.457 . . . . 0.0 110.782 -178.997 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 217' ' ' THR . . . . . 0.402 ' CB ' ' HB3' ' A' ' 196' ' ' ASP . 0.0 OUTLIER -87.91 141.06 28.88 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 177.294 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 218' ' ' ILE . . . . . 0.606 HG22 ' O ' ' A' ' 218' ' ' ILE . 16.6 mm -98.2 74.39 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.77 -178.66 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 46.43 -136.0 0.8 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.295 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -87.03 58.07 4.86 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 120.793 0.33 . . . . 0.0 111.609 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' PHE . . . . . 0.767 ' CZ ' HD22 ' A' ' 183' ' ' LEU . 0.1 OUTLIER -56.25 120.0 6.88 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 178.1 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -80.01 -45.23 18.76 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 176.193 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 223' ' ' ASP . . . . . 0.895 ' OD2' HG12 ' A' ' 190' ' ' VAL . 0.0 OUTLIER -91.35 131.44 36.84 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.761 178.109 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 1.039 HG21 HG21 ' A' ' 164' ' ' THR . 0.1 OUTLIER -121.29 177.61 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-O 121.17 0.51 . . . . 0.0 111.929 -179.877 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.473 ' O ' ' N ' ' A' ' 227' ' ' GLY . 2.3 mtpp 62.92 152.32 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.136 -178.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 226' ' ' GLU . . . . . 0.497 ' HB3' ' O ' ' A' ' 154' ' ' ARG . 0.4 OUTLIER -38.45 90.14 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 CA-C-O 122.186 0.993 . . . . 0.0 112.258 -179.947 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 227' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 225' ' ' LYS . . . -106.45 -39.28 2.1 Favored Glycine 0 N--CA 1.43 -1.741 0 CA-C-N 114.429 -1.26 . . . . 0.0 112.152 -178.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.738 ' CB ' HG21 ' A' ' 190' ' ' VAL . 2.9 p30 -158.23 -164.85 1.57 Allowed 'General case' 0 C--O 1.22 -0.466 0 N-CA-C 115.292 1.59 . . . . 0.0 115.292 -178.277 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 229' ' ' VAL . . . . . 0.483 HG13 ' O ' ' A' ' 151' ' ' ALA . 89.3 t -102.25 144.66 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 177.324 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 230' ' ' ILE . . . . . 0.402 HG13 ' HG ' ' A' ' 183' ' ' LEU . 3.7 mp -114.79 153.61 16.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.217 0.532 . . . . 0.0 112.103 -178.019 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 231' ' ' GLU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 150' ' ' GLN . 20.3 tt0 -140.85 111.88 7.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.374 0.606 . . . . 0.0 111.476 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.547 ' HB3' ' CA ' ' A' ' 149' ' ' GLY . . . -87.78 128.7 35.32 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.896 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -130.81 142.81 50.41 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.916 -179.102 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.598 HG12 HG21 ' A' ' 148' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.111 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 5.9 mmtm . . . . . 0 C--O 1.23 0.078 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 18.9 t -97.39 136.91 26.56 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.631 0 CA-C-O 121.17 0.509 . . . . 0.0 110.527 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.601 HG21 ' O ' ' A' ' 234' ' ' VAL . 2.7 pp -128.94 6.31 2.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.326 178.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' GLY . . . . . 0.569 ' CA ' ' HB3' ' A' ' 232' ' ' ALA . . . 171.21 75.43 0.04 OUTLIER Glycine 0 C--N 1.341 0.843 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.003 179.228 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.462 ' HA ' ' HA ' ' A' ' 231' ' ' GLU . 0.7 OUTLIER -95.14 130.3 41.9 Favored 'General case' 0 CA--C 1.517 -0.317 0 O-C-N 122.551 -0.382 . . . . 0.0 110.419 -179.826 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.475 ' O ' HG13 ' A' ' 229' ' ' VAL . . . -151.04 171.21 17.69 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 120.32 -0.552 . . . . 0.0 112.25 -178.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 229' ' ' VAL . 1.6 mm-40 -119.01 128.0 53.97 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.536 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.489 ' CG1' ' HA ' ' A' ' 226' ' ' GLU . 2.0 p -49.65 142.61 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -178.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -100.77 -63.01 1.17 Allowed 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 104.379 -2.452 . . . . 0.0 104.379 174.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.92 -165.65 1.29 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 113.735 -1.575 . . . . 0.0 109.368 174.37 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.525 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 8.1 p -147.11 163.29 36.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.553 0.216 . . . . 0.0 110.425 177.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.549 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 0.2 OUTLIER -115.48 76.26 0.99 Allowed 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -179.475 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.876 ' CB ' HD13 ' A' ' 224' ' ' ILE . 7.2 tmtm? -86.27 62.97 7.75 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 177.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.403 HG12 ' N ' ' A' ' 161' ' ' LYS . 98.3 t -92.94 158.59 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 CA-C-N 113.589 -1.642 . . . . 0.0 110.538 -178.376 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 19.7 m -93.28 34.57 1.13 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.317 0.58 . . . . 0.0 109.552 177.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.403 ' N ' HG12 ' A' ' 159' ' ' VAL . 1.1 mtpt -151.49 -34.77 0.14 Allowed 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.164 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.76 ' CG1' HD12 ' A' ' 165' ' ' ILE . 86.0 t -97.65 -102.7 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 N-CA-C 109.703 -0.481 . . . . 0.0 109.703 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' GLY . . . . . 0.505 ' N ' HG12 ' A' ' 162' ' ' VAL . . . -159.46 -102.47 0.18 Allowed Glycine 0 N--CA 1.451 -0.326 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 178.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.532 ' CG2' HG21 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -154.21 32.61 0.43 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 113.976 -1.112 . . . . 0.0 108.543 177.611 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.76 HD12 ' CG1' ' A' ' 162' ' ' VAL . 1.8 mt -42.53 95.42 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.481 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.525 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . -90.45 122.94 33.75 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.82 -1.082 . . . . 0.0 112.052 -179.357 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -88.29 146.03 19.38 Favored Glycine 0 N--CA 1.44 -1.053 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 178.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.412 ' HB2' ' CB ' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -143.76 131.4 21.24 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 117.164 0.482 . . . . 0.0 110.072 -179.18 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 169' ' ' TYR . . . . . 0.41 ' O ' ' HA ' ' A' ' 151' ' ' ALA . 17.2 t80 -86.94 122.39 30.74 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 178.244 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.74 HG21 ' O ' ' A' ' 208' ' ' VAL . 38.7 t -85.38 145.17 8.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -176.27 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 2.0 p -138.19 14.92 2.82 Favored 'General case' 0 N--CA 1.457 -0.113 0 CA-C-N 114.662 -1.154 . . . . 0.0 111.912 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.408 ' H ' HG12 ' A' ' 170' ' ' VAL . 10.7 t0 -150.62 -144.36 0.15 Allowed 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -179.111 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -40.48 -105.52 0.01 OUTLIER Glycine 0 CA--C 1.532 1.103 0 N-CA-C 115.13 0.812 . . . . 0.0 115.13 -178.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.618 ' HG2' ' HB2' ' A' ' 209' ' ' ALA . 7.1 mttt -151.4 134.85 16.17 Favored 'General case' 0 CA--C 1.514 -0.417 0 O-C-N 122.526 -0.397 . . . . 0.0 111.957 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.674 ' O ' HD11 ' A' ' 198' ' ' LEU . 6.0 mm -91.81 83.23 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 176.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.78 ' O ' HD12 ' A' ' 195' ' ' ILE . 0.1 OUTLIER -98.59 176.22 5.73 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.54 0.686 . . . . 0.0 112.415 -177.557 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -71.58 -44.67 64.06 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.969 -1.014 . . . . 0.0 111.386 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -88.99 61.83 6.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.249 0.547 . . . . 0.0 110.756 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' SER . . . . . 0.42 ' HB3' HD11 ' A' ' 148' ' ' ILE . 20.3 m -150.09 157.95 43.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.048 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 2.1 mptt -88.68 177.27 6.79 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.661 HG22 ' CA ' ' A' ' 194' ' ' GLU . 2.0 m -141.68 163.71 19.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.399 0.619 . . . . 0.0 111.956 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 182' ' ' ARG . . . . . 0.43 ' N ' ' O ' ' A' ' 231' ' ' GLU . 7.4 ttt180 -151.51 100.09 2.68 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.037 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.852 HD13 ' HB3' ' A' ' 191' ' ' TYR . 5.4 mp -89.2 144.49 26.07 Favored 'General case' 0 CA--C 1.494 -1.184 0 CA-C-O 122.476 1.131 . . . . 0.0 113.868 -178.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.487 ' CA ' HG23 ' A' ' 190' ' ' VAL . 18.1 mt -156.65 129.28 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-N 113.007 -1.906 . . . . 0.0 111.754 179.338 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.413 ' N ' ' CG2' ' A' ' 190' ' ' VAL . 0.1 OUTLIER -88.54 -148.45 0.17 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.028 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -95.46 29.53 2.54 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 118.526 0.603 . . . . 0.0 110.818 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -153.23 -82.39 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.904 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -113.06 -158.26 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 115.519 -0.34 . . . . 0.0 110.704 -179.13 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.414 HG11 ' HG3' ' A' ' 192' ' ' GLU . 40.0 t -87.08 137.02 21.7 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 CA-C-O 121.741 0.781 . . . . 0.0 111.05 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.793 HG21 ' CB ' ' A' ' 228' ' ' ASP . 0.2 OUTLIER -98.88 -35.78 5.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 114.272 -1.331 . . . . 0.0 109.484 -179.462 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 191' ' ' TYR . . . . . 0.852 ' HB3' HD13 ' A' ' 183' ' ' LEU . 14.7 t80 -169.04 157.72 8.07 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.012 -0.994 . . . . 0.0 112.38 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 192' ' ' GLU . . . . . 0.414 ' HG3' HG11 ' A' ' 189' ' ' VAL . 60.9 mt-10 -151.5 162.06 41.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.748 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 135.38 -116.98 1.62 Allowed Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.169 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' GLU . . . . . 0.661 ' CA ' HG22 ' A' ' 181' ' ' VAL . 17.0 pt-20 -149.98 -176.3 5.38 Favored 'General case' 0 CA--C 1.497 -1.085 0 CA-C-O 121.336 0.589 . . . . 0.0 111.432 -179.359 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.78 HD12 ' O ' ' A' ' 176' ' ' THR . 49.1 mt -89.43 146.99 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.352 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.552 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 196' ' ' ASP . . . . . 0.629 ' HB3' HG23 ' A' ' 217' ' ' THR . 0.5 OUTLIER -89.14 -59.87 2.11 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.87 0.366 . . . . 0.0 110.033 179.581 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 1.3 m -151.32 159.08 44.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.87 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.674 HD11 ' O ' ' A' ' 175' ' ' ILE . 0.2 OUTLIER -127.54 122.86 34.4 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 121.435 0.636 . . . . 0.0 112.093 -179.388 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 199' ' ' LYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 13.2 mtmm -150.61 118.15 6.11 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.96 179.11 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 7.5 ttp180 . . . . . 0 C--N 1.324 -0.503 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.309 -179.592 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 204' ' ' ASP . . . . . 0.428 ' HA ' ' HA ' ' A' ' 199' ' ' LYS . 9.8 t70 . . . . . 0 N--CA 1.453 -0.287 0 CA-C-O 121.049 0.452 . . . . 0.0 110.209 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.482 HG23 ' CD2' ' A' ' 198' ' ' LEU . 32.6 m -57.71 158.62 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.961 0 CA-C-O 121.511 0.672 . . . . 0.0 112.179 -179.162 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 206' ' ' ARG . . . . . 0.426 ' O ' ' HA ' ' A' ' 176' ' ' THR . 1.7 ttp180 -89.44 -35.36 16.05 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 114.769 -1.105 . . . . 0.0 112.225 -178.608 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.48 ' HB3' HG22 ' A' ' 176' ' ' THR . 0.3 OUTLIER -140.11 177.55 7.9 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.343 0.592 . . . . 0.0 111.898 -179.456 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.74 ' O ' HG21 ' A' ' 170' ' ' VAL . 0.0 OUTLIER -151.07 77.86 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.167 178.517 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.618 ' HB2' ' HG2' ' A' ' 174' ' ' LYS . . . -98.55 174.35 6.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.168 0.508 . . . . 0.0 112.366 -178.582 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 81.75 -70.08 0.07 Allowed 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.867 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 178.2 37.23 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 120.431 -0.89 . . . . 0.0 112.248 179.034 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' TYR . . . . . 0.648 ' HB3' HG12 ' A' ' 208' ' ' VAL . 1.2 m-85 -104.11 140.49 37.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.966 0.412 . . . . 0.0 111.215 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -95.48 148.61 22.3 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.404 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 214' ' ' CYS . . . . . 0.519 ' HB3' HG21 ' A' ' 208' ' ' VAL . 45.5 t -150.51 146.14 26.42 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.371 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -88.11 112.49 3.89 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.943 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.656 HD12 HD11 ' A' ' 218' ' ' ILE . 0.3 OUTLIER -138.56 143.3 39.36 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 120.864 0.364 . . . . 0.0 111.149 -179.139 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 217' ' ' THR . . . . . 0.629 HG23 ' HB3' ' A' ' 196' ' ' ASP . 0.2 OUTLIER -83.48 142.42 30.95 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 177.951 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 218' ' ' ILE . . . . . 0.656 HD11 HD12 ' A' ' 216' ' ' LEU . 1.6 mp -106.84 92.36 2.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 -178.494 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 2.5 tttp 45.77 -146.98 0.13 Allowed 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.511 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 -87.54 62.46 7.11 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-O 120.857 0.36 . . . . 0.0 110.984 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' PHE . . . . . 0.762 ' CZ ' HD22 ' A' ' 183' ' ' LEU . 0.1 OUTLIER -54.71 119.86 5.93 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 179.31 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -84.19 -47.6 10.67 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 114.771 -1.104 . . . . 0.0 108.368 176.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 223' ' ' ASP . . . . . 0.527 ' OD2' HG12 ' A' ' 190' ' ' VAL . 0.0 OUTLIER -84.78 130.27 34.7 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 178.026 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.876 HD13 ' CB ' ' A' ' 158' ' ' LYS . 1.2 pt -126.46 176.48 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -179.297 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.815 ' HG2' HD12 ' A' ' 224' ' ' ILE . 0.0 OUTLIER 61.12 129.47 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.102 -179.057 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 226' ' ' GLU . . . . . 0.489 ' HA ' ' CG1' ' A' ' 153' ' ' VAL . 3.6 tt0 -11.67 77.97 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 124.249 1.02 . . . . 0.0 113.341 -179.236 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 227' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 225' ' ' LYS . . . -98.26 -40.16 3.55 Favored Glycine 0 N--CA 1.43 -1.759 0 CA-C-N 114.564 -1.198 . . . . 0.0 112.626 -178.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.793 ' CB ' HG21 ' A' ' 190' ' ' VAL . 2.7 p30 -159.03 -160.98 0.9 Allowed 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 115.375 1.62 . . . . 0.0 115.375 -177.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 229' ' ' VAL . . . . . 0.475 HG13 ' O ' ' A' ' 151' ' ' ALA . 91.9 t -108.3 143.88 17.9 Favored 'Isoleucine or valine' 0 C--N 1.343 0.292 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 177.542 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 3.7 mp -111.43 153.32 13.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.252 0.548 . . . . 0.0 112.097 -178.216 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 231' ' ' GLU . . . . . 0.462 ' HA ' ' HA ' ' A' ' 150' ' ' GLN . 15.1 tt0 -141.05 111.32 6.75 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.437 0.637 . . . . 0.0 111.598 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.569 ' HB3' ' CA ' ' A' ' 149' ' ' GLY . . . -87.34 134.21 33.6 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.412 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -138.58 139.27 38.56 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.081 -178.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.601 ' O ' HG21 ' A' ' 148' ' ' ILE . 0.5 OUTLIER . . . . . 0 CA--C 1.534 0.355 0 CA-C-O 120.938 0.399 . . . . 0.0 111.881 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 6.3 tptt . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.762 0.315 . . . . 0.0 110.776 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.675 HG11 ' HB2' ' A' ' 150' ' ' GLN . 5.8 t -61.0 141.0 17.93 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.683 0 CA-C-O 121.294 0.569 . . . . 0.0 111.181 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 1.013 HG21 HG12 ' A' ' 234' ' ' VAL . 0.1 OUTLIER -123.56 -5.65 7.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.871 178.095 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 149' ' ' GLY . . . . . 0.465 ' O ' ' HB3' ' A' ' 232' ' ' ALA . . . -174.38 74.41 0.08 OUTLIER Glycine 0 C--N 1.342 0.869 0 N-CA-C 111.683 -0.567 . . . . 0.0 111.683 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.675 ' HB2' HG11 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -89.49 136.11 33.22 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 179.591 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.498 ' HB1' ' HB2' ' A' ' 168' ' ' CYS . . . -151.93 173.2 15.12 Favored 'General case' 0 N--CA 1.435 -1.176 0 C-N-CA 120.009 -0.677 . . . . 0.0 112.478 -178.099 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.699 ' HG2' HG22 ' A' ' 229' ' ' VAL . 3.8 mt-10 -122.32 121.1 35.94 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.081 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.447 ' CG1' ' HA ' ' A' ' 226' ' ' GLU . 2.2 p -49.71 132.55 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -178.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -90.17 -61.56 1.66 Allowed 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 104.941 -2.244 . . . . 0.0 104.941 175.399 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.48 ' HA ' ' H ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER -162.28 -163.49 0.93 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 113.76 -1.563 . . . . 0.0 109.405 174.902 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.565 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 6.9 p -145.42 156.97 44.09 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 120.845 0.355 . . . . 0.0 110.079 177.248 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.685 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 2.4 m-85 -103.98 73.22 1.14 Allowed 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -177.566 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.95 63.93 8.31 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.585 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 88.2 t -91.4 157.87 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 CA-C-N 113.611 -1.631 . . . . 0.0 110.075 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 3.8 t -92.67 34.4 1.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.145 0.498 . . . . 0.0 109.784 178.256 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -151.45 -33.03 0.15 Allowed 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.445 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.508 HG12 ' N ' ' A' ' 163' ' ' GLY . 90.4 t -100.07 -101.95 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.169 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 -179.543 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' GLY . . . . . 0.508 ' N ' HG12 ' A' ' 162' ' ' VAL . . . -158.74 -103.69 0.2 Allowed Glycine 0 N--CA 1.451 -0.366 0 N-CA-C 111.706 -0.558 . . . . 0.0 111.706 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.515 ' CG2' HG21 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -153.63 34.82 0.45 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 114.406 -0.897 . . . . 0.0 108.932 178.483 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.685 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 2.9 mm -42.88 95.44 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.496 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.565 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . -86.19 119.17 26.18 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.706 -1.133 . . . . 0.0 111.247 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -87.95 150.63 22.37 Favored Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 178.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.675 ' SG ' HD11 ' A' ' 216' ' ' LEU . 0.0 OUTLIER -148.25 136.43 21.19 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 117.364 0.582 . . . . 0.0 111.102 -178.236 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 169' ' ' TYR . . . . . 0.42 ' O ' ' HA ' ' A' ' 151' ' ' ALA . 5.9 t80 -87.66 129.96 34.96 Favored 'General case' 0 C--O 1.221 -0.402 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 177.475 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.795 HG21 ' O ' ' A' ' 208' ' ' VAL . 38.3 t -85.67 145.09 8.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -176.302 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.2 p -138.25 13.18 2.82 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 114.788 -1.096 . . . . 0.0 112.164 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.408 ' CB ' ' HB2' ' A' ' 150' ' ' GLN . 10.4 t0 -149.98 -141.04 0.1 Allowed 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -48.67 -109.59 0.01 OUTLIER Glycine 0 CA--C 1.531 1.033 0 N-CA-C 114.527 0.571 . . . . 0.0 114.527 -179.091 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.659 ' HG2' ' HB2' ' A' ' 209' ' ' ALA . 5.6 mtmt -150.59 138.84 20.29 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 122.397 -0.472 . . . . 0.0 110.603 -179.102 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.431 HG23 ' O ' ' A' ' 175' ' ' ILE . 0.5 OUTLIER -94.38 112.29 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 C-N-CA 119.528 -0.869 . . . . 0.0 109.536 177.439 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.504 ' HB ' ' O ' ' A' ' 206' ' ' ARG . 0.2 OUTLIER -120.36 173.05 7.38 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.654 0.74 . . . . 0.0 112.99 -177.009 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.02 -43.67 86.93 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 114.521 -1.218 . . . . 0.0 109.95 178.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -89.25 56.5 3.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.696 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' SER . . . . . 0.469 ' OG ' HG23 ' A' ' 176' ' ' THR . 5.4 m -150.33 161.39 42.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.86 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 7.6 tptt -89.32 177.62 6.55 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.036 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.782 HG21 HD12 ' A' ' 218' ' ' ILE . 1.5 m -146.13 146.9 18.73 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.548 0 CA-C-O 121.347 0.594 . . . . 0.0 111.04 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' ARG . . . . . 0.551 ' HD2' HD11 ' A' ' 184' ' ' ILE . 5.2 ttm-85 -155.37 99.34 2.05 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.177 -0.92 . . . . 0.0 112.539 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.625 ' C ' HD12 ' A' ' 184' ' ' ILE . 0.3 OUTLIER -97.51 166.59 11.45 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 120.186 -0.606 . . . . 0.0 110.908 179.302 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.756 HG23 ' O ' ' A' ' 188' ' ' ILE . 4.4 mp -151.87 140.08 14.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.143 -0.48 . . . . 0.0 112.057 -177.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.798 ' NH2' HG13 ' A' ' 190' ' ' VAL . 5.2 ptp180 -87.08 -152.67 0.19 Allowed 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.371 -0.832 . . . . 0.0 108.906 178.17 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -94.64 29.04 2.42 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 118.19 0.45 . . . . 0.0 111.489 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.61 ' C ' HD13 ' A' ' 188' ' ' ILE . . . -153.23 -76.12 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.39 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.756 ' O ' HG23 ' A' ' 184' ' ' ILE . 0.2 OUTLIER -117.9 -155.86 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 115.373 -0.414 . . . . 0.0 110.216 -179.522 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.714 HG11 ' CG ' ' A' ' 192' ' ' GLU . 35.1 t -85.95 139.53 17.26 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 CA-C-O 121.573 0.701 . . . . 0.0 110.758 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.831 HG12 ' OD2' ' A' ' 223' ' ' ASP . 0.7 OUTLIER -87.41 -40.76 14.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 114.693 -1.14 . . . . 0.0 108.409 179.898 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 191' ' ' TYR . . . . . 0.453 ' CE2' ' O ' ' A' ' 220' ' ' ASN . 0.6 OUTLIER -171.91 150.21 2.56 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.606 -1.179 . . . . 0.0 111.131 179.322 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 192' ' ' GLU . . . . . 0.714 ' CG ' HG11 ' A' ' 189' ' ' VAL . 32.3 mt-10 -135.53 164.45 27.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.081 0.467 . . . . 0.0 111.19 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 135.87 -160.26 24.52 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' GLU . . . . . 0.541 ' O ' HG23 ' A' ' 218' ' ' ILE . 3.3 pt-20 -108.69 -178.1 3.5 Favored 'General case' 0 CA--C 1.498 -1.052 0 CA-C-N 117.656 0.728 . . . . 0.0 110.723 179.297 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.934 ' CD1' HD13 ' A' ' 216' ' ' LEU . 0.1 OUTLIER -88.39 148.92 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.881 -177.977 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -88.92 -54.94 3.9 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -151.47 152.86 33.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.088 179.065 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.717 HD22 ' HB3' ' A' ' 216' ' ' LEU . 0.2 OUTLIER -122.01 103.42 8.8 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.882 179.872 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 199' ' ' LYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 0.1 OUTLIER -135.96 122.72 21.11 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.428 179.618 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.323 -0.567 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.096 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' ASP . . . . . 0.401 ' HA ' ' HA ' ' A' ' 199' ' ' LYS . 17.4 m-20 . . . . . 0 N--CA 1.453 -0.316 0 CA-C-O 120.97 0.414 . . . . 0.0 110.37 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 35.5 m -62.29 165.23 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.063 0 CA-C-O 121.538 0.685 . . . . 0.0 112.088 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' ARG . . . . . 0.504 ' O ' ' HB ' ' A' ' 176' ' ' THR . 1.6 ttm180 -89.18 -41.7 12.09 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-N 114.726 -1.125 . . . . 0.0 111.368 -178.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -136.2 178.6 6.94 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.249 0.547 . . . . 0.0 111.963 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.795 ' O ' HG21 ' A' ' 170' ' ' VAL . 0.2 OUTLIER -150.96 94.67 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.701 179.108 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.659 ' HB2' ' HG2' ' A' ' 174' ' ' LYS . . . -118.27 178.09 4.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.215 0.531 . . . . 0.0 112.36 -178.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 80.91 -71.8 0.07 Allowed 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.794 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 178.62 37.31 0.06 OUTLIER Glycine 0 N--CA 1.442 -0.933 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.2 179.083 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -104.48 139.11 39.87 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.962 0.41 . . . . 0.0 111.089 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.74 150.92 22.09 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.039 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 214' ' ' CYS . . . . . 0.51 ' CB ' HG21 ' A' ' 208' ' ' VAL . 7.5 t -150.15 146.13 26.71 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.679 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -89.1 115.41 4.47 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.043 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.934 HD13 ' CD1' ' A' ' 195' ' ' ILE . 0.3 OUTLIER -132.18 141.48 49.1 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 120.975 0.417 . . . . 0.0 110.742 -179.827 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 217' ' ' THR . . . . . 0.512 ' OG1' HD13 ' A' ' 165' ' ' ILE . 1.6 m -105.67 140.08 39.29 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 177.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 218' ' ' ILE . . . . . 0.782 HD12 HG21 ' A' ' 181' ' ' VAL . 18.9 mm -89.19 144.32 9.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 120.449 -0.5 . . . . 0.0 109.747 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.78 -10.74 4.11 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -176.504 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 220' ' ' ASN . . . . . 0.453 ' O ' ' CE2' ' A' ' 191' ' ' TYR . 58.2 t30 -153.23 21.1 0.56 Allowed 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 221' ' ' PHE . . . . . 0.485 ' HB2' ' HB ' ' A' ' 218' ' ' ILE . 0.1 OUTLIER -57.95 123.76 16.93 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 -179.681 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 222' ' ' ASN . . . . . 0.401 ' HB2' ' CE1' ' A' ' 191' ' ' TYR . 2.3 t-20 -96.59 -47.76 5.8 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 114.347 -1.297 . . . . 0.0 108.367 176.452 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 223' ' ' ASP . . . . . 0.831 ' OD2' HG12 ' A' ' 190' ' ' VAL . 0.0 OUTLIER -75.66 150.25 37.98 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.095 177.422 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.644 HD13 ' N ' ' A' ' 224' ' ' ILE . 0.2 OUTLIER -143.14 177.78 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -179.209 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.424 ' O ' ' C ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER 56.56 116.25 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 114.443 -1.253 . . . . 0.0 110.073 -179.046 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 226' ' ' GLU . . . . . 0.48 ' H ' ' HA ' ' A' ' 155' ' ' GLN . 3.2 tt0 8.78 63.88 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.523 1.129 . . . . 0.0 113.517 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -61.61 -65.48 3.22 Favored Glycine 0 N--CA 1.432 -1.613 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.4 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.439 ' O ' HG12 ' A' ' 153' ' ' VAL . 0.9 OUTLIER -165.38 -147.48 0.1 Allowed 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 114.236 1.199 . . . . 0.0 114.236 179.381 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 229' ' ' VAL . . . . . 0.699 HG22 ' HG2' ' A' ' 152' ' ' GLU . 91.7 t -89.17 135.09 26.75 Favored 'Isoleucine or valine' 0 C--N 1.346 0.437 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 230' ' ' ILE . . . . . 0.495 ' HA ' ' HA ' ' A' ' 183' ' ' LEU . 2.7 mp -102.93 159.04 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 O-C-N 123.378 0.424 . . . . 0.0 110.859 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 231' ' ' GLU . . . . . 0.46 ' O ' ' N ' ' A' ' 182' ' ' ARG . 5.7 tt0 -149.46 108.43 3.89 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.274 0.559 . . . . 0.0 112.348 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.499 ' O ' HD13 ' A' ' 148' ' ' ILE . . . -87.56 131.67 34.31 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.022 179.149 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 233' ' ' TYR . . . . . 0.539 ' C ' HD12 ' A' ' 148' ' ' ILE . 4.6 p90 -134.33 163.46 29.6 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.577 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 1.013 HG12 HG21 ' A' ' 148' ' ' ILE . 1.9 p . . . . . 0 CA--C 1.536 0.412 0 CA-C-O 120.77 0.319 . . . . 0.0 111.489 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.472 0.649 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.572 HG11 ' HG3' ' A' ' 150' ' ' GLN . 29.1 t -89.45 138.44 19.29 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.732 0 CA-C-O 121.287 0.565 . . . . 0.0 110.193 178.217 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.508 HG23 ' HB1' ' A' ' 232' ' ' ALA . 3.7 tp -121.5 -14.96 7.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.257 177.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' GLY . . . . . 0.5 ' O ' ' HB3' ' A' ' 232' ' ' ALA . . . 165.11 88.56 0.07 OUTLIER Glycine 0 C--N 1.345 1.071 0 C-N-CA 120.131 -1.033 . . . . 0.0 112.864 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.572 ' HG3' HG11 ' A' ' 147' ' ' VAL . 3.0 mt-30 -90.05 142.22 27.91 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.441 ' CB ' ' HB2' ' A' ' 168' ' ' CYS . . . -150.93 174.99 12.47 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 120.107 -0.637 . . . . 0.0 112.148 -179.301 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.826 ' CG ' HG22 ' A' ' 229' ' ' VAL . 0.0 OUTLIER -120.42 123.72 43.72 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.054 179.81 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.7 ' HB ' HD11 ' A' ' 230' ' ' ILE . 2.4 p -55.79 127.77 15.14 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 CA-C-O 121.377 0.608 . . . . 0.0 111.522 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.416 ' CA ' ' NE ' ' A' ' 154' ' ' ARG . 0.0 OUTLIER -89.56 -57.49 2.86 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 105.025 -2.213 . . . . 0.0 105.025 176.209 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.433 ' HA ' ' H ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER -162.76 -163.61 0.9 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.257 -1.338 . . . . 0.0 110.262 174.735 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.597 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 16.7 p -144.42 158.92 43.51 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 177.567 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.657 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 2.4 m-85 -99.98 76.08 1.91 Allowed 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -176.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 7.7 tttt -85.93 63.58 8.11 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 122.071 0.938 . . . . 0.0 108.809 178.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.455 HG12 ' N ' ' A' ' 161' ' ' LYS . 55.0 t -89.89 155.53 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 CA-C-N 113.77 -1.559 . . . . 0.0 109.867 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 3.9 t -90.7 33.58 0.92 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.126 0.489 . . . . 0.0 110.153 178.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.455 ' N ' HG12 ' A' ' 159' ' ' VAL . 3.6 mttt -151.02 -29.67 0.19 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.712 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.489 HG12 ' N ' ' A' ' 163' ' ' GLY . 88.2 t -103.19 -101.79 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 O-C-N 122.195 -0.316 . . . . 0.0 110.275 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' GLY . . . . . 0.489 ' N ' HG12 ' A' ' 162' ' ' VAL . . . -158.5 -103.39 0.19 Allowed Glycine 0 N--CA 1.451 -0.363 0 N-CA-C 111.661 -0.576 . . . . 0.0 111.661 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' THR . . . . . 1.048 HG21 HG21 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -153.14 36.24 0.48 Allowed 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 114.362 -0.919 . . . . 0.0 108.968 178.458 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.657 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 4.9 mt -42.55 101.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.925 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.597 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . -83.62 121.88 27.85 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.004 -0.998 . . . . 0.0 112.871 -178.62 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -89.1 136.08 13.38 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 178.018 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.664 ' HB3' HD13 ' A' ' 230' ' ' ILE . 0.0 OUTLIER -138.14 131.49 30.52 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.898 0.349 . . . . 0.0 110.531 -178.523 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 169' ' ' TYR . . . . . 0.425 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 5.7 t80 -85.94 126.42 34.09 Favored 'General case' 0 C--O 1.219 -0.502 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 178.212 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.578 HG21 ' O ' ' A' ' 208' ' ' VAL . 45.3 t -85.22 145.37 8.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -175.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -133.9 10.52 3.93 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 114.646 -1.161 . . . . 0.0 112.337 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.428 ' O ' ' O ' ' A' ' 173' ' ' GLY . 3.0 t70 -150.12 -145.76 0.18 Allowed 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 118.91 -0.567 . . . . 0.0 109.613 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 172' ' ' ASP . . . -37.68 -108.11 0.0 OUTLIER Glycine 0 CA--C 1.537 1.444 0 N-CA-C 115.338 0.895 . . . . 0.0 115.338 -179.003 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.795 ' HG2' ' HB2' ' A' ' 209' ' ' ALA . 1.7 mtmm -151.51 135.52 16.58 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 122.311 -0.523 . . . . 0.0 111.84 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.624 ' HB ' HG23 ' A' ' 208' ' ' VAL . 2.6 mm -88.44 86.9 2.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 177.314 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.87 ' O ' HD13 ' A' ' 195' ' ' ILE . 0.0 OUTLIER -98.26 170.41 8.9 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.17 -177.767 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -69.02 -39.41 79.26 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.269 179.333 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -89.29 51.85 2.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.97 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' SER . . . . . 0.842 ' O ' HD12 ' A' ' 195' ' ' ILE . 0.7 OUTLIER -142.94 159.49 42.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.75 179.795 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 2.8 mptp? -89.6 177.71 6.47 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.611 HG22 ' CA ' ' A' ' 194' ' ' GLU . 2.8 m -149.43 148.69 15.4 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.509 0 CA-C-O 121.535 0.683 . . . . 0.0 112.237 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 231' ' ' GLU . 23.0 ttp180 -153.83 102.45 2.52 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.671 -1.15 . . . . 0.0 111.678 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.616 ' C ' HD12 ' A' ' 184' ' ' ILE . 0.3 OUTLIER -98.16 169.13 9.81 Favored 'General case' 0 N--CA 1.438 -1.064 0 C-N-CA 120.564 -0.455 . . . . 0.0 111.246 179.869 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.738 HG23 ' O ' ' A' ' 188' ' ' ILE . 4.0 mp -151.01 139.83 14.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.048 -178.147 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.516 ' N ' HG22 ' A' ' 190' ' ' VAL . 0.0 OUTLIER -88.04 -150.73 0.18 Allowed 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.156 -0.929 . . . . 0.0 108.749 178.241 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -94.72 27.75 2.94 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 118.461 0.573 . . . . 0.0 111.454 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -153.11 -77.78 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.688 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.738 ' O ' HG23 ' A' ' 184' ' ' ILE . 0.5 OUTLIER -116.69 -154.34 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-N 115.514 -0.343 . . . . 0.0 110.43 -179.292 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.694 HG11 ' CG ' ' A' ' 192' ' ' GLU . 23.0 t -85.67 138.45 19.05 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 CA-C-O 121.517 0.675 . . . . 0.0 110.803 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.88 HG12 ' OD2' ' A' ' 223' ' ' ASP . 0.7 OUTLIER -87.86 -39.24 12.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 114.739 -1.119 . . . . 0.0 109.0 -179.86 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 191' ' ' TYR . . . . . 0.477 ' HB2' ' CE1' ' A' ' 221' ' ' PHE . 1.0 OUTLIER -172.17 157.67 4.32 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.63 -1.168 . . . . 0.0 110.411 -179.935 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 192' ' ' GLU . . . . . 0.694 ' CG ' HG11 ' A' ' 189' ' ' VAL . 34.1 mt-10 -144.79 157.16 44.28 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.205 0.526 . . . . 0.0 111.182 179.538 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 148.9 -129.82 3.19 Favored Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.524 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' GLU . . . . . 0.611 ' CA ' HG22 ' A' ' 181' ' ' VAL . 12.7 pt-20 -138.97 -175.78 4.27 Favored 'General case' 0 CA--C 1.497 -1.061 0 CA-C-O 121.292 0.567 . . . . 0.0 111.584 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.87 HD13 ' O ' ' A' ' 176' ' ' THR . 3.0 mp -88.13 143.35 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.379 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.405 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 196' ' ' ASP . . . . . 0.407 ' CB ' ' HB ' ' A' ' 217' ' ' THR . 0.6 OUTLIER -89.02 -56.92 3.09 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.164 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 3.0 m -151.61 150.54 30.4 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.942 179.032 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.428 HD21 ' HB3' ' A' ' 214' ' ' CYS . 1.3 tt -120.56 111.56 17.82 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 121.379 0.609 . . . . 0.0 111.169 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 199' ' ' LYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 62.2 mttt -150.62 122.55 8.17 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.286 179.146 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.602 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.509 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' ASP . . . . . 0.402 ' HA ' ' HA ' ' A' ' 199' ' ' LYS . 9.6 p-10 . . . . . 0 N--CA 1.454 -0.27 0 CA-C-O 120.725 0.298 . . . . 0.0 110.652 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 33.9 m -82.87 163.82 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.916 0 CA-C-O 121.481 0.658 . . . . 0.0 112.152 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 206' ' ' ARG . . . . . 0.474 ' O ' ' HB ' ' A' ' 176' ' ' THR . 0.2 OUTLIER -89.11 -36.79 15.53 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.939 -178.53 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.69 ' HB3' HG22 ' A' ' 176' ' ' THR . 1.9 mp0 -141.73 -178.08 5.49 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.343 0.592 . . . . 0.0 111.993 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.624 HG23 ' HB ' ' A' ' 175' ' ' ILE . 0.1 OUTLIER -151.08 91.73 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.681 178.946 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.795 ' HB2' ' HG2' ' A' ' 174' ' ' LYS . . . -112.89 165.87 11.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.022 0.439 . . . . 0.0 112.028 -179.079 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 34.1 tp60 82.26 -69.36 0.07 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.035 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 178.41 37.78 0.06 OUTLIER Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.355 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -97.45 136.05 38.45 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.863 0.363 . . . . 0.0 111.199 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -91.54 146.48 23.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.349 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 214' ' ' CYS . . . . . 0.428 ' HB3' HD21 ' A' ' 198' ' ' LEU . 1.8 m -150.95 142.7 23.74 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.532 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 215' ' ' GLY . . . . . 0.55 ' C ' HG23 ' A' ' 165' ' ' ILE . . . -89.64 103.77 3.04 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.608 -0.806 . . . . 0.0 111.978 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.526 HD12 ' CD1' ' A' ' 218' ' ' ILE . 0.4 OUTLIER -128.86 143.16 50.83 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.078 0.466 . . . . 0.0 111.467 -179.576 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 217' ' ' THR . . . . . 0.407 ' HB ' ' CB ' ' A' ' 196' ' ' ASP . 1.2 m -83.93 143.49 29.81 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 177.343 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 218' ' ' ILE . . . . . 0.599 HG22 ' O ' ' A' ' 218' ' ' ILE . 1.5 mp -106.16 92.09 2.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.943 0.401 . . . . 0.0 110.247 -178.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 4.3 tttp 45.06 -144.24 0.17 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.894 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -87.18 61.33 6.66 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 121.024 0.44 . . . . 0.0 110.817 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' PHE . . . . . 0.477 ' CE1' ' HB2' ' A' ' 191' ' ' TYR . 0.1 OUTLIER -55.92 120.62 7.7 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 114.722 1.379 . . . . 0.0 114.722 179.128 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 21.4 t30 -82.32 -48.55 11.05 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 114.815 -1.084 . . . . 0.0 108.346 176.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 223' ' ' ASP . . . . . 0.88 ' OD2' HG12 ' A' ' 190' ' ' VAL . 0.0 OUTLIER -82.01 137.88 35.0 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 177.668 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 1.048 HG21 HG21 ' A' ' 164' ' ' THR . 0.2 OUTLIER -133.85 179.13 4.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -178.951 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.407 ' O ' ' C ' ' A' ' 226' ' ' GLU . 0.1 OUTLIER 57.09 117.28 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.107 -179.114 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 226' ' ' GLU . . . . . 0.433 ' H ' ' HA ' ' A' ' 155' ' ' GLN . 38.9 tt0 7.71 63.28 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 124.484 1.114 . . . . 0.0 113.758 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 227' ' ' GLY . . . . . 0.457 ' N ' HG11 ' A' ' 153' ' ' VAL . . . -63.49 -66.43 2.54 Favored Glycine 0 N--CA 1.431 -1.655 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.932 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.464 ' O ' HG12 ' A' ' 153' ' ' VAL . 0.7 OUTLIER -164.17 -150.2 0.14 Allowed 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 179.888 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 229' ' ' VAL . . . . . 0.826 HG22 ' CG ' ' A' ' 152' ' ' GLU . 69.2 t -88.49 130.68 37.59 Favored 'Isoleucine or valine' 0 C--N 1.345 0.38 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.208 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 230' ' ' ILE . . . . . 0.7 HD11 ' HB ' ' A' ' 153' ' ' VAL . 5.1 mp -100.37 157.72 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 O-C-N 123.618 0.574 . . . . 0.0 110.961 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 231' ' ' GLU . . . . . 0.453 ' HA ' ' HA ' ' A' ' 150' ' ' GLN . 33.6 tt0 -146.94 112.32 5.55 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 120.246 -0.582 . . . . 0.0 112.427 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.508 ' HB1' HG23 ' A' ' 148' ' ' ILE . . . -88.18 133.91 33.91 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.008 179.268 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 233' ' ' TYR . . . . . 0.405 ' O ' ' CG2' ' A' ' 234' ' ' VAL . 2.9 p90 -136.04 120.3 17.88 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.803 -178.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.405 ' CG2' ' O ' ' A' ' 233' ' ' TYR . 62.6 t . . . . . 0 N--CA 1.464 0.229 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.863 179.347 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.517 ' HG3' HG23 ' A' ' 147' ' ' VAL . 3.8 tppp? . . . . . 0 CA--C 1.529 0.169 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.517 HG23 ' HG3' ' A' ' 146' ' ' LYS . 6.7 t -99.5 140.71 18.23 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.758 0 CA-C-O 121.245 0.545 . . . . 0.0 110.699 179.161 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.472 HD13 ' N ' ' A' ' 149' ' ' GLY . 0.0 OUTLIER -131.33 -2.32 2.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.009 178.784 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 149' ' ' GLY . . . . . 0.539 ' CA ' ' HB3' ' A' ' 232' ' ' ALA . . . -178.43 73.59 0.07 OUTLIER Glycine 0 C--N 1.342 0.889 0 C-N-CA 120.81 -0.71 . . . . 0.0 111.931 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.474 ' HB2' HG11 ' A' ' 147' ' ' VAL . 0.4 OUTLIER -91.67 134.77 34.41 Favored 'General case' 0 CA--C 1.505 -0.769 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.749 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.467 ' HB1' ' O ' ' A' ' 169' ' ' TYR . . . -151.62 175.03 12.76 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-O 121.52 0.676 . . . . 0.0 112.511 -178.186 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.738 ' HG2' HG22 ' A' ' 229' ' ' VAL . 2.4 mt-10 -120.37 127.02 51.91 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.107 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.713 ' HB ' HD11 ' A' ' 230' ' ' ILE . 2.6 p -57.68 128.22 17.92 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.354 0 CA-C-O 121.643 0.735 . . . . 0.0 111.887 -179.067 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.408 ' HD3' ' HB2' ' A' ' 169' ' ' TYR . 0.0 OUTLIER -90.17 -57.25 2.91 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 104.789 -2.3 . . . . 0.0 104.789 175.617 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.426 ' HA ' ' H ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER -163.3 -166.16 1.2 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.094 -1.412 . . . . 0.0 110.363 174.742 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.548 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 18.8 p -151.17 149.88 29.97 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.191 177.466 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.616 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 5.8 m-30 -94.83 72.11 3.51 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -178.416 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? -86.48 61.4 6.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.894 0.854 . . . . 0.0 108.924 178.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.405 HG12 ' H ' ' A' ' 161' ' ' LYS . 49.0 t -89.77 155.59 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-N 114.095 -1.411 . . . . 0.0 109.789 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.75 22.01 3.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.905 0.383 . . . . 0.0 111.177 178.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.405 ' H ' HG12 ' A' ' 159' ' ' VAL . 6.5 mttt -150.9 6.98 0.53 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.982 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 58.4 t -130.81 -99.6 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 CA-C-N 118.374 0.534 . . . . 0.0 110.017 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -158.46 -112.76 0.34 Allowed Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.494 HG22 ' CG2' ' A' ' 224' ' ' ILE . 0.0 OUTLIER -153.7 32.08 0.45 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.401 -0.899 . . . . 0.0 109.18 178.173 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.616 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 1.9 mm -41.09 94.32 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.473 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.604 ' HB3' HD13 ' A' ' 218' ' ' ILE . . . -86.48 113.93 22.81 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.689 -1.141 . . . . 0.0 111.993 -179.138 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -88.3 126.38 8.08 Favored Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 178.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.808 ' HB3' HD13 ' A' ' 230' ' ' ILE . 0.0 OUTLIER -129.79 134.48 47.6 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.83 0.315 . . . . 0.0 110.471 -178.088 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 169' ' ' TYR . . . . . 0.467 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 15.0 t80 -86.27 130.34 34.55 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.081 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.715 HG21 ' O ' ' A' ' 208' ' ' VAL . 42.3 t -85.78 148.57 4.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 113.404 0.891 . . . . 0.0 113.404 -175.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -141.87 15.79 2.12 Favored 'General case' 0 CA--C 1.527 0.076 0 CA-C-N 114.562 -1.199 . . . . 0.0 111.898 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.412 ' H ' HG12 ' A' ' 170' ' ' VAL . 6.6 t0 -150.24 -142.64 0.12 Allowed 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 -179.462 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -45.73 -109.89 0.01 OUTLIER Glycine 0 CA--C 1.533 1.193 0 N-CA-C 115.009 0.764 . . . . 0.0 115.009 -178.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.67 ' HG2' ' HB2' ' A' ' 209' ' ' ALA . 3.8 mttm -151.13 127.01 10.32 Favored 'General case' 0 CA--C 1.512 -0.496 0 O-C-N 122.451 -0.441 . . . . 0.0 111.107 -178.729 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.589 HD12 ' HB2' ' A' ' 232' ' ' ALA . 0.5 OUTLIER -89.03 113.85 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 C-N-CA 119.199 -1.0 . . . . 0.0 109.431 177.811 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.891 ' O ' HD13 ' A' ' 195' ' ' ILE . 0.1 OUTLIER -124.97 169.26 12.27 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.95 -177.376 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.402 ' HG3' ' HB2' ' A' ' 198' ' ' LEU . 0.2 OUTLIER -61.34 -38.74 88.01 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.299 179.414 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -89.28 52.74 2.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.156 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' SER . . . . . 0.754 ' O ' HD12 ' A' ' 195' ' ' ILE . 29.4 m -150.46 157.04 42.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.341 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 0.0 OUTLIER -89.35 176.78 6.79 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.553 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.624 HG22 ' CA ' ' A' ' 194' ' ' GLU . 2.5 m -145.65 149.21 16.7 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.579 0 CA-C-O 121.473 0.654 . . . . 0.0 112.203 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 182' ' ' ARG . . . . . 0.436 ' N ' ' O ' ' A' ' 231' ' ' GLU . 26.8 ttm180 -154.36 102.34 2.43 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.851 -1.068 . . . . 0.0 112.236 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.521 ' CB ' ' HA ' ' A' ' 230' ' ' ILE . 0.3 OUTLIER -99.61 170.67 8.42 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-O 120.932 0.396 . . . . 0.0 110.649 179.363 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.683 HG23 ' O ' ' A' ' 188' ' ' ILE . 36.5 mt -155.5 139.94 9.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.855 -178.279 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.494 ' N ' HG22 ' A' ' 190' ' ' VAL . 6.9 ttm-85 -87.33 -152.64 0.2 Allowed 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.9 178.038 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 18.7 mp0 -94.69 28.67 2.57 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 118.141 0.428 . . . . 0.0 111.32 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -152.72 -79.14 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.487 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.683 ' O ' HG23 ' A' ' 184' ' ' ILE . 0.1 OUTLIER -114.4 -157.22 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 115.536 -0.332 . . . . 0.0 110.227 -179.6 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.779 HG11 ' CG ' ' A' ' 192' ' ' GLU . 22.3 t -86.22 139.54 17.22 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 CA-C-O 121.457 0.646 . . . . 0.0 110.739 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.585 HG23 ' CA ' ' A' ' 184' ' ' ILE . 0.4 OUTLIER -87.89 -35.53 8.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.13 -179.93 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 191' ' ' TYR . . . . . 0.475 ' HB2' ' CE1' ' A' ' 221' ' ' PHE . 22.5 t80 -178.54 146.4 0.36 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.901 179.151 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 192' ' ' GLU . . . . . 0.779 ' CG ' HG11 ' A' ' 189' ' ' VAL . 34.7 mt-10 -135.46 158.08 45.27 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.015 0.436 . . . . 0.0 110.858 179.255 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 147.23 -124.6 1.98 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.736 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' GLU . . . . . 0.624 ' CA ' HG22 ' A' ' 181' ' ' VAL . 13.7 pt-20 -144.15 -174.95 4.43 Favored 'General case' 0 CA--C 1.497 -1.087 0 CA-C-O 121.202 0.525 . . . . 0.0 111.437 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.891 HD13 ' O ' ' A' ' 176' ' ' THR . 3.8 mp -87.72 142.92 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.602 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.03 -52.37 5.12 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.343 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 1.2 m -151.47 145.62 25.33 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.724 178.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.529 HD13 ' HA ' ' A' ' 176' ' ' THR . 4.5 tt -124.06 114.15 19.34 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.394 0.616 . . . . 0.0 111.613 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 56.6 mttt -150.17 121.19 7.69 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.096 -0.957 . . . . 0.0 109.86 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.323 -0.573 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.285 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 22.0 p30 . . . . . 0 N--CA 1.451 -0.401 0 CA-C-O 121.088 0.471 . . . . 0.0 110.043 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 33.9 m -55.12 164.02 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.04 0 CA-C-O 121.47 0.652 . . . . 0.0 112.304 -179.253 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' ARG . . . . . 0.498 ' O ' ' HB ' ' A' ' 176' ' ' THR . 1.6 mtm180 -89.44 -41.34 12.14 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-N 114.715 -1.13 . . . . 0.0 111.34 -178.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.533 ' HB3' HG22 ' A' ' 176' ' ' THR . 0.9 OUTLIER -129.72 -178.59 4.76 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.458 0.647 . . . . 0.0 112.37 -179.131 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.715 ' O ' HG21 ' A' ' 170' ' ' VAL . 0.0 OUTLIER -151.17 81.44 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.269 178.631 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.67 ' HB2' ' HG2' ' A' ' 174' ' ' LYS . . . -100.76 171.79 7.47 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -178.483 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 8.9 tm0? 83.49 -72.67 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.016 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 177.93 37.18 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.345 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -98.21 141.61 30.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.925 0.393 . . . . 0.0 111.303 -179.36 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.5 131.15 43.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.339 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 214' ' ' CYS . . . . . 0.461 ' HB3' HG21 ' A' ' 208' ' ' VAL . 52.5 t -133.17 143.96 49.56 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.676 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -88.5 109.62 3.56 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.978 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.55 HD12 ' CD1' ' A' ' 218' ' ' ILE . 0.4 OUTLIER -135.75 141.77 44.88 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 120.924 0.393 . . . . 0.0 111.478 -179.305 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 217' ' ' THR . . . . . 0.46 ' C ' HD12 ' A' ' 218' ' ' ILE . 0.0 OUTLIER -77.43 146.97 36.22 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 177.662 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 218' ' ' ILE . . . . . 0.607 HG22 ' O ' ' A' ' 218' ' ' ILE . 1.6 mp -112.61 87.83 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.144 0.497 . . . . 0.0 109.755 -179.126 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 6.5 tttp 46.71 -144.85 0.26 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.759 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -87.33 61.09 6.45 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 121.009 0.433 . . . . 0.0 111.135 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 221' ' ' PHE . . . . . 0.512 ' CZ ' HD21 ' A' ' 183' ' ' LEU . 0.1 OUTLIER -55.49 121.42 8.97 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 178.973 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 14.4 t30 -88.63 -45.15 10.08 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.483 176.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 223' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 223' ' ' ASP . 0.0 OUTLIER -81.72 134.7 35.48 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.215 177.604 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.634 HD13 ' H ' ' A' ' 224' ' ' ILE . 0.2 OUTLIER -133.82 -179.64 3.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -179.067 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.422 ' O ' ' C ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER 57.07 114.33 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.698 -178.367 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 226' ' ' GLU . . . . . 0.448 ' HA ' ' CG1' ' A' ' 153' ' ' VAL . 3.0 tt0 8.66 64.22 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 124.633 1.173 . . . . 0.0 113.555 -179.686 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 227' ' ' GLY . . . . . 0.413 ' N ' HG11 ' A' ' 153' ' ' VAL . . . -61.48 -66.86 2.39 Favored Glycine 0 N--CA 1.432 -1.59 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.468 179.367 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.458 ' O ' HG12 ' A' ' 153' ' ' VAL . 0.9 OUTLIER -164.9 -147.99 0.11 Allowed 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 179.435 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 229' ' ' VAL . . . . . 0.738 HG22 ' HG2' ' A' ' 152' ' ' GLU . 98.4 t -89.24 132.16 34.69 Favored 'Isoleucine or valine' 0 C--N 1.347 0.462 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 230' ' ' ILE . . . . . 0.808 HD13 ' HB3' ' A' ' 168' ' ' CYS . 4.5 mp -99.2 157.23 3.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 O-C-N 123.499 0.499 . . . . 0.0 111.196 -179.369 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 231' ' ' GLU . . . . . 0.436 ' O ' ' N ' ' A' ' 182' ' ' ARG . 1.9 tm-20 -147.63 110.24 4.68 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 120.159 -0.616 . . . . 0.0 112.633 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.589 ' HB2' HD12 ' A' ' 175' ' ' ILE . . . -87.8 134.39 33.69 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.472 178.699 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 233' ' ' TYR . . . . . 0.724 ' O ' HG23 ' A' ' 234' ' ' VAL . 6.3 p90 -131.58 147.07 52.5 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.935 0.398 . . . . 0.0 111.703 -179.005 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.724 HG23 ' O ' ' A' ' 233' ' ' TYR . 0.9 OUTLIER . . . . . 0 CA--C 1.536 0.41 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.417 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 1.1 tptp . . . . . 0 CA--C 1.53 0.181 0 N-CA-C 110.529 -0.174 . . . . 0.0 110.529 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.707 ' O ' HD13 ' A' ' 148' ' ' ILE . 5.8 t -58.62 142.42 14.32 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 CA-C-O 121.333 0.587 . . . . 0.0 111.381 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.707 HD13 ' O ' ' A' ' 147' ' ' VAL . 11.6 mm -134.41 13.16 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.57 178.201 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' GLY . . . . . 0.719 ' HA3' ' HB3' ' A' ' 232' ' ' ALA . . . 175.46 65.68 0.06 OUTLIER Glycine 0 C--N 1.343 0.945 0 C-N-CA 121.329 -0.462 . . . . 0.0 112.181 179.31 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.682 ' HB2' HG11 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -89.61 131.19 35.74 Favored 'General case' 0 CA--C 1.507 -0.679 0 O-C-N 122.506 -0.408 . . . . 0.0 110.481 179.83 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.413 ' HA ' ' O ' ' A' ' 169' ' ' TYR . . . -152.18 174.21 14.02 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-O 121.42 0.629 . . . . 0.0 112.448 -178.692 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.739 ' HG2' HG22 ' A' ' 229' ' ' VAL . 7.2 mt-10 -120.63 121.73 38.97 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.487 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.499 HG13 ' HG2' ' A' ' 226' ' ' GLU . 3.1 p -51.45 131.07 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.416 ' HD2' ' HB2' ' A' ' 169' ' ' TYR . 5.1 mmp_? -90.07 -59.27 2.24 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 175.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.544 ' HA ' ' H ' ' A' ' 226' ' ' GLU . 0.3 OUTLIER -162.3 -164.32 1.03 Allowed 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 113.75 -1.568 . . . . 0.0 109.751 175.449 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.537 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 7.0 p -150.47 162.51 40.45 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 177.285 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.557 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 0.2 OUTLIER -115.53 78.41 1.17 Allowed 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -179.123 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 8.6 tttm -86.47 62.57 7.5 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 177.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.49 HG12 ' N ' ' A' ' 161' ' ' LYS . 71.3 t -93.04 156.19 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 CA-C-N 113.606 -1.633 . . . . 0.0 110.488 -178.363 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 46.0 p -91.29 34.64 0.94 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.234 0.54 . . . . 0.0 109.71 178.035 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.49 ' N ' HG12 ' A' ' 159' ' ' VAL . 0.1 OUTLIER -150.76 -32.92 0.17 Allowed 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.206 -179.721 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.514 HG12 ' N ' ' A' ' 163' ' ' GLY . 84.3 t -100.67 -103.05 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' GLY . . . . . 0.514 ' N ' HG12 ' A' ' 162' ' ' VAL . . . -159.35 -101.19 0.17 Allowed Glycine 0 N--CA 1.451 -0.353 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 178.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.468 ' CG2' HG21 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -154.14 33.94 0.43 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 114.115 -1.042 . . . . 0.0 108.51 177.812 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.626 HD12 HG23 ' A' ' 217' ' ' THR . 1.5 mp -42.91 95.26 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.522 -179.256 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.537 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . -89.93 120.51 31.21 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.722 -1.126 . . . . 0.0 112.179 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -88.15 148.0 20.55 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 178.286 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.572 ' HB3' HD12 ' A' ' 230' ' ' ILE . 0.0 OUTLIER -147.73 134.64 20.19 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 117.366 0.583 . . . . 0.0 110.694 -178.455 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 169' ' ' TYR . . . . . 0.416 ' HB2' ' HD2' ' A' ' 154' ' ' ARG . 78.4 t80 -86.53 124.47 32.87 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 177.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.665 HG21 ' O ' ' A' ' 208' ' ' VAL . 22.7 t -85.42 144.3 9.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 113.14 0.792 . . . . 0.0 113.14 -176.103 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.1 p -137.2 14.17 3.04 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 114.779 -1.1 . . . . 0.0 112.078 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.41 ' H ' HG12 ' A' ' 170' ' ' VAL . 5.9 t0 -150.56 -144.68 0.16 Allowed 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -40.27 -105.0 0.01 OUTLIER Glycine 0 CA--C 1.533 1.16 0 N-CA-C 115.264 0.865 . . . . 0.0 115.264 -178.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.438 ' HB2' ' HB3' ' A' ' 207' ' ' GLU . 0.0 OUTLIER -150.93 150.9 31.39 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.061 0.458 . . . . 0.0 111.442 -178.416 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.63 HG21 HD11 ' A' ' 216' ' ' LEU . 16.1 mm -103.67 82.72 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 176.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 0.0 OUTLIER -95.58 172.89 7.78 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.78 1.029 . . . . 0.0 113.78 -176.569 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.553 ' HB2' HD22 ' A' ' 198' ' ' LEU . 7.8 ttp180 -69.42 -48.68 60.28 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 114.1 -1.409 . . . . 0.0 110.792 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -89.45 61.61 5.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.28 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 1.8 m -148.3 157.62 43.6 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.343 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.481 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 1.1 mptt -88.56 173.7 8.5 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.628 HG22 ' CA ' ' A' ' 194' ' ' GLU . 2.9 m -142.49 150.35 18.54 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.568 0 CA-C-O 121.483 0.659 . . . . 0.0 112.595 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 182' ' ' ARG . . . . . 0.421 ' N ' ' O ' ' A' ' 231' ' ' GLU . 43.5 ttp180 -154.83 102.09 2.33 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.847 -1.069 . . . . 0.0 112.479 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.517 ' CB ' ' HA ' ' A' ' 230' ' ' ILE . 0.3 OUTLIER -100.56 170.57 8.29 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 120.426 -0.51 . . . . 0.0 111.004 179.235 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.683 HG23 ' O ' ' A' ' 188' ' ' ILE . 26.6 mt -154.18 140.15 11.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -178.173 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.5 ' N ' HG22 ' A' ' 190' ' ' VAL . 1.2 ttt180 -87.17 -154.18 0.24 Allowed 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.012 -0.995 . . . . 0.0 108.774 178.096 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -94.7 28.74 2.54 Favored 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 122.02 -0.425 . . . . 0.0 111.184 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -152.98 -75.81 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.45 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.683 ' O ' HG23 ' A' ' 184' ' ' ILE . 0.5 OUTLIER -117.75 -156.75 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 115.441 -0.379 . . . . 0.0 110.296 -179.359 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.713 HG11 ' CG ' ' A' ' 192' ' ' GLU . 21.3 t -86.48 139.49 17.28 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.393 0 CA-C-O 121.399 0.619 . . . . 0.0 110.916 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.563 HG23 ' CA ' ' A' ' 184' ' ' ILE . 0.3 OUTLIER -88.58 -35.84 8.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.468 -179.841 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 191' ' ' TYR . . . . . 0.466 ' HB2' ' CE1' ' A' ' 221' ' ' PHE . 31.1 t80 -178.34 144.31 0.3 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.997 179.49 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 192' ' ' GLU . . . . . 0.713 ' CG ' HG11 ' A' ' 189' ' ' VAL . 0.3 OUTLIER -131.87 159.03 39.77 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.937 0.398 . . . . 0.0 110.801 179.293 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 146.16 -126.05 2.41 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.852 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' GLU . . . . . 0.628 ' CA ' HG22 ' A' ' 181' ' ' VAL . 11.0 pt-20 -143.07 -176.37 4.89 Favored 'General case' 0 CA--C 1.499 -1.011 0 CA-C-O 121.289 0.566 . . . . 0.0 111.667 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.523 HG12 HG13 ' A' ' 181' ' ' VAL . 12.3 mm -87.42 143.41 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.485 -179.123 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.78 -57.1 3.03 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.07 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 1.2 m -151.59 152.94 33.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.282 178.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.597 HD11 ' C ' ' A' ' 206' ' ' ARG . 0.3 OUTLIER -134.87 119.05 17.62 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.694 0.759 . . . . 0.0 112.014 179.9 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.28 125.31 9.94 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 114.445 -1.252 . . . . 0.0 109.431 178.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 200' ' ' ARG . . . . . 0.639 ' NH1' HG11 ' A' ' 205' ' ' VAL . 1.2 ptp85 . . . . . 0 C--N 1.316 -0.859 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.244 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 . . . . . 0 N--CA 1.452 -0.35 0 CA-C-O 121.243 0.544 . . . . 0.0 110.066 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.639 HG11 ' NH1' ' A' ' 200' ' ' ARG . 35.3 m -56.55 158.16 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.962 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.796 -179.48 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 206' ' ' ARG . . . . . 0.597 ' C ' HD11 ' A' ' 198' ' ' LEU . 2.5 ttp-105 -89.07 -27.82 20.54 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.716 -178.422 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.438 ' HB3' ' HB2' ' A' ' 174' ' ' LYS . 1.5 mp0 -139.99 178.36 7.32 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.092 0.472 . . . . 0.0 111.162 179.15 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.665 ' O ' HG21 ' A' ' 170' ' ' VAL . 0.5 OUTLIER -151.02 75.74 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.854 179.121 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.431 ' HB2' ' HB3' ' A' ' 174' ' ' LYS . . . -97.27 175.18 6.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.081 0.467 . . . . 0.0 112.223 -178.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 83.88 -75.46 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.858 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 178.26 36.89 0.06 OUTLIER Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.372 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -98.32 144.06 28.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.901 0.382 . . . . 0.0 111.171 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.62 131.32 44.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.021 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 214' ' ' CYS . . . . . 0.53 ' HB3' HG21 ' A' ' 208' ' ' VAL . 50.8 t -134.22 149.86 51.01 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.753 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -88.99 116.54 4.69 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.568 -0.825 . . . . 0.0 111.621 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.63 HD11 HG21 ' A' ' 175' ' ' ILE . 0.1 OUTLIER -143.68 145.65 32.61 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 121.113 0.482 . . . . 0.0 111.386 -178.784 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 217' ' ' THR . . . . . 0.626 HG23 HD12 ' A' ' 165' ' ' ILE . 0.0 OUTLIER -86.44 146.48 26.41 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.348 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 218' ' ' ILE . . . . . 0.623 HG23 HG21 ' A' ' 181' ' ' VAL . 1.6 mp -110.36 87.91 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 1.4 tttt 45.93 -144.44 0.23 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.018 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -87.17 62.03 7.06 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 121.097 0.475 . . . . 0.0 111.016 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 221' ' ' PHE . . . . . 0.51 ' CZ ' HD21 ' A' ' 183' ' ' LEU . 0.1 OUTLIER -55.59 122.23 10.86 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 114.423 1.268 . . . . 0.0 114.423 179.034 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -87.92 -45.69 10.03 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 114.899 -1.046 . . . . 0.0 108.422 176.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 223' ' ' ASP . . . . . 0.452 ' OD1' ' N ' ' A' ' 223' ' ' ASP . 0.0 OUTLIER -81.65 135.14 35.54 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.994 177.588 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.636 HD13 ' N ' ' A' ' 224' ' ' ILE . 0.2 OUTLIER -134.67 179.65 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.718 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.411 ' O ' ' C ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER 57.33 114.44 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 114.479 -1.237 . . . . 0.0 110.052 -178.96 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 226' ' ' GLU . . . . . 0.544 ' H ' ' HA ' ' A' ' 155' ' ' GLN . 5.2 tm-20 11.41 61.1 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 124.671 1.232 . . . . 0.0 112.919 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 227' ' ' GLY . . . . . 0.43 ' N ' HG11 ' A' ' 153' ' ' VAL . . . -60.19 -68.02 1.88 Allowed Glycine 0 N--CA 1.433 -1.541 0 CA-C-N 114.695 -1.139 . . . . 0.0 111.736 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.463 ' O ' HG12 ' A' ' 153' ' ' VAL . 0.8 OUTLIER -164.8 -148.93 0.12 Allowed 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 179.631 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 229' ' ' VAL . . . . . 0.739 HG22 ' HG2' ' A' ' 152' ' ' GLU . 92.1 t -88.44 129.61 39.32 Favored 'Isoleucine or valine' 0 C--N 1.346 0.453 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.517 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 230' ' ' ILE . . . . . 0.572 HD12 ' HB3' ' A' ' 168' ' ' CYS . 17.4 mt -98.94 157.17 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 O-C-N 123.689 0.618 . . . . 0.0 111.564 -179.37 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 231' ' ' GLU . . . . . 0.423 ' CG ' ' HG2' ' A' ' 150' ' ' GLN . 0.0 OUTLIER -146.46 109.97 4.82 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -179.673 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.719 ' HB3' ' HA3' ' A' ' 149' ' ' GLY . . . -88.96 131.14 35.29 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.397 178.544 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 233' ' ' TYR . . . . . 0.438 ' CE1' ' HB3' ' A' ' 180' ' ' LYS . 11.8 p90 -128.95 142.83 50.8 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.724 0.297 . . . . 0.0 110.962 -179.241 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.457 HG12 HG13 ' A' ' 148' ' ' ILE . 0.9 OUTLIER . . . . . 0 CA--C 1.536 0.431 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.607 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.555 ' HG3' HG23 ' A' ' 147' ' ' VAL . 17.4 tptt . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.584 0.23 . . . . 0.0 111.099 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.564 HG11 ' HB2' ' A' ' 150' ' ' GLN . 13.6 t -122.64 142.73 38.03 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.555 0 CA-C-O 121.507 0.67 . . . . 0.0 111.706 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.495 HG22 ' CA ' ' A' ' 233' ' ' TYR . 3.9 tp -118.01 -20.05 5.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.084 178.078 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' GLY . . . . . 0.434 ' O ' ' HB3' ' A' ' 232' ' ' ALA . . . -178.02 85.17 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.445 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.564 ' HB2' HG11 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -93.72 132.98 37.56 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.764 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.439 ' CB ' ' HB2' ' A' ' 168' ' ' CYS . . . -152.14 175.88 12.12 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 119.736 -0.786 . . . . 0.0 113.059 -177.364 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.835 ' HG2' HG22 ' A' ' 229' ' ' VAL . 13.1 mt-10 -120.47 124.09 44.56 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.445 -1.252 . . . . 0.0 110.046 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.474 HG12 ' O ' ' A' ' 228' ' ' ASP . 3.6 p -50.52 134.46 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -178.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -89.46 -61.35 1.72 Allowed 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 175.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.528 ' HA ' ' H ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER -161.13 -160.46 0.73 Allowed 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 113.711 -1.586 . . . . 0.0 109.651 175.595 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.496 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 4.3 p -147.99 168.24 22.83 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 177.535 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.681 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 6.4 m-85 -118.11 75.58 1.02 Allowed 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -178.652 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.05 63.28 7.94 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 122.121 0.962 . . . . 0.0 108.481 178.403 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 83.9 t -90.9 157.75 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 CA-C-N 113.709 -1.587 . . . . 0.0 110.229 -178.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 1.2 m -92.5 34.57 1.05 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.217 0.532 . . . . 0.0 109.849 178.273 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 9.8 mttt -151.67 -32.97 0.15 Allowed 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.442 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.868 HG11 HD12 ' A' ' 165' ' ' ILE . 84.0 t -99.83 -103.21 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.278 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' GLY . . . . . 0.513 ' N ' HG12 ' A' ' 162' ' ' VAL . . . -159.12 -101.56 0.17 Allowed Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 111.481 -0.648 . . . . 0.0 111.481 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.598 ' CG2' HG22 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -153.83 36.18 0.44 Allowed 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 114.152 -1.024 . . . . 0.0 108.49 178.25 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.868 HD12 HG11 ' A' ' 162' ' ' VAL . 3.8 mt -42.14 98.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.441 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.591 ' HB3' HD13 ' A' ' 218' ' ' ILE . . . -91.71 121.05 33.0 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.006 -0.997 . . . . 0.0 112.298 -179.057 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -88.73 150.96 22.01 Favored Glycine 0 N--CA 1.441 -0.969 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 178.056 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.485 ' HB3' HD13 ' A' ' 230' ' ' ILE . 0.0 OUTLIER -145.92 136.05 23.74 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 117.377 0.588 . . . . 0.0 110.776 -178.409 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 169' ' ' TYR . . . . . 0.419 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 31.4 t80 -87.2 123.56 32.36 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 177.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.685 HG21 ' O ' ' A' ' 208' ' ' VAL . 38.8 t -85.13 148.08 5.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -175.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -138.86 16.86 2.67 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-N 114.298 -1.319 . . . . 0.0 111.81 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.543 ' H ' HG12 ' A' ' 170' ' ' VAL . 8.6 t0 -150.19 -147.42 0.23 Allowed 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -179.171 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -44.39 -104.47 0.01 OUTLIER Glycine 0 CA--C 1.53 1.025 0 N-CA-C 114.685 0.634 . . . . 0.0 114.685 -179.031 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.747 ' HG3' ' HB2' ' A' ' 209' ' ' ALA . 0.0 OUTLIER -151.1 126.61 10.11 Favored 'General case' 0 CA--C 1.513 -0.449 0 O-C-N 122.608 -0.348 . . . . 0.0 111.458 -179.04 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.656 HG23 ' O ' ' A' ' 175' ' ' ILE . 1.5 tp -88.82 83.76 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 CA-C-O 122.035 0.922 . . . . 0.0 109.238 177.541 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.518 HG22 ' HB3' ' A' ' 207' ' ' GLU . 0.0 OUTLIER -89.18 -177.91 5.53 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.384 -1.28 . . . . 0.0 112.932 -177.137 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 37.7 mtm180 -74.71 -44.11 51.71 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 114.669 -1.151 . . . . 0.0 110.839 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -89.04 57.68 4.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.75 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 3.3 m -148.22 163.33 37.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.401 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.479 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 2.7 mptm? -93.77 176.48 6.34 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.104 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.546 HG13 HD11 ' A' ' 195' ' ' ILE . 1.1 m -151.14 149.99 13.69 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.476 0 CA-C-O 121.598 0.713 . . . . 0.0 111.952 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 182' ' ' ARG . . . . . 0.449 ' N ' ' O ' ' A' ' 231' ' ' GLU . 41.3 ttp180 -153.39 104.36 2.75 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.108 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.595 HD21 ' CZ ' ' A' ' 221' ' ' PHE . 0.3 OUTLIER -99.49 170.88 8.31 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-O 120.976 0.417 . . . . 0.0 111.008 -179.75 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.759 HG23 ' O ' ' A' ' 188' ' ' ILE . 48.4 mt -152.92 141.64 14.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.194 -177.518 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.472 ' O ' HG22 ' A' ' 184' ' ' ILE . 7.1 ttp180 -86.49 -157.38 0.35 Allowed 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.112 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -94.17 27.14 2.97 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.724 178.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -154.25 -43.59 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.862 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.759 ' O ' HG23 ' A' ' 184' ' ' ILE . 0.4 OUTLIER -150.24 -160.52 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -178.098 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.658 HG11 ' CD ' ' A' ' 192' ' ' GLU . 35.5 t -85.41 134.98 25.87 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.397 0 CA-C-O 121.439 0.638 . . . . 0.0 110.386 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.486 HG23 ' HG ' ' A' ' 183' ' ' LEU . 0.2 OUTLIER -88.79 -32.54 5.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.619 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 191' ' ' TYR . . . . . 0.522 ' CB ' ' CE1' ' A' ' 221' ' ' PHE . 79.8 t80 179.9 158.41 0.72 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.673 178.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 192' ' ' GLU . . . . . 0.658 ' CD ' HG11 ' A' ' 189' ' ' VAL . 7.6 mp0 -143.87 154.28 43.21 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.969 0.414 . . . . 0.0 110.443 178.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 148.5 -129.33 3.08 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.843 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' GLU . . . . . 0.479 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 13.3 pt-20 -139.38 -174.38 3.86 Favored 'General case' 0 CA--C 1.498 -1.039 0 CA-C-O 121.27 0.557 . . . . 0.0 111.393 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.546 HD11 HG13 ' A' ' 181' ' ' VAL . 4.2 mp -88.0 143.84 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.009 -178.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -89.24 -53.29 4.63 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.045 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 18.3 p -151.2 143.22 23.95 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.308 178.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.727 ' CD1' HD22 ' A' ' 216' ' ' LEU . 0.5 OUTLIER -119.67 114.42 22.16 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.329 0.585 . . . . 0.0 111.681 -179.571 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 199' ' ' LYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 26.9 tttt -150.48 122.15 8.04 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.137 179.313 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.323 -0.563 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.968 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' ASP . . . . . 0.403 ' HA ' ' HA ' ' A' ' 199' ' ' LYS . 4.4 t70 . . . . . 0 N--CA 1.453 -0.292 0 CA-C-O 120.959 0.409 . . . . 0.0 110.189 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 32.9 m -61.07 160.06 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 CA-C-O 121.521 0.677 . . . . 0.0 112.242 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 206' ' ' ARG . . . . . 0.431 ' O ' ' HB ' ' A' ' 176' ' ' THR . 0.2 OUTLIER -89.43 -36.74 15.28 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 114.735 -1.121 . . . . 0.0 111.607 -178.616 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.518 ' HB3' HG22 ' A' ' 176' ' ' THR . 0.6 OUTLIER -137.53 177.23 8.02 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.301 0.572 . . . . 0.0 111.895 -179.799 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.685 ' O ' HG21 ' A' ' 170' ' ' VAL . 0.0 OUTLIER -150.86 82.64 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.074 -0.967 . . . . 0.0 109.46 179.058 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.747 ' HB2' ' HG3' ' A' ' 174' ' ' LYS . . . -101.5 171.67 7.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.093 0.473 . . . . 0.0 112.182 -178.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 83.22 -72.55 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.998 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 178.0 37.89 0.06 OUTLIER Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.404 179.085 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' TYR . . . . . 0.419 ' HB3' HG12 ' A' ' 208' ' ' VAL . 2.1 m-85 -98.09 142.93 29.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.95 0.405 . . . . 0.0 111.565 -179.378 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.67 160.71 16.47 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.482 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -150.41 -164.97 2.14 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.863 0.363 . . . . 0.0 111.04 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 215' ' ' GLY . . . . . 0.461 ' C ' HG23 ' A' ' 165' ' ' ILE . . . -148.64 96.23 0.17 Allowed Glycine 0 N--CA 1.451 -0.316 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.727 HD22 ' CD1' ' A' ' 198' ' ' LEU . 0.5 OUTLIER -131.17 143.6 50.73 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -177.642 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 217' ' ' THR . . . . . 0.542 ' C ' HD12 ' A' ' 218' ' ' ILE . 0.0 OUTLIER -78.0 143.79 37.25 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 176.404 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 218' ' ' ILE . . . . . 0.591 HD13 ' HB3' ' A' ' 166' ' ' ALA . 1.6 mp -108.26 88.14 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.709 -178.445 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 9.8 tttt 47.16 -141.91 0.44 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.663 179.212 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -86.42 55.73 3.68 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.091 0.472 . . . . 0.0 110.99 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 221' ' ' PHE . . . . . 0.595 ' CZ ' HD21 ' A' ' 183' ' ' LEU . 0.1 OUTLIER -57.51 132.0 51.85 Favored 'General case' 0 C--N 1.339 0.126 0 N-CA-C 116.086 1.884 . . . . 0.0 116.086 178.964 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.42 -42.3 8.55 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 114.35 -1.296 . . . . 0.0 108.658 175.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 223' ' ' ASP . . . . . 0.542 ' HB3' ' CE1' ' A' ' 221' ' ' PHE . 0.0 OUTLIER -64.96 164.12 13.27 Favored 'General case' 0 C--N 1.351 0.65 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.794 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.609 HD13 ' N ' ' A' ' 224' ' ' ILE . 0.2 OUTLIER -155.36 -177.11 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 114.897 -1.047 . . . . 0.0 111.988 176.39 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.418 ' CG ' HG12 ' A' ' 224' ' ' ILE . 0.0 OUTLIER 34.12 103.92 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.752 1.221 . . . . 0.0 112.345 -179.611 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 226' ' ' GLU . . . . . 0.528 ' H ' ' HA ' ' A' ' 155' ' ' GLN . 18.5 tt0 20.35 59.49 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.228 0 O-C-N 124.487 1.117 . . . . 0.0 113.224 179.099 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -61.65 -61.73 6.5 Favored Glycine 0 N--CA 1.432 -1.574 0 CA-C-N 114.869 -1.06 . . . . 0.0 112.482 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.474 ' O ' HG12 ' A' ' 153' ' ' VAL . 0.6 OUTLIER -164.06 -152.02 0.18 Allowed 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -179.544 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 229' ' ' VAL . . . . . 0.835 HG22 ' HG2' ' A' ' 152' ' ' GLU . 92.2 t -90.02 134.41 29.13 Favored 'Isoleucine or valine' 0 C--N 1.35 0.604 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.945 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 230' ' ' ILE . . . . . 0.485 HD13 ' HB3' ' A' ' 168' ' ' CYS . 2.7 mp -103.39 158.69 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 O-C-N 123.544 0.528 . . . . 0.0 111.228 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 231' ' ' GLU . . . . . 0.449 ' O ' ' N ' ' A' ' 182' ' ' ARG . 9.2 tt0 -147.79 111.32 4.98 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.653 ' HB2' HD12 ' A' ' 175' ' ' ILE . . . -87.7 139.68 30.28 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.683 179.096 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 233' ' ' TYR . . . . . 0.495 ' CA ' HG22 ' A' ' 148' ' ' ILE . 30.3 p90 -139.03 135.01 33.79 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.146 -179.378 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.495 HG12 ' HB ' ' A' ' 148' ' ' ILE . 0.5 OUTLIER . . . . . 0 CA--C 1.54 0.593 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.668 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.814 0.34 . . . . 0.0 110.952 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.719 HG11 ' HB2' ' A' ' 150' ' ' GLN . 20.7 t -58.68 143.22 13.33 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.449 0 CA-C-O 121.415 0.626 . . . . 0.0 111.424 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.542 ' O ' HG22 ' A' ' 148' ' ' ILE . 16.1 mm -129.7 6.98 2.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.843 178.097 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' GLY . . . . . 0.59 ' CA ' ' HB3' ' A' ' 232' ' ' ALA . . . 173.9 72.88 0.05 OUTLIER Glycine 0 C--N 1.343 0.936 0 C-N-CA 121.127 -0.559 . . . . 0.0 111.904 179.606 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.719 ' HB2' HG11 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -93.71 131.5 38.98 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 116.871 0.335 . . . . 0.0 110.305 179.855 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.499 ' O ' HG13 ' A' ' 229' ' ' VAL . . . -151.65 176.47 11.33 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -178.338 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.46 ' HA ' ' HA ' ' A' ' 229' ' ' VAL . 1.9 mt-10 -123.69 125.82 45.45 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.746 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.472 HG12 ' O ' ' A' ' 228' ' ' ASP . 1.8 p -55.16 127.21 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-O 121.569 0.699 . . . . 0.0 112.196 -179.221 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.485 ' O ' ' HB3' ' A' ' 226' ' ' GLU . 0.0 OUTLIER -89.87 -55.16 3.74 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 105.056 -2.201 . . . . 0.0 105.056 175.736 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.83 -164.07 0.86 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.861 174.688 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.554 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 26.3 p -143.41 -175.9 4.73 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 178.253 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.669 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 21.7 m-85 -144.11 76.53 1.51 Allowed 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.475 ' HG2' HG13 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -86.52 62.64 7.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 122.428 1.109 . . . . 0.0 108.498 178.285 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.483 HG12 ' N ' ' A' ' 161' ' ' LYS . 45.8 t -89.85 154.73 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 CA-C-N 113.236 -1.802 . . . . 0.0 110.226 -178.773 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 26.3 t -89.83 36.74 0.86 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.057 0.456 . . . . 0.0 110.006 178.272 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.483 ' N ' HG12 ' A' ' 159' ' ' VAL . 1.4 mttt -150.6 -34.18 0.16 Allowed 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.213 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.501 HG12 ' N ' ' A' ' 163' ' ' GLY . 84.9 t -101.65 -101.81 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' GLY . . . . . 0.501 ' N ' HG12 ' A' ' 162' ' ' VAL . . . -158.79 -101.74 0.18 Allowed Glycine 0 C--O 1.224 -0.498 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 178.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.455 ' C ' HG23 ' A' ' 217' ' ' THR . 0.0 OUTLIER -152.32 37.07 0.53 Allowed 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 177.48 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.669 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 2.2 mm -40.28 93.21 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.338 0.095 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.773 -179.175 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.554 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . -84.98 116.47 23.4 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.457 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -87.49 134.4 12.44 Favored Glycine 0 N--CA 1.438 -1.181 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 178.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.414 ' HB2' ' CB ' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -136.46 131.21 33.73 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.859 0.329 . . . . 0.0 110.374 -178.503 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 169' ' ' TYR . . . . . 0.416 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 41.1 t80 -85.64 126.8 34.2 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 177.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.801 HG21 ' O ' ' A' ' 208' ' ' VAL . 45.4 t -85.73 146.36 6.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -175.817 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.2 p -138.44 14.19 2.77 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 114.402 -1.272 . . . . 0.0 111.807 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.408 ' H ' HG12 ' A' ' 170' ' ' VAL . 4.6 t70 -150.46 -142.58 0.12 Allowed 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -44.54 -105.36 0.01 OUTLIER Glycine 0 CA--C 1.53 1.015 0 N-CA-C 114.455 0.542 . . . . 0.0 114.455 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.808 ' HG2' ' HB2' ' A' ' 209' ' ' ALA . 10.7 mttm -151.8 143.13 23.39 Favored 'General case' 0 CA--C 1.516 -0.347 0 O-C-N 122.301 -0.529 . . . . 0.0 111.995 -179.1 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.622 ' CG1' HG22 ' A' ' 170' ' ' VAL . 11.2 mm -93.23 90.52 3.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 176.744 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.459 HG22 ' HB3' ' A' ' 207' ' ' GLU . 0.1 OUTLIER -106.13 174.7 5.77 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.488 0.661 . . . . 0.0 112.677 -177.495 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.408 ' HG3' ' HB2' ' A' ' 198' ' ' LEU . 0.1 OUTLIER -72.96 -42.59 63.22 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.208 179.351 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -88.28 56.22 3.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.141 -179.073 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -150.2 161.51 42.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.418 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 0.0 OUTLIER -89.18 -177.45 5.41 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.5 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.661 HG11 HG13 ' A' ' 218' ' ' ILE . 1.4 m -146.07 157.29 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 CA-C-O 121.227 0.537 . . . . 0.0 111.638 179.591 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 182' ' ' ARG . . . . . 0.418 ' N ' ' O ' ' A' ' 231' ' ' GLU . 6.0 ttt85 -152.78 102.54 2.7 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.312 -0.858 . . . . 0.0 113.196 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.708 HD12 ' HB3' ' A' ' 191' ' ' TYR . 0.3 OUTLIER -86.36 154.12 21.43 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-O 121.701 0.763 . . . . 0.0 113.034 -179.937 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.476 ' N ' HG23 ' A' ' 190' ' ' VAL . 3.2 mp -148.5 121.24 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 113.989 -1.46 . . . . 0.0 112.27 178.124 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.419 ' N ' HG22 ' A' ' 190' ' ' VAL . 1.3 ttm180 -85.99 -150.44 0.14 Allowed 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 177.269 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -93.99 27.48 2.78 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 118.78 0.718 . . . . 0.0 110.766 178.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -154.81 -77.54 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.835 -0.697 . . . . 0.0 112.673 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -115.44 -155.28 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 115.277 -0.462 . . . . 0.0 110.734 -179.136 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.775 HG11 ' CG ' ' A' ' 192' ' ' GLU . 44.2 t -87.08 135.44 25.21 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.102 0 CA-C-O 121.565 0.698 . . . . 0.0 111.74 -179.181 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.793 HG12 ' OD2' ' A' ' 223' ' ' ASP . 0.2 OUTLIER -89.58 -34.51 6.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 114.665 -1.152 . . . . 0.0 108.961 178.637 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 191' ' ' TYR . . . . . 0.708 ' HB3' HD12 ' A' ' 183' ' ' LEU . 16.6 t80 -158.33 158.79 35.0 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.35 178.786 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 192' ' ' GLU . . . . . 0.775 ' CG ' HG11 ' A' ' 189' ' ' VAL . 14.3 mt-10 -150.33 155.81 40.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.112 178.606 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 134.7 -119.34 2.15 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.257 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 194' ' ' GLU . . . . . 0.628 ' CA ' HG22 ' A' ' 181' ' ' VAL . 17.6 pt-20 -150.32 -175.01 4.91 Favored 'General case' 0 CA--C 1.496 -1.097 0 CA-C-O 121.357 0.599 . . . . 0.0 111.675 -179.111 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.567 ' CD1' HG13 ' A' ' 181' ' ' VAL . 4.3 mp -88.48 143.38 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.322 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 196' ' ' ASP . . . . . 0.421 ' CB ' ' HB ' ' A' ' 217' ' ' THR . 0.4 OUTLIER -88.93 -57.47 2.89 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.412 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 35.2 t -151.53 153.03 33.78 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.222 179.031 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.564 HD21 ' O ' ' A' ' 175' ' ' ILE . 0.1 OUTLIER -123.0 119.22 29.73 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-O 121.37 0.605 . . . . 0.0 111.484 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.34 118.7 6.42 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.126 179.365 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 4.6 ptm85 . . . . . 0 C--N 1.321 -0.653 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.177 179.844 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 19.4 t70 . . . . . 0 N--CA 1.454 -0.26 0 CA-C-O 120.978 0.418 . . . . 0.0 110.078 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 36.0 m -72.12 166.33 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.921 0 CA-C-O 121.618 0.723 . . . . 0.0 112.562 -178.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 206' ' ' ARG . . . . . 0.443 ' O ' ' HA ' ' A' ' 176' ' ' THR . 16.6 ttp180 -89.07 -41.1 12.51 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 114.483 -1.235 . . . . 0.0 111.556 -178.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.459 ' HB3' HG22 ' A' ' 176' ' ' THR . 0.3 OUTLIER -138.09 -177.18 4.71 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.135 0.493 . . . . 0.0 111.684 -179.544 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.801 ' O ' HG21 ' A' ' 170' ' ' VAL . 0.2 OUTLIER -150.88 81.56 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.801 179.316 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.808 ' HB2' ' HG2' ' A' ' 174' ' ' LYS . . . -99.74 175.28 5.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.056 0.455 . . . . 0.0 112.154 -178.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 82.59 -75.0 0.03 OUTLIER 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.697 -179.451 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 178.47 37.31 0.06 OUTLIER Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.376 -0.916 . . . . 0.0 112.362 179.028 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -99.22 145.28 27.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.963 0.411 . . . . 0.0 111.196 -179.407 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.4 131.79 46.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.453 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 214' ' ' CYS . . . . . 0.566 ' HB3' HG21 ' A' ' 208' ' ' VAL . 50.0 t -134.96 144.45 47.42 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.399 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 215' ' ' GLY . . . . . 0.625 ' O ' HD12 ' A' ' 165' ' ' ILE . . . -88.58 108.15 3.42 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.494 -0.86 . . . . 0.0 111.995 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.574 HD12 ' CD1' ' A' ' 218' ' ' ILE . 0.3 OUTLIER -132.54 140.51 48.33 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 120.97 0.414 . . . . 0.0 111.436 -179.264 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 217' ' ' THR . . . . . 0.455 HG23 ' C ' ' A' ' 164' ' ' THR . 0.2 OUTLIER -78.73 138.8 38.42 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 177.907 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 218' ' ' ILE . . . . . 0.661 HG13 HG11 ' A' ' 181' ' ' VAL . 1.4 mp -105.79 95.4 3.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 -178.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 44.04 -145.53 0.11 Allowed 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.928 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 -88.16 63.83 7.42 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-O 120.85 0.357 . . . . 0.0 111.2 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 221' ' ' PHE . . . . . 0.683 ' CZ ' HD13 ' A' ' 183' ' ' LEU . 0.1 OUTLIER -54.4 118.44 4.13 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 179.002 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -84.14 -43.43 15.01 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.755 176.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 223' ' ' ASP . . . . . 0.793 ' OD2' HG12 ' A' ' 190' ' ' VAL . 0.0 OUTLIER -87.74 132.26 34.2 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.97 178.455 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.475 HG13 ' HG2' ' A' ' 158' ' ' LYS . 0.1 OUTLIER -116.61 179.56 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 CA-C-O 121.09 0.471 . . . . 0.0 112.003 -179.646 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.421 ' O ' ' N ' ' A' ' 227' ' ' GLY . 0.0 OUTLIER 55.67 120.88 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.543 179.853 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 226' ' ' GLU . . . . . 0.485 ' HB3' ' O ' ' A' ' 154' ' ' ARG . 3.3 pt-20 -3.97 71.73 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 227' ' ' GLY . . . . . 0.439 ' N ' HG11 ' A' ' 153' ' ' VAL . . . -64.48 -63.42 4.3 Favored Glycine 0 N--CA 1.43 -1.722 0 CA-C-N 114.7 -1.136 . . . . 0.0 111.616 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.472 ' O ' HG12 ' A' ' 153' ' ' VAL . 1.0 OUTLIER -164.76 -148.49 0.11 Allowed 'General case' 0 C--O 1.22 -0.491 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 179.585 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 229' ' ' VAL . . . . . 0.499 HG13 ' O ' ' A' ' 151' ' ' ALA . 61.9 t -89.47 145.76 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.225 0 O-C-N 122.091 -0.381 . . . . 0.0 110.494 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 230' ' ' ILE . . . . . 0.419 HG13 ' CD2' ' A' ' 183' ' ' LEU . 2.6 mp -117.01 154.4 18.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.156 -179.231 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 231' ' ' GLU . . . . . 0.506 ' OE2' HG22 ' A' ' 147' ' ' VAL . 7.5 tt0 -143.27 113.96 7.56 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.403 0.62 . . . . 0.0 111.948 -179.464 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.59 ' HB3' ' CA ' ' A' ' 149' ' ' GLY . . . -88.45 128.45 35.53 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.497 178.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -130.5 129.48 42.95 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.869 -178.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 4.3 t . . . . . 0 C--N 1.328 -0.349 0 CA-C-O 120.982 0.42 . . . . 0.0 111.762 -179.835 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 2.0 tttm . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.663 0.268 . . . . 0.0 110.527 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.706 HG11 ' HB2' ' A' ' 150' ' ' GLN . 14.9 t -59.53 140.9 17.04 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.637 0 CA-C-O 121.308 0.575 . . . . 0.0 111.315 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.704 HD11 ' HB3' ' A' ' 179' ' ' SER . 1.8 pp -124.97 -1.78 5.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.048 178.192 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' GLY . . . . . 0.568 ' CA ' ' HB3' ' A' ' 232' ' ' ALA . . . 179.51 73.95 0.06 OUTLIER Glycine 0 C--N 1.34 0.791 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.165 179.656 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.706 ' HB2' HG11 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -90.99 132.8 35.76 Favored 'General case' 0 CA--C 1.509 -0.61 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.249 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.417 ' CB ' ' HB2' ' A' ' 168' ' ' CYS . . . -151.57 174.71 13.12 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 121.457 0.646 . . . . 0.0 112.458 -178.124 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.752 ' CG ' HG22 ' A' ' 229' ' ' VAL . 0.8 OUTLIER -119.98 122.14 40.52 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.021 179.691 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.443 HG12 ' O ' ' A' ' 228' ' ' ASP . 2.6 p -50.05 134.13 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -89.29 -63.31 1.31 Allowed 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 175.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.469 ' HA ' ' H ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER -161.51 -162.03 0.85 Allowed 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 113.826 -1.534 . . . . 0.0 109.198 175.206 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.514 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 7.5 p -145.89 157.3 43.91 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 120.829 0.347 . . . . 0.0 110.392 177.469 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.681 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 2.3 m-85 -104.21 72.13 1.06 Allowed 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -177.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 16.7 tttt -85.67 63.72 8.22 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 122.125 0.964 . . . . 0.0 108.826 178.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 95.8 t -89.9 158.21 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 CA-C-N 113.673 -1.603 . . . . 0.0 109.906 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 25.2 p -92.62 32.97 1.16 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.224 0.535 . . . . 0.0 110.036 178.461 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 3.2 mtmt -152.02 -31.54 0.15 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.644 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.459 HG12 ' N ' ' A' ' 163' ' ' GLY . 98.5 t -98.98 -101.19 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 O-C-N 122.171 -0.331 . . . . 0.0 110.234 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' GLY . . . . . 0.459 ' N ' HG12 ' A' ' 162' ' ' VAL . . . -158.72 -105.95 0.22 Allowed Glycine 0 N--CA 1.451 -0.361 0 N-CA-C 111.644 -0.583 . . . . 0.0 111.644 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.504 HG21 HG21 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -153.7 34.85 0.45 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.378 -0.911 . . . . 0.0 108.944 178.391 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.681 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 3.8 mm -42.45 94.87 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.577 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.514 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . -87.77 117.8 26.85 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 114.748 -1.114 . . . . 0.0 111.189 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -88.39 153.97 24.72 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 179.24 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.417 ' HB2' ' CB ' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -148.29 136.12 20.88 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.922 0.361 . . . . 0.0 110.81 -178.268 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 169' ' ' TYR . . . . . 0.408 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 33.3 t80 -87.39 124.96 33.95 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 177.737 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.77 HG21 ' O ' ' A' ' 208' ' ' VAL . 24.5 t -85.08 144.51 9.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -175.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -136.41 14.3 3.23 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-N 114.544 -1.207 . . . . 0.0 112.013 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.457 ' H ' HG12 ' A' ' 170' ' ' VAL . 4.2 t0 -150.52 -144.16 0.15 Allowed 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -179.504 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -41.32 -106.0 0.01 OUTLIER Glycine 0 CA--C 1.533 1.188 0 N-CA-C 115.197 0.839 . . . . 0.0 115.197 -178.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.408 ' HB2' ' HB3' ' A' ' 207' ' ' GLU . 0.0 OUTLIER -150.69 146.74 26.66 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.014 0.435 . . . . 0.0 111.619 -178.399 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.599 HG13 HG22 ' A' ' 170' ' ' VAL . 10.6 mm -99.39 83.23 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 176.627 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.457 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 0.1 OUTLIER -95.88 168.5 10.6 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -177.177 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.412 ' CG ' ' HB3' ' A' ' 198' ' ' LEU . 33.8 mtm180 -64.58 -45.07 88.58 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 114.546 -1.206 . . . . 0.0 110.743 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -89.4 59.99 5.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.743 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' SER . . . . . 0.704 ' HB3' HD11 ' A' ' 148' ' ' ILE . 58.9 m -149.13 156.04 41.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.756 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 3.5 mptp? -89.18 -179.33 5.86 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.696 179.511 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.812 HG21 HD12 ' A' ' 218' ' ' ILE . 1.1 m -150.86 150.12 13.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.493 0.663 . . . . 0.0 111.953 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 182' ' ' ARG . . . . . 0.439 ' N ' ' O ' ' A' ' 231' ' ' GLU . 11.5 ttt85 -153.25 102.43 2.61 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.463 179.333 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.622 ' C ' HD12 ' A' ' 184' ' ' ILE . 0.3 OUTLIER -100.58 167.67 10.2 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-O 120.947 0.403 . . . . 0.0 111.382 -179.829 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.666 HG23 ' O ' ' A' ' 188' ' ' ILE . 4.7 mp -151.56 139.98 14.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.944 -177.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.504 ' N ' HG22 ' A' ' 190' ' ' VAL . 0.1 OUTLIER -87.16 -153.19 0.21 Allowed 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.022 -0.99 . . . . 0.0 108.86 178.117 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -94.71 28.02 2.83 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 118.092 0.405 . . . . 0.0 111.296 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -152.96 -76.75 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.556 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.666 ' O ' HG23 ' A' ' 184' ' ' ILE . 0.4 OUTLIER -116.12 -156.57 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 115.525 -0.338 . . . . 0.0 110.319 -179.54 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.759 HG11 ' CD ' ' A' ' 192' ' ' GLU . 31.0 t -86.16 138.84 18.32 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 CA-C-O 121.476 0.655 . . . . 0.0 110.702 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.577 HG23 ' CA ' ' A' ' 184' ' ' ILE . 0.6 OUTLIER -87.68 -37.11 10.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 114.913 -1.04 . . . . 0.0 108.89 179.847 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 191' ' ' TYR . . . . . 0.439 ' HB2' ' CE1' ' A' ' 221' ' ' PHE . 0.5 OUTLIER -178.69 150.49 0.52 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.354 179.617 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 192' ' ' GLU . . . . . 0.759 ' CD ' HG11 ' A' ' 189' ' ' VAL . 2.3 mp0 -137.13 158.35 44.63 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.935 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 144.53 -132.73 4.9 Favored Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.556 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 194' ' ' GLU . . . . . 0.736 ' O ' HG23 ' A' ' 218' ' ' ILE . 4.1 pt-20 -143.58 -179.34 6.37 Favored 'General case' 0 CA--C 1.498 -1.023 0 CA-C-O 121.186 0.517 . . . . 0.0 111.051 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.866 HG12 HD13 ' A' ' 216' ' ' LEU . 4.5 mp -88.73 143.05 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.877 -178.716 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -91.81 -43.79 9.33 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.361 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 48.8 m -151.29 145.56 25.43 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.09 179.117 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.536 HD12 ' HB3' ' A' ' 216' ' ' LEU . 16.7 tp -119.39 113.82 21.39 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.075 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 199' ' ' LYS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 19.7 mtmm -149.56 122.86 8.98 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.368 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.322 -0.594 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.833 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 204' ' ' ASP . . . . . 0.404 ' HA ' ' HA ' ' A' ' 199' ' ' LYS . 19.2 m-20 . . . . . 0 N--CA 1.453 -0.308 0 CA-C-O 120.919 0.39 . . . . 0.0 110.317 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 33.1 m -64.52 159.45 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.878 0 CA-C-O 121.583 0.706 . . . . 0.0 112.313 -179.097 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 206' ' ' ARG . . . . . 0.457 ' O ' ' HA ' ' A' ' 176' ' ' THR . 1.9 ttt180 -89.3 -34.54 16.54 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.875 -178.556 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 176' ' ' THR . 1.6 mp0 -142.03 -179.01 5.97 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.156 0.503 . . . . 0.0 111.527 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.77 ' O ' HG21 ' A' ' 170' ' ' VAL . 1.9 t -150.79 73.03 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.848 179.199 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.401 ' HB2' ' HD2' ' A' ' 174' ' ' LYS . . . -96.25 171.01 8.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.087 0.47 . . . . 0.0 112.206 -178.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 83.11 -76.32 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.766 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 178.31 37.46 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.299 -0.953 . . . . 0.0 112.656 179.092 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -95.83 154.71 17.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.894 0.378 . . . . 0.0 111.2 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -89.55 162.43 15.68 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.355 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 214' ' ' CYS . . . . . 0.598 ' HB3' HG21 ' A' ' 208' ' ' VAL . 29.8 p -150.49 -171.65 3.98 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.874 0.369 . . . . 0.0 111.42 -179.305 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 215' ' ' GLY . . . . . 0.508 ' O ' HD12 ' A' ' 165' ' ' ILE . . . -150.2 98.58 0.19 Allowed Glycine 0 N--CA 1.451 -0.343 0 N-CA-C 111.505 -0.638 . . . . 0.0 111.505 179.557 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.866 HD13 HG12 ' A' ' 195' ' ' ILE . 0.5 OUTLIER -126.27 140.63 52.37 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-O 121.18 0.514 . . . . 0.0 112.242 -179.113 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -100.6 115.19 29.6 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.314 -0.857 . . . . 0.0 108.738 177.553 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 218' ' ' ILE . . . . . 0.812 HD12 HG21 ' A' ' 181' ' ' VAL . 15.6 mm -63.39 140.59 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-O 121.27 0.557 . . . . 0.0 110.626 -178.843 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 219' ' ' LYS . . . . . 0.409 ' HD3' ' HG2' ' A' ' 194' ' ' GLU . 6.1 ptmt -42.45 -28.64 0.22 Allowed 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 -177.724 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 220' ' ' ASN . . . . . 0.433 ' O ' ' CE2' ' A' ' 191' ' ' TYR . 0.2 OUTLIER -152.36 34.4 0.51 Allowed 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 -178.501 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 221' ' ' PHE . . . . . 0.518 ' CZ ' HD21 ' A' ' 183' ' ' LEU . 0.1 OUTLIER -58.25 121.41 10.68 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 178.872 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -89.52 -48.68 7.15 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 114.888 -1.051 . . . . 0.0 108.377 176.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 223' ' ' ASP . . . . . 0.451 ' O ' ' CD1' ' A' ' 221' ' ' PHE . 0.0 OUTLIER -77.14 140.22 40.16 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.292 177.496 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.637 HD13 ' N ' ' A' ' 224' ' ' ILE . 0.2 OUTLIER -134.67 178.01 6.06 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -178.85 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.413 ' O ' ' C ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER 56.61 115.54 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 114.391 -1.277 . . . . 0.0 110.182 -179.147 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 226' ' ' GLU . . . . . 0.469 ' H ' ' HA ' ' A' ' 155' ' ' GLN . 6.5 tt0 7.5 64.28 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 124.65 1.18 . . . . 0.0 113.55 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -61.18 -65.78 3.07 Favored Glycine 0 N--CA 1.431 -1.635 0 CA-C-N 114.694 -1.139 . . . . 0.0 111.764 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.443 ' O ' HG12 ' A' ' 153' ' ' VAL . 0.9 OUTLIER -164.98 -147.67 0.1 Allowed 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 179.859 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 229' ' ' VAL . . . . . 0.752 HG22 ' CG ' ' A' ' 152' ' ' GLU . 76.4 t -89.32 131.51 36.42 Favored 'Isoleucine or valine' 0 C--N 1.348 0.536 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.063 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 230' ' ' ILE . . . . . 0.481 ' HA ' ' HA ' ' A' ' 183' ' ' LEU . 3.7 mt -102.31 159.23 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 O-C-N 123.494 0.496 . . . . 0.0 111.487 -179.21 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 231' ' ' GLU . . . . . 0.448 ' N ' HG22 ' A' ' 230' ' ' ILE . 7.2 tt0 -145.25 110.42 5.22 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.568 ' HB3' ' CA ' ' A' ' 149' ' ' GLY . . . -88.26 129.5 35.35 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.668 178.6 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -130.82 141.5 50.34 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.803 -178.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.561 HG12 HG21 ' A' ' 148' ' ' ILE . 0.3 OUTLIER . . . . . 0 CA--C 1.535 0.38 0 CA-C-O 120.804 0.335 . . . . 0.0 111.135 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 11.6 mmtp . . . . . 0 CA--C 1.528 0.118 0 CA-C-O 120.667 0.27 . . . . 0.0 110.751 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.763 HG11 ' HB2' ' A' ' 150' ' ' GLN . 20.1 t -56.71 137.59 18.42 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.541 0 CA-C-O 121.135 0.493 . . . . 0.0 111.522 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.57 HD13 ' O ' ' A' ' 147' ' ' VAL . 25.7 mm -121.81 -4.31 8.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.27 178.429 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' GLY . . . . . 0.476 ' O ' ' HB3' ' A' ' 232' ' ' ALA . . . -176.72 72.15 0.08 OUTLIER Glycine 0 C--N 1.343 0.926 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.044 179.482 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.763 ' HB2' HG11 ' A' ' 147' ' ' VAL . 2.3 tt0 -90.49 135.15 33.88 Favored 'General case' 0 CA--C 1.512 -0.501 0 O-C-N 122.678 -0.307 . . . . 0.0 110.369 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.436 ' CB ' ' HB2' ' A' ' 168' ' ' CYS . . . -152.56 171.08 18.68 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 120.095 -0.642 . . . . 0.0 112.674 -178.1 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.835 ' CG ' HG22 ' A' ' 229' ' ' VAL . 0.6 OUTLIER -119.84 124.09 45.25 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.031 179.453 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.443 ' HB ' ' O ' ' A' ' 228' ' ' ASP . 3.9 p -52.01 133.26 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -178.484 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -89.29 -60.28 1.99 Allowed 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 104.827 -2.286 . . . . 0.0 104.827 175.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.535 ' HA ' ' H ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER -161.28 -161.94 0.85 Allowed 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 113.04 -1.891 . . . . 0.0 108.773 175.252 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.585 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 1.6 p -150.96 155.56 39.35 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 176.77 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.696 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 2.8 m-85 -104.62 76.38 1.28 Allowed 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -178.548 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -86.07 62.99 7.77 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.628 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.486 HG12 ' N ' ' A' ' 161' ' ' LYS . 54.7 t -89.97 155.35 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 CA-C-N 113.749 -1.569 . . . . 0.0 110.12 -178.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 28.6 t -90.79 34.78 0.9 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.203 0.525 . . . . 0.0 109.973 178.38 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.486 ' N ' HG12 ' A' ' 159' ' ' VAL . 0.5 OUTLIER -150.71 -31.67 0.18 Allowed 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.316 -179.689 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.5 HG12 ' N ' ' A' ' 163' ' ' GLY . 90.5 t -102.71 -102.78 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' GLY . . . . . 0.5 ' N ' HG12 ' A' ' 162' ' ' VAL . . . -158.95 -105.9 0.22 Allowed Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 179.084 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.637 HG21 HG21 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -156.03 54.4 0.58 Allowed 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 178.124 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.696 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 0.1 OUTLIER -34.38 -27.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.214 -0.812 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 -177.003 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.585 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . 36.78 97.52 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 178.348 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -86.39 149.67 22.95 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 109.881 -1.287 . . . . 0.0 109.881 178.595 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.436 ' HB2' ' CB ' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -144.81 135.33 24.44 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 117.216 0.508 . . . . 0.0 110.467 -178.18 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 169' ' ' TYR . . . . . 0.433 ' O ' ' HA ' ' A' ' 151' ' ' ALA . 1.9 t80 -87.96 124.8 34.07 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 177.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.754 HG21 ' O ' ' A' ' 208' ' ' VAL . 41.0 t -85.16 137.92 19.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.635 0.731 . . . . 0.0 112.849 -176.438 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.3 p -129.42 12.0 5.9 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 114.627 -1.169 . . . . 0.0 112.096 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -145.76 -139.21 0.1 Allowed 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -50.84 -110.73 0.01 OUTLIER Glycine 0 CA--C 1.53 1.013 0 C-N-CA 121.058 -0.592 . . . . 0.0 114.151 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.68 ' CG ' ' HB2' ' A' ' 209' ' ' ALA . 0.0 OUTLIER -144.7 137.26 26.43 Favored 'General case' 0 CA--C 1.514 -0.423 0 O-C-N 122.349 -0.501 . . . . 0.0 110.834 -179.272 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.479 HG23 ' O ' ' A' ' 175' ' ' ILE . 0.6 OUTLIER -94.43 112.18 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 C-N-CA 119.556 -0.858 . . . . 0.0 109.165 177.371 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.52 ' HB ' ' O ' ' A' ' 206' ' ' ARG . 0.3 OUTLIER -125.03 177.76 5.89 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.37 0.605 . . . . 0.0 112.09 -177.373 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.411 ' N ' HD13 ' A' ' 198' ' ' LEU . 0.0 OUTLIER -74.8 -36.81 62.47 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.032 -0.986 . . . . 0.0 109.525 179.241 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -88.94 52.04 2.31 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.054 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 179' ' ' SER . . . . . 0.477 ' O ' HD12 ' A' ' 195' ' ' ILE . 0.6 OUTLIER -150.72 159.59 44.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.987 179.799 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.486 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 0.0 OUTLIER -88.98 -177.84 5.56 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.172 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.664 HG21 HG23 ' A' ' 218' ' ' ILE . 2.3 m -142.13 160.39 20.22 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 CA-C-O 121.335 0.588 . . . . 0.0 111.82 179.317 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 182' ' ' ARG . . . . . 0.445 ' N ' ' O ' ' A' ' 231' ' ' GLU . 4.4 ttt-85 -152.66 97.81 2.28 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.099 -0.955 . . . . 0.0 112.806 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.687 HD13 ' CZ ' ' A' ' 221' ' ' PHE . 0.3 OUTLIER -86.25 153.79 21.75 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-O 121.748 0.785 . . . . 0.0 112.58 179.991 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.776 ' N ' HG23 ' A' ' 190' ' ' VAL . 17.8 mt -158.23 131.73 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 114.171 -1.377 . . . . 0.0 112.581 179.555 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.446 ' O ' HG22 ' A' ' 184' ' ' ILE . 0.0 OUTLIER -89.0 -151.74 0.22 Allowed 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.024 -1.472 . . . . 0.0 107.024 176.253 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -95.93 27.54 3.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 118.521 0.601 . . . . 0.0 110.516 178.622 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -153.96 -43.33 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.679 -0.772 . . . . 0.0 113.405 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.668 HG23 ' N ' ' A' ' 189' ' ' VAL . 0.4 OUTLIER -150.15 -158.33 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -177.953 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.668 ' N ' HG23 ' A' ' 188' ' ' ILE . 48.0 t -87.34 138.11 19.7 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 CA-C-O 121.624 0.726 . . . . 0.0 111.204 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.816 HG21 ' CB ' ' A' ' 228' ' ' ASP . 0.1 OUTLIER -98.12 -34.21 4.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 114.645 -1.161 . . . . 0.0 108.864 179.264 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 191' ' ' TYR . . . . . 0.629 ' HB3' HD12 ' A' ' 183' ' ' LEU . 19.1 t80 -158.58 159.75 35.83 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.18 179.096 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 192' ' ' GLU . . . . . 0.65 ' CG ' HG11 ' A' ' 189' ' ' VAL . 19.3 mt-10 -150.34 155.11 39.02 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.61 178.606 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 135.13 -121.48 2.59 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.485 -0.864 . . . . 0.0 112.382 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 194' ' ' GLU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 12.4 pt-20 -150.01 -176.57 5.5 Favored 'General case' 0 CA--C 1.495 -1.143 0 CA-C-O 121.447 0.642 . . . . 0.0 112.031 -178.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.477 HD12 ' O ' ' A' ' 179' ' ' SER . 4.5 mp -89.06 150.28 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 CA-C-N 115.175 -0.921 . . . . 0.0 109.37 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -88.73 -67.98 0.8 Allowed 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.061 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -151.99 154.62 36.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.455 178.534 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.592 HD22 ' C ' ' A' ' 206' ' ' ARG . 0.2 OUTLIER -107.61 127.85 54.02 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.319 0.581 . . . . 0.0 111.711 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 199' ' ' LYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 43.8 tttt -150.63 113.46 4.75 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.388 179.108 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.516 0 CA-C-N 116.081 -0.508 . . . . 0.0 109.823 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 204' ' ' ASP . . . . . 0.422 ' HA ' ' HA ' ' A' ' 199' ' ' LYS . 4.5 p-10 . . . . . 0 N--CA 1.454 -0.267 0 CA-C-O 120.673 0.273 . . . . 0.0 110.44 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.499 HG23 HD23 ' A' ' 198' ' ' LEU . 35.0 m -74.34 176.66 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -0.986 0 CA-C-O 121.576 0.703 . . . . 0.0 112.366 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 206' ' ' ARG . . . . . 0.592 ' C ' HD22 ' A' ' 198' ' ' LEU . 2.1 ttt180 -103.74 -42.24 5.69 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 114.616 -1.175 . . . . 0.0 111.796 -179.01 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.481 ' CB ' HG22 ' A' ' 176' ' ' THR . 1.4 mp0 -131.03 -177.02 4.19 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.207 0.527 . . . . 0.0 112.052 -179.09 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.754 ' O ' HG21 ' A' ' 170' ' ' VAL . 0.9 OUTLIER -151.42 71.26 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.848 178.539 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.68 ' HB2' ' CG ' ' A' ' 174' ' ' LYS . . . -91.65 171.68 9.0 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.094 0.473 . . . . 0.0 112.174 -178.714 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 83.67 -76.87 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.9 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 211' ' ' GLY . . . . . 0.4 ' O ' ' CE1' ' A' ' 169' ' ' TYR . . . 178.04 36.95 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.338 -0.934 . . . . 0.0 112.563 179.17 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -100.45 153.01 19.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.023 0.439 . . . . 0.0 111.239 -179.44 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.2 133.05 45.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.971 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 214' ' ' CYS . . . . . 0.471 ' HB3' HG21 ' A' ' 208' ' ' VAL . 1.8 t -135.73 146.08 47.31 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.976 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -89.66 112.27 3.99 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.868 179.502 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.548 HD12 ' CD1' ' A' ' 218' ' ' ILE . 0.4 OUTLIER -139.95 131.67 27.37 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-O 120.937 0.398 . . . . 0.0 111.012 -179.909 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 217' ' ' THR . . . . . 0.42 ' C ' HD12 ' A' ' 218' ' ' ILE . 0.0 OUTLIER -68.72 142.96 54.85 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.267 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 218' ' ' ILE . . . . . 0.664 HG23 HG21 ' A' ' 181' ' ' VAL . 1.7 mp -108.81 87.42 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 -178.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 219' ' ' LYS . . . . . 0.429 ' HB2' ' O ' ' A' ' 194' ' ' GLU . 2.7 tttt 45.3 -143.47 0.22 Allowed 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.519 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -88.44 63.69 7.18 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-O 120.732 0.301 . . . . 0.0 111.317 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 221' ' ' PHE . . . . . 0.687 ' CZ ' HD13 ' A' ' 183' ' ' LEU . 0.1 OUTLIER -54.91 119.04 4.82 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 178.705 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -82.75 -45.44 14.4 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.651 176.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 223' ' ' ASP . . . . . 0.619 ' OD2' HG12 ' A' ' 190' ' ' VAL . 0.0 OUTLIER -88.16 146.33 25.45 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.031 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.64 HD13 ' N ' ' A' ' 224' ' ' ILE . 0.2 OUTLIER -141.46 -179.18 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.146 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -178.527 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.409 ' O ' ' C ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER 54.87 111.1 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 114.184 -1.371 . . . . 0.0 110.376 -179.127 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 226' ' ' GLU . . . . . 0.535 ' H ' ' HA ' ' A' ' 155' ' ' GLN . 21.9 tt0 14.81 56.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 124.685 1.24 . . . . 0.0 112.504 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -67.45 -56.63 11.06 Favored Glycine 0 N--CA 1.422 -2.262 0 CA-C-N 114.224 -1.353 . . . . 0.0 113.323 -178.575 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.816 ' CB ' HG21 ' A' ' 190' ' ' VAL . 4.3 m-20 -161.25 -164.12 1.11 Allowed 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 115.124 1.527 . . . . 0.0 115.124 -177.659 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 229' ' ' VAL . . . . . 0.835 HG22 ' CG ' ' A' ' 152' ' ' GLU . 63.9 t -88.07 140.87 15.12 Favored 'Isoleucine or valine' 0 C--N 1.346 0.429 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.461 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 230' ' ' ILE . . . . . 0.412 HG13 ' HG ' ' A' ' 183' ' ' LEU . 2.7 mp -112.92 154.55 14.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.958 0.408 . . . . 0.0 111.372 -178.721 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 231' ' ' GLU . . . . . 0.445 ' HA ' ' HA ' ' A' ' 150' ' ' GLN . 5.0 tt0 -144.5 109.5 5.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.328 0.585 . . . . 0.0 111.684 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.476 ' HB3' ' O ' ' A' ' 149' ' ' GLY . . . -87.01 128.5 35.08 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.965 179.436 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 233' ' ' TYR . . . . . 0.423 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 8.8 p90 -131.63 141.22 49.58 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.551 -179.25 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.475 HG12 HG13 ' A' ' 148' ' ' ILE . 4.4 p . . . . . 0 C--N 1.329 -0.317 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.629 0.252 . . . . 0.0 110.479 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.541 HG11 ' HB2' ' A' ' 150' ' ' GLN . 15.7 t -55.38 144.77 6.26 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.526 0 CA-C-O 121.441 0.638 . . . . 0.0 111.483 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.66 HD13 ' OG ' ' A' ' 179' ' ' SER . 2.7 pp -124.63 -6.64 6.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.04 178.798 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' GLY . . . . . 0.558 ' O ' HD11 ' A' ' 175' ' ' ILE . . . -179.32 76.99 0.06 OUTLIER Glycine 0 C--N 1.343 0.964 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.043 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.541 ' HB2' HG11 ' A' ' 147' ' ' VAL . 0.1 OUTLIER -89.9 135.21 33.77 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 179.715 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.506 ' HB1' ' HB2' ' A' ' 168' ' ' CYS . . . -151.35 167.68 27.16 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 120.102 -0.639 . . . . 0.0 112.522 -178.761 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.705 ' HG2' HG22 ' A' ' 229' ' ' VAL . 20.5 mt-10 -120.42 124.51 45.65 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.407 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.502 ' HB ' ' O ' ' A' ' 228' ' ' ASP . 3.1 p -51.17 132.63 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -178.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -89.44 -60.16 2.02 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 104.416 -2.439 . . . . 0.0 104.416 175.138 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.508 ' HA ' ' H ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER -161.45 -163.71 1.03 Allowed 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 113.025 -1.898 . . . . 0.0 108.613 174.786 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.564 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 1.5 p -151.91 143.02 23.21 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 176.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.655 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 5.7 m-30 -91.04 75.37 6.29 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.043 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.66 63.72 8.12 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.967 0.889 . . . . 0.0 108.847 178.752 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.475 HG12 ' H ' ' A' ' 161' ' ' LYS . 49.2 t -89.25 154.85 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-N 113.944 -1.48 . . . . 0.0 109.707 -179.39 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 47.4 t -89.74 33.49 0.85 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.074 0.464 . . . . 0.0 110.406 178.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.475 ' H ' HG12 ' A' ' 159' ' ' VAL . 0.3 OUTLIER -150.93 -29.3 0.2 Allowed 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.597 -179.875 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.474 HG12 ' N ' ' A' ' 163' ' ' GLY . 97.7 t -103.52 -101.53 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 O-C-N 122.132 -0.355 . . . . 0.0 110.15 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' GLY . . . . . 0.474 ' N ' HG12 ' A' ' 162' ' ' VAL . . . -158.51 -110.34 0.29 Allowed Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 111.543 -0.623 . . . . 0.0 111.543 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.595 HG21 HG21 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -155.15 58.96 0.65 Allowed 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 178.253 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.655 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 0.3 OUTLIER -38.7 -22.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.219 -0.54 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 -177.243 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.564 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . 31.02 98.36 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 178.163 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -87.59 150.76 22.72 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 178.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.563 ' SG ' HD11 ' A' ' 216' ' ' LEU . 0.0 OUTLIER -145.07 136.48 25.18 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 117.353 0.577 . . . . 0.0 110.725 -178.482 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 169' ' ' TYR . . . . . 0.445 ' O ' ' HA ' ' A' ' 151' ' ' ALA . 71.9 t80 -87.74 131.05 34.63 Favored 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 106.965 -1.495 . . . . 0.0 106.965 177.668 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.533 HG12 ' N ' ' A' ' 212' ' ' TYR . 4.7 p -86.25 144.84 8.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -176.497 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.4 p -138.53 11.91 2.74 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.416 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -151.48 -147.51 0.23 Allowed 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 119.52 -0.276 . . . . 0.0 110.263 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -39.53 -104.56 0.01 OUTLIER Glycine 0 CA--C 1.531 1.047 0 N-CA-C 115.188 0.835 . . . . 0.0 115.188 -178.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.456 ' HB3' ' HB2' ' A' ' 209' ' ' ALA . 0.0 OUTLIER -150.75 143.89 24.78 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.092 0.472 . . . . 0.0 111.88 -178.716 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.684 HG22 HD11 ' A' ' 198' ' ' LEU . 7.4 mm -99.68 87.15 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 N-CA-C 108.498 -0.926 . . . . 0.0 108.498 176.844 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.517 ' HB ' ' O ' ' A' ' 206' ' ' ARG . 0.2 OUTLIER -100.93 172.82 6.8 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.517 0.675 . . . . 0.0 112.106 -178.061 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -69.2 -43.02 74.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.711 -1.131 . . . . 0.0 111.067 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -88.56 58.59 4.74 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.17 -179.243 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' SER . . . . . 0.66 ' OG ' HD13 ' A' ' 148' ' ' ILE . 1.1 m -149.08 162.69 39.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.797 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.531 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 26.4 mttp -89.0 -170.81 3.04 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.412 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.545 HG22 ' CA ' ' A' ' 194' ' ' GLU . 2.4 m -150.23 160.79 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.539 0 CA-C-O 121.398 0.618 . . . . 0.0 111.711 179.346 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 182' ' ' ARG . . . . . 0.458 ' N ' ' O ' ' A' ' 231' ' ' GLU . 43.3 ttm180 -153.58 98.75 2.26 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.136 -0.938 . . . . 0.0 113.215 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.559 HD13 ' CZ ' ' A' ' 221' ' ' PHE . 0.2 OUTLIER -86.68 148.33 25.5 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-O 121.745 0.783 . . . . 0.0 112.22 179.721 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.743 ' N ' HG23 ' A' ' 190' ' ' VAL . 22.2 mt -157.87 130.14 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 114.311 -1.313 . . . . 0.0 111.485 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -88.52 -151.94 0.21 Allowed 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 177.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -94.71 29.84 2.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 118.354 0.525 . . . . 0.0 110.533 179.05 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -154.04 -45.94 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.668 -0.777 . . . . 0.0 113.182 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.682 ' O ' HG23 ' A' ' 184' ' ' ILE . 0.4 OUTLIER -150.11 -160.56 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -178.106 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.721 HG11 ' CG ' ' A' ' 192' ' ' GLU . 96.1 t -87.09 135.76 24.51 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 CA-C-O 121.684 0.754 . . . . 0.0 110.845 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.873 HG21 ' HB2' ' A' ' 228' ' ' ASP . 0.0 OUTLIER -97.67 -35.44 5.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 114.562 -1.199 . . . . 0.0 108.959 179.343 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 191' ' ' TYR . . . . . 0.485 ' HB3' ' CD1' ' A' ' 183' ' ' LEU . 5.0 t80 -157.51 156.13 31.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.569 179.115 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 192' ' ' GLU . . . . . 0.721 ' CG ' HG11 ' A' ' 189' ' ' VAL . 23.8 mt-10 -151.0 155.39 38.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.218 178.5 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 134.85 -113.15 1.1 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.573 -0.823 . . . . 0.0 112.363 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 194' ' ' GLU . . . . . 0.545 ' CA ' HG22 ' A' ' 181' ' ' VAL . 0.0 OUTLIER -150.77 -176.16 5.4 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-O 121.303 0.573 . . . . 0.0 111.161 -179.051 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.725 HD11 HD12 ' A' ' 216' ' ' LEU . 0.3 OUTLIER -99.13 155.07 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.178 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.495 -179.074 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -89.42 -67.64 0.83 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.26 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 1.3 m -150.91 154.45 37.19 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.949 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.756 HD13 ' HB3' ' A' ' 216' ' ' LEU . 3.5 mm? -107.46 117.8 35.05 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.962 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 199' ' ' LYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 18.1 ttmt -138.13 115.14 10.85 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.812 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 7.6 ttm180 . . . . . 0 C--N 1.325 -0.493 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.846 179.688 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 204' ' ' ASP . . . . . 0.401 ' HA ' ' HA ' ' A' ' 199' ' ' LYS . 16.4 t70 . . . . . 0 N--CA 1.453 -0.293 0 CA-C-O 120.931 0.396 . . . . 0.0 110.279 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 32.7 m -59.28 159.86 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.934 0 CA-C-O 121.603 0.716 . . . . 0.0 112.317 -179.157 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 206' ' ' ARG . . . . . 0.517 ' O ' ' HB ' ' A' ' 176' ' ' THR . 7.6 ttm-85 -89.44 -36.51 15.4 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 114.651 -1.159 . . . . 0.0 111.795 -178.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -141.31 179.42 6.78 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.221 0.534 . . . . 0.0 111.682 -179.579 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.496 ' O ' HG21 ' A' ' 170' ' ' VAL . 0.6 OUTLIER -151.12 70.95 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.729 178.661 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.456 ' HB2' ' HB3' ' A' ' 174' ' ' LYS . . . -97.46 178.47 5.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.138 -178.821 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 81.97 -75.45 0.03 OUTLIER 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.538 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 178.41 38.12 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.401 -0.904 . . . . 0.0 112.286 179.008 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 212' ' ' TYR . . . . . 0.533 ' N ' HG12 ' A' ' 170' ' ' VAL . 0.2 OUTLIER -107.43 150.09 27.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.159 0.504 . . . . 0.0 112.025 -179.118 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -96.57 152.78 18.31 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.076 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 214' ' ' CYS . . . . . 0.472 ' HB3' HG21 ' A' ' 208' ' ' VAL . 18.5 t -150.64 154.34 37.31 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.004 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -89.53 110.24 3.7 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.116 179.122 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.756 ' HB3' HD13 ' A' ' 198' ' ' LEU . 0.2 OUTLIER -134.44 131.36 38.04 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 121.298 0.571 . . . . 0.0 111.59 -179.026 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 217' ' ' THR . . . . . 0.402 ' O ' HD13 ' A' ' 195' ' ' ILE . 0.2 OUTLIER -84.35 130.38 34.8 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.93 179.872 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 218' ' ' ILE . . . . . 0.593 HG22 ' O ' ' A' ' 218' ' ' ILE . 1.5 mp -90.84 79.27 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 34.75 -85.99 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.998 0 O-C-N 124.134 0.896 . . . . 0.0 112.835 -178.664 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 220' ' ' ASN . . . . . 0.439 ' N ' ' O ' ' A' ' 218' ' ' ILE . 5.9 p30 -129.73 65.67 1.48 Allowed 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.589 -179.427 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 221' ' ' PHE . . . . . 0.559 ' CZ ' HD13 ' A' ' 183' ' ' LEU . 0.1 OUTLIER -58.58 119.38 6.94 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 177.883 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -77.91 -44.51 26.79 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 176.312 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 223' ' ' ASP . . . . . 0.829 ' OD2' HG12 ' A' ' 190' ' ' VAL . 0.0 OUTLIER -92.74 143.19 26.55 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.236 177.713 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.638 HD13 ' N ' ' A' ' 224' ' ' ILE . 0.2 OUTLIER -140.48 -179.4 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -178.706 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.414 ' O ' ' C ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER 55.26 110.56 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 114.319 -1.31 . . . . 0.0 110.067 -178.881 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 226' ' ' GLU . . . . . 0.508 ' H ' ' HA ' ' A' ' 155' ' ' GLN . 18.2 tt0 10.95 60.5 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 124.747 1.28 . . . . 0.0 112.948 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -71.59 -58.13 5.58 Favored Glycine 0 N--CA 1.421 -2.348 0 CA-C-N 114.115 -1.402 . . . . 0.0 113.144 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.873 ' HB2' HG21 ' A' ' 190' ' ' VAL . 25.8 m-20 -158.48 -160.62 0.9 Allowed 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -178.019 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 229' ' ' VAL . . . . . 0.705 HG22 ' HG2' ' A' ' 152' ' ' GLU . 42.9 t -88.65 152.98 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 CA-C-O 120.769 0.318 . . . . 0.0 110.15 178.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 230' ' ' ILE . . . . . 0.424 HD13 ' HB3' ' A' ' 168' ' ' CYS . 3.0 mp -120.92 153.93 24.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.753 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 231' ' ' GLU . . . . . 0.458 ' O ' ' N ' ' A' ' 182' ' ' ARG . 20.1 tt0 -147.12 111.58 5.23 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 119.839 -0.744 . . . . 0.0 112.676 -179.385 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.555 ' HB1' HD11 ' A' ' 148' ' ' ILE . . . -87.17 135.58 33.24 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.17 178.677 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 233' ' ' TYR . . . . . 0.63 ' O ' HG23 ' A' ' 234' ' ' VAL . 3.5 p90 -137.64 156.75 47.7 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.062 -178.45 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 233' ' ' TYR . 0.9 OUTLIER . . . . . 0 CA--C 1.536 0.435 0 CA-C-O 121.15 0.5 . . . . 0.0 110.743 179.23 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 4.5 ptpt . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.553 0.216 . . . . 0.0 110.767 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.481 HG11 ' HB2' ' A' ' 150' ' ' GLN . 12.1 t -58.58 139.99 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.611 0 CA-C-O 121.297 0.57 . . . . 0.0 111.506 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.557 HD11 ' HB3' ' A' ' 179' ' ' SER . 2.7 pp -127.06 -1.82 4.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.35 178.654 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' GLY . . . . . 0.512 ' O ' ' HB3' ' A' ' 232' ' ' ALA . . . 178.08 75.34 0.06 OUTLIER Glycine 0 C--N 1.342 0.897 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.912 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.481 ' HB2' HG11 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -89.97 136.41 33.06 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 122.721 -0.282 . . . . 0.0 110.336 -179.969 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.503 ' O ' HG13 ' A' ' 229' ' ' VAL . . . -151.17 179.59 8.16 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-O 121.63 0.729 . . . . 0.0 112.871 -178.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.904 ' HG2' HG22 ' A' ' 229' ' ' VAL . 1.3 tt0 -126.96 120.37 28.94 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.814 -1.084 . . . . 0.0 110.445 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.464 HG12 ' O ' ' A' ' 228' ' ' ASP . 2.2 p -48.13 137.97 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -179.37 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.483 ' O ' ' HB3' ' A' ' 226' ' ' GLU . 3.2 mmp_? -97.44 -61.03 1.45 Allowed 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 105.963 -1.865 . . . . 0.0 105.963 176.093 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.75 -160.53 0.46 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 113.739 -1.573 . . . . 0.0 109.157 175.505 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.49 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 5.9 p -150.92 149.0 29.11 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 177.275 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.601 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 5.6 m-30 -92.6 72.1 5.03 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -178.465 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 15.6 tttt -85.95 62.21 7.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 122.002 0.906 . . . . 0.0 109.071 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 55.2 t -89.64 155.78 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 CA-C-N 113.919 -1.492 . . . . 0.0 109.535 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 9.0 m -89.72 22.41 3.09 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.049 178.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.71 5.66 0.52 Allowed 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.188 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 57.8 t -129.98 -99.17 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 CA-C-N 118.483 0.583 . . . . 0.0 110.14 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -158.02 -113.51 0.38 Allowed Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.415 ' CG2' ' CG2' ' A' ' 224' ' ' ILE . 0.0 OUTLIER -153.98 32.9 0.44 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.462 -0.869 . . . . 0.0 109.098 178.157 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.601 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 1.9 mm -40.27 93.78 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.715 -179.477 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.49 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . -88.25 118.45 27.85 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 114.729 -1.123 . . . . 0.0 111.967 -179.203 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -89.59 151.21 21.69 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.49 179.198 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -147.58 133.45 19.08 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -179.349 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' TYR . . . . . 0.451 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 11.1 t80 -86.8 131.28 34.17 Favored 'General case' 0 C--O 1.219 -0.512 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 178.279 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.508 HG12 ' N ' ' A' ' 212' ' ' TYR . 5.7 p -85.64 147.01 5.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -175.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.1 p -141.87 13.12 2.07 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.04 -0.982 . . . . 0.0 112.359 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.412 ' CB ' ' HB2' ' A' ' 150' ' ' GLN . 10.4 t0 -151.27 -145.87 0.18 Allowed 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -38.96 -103.53 0.01 OUTLIER Glycine 0 CA--C 1.531 1.05 0 N-CA-C 115.275 0.87 . . . . 0.0 115.275 -178.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.565 ' HG2' ' HB2' ' A' ' 209' ' ' ALA . 21.9 mttm -150.47 134.94 17.25 Favored 'General case' 0 CA--C 1.515 -0.402 0 O-C-N 122.591 -0.358 . . . . 0.0 111.871 -178.62 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.557 ' O ' HG22 ' A' ' 175' ' ' ILE . 3.5 mm -93.37 86.89 2.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 176.62 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.723 HG22 ' HB3' ' A' ' 207' ' ' GLU . 0.1 OUTLIER -100.79 172.24 7.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.523 -177.265 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -69.25 -42.1 76.05 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.347 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -88.75 56.32 3.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.415 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 179' ' ' SER . . . . . 0.557 ' HB3' HD11 ' A' ' 148' ' ' ILE . 29.7 m -145.97 157.34 43.88 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.428 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 0.0 OUTLIER -89.25 -172.93 3.83 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.44 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.504 HG22 ' HA ' ' A' ' 194' ' ' GLU . 0.6 OUTLIER -150.1 156.76 6.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.385 0.612 . . . . 0.0 111.473 179.512 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 182' ' ' ARG . . . . . 0.425 ' N ' ' O ' ' A' ' 231' ' ' GLU . 60.2 ttt180 -152.03 101.83 2.76 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.113 -0.948 . . . . 0.0 112.581 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.724 HD12 ' HB3' ' A' ' 191' ' ' TYR . 0.3 OUTLIER -86.16 157.41 20.01 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-O 121.862 0.839 . . . . 0.0 112.918 -179.669 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.614 HD12 ' C ' ' A' ' 183' ' ' LEU . 3.1 mp -151.01 121.36 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 113.885 -1.507 . . . . 0.0 111.935 177.688 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.418 ' HB2' HG22 ' A' ' 190' ' ' VAL . 0.0 OUTLIER -85.45 -151.76 0.15 Allowed 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 177.504 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -93.97 28.57 2.38 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 118.539 0.608 . . . . 0.0 110.829 178.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -154.62 -76.96 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.619 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.452 ' H ' HD12 ' A' ' 188' ' ' ILE . 0.1 OUTLIER -116.47 -156.54 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 115.34 -0.43 . . . . 0.0 110.718 -179.039 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.749 HG11 ' CG ' ' A' ' 192' ' ' GLU . 46.3 t -87.37 133.96 28.9 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.101 0 CA-C-O 121.518 0.675 . . . . 0.0 111.771 -179.235 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.907 HG12 ' OD2' ' A' ' 223' ' ' ASP . 0.2 OUTLIER -89.61 -34.21 6.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 114.778 -1.101 . . . . 0.0 108.884 178.503 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 191' ' ' TYR . . . . . 0.724 ' HB3' HD12 ' A' ' 183' ' ' LEU . 41.5 t80 -157.6 155.87 30.88 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 178.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 192' ' ' GLU . . . . . 0.749 ' CG ' HG11 ' A' ' 189' ' ' VAL . 14.4 mt-10 -150.14 148.83 29.43 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.287 177.342 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 133.05 -127.75 4.85 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.068 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 194' ' ' GLU . . . . . 0.504 ' HA ' HG22 ' A' ' 181' ' ' VAL . 4.5 pt-20 -145.38 -178.88 6.3 Favored 'General case' 0 CA--C 1.499 -0.986 0 CA-C-O 121.662 0.744 . . . . 0.0 112.631 -178.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.778 HG12 HD13 ' A' ' 216' ' ' LEU . 4.7 mp -89.67 153.42 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.115 -179.299 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -93.95 -52.19 4.53 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.231 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 4.6 m -151.38 144.92 24.91 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.858 178.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.793 HD12 HD22 ' A' ' 216' ' ' LEU . 2.8 tt -120.49 118.01 29.14 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.427 0.632 . . . . 0.0 111.647 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 199' ' ' LYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 10.7 tttm -148.83 122.52 9.23 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.672 179.31 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 8.4 ttp85 . . . . . 0 C--N 1.321 -0.637 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.314 -179.52 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 204' ' ' ASP . . . . . 0.406 ' HA ' ' HA ' ' A' ' 199' ' ' LYS . 4.9 p-10 . . . . . 0 N--CA 1.451 -0.402 0 CA-C-O 121.025 0.441 . . . . 0.0 110.107 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.6 HG23 ' CD2' ' A' ' 198' ' ' LEU . 28.3 m -56.29 156.94 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.931 0 CA-C-O 121.515 0.674 . . . . 0.0 112.23 -179.107 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 206' ' ' ARG . . . . . 0.469 ' O ' ' HB ' ' A' ' 176' ' ' THR . 0.1 OUTLIER -89.51 -34.07 16.54 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.899 -178.447 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.723 ' HB3' HG22 ' A' ' 176' ' ' THR . 3.0 mt-10 -141.26 175.75 9.39 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.03 0.443 . . . . 0.0 111.161 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.803 HG12 ' HB3' ' A' ' 212' ' ' TYR . 0.1 OUTLIER -150.8 83.25 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.782 178.761 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.565 ' HB2' ' HG2' ' A' ' 174' ' ' LYS . . . -101.85 174.05 6.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.787 -179.187 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 80.63 -68.76 0.1 Allowed 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.725 -179.503 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 178.95 36.75 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.49 179.132 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 212' ' ' TYR . . . . . 0.803 ' HB3' HG12 ' A' ' 208' ' ' VAL . 2.7 m-85 -100.27 135.01 42.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.022 0.439 . . . . 0.0 111.747 -179.167 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 213' ' ' GLU . . . . . 0.407 ' HG2' ' HA ' ' A' ' 169' ' ' TYR . 6.7 mt-10 -89.73 152.25 21.42 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.22 179.538 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 214' ' ' CYS . . . . . 0.401 ' HB2' HG21 ' A' ' 208' ' ' VAL . 0.7 OUTLIER -150.57 139.89 21.33 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.095 179.967 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -89.08 115.92 4.57 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.662 -0.78 . . . . 0.0 111.733 179.483 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.793 HD22 HD12 ' A' ' 198' ' ' LEU . 0.4 OUTLIER -135.47 141.6 45.38 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 121.119 0.485 . . . . 0.0 111.609 -179.28 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 217' ' ' THR . . . . . 0.403 ' N ' HD13 ' A' ' 165' ' ' ILE . 1.4 m -89.17 133.1 34.54 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.374 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 218' ' ' ILE . . . . . 0.621 ' CD1' HD12 ' A' ' 216' ' ' LEU . 1.6 mp -86.16 134.4 27.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 -179.386 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 219' ' ' LYS . . . . . 0.416 ' HG2' ' O ' ' A' ' 194' ' ' GLU . 5.5 ptmt -39.24 -31.75 0.09 Allowed 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 114.406 1.262 . . . . 0.0 114.406 -177.05 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -153.08 40.38 0.54 Allowed 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 -178.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 221' ' ' PHE . . . . . 0.689 ' CZ ' HD13 ' A' ' 183' ' ' LEU . 0.1 OUTLIER -59.16 115.98 3.55 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 178.626 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -83.67 -42.56 16.51 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.12 -0.946 . . . . 0.0 108.481 176.324 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 223' ' ' ASP . . . . . 0.907 ' OD2' HG12 ' A' ' 190' ' ' VAL . 0.0 OUTLIER -90.53 141.95 28.24 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.893 178.201 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.451 ' C ' HD12 ' A' ' 224' ' ' ILE . 2.5 pp -122.49 -177.97 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.36 0.6 . . . . 0.0 112.423 -179.373 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.461 ' O ' ' N ' ' A' ' 227' ' ' GLY . 11.4 mtpt 59.37 172.76 0.08 Allowed 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.289 -177.805 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 226' ' ' GLU . . . . . 0.483 ' HB3' ' O ' ' A' ' 154' ' ' ARG . 0.3 OUTLIER -58.61 84.09 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.036 0.446 . . . . 0.0 110.831 179.683 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 227' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 225' ' ' LYS . . . -71.65 -61.54 3.79 Favored Glycine 0 N--CA 1.427 -1.911 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 178.475 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.464 ' O ' HG12 ' A' ' 153' ' ' VAL . 0.9 OUTLIER -164.6 -148.3 0.11 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 178.669 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 229' ' ' VAL . . . . . 0.904 HG22 ' HG2' ' A' ' 152' ' ' GLU . 59.4 t -89.48 145.33 7.53 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 O-C-N 122.331 -0.231 . . . . 0.0 110.606 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 230' ' ' ILE . . . . . 0.415 HG13 ' CD2' ' A' ' 183' ' ' LEU . 2.9 mt -116.16 153.07 17.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.205 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 231' ' ' GLU . . . . . 0.479 ' HA ' ' HA ' ' A' ' 150' ' ' GLN . 23.9 tt0 -142.1 111.73 6.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.33 0.586 . . . . 0.0 112.369 -179.431 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' A' ' 149' ' ' GLY . . . -88.89 127.92 35.65 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.942 179.108 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -128.36 144.44 51.13 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.945 -179.011 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.553 HG12 HG12 ' A' ' 148' ' ' ILE . 0.3 OUTLIER . . . . . 0 CA--C 1.535 0.368 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.881 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 12.2 mttp . . . . . 0 CA--C 1.529 0.135 0 N-CA-C 110.417 -0.216 . . . . 0.0 110.417 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.782 ' O ' HD13 ' A' ' 148' ' ' ILE . 6.4 t -115.85 137.59 49.01 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.79 0 CA-C-O 121.356 0.598 . . . . 0.0 110.804 179.128 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.782 HD13 ' O ' ' A' ' 147' ' ' VAL . 31.0 mm -129.45 -3.93 3.01 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.693 178.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' GLY . . . . . 0.522 ' O ' ' HB3' ' A' ' 232' ' ' ALA . . . -171.97 70.77 0.11 Allowed Glycine 0 C--N 1.341 0.806 0 N-CA-C 111.344 -0.703 . . . . 0.0 111.344 179.158 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.643 ' HB2' HG11 ' A' ' 147' ' ' VAL . 0.8 OUTLIER -91.31 136.25 33.23 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-O 120.734 0.302 . . . . 0.0 110.639 -179.643 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.428 ' HB1' ' HB2' ' A' ' 168' ' ' CYS . . . -151.76 175.79 12.06 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 121.537 0.684 . . . . 0.0 112.761 -178.293 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.761 ' HG2' HG22 ' A' ' 229' ' ' VAL . 31.3 mt-10 -126.15 121.64 33.4 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.5 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.474 HG11 ' N ' ' A' ' 227' ' ' GLY . 1.6 p -47.31 144.42 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 121.37 0.605 . . . . 0.0 112.595 -179.108 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.482 ' O ' ' HB3' ' A' ' 226' ' ' GLU . 3.8 mmp_? -109.86 -57.32 2.2 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 176.72 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.55 -162.88 0.61 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 113.755 -1.566 . . . . 0.0 109.776 175.34 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 8.0 p -150.79 163.88 37.55 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 177.598 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.547 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 0.2 OUTLIER -116.05 80.08 1.4 Allowed 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -179.033 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 6.5 tttt -86.53 62.77 7.61 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.684 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.434 HG12 ' N ' ' A' ' 161' ' ' LYS . 71.7 t -92.9 157.32 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 CA-C-N 113.659 -1.61 . . . . 0.0 110.528 -178.49 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 28.9 t -92.33 35.89 1.0 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 177.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.434 ' N ' HG12 ' A' ' 159' ' ' VAL . 0.0 OUTLIER -151.37 -35.22 0.14 Allowed 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.092 -179.592 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.766 HG11 HD12 ' A' ' 165' ' ' ILE . 88.7 t -98.96 -103.7 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.748 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' GLY . . . . . 0.524 ' N ' HG12 ' A' ' 162' ' ' VAL . . . -159.51 -99.99 0.16 Allowed Glycine 0 N--CA 1.452 -0.271 0 N-CA-C 111.194 -0.763 . . . . 0.0 111.194 178.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.477 HG22 HG22 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -153.72 33.83 0.45 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 113.958 -1.121 . . . . 0.0 108.278 177.732 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.766 HD12 HG11 ' A' ' 162' ' ' VAL . 3.6 mt -41.98 95.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.461 0.086 0 CA-C-N 115.155 -0.929 . . . . 0.0 111.664 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.532 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . -87.12 125.23 34.01 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.735 -1.12 . . . . 0.0 112.27 -179.444 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -88.99 144.39 18.02 Favored Glycine 0 N--CA 1.442 -0.951 0 N-CA-C 110.534 -1.027 . . . . 0.0 110.534 178.534 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.428 ' HB2' ' HB1' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -145.69 132.36 19.93 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 117.204 0.502 . . . . 0.0 110.271 -178.884 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 169' ' ' TYR . . . . . 0.421 ' O ' ' HA ' ' A' ' 151' ' ' ALA . 5.6 t80 -87.3 127.37 35.18 Favored 'General case' 0 C--O 1.222 -0.39 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 177.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.833 HG21 ' O ' ' A' ' 208' ' ' VAL . 44.3 t -85.44 142.16 13.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 -176.524 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.4 p -135.38 12.61 3.51 Favored 'General case' 0 C--O 1.231 0.084 0 CA-C-N 114.833 -1.076 . . . . 0.0 112.3 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.417 ' CB ' ' HB2' ' A' ' 150' ' ' GLN . 4.8 t70 -146.87 -144.01 0.15 Allowed 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -179.377 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -45.2 -107.03 0.01 OUTLIER Glycine 0 CA--C 1.532 1.149 0 N-CA-C 114.792 0.677 . . . . 0.0 114.792 -178.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.553 ' HB3' ' HB2' ' A' ' 209' ' ' ALA . 0.0 OUTLIER -150.76 135.0 16.94 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 122.562 -0.375 . . . . 0.0 111.039 -178.943 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.59 ' CG2' HG23 ' A' ' 208' ' ' VAL . 0.5 OUTLIER -92.31 111.45 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 176.47 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.504 ' HB ' ' O ' ' A' ' 206' ' ' ARG . 0.1 OUTLIER -118.54 169.47 9.76 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.458 0.647 . . . . 0.0 112.481 -176.327 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.491 ' HA ' HG21 ' A' ' 195' ' ' ILE . 0.5 OUTLIER -61.13 -40.86 95.41 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.478 179.667 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -95.91 63.64 2.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.251 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 4.8 m -148.8 161.43 41.82 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.92 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 0.0 OUTLIER -88.93 -175.29 4.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.722 179.493 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.549 HG21 HG23 ' A' ' 218' ' ' ILE . 1.6 m -147.93 156.09 9.58 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.478 0 CA-C-O 121.247 0.546 . . . . 0.0 111.731 179.49 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 182' ' ' ARG . . . . . 0.445 ' N ' ' O ' ' A' ' 231' ' ' GLU . 17.9 ttt180 -152.96 100.67 2.52 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.313 -0.858 . . . . 0.0 113.305 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.656 HD13 ' CZ ' ' A' ' 221' ' ' PHE . 0.3 OUTLIER -86.88 156.1 19.98 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-O 121.7 0.762 . . . . 0.0 112.839 -179.869 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.695 ' N ' HG23 ' A' ' 190' ' ' VAL . 28.9 mm -154.01 123.93 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 114.487 -1.233 . . . . 0.0 111.345 178.763 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.569 ' N ' HG22 ' A' ' 190' ' ' VAL . 4.6 ttp180 -85.68 -151.3 0.15 Allowed 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 177.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -93.84 25.8 3.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 118.509 0.595 . . . . 0.0 110.892 178.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -155.12 -67.57 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.498 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -121.16 -156.34 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-N 115.297 -0.452 . . . . 0.0 110.84 -178.869 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.807 HG11 ' CG ' ' A' ' 192' ' ' GLU . 58.3 t -87.39 136.28 23.41 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 CA-C-O 121.287 0.565 . . . . 0.0 111.632 -179.135 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.8 HG12 ' OD2' ' A' ' 223' ' ' ASP . 0.1 OUTLIER -89.57 -33.86 6.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.099 -0.955 . . . . 0.0 108.914 178.614 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 191' ' ' TYR . . . . . 0.612 ' HB3' HD12 ' A' ' 183' ' ' LEU . 16.0 t80 -162.5 157.04 21.73 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.386 -0.825 . . . . 0.0 112.273 178.787 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 192' ' ' GLU . . . . . 0.807 ' CG ' HG11 ' A' ' 189' ' ' VAL . 15.7 mt-10 -149.94 160.08 43.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.902 178.372 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 133.46 -115.4 1.52 Allowed Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.519 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 194' ' ' GLU . . . . . 0.51 ' CA ' HG22 ' A' ' 181' ' ' VAL . 17.1 pt-20 -150.4 -174.87 4.88 Favored 'General case' 0 CA--C 1.496 -1.1 0 CA-C-O 121.247 0.546 . . . . 0.0 111.342 -178.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.812 HD13 ' O ' ' A' ' 217' ' ' THR . 0.4 OUTLIER -88.52 142.84 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.024 -178.921 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.75 -55.35 3.74 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.03 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 17.2 p -152.6 164.68 37.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.051 178.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.782 ' CD1' HD22 ' A' ' 216' ' ' LEU . 21.2 tp -135.16 110.25 8.87 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.417 0.627 . . . . 0.0 111.419 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 199' ' ' LYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 45.4 mttt -137.79 126.91 24.36 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.308 179.472 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 27.8 ttm180 . . . . . 0 C--N 1.32 -0.71 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.274 -179.937 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 204' ' ' ASP . . . . . 0.417 ' HA ' ' HA ' ' A' ' 199' ' ' LYS . 7.1 p-10 . . . . . 0 N--CA 1.452 -0.337 0 CA-C-O 120.741 0.305 . . . . 0.0 110.338 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 28.4 m -59.32 158.7 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -1.011 0 CA-C-O 121.554 0.692 . . . . 0.0 112.001 -179.352 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 206' ' ' ARG . . . . . 0.504 ' O ' ' HB ' ' A' ' 176' ' ' THR . 4.0 ttp180 -89.43 -38.03 14.38 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.505 -178.813 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -141.2 177.46 8.07 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.073 0.463 . . . . 0.0 111.418 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.833 ' O ' HG21 ' A' ' 170' ' ' VAL . 0.1 OUTLIER -151.28 79.78 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.462 178.759 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.553 ' HB2' ' HB3' ' A' ' 174' ' ' LYS . . . -104.49 173.34 6.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.065 0.459 . . . . 0.0 112.204 -178.689 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 84.22 -71.61 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.104 -179.587 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 178.05 37.6 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.394 179.157 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -104.51 140.56 37.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.983 0.421 . . . . 0.0 111.233 -179.418 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -93.26 152.75 18.99 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.28 179.641 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 214' ' ' CYS . . . . . 0.491 ' HB2' HG21 ' A' ' 208' ' ' VAL . 2.3 m -150.54 145.55 26.02 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.767 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -88.26 106.35 3.23 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.484 -0.865 . . . . 0.0 110.998 179.178 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.782 HD22 ' CD1' ' A' ' 198' ' ' LEU . 0.2 OUTLIER -133.53 145.34 50.04 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 120.993 0.425 . . . . 0.0 111.789 -178.055 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 217' ' ' THR . . . . . 0.812 ' O ' HD13 ' A' ' 195' ' ' ILE . 0.2 OUTLIER -86.64 140.79 29.48 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.488 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 218' ' ' ILE . . . . . 0.606 HG22 ' O ' ' A' ' 218' ' ' ILE . 1.6 mp -108.5 94.03 2.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 121.028 -0.269 . . . . 0.0 110.427 -179.158 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 6.1 tttp 42.16 -143.7 0.08 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.133 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 32.1 t30 -87.87 63.71 7.54 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 120.901 0.381 . . . . 0.0 110.9 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 221' ' ' PHE . . . . . 0.656 ' CZ ' HD13 ' A' ' 183' ' ' LEU . 0.1 OUTLIER -54.98 118.01 3.93 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 114.595 1.332 . . . . 0.0 114.595 178.835 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -83.07 -43.55 16.16 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.586 176.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 223' ' ' ASP . . . . . 0.8 ' OD2' HG12 ' A' ' 190' ' ' VAL . 0.0 OUTLIER -89.73 129.97 36.06 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.023 178.264 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.54 HD12 ' HG3' ' A' ' 225' ' ' LYS . 2.0 pt -114.67 178.95 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 CA-C-O 121.191 0.519 . . . . 0.0 111.551 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.54 ' HG3' HD12 ' A' ' 224' ' ' ILE . 11.2 mtpt 62.38 155.63 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.098 -178.506 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 226' ' ' GLU . . . . . 0.482 ' HB3' ' O ' ' A' ' 154' ' ' ARG . 0.6 OUTLIER -45.08 90.35 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 121.199 0.523 . . . . 0.0 111.77 -179.461 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 227' ' ' GLY . . . . . 0.474 ' N ' HG11 ' A' ' 153' ' ' VAL . . . -83.35 -57.97 2.39 Favored Glycine 0 N--CA 1.428 -1.885 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 178.789 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.453 ' O ' HG12 ' A' ' 153' ' ' VAL . 1.0 OUTLIER -163.83 -148.89 0.13 Allowed 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 179.014 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 229' ' ' VAL . . . . . 0.761 HG22 ' HG2' ' A' ' 152' ' ' GLU . 46.1 t -90.33 149.38 4.07 Favored 'Isoleucine or valine' 0 C--N 1.341 0.218 0 CA-C-O 120.75 0.31 . . . . 0.0 110.771 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 2.7 mp -120.17 153.41 23.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.77 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 231' ' ' GLU . . . . . 0.458 ' HA ' ' HA ' ' A' ' 150' ' ' GLN . 0.0 OUTLIER -144.14 109.97 5.31 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.357 0.598 . . . . 0.0 112.559 -179.053 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.522 ' HB3' ' O ' ' A' ' 149' ' ' GLY . . . -88.65 127.46 35.57 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.598 178.638 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 233' ' ' TYR . . . . . 0.423 ' CE1' ' HB3' ' A' ' 180' ' ' LYS . 26.1 p90 -123.02 140.59 52.87 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.013 0.435 . . . . 0.0 111.403 -178.852 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.538 0.496 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.04 179.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.132 0 CA-C-O 120.608 0.242 . . . . 0.0 110.583 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.698 HG11 ' HB2' ' A' ' 150' ' ' GLN . 19.5 t -58.77 141.53 15.62 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.559 0 CA-C-O 121.394 0.616 . . . . 0.0 111.559 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.818 HD13 HG12 ' A' ' 234' ' ' VAL . 1.3 pt -123.7 -8.38 7.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.074 178.247 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' GLY . . . . . 0.504 ' CA ' ' HB3' ' A' ' 232' ' ' ALA . . . -174.63 74.56 0.08 OUTLIER Glycine 0 C--N 1.344 0.981 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.114 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.698 ' HB2' HG11 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -89.38 136.8 32.82 Favored 'General case' 0 CA--C 1.506 -0.725 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.255 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.486 ' HB1' ' HB2' ' A' ' 168' ' ' CYS . . . -151.35 169.15 22.69 Favored 'General case' 0 N--CA 1.435 -1.176 0 C-N-CA 120.164 -0.615 . . . . 0.0 112.387 -178.03 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.742 ' HG2' HG22 ' A' ' 229' ' ' VAL . 12.9 mt-10 -119.85 124.98 47.4 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.024 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.53 ' HB ' HD11 ' A' ' 230' ' ' ILE . 4.0 p -55.9 128.15 15.79 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 CA-C-O 121.325 0.583 . . . . 0.0 111.771 -179.375 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.414 ' CA ' ' NE ' ' A' ' 154' ' ' ARG . 0.0 OUTLIER -89.99 -53.54 4.44 Favored 'General case' 0 N--CA 1.429 -1.521 0 N-CA-C 105.175 -2.158 . . . . 0.0 105.175 175.982 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.542 ' HA ' ' H ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER -162.33 -163.36 0.91 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 114.016 -1.447 . . . . 0.0 110.482 175.233 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.595 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 6.0 p -148.09 -179.57 7.02 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 177.28 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.546 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 0.2 OUTLIER -133.29 79.41 1.83 Allowed 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -179.911 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.572 ' HG3' HD13 ' A' ' 224' ' ' ILE . 5.7 tmtt? -86.34 62.25 7.31 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 177.648 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.498 HG12 ' N ' ' A' ' 161' ' ' LYS . 54.6 t -92.31 156.05 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 CA-C-N 113.633 -1.622 . . . . 0.0 110.455 -178.353 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 52.3 m -90.86 34.81 0.9 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.125 0.488 . . . . 0.0 109.797 178.163 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.498 ' N ' HG12 ' A' ' 159' ' ' VAL . 0.0 OUTLIER -150.51 -32.76 0.18 Allowed 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.291 -179.713 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.509 HG12 ' N ' ' A' ' 163' ' ' GLY . 89.9 t -101.53 -104.02 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.26 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' GLY . . . . . 0.509 ' N ' HG12 ' A' ' 162' ' ' VAL . . . -159.7 -98.27 0.13 Allowed Glycine 0 N--CA 1.451 -0.347 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 178.819 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.558 ' CG2' HG22 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -153.92 34.83 0.44 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 113.996 -1.102 . . . . 0.0 108.246 177.692 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.565 HG22 ' O ' ' A' ' 165' ' ' ILE . 1.8 mm -41.56 94.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.44 -179.438 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.595 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . -84.06 117.57 23.51 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 114.767 -1.106 . . . . 0.0 112.416 -179.189 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -88.29 136.95 14.08 Favored Glycine 0 N--CA 1.439 -1.109 0 N-CA-C 109.934 -1.267 . . . . 0.0 109.934 178.189 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.7 ' SG ' HD11 ' A' ' 216' ' ' LEU . 0.0 OUTLIER -138.43 132.66 31.71 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.938 0.369 . . . . 0.0 110.838 -178.023 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 169' ' ' TYR . . . . . 0.408 ' O ' ' HA ' ' A' ' 151' ' ' ALA . 11.7 t80 -86.8 133.37 33.65 Favored 'General case' 0 C--O 1.222 -0.368 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 177.716 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.779 HG21 ' O ' ' A' ' 208' ' ' VAL . 44.2 t -85.73 143.55 11.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -176.335 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.1 p -135.28 13.57 3.53 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 114.719 -1.128 . . . . 0.0 112.041 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -150.01 -146.71 0.21 Allowed 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -179.505 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -42.12 -102.5 0.01 OUTLIER Glycine 0 CA--C 1.532 1.117 0 N-CA-C 114.777 0.671 . . . . 0.0 114.777 -179.027 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.798 ' HG2' ' HB2' ' A' ' 209' ' ' ALA . 6.3 mttt -150.75 134.61 16.65 Favored 'General case' 0 CA--C 1.514 -0.407 0 O-C-N 122.696 -0.297 . . . . 0.0 111.19 -178.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.666 HG23 ' O ' ' A' ' 175' ' ' ILE . 1.1 tp -95.18 83.51 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-O 122.195 0.997 . . . . 0.0 108.948 177.221 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.531 HG22 ' HB3' ' A' ' 207' ' ' GLU . 0.0 OUTLIER -90.97 -177.61 4.98 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.501 -1.227 . . . . 0.0 113.144 -176.565 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 46.9 mtm180 -76.58 -45.57 29.79 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 114.572 -1.194 . . . . 0.0 111.206 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -88.96 60.64 5.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.104 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' SER . . . . . 0.646 ' HB3' HD11 ' A' ' 148' ' ' ILE . 74.7 m -147.81 160.08 43.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.828 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 0.0 OUTLIER -88.55 178.69 6.45 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.171 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.827 HG21 HG23 ' A' ' 218' ' ' ILE . 2.9 m -146.73 149.17 16.11 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.539 0 CA-C-O 121.449 0.642 . . . . 0.0 112.165 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 182' ' ' ARG . . . . . 0.457 ' N ' ' O ' ' A' ' 231' ' ' GLU . 2.7 ttt180 -154.11 100.28 2.31 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.822 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.494 HD11 ' HB ' ' A' ' 190' ' ' VAL . 0.6 OUTLIER -99.54 165.79 11.46 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-O 121.21 0.528 . . . . 0.0 110.8 179.767 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.853 HG23 ' O ' ' A' ' 188' ' ' ILE . 42.8 mt -157.5 141.32 7.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.467 -178.272 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.514 ' O ' HG22 ' A' ' 184' ' ' ILE . 30.8 ptt180 -87.75 -157.2 0.39 Allowed 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 177.522 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -93.72 30.6 1.75 Allowed 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.004 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -153.45 -45.47 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.7 -0.762 . . . . 0.0 113.053 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.853 ' O ' HG23 ' A' ' 184' ' ' ILE . 0.2 OUTLIER -150.49 -162.95 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-O 120.945 0.402 . . . . 0.0 112.022 -178.035 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.651 ' N ' HG23 ' A' ' 188' ' ' ILE . 21.9 t -85.85 133.2 30.17 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.531 0 CA-C-O 121.505 0.669 . . . . 0.0 109.842 179.011 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.598 HG23 ' CA ' ' A' ' 184' ' ' ILE . 0.5 OUTLIER -88.38 -35.08 7.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.738 -179.187 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 191' ' ' TYR . . . . . 0.49 ' CB ' HD21 ' A' ' 183' ' ' LEU . 0.4 OUTLIER -176.94 166.5 2.48 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.544 179.735 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 192' ' ' GLU . . . . . 0.463 ' OE2' HG11 ' A' ' 189' ' ' VAL . 37.6 mt-10 -151.11 158.5 44.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.924 0.392 . . . . 0.0 111.072 179.046 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 143.95 -131.47 4.45 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.917 -0.658 . . . . 0.0 111.687 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 194' ' ' GLU . . . . . 0.589 ' CA ' HG22 ' A' ' 181' ' ' VAL . 4.4 pt-20 -133.27 -177.6 4.6 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-O 121.237 0.541 . . . . 0.0 111.003 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.869 HD11 HD13 ' A' ' 216' ' ' LEU . 1.1 tt -88.08 149.07 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.293 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.959 -178.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.48 -60.35 1.97 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 179.029 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 9.7 t -152.02 151.1 30.72 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.532 178.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.991 HD13 HD23 ' A' ' 216' ' ' LEU . 10.9 tp -125.93 118.63 25.82 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.481 0.658 . . . . 0.0 111.644 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 199' ' ' LYS . . . . . 0.421 ' N ' HD12 ' A' ' 198' ' ' LEU . 0.5 OUTLIER -150.23 121.09 7.6 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.593 179.009 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 200' ' ' ARG . . . . . 0.432 ' NH1' ' CD1' ' A' ' 212' ' ' TYR . 3.5 ttm180 . . . . . 0 C--N 1.323 -0.578 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.342 -179.361 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 23.9 p30 . . . . . 0 N--CA 1.452 -0.331 0 CA-C-O 121.188 0.518 . . . . 0.0 109.817 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 33.1 m -55.45 160.8 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.925 0 CA-C-O 121.595 0.712 . . . . 0.0 112.549 -178.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 206' ' ' ARG . . . . . 0.447 ' O ' ' HB ' ' A' ' 176' ' ' THR . 4.8 ttm180 -89.3 -37.26 15.06 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 114.642 -1.163 . . . . 0.0 111.524 -178.602 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.531 ' HB3' HG22 ' A' ' 176' ' ' THR . 1.3 mp0 -138.04 179.41 6.45 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.159 0.504 . . . . 0.0 111.512 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.779 ' O ' HG21 ' A' ' 170' ' ' VAL . 0.2 OUTLIER -150.94 78.4 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.842 179.283 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.798 ' HB2' ' HG2' ' A' ' 174' ' ' LYS . . . -97.44 170.31 9.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.052 0.453 . . . . 0.0 112.151 -178.802 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 85.89 -74.99 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.155 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 211' ' ' GLY . . . . . 0.403 ' O ' ' CE2' ' A' ' 169' ' ' TYR . . . 177.86 37.7 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.219 -0.991 . . . . 0.0 112.494 179.11 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 212' ' ' TYR . . . . . 0.432 ' CD1' ' NH1' ' A' ' 200' ' ' ARG . 1.6 m-85 -95.17 148.62 22.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.966 0.413 . . . . 0.0 111.414 -179.343 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -89.54 159.12 17.37 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.095 179.518 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 10.3 p -150.95 -177.88 6.27 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.182 0.515 . . . . 0.0 111.642 -179.136 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -136.71 105.83 0.53 Allowed Glycine 0 N--CA 1.452 -0.3 0 N-CA-C 110.086 -1.205 . . . . 0.0 110.086 178.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.991 HD23 HD13 ' A' ' 198' ' ' LEU . 0.3 OUTLIER -138.86 144.68 39.32 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -177.685 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 217' ' ' THR . . . . . 0.692 ' O ' HD13 ' A' ' 218' ' ' ILE . 0.0 OUTLIER -79.39 -179.06 6.58 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 176.661 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 218' ' ' ILE . . . . . 0.827 HG23 HG21 ' A' ' 181' ' ' VAL . 49.8 mm -141.11 81.66 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 120.024 -0.67 . . . . 0.0 112.737 -178.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 13.7 tttt 44.08 -134.95 0.57 Allowed 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 121.177 -0.209 . . . . 0.0 110.695 177.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -87.7 53.62 2.84 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.088 0.47 . . . . 0.0 110.645 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 221' ' ' PHE . . . . . 0.486 ' HA ' ' CE2' ' A' ' 191' ' ' TYR . 1.2 t80 -56.96 153.52 11.07 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 117.332 2.345 . . . . 0.0 117.332 179.336 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 222' ' ' ASN . . . . . 0.454 ' HB2' ' CE1' ' A' ' 191' ' ' TYR . 7.8 t-20 -122.52 -49.34 2.02 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 112.957 -1.928 . . . . 0.0 111.481 178.719 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 223' ' ' ASP . . . . . 0.454 ' OD1' ' N ' ' A' ' 224' ' ' ILE . 0.0 OUTLIER -61.28 163.82 6.05 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 -178.463 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.572 HD13 ' HG3' ' A' ' 158' ' ' LYS . 17.4 pt -154.13 -178.31 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 176.4 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 34.4 100.65 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 114.466 -1.243 . . . . 0.0 111.926 -179.587 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 226' ' ' GLU . . . . . 0.542 ' H ' ' HA ' ' A' ' 155' ' ' GLN . 38.1 tt0 25.95 57.44 0.06 Allowed 'General case' 0 N--CA 1.482 1.169 0 O-C-N 124.294 0.996 . . . . 0.0 112.277 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 227' ' ' GLY . . . . . 0.448 ' N ' HG11 ' A' ' 153' ' ' VAL . . . -57.83 -69.83 1.16 Allowed Glycine 0 N--CA 1.429 -1.775 0 CA-C-N 114.411 -1.268 . . . . 0.0 113.14 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.56 ' HB2' HG21 ' A' ' 190' ' ' VAL . 8.3 m-20 -157.58 -159.67 0.86 Allowed 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 -178.233 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 229' ' ' VAL . . . . . 0.742 HG22 ' HG2' ' A' ' 152' ' ' GLU . 69.7 t -88.21 136.09 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 O-C-N 122.142 -0.349 . . . . 0.0 110.308 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 230' ' ' ILE . . . . . 0.623 HD13 ' HB3' ' A' ' 168' ' ' CYS . 5.3 mp -102.64 158.52 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 O-C-N 123.639 0.587 . . . . 0.0 111.257 -179.156 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 231' ' ' GLU . . . . . 0.457 ' O ' ' N ' ' A' ' 182' ' ' ARG . 5.2 tm-20 -147.14 109.57 4.56 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.504 ' HB3' ' CA ' ' A' ' 149' ' ' GLY . . . -87.41 130.05 34.81 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.474 178.521 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -132.81 141.96 48.74 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.047 -178.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.818 HG12 HD13 ' A' ' 148' ' ' ILE . 0.3 OUTLIER . . . . . 0 CA--C 1.535 0.382 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.746 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 17.3 tttt . . . . . 0 N--CA 1.462 0.158 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 3.5 t -60.05 140.24 18.39 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.871 0 CA-C-O 121.254 0.55 . . . . 0.0 111.209 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.533 HG21 ' CG1' ' A' ' 234' ' ' VAL . 3.3 tp -132.61 -3.05 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.225 177.695 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' GLY . . . . . 0.494 ' CA ' ' HB3' ' A' ' 232' ' ' ALA . . . -165.77 66.71 0.21 Allowed Glycine 0 C--N 1.341 0.825 0 C-N-CA 119.982 -1.104 . . . . 0.0 112.496 179.465 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.494 ' HA ' ' HA ' ' A' ' 231' ' ' GLU . 1.3 mt-30 -90.0 132.48 35.33 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.451 ' HB1' ' O ' ' A' ' 169' ' ' TYR . . . -152.54 178.33 9.69 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 -177.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.86 ' CG ' HG22 ' A' ' 229' ' ' VAL . 0.1 OUTLIER -123.7 124.18 42.17 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.693 -1.14 . . . . 0.0 110.373 179.904 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.492 ' CG1' ' HA ' ' A' ' 226' ' ' GLU . 2.7 p -49.5 133.06 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -179.209 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.509 ' O ' ' HB3' ' A' ' 226' ' ' GLU . 4.3 mmp_? -89.56 -62.16 1.54 Allowed 'General case' 0 N--CA 1.434 -1.248 0 N-CA-C 105.08 -2.193 . . . . 0.0 105.08 175.595 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.51 -160.08 0.5 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 113.671 -1.604 . . . . 0.0 108.698 174.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 7.6 p -148.97 159.3 44.33 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.871 0.367 . . . . 0.0 110.232 177.342 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.675 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 2.6 m-85 -104.42 73.95 1.14 Allowed 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -177.523 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -85.9 63.42 8.03 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 122.08 0.943 . . . . 0.0 108.794 178.567 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 93.1 t -90.09 158.1 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-N 113.752 -1.567 . . . . 0.0 110.02 -179.37 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 13.9 m -92.52 33.32 1.12 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.132 0.491 . . . . 0.0 110.004 178.435 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -151.84 -31.78 0.15 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.639 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.556 HG12 HD13 ' A' ' 165' ' ' ILE . 93.0 t -99.47 -101.94 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.203 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' GLY . . . . . 0.478 ' N ' HG12 ' A' ' 162' ' ' VAL . . . -158.79 -104.33 0.2 Allowed Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 111.728 -0.549 . . . . 0.0 111.728 179.335 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.552 HG21 HG21 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -153.78 35.63 0.44 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 114.299 -0.95 . . . . 0.0 108.771 178.355 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.675 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 1.7 mp -42.8 95.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-N 115.327 -0.852 . . . . 0.0 111.342 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.532 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . -87.19 120.79 28.84 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 114.649 -1.16 . . . . 0.0 111.859 -179.288 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -89.46 149.91 20.92 Favored Glycine 0 N--CA 1.442 -0.93 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 178.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.811 ' SG ' HD11 ' A' ' 216' ' ' LEU . 0.0 OUTLIER -144.55 133.78 22.96 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 117.061 0.431 . . . . 0.0 110.21 -179.279 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 169' ' ' TYR . . . . . 0.451 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 1.1 t80 -86.94 127.51 35.07 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 178.262 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.659 HG21 ' O ' ' A' ' 208' ' ' VAL . 36.7 t -85.21 142.97 12.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -175.796 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -132.76 9.16 4.21 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 114.289 -1.323 . . . . 0.0 111.921 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.41 ' CB ' ' HB2' ' A' ' 150' ' ' GLN . 5.5 t0 -142.67 -142.42 0.14 Allowed 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -48.26 -104.84 0.01 OUTLIER Glycine 0 CA--C 1.535 1.294 0 C-N-CA 120.636 -0.792 . . . . 0.0 114.387 -179.34 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.824 ' HG3' ' HB2' ' A' ' 209' ' ' ALA . 0.0 OUTLIER -145.45 133.91 21.94 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.003 0.521 . . . . 0.0 110.849 -179.276 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.652 HG23 ' O ' ' A' ' 175' ' ' ILE . 9.0 tp -88.5 84.12 2.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 122.26 1.029 . . . . 0.0 109.425 178.182 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.785 HG22 ' HB3' ' A' ' 207' ' ' GLU . 0.6 OUTLIER -85.99 -174.42 5.09 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.327 -1.306 . . . . 0.0 113.924 -176.585 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -84.71 -45.99 11.89 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 114.417 -1.265 . . . . 0.0 111.439 -179.427 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -88.72 52.89 2.54 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.589 -178.567 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -139.66 161.24 38.0 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.882 179.15 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 1.1 mptt -88.65 -172.21 3.64 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.506 HG22 ' CA ' ' A' ' 194' ' ' GLU . 3.0 m -141.35 161.03 22.22 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.647 0 CA-C-O 121.4 0.619 . . . . 0.0 111.883 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 182' ' ' ARG . . . . . 0.449 ' HB3' ' HB3' ' A' ' 231' ' ' GLU . 8.4 ttt85 -152.09 92.8 1.75 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.04 -0.982 . . . . 0.0 112.099 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.766 HD22 ' CZ ' ' A' ' 221' ' ' PHE . 5.7 mp -88.37 142.33 27.82 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -178.652 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.665 HD13 ' O ' ' A' ' 183' ' ' LEU . 17.3 mm -150.56 128.73 2.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 113.05 -1.886 . . . . 0.0 111.36 179.348 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.421 ' N ' HG22 ' A' ' 190' ' ' VAL . 4.0 ttp180 -88.83 -148.09 0.17 Allowed 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 177.655 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -95.79 28.33 3.11 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 118.473 0.579 . . . . 0.0 110.726 178.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.475 ' C ' HD13 ' A' ' 188' ' ' ILE . . . -153.87 -83.6 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.792 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.475 HD13 ' C ' ' A' ' 187' ' ' GLY . 0.2 OUTLIER -110.22 -157.78 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 115.427 -0.387 . . . . 0.0 110.657 -179.204 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.605 HG11 ' CG ' ' A' ' 192' ' ' GLU . 41.4 t -87.41 135.62 24.92 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 CA-C-O 121.751 0.786 . . . . 0.0 111.262 -179.615 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.878 HG12 ' OD2' ' A' ' 223' ' ' ASP . 0.1 OUTLIER -97.3 -34.04 4.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 114.426 -1.261 . . . . 0.0 109.411 179.76 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 191' ' ' TYR . . . . . 0.746 ' HB3' HD13 ' A' ' 183' ' ' LEU . 41.8 t80 -167.86 154.0 7.54 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.327 -0.852 . . . . 0.0 112.453 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 192' ' ' GLU . . . . . 0.605 ' CG ' HG11 ' A' ' 189' ' ' VAL . 50.7 mt-10 -150.16 158.28 43.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.067 178.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 133.97 -120.48 2.51 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.427 -0.892 . . . . 0.0 112.761 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 194' ' ' GLU . . . . . 0.506 ' CA ' HG22 ' A' ' 181' ' ' VAL . 0.0 OUTLIER -147.92 179.53 7.66 Favored 'General case' 0 CA--C 1.503 -0.857 0 CA-C-O 121.706 0.765 . . . . 0.0 111.797 -179.04 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.949 HD12 HD13 ' A' ' 216' ' ' LEU . 32.9 mm -92.57 153.06 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.308 0 CA-C-N 114.35 -1.295 . . . . 0.0 110.186 -179.186 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -89.97 -58.52 2.48 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.18 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 36.4 p -150.6 156.73 41.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.85 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.918 ' CD1' HD23 ' A' ' 216' ' ' LEU . 5.9 tp -127.88 115.78 19.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.172 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 5.1 ptpt -150.09 120.0 7.13 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.195 -0.912 . . . . 0.0 109.564 179.32 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.523 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.328 -179.249 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 22.7 t70 . . . . . 0 N--CA 1.453 -0.324 0 CA-C-O 121.247 0.546 . . . . 0.0 110.022 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.585 ' O ' HD23 ' A' ' 198' ' ' LEU . 31.9 m -53.91 160.87 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.969 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.352 -179.326 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 206' ' ' ARG . . . . . 0.476 ' O ' ' HB ' ' A' ' 176' ' ' THR . 0.0 OUTLIER -88.86 -36.73 15.83 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.321 -178.859 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.785 ' HB3' HG22 ' A' ' 176' ' ' THR . 0.6 OUTLIER -133.71 176.78 8.24 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.268 0.556 . . . . 0.0 111.821 179.926 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.659 ' O ' HG21 ' A' ' 170' ' ' VAL . 0.2 OUTLIER -150.38 84.24 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.759 179.129 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.824 ' HB2' ' HG3' ' A' ' 174' ' ' LYS . . . -99.99 178.82 4.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.096 0.474 . . . . 0.0 112.086 -178.789 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 81.9 -75.01 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.698 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 211' ' ' GLY . . . . . 0.405 ' O ' ' CE1' ' A' ' 169' ' ' TYR . . . 178.42 37.65 0.06 OUTLIER Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.347 179.033 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -101.75 143.2 31.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.917 0.389 . . . . 0.0 111.372 -179.45 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 213' ' ' GLU . . . . . 0.443 ' HG2' ' CD2' ' A' ' 169' ' ' TYR . 0.0 OUTLIER -98.56 131.5 44.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.454 179.943 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 214' ' ' CYS . . . . . 0.524 ' CB ' HG21 ' A' ' 208' ' ' VAL . 34.6 t -125.84 145.52 50.2 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.333 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -88.38 113.81 4.12 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.148 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.949 HD13 HD12 ' A' ' 195' ' ' ILE . 0.5 OUTLIER -133.81 147.35 51.23 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 120.839 0.352 . . . . 0.0 111.073 -179.26 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.01 138.45 31.97 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 177.038 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 218' ' ' ILE . . . . . 0.648 HG22 ' CE1' ' A' ' 191' ' ' TYR . 19.1 mm -91.33 52.61 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.086 0.469 . . . . 0.0 112.193 -177.467 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 4.6 tptm 61.48 -72.08 0.04 OUTLIER 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.642 178.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 220' ' ' ASN . . . . . 0.426 ' N ' ' O ' ' A' ' 218' ' ' ILE . 5.0 p-10 -145.43 51.45 1.2 Allowed 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.253 -179.089 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 221' ' ' PHE . . . . . 0.766 ' CZ ' HD22 ' A' ' 183' ' ' LEU . 0.1 OUTLIER -57.3 118.49 5.16 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 178.33 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -77.84 -46.3 21.88 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 176.216 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 223' ' ' ASP . . . . . 0.878 ' OD2' HG12 ' A' ' 190' ' ' VAL . 0.0 OUTLIER -88.09 130.39 35.02 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 177.48 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.637 HD13 ' H ' ' A' ' 224' ' ' ILE . 0.2 OUTLIER -117.31 176.77 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 CA-C-O 121.438 0.637 . . . . 0.0 112.466 -179.283 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.463 ' O ' ' N ' ' A' ' 227' ' ' GLY . 10.4 mtmt 62.06 154.28 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.231 -178.62 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 226' ' ' GLU . . . . . 0.509 ' HB3' ' O ' ' A' ' 154' ' ' ARG . 0.2 OUTLIER -39.99 90.77 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 122.235 1.017 . . . . 0.0 111.845 179.939 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 227' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 225' ' ' LYS . . . -106.66 -38.85 2.14 Favored Glycine 0 N--CA 1.429 -1.805 0 CA-C-N 114.356 -1.293 . . . . 0.0 112.207 -178.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.711 ' CB ' HG21 ' A' ' 190' ' ' VAL . 2.9 p30 -157.95 -166.7 2.03 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 115.736 1.754 . . . . 0.0 115.736 -178.166 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 229' ' ' VAL . . . . . 0.86 HG22 ' CG ' ' A' ' 152' ' ' GLU . 40.6 t -97.98 142.48 14.4 Favored 'Isoleucine or valine' 0 C--N 1.343 0.326 0 CA-C-N 114.441 -1.254 . . . . 0.0 108.075 177.623 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 230' ' ' ILE . . . . . 0.403 HG13 ' HG ' ' A' ' 183' ' ' LEU . 3.9 mp -115.48 150.89 17.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.091 0.472 . . . . 0.0 111.831 -178.816 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 231' ' ' GLU . . . . . 0.494 ' HA ' ' HA ' ' A' ' 150' ' ' GLN . 7.4 tt0 -137.69 108.73 6.75 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.271 0.558 . . . . 0.0 110.731 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.494 ' HB3' ' CA ' ' A' ' 149' ' ' GLY . . . -87.8 124.19 33.36 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.808 -179.627 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -123.62 166.97 14.57 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.709 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.533 ' CG1' HG21 ' A' ' 148' ' ' ILE . 9.8 p . . . . . 0 C--N 1.326 -0.444 0 C-N-CA 121.076 -0.249 . . . . 0.0 110.98 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.632 0.253 . . . . 0.0 110.57 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.566 HG11 ' HB2' ' A' ' 150' ' ' GLN . 15.0 t -60.13 139.84 19.03 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 CA-C-O 121.463 0.649 . . . . 0.0 111.356 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.56 ' HB ' HG12 ' A' ' 234' ' ' VAL . 6.9 tp -114.13 -18.97 7.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.231 178.162 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' GLY . . . . . 0.406 ' O ' ' HB3' ' A' ' 232' ' ' ALA . . . 178.97 85.9 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.339 -179.422 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.566 ' HB2' HG11 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -91.44 135.05 34.12 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.664 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.461 ' HB1' ' O ' ' A' ' 169' ' ' TYR . . . -150.78 173.14 14.55 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 -177.751 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.834 ' CG ' HG22 ' A' ' 229' ' ' VAL . 0.4 OUTLIER -117.51 122.82 44.75 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.091 179.715 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.456 HG12 ' O ' ' A' ' 228' ' ' ASP . 2.7 p -55.65 128.92 16.52 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.338 0 CA-C-O 121.326 0.584 . . . . 0.0 111.65 -179.42 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.419 ' CA ' ' NE ' ' A' ' 154' ' ' ARG . 0.0 OUTLIER -89.2 -58.38 2.56 Favored 'General case' 0 N--CA 1.427 -1.606 0 N-CA-C 105.288 -2.115 . . . . 0.0 105.288 176.203 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.43 ' HA ' ' H ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER -163.1 -163.23 0.83 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.691 174.906 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.593 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 7.0 p -147.57 149.01 31.76 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.564 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 0.2 OUTLIER -94.4 80.3 3.92 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -177.984 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 13.8 tttm -85.88 63.69 8.18 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.127 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.42 HG12 ' N ' ' A' ' 161' ' ' LYS . 69.9 t -93.21 157.06 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-N 113.652 -1.613 . . . . 0.0 110.231 -178.748 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -92.07 35.45 0.99 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.208 0.528 . . . . 0.0 109.655 178.129 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.42 ' N ' HG12 ' A' ' 159' ' ' VAL . 5.0 mttt -151.47 -35.32 0.14 Allowed 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.084 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.49 HG12 HD13 ' A' ' 165' ' ' ILE . 95.5 t -97.85 -102.24 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' GLY . . . . . 0.471 ' N ' HG12 ' A' ' 162' ' ' VAL . . . -159.33 -102.8 0.18 Allowed Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 178.8 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' THR . . . . . 1.082 HG21 HG21 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -153.68 35.2 0.45 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.087 -1.056 . . . . 0.0 108.271 177.404 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.564 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 1.5 mp -42.92 96.02 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.541 -179.448 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.593 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . -80.39 118.67 22.23 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.697 -1.138 . . . . 0.0 112.194 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -88.75 141.86 16.73 Favored Glycine 0 N--CA 1.441 -1.022 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 178.421 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.465 ' HB3' HD12 ' A' ' 230' ' ' ILE . 0.0 OUTLIER -141.01 132.39 26.76 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.879 0.339 . . . . 0.0 110.488 -178.491 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 169' ' ' TYR . . . . . 0.461 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 47.5 t80 -85.59 129.36 34.84 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.247 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.69 HG21 ' O ' ' A' ' 208' ' ' VAL . 31.8 t -85.73 149.28 4.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -175.764 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -140.09 15.12 2.44 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 114.427 -1.261 . . . . 0.0 111.826 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.523 ' H ' HG12 ' A' ' 170' ' ' VAL . 9.3 t0 -150.6 -145.26 0.17 Allowed 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -179.346 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -43.48 -105.18 0.01 OUTLIER Glycine 0 CA--C 1.53 0.997 0 N-CA-C 114.84 0.696 . . . . 0.0 114.84 -179.196 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.814 ' HG2' ' HB2' ' A' ' 209' ' ' ALA . 7.6 mttt -151.44 144.28 24.44 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.999 0.428 . . . . 0.0 112.013 -178.678 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.445 ' CG1' HG22 ' A' ' 170' ' ' VAL . 10.3 mm -89.91 87.34 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 176.28 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.653 ' C ' HD11 ' A' ' 198' ' ' LEU . 0.1 OUTLIER -98.1 165.7 11.77 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -176.909 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 20.6 mtm105 -64.85 -44.45 89.75 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 114.55 -1.204 . . . . 0.0 111.083 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -89.3 60.15 5.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.752 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 46.6 m -149.2 159.54 44.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.652 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.538 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 14.9 mttp -89.62 -172.28 3.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.483 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.49 HG22 ' CA ' ' A' ' 194' ' ' GLU . 3.0 m -149.47 146.32 17.16 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.607 0 CA-C-O 121.554 0.692 . . . . 0.0 111.861 179.326 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 182' ' ' ARG . . . . . 0.448 ' N ' ' O ' ' A' ' 231' ' ' GLU . 6.0 ttm180 -154.45 98.83 2.14 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.722 -1.126 . . . . 0.0 112.002 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.628 ' C ' HD12 ' A' ' 184' ' ' ILE . 0.3 OUTLIER -100.88 168.53 9.58 Favored 'General case' 0 N--CA 1.437 -1.093 0 C-N-CA 120.358 -0.537 . . . . 0.0 111.026 179.597 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.771 HG23 ' O ' ' A' ' 188' ' ' ILE . 5.3 mp -151.15 140.07 14.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.156 -177.74 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.464 ' N ' HG22 ' A' ' 190' ' ' VAL . 8.0 ptp180 -87.16 -155.77 0.3 Allowed 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.172 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -93.6 27.23 2.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 118.327 0.512 . . . . 0.0 111.385 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -154.4 -43.87 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.966 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.771 ' O ' HG23 ' A' ' 184' ' ' ILE . 0.4 OUTLIER -150.14 -159.34 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 120.679 0.276 . . . . 0.0 111.711 -177.969 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.668 ' N ' HG23 ' A' ' 188' ' ' ILE . 39.8 t -85.13 135.13 25.49 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 CA-C-O 121.564 0.697 . . . . 0.0 110.349 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.498 ' HB ' HD11 ' A' ' 183' ' ' LEU . 0.3 OUTLIER -87.99 -35.04 7.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.347 -179.848 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 191' ' ' TYR . . . . . 0.48 ' HB2' ' CE1' ' A' ' 221' ' ' PHE . 0.6 OUTLIER -176.66 155.3 1.31 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.042 -179.994 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 192' ' ' GLU . . . . . 0.625 ' CG ' HG11 ' A' ' 189' ' ' VAL . 33.3 mt-10 -141.7 161.14 38.67 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.884 179.732 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 141.28 -137.31 8.03 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 111.377 -0.689 . . . . 0.0 111.377 -179.601 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 194' ' ' GLU . . . . . 0.707 ' O ' HG23 ' A' ' 218' ' ' ILE . 7.2 pt-20 -131.97 -176.07 3.94 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-O 121.011 0.434 . . . . 0.0 111.169 179.634 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.482 HG22 ' N ' ' A' ' 196' ' ' ASP . 5.8 mm -87.21 159.11 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.687 -178.248 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 196' ' ' ASP . . . . . 0.643 ' HB3' HG23 ' A' ' 217' ' ' THR . 4.0 t0 -103.16 -56.98 2.12 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.77 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 18.1 p -151.58 155.01 37.58 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.543 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.653 HD11 ' C ' ' A' ' 176' ' ' THR . 13.6 mt -117.11 128.22 54.92 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.927 179.554 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 10.8 ptpt -151.09 118.45 6.0 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.473 178.534 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 6.6 ttp180 . . . . . 0 C--N 1.321 -0.668 0 CA-C-O 121.433 0.635 . . . . 0.0 111.525 -178.778 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 . . . . . 0 N--CA 1.452 -0.341 0 CA-C-O 120.739 0.304 . . . . 0.0 110.731 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 27.6 m -66.48 155.42 7.19 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.915 0 CA-C-O 121.332 0.587 . . . . 0.0 111.671 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 206' ' ' ARG . . . . . 0.456 ' O ' ' HB ' ' A' ' 176' ' ' THR . 2.7 mtp180 -89.37 -32.74 17.16 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.388 -178.672 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -150.06 179.0 8.42 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.921 0.391 . . . . 0.0 110.713 179.335 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.69 ' O ' HG21 ' A' ' 170' ' ' VAL . 1.8 t -151.07 80.34 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.828 178.793 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.814 ' HB2' ' HG2' ' A' ' 174' ' ' LYS . . . -102.68 174.53 5.85 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.606 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 83.11 -74.33 0.03 OUTLIER 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.09 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 178.11 37.21 0.06 OUTLIER Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.392 -0.909 . . . . 0.0 112.385 179.034 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -98.17 144.69 27.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.919 0.39 . . . . 0.0 111.274 -179.428 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -96.77 130.11 44.08 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.872 179.378 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 214' ' ' CYS . . . . . 0.486 ' CB ' HG21 ' A' ' 208' ' ' VAL . 33.6 t -128.75 144.93 51.28 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.775 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -88.77 110.64 3.69 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.634 -0.793 . . . . 0.0 111.761 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.447 ' CD1' HD12 ' A' ' 195' ' ' ILE . 0.1 OUTLIER -129.0 144.37 51.16 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.116 0.484 . . . . 0.0 111.111 -179.229 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 217' ' ' THR . . . . . 0.643 HG23 ' HB3' ' A' ' 196' ' ' ASP . 0.1 OUTLIER -107.09 141.69 37.92 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 178.147 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 218' ' ' ILE . . . . . 0.707 HG23 ' O ' ' A' ' 194' ' ' GLU . 18.4 mm -90.72 140.45 15.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.241 0.544 . . . . 0.0 110.571 -179.344 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt -42.0 -30.1 0.26 Allowed 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -177.568 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 220' ' ' ASN . . . . . 0.425 ' O ' ' CE2' ' A' ' 191' ' ' TYR . 5.0 t30 -152.46 35.08 0.51 Allowed 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -178.335 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 221' ' ' PHE . . . . . 0.5 ' HB2' ' HB ' ' A' ' 218' ' ' ILE . 0.1 OUTLIER -58.84 120.09 8.37 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 178.891 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -88.11 -46.97 8.85 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 176.456 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 223' ' ' ASP . . . . . 0.459 ' O ' ' CD1' ' A' ' 221' ' ' PHE . 0.0 OUTLIER -79.54 136.25 36.83 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.063 177.403 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 1.082 HG21 HG21 ' A' ' 164' ' ' THR . 0.2 OUTLIER -133.28 178.9 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -178.859 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.412 ' O ' ' C ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER 57.46 116.8 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.853 -178.862 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 226' ' ' GLU . . . . . 0.43 ' H ' ' HA ' ' A' ' 155' ' ' GLN . 0.5 OUTLIER 6.91 63.95 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 124.51 1.124 . . . . 0.0 113.814 -179.545 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 227' ' ' GLY . . . . . 0.437 ' N ' HG11 ' A' ' 153' ' ' VAL . . . -61.39 -66.73 2.48 Favored Glycine 0 N--CA 1.434 -1.497 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.739 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.456 ' O ' HG12 ' A' ' 153' ' ' VAL . 0.8 OUTLIER -165.07 -148.21 0.11 Allowed 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 114.279 1.215 . . . . 0.0 114.279 179.686 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 229' ' ' VAL . . . . . 0.834 HG22 ' CG ' ' A' ' 152' ' ' GLU . 73.0 t -89.14 130.2 38.89 Favored 'Isoleucine or valine' 0 C--N 1.345 0.381 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.701 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 230' ' ' ILE . . . . . 0.497 ' HA ' ' CB ' ' A' ' 183' ' ' LEU . 22.6 mt -101.04 158.32 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.119 0 O-C-N 123.66 0.6 . . . . 0.0 111.332 -179.118 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 231' ' ' GLU . . . . . 0.448 ' O ' ' N ' ' A' ' 182' ' ' ARG . 16.1 tt0 -144.85 111.0 5.51 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.3 0.572 . . . . 0.0 112.522 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.556 ' O ' HG22 ' A' ' 148' ' ' ILE . . . -87.67 122.83 31.85 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.948 178.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -123.84 141.27 52.18 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.022 -179.113 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.56 HG12 ' HB ' ' A' ' 148' ' ' ILE . 0.9 OUTLIER . . . . . 0 CA--C 1.54 0.593 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.017 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 33.2 mttp . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.665 0.269 . . . . 0.0 110.302 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.465 HG11 ' HB2' ' A' ' 150' ' ' GLN . 4.3 t -108.43 141.96 22.32 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.739 0 CA-C-O 121.435 0.636 . . . . 0.0 110.727 179.022 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.643 HG21 HG12 ' A' ' 234' ' ' VAL . 2.6 pp -128.99 -8.85 3.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.635 179.203 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' GLY . . . . . 0.539 ' N ' HD12 ' A' ' 148' ' ' ILE . . . -174.04 75.0 0.09 OUTLIER Glycine 0 C--N 1.341 0.817 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.831 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.465 ' HB2' HG11 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -90.39 137.99 31.9 Favored 'General case' 0 CA--C 1.506 -0.728 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.852 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.534 ' HB1' ' HB2' ' A' ' 168' ' ' CYS . . . -151.66 174.85 12.99 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 120.093 -0.643 . . . . 0.0 112.339 -178.105 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.773 ' HG3' HG22 ' A' ' 229' ' ' VAL . 0.4 OUTLIER -125.12 119.37 28.4 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.507 179.92 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.464 HG11 ' N ' ' A' ' 227' ' ' GLY . 1.1 p -49.07 131.23 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -178.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.557 ' O ' ' HB3' ' A' ' 226' ' ' GLU . 4.0 mmp_? -91.48 -60.17 1.95 Allowed 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 105.249 -2.13 . . . . 0.0 105.249 175.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.73 -159.18 0.44 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 113.743 -1.571 . . . . 0.0 109.422 175.044 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.551 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 9.5 p -148.92 163.17 38.24 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 120.821 0.343 . . . . 0.0 110.647 177.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.656 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 3.7 m-85 -110.13 73.04 0.82 Allowed 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -178.34 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.588 ' HG3' HD13 ' A' ' 224' ' ' ILE . 8.2 tmtm? -85.94 64.36 8.55 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.405 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 92.4 t -92.25 158.22 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 CA-C-N 113.549 -1.66 . . . . 0.0 110.258 -178.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 71.5 m -93.06 34.46 1.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.225 0.535 . . . . 0.0 109.761 178.308 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.63 -33.09 0.15 Allowed 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.386 -179.667 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.516 HG12 ' N ' ' A' ' 163' ' ' GLY . 89.0 t -99.82 -102.19 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.19 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' GLY . . . . . 0.516 ' N ' HG12 ' A' ' 162' ' ' VAL . . . -158.85 -103.4 0.19 Allowed Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 111.522 -0.631 . . . . 0.0 111.522 179.268 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.458 HG21 ' CG2' ' A' ' 224' ' ' ILE . 0.0 OUTLIER -153.64 34.61 0.45 Allowed 'General case' 0 C--O 1.232 0.148 0 CA-C-N 114.311 -0.944 . . . . 0.0 108.801 178.259 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.656 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 1.6 mp -43.3 98.09 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.527 0.096 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.424 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.551 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . -87.08 122.89 31.52 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.854 -1.067 . . . . 0.0 111.698 -179.679 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -87.73 146.54 20.02 Favored Glycine 0 N--CA 1.442 -0.921 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 178.651 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.534 ' HB2' ' HB1' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -147.66 134.37 19.98 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 117.279 0.539 . . . . 0.0 110.771 -178.338 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 169' ' ' TYR . . . . . 0.427 ' O ' ' HA ' ' A' ' 151' ' ' ALA . 22.9 t80 -86.84 134.34 33.55 Favored 'General case' 0 C--O 1.221 -0.414 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 177.555 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.512 HG12 ' N ' ' A' ' 212' ' ' TYR . 9.2 p -86.43 146.63 6.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -176.258 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.2 p -140.95 12.01 2.23 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.557 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.425 ' CB ' ' HB2' ' A' ' 150' ' ' GLN . 9.1 t0 -150.79 -148.14 0.25 Allowed 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -41.48 -104.51 0.01 OUTLIER Glycine 0 CA--C 1.532 1.119 0 N-CA-C 115.09 0.796 . . . . 0.0 115.09 -178.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.707 ' HG3' ' HB2' ' A' ' 209' ' ' ALA . 0.0 OUTLIER -150.64 128.89 11.98 Favored 'General case' 0 CA--C 1.513 -0.457 0 O-C-N 122.722 -0.281 . . . . 0.0 111.368 -178.778 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.658 HG23 ' O ' ' A' ' 175' ' ' ILE . 1.1 tp -89.54 76.78 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 CA-C-O 122.27 1.033 . . . . 0.0 108.981 177.544 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.803 HG22 ' HB3' ' A' ' 207' ' ' GLU . 0.2 OUTLIER -84.03 173.01 11.49 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.015 -1.448 . . . . 0.0 113.543 -176.796 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 43.0 ttp85 -59.96 -51.6 68.98 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 114.2 -1.364 . . . . 0.0 111.536 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -89.55 61.92 5.72 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.68 -178.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 179' ' ' SER . . . . . 0.622 ' HB3' HD13 ' A' ' 148' ' ' ILE . 0.9 OUTLIER -142.68 160.4 40.38 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.443 179.396 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.516 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 11.9 mttt -89.08 -174.39 4.43 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.451 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.698 HG21 HG23 ' A' ' 218' ' ' ILE . 2.4 m -150.7 145.51 16.77 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 CA-C-O 121.573 0.702 . . . . 0.0 112.111 179.537 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 182' ' ' ARG . . . . . 0.465 ' N ' ' O ' ' A' ' 231' ' ' GLU . 16.9 ttt180 -154.87 100.52 2.21 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.725 -1.125 . . . . 0.0 112.051 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.532 ' HA ' ' O ' ' A' ' 229' ' ' VAL . 0.3 OUTLIER -100.15 168.83 9.57 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 120.616 -0.433 . . . . 0.0 110.878 179.551 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.725 HG23 ' O ' ' A' ' 188' ' ' ILE . 27.2 mt -155.5 139.55 8.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.333 -0.394 . . . . 0.0 112.017 -178.069 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.492 ' N ' HG22 ' A' ' 190' ' ' VAL . 0.0 OUTLIER -86.57 -154.02 0.22 Allowed 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.081 178.174 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -94.27 29.11 2.29 Favored 'General case' 0 N--CA 1.455 -0.191 0 O-C-N 122.023 -0.423 . . . . 0.0 111.51 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -152.91 -77.41 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.319 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.725 ' O ' HG23 ' A' ' 184' ' ' ILE . 0.5 OUTLIER -115.49 -157.68 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-N 115.464 -0.368 . . . . 0.0 110.094 -179.765 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.732 HG11 ' CG ' ' A' ' 192' ' ' GLU . 23.4 t -86.83 139.97 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 CA-C-O 121.425 0.631 . . . . 0.0 110.889 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.611 HG23 ' CA ' ' A' ' 184' ' ' ILE . 0.4 OUTLIER -88.22 -35.44 8.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.011 179.883 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 191' ' ' TYR . . . . . 0.463 ' HB2' ' CE1' ' A' ' 221' ' ' PHE . 9.9 t80 -178.91 151.33 0.52 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.014 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 192' ' ' GLU . . . . . 0.732 ' CG ' HG11 ' A' ' 189' ' ' VAL . 34.0 mt-10 -143.47 159.34 42.59 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.68 179.126 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 150.33 -122.9 1.46 Allowed Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.825 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 194' ' ' GLU . . . . . 0.52 ' C ' HG22 ' A' ' 181' ' ' VAL . 8.8 pt-20 -139.31 -177.98 5.16 Favored 'General case' 0 CA--C 1.497 -1.065 0 CA-C-O 121.288 0.566 . . . . 0.0 111.207 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.815 HD11 ' CD1' ' A' ' 216' ' ' LEU . 0.3 OUTLIER -88.27 142.62 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.145 -178.485 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -88.7 -61.69 1.65 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.184 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -151.94 166.05 32.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.529 178.837 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.575 HD21 ' O ' ' A' ' 205' ' ' VAL . 1.3 pt? -139.3 122.41 16.86 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.69 0.757 . . . . 0.0 112.149 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -146.83 127.82 14.55 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 114.406 -1.27 . . . . 0.0 108.719 178.565 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 3.1 ttp85 . . . . . 0 C--N 1.32 -0.709 0 CA-C-O 121.51 0.671 . . . . 0.0 111.82 -178.321 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.45 -0.468 0 CA-C-O 120.695 0.283 . . . . 0.0 110.644 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.575 ' O ' HD21 ' A' ' 198' ' ' LEU . 30.4 m -56.15 173.47 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.068 0 CA-C-O 120.972 0.415 . . . . 0.0 111.361 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 206' ' ' ARG . . . . . 0.478 ' O ' ' HB ' ' A' ' 176' ' ' THR . 2.6 ttp180 -97.34 -40.07 8.91 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.787 -178.587 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.803 ' HB3' HG22 ' A' ' 176' ' ' THR . 1.1 mp0 -143.12 178.12 7.92 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.29 0.567 . . . . 0.0 111.938 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.569 HG23 HG23 ' A' ' 175' ' ' ILE . 0.1 OUTLIER -150.74 81.23 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.743 179.478 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.707 ' HB2' ' HG3' ' A' ' 174' ' ' LYS . . . -105.32 177.5 4.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.999 0.428 . . . . 0.0 112.043 -178.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 83.24 -72.06 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.942 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 211' ' ' GLY . . . . . 0.501 ' HA2' HG13 ' A' ' 170' ' ' VAL . . . 178.63 36.88 0.06 OUTLIER Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.537 -0.839 . . . . 0.0 112.369 179.2 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 212' ' ' TYR . . . . . 0.512 ' N ' HG12 ' A' ' 170' ' ' VAL . 0.5 OUTLIER -104.54 144.45 31.67 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.071 0.463 . . . . 0.0 111.746 -179.232 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -99.56 151.11 21.54 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.933 179.546 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 53.9 t -146.66 148.2 31.8 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.845 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -88.23 108.72 3.45 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.394 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.815 ' CD1' HD11 ' A' ' 195' ' ' ILE . 0.1 OUTLIER -138.27 147.6 43.81 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 121.12 0.486 . . . . 0.0 112.06 -178.208 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 217' ' ' THR . . . . . 0.708 ' O ' HD13 ' A' ' 195' ' ' ILE . 0.0 OUTLIER -88.1 143.86 26.83 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.025 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 218' ' ' ILE . . . . . 0.698 HG23 HG21 ' A' ' 181' ' ' VAL . 1.5 mp -109.42 92.15 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 -179.335 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 1.8 ttpp 44.43 -146.1 0.11 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.852 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -87.67 62.66 7.14 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-O 121.319 0.58 . . . . 0.0 110.808 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 221' ' ' PHE . . . . . 0.49 ' CZ ' HD21 ' A' ' 183' ' ' LEU . 0.1 OUTLIER -54.37 121.6 8.63 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 179.14 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -84.06 -48.66 9.67 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.287 176.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 223' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 223' ' ' ASP . 0.0 OUTLIER -81.0 125.37 30.08 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.122 177.68 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.633 HD12 ' HG2' ' A' ' 225' ' ' LYS . 1.7 pt -115.89 176.86 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.603 0 CA-C-O 121.469 0.652 . . . . 0.0 111.884 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.633 ' HG2' HD12 ' A' ' 224' ' ' ILE . 0.1 OUTLIER 63.88 149.46 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.757 -1.111 . . . . 0.0 108.635 -178.627 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 226' ' ' GLU . . . . . 0.557 ' HB3' ' O ' ' A' ' 154' ' ' ARG . 5.5 pt-20 -36.92 86.5 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 121.986 0.898 . . . . 0.0 112.89 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 227' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 225' ' ' LYS . . . -78.5 -60.17 2.71 Favored Glycine 0 N--CA 1.426 -2.006 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.502 179.452 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.458 ' HB3' ' O ' ' A' ' 184' ' ' ILE . 1.1 t70 -165.21 -144.94 0.08 Allowed 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 229' ' ' VAL . . . . . 0.773 HG22 ' HG3' ' A' ' 152' ' ' GLU . 80.2 t -89.65 134.21 29.48 Favored 'Isoleucine or valine' 0 C--N 1.349 0.555 0 C-N-CA 122.937 0.495 . . . . 0.0 109.881 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 230' ' ' ILE . . . . . 0.501 ' HA ' ' CB ' ' A' ' 183' ' ' LEU . 5.5 mt -103.26 158.04 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 O-C-N 123.435 0.459 . . . . 0.0 110.951 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 231' ' ' GLU . . . . . 0.465 ' O ' ' N ' ' A' ' 182' ' ' ARG . 1.4 tm-20 -148.89 109.88 4.33 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.649 ' HB2' HD12 ' A' ' 175' ' ' ILE . . . -87.59 128.25 35.27 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.354 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 233' ' ' TYR . . . . . 0.456 ' HA ' HG13 ' A' ' 148' ' ' ILE . 11.5 p90 -124.97 143.17 51.03 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.625 -178.164 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.643 HG12 HG21 ' A' ' 148' ' ' ILE . 0.3 OUTLIER . . . . . 0 CA--C 1.534 0.332 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.855 178.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 8.7 p90 . . . . . 0 N--CA 1.487 1.424 0 CA-C-O 120.892 0.377 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -101.25 157.8 16.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.849 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -88.25 59.21 5.13 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.807 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -59.17 -169.13 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.938 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.661 HG11 ' HB2' ' A' ' 150' ' ' GLN . 17.0 t -61.69 141.06 18.12 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.595 0 CA-C-O 121.25 0.548 . . . . 0.0 111.53 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.735 HG21 HG12 ' A' ' 234' ' ' VAL . 0.3 OUTLIER -126.54 2.17 4.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.632 177.48 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.587 ' CA ' ' HB3' ' A' ' 232' ' ' ALA . . . 175.83 74.29 0.05 OUTLIER Glycine 0 C--N 1.341 0.847 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.356 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.661 ' HB2' HG11 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -91.71 132.86 36.08 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.177 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.424 ' O ' HG13 ' A' ' 229' ' ' VAL . . . -151.88 174.16 13.93 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-O 121.466 0.65 . . . . 0.0 112.438 -178.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.681 ' HG2' HG22 ' A' ' 229' ' ' VAL . 50.4 mt-10 -118.71 122.75 43.22 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.274 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.731 ' HB ' HD11 ' A' ' 230' ' ' ILE . 2.4 p -52.1 132.26 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 121.257 0.551 . . . . 0.0 112.436 -178.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.445 ' O ' ' HB3' ' A' ' 226' ' ' GLU . 4.7 mmp_? -89.33 -61.48 1.69 Allowed 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 175.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.435 ' HA ' ' H ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER -162.38 -163.83 0.96 Allowed 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 113.624 -1.625 . . . . 0.0 109.479 174.789 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.553 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 12.2 p -143.82 173.57 11.57 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 177.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.654 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 9.2 m-85 -125.5 75.5 1.48 Allowed 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -178.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -86.2 63.14 7.85 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 177.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.47 HG12 ' N ' ' A' ' 161' ' ' LYS . 66.5 t -91.71 156.02 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 CA-C-N 113.603 -1.635 . . . . 0.0 110.343 -178.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 49.1 p -91.36 34.71 0.94 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.217 0.532 . . . . 0.0 109.845 178.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.47 ' N ' HG12 ' A' ' 159' ' ' VAL . 1.6 mttt -150.84 -32.15 0.17 Allowed 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.358 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.792 HG11 HD12 ' A' ' 165' ' ' ILE . 91.9 t -102.11 -103.31 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' GLY . . . . . 0.512 ' N ' HG12 ' A' ' 162' ' ' VAL . . . -159.04 -100.44 0.16 Allowed Glycine 0 N--CA 1.451 -0.317 0 N-CA-C 111.438 -0.665 . . . . 0.0 111.438 179.157 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.437 ' CG2' ' CG2' ' A' ' 224' ' ' ILE . 0.0 OUTLIER -153.87 35.11 0.44 Allowed 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 114.209 -0.996 . . . . 0.0 108.709 178.266 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.792 HD12 HG11 ' A' ' 162' ' ' VAL . 4.2 mt -42.13 95.57 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.567 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.553 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . -88.07 119.01 28.03 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.744 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -88.07 146.82 19.94 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 178.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.639 ' HB3' HD13 ' A' ' 230' ' ' ILE . 0.0 OUTLIER -147.17 135.28 21.49 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 117.248 0.524 . . . . 0.0 110.833 -178.416 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 169' ' ' TYR . . . . . 0.4 ' O ' ' HA ' ' A' ' 151' ' ' ALA . 5.3 t80 -86.85 124.12 32.73 Favored 'General case' 0 C--O 1.223 -0.301 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 177.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.787 HG21 ' O ' ' A' ' 208' ' ' VAL . 26.9 t -85.53 147.13 5.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 -175.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.2 p -139.86 14.26 2.48 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.924 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.437 ' H ' HG12 ' A' ' 170' ' ' VAL . 3.9 t70 -150.85 -144.66 0.16 Allowed 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -40.3 -105.16 0.01 OUTLIER Glycine 0 CA--C 1.534 1.246 0 N-CA-C 115.208 0.843 . . . . 0.0 115.208 -179.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.817 ' HG2' ' HB2' ' A' ' 209' ' ' ALA . 6.8 mttt -151.04 143.25 24.1 Favored 'General case' 0 CA--C 1.517 -0.315 0 O-C-N 122.557 -0.378 . . . . 0.0 111.764 -178.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.628 HG13 HG22 ' A' ' 170' ' ' VAL . 14.6 mm -95.36 78.94 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 176.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.853 ' O ' HD13 ' A' ' 195' ' ' ILE . 0.0 OUTLIER -97.97 171.06 8.51 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -176.834 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.34 -39.54 74.63 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.28 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -88.58 55.14 3.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.815 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.812 ' O ' HD12 ' A' ' 195' ' ' ILE . 0.9 OUTLIER -150.18 159.65 44.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.603 -179.973 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 0.0 OUTLIER -89.06 -178.49 5.7 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 179.238 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.697 HG21 HG23 ' A' ' 218' ' ' ILE . 3.3 m -149.64 146.24 17.1 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.615 0 CA-C-O 121.599 0.714 . . . . 0.0 112.028 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 231' ' ' GLU . 7.8 ttt180 -154.54 101.93 2.37 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.748 -1.114 . . . . 0.0 112.198 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.643 ' C ' HD12 ' A' ' 184' ' ' ILE . 0.3 OUTLIER -97.46 170.54 8.98 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.636 179.234 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.791 HG23 ' O ' ' A' ' 188' ' ' ILE . 5.3 mp -152.08 141.32 14.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.021 -177.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.486 ' N ' HG22 ' A' ' 190' ' ' VAL . 3.6 ttm180 -86.37 -156.22 0.29 Allowed 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 178.196 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -93.62 26.5 3.03 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.915 179.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -154.07 -43.68 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.062 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.791 ' O ' HG23 ' A' ' 184' ' ' ILE . 0.4 OUTLIER -150.4 -159.74 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -178.001 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.663 ' N ' HG23 ' A' ' 188' ' ' ILE . 22.4 t -84.86 133.68 28.75 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 CA-C-O 121.572 0.701 . . . . 0.0 110.137 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.875 HG12 ' OD2' ' A' ' 223' ' ' ASP . 0.2 OUTLIER -88.32 -38.38 11.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 114.678 -1.147 . . . . 0.0 109.223 -179.213 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 191' ' ' TYR . . . . . 0.479 ' HB2' ' CE1' ' A' ' 221' ' ' PHE . 19.1 t80 -169.62 162.39 9.83 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.201 178.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' GLU . . . . . 0.654 ' CG ' HG11 ' A' ' 189' ' ' VAL . 28.1 mt-10 -150.1 157.97 43.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.041 0.448 . . . . 0.0 111.056 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 146.27 -126.42 2.49 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.077 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 0.597 ' CA ' HG22 ' A' ' 181' ' ' VAL . 3.9 pt-20 -139.92 -176.9 4.75 Favored 'General case' 0 CA--C 1.498 -1.038 0 CA-C-O 121.152 0.501 . . . . 0.0 111.3 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.853 HD13 ' O ' ' A' ' 176' ' ' THR . 3.1 mp -86.85 141.44 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.39 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.351 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.08 -47.48 8.07 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 40.4 m -151.24 163.42 38.92 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.086 179.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.69 HD22 ' HB3' ' A' ' 216' ' ' LEU . 0.1 OUTLIER -134.38 108.84 8.4 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 121.099 0.476 . . . . 0.0 111.073 -179.947 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 199' ' ' LYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 3.3 mtpm? -150.1 118.61 6.49 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.682 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' ARG . . . . . 0.551 HH12 HG11 ' A' ' 205' ' ' VAL . 0.0 OUTLIER -88.21 -160.5 0.64 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.946 179.896 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -87.35 -9.81 53.84 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 121.243 -0.183 . . . . 0.0 111.169 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.45 -57.7 2.03 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-O 120.632 0.253 . . . . 0.0 111.142 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 26.2 p-10 -152.32 -170.62 3.69 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 120.807 0.337 . . . . 0.0 111.049 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' ASP . . . . . 0.401 ' HA ' ' HA ' ' A' ' 199' ' ' LYS . 4.1 m-20 -89.71 72.62 7.69 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.334 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.551 HG11 HH12 ' A' ' 200' ' ' ARG . 32.6 m -64.38 154.83 6.61 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.905 0 CA-C-O 121.501 0.667 . . . . 0.0 112.038 -179.273 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' ARG . . . . . 0.456 ' O ' ' HB ' ' A' ' 176' ' ' THR . 4.3 ttm-85 -89.62 -29.7 18.66 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 114.868 -1.06 . . . . 0.0 112.052 -178.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.699 ' HB3' HG22 ' A' ' 176' ' ' THR . 1.5 mp0 -142.93 178.17 7.85 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.123 0.487 . . . . 0.0 111.078 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.787 ' O ' HG21 ' A' ' 170' ' ' VAL . 0.2 OUTLIER -151.18 75.83 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.882 179.054 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.817 ' HB2' ' HG2' ' A' ' 174' ' ' LYS . . . -98.24 172.81 7.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.053 0.454 . . . . 0.0 112.195 -178.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 83.94 -73.49 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.957 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 178.45 37.71 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.328 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -102.23 142.98 32.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.863 0.363 . . . . 0.0 111.237 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -100.17 131.72 45.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.337 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 214' ' ' CYS . . . . . 0.569 ' HB3' HG21 ' A' ' 208' ' ' VAL . 48.6 t -133.85 148.19 51.26 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.384 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -88.54 111.47 3.79 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.016 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.69 ' HB3' HD22 ' A' ' 198' ' ' LEU . 0.2 OUTLIER -135.73 144.76 46.06 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 120.946 0.403 . . . . 0.0 111.281 -179.141 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 217' ' ' THR . . . . . 0.543 ' C ' HD12 ' A' ' 218' ' ' ILE . 0.2 OUTLIER -82.37 149.0 27.94 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.189 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 218' ' ' ILE . . . . . 0.697 HG23 HG21 ' A' ' 181' ' ' VAL . 1.7 mp -113.96 88.2 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 -179.074 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 2.3 tttt 45.51 -144.72 0.19 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.931 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -87.08 61.35 6.72 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 120.957 0.408 . . . . 0.0 110.889 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.523 ' CZ ' HD21 ' A' ' 183' ' ' LEU . 0.1 OUTLIER -55.23 118.85 4.74 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 179.081 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 21.8 t30 -81.56 -47.46 13.05 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 114.804 -1.089 . . . . 0.0 108.571 176.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' ASP . . . . . 0.875 ' OD2' HG12 ' A' ' 190' ' ' VAL . 0.0 OUTLIER -83.62 139.25 32.94 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.204 177.966 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.636 HD13 ' N ' ' A' ' 224' ' ' ILE . 0.2 OUTLIER -132.27 179.35 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 CA-C-O 121.276 0.56 . . . . 0.0 112.28 -179.542 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.403 ' O ' ' C ' ' A' ' 226' ' ' GLU . 0.3 OUTLIER 58.01 115.87 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.677 -178.756 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 226' ' ' GLU . . . . . 0.445 ' HB3' ' O ' ' A' ' 154' ' ' ARG . 2.6 pt-20 3.64 66.62 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 124.812 1.245 . . . . 0.0 113.931 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -63.35 -62.56 5.27 Favored Glycine 0 N--CA 1.43 -1.745 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.855 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.451 ' O ' HG12 ' A' ' 153' ' ' VAL . 0.8 OUTLIER -164.95 -148.38 0.11 Allowed 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -179.891 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 229' ' ' VAL . . . . . 0.681 HG22 ' HG2' ' A' ' 152' ' ' GLU . 96.4 t -90.37 132.23 35.54 Favored 'Isoleucine or valine' 0 C--N 1.347 0.46 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 230' ' ' ILE . . . . . 0.731 HD11 ' HB ' ' A' ' 153' ' ' VAL . 4.6 mp -98.61 158.8 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 O-C-N 123.477 0.486 . . . . 0.0 111.572 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 231' ' ' GLU . . . . . 0.44 ' O ' ' N ' ' A' ' 182' ' ' ARG . 7.8 tt0 -145.89 109.55 4.79 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.587 ' HB3' ' CA ' ' A' ' 149' ' ' GLY . . . -88.12 126.86 35.34 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.516 178.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -132.57 140.08 48.11 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.107 -178.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.735 HG12 HG21 ' A' ' 148' ' ' ILE . 0.4 OUTLIER -176.64 -162.33 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.937 179.807 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 235' ' ' MET . . . . . 0.652 ' N ' HG13 ' A' ' 234' ' ' VAL . 0.0 OUTLIER -89.46 -163.49 1.01 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.691 0.281 . . . . 0.0 110.63 179.739 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -96.48 36.82 1.32 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.911 0.386 . . . . 0.0 111.366 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -125.78 44.66 2.78 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.904 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.576 HG22 HG11 ' A' ' 234' ' ' VAL . 11.6 t -101.93 159.4 4.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.256 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 239' ' ' ALA . . . . . 0.476 ' N ' HG12 ' A' ' 238' ' ' VAL . . . 70.53 -62.73 0.43 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.354 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 3.4 ttp180 -89.19 -3.42 58.59 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.313 -1.015 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.11 179.983 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.808 0.337 . . . . 0.0 111.129 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -145.22 153.38 41.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.969 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.74 -72.57 0.55 Allowed 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 121.567 0.699 . . . . 0.0 111.147 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 12.7 tttt 64.57 168.14 0.17 Allowed 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.159 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.711 HG11 ' HB2' ' A' ' 150' ' ' GLN . 15.1 t -59.0 140.81 16.81 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.595 0 CA-C-O 121.209 0.528 . . . . 0.0 111.485 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.666 HG13 HG12 ' A' ' 234' ' ' VAL . 0.1 OUTLIER -125.96 -0.85 4.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.819 177.872 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.551 ' CA ' ' HB3' ' A' ' 232' ' ' ALA . . . -176.66 72.95 0.08 OUTLIER Glycine 0 C--N 1.341 0.848 0 C-N-CA 121.109 -0.567 . . . . 0.0 111.817 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.711 ' HB2' HG11 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -91.97 132.3 36.62 Favored 'General case' 0 CA--C 1.511 -0.532 0 O-C-N 122.514 -0.403 . . . . 0.0 110.217 179.899 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.493 ' O ' HG13 ' A' ' 229' ' ' VAL . . . -152.22 177.51 10.46 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -178.184 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.504 ' CD ' HG22 ' A' ' 229' ' ' VAL . 2.1 mm-40 -123.66 125.09 44.16 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.566 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.447 HG12 ' O ' ' A' ' 228' ' ' ASP . 1.4 p -49.82 132.43 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -179.088 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.554 ' O ' ' HB3' ' A' ' 226' ' ' GLU . 4.3 mmp_? -89.58 -61.88 1.6 Allowed 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 105.232 -2.136 . . . . 0.0 105.232 175.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.29 -159.05 0.46 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 113.555 -1.657 . . . . 0.0 108.945 175.113 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.525 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 17.4 p -146.04 175.16 10.67 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 110.34 -0.245 . . . . 0.0 110.34 177.547 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.662 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 12.0 m-85 -129.06 73.25 1.5 Allowed 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -179.068 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 163' ' ' GLY . 4.6 ptmt -85.81 64.38 8.57 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.2 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.491 HG12 ' N ' ' A' ' 161' ' ' LYS . 57.0 t -93.22 156.87 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 CA-C-N 113.294 -1.775 . . . . 0.0 110.527 -178.261 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 92.0 p -91.95 35.91 0.97 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.221 0.534 . . . . 0.0 109.584 178.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.491 ' N ' HG12 ' A' ' 159' ' ' VAL . 0.2 OUTLIER -150.85 -34.04 0.16 Allowed 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.165 -179.576 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.617 HG12 HD13 ' A' ' 165' ' ' ILE . 89.5 t -102.18 -102.04 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' GLY . . . . . 0.511 ' N ' HG12 ' A' ' 162' ' ' VAL . . . -158.54 -102.0 0.18 Allowed Glycine 0 C--O 1.226 -0.384 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.461 HG22 HG22 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -153.37 34.46 0.46 Allowed 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 124.482 1.113 . . . . 0.0 108.145 177.795 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.662 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 1.6 mp -42.15 95.2 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 CA-C-N 115.063 -0.971 . . . . 0.0 112.143 -178.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.525 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . -87.8 117.89 26.95 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.416 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -87.9 149.51 21.63 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.157 -1.02 . . . . 0.0 110.761 179.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.427 ' HB2' ' CB ' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -144.7 135.06 24.34 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.929 0.365 . . . . 0.0 110.537 -178.69 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 169' ' ' TYR . . . . . 0.408 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 91.0 t80 -86.94 124.69 33.43 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 177.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.716 HG21 ' O ' ' A' ' 208' ' ' VAL . 25.0 t -85.06 143.53 11.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -175.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -136.44 14.75 3.21 Favored 'General case' 0 CA--C 1.526 0.053 0 CA-C-N 114.475 -1.239 . . . . 0.0 111.851 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.421 ' H ' HG12 ' A' ' 170' ' ' VAL . 5.0 t0 -150.36 -144.28 0.15 Allowed 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -179.534 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -42.06 -105.06 0.01 OUTLIER Glycine 0 CA--C 1.532 1.107 0 N-CA-C 115.055 0.782 . . . . 0.0 115.055 -179.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.779 ' HG2' ' HB2' ' A' ' 209' ' ' ALA . 17.8 mttt -150.83 143.8 24.65 Favored 'General case' 0 N--CA 1.465 0.312 0 O-C-N 122.585 -0.362 . . . . 0.0 111.582 -178.525 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.61 ' CG1' HG22 ' A' ' 170' ' ' VAL . 13.2 mm -94.96 81.64 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 176.525 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.707 HG22 ' HB3' ' A' ' 207' ' ' GLU . 0.1 OUTLIER -95.47 169.23 10.2 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -177.028 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.406 ' CG ' ' HB3' ' A' ' 198' ' ' LEU . 24.7 mtm105 -65.5 -44.46 86.98 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.977 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.16 60.59 5.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.128 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.49 ' O ' HD12 ' A' ' 195' ' ' ILE . 23.8 m -149.98 161.49 42.22 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.682 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 13.5 mttt -91.46 -169.72 2.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.077 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.552 HG22 ' CA ' ' A' ' 194' ' ' GLU . 1.2 m -150.34 158.1 5.58 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.451 0 CA-C-O 121.235 0.541 . . . . 0.0 111.633 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' ARG . . . . . 0.632 ' NH1' HD11 ' A' ' 184' ' ' ILE . 1.6 ttt85 -152.73 100.53 2.54 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.377 -0.829 . . . . 0.0 112.88 -179.581 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.673 HD12 ' HB3' ' A' ' 191' ' ' TYR . 0.3 OUTLIER -85.99 156.32 20.5 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-O 121.793 0.806 . . . . 0.0 113.149 -179.608 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.699 ' N ' HG23 ' A' ' 190' ' ' VAL . 28.4 mm -154.3 123.96 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 114.254 -1.339 . . . . 0.0 111.296 178.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.571 ' N ' HG22 ' A' ' 190' ' ' VAL . 0.2 OUTLIER -85.74 -150.85 0.14 Allowed 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 177.976 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.84 25.74 3.48 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 118.531 0.605 . . . . 0.0 110.81 178.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -155.03 -68.11 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.478 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -120.61 -156.68 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 115.327 -0.437 . . . . 0.0 110.901 -178.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.761 HG11 ' CG ' ' A' ' 192' ' ' GLU . 59.0 t -87.22 135.85 24.35 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-O 121.303 0.573 . . . . 0.0 111.506 -179.277 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.781 HG12 ' OD2' ' A' ' 223' ' ' ASP . 0.1 OUTLIER -89.37 -33.95 6.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.165 -0.925 . . . . 0.0 108.911 178.764 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 191' ' ' TYR . . . . . 0.673 ' HB3' HD12 ' A' ' 183' ' ' LEU . 15.8 t80 -162.71 159.31 24.14 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.45 178.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' GLU . . . . . 0.761 ' CG ' HG11 ' A' ' 189' ' ' VAL . 19.8 mt-10 -150.17 158.08 43.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.862 178.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 133.02 -119.49 2.39 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.24 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 0.552 ' CA ' HG22 ' A' ' 181' ' ' VAL . 12.2 pt-20 -150.61 -175.17 5.0 Favored 'General case' 0 CA--C 1.5 -0.971 0 CA-C-O 121.179 0.514 . . . . 0.0 111.345 -179.143 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.49 HD12 ' O ' ' A' ' 179' ' ' SER . 4.9 mp -88.86 143.76 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.409 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' ASP . . . . . 0.57 ' HB3' HG23 ' A' ' 217' ' ' THR . 0.6 OUTLIER -88.91 -53.9 4.38 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.5 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -151.72 142.71 23.08 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.783 179.096 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.781 ' CD1' HD22 ' A' ' 216' ' ' LEU . 32.3 tp -115.73 117.51 30.44 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 121.466 0.65 . . . . 0.0 111.922 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 199' ' ' LYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 25.6 mttt -150.36 120.94 7.45 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.952 179.165 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 4.5 ttm180 -87.96 -157.99 0.44 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.991 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 33.9 p90 -86.44 -16.02 38.44 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.606 0.241 . . . . 0.0 110.919 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.51 -60.77 1.64 Allowed 'General case' 0 N--CA 1.441 -0.898 0 CA-C-O 120.594 0.235 . . . . 0.0 110.973 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.86 -164.52 1.96 Allowed 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 120.808 0.337 . . . . 0.0 110.983 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 204' ' ' ASP . . . . . 0.412 ' HA ' ' HA ' ' A' ' 199' ' ' LYS . 7.2 p-10 -89.68 73.16 7.68 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.061 179.214 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 28.3 m -60.96 157.77 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.884 0 CA-C-O 121.596 0.712 . . . . 0.0 112.376 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' ARG . . . . . 0.47 ' O ' ' HB ' ' A' ' 176' ' ' THR . 0.1 OUTLIER -89.31 -35.26 16.22 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 114.616 -1.175 . . . . 0.0 111.454 -178.741 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.707 ' HB3' HG22 ' A' ' 176' ' ' THR . 2.2 mp0 -144.32 178.49 7.88 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.9 0.381 . . . . 0.0 110.878 179.285 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.716 ' O ' HG21 ' A' ' 170' ' ' VAL . 1.3 t -150.93 77.0 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.109 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.779 ' HB2' ' HG2' ' A' ' 174' ' ' LYS . . . -96.85 170.84 8.89 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -178.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 85.77 -75.5 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.233 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 177.89 37.15 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.334 -0.936 . . . . 0.0 112.432 179.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -95.27 150.03 20.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.901 0.381 . . . . 0.0 111.333 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -89.76 159.53 17.0 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.215 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 5.1 p -150.71 -175.48 5.13 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.265 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' GLY . . . . . 0.448 ' C ' HG23 ' A' ' 165' ' ' ILE . . . -144.02 96.97 0.19 Allowed Glycine 0 N--CA 1.451 -0.335 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 179.342 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.781 HD22 ' CD1' ' A' ' 198' ' ' LEU . 0.4 OUTLIER -131.71 142.01 49.7 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 120.932 0.396 . . . . 0.0 111.992 -178.367 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 217' ' ' THR . . . . . 0.57 HG23 ' HB3' ' A' ' 196' ' ' ASP . 0.1 OUTLIER -79.14 132.98 36.74 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 176.877 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 218' ' ' ILE . . . . . 0.578 HG22 ' O ' ' A' ' 218' ' ' ILE . 1.4 mp -98.35 97.49 6.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.459 -177.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 6.5 tttp 42.5 -144.33 0.08 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.978 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -87.66 64.14 7.88 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 120.871 0.367 . . . . 0.0 110.738 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.646 ' CZ ' HD13 ' A' ' 183' ' ' LEU . 0.1 OUTLIER -54.81 118.51 4.31 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 179.075 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -82.76 -43.82 16.31 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 114.691 -1.14 . . . . 0.0 108.548 176.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' ASP . . . . . 0.781 ' OD2' HG12 ' A' ' 190' ' ' VAL . 0.0 OUTLIER -89.57 130.7 35.85 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 178.171 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.617 HD13 ' H ' ' A' ' 224' ' ' ILE . 0.2 OUTLIER -114.96 175.89 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 CA-C-O 121.263 0.554 . . . . 0.0 111.511 179.562 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.469 ' O ' ' N ' ' A' ' 227' ' ' GLY . 5.9 mtmt 63.53 147.74 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.84 -1.073 . . . . 0.0 108.992 -178.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 226' ' ' GLU . . . . . 0.554 ' HB3' ' O ' ' A' ' 154' ' ' ARG . 3.3 pt-20 -36.58 87.98 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.931 0.872 . . . . 0.0 112.855 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 227' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 225' ' ' LYS . . . -81.46 -57.62 2.73 Favored Glycine 0 N--CA 1.427 -1.902 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.873 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.447 ' O ' HG12 ' A' ' 153' ' ' VAL . 1.0 OUTLIER -163.71 -146.91 0.11 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 179.365 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 229' ' ' VAL . . . . . 0.504 HG22 ' CD ' ' A' ' 152' ' ' GLU . 61.6 t -93.64 147.4 5.54 Favored 'Isoleucine or valine' 0 C--N 1.342 0.278 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.62 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 230' ' ' ILE . . . . . 0.409 HG13 ' HG ' ' A' ' 183' ' ' LEU . 2.8 mp -118.6 154.58 20.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.187 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 231' ' ' GLU . . . . . 0.46 ' HA ' ' HA ' ' A' ' 150' ' ' GLN . 10.2 tt0 -142.49 112.26 6.85 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.421 0.629 . . . . 0.0 111.965 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.551 ' HB3' ' CA ' ' A' ' 149' ' ' GLY . . . -86.9 129.81 34.72 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.195 178.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 233' ' ' TYR . . . . . 0.61 ' C ' HD12 ' A' ' 148' ' ' ILE . 6.0 p90 -130.2 144.0 51.11 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.289 -178.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.666 HG12 HG13 ' A' ' 148' ' ' ILE . 0.3 OUTLIER 178.46 -169.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.674 179.399 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 235' ' ' MET . . . . . 0.616 ' N ' HG13 ' A' ' 234' ' ' VAL . 0.8 OUTLIER -96.96 -162.85 0.99 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.068 179.209 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 29.2 mm100 -89.23 77.01 7.56 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.142 0.496 . . . . 0.0 110.784 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' GLU . . . . . 0.824 ' O ' ' HB3' ' A' ' 241' ' ' ALA . 59.3 mt-10 -150.61 40.16 0.74 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.142 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.433 ' O ' ' HB3' ' A' ' 239' ' ' ALA . 0.8 OUTLIER -104.46 163.44 4.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.014 179.751 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 239' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' A' ' 238' ' ' VAL . . . 71.25 -62.38 0.46 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.271 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.23 -3.76 58.44 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 241' ' ' ALA . . . . . 0.824 ' HB3' ' O ' ' A' ' 237' ' ' GLU . . . . . . . . 0 C--N 1.312 -1.05 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.041 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.868 0.366 . . . . 0.0 111.15 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -75.18 -168.5 0.79 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.928 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -89.64 50.87 1.97 Allowed 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.236 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 2.8 tttp -71.35 -168.05 0.29 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.548 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.81 HG11 ' HB2' ' A' ' 150' ' ' GLN . 14.4 t -61.72 139.27 20.93 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.628 0 CA-C-O 121.357 0.599 . . . . 0.0 111.226 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.727 HG21 HG12 ' A' ' 234' ' ' VAL . 1.1 pt -117.64 -11.87 11.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.145 178.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.527 ' O ' ' HB3' ' A' ' 232' ' ' ALA . . . -177.64 77.91 0.07 OUTLIER Glycine 0 C--N 1.34 0.799 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.81 ' HB2' HG11 ' A' ' 147' ' ' VAL . 0.7 OUTLIER -91.29 137.94 31.97 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 120.704 0.288 . . . . 0.0 110.56 -179.65 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.468 ' O ' HG13 ' A' ' 229' ' ' VAL . . . -152.01 178.13 9.75 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -178.288 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.724 ' HG2' HG22 ' A' ' 229' ' ' VAL . 40.4 mt-10 -124.34 124.93 43.45 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.334 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.543 ' HB ' HD11 ' A' ' 230' ' ' ILE . 2.2 p -51.04 133.84 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.098 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.403 ' HD2' ' HB2' ' A' ' 169' ' ' TYR . 4.2 mmp_? -89.52 -63.39 1.29 Allowed 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 104.943 -2.243 . . . . 0.0 104.943 175.319 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.418 ' HA ' ' H ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER -162.4 -162.29 0.8 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 113.664 -1.607 . . . . 0.0 108.839 174.721 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 4.9 p -147.19 143.95 28.58 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 177.194 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.527 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 0.4 OUTLIER -89.96 83.51 6.13 Favored 'General case' 0 CA--C 1.51 -0.583 0 N-CA-C 113.969 1.099 . . . . 0.0 113.969 -177.598 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 10.2 tttp -86.82 62.18 7.24 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 177.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.518 HG12 ' N ' ' A' ' 161' ' ' LYS . 40.9 t -93.32 156.02 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 CA-C-N 113.694 -1.593 . . . . 0.0 110.306 -178.423 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 12.4 t -90.15 35.68 0.86 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.13 0.491 . . . . 0.0 109.954 178.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.518 ' N ' HG12 ' A' ' 159' ' ' VAL . 0.9 OUTLIER -150.41 -32.4 0.18 Allowed 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.343 -179.671 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.523 HG12 ' N ' ' A' ' 163' ' ' GLY . 93.5 t -102.85 -103.23 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.226 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' GLY . . . . . 0.523 ' N ' HG12 ' A' ' 162' ' ' VAL . . . -159.07 -99.07 0.15 Allowed Glycine 0 N--CA 1.452 -0.25 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 178.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' THR . . . . . 1.118 HG21 HG21 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -153.49 34.65 0.45 Allowed 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.282 1.033 . . . . 0.0 108.275 177.72 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.529 HG22 ' O ' ' A' ' 165' ' ' ILE . 1.1 mm -40.86 98.11 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.587 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.672 ' HB3' HD13 ' A' ' 218' ' ' ILE . . . -85.78 119.47 26.13 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.914 -1.039 . . . . 0.0 112.368 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -88.32 151.65 22.86 Favored Glycine 0 N--CA 1.443 -0.892 0 N-CA-C 110.159 -1.176 . . . . 0.0 110.159 178.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.55 ' HB3' HD13 ' A' ' 230' ' ' ILE . 0.0 OUTLIER -145.62 133.74 21.56 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 117.181 0.491 . . . . 0.0 110.724 -178.563 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 169' ' ' TYR . . . . . 0.432 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 10.9 t80 -87.33 127.33 35.19 Favored 'General case' 0 C--O 1.221 -0.429 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 177.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.812 HG21 ' O ' ' A' ' 208' ' ' VAL . 44.2 t -85.23 143.29 11.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -176.211 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -135.99 15.35 3.3 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 114.563 -1.199 . . . . 0.0 111.99 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -150.07 -146.42 0.2 Allowed 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -42.7 -105.11 0.01 OUTLIER Glycine 0 CA--C 1.531 1.071 0 N-CA-C 114.986 0.754 . . . . 0.0 114.986 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.745 ' HG3' ' HB2' ' A' ' 209' ' ' ALA . 0.0 OUTLIER -151.05 135.56 17.04 Favored 'General case' 0 CA--C 1.513 -0.465 0 O-C-N 122.637 -0.331 . . . . 0.0 111.207 -178.864 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.61 ' CG2' HG23 ' A' ' 208' ' ' VAL . 0.5 OUTLIER -95.51 112.13 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 176.909 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.48 ' HB ' ' O ' ' A' ' 206' ' ' ARG . 0.1 OUTLIER -120.93 169.12 10.77 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.468 0.652 . . . . 0.0 112.219 -176.8 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.92 -43.58 98.41 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.931 179.237 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -89.73 61.16 5.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.964 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.702 ' HB3' HD11 ' A' ' 148' ' ' ILE . 57.9 m -148.06 159.23 44.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.819 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 0.0 OUTLIER -89.08 -176.95 5.31 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.344 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.886 ' CG1' HD12 ' A' ' 195' ' ' ILE . 1.4 m -146.15 156.75 12.06 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 CA-C-O 121.466 0.65 . . . . 0.0 112.278 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' ARG . . . . . 0.436 ' N ' ' O ' ' A' ' 231' ' ' GLU . 4.1 ttt180 -153.49 102.65 2.59 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.081 -0.963 . . . . 0.0 113.051 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.738 HD13 ' CZ ' ' A' ' 221' ' ' PHE . 0.3 OUTLIER -86.03 159.55 19.56 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-O 122.143 0.973 . . . . 0.0 113.255 -179.758 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.531 ' N ' HG23 ' A' ' 190' ' ' VAL . 16.2 mt -153.82 122.59 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 113.838 -1.528 . . . . 0.0 112.311 178.13 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.431 ' N ' HG22 ' A' ' 190' ' ' VAL . 0.2 OUTLIER -87.05 -147.93 0.14 Allowed 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 177.848 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 21.0 mm100 -95.47 27.36 3.41 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 118.651 0.659 . . . . 0.0 110.745 178.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.419 ' C ' HD13 ' A' ' 188' ' ' ILE . . . -154.57 -80.24 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.755 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.419 HD13 ' C ' ' A' ' 187' ' ' GLY . 0.3 OUTLIER -112.41 -155.37 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 115.342 -0.429 . . . . 0.0 110.716 -179.107 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.777 HG11 ' CG ' ' A' ' 192' ' ' GLU . 41.2 t -87.04 135.62 24.8 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.096 0 CA-C-O 121.45 0.643 . . . . 0.0 111.576 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.897 HG12 ' OD2' ' A' ' 223' ' ' ASP . 0.2 OUTLIER -89.88 -32.25 5.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.203 178.687 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 191' ' ' TYR . . . . . 0.698 ' HB3' HD12 ' A' ' 183' ' ' LEU . 17.4 t80 -160.06 158.35 30.26 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.496 178.494 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 192' ' ' GLU . . . . . 0.777 ' CG ' HG11 ' A' ' 189' ' ' VAL . 22.3 mt-10 -150.81 154.05 36.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.072 178.178 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 135.29 -119.75 2.18 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.054 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 0.624 ' CA ' HG22 ' A' ' 181' ' ' VAL . 0.0 OUTLIER -148.43 -178.47 6.34 Favored 'General case' 0 CA--C 1.501 -0.904 0 CA-C-O 121.523 0.678 . . . . 0.0 111.663 -179.446 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.886 HD12 ' CG1' ' A' ' 181' ' ' VAL . 0.0 OUTLIER -88.75 147.77 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 CA-C-N 114.64 -1.163 . . . . 0.0 110.257 -178.674 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.68 -54.68 3.96 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 179.157 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 64.2 p -150.93 160.05 44.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.5 179.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.895 ' CD1' HD22 ' A' ' 216' ' ' LEU . 27.2 tp -133.44 110.71 10.18 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.384 0.611 . . . . 0.0 111.205 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 9.7 ptmt -149.8 123.89 9.44 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.414 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 2.6 ttm-85 -87.98 -160.17 0.6 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.896 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -87.1 -12.21 47.82 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.46 0.172 . . . . 0.0 110.988 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.03 -59.13 1.91 Allowed 'General case' 0 N--CA 1.441 -0.916 0 CA-C-O 120.651 0.263 . . . . 0.0 110.876 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -152.49 -174.79 5.02 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 120.88 0.371 . . . . 0.0 111.171 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -89.98 66.61 6.9 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.239 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 33.3 m -58.68 161.3 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.949 0 CA-C-O 121.55 0.69 . . . . 0.0 112.21 -179.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' ARG . . . . . 0.48 ' O ' ' HB ' ' A' ' 176' ' ' THR . 4.4 ttp180 -89.39 -38.17 14.31 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 114.625 -1.17 . . . . 0.0 111.461 -178.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.421 ' OE2' ' HB2' ' A' ' 239' ' ' ALA . 4.1 mt-10 -138.01 177.06 8.16 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.132 0.492 . . . . 0.0 111.332 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.812 ' O ' HG21 ' A' ' 170' ' ' VAL . 0.0 OUTLIER -151.05 81.78 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.544 178.98 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.745 ' HB2' ' HG3' ' A' ' 174' ' ' LYS . . . -101.7 172.52 6.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.102 0.477 . . . . 0.0 112.281 -178.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 2.8 tp-100 83.9 -72.98 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.983 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 178.09 37.95 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.371 -0.918 . . . . 0.0 112.44 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -97.99 143.22 28.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.979 0.419 . . . . 0.0 111.471 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -89.63 158.13 17.73 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.352 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -150.48 -171.09 3.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.015 0.436 . . . . 0.0 111.289 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -137.98 106.36 0.53 Allowed Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 178.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.895 HD22 ' CD1' ' A' ' 198' ' ' LEU . 0.1 OUTLIER -135.17 147.84 49.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.452 0.644 . . . . 0.0 112.602 -177.377 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 217' ' ' THR . . . . . 0.485 ' C ' HD12 ' A' ' 218' ' ' ILE . 0.0 OUTLIER -87.31 142.77 27.64 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 177.355 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 218' ' ' ILE . . . . . 0.672 HD13 ' HB3' ' A' ' 166' ' ' ALA . 1.5 mp -100.52 81.11 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.915 0.388 . . . . 0.0 110.817 -178.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 4.0 ttpt 42.34 -88.94 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.721 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' ASN . . . . . 0.401 ' N ' ' O ' ' A' ' 218' ' ' ILE . 13.0 t-20 -132.6 62.59 1.65 Allowed 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.118 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.738 ' CZ ' HD13 ' A' ' 183' ' ' LEU . 0.1 OUTLIER -59.23 119.55 7.58 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 179.443 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -81.58 -42.51 19.99 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 175.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 223' ' ' ASP . . . . . 0.897 ' OD2' HG12 ' A' ' 190' ' ' VAL . 0.0 OUTLIER -92.81 143.44 26.28 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.339 177.693 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 1.118 HG21 HG21 ' A' ' 164' ' ' THR . 0.2 OUTLIER -135.94 178.14 5.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -179.183 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.412 ' O ' ' C ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER 57.68 119.31 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 114.543 -1.208 . . . . 0.0 110.009 -178.953 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 226' ' ' GLU . . . . . 0.453 ' HA ' ' CG1' ' A' ' 153' ' ' VAL . 5.3 tt0 5.95 65.81 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 124.455 1.102 . . . . 0.0 113.62 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -66.34 -63.74 3.76 Favored Glycine 0 N--CA 1.429 -1.802 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.236 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.441 ' O ' ' HB ' ' A' ' 153' ' ' VAL . 1.0 OUTLIER -165.05 -147.17 0.1 Allowed 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 179.259 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 229' ' ' VAL . . . . . 0.724 HG22 ' HG2' ' A' ' 152' ' ' GLU . 52.6 t -89.8 146.92 5.59 Favored 'Isoleucine or valine' 0 C--N 1.34 0.181 0 CA-C-N 116.71 -0.223 . . . . 0.0 110.412 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 230' ' ' ILE . . . . . 0.55 HD13 ' HB3' ' A' ' 168' ' ' CYS . 4.4 mp -116.63 153.57 18.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.024 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 231' ' ' GLU . . . . . 0.436 ' O ' ' N ' ' A' ' 182' ' ' ARG . 0.1 OUTLIER -142.09 110.74 6.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.281 0.562 . . . . 0.0 111.949 -179.052 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.527 ' HB3' ' O ' ' A' ' 149' ' ' GLY . . . -87.93 127.97 35.37 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.312 178.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -129.3 139.41 51.78 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.349 -178.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.727 HG12 HG21 ' A' ' 148' ' ' ILE . 0.5 OUTLIER -177.56 -175.6 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.881 179.625 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 235' ' ' MET . . . . . 0.507 ' H ' HG22 ' A' ' 234' ' ' VAL . 1.3 mtm -89.13 -163.51 1.0 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.634 0.254 . . . . 0.0 110.709 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -90.22 66.64 6.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.433 0.635 . . . . 0.0 110.707 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' GLU . . . . . 0.725 ' O ' ' HB2' ' A' ' 241' ' ' ALA . 2.2 tt0 -150.97 56.28 0.9 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.091 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.457 ' O ' ' HB3' ' A' ' 239' ' ' ALA . 0.0 OUTLIER -109.51 174.85 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.793 179.607 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 239' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' A' ' 238' ' ' VAL . . . 73.13 -61.05 0.52 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.44 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.34 -5.09 57.79 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 241' ' ' ALA . . . . . 0.725 ' HB2' ' O ' ' A' ' 237' ' ' GLU . . . . . . . . 0 C--N 1.313 -0.984 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.043 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.772 0.32 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 63.34 127.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.088 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -95.16 39.21 1.12 Allowed 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.26 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 5.3 mmtm -112.55 -82.95 0.59 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.605 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 11.9 t -102.46 137.22 31.26 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.712 0 CA-C-O 121.36 0.6 . . . . 0.0 110.988 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.598 HG21 HG12 ' A' ' 234' ' ' VAL . 2.7 pp -131.9 6.85 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.245 178.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.547 ' CA ' ' HB3' ' A' ' 232' ' ' ALA . . . 171.77 73.91 0.04 OUTLIER Glycine 0 C--N 1.341 0.841 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.125 179.412 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.486 ' HA ' ' HA ' ' A' ' 231' ' ' GLU . 0.5 OUTLIER -93.04 132.09 37.46 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 122.551 -0.381 . . . . 0.0 110.613 -179.683 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.483 ' O ' HG13 ' A' ' 229' ' ' VAL . . . -151.22 172.92 15.08 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 121.377 0.608 . . . . 0.0 112.564 -178.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.43 ' HA ' ' HA ' ' A' ' 229' ' ' VAL . 1.8 mm-40 -121.6 126.21 48.54 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.438 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.48 ' CG1' ' HA ' ' A' ' 226' ' ' GLU . 1.9 p -52.39 131.32 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-O 121.344 0.592 . . . . 0.0 112.309 -179.296 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.497 ' O ' ' HB3' ' A' ' 226' ' ' GLU . 0.0 OUTLIER -90.47 -60.34 1.95 Allowed 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 105.142 -2.17 . . . . 0.0 105.142 175.444 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.49 -159.88 0.49 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 114.206 -1.361 . . . . 0.0 109.915 174.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.547 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 12.7 p -150.13 148.2 28.68 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.375 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.574 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 0.2 OUTLIER -90.72 82.47 5.75 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -177.723 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.401 ' CD ' HG13 ' A' ' 224' ' ' ILE . 1.6 tttt -86.44 62.29 7.33 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 177.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.478 HG12 ' N ' ' A' ' 161' ' ' LYS . 54.0 t -91.28 156.08 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 CA-C-N 113.771 -1.559 . . . . 0.0 110.059 -178.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 80.0 p -90.41 34.2 0.88 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.122 0.487 . . . . 0.0 110.161 178.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.478 ' N ' HG12 ' A' ' 159' ' ' VAL . 0.0 OUTLIER -150.75 -32.32 0.17 Allowed 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.471 -179.862 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.494 HG12 ' N ' ' A' ' 163' ' ' GLY . 87.4 t -100.17 -102.68 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.15 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' GLY . . . . . 0.494 ' N ' HG12 ' A' ' 162' ' ' VAL . . . -159.28 -101.51 0.17 Allowed Glycine 0 N--CA 1.451 -0.344 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 178.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' THR . . . . . 1.039 HG21 HG21 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -153.5 36.46 0.46 Allowed 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 177.822 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.696 HD12 ' O ' ' A' ' 215' ' ' GLY . 0.9 OUTLIER -42.31 95.3 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.26 -179.416 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.877 ' O ' HD12 ' A' ' 216' ' ' LEU . . . -82.08 118.68 23.22 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 114.495 -1.229 . . . . 0.0 112.482 -178.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -91.22 143.99 16.94 Favored Glycine 0 N--CA 1.442 -0.965 0 N-CA-C 111.001 -0.839 . . . . 0.0 111.001 178.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.656 ' SG ' HD11 ' A' ' 216' ' ' LEU . 0.0 OUTLIER -137.73 132.95 33.56 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 -179.728 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 169' ' ' TYR . . . . . 0.432 ' HB2' ' HD3' ' A' ' 154' ' ' ARG . 7.4 t80 -85.03 128.16 34.51 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 178.272 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.581 HG21 ' O ' ' A' ' 208' ' ' VAL . 44.4 t -85.96 147.79 5.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -176.084 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.6 p -140.78 14.83 2.31 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-N 114.474 -1.239 . . . . 0.0 111.841 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.406 ' CB ' ' HB2' ' A' ' 150' ' ' GLN . 11.3 t0 -150.8 -144.46 0.15 Allowed 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 -179.183 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -40.15 -104.22 0.01 OUTLIER Glycine 0 CA--C 1.532 1.11 0 N-CA-C 115.209 0.844 . . . . 0.0 115.209 -179.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.671 ' HG2' ' HB2' ' A' ' 209' ' ' ALA . 20.2 mttp -151.13 134.73 16.33 Favored 'General case' 0 CA--C 1.514 -0.427 0 O-C-N 122.517 -0.402 . . . . 0.0 111.839 -178.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.839 ' CG2' HD21 ' A' ' 216' ' ' LEU . 4.6 mm -91.2 83.87 2.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 176.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.967 HG21 HG12 ' A' ' 238' ' ' VAL . 0.0 OUTLIER -98.62 -178.16 3.9 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -176.704 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.59 -45.59 21.33 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-N 114.854 -1.066 . . . . 0.0 111.166 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -88.67 61.39 6.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.393 0.616 . . . . 0.0 110.338 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.533 ' HB3' HD11 ' A' ' 148' ' ' ILE . 16.4 m -149.32 157.74 43.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.986 -179.268 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 1.7 mptt -89.06 -178.17 5.62 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.655 HG22 ' CA ' ' A' ' 194' ' ' GLU . 1.9 m -142.71 161.79 18.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.336 0.589 . . . . 0.0 111.845 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' ARG . . . . . 0.428 ' N ' ' O ' ' A' ' 231' ' ' GLU . 15.1 ttt180 -151.74 98.95 2.54 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.113 -0.948 . . . . 0.0 112.323 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.89 HD13 ' HB3' ' A' ' 191' ' ' TYR . 5.4 mp -89.08 146.14 25.02 Favored 'General case' 0 CA--C 1.497 -1.09 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -178.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.465 ' CA ' HG23 ' A' ' 190' ' ' VAL . 17.8 mt -156.57 128.18 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-N 113.168 -1.833 . . . . 0.0 111.772 179.15 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.403 ' N ' ' CG2' ' A' ' 190' ' ' VAL . 0.1 OUTLIER -88.87 -148.44 0.17 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 177.943 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -94.94 29.69 2.32 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 118.604 0.638 . . . . 0.0 110.998 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -153.6 -83.34 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.869 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.47 ' H ' HD12 ' A' ' 188' ' ' ILE . 0.1 OUTLIER -111.6 -158.7 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 CA-C-N 115.455 -0.372 . . . . 0.0 110.621 -179.252 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.536 HG11 ' CG ' ' A' ' 192' ' ' GLU . 43.4 t -87.13 134.85 26.58 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 CA-C-O 121.68 0.752 . . . . 0.0 110.992 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.895 HG12 ' OD2' ' A' ' 223' ' ' ASP . 0.2 OUTLIER -94.79 -34.84 5.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 114.416 -1.265 . . . . 0.0 109.525 -179.909 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 191' ' ' TYR . . . . . 0.89 ' HB3' HD13 ' A' ' 183' ' ' LEU . 27.0 t80 -170.1 156.14 5.82 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.102 -0.953 . . . . 0.0 112.446 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' GLU . . . . . 0.536 ' CG ' HG11 ' A' ' 189' ' ' VAL . 32.2 mt-10 -151.13 162.12 41.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.634 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 134.76 -114.88 1.33 Allowed Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.558 -0.829 . . . . 0.0 112.343 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 0.655 ' CA ' HG22 ' A' ' 181' ' ' VAL . 0.0 OUTLIER -150.47 -178.43 6.53 Favored 'General case' 0 CA--C 1.503 -0.865 0 CA-C-O 121.323 0.583 . . . . 0.0 110.901 -179.407 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.683 ' CD1' HD22 ' A' ' 216' ' ' LEU . 0.0 OUTLIER -89.76 154.65 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.921 -179.431 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 196' ' ' ASP . . . . . 0.402 ' HB3' ' CB ' ' A' ' 217' ' ' THR . 26.3 t70 -89.8 -66.79 0.89 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 178.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -151.63 146.72 26.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.248 179.04 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.853 ' HG ' HD23 ' A' ' 216' ' ' LEU . 2.4 tt -110.96 119.52 39.34 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.519 0.676 . . . . 0.0 112.487 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 199' ' ' LYS . . . . . 0.558 ' N ' HD23 ' A' ' 198' ' ' LEU . 0.7 OUTLIER -151.55 116.52 5.22 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.491 178.55 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -88.06 -159.71 0.56 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -87.95 13.0 11.82 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.35 -62.11 1.46 Allowed 'General case' 0 N--CA 1.438 -1.04 0 CA-C-O 120.943 0.402 . . . . 0.0 110.384 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -151.97 -172.79 4.33 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.763 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -90.72 71.86 6.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.417 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 34.2 m -66.14 162.39 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.958 0 CA-C-O 121.414 0.626 . . . . 0.0 112.062 -179.257 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' ARG . . . . . 0.468 ' O ' ' HB ' ' A' ' 176' ' ' THR . 5.3 mtp180 -89.15 -37.32 15.14 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.565 -178.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.706 ' HB3' HG22 ' A' ' 176' ' ' THR . 0.5 OUTLIER -141.38 178.35 7.49 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.27 0.557 . . . . 0.0 111.746 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.581 ' O ' HG21 ' A' ' 170' ' ' VAL . 0.0 OUTLIER -151.05 80.59 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.588 179.034 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.671 ' HB2' ' HG2' ' A' ' 174' ' ' LYS . . . -96.47 172.02 8.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.072 0.463 . . . . 0.0 112.038 -178.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 84.83 -73.88 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.055 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 177.87 37.34 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.29 -0.957 . . . . 0.0 112.623 179.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -99.51 145.23 27.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.939 0.399 . . . . 0.0 111.568 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -89.77 161.38 16.06 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.528 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 27.1 p -150.55 -170.03 3.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.967 0.413 . . . . 0.0 111.209 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' GLY . . . . . 0.696 ' O ' HD12 ' A' ' 165' ' ' ILE . . . -139.74 98.68 0.24 Allowed Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 179.028 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.877 HD12 ' O ' ' A' ' 166' ' ' ALA . 0.2 OUTLIER -129.3 151.11 50.32 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 121.06 0.457 . . . . 0.0 110.782 -178.997 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 217' ' ' THR . . . . . 0.402 ' CB ' ' HB3' ' A' ' 196' ' ' ASP . 0.0 OUTLIER -87.91 141.06 28.88 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 177.294 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 218' ' ' ILE . . . . . 0.606 HG22 ' O ' ' A' ' 218' ' ' ILE . 16.6 mm -98.2 74.39 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.77 -178.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 46.43 -136.0 0.8 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.295 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -87.03 58.07 4.86 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 120.793 0.33 . . . . 0.0 111.609 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.767 ' CZ ' HD22 ' A' ' 183' ' ' LEU . 0.1 OUTLIER -56.25 120.0 6.88 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 178.1 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -80.01 -45.23 18.76 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 176.193 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' ASP . . . . . 0.895 ' OD2' HG12 ' A' ' 190' ' ' VAL . 0.0 OUTLIER -91.35 131.44 36.84 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.761 178.109 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 1.039 HG21 HG21 ' A' ' 164' ' ' THR . 0.1 OUTLIER -121.29 177.61 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-O 121.17 0.51 . . . . 0.0 111.929 -179.877 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.473 ' O ' ' N ' ' A' ' 227' ' ' GLY . 2.3 mtpp 62.92 152.32 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.136 -178.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 226' ' ' GLU . . . . . 0.497 ' HB3' ' O ' ' A' ' 154' ' ' ARG . 0.4 OUTLIER -38.45 90.14 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 CA-C-O 122.186 0.993 . . . . 0.0 112.258 -179.947 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 227' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 225' ' ' LYS . . . -106.45 -39.28 2.1 Favored Glycine 0 N--CA 1.43 -1.741 0 CA-C-N 114.429 -1.26 . . . . 0.0 112.152 -178.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.738 ' CB ' HG21 ' A' ' 190' ' ' VAL . 2.9 p30 -158.23 -164.85 1.57 Allowed 'General case' 0 C--O 1.22 -0.466 0 N-CA-C 115.292 1.59 . . . . 0.0 115.292 -178.277 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 229' ' ' VAL . . . . . 0.483 HG13 ' O ' ' A' ' 151' ' ' ALA . 89.3 t -102.25 144.66 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 177.324 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 230' ' ' ILE . . . . . 0.402 HG13 ' HG ' ' A' ' 183' ' ' LEU . 3.7 mp -114.79 153.61 16.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.217 0.532 . . . . 0.0 112.103 -178.019 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 231' ' ' GLU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 150' ' ' GLN . 20.3 tt0 -140.85 111.88 7.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.374 0.606 . . . . 0.0 111.476 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.547 ' HB3' ' CA ' ' A' ' 149' ' ' GLY . . . -87.78 128.7 35.32 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.896 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -130.81 142.81 50.41 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.916 -179.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.598 HG12 HG21 ' A' ' 148' ' ' ILE . 0.3 OUTLIER -178.12 -177.36 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.111 -179.762 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 235' ' ' MET . . . . . 0.508 ' H ' HG22 ' A' ' 234' ' ' VAL . 0.7 OUTLIER -89.7 -157.71 0.48 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.976 179.33 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -88.26 70.82 9.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.442 0.639 . . . . 0.0 110.819 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -150.66 58.73 0.94 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.544 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.967 HG12 HG21 ' A' ' 176' ' ' THR . 0.2 OUTLIER -92.44 -164.35 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.727 -179.438 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 239' ' ' ALA . . . . . 0.454 ' HB2' ' HG3' ' A' ' 207' ' ' GLU . . . -49.62 -71.77 0.06 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.028 0.442 . . . . 0.0 111.243 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -89.83 -6.47 55.85 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.036 179.237 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.316 -0.85 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.168 179.961 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.819 0.342 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -119.66 119.59 34.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.972 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.83 36.03 1.46 Allowed 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.187 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 5.9 mmtm -147.48 -80.39 0.14 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.243 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 18.9 t -97.39 136.91 26.56 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.631 0 CA-C-O 121.17 0.509 . . . . 0.0 110.527 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.601 HG21 ' O ' ' A' ' 234' ' ' VAL . 2.7 pp -128.94 6.31 2.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.326 178.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.569 ' CA ' ' HB3' ' A' ' 232' ' ' ALA . . . 171.21 75.43 0.04 OUTLIER Glycine 0 C--N 1.341 0.843 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.003 179.228 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.462 ' HA ' ' HA ' ' A' ' 231' ' ' GLU . 0.7 OUTLIER -95.14 130.3 41.9 Favored 'General case' 0 CA--C 1.517 -0.317 0 O-C-N 122.551 -0.382 . . . . 0.0 110.419 -179.826 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.475 ' O ' HG13 ' A' ' 229' ' ' VAL . . . -151.04 171.21 17.69 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 120.32 -0.552 . . . . 0.0 112.25 -178.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 229' ' ' VAL . 1.6 mm-40 -119.01 128.0 53.97 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.536 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.489 ' CG1' ' HA ' ' A' ' 226' ' ' GLU . 2.0 p -49.65 142.61 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -178.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -100.77 -63.01 1.17 Allowed 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 104.379 -2.452 . . . . 0.0 104.379 174.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.92 -165.65 1.29 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 113.735 -1.575 . . . . 0.0 109.368 174.37 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.525 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 8.1 p -147.11 163.29 36.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.553 0.216 . . . . 0.0 110.425 177.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.549 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 0.2 OUTLIER -115.48 76.26 0.99 Allowed 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -179.475 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.876 ' CB ' HD13 ' A' ' 224' ' ' ILE . 7.2 tmtm? -86.27 62.97 7.75 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 177.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.403 HG12 ' N ' ' A' ' 161' ' ' LYS . 98.3 t -92.94 158.59 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 CA-C-N 113.589 -1.642 . . . . 0.0 110.538 -178.376 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 19.7 m -93.28 34.57 1.13 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.317 0.58 . . . . 0.0 109.552 177.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.403 ' N ' HG12 ' A' ' 159' ' ' VAL . 1.1 mtpt -151.49 -34.77 0.14 Allowed 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.164 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.76 ' CG1' HD12 ' A' ' 165' ' ' ILE . 86.0 t -97.65 -102.7 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 N-CA-C 109.703 -0.481 . . . . 0.0 109.703 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' GLY . . . . . 0.505 ' N ' HG12 ' A' ' 162' ' ' VAL . . . -159.46 -102.47 0.18 Allowed Glycine 0 N--CA 1.451 -0.326 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 178.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.532 ' CG2' HG21 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -154.21 32.61 0.43 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 113.976 -1.112 . . . . 0.0 108.543 177.611 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.76 HD12 ' CG1' ' A' ' 162' ' ' VAL . 1.8 mt -42.53 95.42 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.481 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.525 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . -90.45 122.94 33.75 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.82 -1.082 . . . . 0.0 112.052 -179.357 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -88.29 146.03 19.38 Favored Glycine 0 N--CA 1.44 -1.053 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 178.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.412 ' HB2' ' CB ' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -143.76 131.4 21.24 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 117.164 0.482 . . . . 0.0 110.072 -179.18 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 169' ' ' TYR . . . . . 0.41 ' O ' ' HA ' ' A' ' 151' ' ' ALA . 17.2 t80 -86.94 122.39 30.74 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 178.244 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.74 HG21 ' O ' ' A' ' 208' ' ' VAL . 38.7 t -85.38 145.17 8.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -176.27 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 2.0 p -138.19 14.92 2.82 Favored 'General case' 0 N--CA 1.457 -0.113 0 CA-C-N 114.662 -1.154 . . . . 0.0 111.912 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.408 ' H ' HG12 ' A' ' 170' ' ' VAL . 10.7 t0 -150.62 -144.36 0.15 Allowed 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -179.111 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -40.48 -105.52 0.01 OUTLIER Glycine 0 CA--C 1.532 1.103 0 N-CA-C 115.13 0.812 . . . . 0.0 115.13 -178.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.618 ' HG2' ' HB2' ' A' ' 209' ' ' ALA . 7.1 mttt -151.4 134.85 16.17 Favored 'General case' 0 CA--C 1.514 -0.417 0 O-C-N 122.526 -0.397 . . . . 0.0 111.957 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.674 ' O ' HD11 ' A' ' 198' ' ' LEU . 6.0 mm -91.81 83.23 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 176.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.78 ' O ' HD12 ' A' ' 195' ' ' ILE . 0.1 OUTLIER -98.59 176.22 5.73 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.54 0.686 . . . . 0.0 112.415 -177.557 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -71.58 -44.67 64.06 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.969 -1.014 . . . . 0.0 111.386 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -88.99 61.83 6.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.249 0.547 . . . . 0.0 110.756 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.42 ' HB3' HD11 ' A' ' 148' ' ' ILE . 20.3 m -150.09 157.95 43.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.048 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 2.1 mptt -88.68 177.27 6.79 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.661 HG22 ' CA ' ' A' ' 194' ' ' GLU . 2.0 m -141.68 163.71 19.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.399 0.619 . . . . 0.0 111.956 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' ARG . . . . . 0.43 ' N ' ' O ' ' A' ' 231' ' ' GLU . 7.4 ttt180 -151.51 100.09 2.68 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.037 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.852 HD13 ' HB3' ' A' ' 191' ' ' TYR . 5.4 mp -89.2 144.49 26.07 Favored 'General case' 0 CA--C 1.494 -1.184 0 CA-C-O 122.476 1.131 . . . . 0.0 113.868 -178.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.487 ' CA ' HG23 ' A' ' 190' ' ' VAL . 18.1 mt -156.65 129.28 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-N 113.007 -1.906 . . . . 0.0 111.754 179.338 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.413 ' N ' ' CG2' ' A' ' 190' ' ' VAL . 0.1 OUTLIER -88.54 -148.45 0.17 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.028 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -95.46 29.53 2.54 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 118.526 0.603 . . . . 0.0 110.818 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -153.23 -82.39 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.904 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -113.06 -158.26 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 115.519 -0.34 . . . . 0.0 110.704 -179.13 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.414 HG11 ' HG3' ' A' ' 192' ' ' GLU . 40.0 t -87.08 137.02 21.7 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 CA-C-O 121.741 0.781 . . . . 0.0 111.05 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.793 HG21 ' CB ' ' A' ' 228' ' ' ASP . 0.2 OUTLIER -98.88 -35.78 5.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 114.272 -1.331 . . . . 0.0 109.484 -179.462 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 191' ' ' TYR . . . . . 0.852 ' HB3' HD13 ' A' ' 183' ' ' LEU . 14.7 t80 -169.04 157.72 8.07 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.012 -0.994 . . . . 0.0 112.38 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' GLU . . . . . 0.414 ' HG3' HG11 ' A' ' 189' ' ' VAL . 60.9 mt-10 -151.5 162.06 41.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.748 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 135.38 -116.98 1.62 Allowed Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.169 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 0.661 ' CA ' HG22 ' A' ' 181' ' ' VAL . 17.0 pt-20 -149.98 -176.3 5.38 Favored 'General case' 0 CA--C 1.497 -1.085 0 CA-C-O 121.336 0.589 . . . . 0.0 111.432 -179.359 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.78 HD12 ' O ' ' A' ' 176' ' ' THR . 49.1 mt -89.43 146.99 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.352 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.552 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' ASP . . . . . 0.629 ' HB3' HG23 ' A' ' 217' ' ' THR . 0.5 OUTLIER -89.14 -59.87 2.11 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.87 0.366 . . . . 0.0 110.033 179.581 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 1.3 m -151.32 159.08 44.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.87 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.674 HD11 ' O ' ' A' ' 175' ' ' ILE . 0.2 OUTLIER -127.54 122.86 34.4 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 121.435 0.636 . . . . 0.0 112.093 -179.388 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 199' ' ' LYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 13.2 mtmm -150.61 118.15 6.11 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.96 179.11 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 7.5 ttp180 -88.15 -160.35 0.62 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.309 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -87.11 -13.92 42.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.775 -0.193 . . . . 0.0 110.889 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -97.18 -57.63 2.22 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-O 120.659 0.266 . . . . 0.0 111.024 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -152.46 -166.5 2.49 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 120.706 0.289 . . . . 0.0 110.854 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' ASP . . . . . 0.428 ' HA ' ' HA ' ' A' ' 199' ' ' LYS . 9.8 t70 -89.72 64.41 6.49 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 121.049 0.452 . . . . 0.0 110.209 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.482 HG23 ' CD2' ' A' ' 198' ' ' LEU . 32.6 m -57.71 158.62 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.961 0 CA-C-O 121.511 0.672 . . . . 0.0 112.179 -179.162 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 206' ' ' ARG . . . . . 0.426 ' O ' ' HA ' ' A' ' 176' ' ' THR . 1.7 ttp180 -89.44 -35.36 16.05 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 114.769 -1.105 . . . . 0.0 112.225 -178.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.48 ' HB3' HG22 ' A' ' 176' ' ' THR . 0.3 OUTLIER -140.11 177.55 7.9 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.343 0.592 . . . . 0.0 111.898 -179.456 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.74 ' O ' HG21 ' A' ' 170' ' ' VAL . 0.0 OUTLIER -151.07 77.86 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.167 178.517 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.618 ' HB2' ' HG2' ' A' ' 174' ' ' LYS . . . -98.55 174.35 6.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.168 0.508 . . . . 0.0 112.366 -178.582 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 81.75 -70.08 0.07 Allowed 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.867 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 178.2 37.23 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 120.431 -0.89 . . . . 0.0 112.248 179.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' TYR . . . . . 0.648 ' HB3' HG12 ' A' ' 208' ' ' VAL . 1.2 m-85 -104.11 140.49 37.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.966 0.412 . . . . 0.0 111.215 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -95.48 148.61 22.3 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.404 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' CYS . . . . . 0.519 ' HB3' HG21 ' A' ' 208' ' ' VAL . 45.5 t -150.51 146.14 26.42 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.371 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -88.11 112.49 3.89 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.943 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.656 HD12 HD11 ' A' ' 218' ' ' ILE . 0.3 OUTLIER -138.56 143.3 39.36 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 120.864 0.364 . . . . 0.0 111.149 -179.139 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 217' ' ' THR . . . . . 0.629 HG23 ' HB3' ' A' ' 196' ' ' ASP . 0.2 OUTLIER -83.48 142.42 30.95 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 177.951 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 218' ' ' ILE . . . . . 0.656 HD11 HD12 ' A' ' 216' ' ' LEU . 1.6 mp -106.84 92.36 2.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 -178.494 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 2.5 tttp 45.77 -146.98 0.13 Allowed 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.511 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 -87.54 62.46 7.11 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-O 120.857 0.36 . . . . 0.0 110.984 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.762 ' CZ ' HD22 ' A' ' 183' ' ' LEU . 0.1 OUTLIER -54.71 119.86 5.93 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 179.31 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -84.19 -47.6 10.67 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 114.771 -1.104 . . . . 0.0 108.368 176.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' ASP . . . . . 0.527 ' OD2' HG12 ' A' ' 190' ' ' VAL . 0.0 OUTLIER -84.78 130.27 34.7 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 178.026 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.876 HD13 ' CB ' ' A' ' 158' ' ' LYS . 1.2 pt -126.46 176.48 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -179.297 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.815 ' HG2' HD12 ' A' ' 224' ' ' ILE . 0.0 OUTLIER 61.12 129.47 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.102 -179.057 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 226' ' ' GLU . . . . . 0.489 ' HA ' ' CG1' ' A' ' 153' ' ' VAL . 3.6 tt0 -11.67 77.97 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 124.249 1.02 . . . . 0.0 113.341 -179.236 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 227' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 225' ' ' LYS . . . -98.26 -40.16 3.55 Favored Glycine 0 N--CA 1.43 -1.759 0 CA-C-N 114.564 -1.198 . . . . 0.0 112.626 -178.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.793 ' CB ' HG21 ' A' ' 190' ' ' VAL . 2.7 p30 -159.03 -160.98 0.9 Allowed 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 115.375 1.62 . . . . 0.0 115.375 -177.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 229' ' ' VAL . . . . . 0.475 HG13 ' O ' ' A' ' 151' ' ' ALA . 91.9 t -108.3 143.88 17.9 Favored 'Isoleucine or valine' 0 C--N 1.343 0.292 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 177.542 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 3.7 mp -111.43 153.32 13.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.252 0.548 . . . . 0.0 112.097 -178.216 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' GLU . . . . . 0.462 ' HA ' ' HA ' ' A' ' 150' ' ' GLN . 15.1 tt0 -141.05 111.32 6.75 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.437 0.637 . . . . 0.0 111.598 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.569 ' HB3' ' CA ' ' A' ' 149' ' ' GLY . . . -87.34 134.21 33.6 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.412 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -138.58 139.27 38.56 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.081 -178.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.601 ' O ' HG21 ' A' ' 148' ' ' ILE . 0.5 OUTLIER -177.39 131.09 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-O 120.938 0.399 . . . . 0.0 111.881 -179.931 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 1.8 mpp? -89.5 56.69 3.67 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -127.48 -152.0 0.5 Allowed 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.67 -178.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 237' ' ' GLU . . . . . 0.686 ' O ' ' HB2' ' A' ' 241' ' ' ALA . 10.3 tt0 -136.86 69.78 1.41 Allowed 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.528 ' O ' ' HB3' ' A' ' 239' ' ' ALA . 4.6 t -83.65 161.07 3.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.216 -178.319 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 239' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' A' ' 238' ' ' VAL . . . 80.74 -56.64 0.32 Allowed 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.182 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 1.6 ttp85 -89.48 -5.42 57.34 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 241' ' ' ALA . . . . . 0.686 ' HB2' ' O ' ' A' ' 237' ' ' GLU . . . . . . . . 0 C--N 1.312 -1.034 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.12 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 12.2 p90 . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 120.653 0.263 . . . . 0.0 111.409 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 60.83 169.37 0.09 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.836 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.06 42.17 1.09 Allowed 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.406 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 6.3 tptt -97.37 -173.29 2.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.776 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.675 HG11 ' HB2' ' A' ' 150' ' ' GLN . 5.8 t -61.0 141.0 17.93 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.683 0 CA-C-O 121.294 0.569 . . . . 0.0 111.181 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 1.013 HG21 HG12 ' A' ' 234' ' ' VAL . 0.1 OUTLIER -123.56 -5.65 7.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.871 178.095 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.465 ' O ' ' HB3' ' A' ' 232' ' ' ALA . . . -174.38 74.41 0.08 OUTLIER Glycine 0 C--N 1.342 0.869 0 N-CA-C 111.683 -0.567 . . . . 0.0 111.683 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.675 ' HB2' HG11 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -89.49 136.11 33.22 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 179.591 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.498 ' HB1' ' HB2' ' A' ' 168' ' ' CYS . . . -151.93 173.2 15.12 Favored 'General case' 0 N--CA 1.435 -1.176 0 C-N-CA 120.009 -0.677 . . . . 0.0 112.478 -178.099 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.699 ' HG2' HG22 ' A' ' 229' ' ' VAL . 3.8 mt-10 -122.32 121.1 35.94 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.081 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.447 ' CG1' ' HA ' ' A' ' 226' ' ' GLU . 2.2 p -49.71 132.55 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -178.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -90.17 -61.56 1.66 Allowed 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 104.941 -2.244 . . . . 0.0 104.941 175.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.48 ' HA ' ' H ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER -162.28 -163.49 0.93 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 113.76 -1.563 . . . . 0.0 109.405 174.902 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.565 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 6.9 p -145.42 156.97 44.09 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 120.845 0.355 . . . . 0.0 110.079 177.248 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.685 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 2.4 m-85 -103.98 73.22 1.14 Allowed 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -177.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.95 63.93 8.31 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 88.2 t -91.4 157.87 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 CA-C-N 113.611 -1.631 . . . . 0.0 110.075 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 3.8 t -92.67 34.4 1.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.145 0.498 . . . . 0.0 109.784 178.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -151.45 -33.03 0.15 Allowed 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.445 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.508 HG12 ' N ' ' A' ' 163' ' ' GLY . 90.4 t -100.07 -101.95 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.169 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 -179.543 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' GLY . . . . . 0.508 ' N ' HG12 ' A' ' 162' ' ' VAL . . . -158.74 -103.69 0.2 Allowed Glycine 0 N--CA 1.451 -0.366 0 N-CA-C 111.706 -0.558 . . . . 0.0 111.706 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.515 ' CG2' HG21 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -153.63 34.82 0.45 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 114.406 -0.897 . . . . 0.0 108.932 178.483 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.685 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 2.9 mm -42.88 95.44 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.496 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.565 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . -86.19 119.17 26.18 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.706 -1.133 . . . . 0.0 111.247 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -87.95 150.63 22.37 Favored Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 178.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.675 ' SG ' HD11 ' A' ' 216' ' ' LEU . 0.0 OUTLIER -148.25 136.43 21.19 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 117.364 0.582 . . . . 0.0 111.102 -178.236 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 169' ' ' TYR . . . . . 0.42 ' O ' ' HA ' ' A' ' 151' ' ' ALA . 5.9 t80 -87.66 129.96 34.96 Favored 'General case' 0 C--O 1.221 -0.402 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 177.475 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.795 HG21 ' O ' ' A' ' 208' ' ' VAL . 38.3 t -85.67 145.09 8.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -176.302 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.2 p -138.25 13.18 2.82 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 114.788 -1.096 . . . . 0.0 112.164 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.408 ' CB ' ' HB2' ' A' ' 150' ' ' GLN . 10.4 t0 -149.98 -141.04 0.1 Allowed 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -48.67 -109.59 0.01 OUTLIER Glycine 0 CA--C 1.531 1.033 0 N-CA-C 114.527 0.571 . . . . 0.0 114.527 -179.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.659 ' HG2' ' HB2' ' A' ' 209' ' ' ALA . 5.6 mtmt -150.59 138.84 20.29 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 122.397 -0.472 . . . . 0.0 110.603 -179.102 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.431 HG23 ' O ' ' A' ' 175' ' ' ILE . 0.5 OUTLIER -94.38 112.29 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 C-N-CA 119.528 -0.869 . . . . 0.0 109.536 177.439 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.917 HG21 HG12 ' A' ' 238' ' ' VAL . 0.2 OUTLIER -120.36 173.05 7.38 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.654 0.74 . . . . 0.0 112.99 -177.009 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.02 -43.67 86.93 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 114.521 -1.218 . . . . 0.0 109.95 178.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -89.25 56.5 3.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.696 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.469 ' OG ' HG23 ' A' ' 176' ' ' THR . 5.4 m -150.33 161.39 42.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.86 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 7.6 tptt -89.32 177.62 6.55 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.036 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.782 HG21 HD12 ' A' ' 218' ' ' ILE . 1.5 m -146.13 146.9 18.73 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.548 0 CA-C-O 121.347 0.594 . . . . 0.0 111.04 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' ARG . . . . . 0.551 ' HD2' HD11 ' A' ' 184' ' ' ILE . 5.2 ttm-85 -155.37 99.34 2.05 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.177 -0.92 . . . . 0.0 112.539 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.625 ' C ' HD12 ' A' ' 184' ' ' ILE . 0.3 OUTLIER -97.51 166.59 11.45 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 120.186 -0.606 . . . . 0.0 110.908 179.302 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.756 HG23 ' O ' ' A' ' 188' ' ' ILE . 4.4 mp -151.87 140.08 14.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.143 -0.48 . . . . 0.0 112.057 -177.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.798 ' NH2' HG13 ' A' ' 190' ' ' VAL . 5.2 ptp180 -87.08 -152.67 0.19 Allowed 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.371 -0.832 . . . . 0.0 108.906 178.17 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -94.64 29.04 2.42 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 118.19 0.45 . . . . 0.0 111.489 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.61 ' C ' HD13 ' A' ' 188' ' ' ILE . . . -153.23 -76.12 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.39 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.756 ' O ' HG23 ' A' ' 184' ' ' ILE . 0.2 OUTLIER -117.9 -155.86 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 115.373 -0.414 . . . . 0.0 110.216 -179.522 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.714 HG11 ' CG ' ' A' ' 192' ' ' GLU . 35.1 t -85.95 139.53 17.26 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 CA-C-O 121.573 0.701 . . . . 0.0 110.758 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.831 HG12 ' OD2' ' A' ' 223' ' ' ASP . 0.7 OUTLIER -87.41 -40.76 14.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 114.693 -1.14 . . . . 0.0 108.409 179.898 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 191' ' ' TYR . . . . . 0.453 ' CE2' ' O ' ' A' ' 220' ' ' ASN . 0.6 OUTLIER -171.91 150.21 2.56 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.606 -1.179 . . . . 0.0 111.131 179.322 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 192' ' ' GLU . . . . . 0.714 ' CG ' HG11 ' A' ' 189' ' ' VAL . 32.3 mt-10 -135.53 164.45 27.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.081 0.467 . . . . 0.0 111.19 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 135.87 -160.26 24.52 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 0.541 ' O ' HG23 ' A' ' 218' ' ' ILE . 3.3 pt-20 -108.69 -178.1 3.5 Favored 'General case' 0 CA--C 1.498 -1.052 0 CA-C-N 117.656 0.728 . . . . 0.0 110.723 179.297 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.934 ' CD1' HD13 ' A' ' 216' ' ' LEU . 0.1 OUTLIER -88.39 148.92 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.881 -177.977 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -88.92 -54.94 3.9 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -151.47 152.86 33.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.088 179.065 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.717 HD22 ' HB3' ' A' ' 216' ' ' LEU . 0.2 OUTLIER -122.01 103.42 8.8 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.882 179.872 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 199' ' ' LYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 0.1 OUTLIER -135.96 122.72 21.11 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.428 179.618 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -88.37 -159.26 0.53 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.096 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -87.03 -10.81 52.15 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 121.295 -0.162 . . . . 0.0 111.101 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.72 -59.44 1.72 Allowed 'General case' 0 N--CA 1.441 -0.909 0 CA-C-O 120.699 0.285 . . . . 0.0 111.01 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -152.27 -169.34 3.32 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 120.804 0.335 . . . . 0.0 110.991 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' ASP . . . . . 0.401 ' HA ' ' HA ' ' A' ' 199' ' ' LYS . 17.4 m-20 -90.16 70.07 7.24 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.37 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 35.5 m -62.29 165.23 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.063 0 CA-C-O 121.538 0.685 . . . . 0.0 112.088 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' ARG . . . . . 0.504 ' O ' ' HB ' ' A' ' 176' ' ' THR . 1.6 ttm180 -89.18 -41.7 12.09 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-N 114.726 -1.125 . . . . 0.0 111.368 -178.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -136.2 178.6 6.94 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.249 0.547 . . . . 0.0 111.963 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.795 ' O ' HG21 ' A' ' 170' ' ' VAL . 0.2 OUTLIER -150.96 94.67 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.701 179.108 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.659 ' HB2' ' HG2' ' A' ' 174' ' ' LYS . . . -118.27 178.09 4.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.215 0.531 . . . . 0.0 112.36 -178.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 80.91 -71.8 0.07 Allowed 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.794 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 178.62 37.31 0.06 OUTLIER Glycine 0 N--CA 1.442 -0.933 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.2 179.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -104.48 139.11 39.87 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.962 0.41 . . . . 0.0 111.089 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.74 150.92 22.09 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.039 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 214' ' ' CYS . . . . . 0.51 ' CB ' HG21 ' A' ' 208' ' ' VAL . 7.5 t -150.15 146.13 26.71 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.679 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -89.1 115.41 4.47 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.043 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.934 HD13 ' CD1' ' A' ' 195' ' ' ILE . 0.3 OUTLIER -132.18 141.48 49.1 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 120.975 0.417 . . . . 0.0 110.742 -179.827 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 217' ' ' THR . . . . . 0.512 ' OG1' HD13 ' A' ' 165' ' ' ILE . 1.6 m -105.67 140.08 39.29 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 177.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 218' ' ' ILE . . . . . 0.782 HD12 HG21 ' A' ' 181' ' ' VAL . 18.9 mm -89.19 144.32 9.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 120.449 -0.5 . . . . 0.0 109.747 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.78 -10.74 4.11 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -176.504 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 220' ' ' ASN . . . . . 0.453 ' O ' ' CE2' ' A' ' 191' ' ' TYR . 58.2 t30 -153.23 21.1 0.56 Allowed 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.485 ' HB2' ' HB ' ' A' ' 218' ' ' ILE . 0.1 OUTLIER -57.95 123.76 16.93 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 -179.681 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 222' ' ' ASN . . . . . 0.401 ' HB2' ' CE1' ' A' ' 191' ' ' TYR . 2.3 t-20 -96.59 -47.76 5.8 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 114.347 -1.297 . . . . 0.0 108.367 176.452 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 223' ' ' ASP . . . . . 0.831 ' OD2' HG12 ' A' ' 190' ' ' VAL . 0.0 OUTLIER -75.66 150.25 37.98 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.095 177.422 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.644 HD13 ' N ' ' A' ' 224' ' ' ILE . 0.2 OUTLIER -143.14 177.78 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -179.209 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.424 ' O ' ' C ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER 56.56 116.25 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 114.443 -1.253 . . . . 0.0 110.073 -179.046 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 226' ' ' GLU . . . . . 0.48 ' H ' ' HA ' ' A' ' 155' ' ' GLN . 3.2 tt0 8.78 63.88 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.523 1.129 . . . . 0.0 113.517 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -61.61 -65.48 3.22 Favored Glycine 0 N--CA 1.432 -1.613 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.4 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.439 ' O ' HG12 ' A' ' 153' ' ' VAL . 0.9 OUTLIER -165.38 -147.48 0.1 Allowed 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 114.236 1.199 . . . . 0.0 114.236 179.381 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 229' ' ' VAL . . . . . 0.699 HG22 ' HG2' ' A' ' 152' ' ' GLU . 91.7 t -89.17 135.09 26.75 Favored 'Isoleucine or valine' 0 C--N 1.346 0.437 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 230' ' ' ILE . . . . . 0.495 ' HA ' ' HA ' ' A' ' 183' ' ' LEU . 2.7 mp -102.93 159.04 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 O-C-N 123.378 0.424 . . . . 0.0 110.859 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 231' ' ' GLU . . . . . 0.46 ' O ' ' N ' ' A' ' 182' ' ' ARG . 5.7 tt0 -149.46 108.43 3.89 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.274 0.559 . . . . 0.0 112.348 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.499 ' O ' HD13 ' A' ' 148' ' ' ILE . . . -87.56 131.67 34.31 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.022 179.149 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 233' ' ' TYR . . . . . 0.539 ' C ' HD12 ' A' ' 148' ' ' ILE . 4.6 p90 -134.33 163.46 29.6 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.577 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 1.013 HG12 HG21 ' A' ' 148' ' ' ILE . 1.9 p -175.07 171.32 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-O 120.77 0.319 . . . . 0.0 111.489 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 235' ' ' MET . . . . . 0.507 ' H ' HG22 ' A' ' 234' ' ' VAL . 3.2 mtm -99.52 34.55 2.18 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.293 0.568 . . . . 0.0 110.631 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 236' ' ' GLN . . . . . 0.786 ' H ' HG13 ' A' ' 234' ' ' VAL . 1.0 OUTLIER -150.53 -158.91 0.96 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.827 -179.957 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -98.82 -90.45 0.29 Allowed 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 120.838 0.352 . . . . 0.0 110.331 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.917 HG12 HG21 ' A' ' 176' ' ' THR . 0.1 OUTLIER -154.2 -176.11 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.644 179.78 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 239' ' ' ALA . . . . . 0.443 ' H ' HG12 ' A' ' 238' ' ' VAL . . . 66.61 -72.3 0.09 Allowed 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.998 179.53 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.53 -1.23 57.97 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.153 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 241' ' ' ALA . . . . . 0.691 ' HB3' ' HB3' ' A' ' 236' ' ' GLN . . . . . . . . 0 C--N 1.317 -0.824 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.061 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.415 0 CA-C-O 120.778 0.323 . . . . 0.0 111.14 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 59.36 89.48 0.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.967 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.456 ' CA ' ' HA ' ' A' ' 235' ' ' MET . 0.6 OUTLIER -90.43 65.92 6.28 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-O 121.226 0.536 . . . . 0.0 111.773 -179.826 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -39.66 -65.6 0.37 Allowed 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.68 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.572 HG11 ' HG3' ' A' ' 150' ' ' GLN . 29.1 t -89.45 138.44 19.29 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.732 0 CA-C-O 121.287 0.565 . . . . 0.0 110.193 178.217 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.538 HD11 ' HB ' ' A' ' 238' ' ' VAL . 3.7 tp -121.5 -14.96 7.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.257 177.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.5 ' O ' ' HB3' ' A' ' 232' ' ' ALA . . . 165.11 88.56 0.07 OUTLIER Glycine 0 C--N 1.345 1.071 0 C-N-CA 120.131 -1.033 . . . . 0.0 112.864 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.572 ' HG3' HG11 ' A' ' 147' ' ' VAL . 3.0 mt-30 -90.05 142.22 27.91 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.441 ' CB ' ' HB2' ' A' ' 168' ' ' CYS . . . -150.93 174.99 12.47 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 120.107 -0.637 . . . . 0.0 112.148 -179.301 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.826 ' CG ' HG22 ' A' ' 229' ' ' VAL . 0.0 OUTLIER -120.42 123.72 43.72 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.054 179.81 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.7 ' HB ' HD11 ' A' ' 230' ' ' ILE . 2.4 p -55.79 127.77 15.14 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 CA-C-O 121.377 0.608 . . . . 0.0 111.522 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.416 ' CA ' ' NE ' ' A' ' 154' ' ' ARG . 0.0 OUTLIER -89.56 -57.49 2.86 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 105.025 -2.213 . . . . 0.0 105.025 176.209 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.433 ' HA ' ' H ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER -162.76 -163.61 0.9 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.257 -1.338 . . . . 0.0 110.262 174.735 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.597 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 16.7 p -144.42 158.92 43.51 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 177.567 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.657 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 2.4 m-85 -99.98 76.08 1.91 Allowed 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -176.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 7.7 tttt -85.93 63.58 8.11 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 122.071 0.938 . . . . 0.0 108.809 178.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.455 HG12 ' N ' ' A' ' 161' ' ' LYS . 55.0 t -89.89 155.53 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 CA-C-N 113.77 -1.559 . . . . 0.0 109.867 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 3.9 t -90.7 33.58 0.92 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.126 0.489 . . . . 0.0 110.153 178.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.455 ' N ' HG12 ' A' ' 159' ' ' VAL . 3.6 mttt -151.02 -29.67 0.19 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.712 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.489 HG12 ' N ' ' A' ' 163' ' ' GLY . 88.2 t -103.19 -101.79 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 O-C-N 122.195 -0.316 . . . . 0.0 110.275 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' GLY . . . . . 0.489 ' N ' HG12 ' A' ' 162' ' ' VAL . . . -158.5 -103.39 0.19 Allowed Glycine 0 N--CA 1.451 -0.363 0 N-CA-C 111.661 -0.576 . . . . 0.0 111.661 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' THR . . . . . 1.048 HG21 HG21 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -153.14 36.24 0.48 Allowed 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 114.362 -0.919 . . . . 0.0 108.968 178.458 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.657 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 4.9 mt -42.55 101.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.925 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.597 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . -83.62 121.88 27.85 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.004 -0.998 . . . . 0.0 112.871 -178.62 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -89.1 136.08 13.38 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 178.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.664 ' HB3' HD13 ' A' ' 230' ' ' ILE . 0.0 OUTLIER -138.14 131.49 30.52 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.898 0.349 . . . . 0.0 110.531 -178.523 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 169' ' ' TYR . . . . . 0.425 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 5.7 t80 -85.94 126.42 34.09 Favored 'General case' 0 C--O 1.219 -0.502 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 178.212 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.578 HG21 ' O ' ' A' ' 208' ' ' VAL . 45.3 t -85.22 145.37 8.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -175.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -133.9 10.52 3.93 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 114.646 -1.161 . . . . 0.0 112.337 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.428 ' O ' ' O ' ' A' ' 173' ' ' GLY . 3.0 t70 -150.12 -145.76 0.18 Allowed 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 118.91 -0.567 . . . . 0.0 109.613 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 172' ' ' ASP . . . -37.68 -108.11 0.0 OUTLIER Glycine 0 CA--C 1.537 1.444 0 N-CA-C 115.338 0.895 . . . . 0.0 115.338 -179.003 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.795 ' HG2' ' HB2' ' A' ' 209' ' ' ALA . 1.7 mtmm -151.51 135.52 16.58 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 122.311 -0.523 . . . . 0.0 111.84 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.624 ' HB ' HG23 ' A' ' 208' ' ' VAL . 2.6 mm -88.44 86.9 2.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 177.314 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.87 ' O ' HD13 ' A' ' 195' ' ' ILE . 0.0 OUTLIER -98.26 170.41 8.9 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.17 -177.767 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -69.02 -39.41 79.26 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.269 179.333 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' ASP . . . . . 0.408 ' O ' HG13 ' A' ' 238' ' ' VAL . 38.8 m-20 -89.29 51.85 2.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.97 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.842 ' O ' HD12 ' A' ' 195' ' ' ILE . 0.7 OUTLIER -142.94 159.49 42.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.75 179.795 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 2.8 mptp? -89.6 177.71 6.47 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.611 HG22 ' CA ' ' A' ' 194' ' ' GLU . 2.8 m -149.43 148.69 15.4 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.509 0 CA-C-O 121.535 0.683 . . . . 0.0 112.237 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 231' ' ' GLU . 23.0 ttp180 -153.83 102.45 2.52 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.671 -1.15 . . . . 0.0 111.678 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.616 ' C ' HD12 ' A' ' 184' ' ' ILE . 0.3 OUTLIER -98.16 169.13 9.81 Favored 'General case' 0 N--CA 1.438 -1.064 0 C-N-CA 120.564 -0.455 . . . . 0.0 111.246 179.869 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.738 HG23 ' O ' ' A' ' 188' ' ' ILE . 4.0 mp -151.01 139.83 14.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.048 -178.147 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.516 ' N ' HG22 ' A' ' 190' ' ' VAL . 0.0 OUTLIER -88.04 -150.73 0.18 Allowed 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.156 -0.929 . . . . 0.0 108.749 178.241 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -94.72 27.75 2.94 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 118.461 0.573 . . . . 0.0 111.454 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -153.11 -77.78 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.688 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.738 ' O ' HG23 ' A' ' 184' ' ' ILE . 0.5 OUTLIER -116.69 -154.34 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-N 115.514 -0.343 . . . . 0.0 110.43 -179.292 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.694 HG11 ' CG ' ' A' ' 192' ' ' GLU . 23.0 t -85.67 138.45 19.05 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 CA-C-O 121.517 0.675 . . . . 0.0 110.803 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.88 HG12 ' OD2' ' A' ' 223' ' ' ASP . 0.7 OUTLIER -87.86 -39.24 12.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 114.739 -1.119 . . . . 0.0 109.0 -179.86 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 191' ' ' TYR . . . . . 0.477 ' HB2' ' CE1' ' A' ' 221' ' ' PHE . 1.0 OUTLIER -172.17 157.67 4.32 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.63 -1.168 . . . . 0.0 110.411 -179.935 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 192' ' ' GLU . . . . . 0.694 ' CG ' HG11 ' A' ' 189' ' ' VAL . 34.1 mt-10 -144.79 157.16 44.28 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.205 0.526 . . . . 0.0 111.182 179.538 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 148.9 -129.82 3.19 Favored Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.524 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 0.611 ' CA ' HG22 ' A' ' 181' ' ' VAL . 12.7 pt-20 -138.97 -175.78 4.27 Favored 'General case' 0 CA--C 1.497 -1.061 0 CA-C-O 121.292 0.567 . . . . 0.0 111.584 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.87 HD13 ' O ' ' A' ' 176' ' ' THR . 3.0 mp -88.13 143.35 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.379 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.405 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' ASP . . . . . 0.407 ' CB ' ' HB ' ' A' ' 217' ' ' THR . 0.6 OUTLIER -89.02 -56.92 3.09 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.164 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 3.0 m -151.61 150.54 30.4 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.942 179.032 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.428 HD21 ' HB3' ' A' ' 214' ' ' CYS . 1.3 tt -120.56 111.56 17.82 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 121.379 0.609 . . . . 0.0 111.169 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 199' ' ' LYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 62.2 mttt -150.62 122.55 8.17 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.286 179.146 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.57 -160.8 0.64 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.509 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -87.27 -8.15 57.08 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 121.23 -0.188 . . . . 0.0 111.04 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.52 -58.74 1.82 Allowed 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 120.628 0.251 . . . . 0.0 111.006 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -152.23 -175.11 5.12 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-O 120.876 0.37 . . . . 0.0 111.095 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' ASP . . . . . 0.402 ' HA ' ' HA ' ' A' ' 199' ' ' LYS . 9.6 p-10 -94.84 92.06 6.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.652 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 33.9 m -82.87 163.82 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.916 0 CA-C-O 121.481 0.658 . . . . 0.0 112.152 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' ARG . . . . . 0.474 ' O ' ' HB ' ' A' ' 176' ' ' THR . 0.2 OUTLIER -89.11 -36.79 15.53 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.939 -178.53 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.69 ' HB3' HG22 ' A' ' 176' ' ' THR . 1.9 mp0 -141.73 -178.08 5.49 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.343 0.592 . . . . 0.0 111.993 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.624 HG23 ' HB ' ' A' ' 175' ' ' ILE . 0.1 OUTLIER -151.08 91.73 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.681 178.946 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.795 ' HB2' ' HG2' ' A' ' 174' ' ' LYS . . . -112.89 165.87 11.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.022 0.439 . . . . 0.0 112.028 -179.079 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 34.1 tp60 82.26 -69.36 0.07 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.035 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 178.41 37.78 0.06 OUTLIER Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.355 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -97.45 136.05 38.45 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.863 0.363 . . . . 0.0 111.199 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -91.54 146.48 23.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.349 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' CYS . . . . . 0.428 ' HB3' HD21 ' A' ' 198' ' ' LEU . 1.8 m -150.95 142.7 23.74 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.532 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 215' ' ' GLY . . . . . 0.55 ' C ' HG23 ' A' ' 165' ' ' ILE . . . -89.64 103.77 3.04 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.608 -0.806 . . . . 0.0 111.978 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.526 HD12 ' CD1' ' A' ' 218' ' ' ILE . 0.4 OUTLIER -128.86 143.16 50.83 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.078 0.466 . . . . 0.0 111.467 -179.576 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 217' ' ' THR . . . . . 0.407 ' HB ' ' CB ' ' A' ' 196' ' ' ASP . 1.2 m -83.93 143.49 29.81 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 177.343 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 218' ' ' ILE . . . . . 0.599 HG22 ' O ' ' A' ' 218' ' ' ILE . 1.5 mp -106.16 92.09 2.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.943 0.401 . . . . 0.0 110.247 -178.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 4.3 tttp 45.06 -144.24 0.17 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.894 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -87.18 61.33 6.66 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 121.024 0.44 . . . . 0.0 110.817 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.477 ' CE1' ' HB2' ' A' ' 191' ' ' TYR . 0.1 OUTLIER -55.92 120.62 7.7 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 114.722 1.379 . . . . 0.0 114.722 179.128 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 21.4 t30 -82.32 -48.55 11.05 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 114.815 -1.084 . . . . 0.0 108.346 176.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' ASP . . . . . 0.88 ' OD2' HG12 ' A' ' 190' ' ' VAL . 0.0 OUTLIER -82.01 137.88 35.0 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 177.668 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 1.048 HG21 HG21 ' A' ' 164' ' ' THR . 0.2 OUTLIER -133.85 179.13 4.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -178.951 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.407 ' O ' ' C ' ' A' ' 226' ' ' GLU . 0.1 OUTLIER 57.09 117.28 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.107 -179.114 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 226' ' ' GLU . . . . . 0.433 ' H ' ' HA ' ' A' ' 155' ' ' GLN . 38.9 tt0 7.71 63.28 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 124.484 1.114 . . . . 0.0 113.758 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 227' ' ' GLY . . . . . 0.457 ' N ' HG11 ' A' ' 153' ' ' VAL . . . -63.49 -66.43 2.54 Favored Glycine 0 N--CA 1.431 -1.655 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.932 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.464 ' O ' HG12 ' A' ' 153' ' ' VAL . 0.7 OUTLIER -164.17 -150.2 0.14 Allowed 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 179.888 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 229' ' ' VAL . . . . . 0.826 HG22 ' CG ' ' A' ' 152' ' ' GLU . 69.2 t -88.49 130.68 37.59 Favored 'Isoleucine or valine' 0 C--N 1.345 0.38 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.208 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 230' ' ' ILE . . . . . 0.7 HD11 ' HB ' ' A' ' 153' ' ' VAL . 5.1 mp -100.37 157.72 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 O-C-N 123.618 0.574 . . . . 0.0 110.961 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 231' ' ' GLU . . . . . 0.453 ' HA ' ' HA ' ' A' ' 150' ' ' GLN . 33.6 tt0 -146.94 112.32 5.55 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 120.246 -0.582 . . . . 0.0 112.427 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.508 ' HB1' HG23 ' A' ' 148' ' ' ILE . . . -88.18 133.91 33.91 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.008 179.268 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 233' ' ' TYR . . . . . 0.405 ' O ' ' CG2' ' A' ' 234' ' ' VAL . 2.9 p90 -136.04 120.3 17.88 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.803 -178.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.405 ' CG2' ' O ' ' A' ' 233' ' ' TYR . 62.6 t -159.97 111.17 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.863 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 235' ' ' MET . . . . . 0.456 ' HA ' ' CA ' ' A' ' 145' ' ' GLU . 18.5 mtm -86.88 59.36 5.59 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.583 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 19.6 mm100 -132.06 -145.2 0.26 Allowed 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.426 -0.807 . . . . 0.0 111.485 -177.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' GLU . . . . . 0.762 ' O ' ' HB2' ' A' ' 241' ' ' ALA . 13.3 mm-40 -126.49 66.04 1.24 Allowed 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.559 0.695 . . . . 0.0 109.318 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.538 ' HB ' HD11 ' A' ' 148' ' ' ILE . 12.5 t -83.43 160.46 3.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.81 -178.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 239' ' ' ALA . . . . . 0.521 ' HB3' ' O ' ' A' ' 238' ' ' VAL . . . 80.64 -56.24 0.33 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 122.854 0.461 . . . . 0.0 111.215 -179.298 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.87 -6.2 56.06 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 241' ' ' ALA . . . . . 0.762 ' HB2' ' O ' ' A' ' 237' ' ' GLU . . . . . . . . 0 C--N 1.312 -1.03 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.064 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 . . . . . 0 N--CA 1.485 1.312 0 CA-C-O 120.756 0.312 . . . . 0.0 111.202 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -147.23 140.2 25.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.951 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.98 37.39 1.23 Allowed 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.35 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.517 ' HG3' HG23 ' A' ' 147' ' ' VAL . 3.8 tppp? -135.17 -82.68 0.42 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.251 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.517 HG23 ' HG3' ' A' ' 146' ' ' LYS . 6.7 t -99.5 140.71 18.23 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.758 0 CA-C-O 121.245 0.545 . . . . 0.0 110.699 179.161 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.472 HD13 ' N ' ' A' ' 149' ' ' GLY . 0.0 OUTLIER -131.33 -2.32 2.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.009 178.784 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.539 ' CA ' ' HB3' ' A' ' 232' ' ' ALA . . . -178.43 73.59 0.07 OUTLIER Glycine 0 C--N 1.342 0.889 0 C-N-CA 120.81 -0.71 . . . . 0.0 111.931 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.474 ' HB2' HG11 ' A' ' 147' ' ' VAL . 0.4 OUTLIER -91.67 134.77 34.41 Favored 'General case' 0 CA--C 1.505 -0.769 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.749 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.467 ' HB1' ' O ' ' A' ' 169' ' ' TYR . . . -151.62 175.03 12.76 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-O 121.52 0.676 . . . . 0.0 112.511 -178.186 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.738 ' HG2' HG22 ' A' ' 229' ' ' VAL . 2.4 mt-10 -120.37 127.02 51.91 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.107 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.713 ' HB ' HD11 ' A' ' 230' ' ' ILE . 2.6 p -57.68 128.22 17.92 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.354 0 CA-C-O 121.643 0.735 . . . . 0.0 111.887 -179.067 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.408 ' HD3' ' HB2' ' A' ' 169' ' ' TYR . 0.0 OUTLIER -90.17 -57.25 2.91 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 104.789 -2.3 . . . . 0.0 104.789 175.617 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.426 ' HA ' ' H ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER -163.3 -166.16 1.2 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.094 -1.412 . . . . 0.0 110.363 174.742 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.548 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 18.8 p -151.17 149.88 29.97 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.191 177.466 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.616 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 5.8 m-30 -94.83 72.11 3.51 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -178.416 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? -86.48 61.4 6.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.894 0.854 . . . . 0.0 108.924 178.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.405 HG12 ' H ' ' A' ' 161' ' ' LYS . 49.0 t -89.77 155.59 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-N 114.095 -1.411 . . . . 0.0 109.789 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.75 22.01 3.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.905 0.383 . . . . 0.0 111.177 178.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.405 ' H ' HG12 ' A' ' 159' ' ' VAL . 6.5 mttt -150.9 6.98 0.53 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.982 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 58.4 t -130.81 -99.6 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 CA-C-N 118.374 0.534 . . . . 0.0 110.017 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -158.46 -112.76 0.34 Allowed Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.494 HG22 ' CG2' ' A' ' 224' ' ' ILE . 0.0 OUTLIER -153.7 32.08 0.45 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.401 -0.899 . . . . 0.0 109.18 178.173 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.616 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 1.9 mm -41.09 94.32 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.473 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.604 ' HB3' HD13 ' A' ' 218' ' ' ILE . . . -86.48 113.93 22.81 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.689 -1.141 . . . . 0.0 111.993 -179.138 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -88.3 126.38 8.08 Favored Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 178.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.808 ' HB3' HD13 ' A' ' 230' ' ' ILE . 0.0 OUTLIER -129.79 134.48 47.6 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.83 0.315 . . . . 0.0 110.471 -178.088 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 169' ' ' TYR . . . . . 0.467 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 15.0 t80 -86.27 130.34 34.55 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.081 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.715 HG21 ' O ' ' A' ' 208' ' ' VAL . 42.3 t -85.78 148.57 4.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 113.404 0.891 . . . . 0.0 113.404 -175.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -141.87 15.79 2.12 Favored 'General case' 0 CA--C 1.527 0.076 0 CA-C-N 114.562 -1.199 . . . . 0.0 111.898 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.412 ' H ' HG12 ' A' ' 170' ' ' VAL . 6.6 t0 -150.24 -142.64 0.12 Allowed 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 -179.462 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -45.73 -109.89 0.01 OUTLIER Glycine 0 CA--C 1.533 1.193 0 N-CA-C 115.009 0.764 . . . . 0.0 115.009 -178.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.67 ' HG2' ' HB2' ' A' ' 209' ' ' ALA . 3.8 mttm -151.13 127.01 10.32 Favored 'General case' 0 CA--C 1.512 -0.496 0 O-C-N 122.451 -0.441 . . . . 0.0 111.107 -178.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.589 HD12 ' HB2' ' A' ' 232' ' ' ALA . 0.5 OUTLIER -89.03 113.85 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 C-N-CA 119.199 -1.0 . . . . 0.0 109.431 177.811 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.891 ' O ' HD13 ' A' ' 195' ' ' ILE . 0.1 OUTLIER -124.97 169.26 12.27 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.95 -177.376 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.402 ' HG3' ' HB2' ' A' ' 198' ' ' LEU . 0.2 OUTLIER -61.34 -38.74 88.01 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.299 179.414 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -89.28 52.74 2.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.156 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.754 ' O ' HD12 ' A' ' 195' ' ' ILE . 29.4 m -150.46 157.04 42.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.341 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 0.0 OUTLIER -89.35 176.78 6.79 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.553 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.624 HG22 ' CA ' ' A' ' 194' ' ' GLU . 2.5 m -145.65 149.21 16.7 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.579 0 CA-C-O 121.473 0.654 . . . . 0.0 112.203 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' ARG . . . . . 0.436 ' N ' ' O ' ' A' ' 231' ' ' GLU . 26.8 ttm180 -154.36 102.34 2.43 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.851 -1.068 . . . . 0.0 112.236 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.521 ' CB ' ' HA ' ' A' ' 230' ' ' ILE . 0.3 OUTLIER -99.61 170.67 8.42 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-O 120.932 0.396 . . . . 0.0 110.649 179.363 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.683 HG23 ' O ' ' A' ' 188' ' ' ILE . 36.5 mt -155.5 139.94 9.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.855 -178.279 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.494 ' N ' HG22 ' A' ' 190' ' ' VAL . 6.9 ttm-85 -87.33 -152.64 0.2 Allowed 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.9 178.038 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 18.7 mp0 -94.69 28.67 2.57 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 118.141 0.428 . . . . 0.0 111.32 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -152.72 -79.14 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.487 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.683 ' O ' HG23 ' A' ' 184' ' ' ILE . 0.1 OUTLIER -114.4 -157.22 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 115.536 -0.332 . . . . 0.0 110.227 -179.6 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.779 HG11 ' CG ' ' A' ' 192' ' ' GLU . 22.3 t -86.22 139.54 17.22 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 CA-C-O 121.457 0.646 . . . . 0.0 110.739 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.585 HG23 ' CA ' ' A' ' 184' ' ' ILE . 0.4 OUTLIER -87.89 -35.53 8.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.13 -179.93 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 191' ' ' TYR . . . . . 0.475 ' HB2' ' CE1' ' A' ' 221' ' ' PHE . 22.5 t80 -178.54 146.4 0.36 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.901 179.151 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' GLU . . . . . 0.779 ' CG ' HG11 ' A' ' 189' ' ' VAL . 34.7 mt-10 -135.46 158.08 45.27 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.015 0.436 . . . . 0.0 110.858 179.255 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 147.23 -124.6 1.98 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.736 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 0.624 ' CA ' HG22 ' A' ' 181' ' ' VAL . 13.7 pt-20 -144.15 -174.95 4.43 Favored 'General case' 0 CA--C 1.497 -1.087 0 CA-C-O 121.202 0.525 . . . . 0.0 111.437 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.891 HD13 ' O ' ' A' ' 176' ' ' THR . 3.8 mp -87.72 142.92 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.602 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.03 -52.37 5.12 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.343 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 1.2 m -151.47 145.62 25.33 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.724 178.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.529 HD13 ' HA ' ' A' ' 176' ' ' THR . 4.5 tt -124.06 114.15 19.34 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.394 0.616 . . . . 0.0 111.613 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 56.6 mttt -150.17 121.19 7.69 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.096 -0.957 . . . . 0.0 109.86 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.19 -160.03 0.6 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.285 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -86.74 -16.64 35.79 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.528 0.204 . . . . 0.0 110.778 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.96 -59.67 2.14 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-O 120.655 0.264 . . . . 0.0 110.617 179.15 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -152.96 -171.09 3.82 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 120.964 0.411 . . . . 0.0 111.083 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 22.0 p30 -89.95 57.83 3.96 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.043 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 33.9 m -55.12 164.02 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.04 0 CA-C-O 121.47 0.652 . . . . 0.0 112.304 -179.253 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' ARG . . . . . 0.498 ' O ' ' HB ' ' A' ' 176' ' ' THR . 1.6 mtm180 -89.44 -41.34 12.14 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-N 114.715 -1.13 . . . . 0.0 111.34 -178.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.545 ' HG3' ' HB2' ' A' ' 239' ' ' ALA . 0.9 OUTLIER -129.72 -178.59 4.76 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.458 0.647 . . . . 0.0 112.37 -179.131 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.715 ' O ' HG21 ' A' ' 170' ' ' VAL . 0.0 OUTLIER -151.17 81.44 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.269 178.631 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.67 ' HB2' ' HG2' ' A' ' 174' ' ' LYS . . . -100.76 171.79 7.47 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -178.483 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 8.9 tm0? 83.49 -72.67 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.016 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 177.93 37.18 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.345 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -98.21 141.61 30.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.925 0.393 . . . . 0.0 111.303 -179.36 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.5 131.15 43.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.339 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 214' ' ' CYS . . . . . 0.461 ' HB3' HG21 ' A' ' 208' ' ' VAL . 52.5 t -133.17 143.96 49.56 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.676 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -88.5 109.62 3.56 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.978 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.55 HD12 ' CD1' ' A' ' 218' ' ' ILE . 0.4 OUTLIER -135.75 141.77 44.88 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 120.924 0.393 . . . . 0.0 111.478 -179.305 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 217' ' ' THR . . . . . 0.46 ' C ' HD12 ' A' ' 218' ' ' ILE . 0.0 OUTLIER -77.43 146.97 36.22 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 177.662 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 218' ' ' ILE . . . . . 0.607 HG22 ' O ' ' A' ' 218' ' ' ILE . 1.6 mp -112.61 87.83 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.144 0.497 . . . . 0.0 109.755 -179.126 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 6.5 tttp 46.71 -144.85 0.26 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.759 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -87.33 61.09 6.45 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 121.009 0.433 . . . . 0.0 111.135 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.512 ' CZ ' HD21 ' A' ' 183' ' ' LEU . 0.1 OUTLIER -55.49 121.42 8.97 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 178.973 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 14.4 t30 -88.63 -45.15 10.08 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.483 176.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 223' ' ' ASP . 0.0 OUTLIER -81.72 134.7 35.48 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.215 177.604 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.634 HD13 ' H ' ' A' ' 224' ' ' ILE . 0.2 OUTLIER -133.82 -179.64 3.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -179.067 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.422 ' O ' ' C ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER 57.07 114.33 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.698 -178.367 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 226' ' ' GLU . . . . . 0.448 ' HA ' ' CG1' ' A' ' 153' ' ' VAL . 3.0 tt0 8.66 64.22 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 124.633 1.173 . . . . 0.0 113.555 -179.686 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 227' ' ' GLY . . . . . 0.413 ' N ' HG11 ' A' ' 153' ' ' VAL . . . -61.48 -66.86 2.39 Favored Glycine 0 N--CA 1.432 -1.59 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.468 179.367 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.458 ' O ' HG12 ' A' ' 153' ' ' VAL . 0.9 OUTLIER -164.9 -147.99 0.11 Allowed 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 179.435 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 229' ' ' VAL . . . . . 0.738 HG22 ' HG2' ' A' ' 152' ' ' GLU . 98.4 t -89.24 132.16 34.69 Favored 'Isoleucine or valine' 0 C--N 1.347 0.462 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 230' ' ' ILE . . . . . 0.808 HD13 ' HB3' ' A' ' 168' ' ' CYS . 4.5 mp -99.2 157.23 3.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 O-C-N 123.499 0.499 . . . . 0.0 111.196 -179.369 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 231' ' ' GLU . . . . . 0.436 ' O ' ' N ' ' A' ' 182' ' ' ARG . 1.9 tm-20 -147.63 110.24 4.68 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 120.159 -0.616 . . . . 0.0 112.633 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.589 ' HB2' HD12 ' A' ' 175' ' ' ILE . . . -87.8 134.39 33.69 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.472 178.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 233' ' ' TYR . . . . . 0.724 ' O ' HG23 ' A' ' 234' ' ' VAL . 6.3 p90 -131.58 147.07 52.5 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.935 0.398 . . . . 0.0 111.703 -179.005 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.724 HG23 ' O ' ' A' ' 233' ' ' TYR . 0.9 OUTLIER -179.77 167.28 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.417 179.959 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 235' ' ' MET . . . . . 0.411 ' N ' ' CG1' ' A' ' 234' ' ' VAL . 1.9 mtm -88.88 -73.54 0.5 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.565 0.698 . . . . 0.0 110.527 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -150.03 73.2 1.15 Allowed 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.896 179.369 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -150.94 57.97 0.91 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.788 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.858 HG12 HG21 ' A' ' 176' ' ' THR . 0.2 OUTLIER -94.96 -165.52 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.682 -179.701 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 239' ' ' ALA . . . . . 0.545 ' HB2' ' HG3' ' A' ' 207' ' ' GLU . . . -55.05 -73.23 0.05 Allowed 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.942 0.401 . . . . 0.0 111.038 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.83 -5.49 58.0 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.261 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 241' ' ' ALA . . . . . 0.522 ' HB3' HG23 ' A' ' 238' ' ' VAL . . . . . . . . 0 C--N 1.313 -0.995 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.076 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 87.6 t80 . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.859 0.361 . . . . 0.0 111.204 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 59.96 28.92 18.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.018 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -89.86 49.39 1.71 Allowed 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.442 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 1.1 tptp -83.11 -162.68 0.63 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.529 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.707 ' O ' HD13 ' A' ' 148' ' ' ILE . 5.8 t -58.62 142.42 14.32 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 CA-C-O 121.333 0.587 . . . . 0.0 111.381 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.983 HG21 HG21 ' A' ' 238' ' ' VAL . 11.6 mm -134.41 13.16 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.57 178.201 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.719 ' HA3' ' HB3' ' A' ' 232' ' ' ALA . . . 175.46 65.68 0.06 OUTLIER Glycine 0 C--N 1.343 0.945 0 C-N-CA 121.329 -0.462 . . . . 0.0 112.181 179.31 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.682 ' HB2' HG11 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -89.61 131.19 35.74 Favored 'General case' 0 CA--C 1.507 -0.679 0 O-C-N 122.506 -0.408 . . . . 0.0 110.481 179.83 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.413 ' HA ' ' O ' ' A' ' 169' ' ' TYR . . . -152.18 174.21 14.02 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-O 121.42 0.629 . . . . 0.0 112.448 -178.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.739 ' HG2' HG22 ' A' ' 229' ' ' VAL . 7.2 mt-10 -120.63 121.73 38.97 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.487 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.499 HG13 ' HG2' ' A' ' 226' ' ' GLU . 3.1 p -51.45 131.07 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.416 ' HD2' ' HB2' ' A' ' 169' ' ' TYR . 5.1 mmp_? -90.07 -59.27 2.24 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 175.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.544 ' HA ' ' H ' ' A' ' 226' ' ' GLU . 0.3 OUTLIER -162.3 -164.32 1.03 Allowed 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 113.75 -1.568 . . . . 0.0 109.751 175.449 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.537 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 7.0 p -150.47 162.51 40.45 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 177.285 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.557 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 0.2 OUTLIER -115.53 78.41 1.17 Allowed 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -179.123 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 8.6 tttm -86.47 62.57 7.5 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 177.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.49 HG12 ' N ' ' A' ' 161' ' ' LYS . 71.3 t -93.04 156.19 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 CA-C-N 113.606 -1.633 . . . . 0.0 110.488 -178.363 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 46.0 p -91.29 34.64 0.94 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.234 0.54 . . . . 0.0 109.71 178.035 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.49 ' N ' HG12 ' A' ' 159' ' ' VAL . 0.1 OUTLIER -150.76 -32.92 0.17 Allowed 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.206 -179.721 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.514 HG12 ' N ' ' A' ' 163' ' ' GLY . 84.3 t -100.67 -103.05 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' GLY . . . . . 0.514 ' N ' HG12 ' A' ' 162' ' ' VAL . . . -159.35 -101.19 0.17 Allowed Glycine 0 N--CA 1.451 -0.353 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 178.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.468 ' CG2' HG21 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -154.14 33.94 0.43 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 114.115 -1.042 . . . . 0.0 108.51 177.812 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.626 HD12 HG23 ' A' ' 217' ' ' THR . 1.5 mp -42.91 95.26 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.522 -179.256 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.537 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . -89.93 120.51 31.21 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.722 -1.126 . . . . 0.0 112.179 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -88.15 148.0 20.55 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 178.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.572 ' HB3' HD12 ' A' ' 230' ' ' ILE . 0.0 OUTLIER -147.73 134.64 20.19 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 117.366 0.583 . . . . 0.0 110.694 -178.455 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 169' ' ' TYR . . . . . 0.416 ' HB2' ' HD2' ' A' ' 154' ' ' ARG . 78.4 t80 -86.53 124.47 32.87 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 177.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.665 HG21 ' O ' ' A' ' 208' ' ' VAL . 22.7 t -85.42 144.3 9.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 113.14 0.792 . . . . 0.0 113.14 -176.103 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.1 p -137.2 14.17 3.04 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 114.779 -1.1 . . . . 0.0 112.078 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.41 ' H ' HG12 ' A' ' 170' ' ' VAL . 5.9 t0 -150.56 -144.68 0.16 Allowed 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -40.27 -105.0 0.01 OUTLIER Glycine 0 CA--C 1.533 1.16 0 N-CA-C 115.264 0.865 . . . . 0.0 115.264 -178.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.438 ' HB2' ' HB3' ' A' ' 207' ' ' GLU . 0.0 OUTLIER -150.93 150.9 31.39 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.061 0.458 . . . . 0.0 111.442 -178.416 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.63 HG21 HD11 ' A' ' 216' ' ' LEU . 16.1 mm -103.67 82.72 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 176.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.525 HG21 HG12 ' A' ' 238' ' ' VAL . 0.0 OUTLIER -95.58 172.89 7.78 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.78 1.029 . . . . 0.0 113.78 -176.569 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.553 ' HB2' HD22 ' A' ' 198' ' ' LEU . 7.8 ttp180 -69.42 -48.68 60.28 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 114.1 -1.409 . . . . 0.0 110.792 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -89.45 61.61 5.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.28 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 1.8 m -148.3 157.62 43.6 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.343 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.481 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 1.1 mptt -88.56 173.7 8.5 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.628 HG22 ' CA ' ' A' ' 194' ' ' GLU . 2.9 m -142.49 150.35 18.54 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.568 0 CA-C-O 121.483 0.659 . . . . 0.0 112.595 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' ARG . . . . . 0.421 ' N ' ' O ' ' A' ' 231' ' ' GLU . 43.5 ttp180 -154.83 102.09 2.33 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.847 -1.069 . . . . 0.0 112.479 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.517 ' CB ' ' HA ' ' A' ' 230' ' ' ILE . 0.3 OUTLIER -100.56 170.57 8.29 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 120.426 -0.51 . . . . 0.0 111.004 179.235 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.683 HG23 ' O ' ' A' ' 188' ' ' ILE . 26.6 mt -154.18 140.15 11.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -178.173 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.5 ' N ' HG22 ' A' ' 190' ' ' VAL . 1.2 ttt180 -87.17 -154.18 0.24 Allowed 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.012 -0.995 . . . . 0.0 108.774 178.096 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -94.7 28.74 2.54 Favored 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 122.02 -0.425 . . . . 0.0 111.184 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -152.98 -75.81 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.45 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.683 ' O ' HG23 ' A' ' 184' ' ' ILE . 0.5 OUTLIER -117.75 -156.75 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 115.441 -0.379 . . . . 0.0 110.296 -179.359 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.713 HG11 ' CG ' ' A' ' 192' ' ' GLU . 21.3 t -86.48 139.49 17.28 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.393 0 CA-C-O 121.399 0.619 . . . . 0.0 110.916 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.563 HG23 ' CA ' ' A' ' 184' ' ' ILE . 0.3 OUTLIER -88.58 -35.84 8.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.468 -179.841 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 191' ' ' TYR . . . . . 0.466 ' HB2' ' CE1' ' A' ' 221' ' ' PHE . 31.1 t80 -178.34 144.31 0.3 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.997 179.49 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' GLU . . . . . 0.713 ' CG ' HG11 ' A' ' 189' ' ' VAL . 0.3 OUTLIER -131.87 159.03 39.77 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.937 0.398 . . . . 0.0 110.801 179.293 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 146.16 -126.05 2.41 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.852 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 0.628 ' CA ' HG22 ' A' ' 181' ' ' VAL . 11.0 pt-20 -143.07 -176.37 4.89 Favored 'General case' 0 CA--C 1.499 -1.011 0 CA-C-O 121.289 0.566 . . . . 0.0 111.667 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.523 HG12 HG13 ' A' ' 181' ' ' VAL . 12.3 mm -87.42 143.41 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.485 -179.123 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.78 -57.1 3.03 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.07 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 1.2 m -151.59 152.94 33.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.282 178.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.597 HD11 ' C ' ' A' ' 206' ' ' ARG . 0.3 OUTLIER -134.87 119.05 17.62 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.694 0.759 . . . . 0.0 112.014 179.9 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.28 125.31 9.94 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 114.445 -1.252 . . . . 0.0 109.431 178.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' ARG . . . . . 0.639 ' NH1' HG11 ' A' ' 205' ' ' VAL . 1.2 ptp85 -86.88 -145.98 0.12 Allowed 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.244 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -84.5 108.57 17.36 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 54.13 29.38 10.32 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.501 -179.334 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -150.61 116.43 5.54 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 120.933 0.397 . . . . 0.0 111.342 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -89.49 55.2 3.15 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.066 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.639 HG11 ' NH1' ' A' ' 200' ' ' ARG . 35.3 m -56.55 158.16 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.962 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.796 -179.48 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 206' ' ' ARG . . . . . 0.597 ' C ' HD11 ' A' ' 198' ' ' LEU . 2.5 ttp-105 -89.07 -27.82 20.54 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.716 -178.422 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.438 ' HB3' ' HB2' ' A' ' 174' ' ' LYS . 1.5 mp0 -139.99 178.36 7.32 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.092 0.472 . . . . 0.0 111.162 179.15 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.665 ' O ' HG21 ' A' ' 170' ' ' VAL . 0.5 OUTLIER -151.02 75.74 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.854 179.121 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.431 ' HB2' ' HB3' ' A' ' 174' ' ' LYS . . . -97.27 175.18 6.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.081 0.467 . . . . 0.0 112.223 -178.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 83.88 -75.46 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.858 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 178.26 36.89 0.06 OUTLIER Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.372 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -98.32 144.06 28.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.901 0.382 . . . . 0.0 111.171 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.62 131.32 44.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.021 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 214' ' ' CYS . . . . . 0.53 ' HB3' HG21 ' A' ' 208' ' ' VAL . 50.8 t -134.22 149.86 51.01 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.753 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -88.99 116.54 4.69 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.568 -0.825 . . . . 0.0 111.621 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.63 HD11 HG21 ' A' ' 175' ' ' ILE . 0.1 OUTLIER -143.68 145.65 32.61 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 121.113 0.482 . . . . 0.0 111.386 -178.784 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 217' ' ' THR . . . . . 0.626 HG23 HD12 ' A' ' 165' ' ' ILE . 0.0 OUTLIER -86.44 146.48 26.41 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.348 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 218' ' ' ILE . . . . . 0.623 HG23 HG21 ' A' ' 181' ' ' VAL . 1.6 mp -110.36 87.91 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 1.4 tttt 45.93 -144.44 0.23 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.018 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -87.17 62.03 7.06 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 121.097 0.475 . . . . 0.0 111.016 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.51 ' CZ ' HD21 ' A' ' 183' ' ' LEU . 0.1 OUTLIER -55.59 122.23 10.86 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 114.423 1.268 . . . . 0.0 114.423 179.034 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -87.92 -45.69 10.03 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 114.899 -1.046 . . . . 0.0 108.422 176.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' ASP . . . . . 0.452 ' OD1' ' N ' ' A' ' 223' ' ' ASP . 0.0 OUTLIER -81.65 135.14 35.54 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.994 177.588 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.636 HD13 ' N ' ' A' ' 224' ' ' ILE . 0.2 OUTLIER -134.67 179.65 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.718 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.411 ' O ' ' C ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER 57.33 114.44 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 114.479 -1.237 . . . . 0.0 110.052 -178.96 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 226' ' ' GLU . . . . . 0.544 ' H ' ' HA ' ' A' ' 155' ' ' GLN . 5.2 tm-20 11.41 61.1 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 124.671 1.232 . . . . 0.0 112.919 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 227' ' ' GLY . . . . . 0.43 ' N ' HG11 ' A' ' 153' ' ' VAL . . . -60.19 -68.02 1.88 Allowed Glycine 0 N--CA 1.433 -1.541 0 CA-C-N 114.695 -1.139 . . . . 0.0 111.736 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.463 ' O ' HG12 ' A' ' 153' ' ' VAL . 0.8 OUTLIER -164.8 -148.93 0.12 Allowed 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 179.631 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 229' ' ' VAL . . . . . 0.739 HG22 ' HG2' ' A' ' 152' ' ' GLU . 92.1 t -88.44 129.61 39.32 Favored 'Isoleucine or valine' 0 C--N 1.346 0.453 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.517 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 230' ' ' ILE . . . . . 0.572 HD12 ' HB3' ' A' ' 168' ' ' CYS . 17.4 mt -98.94 157.17 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 O-C-N 123.689 0.618 . . . . 0.0 111.564 -179.37 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 231' ' ' GLU . . . . . 0.423 ' CG ' ' HG2' ' A' ' 150' ' ' GLN . 0.0 OUTLIER -146.46 109.97 4.82 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -179.673 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.719 ' HB3' ' HA3' ' A' ' 149' ' ' GLY . . . -88.96 131.14 35.29 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.397 178.544 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 233' ' ' TYR . . . . . 0.438 ' CE1' ' HB3' ' A' ' 180' ' ' LYS . 11.8 p90 -128.95 142.83 50.8 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.724 0.297 . . . . 0.0 110.962 -179.241 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.68 HG11 HG22 ' A' ' 238' ' ' VAL . 0.9 OUTLIER -175.62 -172.64 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.607 -179.906 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 235' ' ' MET . . . . . 0.55 ' H ' HG22 ' A' ' 234' ' ' VAL . 7.8 mtm -88.68 -162.74 0.88 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.671 0.272 . . . . 0.0 110.842 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 68.9 mm-40 -95.56 37.83 1.18 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.934 0.397 . . . . 0.0 111.361 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' GLU . . . . . 0.804 ' O ' ' HB3' ' A' ' 241' ' ' ALA . 1.6 mp0 -131.58 46.31 2.67 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.79 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.983 HG21 HG21 ' A' ' 148' ' ' ILE . 2.8 t -93.46 161.95 2.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.986 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 239' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' A' ' 238' ' ' VAL . . . 72.86 -60.86 0.52 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.517 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -89.19 -4.36 58.26 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 241' ' ' ALA . . . . . 0.804 ' HB3' ' O ' ' A' ' 237' ' ' GLU . . . . . . . . 0 C--N 1.312 -1.065 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.01 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.836 0.351 . . . . 0.0 111.307 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 59.25 85.61 0.1 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.033 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.56 40.69 1.15 Allowed 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.091 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.555 ' HG3' HG23 ' A' ' 147' ' ' VAL . 17.4 tptt -94.73 -76.59 0.48 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.099 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.564 HG11 ' HB2' ' A' ' 150' ' ' GLN . 13.6 t -122.64 142.73 38.03 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.555 0 CA-C-O 121.507 0.67 . . . . 0.0 111.706 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.706 ' CD1' HG21 ' A' ' 238' ' ' VAL . 3.9 tp -118.01 -20.05 5.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.084 178.078 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.434 ' O ' ' HB3' ' A' ' 232' ' ' ALA . . . -178.02 85.17 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.445 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.564 ' HB2' HG11 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -93.72 132.98 37.56 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.764 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.439 ' CB ' ' HB2' ' A' ' 168' ' ' CYS . . . -152.14 175.88 12.12 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 119.736 -0.786 . . . . 0.0 113.059 -177.364 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.835 ' HG2' HG22 ' A' ' 229' ' ' VAL . 13.1 mt-10 -120.47 124.09 44.56 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.445 -1.252 . . . . 0.0 110.046 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.474 HG12 ' O ' ' A' ' 228' ' ' ASP . 3.6 p -50.52 134.46 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -178.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -89.46 -61.35 1.72 Allowed 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 175.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.528 ' HA ' ' H ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER -161.13 -160.46 0.73 Allowed 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 113.711 -1.586 . . . . 0.0 109.651 175.595 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.496 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 4.3 p -147.99 168.24 22.83 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 177.535 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.681 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 6.4 m-85 -118.11 75.58 1.02 Allowed 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -178.652 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.05 63.28 7.94 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 122.121 0.962 . . . . 0.0 108.481 178.403 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 83.9 t -90.9 157.75 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 CA-C-N 113.709 -1.587 . . . . 0.0 110.229 -178.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 1.2 m -92.5 34.57 1.05 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.217 0.532 . . . . 0.0 109.849 178.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 9.8 mttt -151.67 -32.97 0.15 Allowed 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.442 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.868 HG11 HD12 ' A' ' 165' ' ' ILE . 84.0 t -99.83 -103.21 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.278 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' GLY . . . . . 0.513 ' N ' HG12 ' A' ' 162' ' ' VAL . . . -159.12 -101.56 0.17 Allowed Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 111.481 -0.648 . . . . 0.0 111.481 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.598 ' CG2' HG22 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -153.83 36.18 0.44 Allowed 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 114.152 -1.024 . . . . 0.0 108.49 178.25 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.868 HD12 HG11 ' A' ' 162' ' ' VAL . 3.8 mt -42.14 98.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.441 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.591 ' HB3' HD13 ' A' ' 218' ' ' ILE . . . -91.71 121.05 33.0 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.006 -0.997 . . . . 0.0 112.298 -179.057 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -88.73 150.96 22.01 Favored Glycine 0 N--CA 1.441 -0.969 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 178.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.485 ' HB3' HD13 ' A' ' 230' ' ' ILE . 0.0 OUTLIER -145.92 136.05 23.74 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 117.377 0.588 . . . . 0.0 110.776 -178.409 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 169' ' ' TYR . . . . . 0.419 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 31.4 t80 -87.2 123.56 32.36 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 177.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.685 HG21 ' O ' ' A' ' 208' ' ' VAL . 38.8 t -85.13 148.08 5.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -175.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -138.86 16.86 2.67 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-N 114.298 -1.319 . . . . 0.0 111.81 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.543 ' H ' HG12 ' A' ' 170' ' ' VAL . 8.6 t0 -150.19 -147.42 0.23 Allowed 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -179.171 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -44.39 -104.47 0.01 OUTLIER Glycine 0 CA--C 1.53 1.025 0 N-CA-C 114.685 0.634 . . . . 0.0 114.685 -179.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.747 ' HG3' ' HB2' ' A' ' 209' ' ' ALA . 0.0 OUTLIER -151.1 126.61 10.11 Favored 'General case' 0 CA--C 1.513 -0.449 0 O-C-N 122.608 -0.348 . . . . 0.0 111.458 -179.04 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.656 HG23 ' O ' ' A' ' 175' ' ' ILE . 1.5 tp -88.82 83.76 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 CA-C-O 122.035 0.922 . . . . 0.0 109.238 177.541 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.518 HG22 ' HB3' ' A' ' 207' ' ' GLU . 0.0 OUTLIER -89.18 -177.91 5.53 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.384 -1.28 . . . . 0.0 112.932 -177.137 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 37.7 mtm180 -74.71 -44.11 51.71 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 114.669 -1.151 . . . . 0.0 110.839 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' ASP . . . . . 0.531 ' O ' HG13 ' A' ' 238' ' ' VAL . 22.9 t70 -89.04 57.68 4.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.75 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.575 ' OG ' HG11 ' A' ' 238' ' ' VAL . 3.3 m -148.22 163.33 37.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.401 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.479 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 2.7 mptm? -93.77 176.48 6.34 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.104 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.546 HG13 HD11 ' A' ' 195' ' ' ILE . 1.1 m -151.14 149.99 13.69 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.476 0 CA-C-O 121.598 0.713 . . . . 0.0 111.952 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' ARG . . . . . 0.449 ' N ' ' O ' ' A' ' 231' ' ' GLU . 41.3 ttp180 -153.39 104.36 2.75 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.108 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.595 HD21 ' CZ ' ' A' ' 221' ' ' PHE . 0.3 OUTLIER -99.49 170.88 8.31 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-O 120.976 0.417 . . . . 0.0 111.008 -179.75 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.759 HG23 ' O ' ' A' ' 188' ' ' ILE . 48.4 mt -152.92 141.64 14.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.194 -177.518 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.472 ' O ' HG22 ' A' ' 184' ' ' ILE . 7.1 ttp180 -86.49 -157.38 0.35 Allowed 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.112 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -94.17 27.14 2.97 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.724 178.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -154.25 -43.59 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.862 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.759 ' O ' HG23 ' A' ' 184' ' ' ILE . 0.4 OUTLIER -150.24 -160.52 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -178.098 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.658 HG11 ' CD ' ' A' ' 192' ' ' GLU . 35.5 t -85.41 134.98 25.87 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.397 0 CA-C-O 121.439 0.638 . . . . 0.0 110.386 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.486 HG23 ' HG ' ' A' ' 183' ' ' LEU . 0.2 OUTLIER -88.79 -32.54 5.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.619 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 191' ' ' TYR . . . . . 0.522 ' CB ' ' CE1' ' A' ' 221' ' ' PHE . 79.8 t80 179.9 158.41 0.72 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.673 178.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' GLU . . . . . 0.658 ' CD ' HG11 ' A' ' 189' ' ' VAL . 7.6 mp0 -143.87 154.28 43.21 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.969 0.414 . . . . 0.0 110.443 178.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 148.5 -129.33 3.08 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.843 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 0.479 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 13.3 pt-20 -139.38 -174.38 3.86 Favored 'General case' 0 CA--C 1.498 -1.039 0 CA-C-O 121.27 0.557 . . . . 0.0 111.393 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.546 HD11 HG13 ' A' ' 181' ' ' VAL . 4.2 mp -88.0 143.84 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.009 -178.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -89.24 -53.29 4.63 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 18.3 p -151.2 143.22 23.95 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.308 178.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.727 ' CD1' HD22 ' A' ' 216' ' ' LEU . 0.5 OUTLIER -119.67 114.42 22.16 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.329 0.585 . . . . 0.0 111.681 -179.571 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 199' ' ' LYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 26.9 tttt -150.48 122.15 8.04 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.137 179.313 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -88.04 -160.16 0.6 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.968 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -87.03 -12.76 46.37 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.489 0.185 . . . . 0.0 110.931 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.97 -59.28 1.94 Allowed 'General case' 0 N--CA 1.44 -0.952 0 CA-C-O 120.633 0.254 . . . . 0.0 110.775 179.371 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -152.54 -169.29 3.3 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 120.907 0.384 . . . . 0.0 111.01 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' ASP . . . . . 0.403 ' HA ' ' HA ' ' A' ' 199' ' ' LYS . 4.4 t70 -93.07 66.31 4.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.189 179.283 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 32.9 m -61.07 160.06 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 CA-C-O 121.521 0.677 . . . . 0.0 112.242 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' ARG . . . . . 0.431 ' O ' ' HB ' ' A' ' 176' ' ' THR . 0.2 OUTLIER -89.43 -36.74 15.28 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 114.735 -1.121 . . . . 0.0 111.607 -178.616 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.518 ' HB3' HG22 ' A' ' 176' ' ' THR . 0.6 OUTLIER -137.53 177.23 8.02 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.301 0.572 . . . . 0.0 111.895 -179.799 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.685 ' O ' HG21 ' A' ' 170' ' ' VAL . 0.0 OUTLIER -150.86 82.64 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.074 -0.967 . . . . 0.0 109.46 179.058 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.747 ' HB2' ' HG3' ' A' ' 174' ' ' LYS . . . -101.5 171.67 7.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.093 0.473 . . . . 0.0 112.182 -178.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 83.22 -72.55 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.998 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 178.0 37.89 0.06 OUTLIER Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.404 179.085 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' TYR . . . . . 0.419 ' HB3' HG12 ' A' ' 208' ' ' VAL . 2.1 m-85 -98.09 142.93 29.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.95 0.405 . . . . 0.0 111.565 -179.378 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.67 160.71 16.47 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.482 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -150.41 -164.97 2.14 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.863 0.363 . . . . 0.0 111.04 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 215' ' ' GLY . . . . . 0.461 ' C ' HG23 ' A' ' 165' ' ' ILE . . . -148.64 96.23 0.17 Allowed Glycine 0 N--CA 1.451 -0.316 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.727 HD22 ' CD1' ' A' ' 198' ' ' LEU . 0.5 OUTLIER -131.17 143.6 50.73 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -177.642 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 217' ' ' THR . . . . . 0.542 ' C ' HD12 ' A' ' 218' ' ' ILE . 0.0 OUTLIER -78.0 143.79 37.25 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 176.404 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 218' ' ' ILE . . . . . 0.591 HD13 ' HB3' ' A' ' 166' ' ' ALA . 1.6 mp -108.26 88.14 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.709 -178.445 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 9.8 tttt 47.16 -141.91 0.44 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.663 179.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -86.42 55.73 3.68 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.091 0.472 . . . . 0.0 110.99 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.595 ' CZ ' HD21 ' A' ' 183' ' ' LEU . 0.1 OUTLIER -57.51 132.0 51.85 Favored 'General case' 0 C--N 1.339 0.126 0 N-CA-C 116.086 1.884 . . . . 0.0 116.086 178.964 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.42 -42.3 8.55 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 114.35 -1.296 . . . . 0.0 108.658 175.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 223' ' ' ASP . . . . . 0.542 ' HB3' ' CE1' ' A' ' 221' ' ' PHE . 0.0 OUTLIER -64.96 164.12 13.27 Favored 'General case' 0 C--N 1.351 0.65 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.794 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.609 HD13 ' N ' ' A' ' 224' ' ' ILE . 0.2 OUTLIER -155.36 -177.11 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 114.897 -1.047 . . . . 0.0 111.988 176.39 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.418 ' CG ' HG12 ' A' ' 224' ' ' ILE . 0.0 OUTLIER 34.12 103.92 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.752 1.221 . . . . 0.0 112.345 -179.611 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 226' ' ' GLU . . . . . 0.528 ' H ' ' HA ' ' A' ' 155' ' ' GLN . 18.5 tt0 20.35 59.49 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.228 0 O-C-N 124.487 1.117 . . . . 0.0 113.224 179.099 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -61.65 -61.73 6.5 Favored Glycine 0 N--CA 1.432 -1.574 0 CA-C-N 114.869 -1.06 . . . . 0.0 112.482 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.474 ' O ' HG12 ' A' ' 153' ' ' VAL . 0.6 OUTLIER -164.06 -152.02 0.18 Allowed 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -179.544 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 229' ' ' VAL . . . . . 0.835 HG22 ' HG2' ' A' ' 152' ' ' GLU . 92.2 t -90.02 134.41 29.13 Favored 'Isoleucine or valine' 0 C--N 1.35 0.604 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.945 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 230' ' ' ILE . . . . . 0.485 HD13 ' HB3' ' A' ' 168' ' ' CYS . 2.7 mp -103.39 158.69 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 O-C-N 123.544 0.528 . . . . 0.0 111.228 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 231' ' ' GLU . . . . . 0.449 ' O ' ' N ' ' A' ' 182' ' ' ARG . 9.2 tt0 -147.79 111.32 4.98 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.653 ' HB2' HD12 ' A' ' 175' ' ' ILE . . . -87.7 139.68 30.28 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.683 179.096 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 233' ' ' TYR . . . . . 0.495 ' CA ' HG22 ' A' ' 148' ' ' ILE . 30.3 p90 -139.03 135.01 33.79 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.146 -179.378 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.635 HG13 ' N ' ' A' ' 235' ' ' MET . 0.5 OUTLIER -176.93 -161.05 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.668 179.716 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 235' ' ' MET . . . . . 0.635 ' N ' HG13 ' A' ' 234' ' ' VAL . 0.0 OUTLIER -95.94 -167.54 1.61 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.795 0.331 . . . . 0.0 110.687 -179.892 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.91 32.7 2.55 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.092 0.472 . . . . 0.0 111.334 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -118.84 43.04 2.65 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.023 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.706 HG21 ' CD1' ' A' ' 148' ' ' ILE . 0.6 OUTLIER -108.44 168.38 3.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.075 -179.137 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 239' ' ' ALA . . . . . 0.438 ' H ' HG12 ' A' ' 238' ' ' VAL . . . 69.84 -64.87 0.33 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.885 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.67 -3.95 57.99 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.313 -0.987 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.059 -179.995 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.765 0.317 . . . . 0.0 111.215 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -67.98 139.65 56.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.972 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -93.84 42.23 1.09 Allowed 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.389 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -94.3 -178.51 4.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.952 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.719 HG11 ' HB2' ' A' ' 150' ' ' GLN . 20.7 t -58.68 143.22 13.33 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.449 0 CA-C-O 121.415 0.626 . . . . 0.0 111.424 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.542 ' O ' HG22 ' A' ' 148' ' ' ILE . 16.1 mm -129.7 6.98 2.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.843 178.097 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.59 ' CA ' ' HB3' ' A' ' 232' ' ' ALA . . . 173.9 72.88 0.05 OUTLIER Glycine 0 C--N 1.343 0.936 0 C-N-CA 121.127 -0.559 . . . . 0.0 111.904 179.606 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.719 ' HB2' HG11 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -93.71 131.5 38.98 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 116.871 0.335 . . . . 0.0 110.305 179.855 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.499 ' O ' HG13 ' A' ' 229' ' ' VAL . . . -151.65 176.47 11.33 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -178.338 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.46 ' HA ' ' HA ' ' A' ' 229' ' ' VAL . 1.9 mt-10 -123.69 125.82 45.45 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.746 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.472 HG12 ' O ' ' A' ' 228' ' ' ASP . 1.8 p -55.16 127.21 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-O 121.569 0.699 . . . . 0.0 112.196 -179.221 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.485 ' O ' ' HB3' ' A' ' 226' ' ' GLU . 0.0 OUTLIER -89.87 -55.16 3.74 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 105.056 -2.201 . . . . 0.0 105.056 175.736 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.83 -164.07 0.86 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.861 174.688 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.554 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 26.3 p -143.41 -175.9 4.73 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 178.253 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.669 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 21.7 m-85 -144.11 76.53 1.51 Allowed 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.475 ' HG2' HG13 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -86.52 62.64 7.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 122.428 1.109 . . . . 0.0 108.498 178.285 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.483 HG12 ' N ' ' A' ' 161' ' ' LYS . 45.8 t -89.85 154.73 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 CA-C-N 113.236 -1.802 . . . . 0.0 110.226 -178.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 26.3 t -89.83 36.74 0.86 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.057 0.456 . . . . 0.0 110.006 178.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.483 ' N ' HG12 ' A' ' 159' ' ' VAL . 1.4 mttt -150.6 -34.18 0.16 Allowed 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.213 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.501 HG12 ' N ' ' A' ' 163' ' ' GLY . 84.9 t -101.65 -101.81 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' GLY . . . . . 0.501 ' N ' HG12 ' A' ' 162' ' ' VAL . . . -158.79 -101.74 0.18 Allowed Glycine 0 C--O 1.224 -0.498 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 178.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.455 ' C ' HG23 ' A' ' 217' ' ' THR . 0.0 OUTLIER -152.32 37.07 0.53 Allowed 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 177.48 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.669 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 2.2 mm -40.28 93.21 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.338 0.095 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.773 -179.175 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.554 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . -84.98 116.47 23.4 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.457 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -87.49 134.4 12.44 Favored Glycine 0 N--CA 1.438 -1.181 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 178.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.414 ' HB2' ' CB ' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -136.46 131.21 33.73 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.859 0.329 . . . . 0.0 110.374 -178.503 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 169' ' ' TYR . . . . . 0.416 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 41.1 t80 -85.64 126.8 34.2 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 177.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.801 HG21 ' O ' ' A' ' 208' ' ' VAL . 45.4 t -85.73 146.36 6.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -175.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.2 p -138.44 14.19 2.77 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 114.402 -1.272 . . . . 0.0 111.807 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.408 ' H ' HG12 ' A' ' 170' ' ' VAL . 4.6 t70 -150.46 -142.58 0.12 Allowed 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -44.54 -105.36 0.01 OUTLIER Glycine 0 CA--C 1.53 1.015 0 N-CA-C 114.455 0.542 . . . . 0.0 114.455 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.808 ' HG2' ' HB2' ' A' ' 209' ' ' ALA . 10.7 mttm -151.8 143.13 23.39 Favored 'General case' 0 CA--C 1.516 -0.347 0 O-C-N 122.301 -0.529 . . . . 0.0 111.995 -179.1 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.622 ' CG1' HG22 ' A' ' 170' ' ' VAL . 11.2 mm -93.23 90.52 3.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 176.744 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.459 HG22 ' HB3' ' A' ' 207' ' ' GLU . 0.1 OUTLIER -106.13 174.7 5.77 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.488 0.661 . . . . 0.0 112.677 -177.495 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.408 ' HG3' ' HB2' ' A' ' 198' ' ' LEU . 0.1 OUTLIER -72.96 -42.59 63.22 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.208 179.351 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -88.28 56.22 3.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.141 -179.073 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.495 ' OG ' HG21 ' A' ' 238' ' ' VAL . 0.5 OUTLIER -150.2 161.51 42.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.418 179.697 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 0.0 OUTLIER -89.18 -177.45 5.41 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.5 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.661 HG11 HG13 ' A' ' 218' ' ' ILE . 1.4 m -146.07 157.29 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 CA-C-O 121.227 0.537 . . . . 0.0 111.638 179.591 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 182' ' ' ARG . . . . . 0.418 ' N ' ' O ' ' A' ' 231' ' ' GLU . 6.0 ttt85 -152.78 102.54 2.7 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.312 -0.858 . . . . 0.0 113.196 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.708 HD12 ' HB3' ' A' ' 191' ' ' TYR . 0.3 OUTLIER -86.36 154.12 21.43 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-O 121.701 0.763 . . . . 0.0 113.034 -179.937 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.476 ' N ' HG23 ' A' ' 190' ' ' VAL . 3.2 mp -148.5 121.24 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 113.989 -1.46 . . . . 0.0 112.27 178.124 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.419 ' N ' HG22 ' A' ' 190' ' ' VAL . 1.3 ttm180 -85.99 -150.44 0.14 Allowed 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 177.269 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -93.99 27.48 2.78 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 118.78 0.718 . . . . 0.0 110.766 178.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -154.81 -77.54 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.835 -0.697 . . . . 0.0 112.673 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -115.44 -155.28 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 115.277 -0.462 . . . . 0.0 110.734 -179.136 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.775 HG11 ' CG ' ' A' ' 192' ' ' GLU . 44.2 t -87.08 135.44 25.21 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.102 0 CA-C-O 121.565 0.698 . . . . 0.0 111.74 -179.181 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.793 HG12 ' OD2' ' A' ' 223' ' ' ASP . 0.2 OUTLIER -89.58 -34.51 6.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 114.665 -1.152 . . . . 0.0 108.961 178.637 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 191' ' ' TYR . . . . . 0.708 ' HB3' HD12 ' A' ' 183' ' ' LEU . 16.6 t80 -158.33 158.79 35.0 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.35 178.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 192' ' ' GLU . . . . . 0.775 ' CG ' HG11 ' A' ' 189' ' ' VAL . 14.3 mt-10 -150.33 155.81 40.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.112 178.606 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 134.7 -119.34 2.15 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.257 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 0.628 ' CA ' HG22 ' A' ' 181' ' ' VAL . 17.6 pt-20 -150.32 -175.01 4.91 Favored 'General case' 0 CA--C 1.496 -1.097 0 CA-C-O 121.357 0.599 . . . . 0.0 111.675 -179.111 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.567 ' CD1' HG13 ' A' ' 181' ' ' VAL . 4.3 mp -88.48 143.38 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.322 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 196' ' ' ASP . . . . . 0.421 ' CB ' ' HB ' ' A' ' 217' ' ' THR . 0.4 OUTLIER -88.93 -57.47 2.89 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.412 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 35.2 t -151.53 153.03 33.78 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.222 179.031 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.564 HD21 ' O ' ' A' ' 175' ' ' ILE . 0.1 OUTLIER -123.0 119.22 29.73 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-O 121.37 0.605 . . . . 0.0 111.484 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.34 118.7 6.42 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.126 179.365 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 4.6 ptm85 -87.86 -144.27 0.13 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.177 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -84.57 109.32 17.87 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 53.0 29.25 7.65 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.767 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -150.85 130.31 12.94 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 120.947 0.403 . . . . 0.0 111.316 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -98.34 71.42 2.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.078 179.331 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 36.0 m -72.12 166.33 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.921 0 CA-C-O 121.618 0.723 . . . . 0.0 112.562 -178.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 206' ' ' ARG . . . . . 0.443 ' O ' ' HA ' ' A' ' 176' ' ' THR . 16.6 ttp180 -89.07 -41.1 12.51 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 114.483 -1.235 . . . . 0.0 111.556 -178.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.459 ' HB3' HG22 ' A' ' 176' ' ' THR . 0.3 OUTLIER -138.09 -177.18 4.71 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.135 0.493 . . . . 0.0 111.684 -179.544 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.801 ' O ' HG21 ' A' ' 170' ' ' VAL . 0.2 OUTLIER -150.88 81.56 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.801 179.316 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.808 ' HB2' ' HG2' ' A' ' 174' ' ' LYS . . . -99.74 175.28 5.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.056 0.455 . . . . 0.0 112.154 -178.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 82.59 -75.0 0.03 OUTLIER 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.697 -179.451 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 178.47 37.31 0.06 OUTLIER Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.376 -0.916 . . . . 0.0 112.362 179.028 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -99.22 145.28 27.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.963 0.411 . . . . 0.0 111.196 -179.407 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.4 131.79 46.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.453 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 214' ' ' CYS . . . . . 0.566 ' HB3' HG21 ' A' ' 208' ' ' VAL . 50.0 t -134.96 144.45 47.42 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.399 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 215' ' ' GLY . . . . . 0.625 ' O ' HD12 ' A' ' 165' ' ' ILE . . . -88.58 108.15 3.42 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.494 -0.86 . . . . 0.0 111.995 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.574 HD12 ' CD1' ' A' ' 218' ' ' ILE . 0.3 OUTLIER -132.54 140.51 48.33 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 120.97 0.414 . . . . 0.0 111.436 -179.264 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 217' ' ' THR . . . . . 0.455 HG23 ' C ' ' A' ' 164' ' ' THR . 0.2 OUTLIER -78.73 138.8 38.42 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 177.907 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 218' ' ' ILE . . . . . 0.661 HG13 HG11 ' A' ' 181' ' ' VAL . 1.4 mp -105.79 95.4 3.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 -178.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 44.04 -145.53 0.11 Allowed 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.928 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 -88.16 63.83 7.42 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-O 120.85 0.357 . . . . 0.0 111.2 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.683 ' CZ ' HD13 ' A' ' 183' ' ' LEU . 0.1 OUTLIER -54.4 118.44 4.13 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 179.002 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -84.14 -43.43 15.01 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.755 176.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 223' ' ' ASP . . . . . 0.793 ' OD2' HG12 ' A' ' 190' ' ' VAL . 0.0 OUTLIER -87.74 132.26 34.2 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.97 178.455 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.475 HG13 ' HG2' ' A' ' 158' ' ' LYS . 0.1 OUTLIER -116.61 179.56 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 CA-C-O 121.09 0.471 . . . . 0.0 112.003 -179.646 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.421 ' O ' ' N ' ' A' ' 227' ' ' GLY . 0.0 OUTLIER 55.67 120.88 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.543 179.853 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 226' ' ' GLU . . . . . 0.485 ' HB3' ' O ' ' A' ' 154' ' ' ARG . 3.3 pt-20 -3.97 71.73 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 227' ' ' GLY . . . . . 0.439 ' N ' HG11 ' A' ' 153' ' ' VAL . . . -64.48 -63.42 4.3 Favored Glycine 0 N--CA 1.43 -1.722 0 CA-C-N 114.7 -1.136 . . . . 0.0 111.616 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.472 ' O ' HG12 ' A' ' 153' ' ' VAL . 1.0 OUTLIER -164.76 -148.49 0.11 Allowed 'General case' 0 C--O 1.22 -0.491 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 179.585 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 229' ' ' VAL . . . . . 0.499 HG13 ' O ' ' A' ' 151' ' ' ALA . 61.9 t -89.47 145.76 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.225 0 O-C-N 122.091 -0.381 . . . . 0.0 110.494 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 230' ' ' ILE . . . . . 0.419 HG13 ' CD2' ' A' ' 183' ' ' LEU . 2.6 mp -117.01 154.4 18.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.156 -179.231 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 231' ' ' GLU . . . . . 0.506 ' OE2' HG22 ' A' ' 147' ' ' VAL . 7.5 tt0 -143.27 113.96 7.56 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.403 0.62 . . . . 0.0 111.948 -179.464 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.59 ' HB3' ' CA ' ' A' ' 149' ' ' GLY . . . -88.45 128.45 35.53 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.497 178.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -130.5 129.48 42.95 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.869 -178.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.604 HG12 ' HG3' ' A' ' 236' ' ' GLN . 4.3 t -153.98 139.4 10.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.982 0.42 . . . . 0.0 111.762 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.59 37.25 1.96 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 178.432 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 236' ' ' GLN . . . . . 0.604 ' HG3' HG12 ' A' ' 234' ' ' VAL . 45.7 mt-30 -120.08 -143.54 0.35 Allowed 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.316 -178.439 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -137.31 72.77 1.42 Allowed 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.52 ' O ' ' HB3' ' A' ' 239' ' ' ALA . 2.1 t -82.72 160.64 3.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.862 -178.44 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 239' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' A' ' 238' ' ' VAL . . . 78.62 -59.77 0.41 Allowed 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.842 -179.253 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.8 -7.66 53.87 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.312 -1.031 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.038 179.998 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 2.8 t80 . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.888 0.375 . . . . 0.0 111.251 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 60.64 -175.47 0.11 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.97 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -93.7 42.46 1.1 Allowed 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.453 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 2.0 tttm -76.26 -166.33 0.6 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.527 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.706 HG11 ' HB2' ' A' ' 150' ' ' GLN . 14.9 t -59.53 140.9 17.04 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.637 0 CA-C-O 121.308 0.575 . . . . 0.0 111.315 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.704 HD11 ' HB3' ' A' ' 179' ' ' SER . 1.8 pp -124.97 -1.78 5.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.048 178.192 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.568 ' CA ' ' HB3' ' A' ' 232' ' ' ALA . . . 179.51 73.95 0.06 OUTLIER Glycine 0 C--N 1.34 0.791 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.165 179.656 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.706 ' HB2' HG11 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -90.99 132.8 35.76 Favored 'General case' 0 CA--C 1.509 -0.61 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.249 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.417 ' CB ' ' HB2' ' A' ' 168' ' ' CYS . . . -151.57 174.71 13.12 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 121.457 0.646 . . . . 0.0 112.458 -178.124 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.752 ' CG ' HG22 ' A' ' 229' ' ' VAL . 0.8 OUTLIER -119.98 122.14 40.52 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.021 179.691 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.443 HG12 ' O ' ' A' ' 228' ' ' ASP . 2.6 p -50.05 134.13 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -89.29 -63.31 1.31 Allowed 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 175.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.469 ' HA ' ' H ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER -161.51 -162.03 0.85 Allowed 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 113.826 -1.534 . . . . 0.0 109.198 175.206 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.514 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 7.5 p -145.89 157.3 43.91 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 120.829 0.347 . . . . 0.0 110.392 177.469 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.681 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 2.3 m-85 -104.21 72.13 1.06 Allowed 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -177.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 16.7 tttt -85.67 63.72 8.22 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 122.125 0.964 . . . . 0.0 108.826 178.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 95.8 t -89.9 158.21 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 CA-C-N 113.673 -1.603 . . . . 0.0 109.906 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 25.2 p -92.62 32.97 1.16 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.224 0.535 . . . . 0.0 110.036 178.461 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 3.2 mtmt -152.02 -31.54 0.15 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.644 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.459 HG12 ' N ' ' A' ' 163' ' ' GLY . 98.5 t -98.98 -101.19 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 O-C-N 122.171 -0.331 . . . . 0.0 110.234 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' GLY . . . . . 0.459 ' N ' HG12 ' A' ' 162' ' ' VAL . . . -158.72 -105.95 0.22 Allowed Glycine 0 N--CA 1.451 -0.361 0 N-CA-C 111.644 -0.583 . . . . 0.0 111.644 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.504 HG21 HG21 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -153.7 34.85 0.45 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.378 -0.911 . . . . 0.0 108.944 178.391 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.681 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 3.8 mm -42.45 94.87 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.577 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.514 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . -87.77 117.8 26.85 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 114.748 -1.114 . . . . 0.0 111.189 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -88.39 153.97 24.72 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 179.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.417 ' HB2' ' CB ' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -148.29 136.12 20.88 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.922 0.361 . . . . 0.0 110.81 -178.268 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 169' ' ' TYR . . . . . 0.408 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 33.3 t80 -87.39 124.96 33.95 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 177.737 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.77 HG21 ' O ' ' A' ' 208' ' ' VAL . 24.5 t -85.08 144.51 9.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -175.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -136.41 14.3 3.23 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-N 114.544 -1.207 . . . . 0.0 112.013 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.457 ' H ' HG12 ' A' ' 170' ' ' VAL . 4.2 t0 -150.52 -144.16 0.15 Allowed 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -179.504 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -41.32 -106.0 0.01 OUTLIER Glycine 0 CA--C 1.533 1.188 0 N-CA-C 115.197 0.839 . . . . 0.0 115.197 -178.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.408 ' HB2' ' HB3' ' A' ' 207' ' ' GLU . 0.0 OUTLIER -150.69 146.74 26.66 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.014 0.435 . . . . 0.0 111.619 -178.399 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.599 HG13 HG22 ' A' ' 170' ' ' VAL . 10.6 mm -99.39 83.23 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 176.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.561 HG21 ' HB ' ' A' ' 238' ' ' VAL . 0.1 OUTLIER -95.88 168.5 10.6 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -177.177 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.412 ' CG ' ' HB3' ' A' ' 198' ' ' LEU . 33.8 mtm180 -64.58 -45.07 88.58 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 114.546 -1.206 . . . . 0.0 110.743 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -89.4 59.99 5.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.743 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.704 ' HB3' HD11 ' A' ' 148' ' ' ILE . 58.9 m -149.13 156.04 41.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.756 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 3.5 mptp? -89.18 -179.33 5.86 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.696 179.511 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.812 HG21 HD12 ' A' ' 218' ' ' ILE . 1.1 m -150.86 150.12 13.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.493 0.663 . . . . 0.0 111.953 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 182' ' ' ARG . . . . . 0.439 ' N ' ' O ' ' A' ' 231' ' ' GLU . 11.5 ttt85 -153.25 102.43 2.61 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.463 179.333 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.622 ' C ' HD12 ' A' ' 184' ' ' ILE . 0.3 OUTLIER -100.58 167.67 10.2 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-O 120.947 0.403 . . . . 0.0 111.382 -179.829 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.666 HG23 ' O ' ' A' ' 188' ' ' ILE . 4.7 mp -151.56 139.98 14.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.944 -177.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.504 ' N ' HG22 ' A' ' 190' ' ' VAL . 0.1 OUTLIER -87.16 -153.19 0.21 Allowed 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.022 -0.99 . . . . 0.0 108.86 178.117 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -94.71 28.02 2.83 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 118.092 0.405 . . . . 0.0 111.296 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -152.96 -76.75 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.556 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.666 ' O ' HG23 ' A' ' 184' ' ' ILE . 0.4 OUTLIER -116.12 -156.57 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 115.525 -0.338 . . . . 0.0 110.319 -179.54 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.759 HG11 ' CD ' ' A' ' 192' ' ' GLU . 31.0 t -86.16 138.84 18.32 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 CA-C-O 121.476 0.655 . . . . 0.0 110.702 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.577 HG23 ' CA ' ' A' ' 184' ' ' ILE . 0.6 OUTLIER -87.68 -37.11 10.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 114.913 -1.04 . . . . 0.0 108.89 179.847 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 191' ' ' TYR . . . . . 0.439 ' HB2' ' CE1' ' A' ' 221' ' ' PHE . 0.5 OUTLIER -178.69 150.49 0.52 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.354 179.617 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 192' ' ' GLU . . . . . 0.759 ' CD ' HG11 ' A' ' 189' ' ' VAL . 2.3 mp0 -137.13 158.35 44.63 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.935 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 144.53 -132.73 4.9 Favored Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.556 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 0.736 ' O ' HG23 ' A' ' 218' ' ' ILE . 4.1 pt-20 -143.58 -179.34 6.37 Favored 'General case' 0 CA--C 1.498 -1.023 0 CA-C-O 121.186 0.517 . . . . 0.0 111.051 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.866 HG12 HD13 ' A' ' 216' ' ' LEU . 4.5 mp -88.73 143.05 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.877 -178.716 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -91.81 -43.79 9.33 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.361 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 48.8 m -151.29 145.56 25.43 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.09 179.117 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.536 HD12 ' HB3' ' A' ' 216' ' ' LEU . 16.7 tp -119.39 113.82 21.39 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.075 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 199' ' ' LYS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 19.7 mtmm -149.56 122.86 8.98 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.368 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -87.76 -159.77 0.56 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.833 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -87.17 -7.77 57.61 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 121.097 -0.241 . . . . 0.0 111.295 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 10.4 tptt -102.86 -59.41 1.71 Allowed 'General case' 0 N--CA 1.441 -0.902 0 CA-C-O 120.712 0.291 . . . . 0.0 110.975 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 -152.46 -171.07 3.82 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 120.764 0.316 . . . . 0.0 111.021 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 204' ' ' ASP . . . . . 0.404 ' HA ' ' HA ' ' A' ' 199' ' ' LYS . 19.2 m-20 -89.61 75.07 7.53 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.317 179.346 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 33.1 m -64.52 159.45 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.878 0 CA-C-O 121.583 0.706 . . . . 0.0 112.313 -179.097 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 206' ' ' ARG . . . . . 0.457 ' O ' ' HA ' ' A' ' 176' ' ' THR . 1.9 ttt180 -89.3 -34.54 16.54 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.875 -178.556 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 176' ' ' THR . 1.6 mp0 -142.03 -179.01 5.97 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.156 0.503 . . . . 0.0 111.527 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.77 ' O ' HG21 ' A' ' 170' ' ' VAL . 1.9 t -150.79 73.03 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.848 179.199 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.401 ' HB2' ' HD2' ' A' ' 174' ' ' LYS . . . -96.25 171.01 8.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.087 0.47 . . . . 0.0 112.206 -178.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 83.11 -76.32 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.766 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 178.31 37.46 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.299 -0.953 . . . . 0.0 112.656 179.092 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -95.83 154.71 17.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.894 0.378 . . . . 0.0 111.2 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -89.55 162.43 15.68 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.355 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 214' ' ' CYS . . . . . 0.598 ' HB3' HG21 ' A' ' 208' ' ' VAL . 29.8 p -150.49 -171.65 3.98 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.874 0.369 . . . . 0.0 111.42 -179.305 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 215' ' ' GLY . . . . . 0.508 ' O ' HD12 ' A' ' 165' ' ' ILE . . . -150.2 98.58 0.19 Allowed Glycine 0 N--CA 1.451 -0.343 0 N-CA-C 111.505 -0.638 . . . . 0.0 111.505 179.557 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.866 HD13 HG12 ' A' ' 195' ' ' ILE . 0.5 OUTLIER -126.27 140.63 52.37 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-O 121.18 0.514 . . . . 0.0 112.242 -179.113 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -100.6 115.19 29.6 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.314 -0.857 . . . . 0.0 108.738 177.553 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 218' ' ' ILE . . . . . 0.812 HD12 HG21 ' A' ' 181' ' ' VAL . 15.6 mm -63.39 140.59 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-O 121.27 0.557 . . . . 0.0 110.626 -178.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 219' ' ' LYS . . . . . 0.409 ' HD3' ' HG2' ' A' ' 194' ' ' GLU . 6.1 ptmt -42.45 -28.64 0.22 Allowed 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 -177.724 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 220' ' ' ASN . . . . . 0.433 ' O ' ' CE2' ' A' ' 191' ' ' TYR . 0.2 OUTLIER -152.36 34.4 0.51 Allowed 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 -178.501 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.518 ' CZ ' HD21 ' A' ' 183' ' ' LEU . 0.1 OUTLIER -58.25 121.41 10.68 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 178.872 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -89.52 -48.68 7.15 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 114.888 -1.051 . . . . 0.0 108.377 176.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 223' ' ' ASP . . . . . 0.451 ' O ' ' CD1' ' A' ' 221' ' ' PHE . 0.0 OUTLIER -77.14 140.22 40.16 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.292 177.496 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.637 HD13 ' N ' ' A' ' 224' ' ' ILE . 0.2 OUTLIER -134.67 178.01 6.06 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -178.85 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.413 ' O ' ' C ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER 56.61 115.54 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 114.391 -1.277 . . . . 0.0 110.182 -179.147 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 226' ' ' GLU . . . . . 0.469 ' H ' ' HA ' ' A' ' 155' ' ' GLN . 6.5 tt0 7.5 64.28 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 124.65 1.18 . . . . 0.0 113.55 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -61.18 -65.78 3.07 Favored Glycine 0 N--CA 1.431 -1.635 0 CA-C-N 114.694 -1.139 . . . . 0.0 111.764 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.443 ' O ' HG12 ' A' ' 153' ' ' VAL . 0.9 OUTLIER -164.98 -147.67 0.1 Allowed 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 179.859 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 229' ' ' VAL . . . . . 0.752 HG22 ' CG ' ' A' ' 152' ' ' GLU . 76.4 t -89.32 131.51 36.42 Favored 'Isoleucine or valine' 0 C--N 1.348 0.536 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.063 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 230' ' ' ILE . . . . . 0.481 ' HA ' ' HA ' ' A' ' 183' ' ' LEU . 3.7 mt -102.31 159.23 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 O-C-N 123.494 0.496 . . . . 0.0 111.487 -179.21 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 231' ' ' GLU . . . . . 0.448 ' N ' HG22 ' A' ' 230' ' ' ILE . 7.2 tt0 -145.25 110.42 5.22 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.568 ' HB3' ' CA ' ' A' ' 149' ' ' GLY . . . -88.26 129.5 35.35 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.668 178.6 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -130.82 141.5 50.34 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.803 -178.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.561 HG12 HG21 ' A' ' 148' ' ' ILE . 0.3 OUTLIER -178.81 -173.78 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-O 120.804 0.335 . . . . 0.0 111.135 179.971 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 235' ' ' MET . . . . . 0.503 ' H ' HG22 ' A' ' 234' ' ' VAL . 0.0 OUTLIER -89.65 -163.73 1.05 Allowed 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.21 179.524 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 6.0 pm0 -90.06 77.25 6.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.107 0.479 . . . . 0.0 110.71 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -150.84 39.35 0.7 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.007 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.561 ' HB ' HG21 ' A' ' 176' ' ' THR . 3.0 m -109.64 148.01 13.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.555 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . 69.67 -63.65 0.38 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.168 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.4 -3.88 58.26 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 121.147 0.499 . . . . 0.0 112.326 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.314 -0.959 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.145 179.932 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.811 0.339 . . . . 0.0 111.202 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -131.12 126.27 35.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.885 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.54 40.63 1.09 Allowed 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.391 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 11.6 mmtp -123.79 -165.62 1.37 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.751 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.763 HG11 ' HB2' ' A' ' 150' ' ' GLN . 20.1 t -56.71 137.59 18.42 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.541 0 CA-C-O 121.135 0.493 . . . . 0.0 111.522 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.57 HD13 ' O ' ' A' ' 147' ' ' VAL . 25.7 mm -121.81 -4.31 8.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.27 178.429 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.476 ' O ' ' HB3' ' A' ' 232' ' ' ALA . . . -176.72 72.15 0.08 OUTLIER Glycine 0 C--N 1.343 0.926 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.044 179.482 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.763 ' HB2' HG11 ' A' ' 147' ' ' VAL . 2.3 tt0 -90.49 135.15 33.88 Favored 'General case' 0 CA--C 1.512 -0.501 0 O-C-N 122.678 -0.307 . . . . 0.0 110.369 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.436 ' CB ' ' HB2' ' A' ' 168' ' ' CYS . . . -152.56 171.08 18.68 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 120.095 -0.642 . . . . 0.0 112.674 -178.1 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.835 ' CG ' HG22 ' A' ' 229' ' ' VAL . 0.6 OUTLIER -119.84 124.09 45.25 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.031 179.453 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.443 ' HB ' ' O ' ' A' ' 228' ' ' ASP . 3.9 p -52.01 133.26 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -178.484 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -89.29 -60.28 1.99 Allowed 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 104.827 -2.286 . . . . 0.0 104.827 175.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.535 ' HA ' ' H ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER -161.28 -161.94 0.85 Allowed 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 113.04 -1.891 . . . . 0.0 108.773 175.252 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.585 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 1.6 p -150.96 155.56 39.35 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 176.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.696 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 2.8 m-85 -104.62 76.38 1.28 Allowed 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -178.548 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -86.07 62.99 7.77 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.628 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.486 HG12 ' N ' ' A' ' 161' ' ' LYS . 54.7 t -89.97 155.35 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 CA-C-N 113.749 -1.569 . . . . 0.0 110.12 -178.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 28.6 t -90.79 34.78 0.9 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.203 0.525 . . . . 0.0 109.973 178.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.486 ' N ' HG12 ' A' ' 159' ' ' VAL . 0.5 OUTLIER -150.71 -31.67 0.18 Allowed 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.316 -179.689 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.5 HG12 ' N ' ' A' ' 163' ' ' GLY . 90.5 t -102.71 -102.78 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' GLY . . . . . 0.5 ' N ' HG12 ' A' ' 162' ' ' VAL . . . -158.95 -105.9 0.22 Allowed Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 179.084 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.637 HG21 HG21 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -156.03 54.4 0.58 Allowed 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 178.124 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.696 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 0.1 OUTLIER -34.38 -27.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.214 -0.812 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 -177.003 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.585 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . 36.78 97.52 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 178.348 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -86.39 149.67 22.95 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 109.881 -1.287 . . . . 0.0 109.881 178.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.436 ' HB2' ' CB ' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -144.81 135.33 24.44 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 117.216 0.508 . . . . 0.0 110.467 -178.18 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 169' ' ' TYR . . . . . 0.433 ' O ' ' HA ' ' A' ' 151' ' ' ALA . 1.9 t80 -87.96 124.8 34.07 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 177.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.754 HG21 ' O ' ' A' ' 208' ' ' VAL . 41.0 t -85.16 137.92 19.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.635 0.731 . . . . 0.0 112.849 -176.438 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.3 p -129.42 12.0 5.9 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 114.627 -1.169 . . . . 0.0 112.096 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -145.76 -139.21 0.1 Allowed 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -50.84 -110.73 0.01 OUTLIER Glycine 0 CA--C 1.53 1.013 0 C-N-CA 121.058 -0.592 . . . . 0.0 114.151 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.68 ' CG ' ' HB2' ' A' ' 209' ' ' ALA . 0.0 OUTLIER -144.7 137.26 26.43 Favored 'General case' 0 CA--C 1.514 -0.423 0 O-C-N 122.349 -0.501 . . . . 0.0 110.834 -179.272 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.479 HG23 ' O ' ' A' ' 175' ' ' ILE . 0.6 OUTLIER -94.43 112.18 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 C-N-CA 119.556 -0.858 . . . . 0.0 109.165 177.371 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.52 ' HB ' ' O ' ' A' ' 206' ' ' ARG . 0.3 OUTLIER -125.03 177.76 5.89 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.37 0.605 . . . . 0.0 112.09 -177.373 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.411 ' N ' HD13 ' A' ' 198' ' ' LEU . 0.0 OUTLIER -74.8 -36.81 62.47 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.032 -0.986 . . . . 0.0 109.525 179.241 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 178' ' ' ASP . . . . . 0.446 ' O ' HG13 ' A' ' 238' ' ' VAL . 5.1 m-20 -88.94 52.04 2.31 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.054 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.477 ' O ' HD12 ' A' ' 195' ' ' ILE . 0.6 OUTLIER -150.72 159.59 44.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.987 179.799 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.486 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 0.0 OUTLIER -88.98 -177.84 5.56 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.172 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.664 HG21 HG23 ' A' ' 218' ' ' ILE . 2.3 m -142.13 160.39 20.22 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 CA-C-O 121.335 0.588 . . . . 0.0 111.82 179.317 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' ARG . . . . . 0.445 ' N ' ' O ' ' A' ' 231' ' ' GLU . 4.4 ttt-85 -152.66 97.81 2.28 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.099 -0.955 . . . . 0.0 112.806 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.687 HD13 ' CZ ' ' A' ' 221' ' ' PHE . 0.3 OUTLIER -86.25 153.79 21.75 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-O 121.748 0.785 . . . . 0.0 112.58 179.991 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.776 ' N ' HG23 ' A' ' 190' ' ' VAL . 17.8 mt -158.23 131.73 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 114.171 -1.377 . . . . 0.0 112.581 179.555 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.446 ' O ' HG22 ' A' ' 184' ' ' ILE . 0.0 OUTLIER -89.0 -151.74 0.22 Allowed 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.024 -1.472 . . . . 0.0 107.024 176.253 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -95.93 27.54 3.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 118.521 0.601 . . . . 0.0 110.516 178.622 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -153.96 -43.33 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.679 -0.772 . . . . 0.0 113.405 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.668 HG23 ' N ' ' A' ' 189' ' ' VAL . 0.4 OUTLIER -150.15 -158.33 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -177.953 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.668 ' N ' HG23 ' A' ' 188' ' ' ILE . 48.0 t -87.34 138.11 19.7 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 CA-C-O 121.624 0.726 . . . . 0.0 111.204 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.816 HG21 ' CB ' ' A' ' 228' ' ' ASP . 0.1 OUTLIER -98.12 -34.21 4.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 114.645 -1.161 . . . . 0.0 108.864 179.264 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 191' ' ' TYR . . . . . 0.629 ' HB3' HD12 ' A' ' 183' ' ' LEU . 19.1 t80 -158.58 159.75 35.83 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.18 179.096 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 192' ' ' GLU . . . . . 0.65 ' CG ' HG11 ' A' ' 189' ' ' VAL . 19.3 mt-10 -150.34 155.11 39.02 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.61 178.606 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 135.13 -121.48 2.59 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.485 -0.864 . . . . 0.0 112.382 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 12.4 pt-20 -150.01 -176.57 5.5 Favored 'General case' 0 CA--C 1.495 -1.143 0 CA-C-O 121.447 0.642 . . . . 0.0 112.031 -178.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.477 HD12 ' O ' ' A' ' 179' ' ' SER . 4.5 mp -89.06 150.28 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 CA-C-N 115.175 -0.921 . . . . 0.0 109.37 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -88.73 -67.98 0.8 Allowed 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.061 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -151.99 154.62 36.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.455 178.534 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.592 HD22 ' C ' ' A' ' 206' ' ' ARG . 0.2 OUTLIER -107.61 127.85 54.02 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.319 0.581 . . . . 0.0 111.711 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 199' ' ' LYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 43.8 tttt -150.63 113.46 4.75 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.388 179.108 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.18 -161.66 0.75 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.081 -0.508 . . . . 0.0 109.823 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -87.76 -13.23 42.91 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.474 0.178 . . . . 0.0 110.972 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.85 -55.07 2.74 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 120.569 0.223 . . . . 0.0 111.229 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -152.38 -173.41 4.54 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 120.858 0.361 . . . . 0.0 111.234 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 204' ' ' ASP . . . . . 0.422 ' HA ' ' HA ' ' A' ' 199' ' ' LYS . 4.5 p-10 -89.96 82.2 6.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.44 179.385 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.499 HG23 HD23 ' A' ' 198' ' ' LEU . 35.0 m -74.34 176.66 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -0.986 0 CA-C-O 121.576 0.703 . . . . 0.0 112.366 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 206' ' ' ARG . . . . . 0.592 ' C ' HD22 ' A' ' 198' ' ' LEU . 2.1 ttt180 -103.74 -42.24 5.69 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 114.616 -1.175 . . . . 0.0 111.796 -179.01 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.501 ' HG2' ' HB2' ' A' ' 239' ' ' ALA . 1.4 mp0 -131.03 -177.02 4.19 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.207 0.527 . . . . 0.0 112.052 -179.09 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.754 ' O ' HG21 ' A' ' 170' ' ' VAL . 0.9 OUTLIER -151.42 71.26 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.848 178.539 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.68 ' HB2' ' CG ' ' A' ' 174' ' ' LYS . . . -91.65 171.68 9.0 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.094 0.473 . . . . 0.0 112.174 -178.714 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 83.67 -76.87 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.9 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 211' ' ' GLY . . . . . 0.4 ' O ' ' CE1' ' A' ' 169' ' ' TYR . . . 178.04 36.95 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.338 -0.934 . . . . 0.0 112.563 179.17 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -100.45 153.01 19.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.023 0.439 . . . . 0.0 111.239 -179.44 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.2 133.05 45.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.971 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 214' ' ' CYS . . . . . 0.471 ' HB3' HG21 ' A' ' 208' ' ' VAL . 1.8 t -135.73 146.08 47.31 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.976 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -89.66 112.27 3.99 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.868 179.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.548 HD12 ' CD1' ' A' ' 218' ' ' ILE . 0.4 OUTLIER -139.95 131.67 27.37 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-O 120.937 0.398 . . . . 0.0 111.012 -179.909 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 217' ' ' THR . . . . . 0.42 ' C ' HD12 ' A' ' 218' ' ' ILE . 0.0 OUTLIER -68.72 142.96 54.85 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.267 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 218' ' ' ILE . . . . . 0.664 HG23 HG21 ' A' ' 181' ' ' VAL . 1.7 mp -108.81 87.42 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 -178.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 219' ' ' LYS . . . . . 0.429 ' HB2' ' O ' ' A' ' 194' ' ' GLU . 2.7 tttt 45.3 -143.47 0.22 Allowed 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.519 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -88.44 63.69 7.18 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-O 120.732 0.301 . . . . 0.0 111.317 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.687 ' CZ ' HD13 ' A' ' 183' ' ' LEU . 0.1 OUTLIER -54.91 119.04 4.82 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 178.705 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -82.75 -45.44 14.4 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.651 176.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 223' ' ' ASP . . . . . 0.619 ' OD2' HG12 ' A' ' 190' ' ' VAL . 0.0 OUTLIER -88.16 146.33 25.45 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.031 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.64 HD13 ' N ' ' A' ' 224' ' ' ILE . 0.2 OUTLIER -141.46 -179.18 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.146 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -178.527 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.409 ' O ' ' C ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER 54.87 111.1 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 114.184 -1.371 . . . . 0.0 110.376 -179.127 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 226' ' ' GLU . . . . . 0.535 ' H ' ' HA ' ' A' ' 155' ' ' GLN . 21.9 tt0 14.81 56.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 124.685 1.24 . . . . 0.0 112.504 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -67.45 -56.63 11.06 Favored Glycine 0 N--CA 1.422 -2.262 0 CA-C-N 114.224 -1.353 . . . . 0.0 113.323 -178.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.816 ' CB ' HG21 ' A' ' 190' ' ' VAL . 4.3 m-20 -161.25 -164.12 1.11 Allowed 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 115.124 1.527 . . . . 0.0 115.124 -177.659 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 229' ' ' VAL . . . . . 0.835 HG22 ' CG ' ' A' ' 152' ' ' GLU . 63.9 t -88.07 140.87 15.12 Favored 'Isoleucine or valine' 0 C--N 1.346 0.429 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.461 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 230' ' ' ILE . . . . . 0.412 HG13 ' HG ' ' A' ' 183' ' ' LEU . 2.7 mp -112.92 154.55 14.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.958 0.408 . . . . 0.0 111.372 -178.721 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 231' ' ' GLU . . . . . 0.445 ' HA ' ' HA ' ' A' ' 150' ' ' GLN . 5.0 tt0 -144.5 109.5 5.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.328 0.585 . . . . 0.0 111.684 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.476 ' HB3' ' O ' ' A' ' 149' ' ' GLY . . . -87.01 128.5 35.08 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.965 179.436 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 233' ' ' TYR . . . . . 0.423 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 8.8 p90 -131.63 141.22 49.58 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.551 -179.25 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.475 HG12 HG13 ' A' ' 148' ' ' ILE . 4.4 p -175.97 137.76 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.29 67.31 1.56 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 236' ' ' GLN . . . . . 0.4 ' HG2' ' CG1' ' A' ' 234' ' ' VAL . 2.1 pt20 -142.79 -146.99 0.2 Allowed 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.741 -178.178 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -135.09 74.71 1.53 Allowed 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.507 ' O ' ' HB3' ' A' ' 239' ' ' ALA . 1.2 t -82.45 161.19 3.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.796 -178.348 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 239' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 238' ' ' VAL . . . 81.22 -56.66 0.28 Allowed 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.944 -179.317 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.82 -7.87 53.35 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.312 -1.022 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.153 179.951 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 120.881 0.372 . . . . 0.0 111.22 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -140.22 127.22 20.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.88 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -93.84 40.49 1.08 Allowed 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.592 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -127.55 -169.91 2.13 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.479 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.541 HG11 ' HB2' ' A' ' 150' ' ' GLN . 15.7 t -55.38 144.77 6.26 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.526 0 CA-C-O 121.441 0.638 . . . . 0.0 111.483 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.66 HD13 ' OG ' ' A' ' 179' ' ' SER . 2.7 pp -124.63 -6.64 6.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.04 178.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.558 ' O ' HD11 ' A' ' 175' ' ' ILE . . . -179.32 76.99 0.06 OUTLIER Glycine 0 C--N 1.343 0.964 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.043 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.541 ' HB2' HG11 ' A' ' 147' ' ' VAL . 0.1 OUTLIER -89.9 135.21 33.77 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 179.715 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.506 ' HB1' ' HB2' ' A' ' 168' ' ' CYS . . . -151.35 167.68 27.16 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 120.102 -0.639 . . . . 0.0 112.522 -178.761 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.705 ' HG2' HG22 ' A' ' 229' ' ' VAL . 20.5 mt-10 -120.42 124.51 45.65 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.407 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.502 ' HB ' ' O ' ' A' ' 228' ' ' ASP . 3.1 p -51.17 132.63 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -178.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -89.44 -60.16 2.02 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 104.416 -2.439 . . . . 0.0 104.416 175.138 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.508 ' HA ' ' H ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER -161.45 -163.71 1.03 Allowed 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 113.025 -1.898 . . . . 0.0 108.613 174.786 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.564 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 1.5 p -151.91 143.02 23.21 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 176.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.655 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 5.7 m-30 -91.04 75.37 6.29 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.043 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.66 63.72 8.12 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.967 0.889 . . . . 0.0 108.847 178.752 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.475 HG12 ' H ' ' A' ' 161' ' ' LYS . 49.2 t -89.25 154.85 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-N 113.944 -1.48 . . . . 0.0 109.707 -179.39 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 47.4 t -89.74 33.49 0.85 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.074 0.464 . . . . 0.0 110.406 178.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.475 ' H ' HG12 ' A' ' 159' ' ' VAL . 0.3 OUTLIER -150.93 -29.3 0.2 Allowed 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.597 -179.875 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.474 HG12 ' N ' ' A' ' 163' ' ' GLY . 97.7 t -103.52 -101.53 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 O-C-N 122.132 -0.355 . . . . 0.0 110.15 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' GLY . . . . . 0.474 ' N ' HG12 ' A' ' 162' ' ' VAL . . . -158.51 -110.34 0.29 Allowed Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 111.543 -0.623 . . . . 0.0 111.543 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.595 HG21 HG21 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -155.15 58.96 0.65 Allowed 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 178.253 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.655 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 0.3 OUTLIER -38.7 -22.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.219 -0.54 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 -177.243 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.564 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . 31.02 98.36 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 178.163 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -87.59 150.76 22.72 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 178.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.563 ' SG ' HD11 ' A' ' 216' ' ' LEU . 0.0 OUTLIER -145.07 136.48 25.18 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 117.353 0.577 . . . . 0.0 110.725 -178.482 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 169' ' ' TYR . . . . . 0.445 ' O ' ' HA ' ' A' ' 151' ' ' ALA . 71.9 t80 -87.74 131.05 34.63 Favored 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 106.965 -1.495 . . . . 0.0 106.965 177.668 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.533 HG12 ' N ' ' A' ' 212' ' ' TYR . 4.7 p -86.25 144.84 8.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -176.497 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.4 p -138.53 11.91 2.74 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.416 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -151.48 -147.51 0.23 Allowed 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 119.52 -0.276 . . . . 0.0 110.263 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -39.53 -104.56 0.01 OUTLIER Glycine 0 CA--C 1.531 1.047 0 N-CA-C 115.188 0.835 . . . . 0.0 115.188 -178.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.456 ' HB3' ' HB2' ' A' ' 209' ' ' ALA . 0.0 OUTLIER -150.75 143.89 24.78 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.092 0.472 . . . . 0.0 111.88 -178.716 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.684 HG22 HD11 ' A' ' 198' ' ' LEU . 7.4 mm -99.68 87.15 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 N-CA-C 108.498 -0.926 . . . . 0.0 108.498 176.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.517 ' HB ' ' O ' ' A' ' 206' ' ' ARG . 0.2 OUTLIER -100.93 172.82 6.8 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.517 0.675 . . . . 0.0 112.106 -178.061 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -69.2 -43.02 74.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.711 -1.131 . . . . 0.0 111.067 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' ASP . . . . . 0.482 ' O ' HG11 ' A' ' 238' ' ' VAL . 61.4 t0 -88.56 58.59 4.74 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.17 -179.243 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.66 ' OG ' HD13 ' A' ' 148' ' ' ILE . 1.1 m -149.08 162.69 39.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.797 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.531 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 26.4 mttp -89.0 -170.81 3.04 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.412 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.545 HG22 ' CA ' ' A' ' 194' ' ' GLU . 2.4 m -150.23 160.79 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.539 0 CA-C-O 121.398 0.618 . . . . 0.0 111.711 179.346 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' ARG . . . . . 0.458 ' N ' ' O ' ' A' ' 231' ' ' GLU . 43.3 ttm180 -153.58 98.75 2.26 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.136 -0.938 . . . . 0.0 113.215 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.559 HD13 ' CZ ' ' A' ' 221' ' ' PHE . 0.2 OUTLIER -86.68 148.33 25.5 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-O 121.745 0.783 . . . . 0.0 112.22 179.721 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.743 ' N ' HG23 ' A' ' 190' ' ' VAL . 22.2 mt -157.87 130.14 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 114.311 -1.313 . . . . 0.0 111.485 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -88.52 -151.94 0.21 Allowed 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 177.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -94.71 29.84 2.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 118.354 0.525 . . . . 0.0 110.533 179.05 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -154.04 -45.94 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.668 -0.777 . . . . 0.0 113.182 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.682 ' O ' HG23 ' A' ' 184' ' ' ILE . 0.4 OUTLIER -150.11 -160.56 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -178.106 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.721 HG11 ' CG ' ' A' ' 192' ' ' GLU . 96.1 t -87.09 135.76 24.51 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 CA-C-O 121.684 0.754 . . . . 0.0 110.845 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.873 HG21 ' HB2' ' A' ' 228' ' ' ASP . 0.0 OUTLIER -97.67 -35.44 5.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 114.562 -1.199 . . . . 0.0 108.959 179.343 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 191' ' ' TYR . . . . . 0.485 ' HB3' ' CD1' ' A' ' 183' ' ' LEU . 5.0 t80 -157.51 156.13 31.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.569 179.115 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 192' ' ' GLU . . . . . 0.721 ' CG ' HG11 ' A' ' 189' ' ' VAL . 23.8 mt-10 -151.0 155.39 38.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.218 178.5 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 134.85 -113.15 1.1 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.573 -0.823 . . . . 0.0 112.363 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 0.545 ' CA ' HG22 ' A' ' 181' ' ' VAL . 0.0 OUTLIER -150.77 -176.16 5.4 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-O 121.303 0.573 . . . . 0.0 111.161 -179.051 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.725 HD11 HD12 ' A' ' 216' ' ' LEU . 0.3 OUTLIER -99.13 155.07 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.178 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.495 -179.074 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -89.42 -67.64 0.83 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.26 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 1.3 m -150.91 154.45 37.19 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.949 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.756 HD13 ' HB3' ' A' ' 216' ' ' LEU . 3.5 mm? -107.46 117.8 35.05 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.962 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 199' ' ' LYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 18.1 ttmt -138.13 115.14 10.85 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.812 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 7.6 ttm180 -88.83 -158.7 0.51 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.846 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -87.11 -6.75 58.56 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 121.227 -0.189 . . . . 0.0 111.35 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -105.54 -59.71 1.73 Allowed 'General case' 0 N--CA 1.442 -0.87 0 CA-C-O 120.708 0.29 . . . . 0.0 111.154 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -151.82 -163.39 1.73 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.72 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 204' ' ' ASP . . . . . 0.401 ' HA ' ' HA ' ' A' ' 199' ' ' LYS . 16.4 t70 -89.06 75.4 7.94 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 120.931 0.396 . . . . 0.0 110.279 179.428 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 32.7 m -59.28 159.86 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.934 0 CA-C-O 121.603 0.716 . . . . 0.0 112.317 -179.157 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 206' ' ' ARG . . . . . 0.517 ' O ' ' HB ' ' A' ' 176' ' ' THR . 7.6 ttm-85 -89.44 -36.51 15.4 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 114.651 -1.159 . . . . 0.0 111.795 -178.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -141.31 179.42 6.78 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.221 0.534 . . . . 0.0 111.682 -179.579 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.496 ' O ' HG21 ' A' ' 170' ' ' VAL . 0.6 OUTLIER -151.12 70.95 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.729 178.661 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.456 ' HB2' ' HB3' ' A' ' 174' ' ' LYS . . . -97.46 178.47 5.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.138 -178.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 81.97 -75.45 0.03 OUTLIER 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.538 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 178.41 38.12 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.401 -0.904 . . . . 0.0 112.286 179.008 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 212' ' ' TYR . . . . . 0.533 ' N ' HG12 ' A' ' 170' ' ' VAL . 0.2 OUTLIER -107.43 150.09 27.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.159 0.504 . . . . 0.0 112.025 -179.118 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -96.57 152.78 18.31 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.076 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 214' ' ' CYS . . . . . 0.472 ' HB3' HG21 ' A' ' 208' ' ' VAL . 18.5 t -150.64 154.34 37.31 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.004 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -89.53 110.24 3.7 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.116 179.122 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.756 ' HB3' HD13 ' A' ' 198' ' ' LEU . 0.2 OUTLIER -134.44 131.36 38.04 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 121.298 0.571 . . . . 0.0 111.59 -179.026 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 217' ' ' THR . . . . . 0.402 ' O ' HD13 ' A' ' 195' ' ' ILE . 0.2 OUTLIER -84.35 130.38 34.8 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.93 179.872 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 218' ' ' ILE . . . . . 0.593 HG22 ' O ' ' A' ' 218' ' ' ILE . 1.5 mp -90.84 79.27 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 34.75 -85.99 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.998 0 O-C-N 124.134 0.896 . . . . 0.0 112.835 -178.664 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 220' ' ' ASN . . . . . 0.439 ' N ' ' O ' ' A' ' 218' ' ' ILE . 5.9 p30 -129.73 65.67 1.48 Allowed 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.589 -179.427 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.559 ' CZ ' HD13 ' A' ' 183' ' ' LEU . 0.1 OUTLIER -58.58 119.38 6.94 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 177.883 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -77.91 -44.51 26.79 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 176.312 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 223' ' ' ASP . . . . . 0.829 ' OD2' HG12 ' A' ' 190' ' ' VAL . 0.0 OUTLIER -92.74 143.19 26.55 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.236 177.713 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.638 HD13 ' N ' ' A' ' 224' ' ' ILE . 0.2 OUTLIER -140.48 -179.4 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -178.706 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.414 ' O ' ' C ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER 55.26 110.56 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 114.319 -1.31 . . . . 0.0 110.067 -178.881 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 226' ' ' GLU . . . . . 0.508 ' H ' ' HA ' ' A' ' 155' ' ' GLN . 18.2 tt0 10.95 60.5 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 124.747 1.28 . . . . 0.0 112.948 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -71.59 -58.13 5.58 Favored Glycine 0 N--CA 1.421 -2.348 0 CA-C-N 114.115 -1.402 . . . . 0.0 113.144 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.873 ' HB2' HG21 ' A' ' 190' ' ' VAL . 25.8 m-20 -158.48 -160.62 0.9 Allowed 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -178.019 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 229' ' ' VAL . . . . . 0.705 HG22 ' HG2' ' A' ' 152' ' ' GLU . 42.9 t -88.65 152.98 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 CA-C-O 120.769 0.318 . . . . 0.0 110.15 178.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 230' ' ' ILE . . . . . 0.424 HD13 ' HB3' ' A' ' 168' ' ' CYS . 3.0 mp -120.92 153.93 24.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.753 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 231' ' ' GLU . . . . . 0.458 ' O ' ' N ' ' A' ' 182' ' ' ARG . 20.1 tt0 -147.12 111.58 5.23 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 119.839 -0.744 . . . . 0.0 112.676 -179.385 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.555 ' HB1' HD11 ' A' ' 148' ' ' ILE . . . -87.17 135.58 33.24 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.17 178.677 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 233' ' ' TYR . . . . . 0.63 ' O ' HG23 ' A' ' 234' ' ' VAL . 3.5 p90 -137.64 156.75 47.7 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.062 -178.45 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 233' ' ' TYR . 0.9 OUTLIER 171.55 149.68 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-O 121.15 0.5 . . . . 0.0 110.743 179.23 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.15 45.74 1.15 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.557 178.683 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 236' ' ' GLN . . . . . 0.43 ' H ' HG12 ' A' ' 234' ' ' VAL . 0.2 OUTLIER -133.15 -154.1 0.59 Allowed 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.216 -0.447 . . . . 0.0 112.158 -177.929 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -142.7 75.43 1.49 Allowed 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.508 ' O ' ' HB2' ' A' ' 239' ' ' ALA . 2.4 t -83.08 142.18 13.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 114.67 -1.15 . . . . 0.0 112.422 -176.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 239' ' ' ALA . . . . . 0.508 ' HB2' ' O ' ' A' ' 238' ' ' VAL . . . 152.74 -51.28 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 114.443 -1.253 . . . . 0.0 110.292 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.84 -7.51 54.13 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.312 -1.047 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.042 -179.977 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.847 0.356 . . . . 0.0 111.234 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -129.53 -167.64 1.83 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.856 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -93.48 42.21 1.09 Allowed 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.456 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 4.5 ptpt -61.6 -171.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.767 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.481 HG11 ' HB2' ' A' ' 150' ' ' GLN . 12.1 t -58.58 139.99 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.611 0 CA-C-O 121.297 0.57 . . . . 0.0 111.506 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.557 HD11 ' HB3' ' A' ' 179' ' ' SER . 2.7 pp -127.06 -1.82 4.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.35 178.654 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.512 ' O ' ' HB3' ' A' ' 232' ' ' ALA . . . 178.08 75.34 0.06 OUTLIER Glycine 0 C--N 1.342 0.897 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.912 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.481 ' HB2' HG11 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -89.97 136.41 33.06 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 122.721 -0.282 . . . . 0.0 110.336 -179.969 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.503 ' O ' HG13 ' A' ' 229' ' ' VAL . . . -151.17 179.59 8.16 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-O 121.63 0.729 . . . . 0.0 112.871 -178.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.904 ' HG2' HG22 ' A' ' 229' ' ' VAL . 1.3 tt0 -126.96 120.37 28.94 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.814 -1.084 . . . . 0.0 110.445 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.464 HG12 ' O ' ' A' ' 228' ' ' ASP . 2.2 p -48.13 137.97 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -179.37 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.483 ' O ' ' HB3' ' A' ' 226' ' ' GLU . 3.2 mmp_? -97.44 -61.03 1.45 Allowed 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 105.963 -1.865 . . . . 0.0 105.963 176.093 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.75 -160.53 0.46 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 113.739 -1.573 . . . . 0.0 109.157 175.505 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.49 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 5.9 p -150.92 149.0 29.11 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 177.275 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.601 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 5.6 m-30 -92.6 72.1 5.03 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -178.465 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 15.6 tttt -85.95 62.21 7.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 122.002 0.906 . . . . 0.0 109.071 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 55.2 t -89.64 155.78 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 CA-C-N 113.919 -1.492 . . . . 0.0 109.535 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 9.0 m -89.72 22.41 3.09 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.049 178.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.71 5.66 0.52 Allowed 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.188 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 57.8 t -129.98 -99.17 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 CA-C-N 118.483 0.583 . . . . 0.0 110.14 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -158.02 -113.51 0.38 Allowed Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.415 ' CG2' ' CG2' ' A' ' 224' ' ' ILE . 0.0 OUTLIER -153.98 32.9 0.44 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.462 -0.869 . . . . 0.0 109.098 178.157 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.601 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 1.9 mm -40.27 93.78 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.715 -179.477 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.49 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . -88.25 118.45 27.85 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 114.729 -1.123 . . . . 0.0 111.967 -179.203 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -89.59 151.21 21.69 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.49 179.198 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -147.58 133.45 19.08 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -179.349 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' TYR . . . . . 0.451 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 11.1 t80 -86.8 131.28 34.17 Favored 'General case' 0 C--O 1.219 -0.512 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 178.279 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.508 HG12 ' N ' ' A' ' 212' ' ' TYR . 5.7 p -85.64 147.01 5.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -175.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.1 p -141.87 13.12 2.07 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.04 -0.982 . . . . 0.0 112.359 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.412 ' CB ' ' HB2' ' A' ' 150' ' ' GLN . 10.4 t0 -151.27 -145.87 0.18 Allowed 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -38.96 -103.53 0.01 OUTLIER Glycine 0 CA--C 1.531 1.05 0 N-CA-C 115.275 0.87 . . . . 0.0 115.275 -178.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.565 ' HG2' ' HB2' ' A' ' 209' ' ' ALA . 21.9 mttm -150.47 134.94 17.25 Favored 'General case' 0 CA--C 1.515 -0.402 0 O-C-N 122.591 -0.358 . . . . 0.0 111.871 -178.62 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.557 ' O ' HG22 ' A' ' 175' ' ' ILE . 3.5 mm -93.37 86.89 2.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 176.62 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.723 HG22 ' HB3' ' A' ' 207' ' ' GLU . 0.1 OUTLIER -100.79 172.24 7.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.523 -177.265 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -69.25 -42.1 76.05 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.347 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -88.75 56.32 3.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.415 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.557 ' HB3' HD11 ' A' ' 148' ' ' ILE . 29.7 m -145.97 157.34 43.88 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.428 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 0.0 OUTLIER -89.25 -172.93 3.83 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.44 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.504 HG22 ' HA ' ' A' ' 194' ' ' GLU . 0.6 OUTLIER -150.1 156.76 6.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.385 0.612 . . . . 0.0 111.473 179.512 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 182' ' ' ARG . . . . . 0.425 ' N ' ' O ' ' A' ' 231' ' ' GLU . 60.2 ttt180 -152.03 101.83 2.76 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.113 -0.948 . . . . 0.0 112.581 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.724 HD12 ' HB3' ' A' ' 191' ' ' TYR . 0.3 OUTLIER -86.16 157.41 20.01 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-O 121.862 0.839 . . . . 0.0 112.918 -179.669 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.614 HD12 ' C ' ' A' ' 183' ' ' LEU . 3.1 mp -151.01 121.36 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 113.885 -1.507 . . . . 0.0 111.935 177.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.418 ' HB2' HG22 ' A' ' 190' ' ' VAL . 0.0 OUTLIER -85.45 -151.76 0.15 Allowed 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 177.504 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -93.97 28.57 2.38 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 118.539 0.608 . . . . 0.0 110.829 178.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -154.62 -76.96 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.619 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.452 ' H ' HD12 ' A' ' 188' ' ' ILE . 0.1 OUTLIER -116.47 -156.54 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 115.34 -0.43 . . . . 0.0 110.718 -179.039 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.749 HG11 ' CG ' ' A' ' 192' ' ' GLU . 46.3 t -87.37 133.96 28.9 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.101 0 CA-C-O 121.518 0.675 . . . . 0.0 111.771 -179.235 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.907 HG12 ' OD2' ' A' ' 223' ' ' ASP . 0.2 OUTLIER -89.61 -34.21 6.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 114.778 -1.101 . . . . 0.0 108.884 178.503 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 191' ' ' TYR . . . . . 0.724 ' HB3' HD12 ' A' ' 183' ' ' LEU . 41.5 t80 -157.6 155.87 30.88 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 178.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 192' ' ' GLU . . . . . 0.749 ' CG ' HG11 ' A' ' 189' ' ' VAL . 14.4 mt-10 -150.14 148.83 29.43 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.287 177.342 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 133.05 -127.75 4.85 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.068 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 0.504 ' HA ' HG22 ' A' ' 181' ' ' VAL . 4.5 pt-20 -145.38 -178.88 6.3 Favored 'General case' 0 CA--C 1.499 -0.986 0 CA-C-O 121.662 0.744 . . . . 0.0 112.631 -178.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.778 HG12 HD13 ' A' ' 216' ' ' LEU . 4.7 mp -89.67 153.42 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.115 -179.299 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -93.95 -52.19 4.53 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.231 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 4.6 m -151.38 144.92 24.91 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.858 178.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.793 HD12 HD22 ' A' ' 216' ' ' LEU . 2.8 tt -120.49 118.01 29.14 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.427 0.632 . . . . 0.0 111.647 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 199' ' ' LYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 10.7 tttm -148.83 122.52 9.23 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.672 179.31 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 8.4 ttp85 -87.81 -160.38 0.61 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.314 -179.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -86.89 -15.1 40.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.522 0.201 . . . . 0.0 110.902 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -93.56 -58.73 2.19 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-O 120.633 0.254 . . . . 0.0 110.698 179.276 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -152.83 -170.54 3.66 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 120.863 0.363 . . . . 0.0 111.164 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 204' ' ' ASP . . . . . 0.406 ' HA ' ' HA ' ' A' ' 199' ' ' LYS . 4.9 p-10 -90.0 63.35 5.91 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.107 179.24 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.6 HG23 ' CD2' ' A' ' 198' ' ' LEU . 28.3 m -56.29 156.94 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.931 0 CA-C-O 121.515 0.674 . . . . 0.0 112.23 -179.107 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 206' ' ' ARG . . . . . 0.469 ' O ' ' HB ' ' A' ' 176' ' ' THR . 0.1 OUTLIER -89.51 -34.07 16.54 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.899 -178.447 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.79 ' OE2' ' HB2' ' A' ' 239' ' ' ALA . 3.0 mt-10 -141.26 175.75 9.39 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.03 0.443 . . . . 0.0 111.161 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.803 HG12 ' HB3' ' A' ' 212' ' ' TYR . 0.1 OUTLIER -150.8 83.25 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.782 178.761 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.565 ' HB2' ' HG2' ' A' ' 174' ' ' LYS . . . -101.85 174.05 6.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.787 -179.187 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 80.63 -68.76 0.1 Allowed 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.725 -179.503 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 178.95 36.75 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.49 179.132 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 212' ' ' TYR . . . . . 0.803 ' HB3' HG12 ' A' ' 208' ' ' VAL . 2.7 m-85 -100.27 135.01 42.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.022 0.439 . . . . 0.0 111.747 -179.167 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 213' ' ' GLU . . . . . 0.407 ' HG2' ' HA ' ' A' ' 169' ' ' TYR . 6.7 mt-10 -89.73 152.25 21.42 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.22 179.538 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 214' ' ' CYS . . . . . 0.401 ' HB2' HG21 ' A' ' 208' ' ' VAL . 0.7 OUTLIER -150.57 139.89 21.33 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.095 179.967 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -89.08 115.92 4.57 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.662 -0.78 . . . . 0.0 111.733 179.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.793 HD22 HD12 ' A' ' 198' ' ' LEU . 0.4 OUTLIER -135.47 141.6 45.38 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 121.119 0.485 . . . . 0.0 111.609 -179.28 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 217' ' ' THR . . . . . 0.403 ' N ' HD13 ' A' ' 165' ' ' ILE . 1.4 m -89.17 133.1 34.54 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.374 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 218' ' ' ILE . . . . . 0.621 ' CD1' HD12 ' A' ' 216' ' ' LEU . 1.6 mp -86.16 134.4 27.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 -179.386 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 219' ' ' LYS . . . . . 0.416 ' HG2' ' O ' ' A' ' 194' ' ' GLU . 5.5 ptmt -39.24 -31.75 0.09 Allowed 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 114.406 1.262 . . . . 0.0 114.406 -177.05 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -153.08 40.38 0.54 Allowed 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 -178.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.689 ' CZ ' HD13 ' A' ' 183' ' ' LEU . 0.1 OUTLIER -59.16 115.98 3.55 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 178.626 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -83.67 -42.56 16.51 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.12 -0.946 . . . . 0.0 108.481 176.324 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 223' ' ' ASP . . . . . 0.907 ' OD2' HG12 ' A' ' 190' ' ' VAL . 0.0 OUTLIER -90.53 141.95 28.24 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.893 178.201 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.451 ' C ' HD12 ' A' ' 224' ' ' ILE . 2.5 pp -122.49 -177.97 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.36 0.6 . . . . 0.0 112.423 -179.373 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.461 ' O ' ' N ' ' A' ' 227' ' ' GLY . 11.4 mtpt 59.37 172.76 0.08 Allowed 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.289 -177.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 226' ' ' GLU . . . . . 0.483 ' HB3' ' O ' ' A' ' 154' ' ' ARG . 0.3 OUTLIER -58.61 84.09 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.036 0.446 . . . . 0.0 110.831 179.683 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 227' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 225' ' ' LYS . . . -71.65 -61.54 3.79 Favored Glycine 0 N--CA 1.427 -1.911 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 178.475 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.464 ' O ' HG12 ' A' ' 153' ' ' VAL . 0.9 OUTLIER -164.6 -148.3 0.11 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 178.669 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 229' ' ' VAL . . . . . 0.904 HG22 ' HG2' ' A' ' 152' ' ' GLU . 59.4 t -89.48 145.33 7.53 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 O-C-N 122.331 -0.231 . . . . 0.0 110.606 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 230' ' ' ILE . . . . . 0.415 HG13 ' CD2' ' A' ' 183' ' ' LEU . 2.9 mt -116.16 153.07 17.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.205 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 231' ' ' GLU . . . . . 0.479 ' HA ' ' HA ' ' A' ' 150' ' ' GLN . 23.9 tt0 -142.1 111.73 6.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.33 0.586 . . . . 0.0 112.369 -179.431 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' A' ' 149' ' ' GLY . . . -88.89 127.92 35.65 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.942 179.108 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -128.36 144.44 51.13 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.945 -179.011 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.617 HG13 ' N ' ' A' ' 235' ' ' MET . 0.3 OUTLIER -178.95 -166.99 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.881 -179.891 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 235' ' ' MET . . . . . 0.617 ' N ' HG13 ' A' ' 234' ' ' VAL . 0.0 OUTLIER -99.58 -164.23 1.11 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.141 179.304 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 -89.72 75.27 7.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.152 0.501 . . . . 0.0 110.694 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -150.64 39.23 0.71 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.099 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.431 ' O ' ' HB3' ' A' ' 239' ' ' ALA . 0.3 OUTLIER -108.1 167.69 3.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.102 179.744 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 239' ' ' ALA . . . . . 0.79 ' HB2' ' OE2' ' A' ' 207' ' ' GLU . . . 70.91 -63.34 0.42 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.104 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -89.4 -4.26 58.1 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.313 -1.003 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.061 179.971 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 120.819 0.342 . . . . 0.0 111.13 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 60.34 99.6 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.903 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -94.95 38.86 1.11 Allowed 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.452 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 12.2 mttp -94.6 -83.5 0.34 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.417 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.782 ' O ' HD13 ' A' ' 148' ' ' ILE . 6.4 t -115.85 137.59 49.01 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.79 0 CA-C-O 121.356 0.598 . . . . 0.0 110.804 179.128 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.782 HD13 ' O ' ' A' ' 147' ' ' VAL . 31.0 mm -129.45 -3.93 3.01 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.693 178.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.522 ' O ' ' HB3' ' A' ' 232' ' ' ALA . . . -171.97 70.77 0.11 Allowed Glycine 0 C--N 1.341 0.806 0 N-CA-C 111.344 -0.703 . . . . 0.0 111.344 179.158 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.643 ' HB2' HG11 ' A' ' 147' ' ' VAL . 0.8 OUTLIER -91.31 136.25 33.23 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-O 120.734 0.302 . . . . 0.0 110.639 -179.643 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.428 ' HB1' ' HB2' ' A' ' 168' ' ' CYS . . . -151.76 175.79 12.06 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 121.537 0.684 . . . . 0.0 112.761 -178.293 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.761 ' HG2' HG22 ' A' ' 229' ' ' VAL . 31.3 mt-10 -126.15 121.64 33.4 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.5 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.474 HG11 ' N ' ' A' ' 227' ' ' GLY . 1.6 p -47.31 144.42 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 121.37 0.605 . . . . 0.0 112.595 -179.108 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.482 ' O ' ' HB3' ' A' ' 226' ' ' GLU . 3.8 mmp_? -109.86 -57.32 2.2 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 176.72 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.55 -162.88 0.61 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 113.755 -1.566 . . . . 0.0 109.776 175.34 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 8.0 p -150.79 163.88 37.55 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 177.598 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.547 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 0.2 OUTLIER -116.05 80.08 1.4 Allowed 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -179.033 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 6.5 tttt -86.53 62.77 7.61 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.434 HG12 ' N ' ' A' ' 161' ' ' LYS . 71.7 t -92.9 157.32 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 CA-C-N 113.659 -1.61 . . . . 0.0 110.528 -178.49 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 28.9 t -92.33 35.89 1.0 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 177.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.434 ' N ' HG12 ' A' ' 159' ' ' VAL . 0.0 OUTLIER -151.37 -35.22 0.14 Allowed 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.092 -179.592 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.766 HG11 HD12 ' A' ' 165' ' ' ILE . 88.7 t -98.96 -103.7 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.748 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' GLY . . . . . 0.524 ' N ' HG12 ' A' ' 162' ' ' VAL . . . -159.51 -99.99 0.16 Allowed Glycine 0 N--CA 1.452 -0.271 0 N-CA-C 111.194 -0.763 . . . . 0.0 111.194 178.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.477 HG22 HG22 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -153.72 33.83 0.45 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 113.958 -1.121 . . . . 0.0 108.278 177.732 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.766 HD12 HG11 ' A' ' 162' ' ' VAL . 3.6 mt -41.98 95.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.461 0.086 0 CA-C-N 115.155 -0.929 . . . . 0.0 111.664 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.532 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . -87.12 125.23 34.01 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.735 -1.12 . . . . 0.0 112.27 -179.444 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -88.99 144.39 18.02 Favored Glycine 0 N--CA 1.442 -0.951 0 N-CA-C 110.534 -1.027 . . . . 0.0 110.534 178.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.428 ' HB2' ' HB1' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -145.69 132.36 19.93 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 117.204 0.502 . . . . 0.0 110.271 -178.884 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 169' ' ' TYR . . . . . 0.421 ' O ' ' HA ' ' A' ' 151' ' ' ALA . 5.6 t80 -87.3 127.37 35.18 Favored 'General case' 0 C--O 1.222 -0.39 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 177.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.833 HG21 ' O ' ' A' ' 208' ' ' VAL . 44.3 t -85.44 142.16 13.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 -176.524 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.4 p -135.38 12.61 3.51 Favored 'General case' 0 C--O 1.231 0.084 0 CA-C-N 114.833 -1.076 . . . . 0.0 112.3 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.417 ' CB ' ' HB2' ' A' ' 150' ' ' GLN . 4.8 t70 -146.87 -144.01 0.15 Allowed 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -179.377 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -45.2 -107.03 0.01 OUTLIER Glycine 0 CA--C 1.532 1.149 0 N-CA-C 114.792 0.677 . . . . 0.0 114.792 -178.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.553 ' HB3' ' HB2' ' A' ' 209' ' ' ALA . 0.0 OUTLIER -150.76 135.0 16.94 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 122.562 -0.375 . . . . 0.0 111.039 -178.943 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.59 ' CG2' HG23 ' A' ' 208' ' ' VAL . 0.5 OUTLIER -92.31 111.45 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 176.47 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.504 ' HB ' ' O ' ' A' ' 206' ' ' ARG . 0.1 OUTLIER -118.54 169.47 9.76 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.458 0.647 . . . . 0.0 112.481 -176.327 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.491 ' HA ' HG21 ' A' ' 195' ' ' ILE . 0.5 OUTLIER -61.13 -40.86 95.41 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.478 179.667 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -95.91 63.64 2.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.251 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.457 ' OG ' HG11 ' A' ' 238' ' ' VAL . 4.8 m -148.8 161.43 41.82 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.92 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 0.0 OUTLIER -88.93 -175.29 4.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.722 179.493 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.549 HG21 HG23 ' A' ' 218' ' ' ILE . 1.6 m -147.93 156.09 9.58 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.478 0 CA-C-O 121.247 0.546 . . . . 0.0 111.731 179.49 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 182' ' ' ARG . . . . . 0.445 ' N ' ' O ' ' A' ' 231' ' ' GLU . 17.9 ttt180 -152.96 100.67 2.52 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.313 -0.858 . . . . 0.0 113.305 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.656 HD13 ' CZ ' ' A' ' 221' ' ' PHE . 0.3 OUTLIER -86.88 156.1 19.98 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-O 121.7 0.762 . . . . 0.0 112.839 -179.869 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.695 ' N ' HG23 ' A' ' 190' ' ' VAL . 28.9 mm -154.01 123.93 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 114.487 -1.233 . . . . 0.0 111.345 178.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.569 ' N ' HG22 ' A' ' 190' ' ' VAL . 4.6 ttp180 -85.68 -151.3 0.15 Allowed 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 177.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -93.84 25.8 3.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 118.509 0.595 . . . . 0.0 110.892 178.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -155.12 -67.57 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.498 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -121.16 -156.34 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-N 115.297 -0.452 . . . . 0.0 110.84 -178.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.807 HG11 ' CG ' ' A' ' 192' ' ' GLU . 58.3 t -87.39 136.28 23.41 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 CA-C-O 121.287 0.565 . . . . 0.0 111.632 -179.135 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.8 HG12 ' OD2' ' A' ' 223' ' ' ASP . 0.1 OUTLIER -89.57 -33.86 6.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.099 -0.955 . . . . 0.0 108.914 178.614 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 191' ' ' TYR . . . . . 0.612 ' HB3' HD12 ' A' ' 183' ' ' LEU . 16.0 t80 -162.5 157.04 21.73 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.386 -0.825 . . . . 0.0 112.273 178.787 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 192' ' ' GLU . . . . . 0.807 ' CG ' HG11 ' A' ' 189' ' ' VAL . 15.7 mt-10 -149.94 160.08 43.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.902 178.372 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 133.46 -115.4 1.52 Allowed Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.519 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 0.51 ' CA ' HG22 ' A' ' 181' ' ' VAL . 17.1 pt-20 -150.4 -174.87 4.88 Favored 'General case' 0 CA--C 1.496 -1.1 0 CA-C-O 121.247 0.546 . . . . 0.0 111.342 -178.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.812 HD13 ' O ' ' A' ' 217' ' ' THR . 0.4 OUTLIER -88.52 142.84 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.024 -178.921 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.75 -55.35 3.74 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.03 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 17.2 p -152.6 164.68 37.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.051 178.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.782 ' CD1' HD22 ' A' ' 216' ' ' LEU . 21.2 tp -135.16 110.25 8.87 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.417 0.627 . . . . 0.0 111.419 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 199' ' ' LYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 45.4 mttt -137.79 126.91 24.36 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.308 179.472 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 27.8 ttm180 -87.56 -112.66 0.06 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.274 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -88.37 -79.23 0.31 Allowed 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 117.939 0.336 . . . . 0.0 110.463 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -115.31 20.78 14.63 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 111.728 0.27 . . . . 0.0 111.728 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -151.22 153.33 34.71 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 120.969 0.414 . . . . 0.0 111.612 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 204' ' ' ASP . . . . . 0.417 ' HA ' ' HA ' ' A' ' 199' ' ' LYS . 7.1 p-10 -89.86 79.34 6.67 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.338 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 28.4 m -59.32 158.7 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -1.011 0 CA-C-O 121.554 0.692 . . . . 0.0 112.001 -179.352 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 206' ' ' ARG . . . . . 0.504 ' O ' ' HB ' ' A' ' 176' ' ' THR . 4.0 ttp180 -89.43 -38.03 14.38 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.505 -178.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -141.2 177.46 8.07 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.073 0.463 . . . . 0.0 111.418 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.833 ' O ' HG21 ' A' ' 170' ' ' VAL . 0.1 OUTLIER -151.28 79.78 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.462 178.759 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.553 ' HB2' ' HB3' ' A' ' 174' ' ' LYS . . . -104.49 173.34 6.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.065 0.459 . . . . 0.0 112.204 -178.689 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 84.22 -71.61 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.104 -179.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 178.05 37.6 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.394 179.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -104.51 140.56 37.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.983 0.421 . . . . 0.0 111.233 -179.418 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -93.26 152.75 18.99 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.28 179.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 214' ' ' CYS . . . . . 0.491 ' HB2' HG21 ' A' ' 208' ' ' VAL . 2.3 m -150.54 145.55 26.02 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.767 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -88.26 106.35 3.23 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.484 -0.865 . . . . 0.0 110.998 179.178 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.782 HD22 ' CD1' ' A' ' 198' ' ' LEU . 0.2 OUTLIER -133.53 145.34 50.04 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 120.993 0.425 . . . . 0.0 111.789 -178.055 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 217' ' ' THR . . . . . 0.812 ' O ' HD13 ' A' ' 195' ' ' ILE . 0.2 OUTLIER -86.64 140.79 29.48 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.488 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 218' ' ' ILE . . . . . 0.606 HG22 ' O ' ' A' ' 218' ' ' ILE . 1.6 mp -108.5 94.03 2.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 121.028 -0.269 . . . . 0.0 110.427 -179.158 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 6.1 tttp 42.16 -143.7 0.08 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.133 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 32.1 t30 -87.87 63.71 7.54 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 120.901 0.381 . . . . 0.0 110.9 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.656 ' CZ ' HD13 ' A' ' 183' ' ' LEU . 0.1 OUTLIER -54.98 118.01 3.93 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 114.595 1.332 . . . . 0.0 114.595 178.835 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -83.07 -43.55 16.16 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.586 176.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 223' ' ' ASP . . . . . 0.8 ' OD2' HG12 ' A' ' 190' ' ' VAL . 0.0 OUTLIER -89.73 129.97 36.06 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.023 178.264 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.54 HD12 ' HG3' ' A' ' 225' ' ' LYS . 2.0 pt -114.67 178.95 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 CA-C-O 121.191 0.519 . . . . 0.0 111.551 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.54 ' HG3' HD12 ' A' ' 224' ' ' ILE . 11.2 mtpt 62.38 155.63 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.098 -178.506 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 226' ' ' GLU . . . . . 0.482 ' HB3' ' O ' ' A' ' 154' ' ' ARG . 0.6 OUTLIER -45.08 90.35 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 121.199 0.523 . . . . 0.0 111.77 -179.461 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 227' ' ' GLY . . . . . 0.474 ' N ' HG11 ' A' ' 153' ' ' VAL . . . -83.35 -57.97 2.39 Favored Glycine 0 N--CA 1.428 -1.885 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 178.789 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.453 ' O ' HG12 ' A' ' 153' ' ' VAL . 1.0 OUTLIER -163.83 -148.89 0.13 Allowed 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 179.014 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 229' ' ' VAL . . . . . 0.761 HG22 ' HG2' ' A' ' 152' ' ' GLU . 46.1 t -90.33 149.38 4.07 Favored 'Isoleucine or valine' 0 C--N 1.341 0.218 0 CA-C-O 120.75 0.31 . . . . 0.0 110.771 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 2.7 mp -120.17 153.41 23.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.77 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 231' ' ' GLU . . . . . 0.458 ' HA ' ' HA ' ' A' ' 150' ' ' GLN . 0.0 OUTLIER -144.14 109.97 5.31 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.357 0.598 . . . . 0.0 112.559 -179.053 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.522 ' HB3' ' O ' ' A' ' 149' ' ' GLY . . . -88.65 127.46 35.57 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.598 178.638 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 233' ' ' TYR . . . . . 0.423 ' CE1' ' HB3' ' A' ' 180' ' ' LYS . 26.1 p90 -123.02 140.59 52.87 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.013 0.435 . . . . 0.0 111.403 -178.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.534 HG13 ' N ' ' A' ' 235' ' ' MET . 0.9 OUTLIER -176.14 -163.07 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.04 179.716 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 235' ' ' MET . . . . . 0.534 ' N ' HG13 ' A' ' 234' ' ' VAL . 0.0 OUTLIER -89.41 -171.12 3.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.708 0.289 . . . . 0.0 110.742 179.945 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -96.27 37.53 1.25 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.885 0.374 . . . . 0.0 111.364 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -137.67 50.33 1.95 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.047 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.724 HG21 HG21 ' A' ' 148' ' ' ILE . 0.2 OUTLIER -105.35 137.65 33.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.755 179.868 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 239' ' ' ALA . . . . . 0.52 ' HB2' ' O ' ' A' ' 238' ' ' VAL . . . 167.52 -81.03 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.738 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.98 -8.56 45.79 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.312 -1.041 0 CA-C-N 115.635 -0.712 . . . . 0.0 111.09 -179.962 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.798 0.332 . . . . 0.0 111.068 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -75.91 89.95 2.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.986 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.87 40.07 1.13 Allowed 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.24 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.55 -164.01 1.03 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.583 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.698 HG11 ' HB2' ' A' ' 150' ' ' GLN . 19.5 t -58.77 141.53 15.62 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.559 0 CA-C-O 121.394 0.616 . . . . 0.0 111.559 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.818 HD13 HG12 ' A' ' 234' ' ' VAL . 1.3 pt -123.7 -8.38 7.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.074 178.247 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.504 ' CA ' ' HB3' ' A' ' 232' ' ' ALA . . . -174.63 74.56 0.08 OUTLIER Glycine 0 C--N 1.344 0.981 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.114 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.698 ' HB2' HG11 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -89.38 136.8 32.82 Favored 'General case' 0 CA--C 1.506 -0.725 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.255 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.486 ' HB1' ' HB2' ' A' ' 168' ' ' CYS . . . -151.35 169.15 22.69 Favored 'General case' 0 N--CA 1.435 -1.176 0 C-N-CA 120.164 -0.615 . . . . 0.0 112.387 -178.03 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.742 ' HG2' HG22 ' A' ' 229' ' ' VAL . 12.9 mt-10 -119.85 124.98 47.4 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.024 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.53 ' HB ' HD11 ' A' ' 230' ' ' ILE . 4.0 p -55.9 128.15 15.79 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 CA-C-O 121.325 0.583 . . . . 0.0 111.771 -179.375 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.414 ' CA ' ' NE ' ' A' ' 154' ' ' ARG . 0.0 OUTLIER -89.99 -53.54 4.44 Favored 'General case' 0 N--CA 1.429 -1.521 0 N-CA-C 105.175 -2.158 . . . . 0.0 105.175 175.982 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.542 ' HA ' ' H ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER -162.33 -163.36 0.91 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 114.016 -1.447 . . . . 0.0 110.482 175.233 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.595 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 6.0 p -148.09 -179.57 7.02 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 177.28 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.546 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 0.2 OUTLIER -133.29 79.41 1.83 Allowed 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -179.911 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.572 ' HG3' HD13 ' A' ' 224' ' ' ILE . 5.7 tmtt? -86.34 62.25 7.31 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 177.648 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.498 HG12 ' N ' ' A' ' 161' ' ' LYS . 54.6 t -92.31 156.05 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 CA-C-N 113.633 -1.622 . . . . 0.0 110.455 -178.353 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 52.3 m -90.86 34.81 0.9 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.125 0.488 . . . . 0.0 109.797 178.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.498 ' N ' HG12 ' A' ' 159' ' ' VAL . 0.0 OUTLIER -150.51 -32.76 0.18 Allowed 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.291 -179.713 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.509 HG12 ' N ' ' A' ' 163' ' ' GLY . 89.9 t -101.53 -104.02 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.26 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' GLY . . . . . 0.509 ' N ' HG12 ' A' ' 162' ' ' VAL . . . -159.7 -98.27 0.13 Allowed Glycine 0 N--CA 1.451 -0.347 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 178.819 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.558 ' CG2' HG22 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -153.92 34.83 0.44 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 113.996 -1.102 . . . . 0.0 108.246 177.692 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.565 HG22 ' O ' ' A' ' 165' ' ' ILE . 1.8 mm -41.56 94.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.44 -179.438 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.595 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . -84.06 117.57 23.51 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 114.767 -1.106 . . . . 0.0 112.416 -179.189 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -88.29 136.95 14.08 Favored Glycine 0 N--CA 1.439 -1.109 0 N-CA-C 109.934 -1.267 . . . . 0.0 109.934 178.189 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.7 ' SG ' HD11 ' A' ' 216' ' ' LEU . 0.0 OUTLIER -138.43 132.66 31.71 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.938 0.369 . . . . 0.0 110.838 -178.023 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 169' ' ' TYR . . . . . 0.408 ' O ' ' HA ' ' A' ' 151' ' ' ALA . 11.7 t80 -86.8 133.37 33.65 Favored 'General case' 0 C--O 1.222 -0.368 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 177.716 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.779 HG21 ' O ' ' A' ' 208' ' ' VAL . 44.2 t -85.73 143.55 11.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -176.335 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.1 p -135.28 13.57 3.53 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 114.719 -1.128 . . . . 0.0 112.041 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -150.01 -146.71 0.21 Allowed 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -179.505 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -42.12 -102.5 0.01 OUTLIER Glycine 0 CA--C 1.532 1.117 0 N-CA-C 114.777 0.671 . . . . 0.0 114.777 -179.027 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.798 ' HG2' ' HB2' ' A' ' 209' ' ' ALA . 6.3 mttt -150.75 134.61 16.65 Favored 'General case' 0 CA--C 1.514 -0.407 0 O-C-N 122.696 -0.297 . . . . 0.0 111.19 -178.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.666 HG23 ' O ' ' A' ' 175' ' ' ILE . 1.1 tp -95.18 83.51 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-O 122.195 0.997 . . . . 0.0 108.948 177.221 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.531 HG22 ' HB3' ' A' ' 207' ' ' GLU . 0.0 OUTLIER -90.97 -177.61 4.98 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.501 -1.227 . . . . 0.0 113.144 -176.565 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 46.9 mtm180 -76.58 -45.57 29.79 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 114.572 -1.194 . . . . 0.0 111.206 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -88.96 60.64 5.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.104 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.646 ' HB3' HD11 ' A' ' 148' ' ' ILE . 74.7 m -147.81 160.08 43.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.828 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 0.0 OUTLIER -88.55 178.69 6.45 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.171 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.827 HG21 HG23 ' A' ' 218' ' ' ILE . 2.9 m -146.73 149.17 16.11 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.539 0 CA-C-O 121.449 0.642 . . . . 0.0 112.165 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 182' ' ' ARG . . . . . 0.457 ' N ' ' O ' ' A' ' 231' ' ' GLU . 2.7 ttt180 -154.11 100.28 2.31 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.822 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.494 HD11 ' HB ' ' A' ' 190' ' ' VAL . 0.6 OUTLIER -99.54 165.79 11.46 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-O 121.21 0.528 . . . . 0.0 110.8 179.767 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.853 HG23 ' O ' ' A' ' 188' ' ' ILE . 42.8 mt -157.5 141.32 7.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.467 -178.272 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.514 ' O ' HG22 ' A' ' 184' ' ' ILE . 30.8 ptt180 -87.75 -157.2 0.39 Allowed 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 177.522 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -93.72 30.6 1.75 Allowed 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.004 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -153.45 -45.47 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.7 -0.762 . . . . 0.0 113.053 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.853 ' O ' HG23 ' A' ' 184' ' ' ILE . 0.2 OUTLIER -150.49 -162.95 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-O 120.945 0.402 . . . . 0.0 112.022 -178.035 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.651 ' N ' HG23 ' A' ' 188' ' ' ILE . 21.9 t -85.85 133.2 30.17 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.531 0 CA-C-O 121.505 0.669 . . . . 0.0 109.842 179.011 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.598 HG23 ' CA ' ' A' ' 184' ' ' ILE . 0.5 OUTLIER -88.38 -35.08 7.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.738 -179.187 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 191' ' ' TYR . . . . . 0.49 ' CB ' HD21 ' A' ' 183' ' ' LEU . 0.4 OUTLIER -176.94 166.5 2.48 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.544 179.735 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 192' ' ' GLU . . . . . 0.463 ' OE2' HG11 ' A' ' 189' ' ' VAL . 37.6 mt-10 -151.11 158.5 44.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.924 0.392 . . . . 0.0 111.072 179.046 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 143.95 -131.47 4.45 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.917 -0.658 . . . . 0.0 111.687 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 0.589 ' CA ' HG22 ' A' ' 181' ' ' VAL . 4.4 pt-20 -133.27 -177.6 4.6 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-O 121.237 0.541 . . . . 0.0 111.003 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.869 HD11 HD13 ' A' ' 216' ' ' LEU . 1.1 tt -88.08 149.07 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.293 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.959 -178.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.48 -60.35 1.97 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 179.029 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 9.7 t -152.02 151.1 30.72 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.532 178.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.991 HD13 HD23 ' A' ' 216' ' ' LEU . 10.9 tp -125.93 118.63 25.82 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.481 0.658 . . . . 0.0 111.644 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 199' ' ' LYS . . . . . 0.421 ' N ' HD12 ' A' ' 198' ' ' LEU . 0.5 OUTLIER -150.23 121.09 7.6 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.593 179.009 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 200' ' ' ARG . . . . . 0.432 ' NH1' ' CD1' ' A' ' 212' ' ' TYR . 3.5 ttm180 -87.77 -159.88 0.57 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.342 -179.361 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -86.75 -11.66 50.44 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.475 0.178 . . . . 0.0 111.093 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.76 -60.34 1.67 Allowed 'General case' 0 N--CA 1.44 -0.94 0 CA-C-O 120.67 0.272 . . . . 0.0 110.641 179.338 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -152.8 -170.82 3.74 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.779 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 23.9 p30 -89.61 63.07 6.11 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.188 0.518 . . . . 0.0 109.817 179.075 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 33.1 m -55.45 160.8 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.925 0 CA-C-O 121.595 0.712 . . . . 0.0 112.549 -178.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 206' ' ' ARG . . . . . 0.447 ' O ' ' HB ' ' A' ' 176' ' ' THR . 4.8 ttm180 -89.3 -37.26 15.06 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 114.642 -1.163 . . . . 0.0 111.524 -178.602 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.531 ' HB3' HG22 ' A' ' 176' ' ' THR . 1.3 mp0 -138.04 179.41 6.45 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.159 0.504 . . . . 0.0 111.512 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.779 ' O ' HG21 ' A' ' 170' ' ' VAL . 0.2 OUTLIER -150.94 78.4 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.842 179.283 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.798 ' HB2' ' HG2' ' A' ' 174' ' ' LYS . . . -97.44 170.31 9.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.052 0.453 . . . . 0.0 112.151 -178.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 85.89 -74.99 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.155 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 211' ' ' GLY . . . . . 0.403 ' O ' ' CE2' ' A' ' 169' ' ' TYR . . . 177.86 37.7 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.219 -0.991 . . . . 0.0 112.494 179.11 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 212' ' ' TYR . . . . . 0.432 ' CD1' ' NH1' ' A' ' 200' ' ' ARG . 1.6 m-85 -95.17 148.62 22.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.966 0.413 . . . . 0.0 111.414 -179.343 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -89.54 159.12 17.37 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.095 179.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 10.3 p -150.95 -177.88 6.27 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.182 0.515 . . . . 0.0 111.642 -179.136 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -136.71 105.83 0.53 Allowed Glycine 0 N--CA 1.452 -0.3 0 N-CA-C 110.086 -1.205 . . . . 0.0 110.086 178.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.991 HD23 HD13 ' A' ' 198' ' ' LEU . 0.3 OUTLIER -138.86 144.68 39.32 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -177.685 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 217' ' ' THR . . . . . 0.692 ' O ' HD13 ' A' ' 218' ' ' ILE . 0.0 OUTLIER -79.39 -179.06 6.58 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 176.661 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 218' ' ' ILE . . . . . 0.827 HG23 HG21 ' A' ' 181' ' ' VAL . 49.8 mm -141.11 81.66 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 120.024 -0.67 . . . . 0.0 112.737 -178.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 13.7 tttt 44.08 -134.95 0.57 Allowed 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 121.177 -0.209 . . . . 0.0 110.695 177.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -87.7 53.62 2.84 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.088 0.47 . . . . 0.0 110.645 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.486 ' HA ' ' CE2' ' A' ' 191' ' ' TYR . 1.2 t80 -56.96 153.52 11.07 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 117.332 2.345 . . . . 0.0 117.332 179.336 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 222' ' ' ASN . . . . . 0.454 ' HB2' ' CE1' ' A' ' 191' ' ' TYR . 7.8 t-20 -122.52 -49.34 2.02 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 112.957 -1.928 . . . . 0.0 111.481 178.719 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 223' ' ' ASP . . . . . 0.454 ' OD1' ' N ' ' A' ' 224' ' ' ILE . 0.0 OUTLIER -61.28 163.82 6.05 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 -178.463 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.572 HD13 ' HG3' ' A' ' 158' ' ' LYS . 17.4 pt -154.13 -178.31 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 176.4 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 34.4 100.65 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 114.466 -1.243 . . . . 0.0 111.926 -179.587 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 226' ' ' GLU . . . . . 0.542 ' H ' ' HA ' ' A' ' 155' ' ' GLN . 38.1 tt0 25.95 57.44 0.06 Allowed 'General case' 0 N--CA 1.482 1.169 0 O-C-N 124.294 0.996 . . . . 0.0 112.277 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 227' ' ' GLY . . . . . 0.448 ' N ' HG11 ' A' ' 153' ' ' VAL . . . -57.83 -69.83 1.16 Allowed Glycine 0 N--CA 1.429 -1.775 0 CA-C-N 114.411 -1.268 . . . . 0.0 113.14 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.56 ' HB2' HG21 ' A' ' 190' ' ' VAL . 8.3 m-20 -157.58 -159.67 0.86 Allowed 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 -178.233 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 229' ' ' VAL . . . . . 0.742 HG22 ' HG2' ' A' ' 152' ' ' GLU . 69.7 t -88.21 136.09 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 O-C-N 122.142 -0.349 . . . . 0.0 110.308 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 230' ' ' ILE . . . . . 0.623 HD13 ' HB3' ' A' ' 168' ' ' CYS . 5.3 mp -102.64 158.52 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 O-C-N 123.639 0.587 . . . . 0.0 111.257 -179.156 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 231' ' ' GLU . . . . . 0.457 ' O ' ' N ' ' A' ' 182' ' ' ARG . 5.2 tm-20 -147.14 109.57 4.56 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.504 ' HB3' ' CA ' ' A' ' 149' ' ' GLY . . . -87.41 130.05 34.81 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.474 178.521 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -132.81 141.96 48.74 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.047 -178.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.818 HG12 HD13 ' A' ' 148' ' ' ILE . 0.3 OUTLIER -179.6 -167.14 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.746 -179.832 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 235' ' ' MET . . . . . 0.621 ' N ' HG13 ' A' ' 234' ' ' VAL . 1.5 ttm -97.3 -163.47 1.05 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.009 179.13 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -89.5 77.26 7.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.157 0.503 . . . . 0.0 110.808 179.813 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -150.87 38.75 0.68 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.116 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.408 ' HB ' HG21 ' A' ' 176' ' ' THR . 2.0 m -106.14 161.14 5.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.266 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 239' ' ' ALA . . . . . 0.456 ' HB2' ' OE2' ' A' ' 207' ' ' GLU . . . 70.02 -64.39 0.36 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.023 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.73 -3.52 58.14 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.314 -0.966 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.046 179.957 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.842 0.353 . . . . 0.0 111.15 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -177.13 136.14 0.21 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.877 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.456 ' N ' ' HA ' ' A' ' 235' ' ' MET . 0.0 OUTLIER -98.66 34.6 2.01 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.437 179.775 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 17.3 tttt 68.06 166.94 0.25 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -178.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 3.5 t -60.05 140.24 18.39 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.871 0 CA-C-O 121.254 0.55 . . . . 0.0 111.209 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.533 HG21 ' CG1' ' A' ' 234' ' ' VAL . 3.3 tp -132.61 -3.05 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.225 177.695 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.494 ' CA ' ' HB3' ' A' ' 232' ' ' ALA . . . -165.77 66.71 0.21 Allowed Glycine 0 C--N 1.341 0.825 0 C-N-CA 119.982 -1.104 . . . . 0.0 112.496 179.465 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.494 ' HA ' ' HA ' ' A' ' 231' ' ' GLU . 1.3 mt-30 -90.0 132.48 35.33 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.451 ' HB1' ' O ' ' A' ' 169' ' ' TYR . . . -152.54 178.33 9.69 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 -177.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.86 ' CG ' HG22 ' A' ' 229' ' ' VAL . 0.1 OUTLIER -123.7 124.18 42.17 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.693 -1.14 . . . . 0.0 110.373 179.904 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.492 ' CG1' ' HA ' ' A' ' 226' ' ' GLU . 2.7 p -49.5 133.06 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -179.209 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.509 ' O ' ' HB3' ' A' ' 226' ' ' GLU . 4.3 mmp_? -89.56 -62.16 1.54 Allowed 'General case' 0 N--CA 1.434 -1.248 0 N-CA-C 105.08 -2.193 . . . . 0.0 105.08 175.595 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.51 -160.08 0.5 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 113.671 -1.604 . . . . 0.0 108.698 174.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 7.6 p -148.97 159.3 44.33 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.871 0.367 . . . . 0.0 110.232 177.342 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.675 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 2.6 m-85 -104.42 73.95 1.14 Allowed 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -177.523 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -85.9 63.42 8.03 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 122.08 0.943 . . . . 0.0 108.794 178.567 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 93.1 t -90.09 158.1 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-N 113.752 -1.567 . . . . 0.0 110.02 -179.37 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 13.9 m -92.52 33.32 1.12 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.132 0.491 . . . . 0.0 110.004 178.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -151.84 -31.78 0.15 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.639 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.556 HG12 HD13 ' A' ' 165' ' ' ILE . 93.0 t -99.47 -101.94 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.203 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' GLY . . . . . 0.478 ' N ' HG12 ' A' ' 162' ' ' VAL . . . -158.79 -104.33 0.2 Allowed Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 111.728 -0.549 . . . . 0.0 111.728 179.335 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.552 HG21 HG21 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -153.78 35.63 0.44 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 114.299 -0.95 . . . . 0.0 108.771 178.355 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.675 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 1.7 mp -42.8 95.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-N 115.327 -0.852 . . . . 0.0 111.342 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.532 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . -87.19 120.79 28.84 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 114.649 -1.16 . . . . 0.0 111.859 -179.288 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -89.46 149.91 20.92 Favored Glycine 0 N--CA 1.442 -0.93 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 178.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.811 ' SG ' HD11 ' A' ' 216' ' ' LEU . 0.0 OUTLIER -144.55 133.78 22.96 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 117.061 0.431 . . . . 0.0 110.21 -179.279 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 169' ' ' TYR . . . . . 0.451 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 1.1 t80 -86.94 127.51 35.07 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 178.262 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.659 HG21 ' O ' ' A' ' 208' ' ' VAL . 36.7 t -85.21 142.97 12.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -175.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -132.76 9.16 4.21 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 114.289 -1.323 . . . . 0.0 111.921 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.41 ' CB ' ' HB2' ' A' ' 150' ' ' GLN . 5.5 t0 -142.67 -142.42 0.14 Allowed 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -48.26 -104.84 0.01 OUTLIER Glycine 0 CA--C 1.535 1.294 0 C-N-CA 120.636 -0.792 . . . . 0.0 114.387 -179.34 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.916 ' HD3' HG11 ' A' ' 238' ' ' VAL . 0.0 OUTLIER -145.45 133.91 21.94 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.003 0.521 . . . . 0.0 110.849 -179.276 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.652 HG23 ' O ' ' A' ' 175' ' ' ILE . 9.0 tp -88.5 84.12 2.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 122.26 1.029 . . . . 0.0 109.425 178.182 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' THR . . . . . 1.003 HG21 HG12 ' A' ' 238' ' ' VAL . 0.6 OUTLIER -85.99 -174.42 5.09 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.327 -1.306 . . . . 0.0 113.924 -176.585 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -84.71 -45.99 11.89 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 114.417 -1.265 . . . . 0.0 111.439 -179.427 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -88.72 52.89 2.54 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.589 -178.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -139.66 161.24 38.0 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.882 179.15 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 1.1 mptt -88.65 -172.21 3.64 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.506 HG22 ' CA ' ' A' ' 194' ' ' GLU . 3.0 m -141.35 161.03 22.22 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.647 0 CA-C-O 121.4 0.619 . . . . 0.0 111.883 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 182' ' ' ARG . . . . . 0.449 ' HB3' ' HB3' ' A' ' 231' ' ' GLU . 8.4 ttt85 -152.09 92.8 1.75 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.04 -0.982 . . . . 0.0 112.099 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.766 HD22 ' CZ ' ' A' ' 221' ' ' PHE . 5.7 mp -88.37 142.33 27.82 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -178.652 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.665 HD13 ' O ' ' A' ' 183' ' ' LEU . 17.3 mm -150.56 128.73 2.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 113.05 -1.886 . . . . 0.0 111.36 179.348 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.421 ' N ' HG22 ' A' ' 190' ' ' VAL . 4.0 ttp180 -88.83 -148.09 0.17 Allowed 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 177.655 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -95.79 28.33 3.11 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 118.473 0.579 . . . . 0.0 110.726 178.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.475 ' C ' HD13 ' A' ' 188' ' ' ILE . . . -153.87 -83.6 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.792 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.475 HD13 ' C ' ' A' ' 187' ' ' GLY . 0.2 OUTLIER -110.22 -157.78 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 115.427 -0.387 . . . . 0.0 110.657 -179.204 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.605 HG11 ' CG ' ' A' ' 192' ' ' GLU . 41.4 t -87.41 135.62 24.92 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 CA-C-O 121.751 0.786 . . . . 0.0 111.262 -179.615 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.878 HG12 ' OD2' ' A' ' 223' ' ' ASP . 0.1 OUTLIER -97.3 -34.04 4.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 114.426 -1.261 . . . . 0.0 109.411 179.76 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 191' ' ' TYR . . . . . 0.746 ' HB3' HD13 ' A' ' 183' ' ' LEU . 41.8 t80 -167.86 154.0 7.54 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.327 -0.852 . . . . 0.0 112.453 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 192' ' ' GLU . . . . . 0.605 ' CG ' HG11 ' A' ' 189' ' ' VAL . 50.7 mt-10 -150.16 158.28 43.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.067 178.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 133.97 -120.48 2.51 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.427 -0.892 . . . . 0.0 112.761 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 0.506 ' CA ' HG22 ' A' ' 181' ' ' VAL . 0.0 OUTLIER -147.92 179.53 7.66 Favored 'General case' 0 CA--C 1.503 -0.857 0 CA-C-O 121.706 0.765 . . . . 0.0 111.797 -179.04 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.949 HD12 HD13 ' A' ' 216' ' ' LEU . 32.9 mm -92.57 153.06 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.308 0 CA-C-N 114.35 -1.295 . . . . 0.0 110.186 -179.186 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -89.97 -58.52 2.48 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 36.4 p -150.6 156.73 41.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.85 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.918 ' CD1' HD23 ' A' ' 216' ' ' LEU . 5.9 tp -127.88 115.78 19.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.172 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 5.1 ptpt -150.09 120.0 7.13 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.195 -0.912 . . . . 0.0 109.564 179.32 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.88 -159.79 0.56 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.328 -179.249 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -86.62 -11.09 52.4 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 120.533 0.206 . . . . 0.0 111.101 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -94.48 -60.39 1.73 Allowed 'General case' 0 N--CA 1.439 -0.993 0 CA-C-O 120.739 0.304 . . . . 0.0 110.641 179.218 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -152.66 -174.3 4.86 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.085 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -89.61 56.1 3.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.247 0.546 . . . . 0.0 110.022 179.195 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.585 ' O ' HD23 ' A' ' 198' ' ' LEU . 31.9 m -53.91 160.87 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.969 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.352 -179.326 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 206' ' ' ARG . . . . . 0.476 ' O ' ' HB ' ' A' ' 176' ' ' THR . 0.0 OUTLIER -88.86 -36.73 15.83 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.321 -178.859 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.785 ' HB3' HG22 ' A' ' 176' ' ' THR . 0.6 OUTLIER -133.71 176.78 8.24 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.268 0.556 . . . . 0.0 111.821 179.926 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.659 ' O ' HG21 ' A' ' 170' ' ' VAL . 0.2 OUTLIER -150.38 84.24 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.759 179.129 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.824 ' HB2' ' HG3' ' A' ' 174' ' ' LYS . . . -99.99 178.82 4.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.096 0.474 . . . . 0.0 112.086 -178.789 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 81.9 -75.01 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.698 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 211' ' ' GLY . . . . . 0.405 ' O ' ' CE1' ' A' ' 169' ' ' TYR . . . 178.42 37.65 0.06 OUTLIER Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.347 179.033 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -101.75 143.2 31.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.917 0.389 . . . . 0.0 111.372 -179.45 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 213' ' ' GLU . . . . . 0.443 ' HG2' ' CD2' ' A' ' 169' ' ' TYR . 0.0 OUTLIER -98.56 131.5 44.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.454 179.943 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 214' ' ' CYS . . . . . 0.524 ' CB ' HG21 ' A' ' 208' ' ' VAL . 34.6 t -125.84 145.52 50.2 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.333 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -88.38 113.81 4.12 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.148 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.949 HD13 HD12 ' A' ' 195' ' ' ILE . 0.5 OUTLIER -133.81 147.35 51.23 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 120.839 0.352 . . . . 0.0 111.073 -179.26 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.01 138.45 31.97 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 177.038 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 218' ' ' ILE . . . . . 0.648 HG22 ' CE1' ' A' ' 191' ' ' TYR . 19.1 mm -91.33 52.61 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.086 0.469 . . . . 0.0 112.193 -177.467 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 4.6 tptm 61.48 -72.08 0.04 OUTLIER 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.642 178.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 220' ' ' ASN . . . . . 0.426 ' N ' ' O ' ' A' ' 218' ' ' ILE . 5.0 p-10 -145.43 51.45 1.2 Allowed 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.253 -179.089 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.766 ' CZ ' HD22 ' A' ' 183' ' ' LEU . 0.1 OUTLIER -57.3 118.49 5.16 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 178.33 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -77.84 -46.3 21.88 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 176.216 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 223' ' ' ASP . . . . . 0.878 ' OD2' HG12 ' A' ' 190' ' ' VAL . 0.0 OUTLIER -88.09 130.39 35.02 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 177.48 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.637 HD13 ' H ' ' A' ' 224' ' ' ILE . 0.2 OUTLIER -117.31 176.77 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 CA-C-O 121.438 0.637 . . . . 0.0 112.466 -179.283 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.463 ' O ' ' N ' ' A' ' 227' ' ' GLY . 10.4 mtmt 62.06 154.28 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.231 -178.62 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 226' ' ' GLU . . . . . 0.509 ' HB3' ' O ' ' A' ' 154' ' ' ARG . 0.2 OUTLIER -39.99 90.77 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 122.235 1.017 . . . . 0.0 111.845 179.939 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 227' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 225' ' ' LYS . . . -106.66 -38.85 2.14 Favored Glycine 0 N--CA 1.429 -1.805 0 CA-C-N 114.356 -1.293 . . . . 0.0 112.207 -178.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.711 ' CB ' HG21 ' A' ' 190' ' ' VAL . 2.9 p30 -157.95 -166.7 2.03 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 115.736 1.754 . . . . 0.0 115.736 -178.166 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 229' ' ' VAL . . . . . 0.86 HG22 ' CG ' ' A' ' 152' ' ' GLU . 40.6 t -97.98 142.48 14.4 Favored 'Isoleucine or valine' 0 C--N 1.343 0.326 0 CA-C-N 114.441 -1.254 . . . . 0.0 108.075 177.623 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 230' ' ' ILE . . . . . 0.403 HG13 ' HG ' ' A' ' 183' ' ' LEU . 3.9 mp -115.48 150.89 17.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.091 0.472 . . . . 0.0 111.831 -178.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 231' ' ' GLU . . . . . 0.494 ' HA ' ' HA ' ' A' ' 150' ' ' GLN . 7.4 tt0 -137.69 108.73 6.75 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.271 0.558 . . . . 0.0 110.731 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.494 ' HB3' ' CA ' ' A' ' 149' ' ' GLY . . . -87.8 124.19 33.36 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.808 -179.627 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -123.62 166.97 14.57 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.709 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.533 ' CG1' HG21 ' A' ' 148' ' ' ILE . 9.8 p -176.19 150.49 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 121.076 -0.249 . . . . 0.0 110.98 -179.627 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 235' ' ' MET . . . . . 0.456 ' HA ' ' N ' ' A' ' 145' ' ' GLU . 0.0 OUTLIER -97.06 30.94 2.55 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.123 0.487 . . . . 0.0 109.695 178.798 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -133.72 -155.88 0.7 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -98.56 -99.57 0.21 Allowed 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 179.122 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 1.003 HG12 HG21 ' A' ' 176' ' ' THR . 0.6 OUTLIER -154.47 -158.05 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.159 -179.883 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 239' ' ' ALA . . . . . 0.561 ' H ' HG12 ' A' ' 238' ' ' VAL . . . -47.36 -78.62 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 122.97 0.508 . . . . 0.0 111.318 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -90.68 -5.22 56.07 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.953 179.273 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.314 -0.951 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.072 179.994 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 . . . . . 0 N--CA 1.487 1.424 0 N-CA-C 111.714 0.264 . . . . 0.0 111.714 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 179.46 138.76 0.11 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.768 0.318 . . . . 0.0 110.673 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.3 39.5 1.12 Allowed 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.392 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -76.91 -179.21 5.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.57 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.566 HG11 ' HB2' ' A' ' 150' ' ' GLN . 15.0 t -60.13 139.84 19.03 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 CA-C-O 121.463 0.649 . . . . 0.0 111.356 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.872 ' CD1' HG21 ' A' ' 238' ' ' VAL . 6.9 tp -114.13 -18.97 7.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.231 178.162 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.406 ' O ' ' HB3' ' A' ' 232' ' ' ALA . . . 178.97 85.9 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.339 -179.422 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.566 ' HB2' HG11 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -91.44 135.05 34.12 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.664 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.461 ' HB1' ' O ' ' A' ' 169' ' ' TYR . . . -150.78 173.14 14.55 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 -177.751 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.834 ' CG ' HG22 ' A' ' 229' ' ' VAL . 0.4 OUTLIER -117.51 122.82 44.75 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.091 179.715 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.456 HG12 ' O ' ' A' ' 228' ' ' ASP . 2.7 p -55.65 128.92 16.52 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.338 0 CA-C-O 121.326 0.584 . . . . 0.0 111.65 -179.42 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.419 ' CA ' ' NE ' ' A' ' 154' ' ' ARG . 0.0 OUTLIER -89.2 -58.38 2.56 Favored 'General case' 0 N--CA 1.427 -1.606 0 N-CA-C 105.288 -2.115 . . . . 0.0 105.288 176.203 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.43 ' HA ' ' H ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER -163.1 -163.23 0.83 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.691 174.906 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.593 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 7.0 p -147.57 149.01 31.76 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.564 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 0.2 OUTLIER -94.4 80.3 3.92 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -177.984 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 13.8 tttm -85.88 63.69 8.18 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.127 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.42 HG12 ' N ' ' A' ' 161' ' ' LYS . 69.9 t -93.21 157.06 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-N 113.652 -1.613 . . . . 0.0 110.231 -178.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -92.07 35.45 0.99 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.208 0.528 . . . . 0.0 109.655 178.129 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.42 ' N ' HG12 ' A' ' 159' ' ' VAL . 5.0 mttt -151.47 -35.32 0.14 Allowed 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.084 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.49 HG12 HD13 ' A' ' 165' ' ' ILE . 95.5 t -97.85 -102.24 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' GLY . . . . . 0.471 ' N ' HG12 ' A' ' 162' ' ' VAL . . . -159.33 -102.8 0.18 Allowed Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 178.8 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' THR . . . . . 1.082 HG21 HG21 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -153.68 35.2 0.45 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.087 -1.056 . . . . 0.0 108.271 177.404 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.564 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 1.5 mp -42.92 96.02 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.541 -179.448 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.593 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . -80.39 118.67 22.23 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.697 -1.138 . . . . 0.0 112.194 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -88.75 141.86 16.73 Favored Glycine 0 N--CA 1.441 -1.022 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 178.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.465 ' HB3' HD12 ' A' ' 230' ' ' ILE . 0.0 OUTLIER -141.01 132.39 26.76 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.879 0.339 . . . . 0.0 110.488 -178.491 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 169' ' ' TYR . . . . . 0.461 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 47.5 t80 -85.59 129.36 34.84 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.247 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.69 HG21 ' O ' ' A' ' 208' ' ' VAL . 31.8 t -85.73 149.28 4.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -175.764 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -140.09 15.12 2.44 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 114.427 -1.261 . . . . 0.0 111.826 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.523 ' H ' HG12 ' A' ' 170' ' ' VAL . 9.3 t0 -150.6 -145.26 0.17 Allowed 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -179.346 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -43.48 -105.18 0.01 OUTLIER Glycine 0 CA--C 1.53 0.997 0 N-CA-C 114.84 0.696 . . . . 0.0 114.84 -179.196 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.814 ' HG2' ' HB2' ' A' ' 209' ' ' ALA . 7.6 mttt -151.44 144.28 24.44 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.999 0.428 . . . . 0.0 112.013 -178.678 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.445 ' CG1' HG22 ' A' ' 170' ' ' VAL . 10.3 mm -89.91 87.34 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 176.28 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.653 ' C ' HD11 ' A' ' 198' ' ' LEU . 0.1 OUTLIER -98.1 165.7 11.77 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -176.909 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 20.6 mtm105 -64.85 -44.45 89.75 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 114.55 -1.204 . . . . 0.0 111.083 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -89.3 60.15 5.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.752 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 46.6 m -149.2 159.54 44.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.652 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.538 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 14.9 mttp -89.62 -172.28 3.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.483 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.49 HG22 ' CA ' ' A' ' 194' ' ' GLU . 3.0 m -149.47 146.32 17.16 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.607 0 CA-C-O 121.554 0.692 . . . . 0.0 111.861 179.326 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 182' ' ' ARG . . . . . 0.448 ' N ' ' O ' ' A' ' 231' ' ' GLU . 6.0 ttm180 -154.45 98.83 2.14 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.722 -1.126 . . . . 0.0 112.002 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.628 ' C ' HD12 ' A' ' 184' ' ' ILE . 0.3 OUTLIER -100.88 168.53 9.58 Favored 'General case' 0 N--CA 1.437 -1.093 0 C-N-CA 120.358 -0.537 . . . . 0.0 111.026 179.597 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.771 HG23 ' O ' ' A' ' 188' ' ' ILE . 5.3 mp -151.15 140.07 14.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.156 -177.74 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.464 ' N ' HG22 ' A' ' 190' ' ' VAL . 8.0 ptp180 -87.16 -155.77 0.3 Allowed 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.172 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -93.6 27.23 2.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 118.327 0.512 . . . . 0.0 111.385 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -154.4 -43.87 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.966 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.771 ' O ' HG23 ' A' ' 184' ' ' ILE . 0.4 OUTLIER -150.14 -159.34 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 120.679 0.276 . . . . 0.0 111.711 -177.969 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.668 ' N ' HG23 ' A' ' 188' ' ' ILE . 39.8 t -85.13 135.13 25.49 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 CA-C-O 121.564 0.697 . . . . 0.0 110.349 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.498 ' HB ' HD11 ' A' ' 183' ' ' LEU . 0.3 OUTLIER -87.99 -35.04 7.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.347 -179.848 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 191' ' ' TYR . . . . . 0.48 ' HB2' ' CE1' ' A' ' 221' ' ' PHE . 0.6 OUTLIER -176.66 155.3 1.31 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.042 -179.994 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 192' ' ' GLU . . . . . 0.625 ' CG ' HG11 ' A' ' 189' ' ' VAL . 33.3 mt-10 -141.7 161.14 38.67 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.884 179.732 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 141.28 -137.31 8.03 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 111.377 -0.689 . . . . 0.0 111.377 -179.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 0.707 ' O ' HG23 ' A' ' 218' ' ' ILE . 7.2 pt-20 -131.97 -176.07 3.94 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-O 121.011 0.434 . . . . 0.0 111.169 179.634 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.482 HG22 ' N ' ' A' ' 196' ' ' ASP . 5.8 mm -87.21 159.11 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.687 -178.248 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 196' ' ' ASP . . . . . 0.643 ' HB3' HG23 ' A' ' 217' ' ' THR . 4.0 t0 -103.16 -56.98 2.12 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.77 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 18.1 p -151.58 155.01 37.58 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.543 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.653 HD11 ' C ' ' A' ' 176' ' ' THR . 13.6 mt -117.11 128.22 54.92 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.927 179.554 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 10.8 ptpt -151.09 118.45 6.0 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.473 178.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 6.6 ttp180 -88.74 -39.11 14.19 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.433 0.635 . . . . 0.0 111.525 -178.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -151.61 -86.4 0.07 Allowed 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 114.979 -1.009 . . . . 0.0 110.782 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.19 22.76 11.68 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 116.733 -0.212 . . . . 0.0 111.154 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -150.49 155.37 39.38 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 120.896 0.379 . . . . 0.0 110.938 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -89.83 90.7 8.3 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.731 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 27.6 m -66.48 155.42 7.19 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.915 0 CA-C-O 121.332 0.587 . . . . 0.0 111.671 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 206' ' ' ARG . . . . . 0.456 ' O ' ' HB ' ' A' ' 176' ' ' THR . 2.7 mtp180 -89.37 -32.74 17.16 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.388 -178.672 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -150.06 179.0 8.42 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.921 0.391 . . . . 0.0 110.713 179.335 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.69 ' O ' HG21 ' A' ' 170' ' ' VAL . 1.8 t -151.07 80.34 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.828 178.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.814 ' HB2' ' HG2' ' A' ' 174' ' ' LYS . . . -102.68 174.53 5.85 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.606 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 83.11 -74.33 0.03 OUTLIER 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.09 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 178.11 37.21 0.06 OUTLIER Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.392 -0.909 . . . . 0.0 112.385 179.034 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -98.17 144.69 27.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.919 0.39 . . . . 0.0 111.274 -179.428 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -96.77 130.11 44.08 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.872 179.378 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 214' ' ' CYS . . . . . 0.486 ' CB ' HG21 ' A' ' 208' ' ' VAL . 33.6 t -128.75 144.93 51.28 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.775 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -88.77 110.64 3.69 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.634 -0.793 . . . . 0.0 111.761 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.447 ' CD1' HD12 ' A' ' 195' ' ' ILE . 0.1 OUTLIER -129.0 144.37 51.16 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.116 0.484 . . . . 0.0 111.111 -179.229 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 217' ' ' THR . . . . . 0.643 HG23 ' HB3' ' A' ' 196' ' ' ASP . 0.1 OUTLIER -107.09 141.69 37.92 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 178.147 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 218' ' ' ILE . . . . . 0.707 HG23 ' O ' ' A' ' 194' ' ' GLU . 18.4 mm -90.72 140.45 15.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.241 0.544 . . . . 0.0 110.571 -179.344 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt -42.0 -30.1 0.26 Allowed 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -177.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 220' ' ' ASN . . . . . 0.425 ' O ' ' CE2' ' A' ' 191' ' ' TYR . 5.0 t30 -152.46 35.08 0.51 Allowed 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -178.335 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.5 ' HB2' ' HB ' ' A' ' 218' ' ' ILE . 0.1 OUTLIER -58.84 120.09 8.37 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 178.891 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -88.11 -46.97 8.85 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 176.456 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 223' ' ' ASP . . . . . 0.459 ' O ' ' CD1' ' A' ' 221' ' ' PHE . 0.0 OUTLIER -79.54 136.25 36.83 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.063 177.403 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 1.082 HG21 HG21 ' A' ' 164' ' ' THR . 0.2 OUTLIER -133.28 178.9 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -178.859 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.412 ' O ' ' C ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER 57.46 116.8 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.853 -178.862 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 226' ' ' GLU . . . . . 0.43 ' H ' ' HA ' ' A' ' 155' ' ' GLN . 0.5 OUTLIER 6.91 63.95 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 124.51 1.124 . . . . 0.0 113.814 -179.545 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 227' ' ' GLY . . . . . 0.437 ' N ' HG11 ' A' ' 153' ' ' VAL . . . -61.39 -66.73 2.48 Favored Glycine 0 N--CA 1.434 -1.497 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.739 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.456 ' O ' HG12 ' A' ' 153' ' ' VAL . 0.8 OUTLIER -165.07 -148.21 0.11 Allowed 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 114.279 1.215 . . . . 0.0 114.279 179.686 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 229' ' ' VAL . . . . . 0.834 HG22 ' CG ' ' A' ' 152' ' ' GLU . 73.0 t -89.14 130.2 38.89 Favored 'Isoleucine or valine' 0 C--N 1.345 0.381 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.701 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 230' ' ' ILE . . . . . 0.497 ' HA ' ' CB ' ' A' ' 183' ' ' LEU . 22.6 mt -101.04 158.32 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.119 0 O-C-N 123.66 0.6 . . . . 0.0 111.332 -179.118 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 231' ' ' GLU . . . . . 0.448 ' O ' ' N ' ' A' ' 182' ' ' ARG . 16.1 tt0 -144.85 111.0 5.51 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.3 0.572 . . . . 0.0 112.522 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.556 ' O ' HG22 ' A' ' 148' ' ' ILE . . . -87.67 122.83 31.85 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.948 178.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -123.84 141.27 52.18 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.022 -179.113 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.583 HG22 ' H ' ' A' ' 235' ' ' MET . 0.9 OUTLIER -175.99 -175.71 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.017 179.837 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 235' ' ' MET . . . . . 0.583 ' H ' HG22 ' A' ' 234' ' ' VAL . 0.5 OUTLIER -89.43 -162.64 0.89 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.657 0.265 . . . . 0.0 111.106 -179.775 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.78 38.09 1.07 Allowed 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.874 0.369 . . . . 0.0 111.885 -179.471 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -123.62 46.41 2.23 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.167 0.508 . . . . 0.0 110.057 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.872 HG21 ' CD1' ' A' ' 148' ' ' ILE . 1.4 t -108.24 168.35 3.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.298 -178.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 239' ' ' ALA . . . . . 0.501 ' H ' HG12 ' A' ' 238' ' ' VAL . . . 69.71 -64.68 0.34 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.052 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.62 -3.21 58.37 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.314 -0.938 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.978 -179.994 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.415 ' CE1' ' HE3' ' A' ' 174' ' ' LYS . 25.4 m-85 . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.822 0.344 . . . . 0.0 111.24 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -140.81 179.16 6.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.867 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.11 37.08 1.26 Allowed 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.303 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 33.2 mttp -119.17 -80.26 0.61 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.302 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.465 HG11 ' HB2' ' A' ' 150' ' ' GLN . 4.3 t -108.43 141.96 22.32 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.739 0 CA-C-O 121.435 0.636 . . . . 0.0 110.727 179.022 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.643 HG21 HG12 ' A' ' 234' ' ' VAL . 2.6 pp -128.99 -8.85 3.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.635 179.203 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.539 ' N ' HD12 ' A' ' 148' ' ' ILE . . . -174.04 75.0 0.09 OUTLIER Glycine 0 C--N 1.341 0.817 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.831 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.465 ' HB2' HG11 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -90.39 137.99 31.9 Favored 'General case' 0 CA--C 1.506 -0.728 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.852 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.534 ' HB1' ' HB2' ' A' ' 168' ' ' CYS . . . -151.66 174.85 12.99 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 120.093 -0.643 . . . . 0.0 112.339 -178.105 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.773 ' HG3' HG22 ' A' ' 229' ' ' VAL . 0.4 OUTLIER -125.12 119.37 28.4 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.507 179.92 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.464 HG11 ' N ' ' A' ' 227' ' ' GLY . 1.1 p -49.07 131.23 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -178.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.557 ' O ' ' HB3' ' A' ' 226' ' ' GLU . 4.0 mmp_? -91.48 -60.17 1.95 Allowed 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 105.249 -2.13 . . . . 0.0 105.249 175.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.73 -159.18 0.44 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 113.743 -1.571 . . . . 0.0 109.422 175.044 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.551 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 9.5 p -148.92 163.17 38.24 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 120.821 0.343 . . . . 0.0 110.647 177.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.656 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 3.7 m-85 -110.13 73.04 0.82 Allowed 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -178.34 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.588 ' HG3' HD13 ' A' ' 224' ' ' ILE . 8.2 tmtm? -85.94 64.36 8.55 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.405 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 92.4 t -92.25 158.22 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 CA-C-N 113.549 -1.66 . . . . 0.0 110.258 -178.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 71.5 m -93.06 34.46 1.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.225 0.535 . . . . 0.0 109.761 178.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.63 -33.09 0.15 Allowed 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.386 -179.667 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.516 HG12 ' N ' ' A' ' 163' ' ' GLY . 89.0 t -99.82 -102.19 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.19 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' GLY . . . . . 0.516 ' N ' HG12 ' A' ' 162' ' ' VAL . . . -158.85 -103.4 0.19 Allowed Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 111.522 -0.631 . . . . 0.0 111.522 179.268 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.458 HG21 ' CG2' ' A' ' 224' ' ' ILE . 0.0 OUTLIER -153.64 34.61 0.45 Allowed 'General case' 0 C--O 1.232 0.148 0 CA-C-N 114.311 -0.944 . . . . 0.0 108.801 178.259 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.656 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 1.6 mp -43.3 98.09 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.527 0.096 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.424 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.551 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . -87.08 122.89 31.52 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.854 -1.067 . . . . 0.0 111.698 -179.679 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -87.73 146.54 20.02 Favored Glycine 0 N--CA 1.442 -0.921 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 178.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.534 ' HB2' ' HB1' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -147.66 134.37 19.98 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 117.279 0.539 . . . . 0.0 110.771 -178.338 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 169' ' ' TYR . . . . . 0.427 ' O ' ' HA ' ' A' ' 151' ' ' ALA . 22.9 t80 -86.84 134.34 33.55 Favored 'General case' 0 C--O 1.221 -0.414 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 177.555 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.512 HG12 ' N ' ' A' ' 212' ' ' TYR . 9.2 p -86.43 146.63 6.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -176.258 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.2 p -140.95 12.01 2.23 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.557 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.425 ' CB ' ' HB2' ' A' ' 150' ' ' GLN . 9.1 t0 -150.79 -148.14 0.25 Allowed 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -41.48 -104.51 0.01 OUTLIER Glycine 0 CA--C 1.532 1.119 0 N-CA-C 115.09 0.796 . . . . 0.0 115.09 -178.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.707 ' HG3' ' HB2' ' A' ' 209' ' ' ALA . 0.0 OUTLIER -150.64 128.89 11.98 Favored 'General case' 0 CA--C 1.513 -0.457 0 O-C-N 122.722 -0.281 . . . . 0.0 111.368 -178.778 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.658 HG23 ' O ' ' A' ' 175' ' ' ILE . 1.1 tp -89.54 76.78 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 CA-C-O 122.27 1.033 . . . . 0.0 108.981 177.544 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.803 HG22 ' HB3' ' A' ' 207' ' ' GLU . 0.2 OUTLIER -84.03 173.01 11.49 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.015 -1.448 . . . . 0.0 113.543 -176.796 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 43.0 ttp85 -59.96 -51.6 68.98 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 114.2 -1.364 . . . . 0.0 111.536 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -89.55 61.92 5.72 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.68 -178.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.622 ' HB3' HD13 ' A' ' 148' ' ' ILE . 0.9 OUTLIER -142.68 160.4 40.38 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.443 179.396 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.516 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 11.9 mttt -89.08 -174.39 4.43 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.451 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.698 HG21 HG23 ' A' ' 218' ' ' ILE . 2.4 m -150.7 145.51 16.77 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 CA-C-O 121.573 0.702 . . . . 0.0 112.111 179.537 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 182' ' ' ARG . . . . . 0.465 ' N ' ' O ' ' A' ' 231' ' ' GLU . 16.9 ttt180 -154.87 100.52 2.21 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.725 -1.125 . . . . 0.0 112.051 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.532 ' HA ' ' O ' ' A' ' 229' ' ' VAL . 0.3 OUTLIER -100.15 168.83 9.57 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 120.616 -0.433 . . . . 0.0 110.878 179.551 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.725 HG23 ' O ' ' A' ' 188' ' ' ILE . 27.2 mt -155.5 139.55 8.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.333 -0.394 . . . . 0.0 112.017 -178.069 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.492 ' N ' HG22 ' A' ' 190' ' ' VAL . 0.0 OUTLIER -86.57 -154.02 0.22 Allowed 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.081 178.174 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -94.27 29.11 2.29 Favored 'General case' 0 N--CA 1.455 -0.191 0 O-C-N 122.023 -0.423 . . . . 0.0 111.51 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -152.91 -77.41 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.319 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.725 ' O ' HG23 ' A' ' 184' ' ' ILE . 0.5 OUTLIER -115.49 -157.68 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-N 115.464 -0.368 . . . . 0.0 110.094 -179.765 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.732 HG11 ' CG ' ' A' ' 192' ' ' GLU . 23.4 t -86.83 139.97 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 CA-C-O 121.425 0.631 . . . . 0.0 110.889 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.611 HG23 ' CA ' ' A' ' 184' ' ' ILE . 0.4 OUTLIER -88.22 -35.44 8.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.011 179.883 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 191' ' ' TYR . . . . . 0.463 ' HB2' ' CE1' ' A' ' 221' ' ' PHE . 9.9 t80 -178.91 151.33 0.52 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.014 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 192' ' ' GLU . . . . . 0.732 ' CG ' HG11 ' A' ' 189' ' ' VAL . 34.0 mt-10 -143.47 159.34 42.59 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.68 179.126 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 150.33 -122.9 1.46 Allowed Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.825 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 0.52 ' C ' HG22 ' A' ' 181' ' ' VAL . 8.8 pt-20 -139.31 -177.98 5.16 Favored 'General case' 0 CA--C 1.497 -1.065 0 CA-C-O 121.288 0.566 . . . . 0.0 111.207 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.815 HD11 ' CD1' ' A' ' 216' ' ' LEU . 0.3 OUTLIER -88.27 142.62 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.145 -178.485 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -88.7 -61.69 1.65 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.184 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -151.94 166.05 32.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.529 178.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.575 HD21 ' O ' ' A' ' 205' ' ' VAL . 1.3 pt? -139.3 122.41 16.86 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.69 0.757 . . . . 0.0 112.149 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -146.83 127.82 14.55 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 114.406 -1.27 . . . . 0.0 108.719 178.565 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 3.1 ttp85 -88.8 -38.19 14.83 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.51 0.671 . . . . 0.0 111.82 -178.321 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.459 ' N ' ' CD1' ' A' ' 201' ' ' TYR . 0.0 OUTLIER -151.52 -96.32 0.06 Allowed 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.139 179.504 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 5.3 tttp -107.07 20.63 18.74 Favored 'General case' 0 N--CA 1.44 -0.97 0 O-C-N 122.33 -0.231 . . . . 0.0 110.908 179.323 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -150.82 144.11 24.85 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 120.864 0.364 . . . . 0.0 110.828 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.67 82.32 6.33 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.644 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.575 ' O ' HD21 ' A' ' 198' ' ' LEU . 30.4 m -56.15 173.47 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.068 0 CA-C-O 120.972 0.415 . . . . 0.0 111.361 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 206' ' ' ARG . . . . . 0.478 ' O ' ' HB ' ' A' ' 176' ' ' THR . 2.6 ttp180 -97.34 -40.07 8.91 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.787 -178.587 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.803 ' HB3' HG22 ' A' ' 176' ' ' THR . 1.1 mp0 -143.12 178.12 7.92 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.29 0.567 . . . . 0.0 111.938 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.569 HG23 HG23 ' A' ' 175' ' ' ILE . 0.1 OUTLIER -150.74 81.23 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.743 179.478 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.707 ' HB2' ' HG3' ' A' ' 174' ' ' LYS . . . -105.32 177.5 4.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.999 0.428 . . . . 0.0 112.043 -178.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 83.24 -72.06 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.942 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 211' ' ' GLY . . . . . 0.501 ' HA2' HG13 ' A' ' 170' ' ' VAL . . . 178.63 36.88 0.06 OUTLIER Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.537 -0.839 . . . . 0.0 112.369 179.2 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 212' ' ' TYR . . . . . 0.512 ' N ' HG12 ' A' ' 170' ' ' VAL . 0.5 OUTLIER -104.54 144.45 31.67 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.071 0.463 . . . . 0.0 111.746 -179.232 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -99.56 151.11 21.54 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.933 179.546 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 53.9 t -146.66 148.2 31.8 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.845 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -88.23 108.72 3.45 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.394 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.815 ' CD1' HD11 ' A' ' 195' ' ' ILE . 0.1 OUTLIER -138.27 147.6 43.81 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 121.12 0.486 . . . . 0.0 112.06 -178.208 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 217' ' ' THR . . . . . 0.708 ' O ' HD13 ' A' ' 195' ' ' ILE . 0.0 OUTLIER -88.1 143.86 26.83 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.025 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 218' ' ' ILE . . . . . 0.698 HG23 HG21 ' A' ' 181' ' ' VAL . 1.5 mp -109.42 92.15 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 -179.335 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 1.8 ttpp 44.43 -146.1 0.11 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.852 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -87.67 62.66 7.14 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-O 121.319 0.58 . . . . 0.0 110.808 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.49 ' CZ ' HD21 ' A' ' 183' ' ' LEU . 0.1 OUTLIER -54.37 121.6 8.63 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 179.14 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -84.06 -48.66 9.67 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.287 176.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 223' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 223' ' ' ASP . 0.0 OUTLIER -81.0 125.37 30.08 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.122 177.68 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.633 HD12 ' HG2' ' A' ' 225' ' ' LYS . 1.7 pt -115.89 176.86 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.603 0 CA-C-O 121.469 0.652 . . . . 0.0 111.884 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.633 ' HG2' HD12 ' A' ' 224' ' ' ILE . 0.1 OUTLIER 63.88 149.46 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.757 -1.111 . . . . 0.0 108.635 -178.627 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 226' ' ' GLU . . . . . 0.557 ' HB3' ' O ' ' A' ' 154' ' ' ARG . 5.5 pt-20 -36.92 86.5 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 121.986 0.898 . . . . 0.0 112.89 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 227' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 225' ' ' LYS . . . -78.5 -60.17 2.71 Favored Glycine 0 N--CA 1.426 -2.006 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.502 179.452 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.458 ' HB3' ' O ' ' A' ' 184' ' ' ILE . 1.1 t70 -165.21 -144.94 0.08 Allowed 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 229' ' ' VAL . . . . . 0.773 HG22 ' HG3' ' A' ' 152' ' ' GLU . 80.2 t -89.65 134.21 29.48 Favored 'Isoleucine or valine' 0 C--N 1.349 0.555 0 C-N-CA 122.937 0.495 . . . . 0.0 109.881 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 230' ' ' ILE . . . . . 0.501 ' HA ' ' CB ' ' A' ' 183' ' ' LEU . 5.5 mt -103.26 158.04 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 O-C-N 123.435 0.459 . . . . 0.0 110.951 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 231' ' ' GLU . . . . . 0.465 ' O ' ' N ' ' A' ' 182' ' ' ARG . 1.4 tm-20 -148.89 109.88 4.33 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.649 ' HB2' HD12 ' A' ' 175' ' ' ILE . . . -87.59 128.25 35.27 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.354 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 233' ' ' TYR . . . . . 0.456 ' HA ' HG13 ' A' ' 148' ' ' ILE . 11.5 p90 -124.97 143.17 51.03 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.625 -178.164 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.643 HG12 HG21 ' A' ' 148' ' ' ILE . 0.3 OUTLIER 179.97 -173.83 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.855 178.909 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 235' ' ' MET . . . . . 0.586 ' N ' HG13 ' A' ' 234' ' ' VAL . 3.6 mmt -89.87 -162.38 0.88 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.437 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -89.52 53.64 2.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.243 0.544 . . . . 0.0 110.9 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -133.64 44.56 2.76 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.111 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.408 ' O ' ' HB3' ' A' ' 239' ' ' ALA . 1.7 m -104.05 166.91 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.98 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 239' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 238' ' ' VAL . . . 69.92 -64.54 0.35 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.923 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 3.5 ttp180 -89.68 -3.65 58.12 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.313 -1.012 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.114 179.967 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.665 0.269 . . . . 0.0 110.938 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.661 HG11 ' HB2' ' A' ' 150' ' ' GLN . 17.0 t -61.69 141.06 18.12 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.595 0 CA-C-O 121.25 0.548 . . . . 0.0 111.53 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.735 HG21 HG12 ' A' ' 234' ' ' VAL . 0.3 OUTLIER -126.54 2.17 4.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.632 177.48 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.587 ' CA ' ' HB3' ' A' ' 232' ' ' ALA . . . 175.83 74.29 0.05 OUTLIER Glycine 0 C--N 1.341 0.847 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.356 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.661 ' HB2' HG11 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -91.71 132.86 36.08 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.177 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.424 ' O ' HG13 ' A' ' 229' ' ' VAL . . . -151.88 174.16 13.93 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-O 121.466 0.65 . . . . 0.0 112.438 -178.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.681 ' HG2' HG22 ' A' ' 229' ' ' VAL . 50.4 mt-10 -118.71 122.75 43.22 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.274 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.731 ' HB ' HD11 ' A' ' 230' ' ' ILE . 2.4 p -52.1 132.26 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 121.257 0.551 . . . . 0.0 112.436 -178.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.445 ' O ' ' HB3' ' A' ' 226' ' ' GLU . 4.7 mmp_? -89.33 -61.48 1.69 Allowed 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 175.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.435 ' HA ' ' H ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER -162.38 -163.83 0.96 Allowed 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 113.624 -1.625 . . . . 0.0 109.479 174.789 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.553 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 12.2 p -143.82 173.57 11.57 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 177.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.654 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 9.2 m-85 -125.5 75.5 1.48 Allowed 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -178.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -86.2 63.14 7.85 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 177.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.47 HG12 ' N ' ' A' ' 161' ' ' LYS . 66.5 t -91.71 156.02 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 CA-C-N 113.603 -1.635 . . . . 0.0 110.343 -178.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 49.1 p -91.36 34.71 0.94 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.217 0.532 . . . . 0.0 109.845 178.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.47 ' N ' HG12 ' A' ' 159' ' ' VAL . 1.6 mttt -150.84 -32.15 0.17 Allowed 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.358 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.792 HG11 HD12 ' A' ' 165' ' ' ILE . 91.9 t -102.11 -103.31 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . 0.512 ' N ' HG12 ' A' ' 162' ' ' VAL . . . -159.04 -100.44 0.16 Allowed Glycine 0 N--CA 1.451 -0.317 0 N-CA-C 111.438 -0.665 . . . . 0.0 111.438 179.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.437 ' CG2' ' CG2' ' A' ' 224' ' ' ILE . 0.0 OUTLIER -153.87 35.11 0.44 Allowed 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 114.209 -0.996 . . . . 0.0 108.709 178.266 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.792 HD12 HG11 ' A' ' 162' ' ' VAL . 4.2 mt -42.13 95.57 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.567 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.553 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . -88.07 119.01 28.03 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.744 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -88.07 146.82 19.94 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 178.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.639 ' HB3' HD13 ' A' ' 230' ' ' ILE . 0.0 OUTLIER -147.17 135.28 21.49 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 117.248 0.524 . . . . 0.0 110.833 -178.416 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . 0.4 ' O ' ' HA ' ' A' ' 151' ' ' ALA . 5.3 t80 -86.85 124.12 32.73 Favored 'General case' 0 C--O 1.223 -0.301 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 177.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.787 HG21 ' O ' ' A' ' 208' ' ' VAL . 26.9 t -85.53 147.13 5.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 -175.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.2 p -139.86 14.26 2.48 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.924 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.437 ' H ' HG12 ' A' ' 170' ' ' VAL . 3.9 t70 -150.85 -144.66 0.16 Allowed 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -40.3 -105.16 0.01 OUTLIER Glycine 0 CA--C 1.534 1.246 0 N-CA-C 115.208 0.843 . . . . 0.0 115.208 -179.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.817 ' HG2' ' HB2' ' A' ' 209' ' ' ALA . 6.8 mttt -151.04 143.25 24.1 Favored 'General case' 0 CA--C 1.517 -0.315 0 O-C-N 122.557 -0.378 . . . . 0.0 111.764 -178.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.628 HG13 HG22 ' A' ' 170' ' ' VAL . 14.6 mm -95.36 78.94 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 176.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.853 ' O ' HD13 ' A' ' 195' ' ' ILE . 0.0 OUTLIER -97.97 171.06 8.51 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -176.834 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.34 -39.54 74.63 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.28 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -88.58 55.14 3.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.815 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . 0.812 ' O ' HD12 ' A' ' 195' ' ' ILE . 0.9 OUTLIER -150.18 159.65 44.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.603 -179.973 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 0.0 OUTLIER -89.06 -178.49 5.7 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 179.238 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.697 HG21 HG23 ' A' ' 218' ' ' ILE . 3.3 m -149.64 146.24 17.1 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.615 0 CA-C-O 121.599 0.714 . . . . 0.0 112.028 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 231' ' ' GLU . 7.8 ttt180 -154.54 101.93 2.37 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.748 -1.114 . . . . 0.0 112.198 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.643 ' C ' HD12 ' A' ' 184' ' ' ILE . 0.3 OUTLIER -97.46 170.54 8.98 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.636 179.234 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.791 HG23 ' O ' ' A' ' 188' ' ' ILE . 5.3 mp -152.08 141.32 14.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.021 -177.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.486 ' N ' HG22 ' A' ' 190' ' ' VAL . 3.6 ttm180 -86.37 -156.22 0.29 Allowed 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 178.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -93.62 26.5 3.03 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.915 179.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -154.07 -43.68 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.062 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.791 ' O ' HG23 ' A' ' 184' ' ' ILE . 0.4 OUTLIER -150.4 -159.74 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -178.001 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.663 ' N ' HG23 ' A' ' 188' ' ' ILE . 22.4 t -84.86 133.68 28.75 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 CA-C-O 121.572 0.701 . . . . 0.0 110.137 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.875 HG12 ' OD2' ' A' ' 223' ' ' ASP . 0.2 OUTLIER -88.32 -38.38 11.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 114.678 -1.147 . . . . 0.0 109.223 -179.213 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . 0.479 ' HB2' ' CE1' ' A' ' 221' ' ' PHE . 19.1 t80 -169.62 162.39 9.83 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.201 178.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . 0.654 ' CG ' HG11 ' A' ' 189' ' ' VAL . 28.1 mt-10 -150.1 157.97 43.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.041 0.448 . . . . 0.0 111.056 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 146.27 -126.42 2.49 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.077 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . 0.597 ' CA ' HG22 ' A' ' 181' ' ' VAL . 3.9 pt-20 -139.92 -176.9 4.75 Favored 'General case' 0 CA--C 1.498 -1.038 0 CA-C-O 121.152 0.501 . . . . 0.0 111.3 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.853 HD13 ' O ' ' A' ' 176' ' ' THR . 3.1 mp -86.85 141.44 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.39 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.351 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.08 -47.48 8.07 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 40.4 m -151.24 163.42 38.92 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.086 179.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.69 HD22 ' HB3' ' A' ' 216' ' ' LEU . 0.1 OUTLIER -134.38 108.84 8.4 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 121.099 0.476 . . . . 0.0 111.073 -179.947 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 3.3 mtpm? -150.1 118.61 6.49 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.682 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . 0.551 HH12 HG11 ' A' ' 205' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.527 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.946 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . 0.401 ' HA ' ' HA ' ' A' ' 199' ' ' LYS . 4.1 m-20 . . . . . 0 N--CA 1.454 -0.275 0 CA-C-O 121.002 0.43 . . . . 0.0 110.334 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.551 HG11 HH12 ' A' ' 200' ' ' ARG . 32.6 m -64.38 154.83 6.61 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.905 0 CA-C-O 121.501 0.667 . . . . 0.0 112.038 -179.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . 0.456 ' O ' ' HB ' ' A' ' 176' ' ' THR . 4.3 ttm-85 -89.62 -29.7 18.66 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 114.868 -1.06 . . . . 0.0 112.052 -178.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.699 ' HB3' HG22 ' A' ' 176' ' ' THR . 1.5 mp0 -142.93 178.17 7.85 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.123 0.487 . . . . 0.0 111.078 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.787 ' O ' HG21 ' A' ' 170' ' ' VAL . 0.2 OUTLIER -151.18 75.83 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.882 179.054 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.817 ' HB2' ' HG2' ' A' ' 174' ' ' LYS . . . -98.24 172.81 7.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.053 0.454 . . . . 0.0 112.195 -178.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 83.94 -73.49 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.957 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 178.45 37.71 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.328 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -102.23 142.98 32.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.863 0.363 . . . . 0.0 111.237 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -100.17 131.72 45.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.337 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' CYS . . . . . 0.569 ' HB3' HG21 ' A' ' 208' ' ' VAL . 48.6 t -133.85 148.19 51.26 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.384 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -88.54 111.47 3.79 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.016 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.69 ' HB3' HD22 ' A' ' 198' ' ' LEU . 0.2 OUTLIER -135.73 144.76 46.06 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 120.946 0.403 . . . . 0.0 111.281 -179.141 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . 0.543 ' C ' HD12 ' A' ' 218' ' ' ILE . 0.2 OUTLIER -82.37 149.0 27.94 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.189 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . 0.697 HG23 HG21 ' A' ' 181' ' ' VAL . 1.7 mp -113.96 88.2 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 -179.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 2.3 tttt 45.51 -144.72 0.19 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.931 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -87.08 61.35 6.72 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 120.957 0.408 . . . . 0.0 110.889 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . 0.523 ' CZ ' HD21 ' A' ' 183' ' ' LEU . 0.1 OUTLIER -55.23 118.85 4.74 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 179.081 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 21.8 t30 -81.56 -47.46 13.05 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 114.804 -1.089 . . . . 0.0 108.571 176.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . 0.875 ' OD2' HG12 ' A' ' 190' ' ' VAL . 0.0 OUTLIER -83.62 139.25 32.94 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.204 177.966 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.636 ' N ' HD13 ' A' ' 224' ' ' ILE . 0.2 OUTLIER -132.27 179.35 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 CA-C-O 121.276 0.56 . . . . 0.0 112.28 -179.542 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.403 ' O ' ' C ' ' A' ' 226' ' ' GLU . 0.3 OUTLIER 58.01 115.87 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.677 -178.756 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . 0.445 ' HB3' ' O ' ' A' ' 154' ' ' ARG . 2.6 pt-20 3.64 66.62 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 124.812 1.245 . . . . 0.0 113.931 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -63.35 -62.56 5.27 Favored Glycine 0 N--CA 1.43 -1.745 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.855 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.451 ' O ' HG12 ' A' ' 153' ' ' VAL . 0.8 OUTLIER -164.95 -148.38 0.11 Allowed 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -179.891 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . 0.681 HG22 ' HG2' ' A' ' 152' ' ' GLU . 96.4 t -90.37 132.23 35.54 Favored 'Isoleucine or valine' 0 C--N 1.347 0.46 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . 0.731 HD11 ' HB ' ' A' ' 153' ' ' VAL . 4.6 mp -98.61 158.8 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 O-C-N 123.477 0.486 . . . . 0.0 111.572 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' GLU . . . . . 0.44 ' O ' ' N ' ' A' ' 182' ' ' ARG . 7.8 tt0 -145.89 109.55 4.79 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.587 ' HB3' ' CA ' ' A' ' 149' ' ' GLY . . . -88.12 126.86 35.34 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.516 178.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -132.57 140.08 48.11 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.107 -178.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.735 HG12 HG21 ' A' ' 148' ' ' ILE . 0.4 OUTLIER . . . . . 0 CA--C 1.538 0.508 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.937 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 12.7 tttt . . . . . 0 N--CA 1.461 0.079 0 CA-C-O 120.874 0.369 . . . . 0.0 111.159 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.711 HG11 ' HB2' ' A' ' 150' ' ' GLN . 15.1 t -59.0 140.81 16.81 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.595 0 CA-C-O 121.209 0.528 . . . . 0.0 111.485 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.666 HG13 HG12 ' A' ' 234' ' ' VAL . 0.1 OUTLIER -125.96 -0.85 4.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.819 177.872 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.551 ' CA ' ' HB3' ' A' ' 232' ' ' ALA . . . -176.66 72.95 0.08 OUTLIER Glycine 0 C--N 1.341 0.848 0 C-N-CA 121.109 -0.567 . . . . 0.0 111.817 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.711 ' HB2' HG11 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -91.97 132.3 36.62 Favored 'General case' 0 CA--C 1.511 -0.532 0 O-C-N 122.514 -0.403 . . . . 0.0 110.217 179.899 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.493 ' O ' HG13 ' A' ' 229' ' ' VAL . . . -152.22 177.51 10.46 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -178.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.504 ' CD ' HG22 ' A' ' 229' ' ' VAL . 2.1 mm-40 -123.66 125.09 44.16 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.566 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.447 HG11 ' N ' ' A' ' 227' ' ' GLY . 1.4 p -49.82 132.43 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -179.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.554 ' O ' ' HB3' ' A' ' 226' ' ' GLU . 4.3 mmp_? -89.58 -61.88 1.6 Allowed 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 105.232 -2.136 . . . . 0.0 105.232 175.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.29 -159.05 0.46 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 113.555 -1.657 . . . . 0.0 108.945 175.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.525 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 17.4 p -146.04 175.16 10.67 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 110.34 -0.245 . . . . 0.0 110.34 177.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.662 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 12.0 m-85 -129.06 73.25 1.5 Allowed 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -179.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 163' ' ' GLY . 4.6 ptmt -85.81 64.38 8.57 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.491 HG12 ' N ' ' A' ' 161' ' ' LYS . 57.0 t -93.22 156.87 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 CA-C-N 113.294 -1.775 . . . . 0.0 110.527 -178.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 92.0 p -91.95 35.91 0.97 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.221 0.534 . . . . 0.0 109.584 178.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.491 ' N ' HG12 ' A' ' 159' ' ' VAL . 0.2 OUTLIER -150.85 -34.04 0.16 Allowed 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.165 -179.576 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.617 HG12 HD13 ' A' ' 165' ' ' ILE . 89.5 t -102.18 -102.04 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . 0.511 ' N ' HG12 ' A' ' 162' ' ' VAL . . . -158.54 -102.0 0.18 Allowed Glycine 0 C--O 1.226 -0.384 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.461 HG22 HG22 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -153.37 34.46 0.46 Allowed 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 124.482 1.113 . . . . 0.0 108.145 177.795 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.662 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 1.6 mp -42.15 95.2 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 CA-C-N 115.063 -0.971 . . . . 0.0 112.143 -178.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.525 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . -87.8 117.89 26.95 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.416 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -87.9 149.51 21.63 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.157 -1.02 . . . . 0.0 110.761 179.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.427 ' HB2' ' CB ' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -144.7 135.06 24.34 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.929 0.365 . . . . 0.0 110.537 -178.69 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . 0.408 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 91.0 t80 -86.94 124.69 33.43 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 177.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.716 HG21 ' O ' ' A' ' 208' ' ' VAL . 25.0 t -85.06 143.53 11.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -175.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -136.44 14.75 3.21 Favored 'General case' 0 CA--C 1.526 0.053 0 CA-C-N 114.475 -1.239 . . . . 0.0 111.851 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.421 ' H ' HG12 ' A' ' 170' ' ' VAL . 5.0 t0 -150.36 -144.28 0.15 Allowed 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -179.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -42.06 -105.06 0.01 OUTLIER Glycine 0 CA--C 1.532 1.107 0 N-CA-C 115.055 0.782 . . . . 0.0 115.055 -179.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.779 ' HG2' ' HB2' ' A' ' 209' ' ' ALA . 17.8 mttt -150.83 143.8 24.65 Favored 'General case' 0 N--CA 1.465 0.312 0 O-C-N 122.585 -0.362 . . . . 0.0 111.582 -178.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.61 ' CG1' HG22 ' A' ' 170' ' ' VAL . 13.2 mm -94.96 81.64 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 176.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.707 HG22 ' HB3' ' A' ' 207' ' ' GLU . 0.1 OUTLIER -95.47 169.23 10.2 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -177.028 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.406 ' CG ' ' HB3' ' A' ' 198' ' ' LEU . 24.7 mtm105 -65.5 -44.46 86.98 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.977 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.16 60.59 5.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.128 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . 0.49 ' O ' HD12 ' A' ' 195' ' ' ILE . 23.8 m -149.98 161.49 42.22 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.682 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 13.5 mttt -91.46 -169.72 2.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.077 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.552 HG22 ' CA ' ' A' ' 194' ' ' GLU . 1.2 m -150.34 158.1 5.58 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.451 0 CA-C-O 121.235 0.541 . . . . 0.0 111.633 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . 0.632 ' NH1' HD11 ' A' ' 184' ' ' ILE . 1.6 ttt85 -152.73 100.53 2.54 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.377 -0.829 . . . . 0.0 112.88 -179.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.673 HD12 ' HB3' ' A' ' 191' ' ' TYR . 0.3 OUTLIER -85.99 156.32 20.5 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-O 121.793 0.806 . . . . 0.0 113.149 -179.608 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.699 ' N ' HG23 ' A' ' 190' ' ' VAL . 28.4 mm -154.3 123.96 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 114.254 -1.339 . . . . 0.0 111.296 178.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.571 ' N ' HG22 ' A' ' 190' ' ' VAL . 0.2 OUTLIER -85.74 -150.85 0.14 Allowed 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 177.976 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.84 25.74 3.48 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 118.531 0.605 . . . . 0.0 110.81 178.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -155.03 -68.11 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.478 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -120.61 -156.68 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 115.327 -0.437 . . . . 0.0 110.901 -178.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.761 HG11 ' CG ' ' A' ' 192' ' ' GLU . 59.0 t -87.22 135.85 24.35 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-O 121.303 0.573 . . . . 0.0 111.506 -179.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.781 HG12 ' OD2' ' A' ' 223' ' ' ASP . 0.1 OUTLIER -89.37 -33.95 6.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.165 -0.925 . . . . 0.0 108.911 178.764 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . 0.673 ' HB3' HD12 ' A' ' 183' ' ' LEU . 15.8 t80 -162.71 159.31 24.14 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.45 178.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . 0.761 ' CG ' HG11 ' A' ' 189' ' ' VAL . 19.8 mt-10 -150.17 158.08 43.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.862 178.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 133.02 -119.49 2.39 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.24 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . 0.552 ' CA ' HG22 ' A' ' 181' ' ' VAL . 12.2 pt-20 -150.61 -175.17 5.0 Favored 'General case' 0 CA--C 1.5 -0.971 0 CA-C-O 121.179 0.514 . . . . 0.0 111.345 -179.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.49 HD12 ' O ' ' A' ' 179' ' ' SER . 4.9 mp -88.86 143.76 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.409 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' ASP . . . . . 0.57 ' HB3' HG23 ' A' ' 217' ' ' THR . 0.6 OUTLIER -88.91 -53.9 4.38 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.5 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -151.72 142.71 23.08 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.783 179.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.781 ' CD1' HD22 ' A' ' 216' ' ' LEU . 32.3 tp -115.73 117.51 30.44 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 121.466 0.65 . . . . 0.0 111.922 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 25.6 mttt -150.36 120.94 7.45 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.952 179.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 4.5 ttm180 . . . . . 0 C--N 1.322 -0.591 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.991 -179.666 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . 0.412 ' HA ' ' HA ' ' A' ' 199' ' ' LYS . 7.2 p-10 . . . . . 0 N--CA 1.453 -0.299 0 CA-C-O 120.905 0.383 . . . . 0.0 110.061 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 28.3 m -60.96 157.77 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.884 0 CA-C-O 121.596 0.712 . . . . 0.0 112.376 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . 0.47 ' O ' ' HB ' ' A' ' 176' ' ' THR . 0.1 OUTLIER -89.31 -35.26 16.22 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 114.616 -1.175 . . . . 0.0 111.454 -178.741 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.707 ' HB3' HG22 ' A' ' 176' ' ' THR . 2.2 mp0 -144.32 178.49 7.88 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.9 0.381 . . . . 0.0 110.878 179.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.716 ' O ' HG21 ' A' ' 170' ' ' VAL . 1.3 t -150.93 77.0 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.109 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.779 ' HB2' ' HG2' ' A' ' 174' ' ' LYS . . . -96.85 170.84 8.89 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -178.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 85.77 -75.5 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.233 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 177.89 37.15 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.334 -0.936 . . . . 0.0 112.432 179.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -95.27 150.03 20.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.901 0.381 . . . . 0.0 111.333 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -89.76 159.53 17.0 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.215 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 5.1 p -150.71 -175.48 5.13 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.265 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . 0.448 ' C ' HG23 ' A' ' 165' ' ' ILE . . . -144.02 96.97 0.19 Allowed Glycine 0 N--CA 1.451 -0.335 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 179.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.781 HD22 ' CD1' ' A' ' 198' ' ' LEU . 0.4 OUTLIER -131.71 142.01 49.7 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 120.932 0.396 . . . . 0.0 111.992 -178.367 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . 0.57 HG23 ' HB3' ' A' ' 196' ' ' ASP . 0.1 OUTLIER -79.14 132.98 36.74 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 176.877 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . 0.578 HG22 ' O ' ' A' ' 218' ' ' ILE . 1.4 mp -98.35 97.49 6.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.459 -177.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 6.5 tttp 42.5 -144.33 0.08 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.978 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -87.66 64.14 7.88 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 120.871 0.367 . . . . 0.0 110.738 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . 0.646 ' CZ ' HD13 ' A' ' 183' ' ' LEU . 0.1 OUTLIER -54.81 118.51 4.31 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 179.075 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -82.76 -43.82 16.31 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 114.691 -1.14 . . . . 0.0 108.548 176.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . 0.781 ' OD2' HG12 ' A' ' 190' ' ' VAL . 0.0 OUTLIER -89.57 130.7 35.85 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 178.171 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.617 HD13 ' H ' ' A' ' 224' ' ' ILE . 0.2 OUTLIER -114.96 175.89 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 CA-C-O 121.263 0.554 . . . . 0.0 111.511 179.562 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.469 ' O ' ' N ' ' A' ' 227' ' ' GLY . 5.9 mtmt 63.53 147.74 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.84 -1.073 . . . . 0.0 108.992 -178.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . 0.554 ' HB3' ' O ' ' A' ' 154' ' ' ARG . 3.3 pt-20 -36.58 87.98 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.931 0.872 . . . . 0.0 112.855 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 225' ' ' LYS . . . -81.46 -57.62 2.73 Favored Glycine 0 N--CA 1.427 -1.902 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.873 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.447 ' O ' HG12 ' A' ' 153' ' ' VAL . 1.0 OUTLIER -163.71 -146.91 0.11 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 179.365 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . 0.504 HG22 ' CD ' ' A' ' 152' ' ' GLU . 61.6 t -93.64 147.4 5.54 Favored 'Isoleucine or valine' 0 C--N 1.342 0.278 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.62 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . 0.409 HG13 ' HG ' ' A' ' 183' ' ' LEU . 2.8 mp -118.6 154.58 20.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.187 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' GLU . . . . . 0.46 ' HA ' ' HA ' ' A' ' 150' ' ' GLN . 10.2 tt0 -142.49 112.26 6.85 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.421 0.629 . . . . 0.0 111.965 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.551 ' HB3' ' CA ' ' A' ' 149' ' ' GLY . . . -86.9 129.81 34.72 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.195 178.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' TYR . . . . . 0.61 ' C ' HD12 ' A' ' 148' ' ' ILE . 6.0 p90 -130.2 144.0 51.11 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.289 -178.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.666 HG12 HG13 ' A' ' 148' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.674 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 2.8 tttp . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.634 0.254 . . . . 0.0 110.548 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.81 HG11 ' HB2' ' A' ' 150' ' ' GLN . 14.4 t -61.72 139.27 20.93 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.628 0 CA-C-O 121.357 0.599 . . . . 0.0 111.226 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.727 HG21 HG12 ' A' ' 234' ' ' VAL . 1.1 pt -117.64 -11.87 11.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.145 178.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.527 ' O ' ' HB3' ' A' ' 232' ' ' ALA . . . -177.64 77.91 0.07 OUTLIER Glycine 0 C--N 1.34 0.799 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.81 ' HB2' HG11 ' A' ' 147' ' ' VAL . 0.7 OUTLIER -91.29 137.94 31.97 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 120.704 0.288 . . . . 0.0 110.56 -179.65 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.468 ' O ' HG13 ' A' ' 229' ' ' VAL . . . -152.01 178.13 9.75 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -178.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.724 ' HG2' HG22 ' A' ' 229' ' ' VAL . 40.4 mt-10 -124.34 124.93 43.45 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.334 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.543 ' HB ' HD11 ' A' ' 230' ' ' ILE . 2.2 p -51.04 133.84 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.403 ' HD2' ' HB2' ' A' ' 169' ' ' TYR . 4.2 mmp_? -89.52 -63.39 1.29 Allowed 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 104.943 -2.243 . . . . 0.0 104.943 175.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.418 ' HA ' ' H ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER -162.4 -162.29 0.8 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 113.664 -1.607 . . . . 0.0 108.839 174.721 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 4.9 p -147.19 143.95 28.58 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 177.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.527 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 0.4 OUTLIER -89.96 83.51 6.13 Favored 'General case' 0 CA--C 1.51 -0.583 0 N-CA-C 113.969 1.099 . . . . 0.0 113.969 -177.598 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 10.2 tttp -86.82 62.18 7.24 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 177.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.518 HG12 ' N ' ' A' ' 161' ' ' LYS . 40.9 t -93.32 156.02 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 CA-C-N 113.694 -1.593 . . . . 0.0 110.306 -178.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 12.4 t -90.15 35.68 0.86 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.13 0.491 . . . . 0.0 109.954 178.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.518 ' N ' HG12 ' A' ' 159' ' ' VAL . 0.9 OUTLIER -150.41 -32.4 0.18 Allowed 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.343 -179.671 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.523 HG12 ' N ' ' A' ' 163' ' ' GLY . 93.5 t -102.85 -103.23 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.226 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . 0.523 ' N ' HG12 ' A' ' 162' ' ' VAL . . . -159.07 -99.07 0.15 Allowed Glycine 0 N--CA 1.452 -0.25 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 178.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 1.118 HG21 HG21 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -153.49 34.65 0.45 Allowed 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.282 1.033 . . . . 0.0 108.275 177.72 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.529 HG22 ' O ' ' A' ' 165' ' ' ILE . 1.1 mm -40.86 98.11 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.587 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.672 ' HB3' HD13 ' A' ' 218' ' ' ILE . . . -85.78 119.47 26.13 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.914 -1.039 . . . . 0.0 112.368 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -88.32 151.65 22.86 Favored Glycine 0 N--CA 1.443 -0.892 0 N-CA-C 110.159 -1.176 . . . . 0.0 110.159 178.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.55 ' HB3' HD13 ' A' ' 230' ' ' ILE . 0.0 OUTLIER -145.62 133.74 21.56 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 117.181 0.491 . . . . 0.0 110.724 -178.563 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . 0.432 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 10.9 t80 -87.33 127.33 35.19 Favored 'General case' 0 C--O 1.221 -0.429 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 177.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.812 HG21 ' O ' ' A' ' 208' ' ' VAL . 44.2 t -85.23 143.29 11.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -176.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -135.99 15.35 3.3 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 114.563 -1.199 . . . . 0.0 111.99 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -150.07 -146.42 0.2 Allowed 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -42.7 -105.11 0.01 OUTLIER Glycine 0 CA--C 1.531 1.071 0 N-CA-C 114.986 0.754 . . . . 0.0 114.986 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.745 ' HG3' ' HB2' ' A' ' 209' ' ' ALA . 0.0 OUTLIER -151.05 135.56 17.04 Favored 'General case' 0 CA--C 1.513 -0.465 0 O-C-N 122.637 -0.331 . . . . 0.0 111.207 -178.864 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.61 ' CG2' HG23 ' A' ' 208' ' ' VAL . 0.5 OUTLIER -95.51 112.13 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 176.909 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.48 ' HB ' ' O ' ' A' ' 206' ' ' ARG . 0.1 OUTLIER -120.93 169.12 10.77 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.468 0.652 . . . . 0.0 112.219 -176.8 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.92 -43.58 98.41 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.931 179.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -89.73 61.16 5.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.964 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . 0.702 ' HB3' HD11 ' A' ' 148' ' ' ILE . 57.9 m -148.06 159.23 44.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.819 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 0.0 OUTLIER -89.08 -176.95 5.31 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.344 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.886 ' CG1' HD12 ' A' ' 195' ' ' ILE . 1.4 m -146.15 156.75 12.06 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 CA-C-O 121.466 0.65 . . . . 0.0 112.278 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . 0.436 ' N ' ' O ' ' A' ' 231' ' ' GLU . 4.1 ttt180 -153.49 102.65 2.59 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.081 -0.963 . . . . 0.0 113.051 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.738 HD13 ' CZ ' ' A' ' 221' ' ' PHE . 0.3 OUTLIER -86.03 159.55 19.56 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-O 122.143 0.973 . . . . 0.0 113.255 -179.758 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.531 ' N ' HG23 ' A' ' 190' ' ' VAL . 16.2 mt -153.82 122.59 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 113.838 -1.528 . . . . 0.0 112.311 178.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.431 ' N ' HG22 ' A' ' 190' ' ' VAL . 0.2 OUTLIER -87.05 -147.93 0.14 Allowed 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 177.848 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 21.0 mm100 -95.47 27.36 3.41 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 118.651 0.659 . . . . 0.0 110.745 178.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.419 ' C ' HD13 ' A' ' 188' ' ' ILE . . . -154.57 -80.24 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.755 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.419 HD13 ' C ' ' A' ' 187' ' ' GLY . 0.3 OUTLIER -112.41 -155.37 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 115.342 -0.429 . . . . 0.0 110.716 -179.107 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.777 HG11 ' CG ' ' A' ' 192' ' ' GLU . 41.2 t -87.04 135.62 24.8 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.096 0 CA-C-O 121.45 0.643 . . . . 0.0 111.576 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.897 HG12 ' OD2' ' A' ' 223' ' ' ASP . 0.2 OUTLIER -89.88 -32.25 5.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.203 178.687 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . 0.698 ' HB3' HD12 ' A' ' 183' ' ' LEU . 17.4 t80 -160.06 158.35 30.26 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.496 178.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . 0.777 ' CG ' HG11 ' A' ' 189' ' ' VAL . 22.3 mt-10 -150.81 154.05 36.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.072 178.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 135.29 -119.75 2.18 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.054 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . 0.624 ' CA ' HG22 ' A' ' 181' ' ' VAL . 0.0 OUTLIER -148.43 -178.47 6.34 Favored 'General case' 0 CA--C 1.501 -0.904 0 CA-C-O 121.523 0.678 . . . . 0.0 111.663 -179.446 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.886 HD12 ' CG1' ' A' ' 181' ' ' VAL . 0.0 OUTLIER -88.75 147.77 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 CA-C-N 114.64 -1.163 . . . . 0.0 110.257 -178.674 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.68 -54.68 3.96 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 179.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 64.2 p -150.93 160.05 44.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.5 179.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.895 ' CD1' HD22 ' A' ' 216' ' ' LEU . 27.2 tp -133.44 110.71 10.18 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.384 0.611 . . . . 0.0 111.205 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 9.7 ptmt -149.8 123.89 9.44 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.414 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 2.6 ttm-85 . . . . . 0 C--N 1.322 -0.589 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.896 -179.938 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 . . . . . 0 N--CA 1.453 -0.294 0 CA-C-O 120.996 0.427 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 33.3 m -58.68 161.3 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.949 0 CA-C-O 121.55 0.69 . . . . 0.0 112.21 -179.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . 0.48 ' O ' ' HB ' ' A' ' 176' ' ' THR . 4.4 ttp180 -89.39 -38.17 14.31 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 114.625 -1.17 . . . . 0.0 111.461 -178.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -138.01 177.06 8.16 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.132 0.492 . . . . 0.0 111.332 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.812 ' O ' HG21 ' A' ' 170' ' ' VAL . 0.0 OUTLIER -151.05 81.78 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.544 178.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.745 ' HB2' ' HG3' ' A' ' 174' ' ' LYS . . . -101.7 172.52 6.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.102 0.477 . . . . 0.0 112.281 -178.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 2.8 tp-100 83.9 -72.98 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.983 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 178.09 37.95 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.371 -0.918 . . . . 0.0 112.44 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -97.99 143.22 28.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.979 0.419 . . . . 0.0 111.471 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -89.63 158.13 17.73 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.352 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -150.48 -171.09 3.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.015 0.436 . . . . 0.0 111.289 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -137.98 106.36 0.53 Allowed Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 178.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.895 HD22 ' CD1' ' A' ' 198' ' ' LEU . 0.1 OUTLIER -135.17 147.84 49.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.452 0.644 . . . . 0.0 112.602 -177.377 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . 0.485 ' C ' HD12 ' A' ' 218' ' ' ILE . 0.0 OUTLIER -87.31 142.77 27.64 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 177.355 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . 0.672 HD13 ' HB3' ' A' ' 166' ' ' ALA . 1.5 mp -100.52 81.11 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.915 0.388 . . . . 0.0 110.817 -178.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 4.0 ttpt 42.34 -88.94 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.721 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' ASN . . . . . 0.401 ' N ' ' O ' ' A' ' 218' ' ' ILE . 13.0 t-20 -132.6 62.59 1.65 Allowed 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.118 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . 0.738 ' CZ ' HD13 ' A' ' 183' ' ' LEU . 0.1 OUTLIER -59.23 119.55 7.58 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 179.443 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -81.58 -42.51 19.99 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 175.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . 0.897 ' OD2' HG12 ' A' ' 190' ' ' VAL . 0.0 OUTLIER -92.81 143.44 26.28 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.339 177.693 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 1.118 HG21 HG21 ' A' ' 164' ' ' THR . 0.2 OUTLIER -135.94 178.14 5.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -179.183 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.412 ' O ' ' C ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER 57.68 119.31 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 114.543 -1.208 . . . . 0.0 110.009 -178.953 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . 0.453 ' HA ' ' CG1' ' A' ' 153' ' ' VAL . 5.3 tt0 5.95 65.81 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 124.455 1.102 . . . . 0.0 113.62 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -66.34 -63.74 3.76 Favored Glycine 0 N--CA 1.429 -1.802 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.236 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.441 ' O ' ' HB ' ' A' ' 153' ' ' VAL . 1.0 OUTLIER -165.05 -147.17 0.1 Allowed 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 179.259 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . 0.724 HG22 ' HG2' ' A' ' 152' ' ' GLU . 52.6 t -89.8 146.92 5.59 Favored 'Isoleucine or valine' 0 C--N 1.34 0.181 0 CA-C-N 116.71 -0.223 . . . . 0.0 110.412 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . 0.55 HD13 ' HB3' ' A' ' 168' ' ' CYS . 4.4 mp -116.63 153.57 18.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.024 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' GLU . . . . . 0.436 ' O ' ' N ' ' A' ' 182' ' ' ARG . 0.1 OUTLIER -142.09 110.74 6.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.281 0.562 . . . . 0.0 111.949 -179.052 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.527 ' HB3' ' O ' ' A' ' 149' ' ' GLY . . . -87.93 127.97 35.37 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.312 178.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -129.3 139.41 51.78 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.349 -178.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.727 HG12 HG21 ' A' ' 148' ' ' ILE . 0.5 OUTLIER . . . . . 0 CA--C 1.535 0.396 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.881 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 5.3 mmtm . . . . . 0 CA--C 1.529 0.143 0 CA-C-O 120.441 0.162 . . . . 0.0 110.605 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 11.9 t -102.46 137.22 31.26 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.712 0 CA-C-O 121.36 0.6 . . . . 0.0 110.988 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.598 HG21 HG12 ' A' ' 234' ' ' VAL . 2.7 pp -131.9 6.85 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.245 178.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.547 ' CA ' ' HB3' ' A' ' 232' ' ' ALA . . . 171.77 73.91 0.04 OUTLIER Glycine 0 C--N 1.341 0.841 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.125 179.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.486 ' HA ' ' HA ' ' A' ' 231' ' ' GLU . 0.5 OUTLIER -93.04 132.09 37.46 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 122.551 -0.381 . . . . 0.0 110.613 -179.683 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.483 ' O ' HG13 ' A' ' 229' ' ' VAL . . . -151.22 172.92 15.08 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 121.377 0.608 . . . . 0.0 112.564 -178.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.43 ' HA ' ' HA ' ' A' ' 229' ' ' VAL . 1.8 mm-40 -121.6 126.21 48.54 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.438 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.48 ' CG1' ' HA ' ' A' ' 226' ' ' GLU . 1.9 p -52.39 131.32 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-O 121.344 0.592 . . . . 0.0 112.309 -179.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.497 ' O ' ' HB3' ' A' ' 226' ' ' GLU . 0.0 OUTLIER -90.47 -60.34 1.95 Allowed 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 105.142 -2.17 . . . . 0.0 105.142 175.444 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.49 -159.88 0.49 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 114.206 -1.361 . . . . 0.0 109.915 174.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.547 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 12.7 p -150.13 148.2 28.68 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.574 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 0.2 OUTLIER -90.72 82.47 5.75 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -177.723 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.401 ' CD ' HG13 ' A' ' 224' ' ' ILE . 1.6 tttt -86.44 62.29 7.33 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 177.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.478 HG12 ' N ' ' A' ' 161' ' ' LYS . 54.0 t -91.28 156.08 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 CA-C-N 113.771 -1.559 . . . . 0.0 110.059 -178.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 80.0 p -90.41 34.2 0.88 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.122 0.487 . . . . 0.0 110.161 178.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.478 ' N ' HG12 ' A' ' 159' ' ' VAL . 0.0 OUTLIER -150.75 -32.32 0.17 Allowed 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.471 -179.862 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.494 HG12 ' N ' ' A' ' 163' ' ' GLY . 87.4 t -100.17 -102.68 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.15 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . 0.494 ' N ' HG12 ' A' ' 162' ' ' VAL . . . -159.28 -101.51 0.17 Allowed Glycine 0 N--CA 1.451 -0.344 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 178.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 1.039 HG21 HG21 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -153.5 36.46 0.46 Allowed 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 177.822 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.696 HD12 ' O ' ' A' ' 215' ' ' GLY . 0.9 OUTLIER -42.31 95.3 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.26 -179.416 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.877 ' O ' HD12 ' A' ' 216' ' ' LEU . . . -82.08 118.68 23.22 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 114.495 -1.229 . . . . 0.0 112.482 -178.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -91.22 143.99 16.94 Favored Glycine 0 N--CA 1.442 -0.965 0 N-CA-C 111.001 -0.839 . . . . 0.0 111.001 178.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.656 ' SG ' HD11 ' A' ' 216' ' ' LEU . 0.0 OUTLIER -137.73 132.95 33.56 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 -179.728 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . 0.432 ' HB2' ' HD3' ' A' ' 154' ' ' ARG . 7.4 t80 -85.03 128.16 34.51 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 178.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.581 HG21 ' O ' ' A' ' 208' ' ' VAL . 44.4 t -85.96 147.79 5.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -176.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.6 p -140.78 14.83 2.31 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-N 114.474 -1.239 . . . . 0.0 111.841 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.406 ' CB ' ' HB2' ' A' ' 150' ' ' GLN . 11.3 t0 -150.8 -144.46 0.15 Allowed 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 -179.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -40.15 -104.22 0.01 OUTLIER Glycine 0 CA--C 1.532 1.11 0 N-CA-C 115.209 0.844 . . . . 0.0 115.209 -179.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.671 ' HG2' ' HB2' ' A' ' 209' ' ' ALA . 20.2 mttp -151.13 134.73 16.33 Favored 'General case' 0 CA--C 1.514 -0.427 0 O-C-N 122.517 -0.402 . . . . 0.0 111.839 -178.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.839 ' CG2' HD21 ' A' ' 216' ' ' LEU . 4.6 mm -91.2 83.87 2.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 176.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.706 HG22 ' HB3' ' A' ' 207' ' ' GLU . 0.0 OUTLIER -98.62 -178.16 3.9 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -176.704 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.59 -45.59 21.33 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-N 114.854 -1.066 . . . . 0.0 111.166 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -88.67 61.39 6.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.393 0.616 . . . . 0.0 110.338 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . 0.533 ' HB3' HD11 ' A' ' 148' ' ' ILE . 16.4 m -149.32 157.74 43.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.986 -179.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 1.7 mptt -89.06 -178.17 5.62 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.655 HG22 ' CA ' ' A' ' 194' ' ' GLU . 1.9 m -142.71 161.79 18.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.336 0.589 . . . . 0.0 111.845 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . 0.428 ' N ' ' O ' ' A' ' 231' ' ' GLU . 15.1 ttt180 -151.74 98.95 2.54 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.113 -0.948 . . . . 0.0 112.323 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.89 HD13 ' HB3' ' A' ' 191' ' ' TYR . 5.4 mp -89.08 146.14 25.02 Favored 'General case' 0 CA--C 1.497 -1.09 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -178.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.465 ' CA ' HG23 ' A' ' 190' ' ' VAL . 17.8 mt -156.57 128.18 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-N 113.168 -1.833 . . . . 0.0 111.772 179.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.403 ' N ' ' CG2' ' A' ' 190' ' ' VAL . 0.1 OUTLIER -88.87 -148.44 0.17 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 177.943 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -94.94 29.69 2.32 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 118.604 0.638 . . . . 0.0 110.998 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -153.6 -83.34 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.869 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.47 ' H ' HD12 ' A' ' 188' ' ' ILE . 0.1 OUTLIER -111.6 -158.7 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 CA-C-N 115.455 -0.372 . . . . 0.0 110.621 -179.252 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.536 HG11 ' CG ' ' A' ' 192' ' ' GLU . 43.4 t -87.13 134.85 26.58 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 CA-C-O 121.68 0.752 . . . . 0.0 110.992 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.895 HG12 ' OD2' ' A' ' 223' ' ' ASP . 0.2 OUTLIER -94.79 -34.84 5.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 114.416 -1.265 . . . . 0.0 109.525 -179.909 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . 0.89 ' HB3' HD13 ' A' ' 183' ' ' LEU . 27.0 t80 -170.1 156.14 5.82 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.102 -0.953 . . . . 0.0 112.446 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . 0.536 ' CG ' HG11 ' A' ' 189' ' ' VAL . 32.2 mt-10 -151.13 162.12 41.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.634 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 134.76 -114.88 1.33 Allowed Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.558 -0.829 . . . . 0.0 112.343 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . 0.655 ' CA ' HG22 ' A' ' 181' ' ' VAL . 0.0 OUTLIER -150.47 -178.43 6.53 Favored 'General case' 0 CA--C 1.503 -0.865 0 CA-C-O 121.323 0.583 . . . . 0.0 110.901 -179.407 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.683 ' CD1' HD22 ' A' ' 216' ' ' LEU . 0.0 OUTLIER -89.76 154.65 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.921 -179.431 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' ASP . . . . . 0.402 ' HB3' ' CB ' ' A' ' 217' ' ' THR . 26.3 t70 -89.8 -66.79 0.89 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 178.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -151.63 146.72 26.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.248 179.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.853 ' HG ' HD23 ' A' ' 216' ' ' LEU . 2.4 tt -110.96 119.52 39.34 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.519 0.676 . . . . 0.0 112.487 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . 0.558 ' N ' HD23 ' A' ' 198' ' ' LEU . 0.7 OUTLIER -151.55 116.52 5.22 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.491 178.55 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.325 -0.463 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 5.1 t70 . . . . . 0 N--CA 1.453 -0.276 0 CA-C-O 120.96 0.41 . . . . 0.0 110.417 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 34.2 m -66.14 162.39 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.958 0 CA-C-O 121.414 0.626 . . . . 0.0 112.062 -179.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . 0.468 ' O ' ' HB ' ' A' ' 176' ' ' THR . 5.3 mtp180 -89.15 -37.32 15.14 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.565 -178.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.706 ' HB3' HG22 ' A' ' 176' ' ' THR . 0.5 OUTLIER -141.38 178.35 7.49 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.27 0.557 . . . . 0.0 111.746 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.581 ' O ' HG21 ' A' ' 170' ' ' VAL . 0.0 OUTLIER -151.05 80.59 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.588 179.034 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.671 ' HB2' ' HG2' ' A' ' 174' ' ' LYS . . . -96.47 172.02 8.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.072 0.463 . . . . 0.0 112.038 -178.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 84.83 -73.88 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.055 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 177.87 37.34 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.29 -0.957 . . . . 0.0 112.623 179.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -99.51 145.23 27.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.939 0.399 . . . . 0.0 111.568 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -89.77 161.38 16.06 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.528 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 27.1 p -150.55 -170.03 3.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.967 0.413 . . . . 0.0 111.209 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . 0.696 ' O ' HD12 ' A' ' 165' ' ' ILE . . . -139.74 98.68 0.24 Allowed Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 179.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.877 HD12 ' O ' ' A' ' 166' ' ' ALA . 0.2 OUTLIER -129.3 151.11 50.32 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 121.06 0.457 . . . . 0.0 110.782 -178.997 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . 0.402 ' CB ' ' HB3' ' A' ' 196' ' ' ASP . 0.0 OUTLIER -87.91 141.06 28.88 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 177.294 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . 0.606 HG22 ' O ' ' A' ' 218' ' ' ILE . 16.6 mm -98.2 74.39 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.77 -178.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 46.43 -136.0 0.8 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.295 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -87.03 58.07 4.86 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 120.793 0.33 . . . . 0.0 111.609 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . 0.767 ' CZ ' HD22 ' A' ' 183' ' ' LEU . 0.1 OUTLIER -56.25 120.0 6.88 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 178.1 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -80.01 -45.23 18.76 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 176.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . 0.895 ' OD2' HG12 ' A' ' 190' ' ' VAL . 0.0 OUTLIER -91.35 131.44 36.84 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.761 178.109 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 1.039 HG21 HG21 ' A' ' 164' ' ' THR . 0.1 OUTLIER -121.29 177.61 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-O 121.17 0.51 . . . . 0.0 111.929 -179.877 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.473 ' O ' ' N ' ' A' ' 227' ' ' GLY . 2.3 mtpp 62.92 152.32 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.136 -178.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . 0.497 ' HB3' ' O ' ' A' ' 154' ' ' ARG . 0.4 OUTLIER -38.45 90.14 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 CA-C-O 122.186 0.993 . . . . 0.0 112.258 -179.947 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 225' ' ' LYS . . . -106.45 -39.28 2.1 Favored Glycine 0 N--CA 1.43 -1.741 0 CA-C-N 114.429 -1.26 . . . . 0.0 112.152 -178.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.738 ' CB ' HG21 ' A' ' 190' ' ' VAL . 2.9 p30 -158.23 -164.85 1.57 Allowed 'General case' 0 C--O 1.22 -0.466 0 N-CA-C 115.292 1.59 . . . . 0.0 115.292 -178.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . 0.483 HG13 ' O ' ' A' ' 151' ' ' ALA . 89.3 t -102.25 144.66 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 177.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . 0.402 HG13 ' HG ' ' A' ' 183' ' ' LEU . 3.7 mp -114.79 153.61 16.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.217 0.532 . . . . 0.0 112.103 -178.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' GLU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 150' ' ' GLN . 20.3 tt0 -140.85 111.88 7.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.374 0.606 . . . . 0.0 111.476 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.547 ' HB3' ' CA ' ' A' ' 149' ' ' GLY . . . -87.78 128.7 35.32 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.896 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -130.81 142.81 50.41 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.916 -179.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.598 HG12 HG21 ' A' ' 148' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.111 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 5.9 mmtm . . . . . 0 C--O 1.23 0.078 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 18.9 t -97.39 136.91 26.56 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.631 0 CA-C-O 121.17 0.509 . . . . 0.0 110.527 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.601 HG21 ' O ' ' A' ' 234' ' ' VAL . 2.7 pp -128.94 6.31 2.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.326 178.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.569 ' CA ' ' HB3' ' A' ' 232' ' ' ALA . . . 171.21 75.43 0.04 OUTLIER Glycine 0 C--N 1.341 0.843 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.003 179.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.462 ' HA ' ' HA ' ' A' ' 231' ' ' GLU . 0.7 OUTLIER -95.14 130.3 41.9 Favored 'General case' 0 CA--C 1.517 -0.317 0 O-C-N 122.551 -0.382 . . . . 0.0 110.419 -179.826 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.475 ' O ' HG13 ' A' ' 229' ' ' VAL . . . -151.04 171.21 17.69 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 120.32 -0.552 . . . . 0.0 112.25 -178.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 229' ' ' VAL . 1.6 mm-40 -119.01 128.0 53.97 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.536 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.489 ' CG1' ' HA ' ' A' ' 226' ' ' GLU . 2.0 p -49.65 142.61 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -178.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -100.77 -63.01 1.17 Allowed 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 104.379 -2.452 . . . . 0.0 104.379 174.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.92 -165.65 1.29 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 113.735 -1.575 . . . . 0.0 109.368 174.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.525 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 8.1 p -147.11 163.29 36.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.553 0.216 . . . . 0.0 110.425 177.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.549 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 0.2 OUTLIER -115.48 76.26 0.99 Allowed 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -179.475 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.876 ' CB ' HD13 ' A' ' 224' ' ' ILE . 7.2 tmtm? -86.27 62.97 7.75 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 177.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.403 HG12 ' N ' ' A' ' 161' ' ' LYS . 98.3 t -92.94 158.59 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 CA-C-N 113.589 -1.642 . . . . 0.0 110.538 -178.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 19.7 m -93.28 34.57 1.13 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.317 0.58 . . . . 0.0 109.552 177.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.403 ' N ' HG12 ' A' ' 159' ' ' VAL . 1.1 mtpt -151.49 -34.77 0.14 Allowed 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.164 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.76 ' CG1' HD12 ' A' ' 165' ' ' ILE . 86.0 t -97.65 -102.7 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 N-CA-C 109.703 -0.481 . . . . 0.0 109.703 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . 0.505 ' N ' HG12 ' A' ' 162' ' ' VAL . . . -159.46 -102.47 0.18 Allowed Glycine 0 N--CA 1.451 -0.326 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 178.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.532 ' CG2' HG21 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -154.21 32.61 0.43 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 113.976 -1.112 . . . . 0.0 108.543 177.611 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.76 HD12 ' CG1' ' A' ' 162' ' ' VAL . 1.8 mt -42.53 95.42 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.481 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.525 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . -90.45 122.94 33.75 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.82 -1.082 . . . . 0.0 112.052 -179.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -88.29 146.03 19.38 Favored Glycine 0 N--CA 1.44 -1.053 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 178.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.412 ' HB2' ' CB ' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -143.76 131.4 21.24 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 117.164 0.482 . . . . 0.0 110.072 -179.18 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . 0.41 ' O ' ' HA ' ' A' ' 151' ' ' ALA . 17.2 t80 -86.94 122.39 30.74 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 178.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.74 HG21 ' O ' ' A' ' 208' ' ' VAL . 38.7 t -85.38 145.17 8.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -176.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 2.0 p -138.19 14.92 2.82 Favored 'General case' 0 N--CA 1.457 -0.113 0 CA-C-N 114.662 -1.154 . . . . 0.0 111.912 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.408 ' H ' HG12 ' A' ' 170' ' ' VAL . 10.7 t0 -150.62 -144.36 0.15 Allowed 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -179.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -40.48 -105.52 0.01 OUTLIER Glycine 0 CA--C 1.532 1.103 0 N-CA-C 115.13 0.812 . . . . 0.0 115.13 -178.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.618 ' HG2' ' HB2' ' A' ' 209' ' ' ALA . 7.1 mttt -151.4 134.85 16.17 Favored 'General case' 0 CA--C 1.514 -0.417 0 O-C-N 122.526 -0.397 . . . . 0.0 111.957 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.674 ' O ' HD11 ' A' ' 198' ' ' LEU . 6.0 mm -91.81 83.23 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 176.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.78 ' O ' HD12 ' A' ' 195' ' ' ILE . 0.1 OUTLIER -98.59 176.22 5.73 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.54 0.686 . . . . 0.0 112.415 -177.557 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -71.58 -44.67 64.06 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.969 -1.014 . . . . 0.0 111.386 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -88.99 61.83 6.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.249 0.547 . . . . 0.0 110.756 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . 0.42 ' HB3' HD11 ' A' ' 148' ' ' ILE . 20.3 m -150.09 157.95 43.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.048 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 2.1 mptt -88.68 177.27 6.79 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.661 HG22 ' CA ' ' A' ' 194' ' ' GLU . 2.0 m -141.68 163.71 19.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.399 0.619 . . . . 0.0 111.956 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . 0.43 ' N ' ' O ' ' A' ' 231' ' ' GLU . 7.4 ttt180 -151.51 100.09 2.68 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.037 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.852 HD13 ' HB3' ' A' ' 191' ' ' TYR . 5.4 mp -89.2 144.49 26.07 Favored 'General case' 0 CA--C 1.494 -1.184 0 CA-C-O 122.476 1.131 . . . . 0.0 113.868 -178.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.487 ' CA ' HG23 ' A' ' 190' ' ' VAL . 18.1 mt -156.65 129.28 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-N 113.007 -1.906 . . . . 0.0 111.754 179.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.413 ' N ' ' CG2' ' A' ' 190' ' ' VAL . 0.1 OUTLIER -88.54 -148.45 0.17 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.028 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -95.46 29.53 2.54 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 118.526 0.603 . . . . 0.0 110.818 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -153.23 -82.39 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.904 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -113.06 -158.26 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 115.519 -0.34 . . . . 0.0 110.704 -179.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.414 HG11 ' HG3' ' A' ' 192' ' ' GLU . 40.0 t -87.08 137.02 21.7 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 CA-C-O 121.741 0.781 . . . . 0.0 111.05 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.793 HG21 ' CB ' ' A' ' 228' ' ' ASP . 0.2 OUTLIER -98.88 -35.78 5.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 114.272 -1.331 . . . . 0.0 109.484 -179.462 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . 0.852 ' HB3' HD13 ' A' ' 183' ' ' LEU . 14.7 t80 -169.04 157.72 8.07 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.012 -0.994 . . . . 0.0 112.38 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . 0.414 ' HG3' HG11 ' A' ' 189' ' ' VAL . 60.9 mt-10 -151.5 162.06 41.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.748 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 135.38 -116.98 1.62 Allowed Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.169 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . 0.661 ' CA ' HG22 ' A' ' 181' ' ' VAL . 17.0 pt-20 -149.98 -176.3 5.38 Favored 'General case' 0 CA--C 1.497 -1.085 0 CA-C-O 121.336 0.589 . . . . 0.0 111.432 -179.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.78 HD12 ' O ' ' A' ' 176' ' ' THR . 49.1 mt -89.43 146.99 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.352 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.552 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' ASP . . . . . 0.629 ' HB3' HG23 ' A' ' 217' ' ' THR . 0.5 OUTLIER -89.14 -59.87 2.11 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.87 0.366 . . . . 0.0 110.033 179.581 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 1.3 m -151.32 159.08 44.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.87 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.674 HD11 ' O ' ' A' ' 175' ' ' ILE . 0.2 OUTLIER -127.54 122.86 34.4 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 121.435 0.636 . . . . 0.0 112.093 -179.388 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 13.2 mtmm -150.61 118.15 6.11 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.96 179.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 7.5 ttp180 . . . . . 0 C--N 1.324 -0.503 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.309 -179.592 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . 0.428 ' HA ' ' HA ' ' A' ' 199' ' ' LYS . 9.8 t70 . . . . . 0 N--CA 1.453 -0.287 0 CA-C-O 121.049 0.452 . . . . 0.0 110.209 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.482 HG23 ' CD2' ' A' ' 198' ' ' LEU . 32.6 m -57.71 158.62 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.961 0 CA-C-O 121.511 0.672 . . . . 0.0 112.179 -179.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . 0.426 ' O ' ' HA ' ' A' ' 176' ' ' THR . 1.7 ttp180 -89.44 -35.36 16.05 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 114.769 -1.105 . . . . 0.0 112.225 -178.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.48 ' HB3' HG22 ' A' ' 176' ' ' THR . 0.3 OUTLIER -140.11 177.55 7.9 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.343 0.592 . . . . 0.0 111.898 -179.456 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.74 ' O ' HG21 ' A' ' 170' ' ' VAL . 0.0 OUTLIER -151.07 77.86 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.167 178.517 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.618 ' HB2' ' HG2' ' A' ' 174' ' ' LYS . . . -98.55 174.35 6.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.168 0.508 . . . . 0.0 112.366 -178.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 81.75 -70.08 0.07 Allowed 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.867 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 178.2 37.23 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 120.431 -0.89 . . . . 0.0 112.248 179.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . 0.648 ' HB3' HG12 ' A' ' 208' ' ' VAL . 1.2 m-85 -104.11 140.49 37.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.966 0.412 . . . . 0.0 111.215 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -95.48 148.61 22.3 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.404 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' CYS . . . . . 0.519 ' HB3' HG21 ' A' ' 208' ' ' VAL . 45.5 t -150.51 146.14 26.42 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.371 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -88.11 112.49 3.89 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.943 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.656 HD12 HD11 ' A' ' 218' ' ' ILE . 0.3 OUTLIER -138.56 143.3 39.36 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 120.864 0.364 . . . . 0.0 111.149 -179.139 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . 0.629 HG23 ' HB3' ' A' ' 196' ' ' ASP . 0.2 OUTLIER -83.48 142.42 30.95 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 177.951 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . 0.656 HD11 HD12 ' A' ' 216' ' ' LEU . 1.6 mp -106.84 92.36 2.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 -178.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 2.5 tttp 45.77 -146.98 0.13 Allowed 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.511 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 -87.54 62.46 7.11 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-O 120.857 0.36 . . . . 0.0 110.984 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . 0.762 ' CZ ' HD22 ' A' ' 183' ' ' LEU . 0.1 OUTLIER -54.71 119.86 5.93 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 179.31 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -84.19 -47.6 10.67 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 114.771 -1.104 . . . . 0.0 108.368 176.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . 0.527 ' OD2' HG12 ' A' ' 190' ' ' VAL . 0.0 OUTLIER -84.78 130.27 34.7 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 178.026 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.876 HD13 ' CB ' ' A' ' 158' ' ' LYS . 1.2 pt -126.46 176.48 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -179.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.815 ' HG2' HD12 ' A' ' 224' ' ' ILE . 0.0 OUTLIER 61.12 129.47 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.102 -179.057 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . 0.489 ' HA ' ' CG1' ' A' ' 153' ' ' VAL . 3.6 tt0 -11.67 77.97 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 124.249 1.02 . . . . 0.0 113.341 -179.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 225' ' ' LYS . . . -98.26 -40.16 3.55 Favored Glycine 0 N--CA 1.43 -1.759 0 CA-C-N 114.564 -1.198 . . . . 0.0 112.626 -178.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.793 ' CB ' HG21 ' A' ' 190' ' ' VAL . 2.7 p30 -159.03 -160.98 0.9 Allowed 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 115.375 1.62 . . . . 0.0 115.375 -177.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . 0.475 HG13 ' O ' ' A' ' 151' ' ' ALA . 91.9 t -108.3 143.88 17.9 Favored 'Isoleucine or valine' 0 C--N 1.343 0.292 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 177.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 3.7 mp -111.43 153.32 13.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.252 0.548 . . . . 0.0 112.097 -178.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' GLU . . . . . 0.462 ' HA ' ' HA ' ' A' ' 150' ' ' GLN . 15.1 tt0 -141.05 111.32 6.75 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.437 0.637 . . . . 0.0 111.598 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.569 ' HB3' ' CA ' ' A' ' 149' ' ' GLY . . . -87.34 134.21 33.6 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.412 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -138.58 139.27 38.56 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.081 -178.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.601 ' O ' HG21 ' A' ' 148' ' ' ILE . 0.5 OUTLIER . . . . . 0 CA--C 1.534 0.355 0 CA-C-O 120.938 0.399 . . . . 0.0 111.881 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 6.3 tptt . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.762 0.315 . . . . 0.0 110.776 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.675 HG11 ' HB2' ' A' ' 150' ' ' GLN . 5.8 t -61.0 141.0 17.93 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.683 0 CA-C-O 121.294 0.569 . . . . 0.0 111.181 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 1.013 HG21 HG12 ' A' ' 234' ' ' VAL . 0.1 OUTLIER -123.56 -5.65 7.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.871 178.095 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.465 ' O ' ' HB3' ' A' ' 232' ' ' ALA . . . -174.38 74.41 0.08 OUTLIER Glycine 0 C--N 1.342 0.869 0 N-CA-C 111.683 -0.567 . . . . 0.0 111.683 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.675 ' HB2' HG11 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -89.49 136.11 33.22 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 179.591 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.498 ' HB1' ' HB2' ' A' ' 168' ' ' CYS . . . -151.93 173.2 15.12 Favored 'General case' 0 N--CA 1.435 -1.176 0 C-N-CA 120.009 -0.677 . . . . 0.0 112.478 -178.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.699 ' HG2' HG22 ' A' ' 229' ' ' VAL . 3.8 mt-10 -122.32 121.1 35.94 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.081 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.447 ' CG1' ' HA ' ' A' ' 226' ' ' GLU . 2.2 p -49.71 132.55 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -178.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -90.17 -61.56 1.66 Allowed 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 104.941 -2.244 . . . . 0.0 104.941 175.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.48 ' HA ' ' H ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER -162.28 -163.49 0.93 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 113.76 -1.563 . . . . 0.0 109.405 174.902 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.565 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 6.9 p -145.42 156.97 44.09 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 120.845 0.355 . . . . 0.0 110.079 177.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.685 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 2.4 m-85 -103.98 73.22 1.14 Allowed 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -177.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.95 63.93 8.31 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 88.2 t -91.4 157.87 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 CA-C-N 113.611 -1.631 . . . . 0.0 110.075 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 3.8 t -92.67 34.4 1.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.145 0.498 . . . . 0.0 109.784 178.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -151.45 -33.03 0.15 Allowed 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.445 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.508 HG12 ' N ' ' A' ' 163' ' ' GLY . 90.4 t -100.07 -101.95 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.169 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 -179.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . 0.508 ' N ' HG12 ' A' ' 162' ' ' VAL . . . -158.74 -103.69 0.2 Allowed Glycine 0 N--CA 1.451 -0.366 0 N-CA-C 111.706 -0.558 . . . . 0.0 111.706 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.515 ' CG2' HG21 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -153.63 34.82 0.45 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 114.406 -0.897 . . . . 0.0 108.932 178.483 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.685 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 2.9 mm -42.88 95.44 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.496 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.565 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . -86.19 119.17 26.18 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.706 -1.133 . . . . 0.0 111.247 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -87.95 150.63 22.37 Favored Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 178.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.675 ' SG ' HD11 ' A' ' 216' ' ' LEU . 0.0 OUTLIER -148.25 136.43 21.19 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 117.364 0.582 . . . . 0.0 111.102 -178.236 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . 0.42 ' O ' ' HA ' ' A' ' 151' ' ' ALA . 5.9 t80 -87.66 129.96 34.96 Favored 'General case' 0 C--O 1.221 -0.402 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 177.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.795 HG21 ' O ' ' A' ' 208' ' ' VAL . 38.3 t -85.67 145.09 8.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -176.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.2 p -138.25 13.18 2.82 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 114.788 -1.096 . . . . 0.0 112.164 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.408 ' CB ' ' HB2' ' A' ' 150' ' ' GLN . 10.4 t0 -149.98 -141.04 0.1 Allowed 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -48.67 -109.59 0.01 OUTLIER Glycine 0 CA--C 1.531 1.033 0 N-CA-C 114.527 0.571 . . . . 0.0 114.527 -179.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.659 ' HG2' ' HB2' ' A' ' 209' ' ' ALA . 5.6 mtmt -150.59 138.84 20.29 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 122.397 -0.472 . . . . 0.0 110.603 -179.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.431 ' O ' HG23 ' A' ' 175' ' ' ILE . 0.5 OUTLIER -94.38 112.29 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 C-N-CA 119.528 -0.869 . . . . 0.0 109.536 177.439 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.504 ' HB ' ' O ' ' A' ' 206' ' ' ARG . 0.2 OUTLIER -120.36 173.05 7.38 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.654 0.74 . . . . 0.0 112.99 -177.009 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.02 -43.67 86.93 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 114.521 -1.218 . . . . 0.0 109.95 178.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -89.25 56.5 3.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.696 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . 0.469 ' OG ' HG23 ' A' ' 176' ' ' THR . 5.4 m -150.33 161.39 42.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.86 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 7.6 tptt -89.32 177.62 6.55 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.036 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.782 HG21 HD12 ' A' ' 218' ' ' ILE . 1.5 m -146.13 146.9 18.73 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.548 0 CA-C-O 121.347 0.594 . . . . 0.0 111.04 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . 0.551 ' HD2' HD11 ' A' ' 184' ' ' ILE . 5.2 ttm-85 -155.37 99.34 2.05 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.177 -0.92 . . . . 0.0 112.539 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.625 ' C ' HD12 ' A' ' 184' ' ' ILE . 0.3 OUTLIER -97.51 166.59 11.45 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 120.186 -0.606 . . . . 0.0 110.908 179.302 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.756 HG23 ' O ' ' A' ' 188' ' ' ILE . 4.4 mp -151.87 140.08 14.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.143 -0.48 . . . . 0.0 112.057 -177.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.798 ' NH2' HG13 ' A' ' 190' ' ' VAL . 5.2 ptp180 -87.08 -152.67 0.19 Allowed 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.371 -0.832 . . . . 0.0 108.906 178.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -94.64 29.04 2.42 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 118.19 0.45 . . . . 0.0 111.489 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.61 ' C ' HD13 ' A' ' 188' ' ' ILE . . . -153.23 -76.12 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.39 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.756 ' O ' HG23 ' A' ' 184' ' ' ILE . 0.2 OUTLIER -117.9 -155.86 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 115.373 -0.414 . . . . 0.0 110.216 -179.522 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.714 HG11 ' CG ' ' A' ' 192' ' ' GLU . 35.1 t -85.95 139.53 17.26 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 CA-C-O 121.573 0.701 . . . . 0.0 110.758 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.831 HG12 ' OD2' ' A' ' 223' ' ' ASP . 0.7 OUTLIER -87.41 -40.76 14.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 114.693 -1.14 . . . . 0.0 108.409 179.898 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . 0.453 ' CE2' ' O ' ' A' ' 220' ' ' ASN . 0.6 OUTLIER -171.91 150.21 2.56 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.606 -1.179 . . . . 0.0 111.131 179.322 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . 0.714 ' CG ' HG11 ' A' ' 189' ' ' VAL . 32.3 mt-10 -135.53 164.45 27.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.081 0.467 . . . . 0.0 111.19 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 135.87 -160.26 24.52 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . 0.541 ' O ' HG23 ' A' ' 218' ' ' ILE . 3.3 pt-20 -108.69 -178.1 3.5 Favored 'General case' 0 CA--C 1.498 -1.052 0 CA-C-N 117.656 0.728 . . . . 0.0 110.723 179.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.934 ' CD1' HD13 ' A' ' 216' ' ' LEU . 0.1 OUTLIER -88.39 148.92 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.881 -177.977 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -88.92 -54.94 3.9 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -151.47 152.86 33.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.088 179.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.717 HD22 ' HB3' ' A' ' 216' ' ' LEU . 0.2 OUTLIER -122.01 103.42 8.8 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.882 179.872 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 0.1 OUTLIER -135.96 122.72 21.11 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.428 179.618 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.323 -0.567 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.096 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . 0.401 ' HA ' ' HA ' ' A' ' 199' ' ' LYS . 17.4 m-20 . . . . . 0 N--CA 1.453 -0.316 0 CA-C-O 120.97 0.414 . . . . 0.0 110.37 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 35.5 m -62.29 165.23 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.063 0 CA-C-O 121.538 0.685 . . . . 0.0 112.088 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . 0.504 ' O ' ' HB ' ' A' ' 176' ' ' THR . 1.6 ttm180 -89.18 -41.7 12.09 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-N 114.726 -1.125 . . . . 0.0 111.368 -178.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -136.2 178.6 6.94 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.249 0.547 . . . . 0.0 111.963 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.795 ' O ' HG21 ' A' ' 170' ' ' VAL . 0.2 OUTLIER -150.96 94.67 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.701 179.108 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.659 ' HB2' ' HG2' ' A' ' 174' ' ' LYS . . . -118.27 178.09 4.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.215 0.531 . . . . 0.0 112.36 -178.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 80.91 -71.8 0.07 Allowed 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.794 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 178.62 37.31 0.06 OUTLIER Glycine 0 N--CA 1.442 -0.933 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.2 179.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -104.48 139.11 39.87 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.962 0.41 . . . . 0.0 111.089 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.74 150.92 22.09 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.039 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' CYS . . . . . 0.51 ' CB ' HG21 ' A' ' 208' ' ' VAL . 7.5 t -150.15 146.13 26.71 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.679 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -89.1 115.41 4.47 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.043 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.934 HD13 ' CD1' ' A' ' 195' ' ' ILE . 0.3 OUTLIER -132.18 141.48 49.1 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 120.975 0.417 . . . . 0.0 110.742 -179.827 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . 0.512 ' OG1' HD13 ' A' ' 165' ' ' ILE . 1.6 m -105.67 140.08 39.29 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 177.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . 0.782 HD12 HG21 ' A' ' 181' ' ' VAL . 18.9 mm -89.19 144.32 9.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 120.449 -0.5 . . . . 0.0 109.747 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.78 -10.74 4.11 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -176.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' ASN . . . . . 0.453 ' O ' ' CE2' ' A' ' 191' ' ' TYR . 58.2 t30 -153.23 21.1 0.56 Allowed 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . 0.485 ' HB2' ' HB ' ' A' ' 218' ' ' ILE . 0.1 OUTLIER -57.95 123.76 16.93 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 -179.681 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . 0.401 ' HB2' ' CE1' ' A' ' 191' ' ' TYR . 2.3 t-20 -96.59 -47.76 5.8 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 114.347 -1.297 . . . . 0.0 108.367 176.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . 0.831 ' OD2' HG12 ' A' ' 190' ' ' VAL . 0.0 OUTLIER -75.66 150.25 37.98 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.095 177.422 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.644 ' N ' HD13 ' A' ' 224' ' ' ILE . 0.2 OUTLIER -143.14 177.78 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -179.209 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.424 ' O ' ' C ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER 56.56 116.25 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 114.443 -1.253 . . . . 0.0 110.073 -179.046 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . 0.48 ' H ' ' HA ' ' A' ' 155' ' ' GLN . 3.2 tt0 8.78 63.88 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.523 1.129 . . . . 0.0 113.517 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -61.61 -65.48 3.22 Favored Glycine 0 N--CA 1.432 -1.613 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.4 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.439 ' O ' HG12 ' A' ' 153' ' ' VAL . 0.9 OUTLIER -165.38 -147.48 0.1 Allowed 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 114.236 1.199 . . . . 0.0 114.236 179.381 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . 0.699 HG22 ' HG2' ' A' ' 152' ' ' GLU . 91.7 t -89.17 135.09 26.75 Favored 'Isoleucine or valine' 0 C--N 1.346 0.437 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . 0.495 ' HA ' ' HA ' ' A' ' 183' ' ' LEU . 2.7 mp -102.93 159.04 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 O-C-N 123.378 0.424 . . . . 0.0 110.859 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' GLU . . . . . 0.46 ' O ' ' N ' ' A' ' 182' ' ' ARG . 5.7 tt0 -149.46 108.43 3.89 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.274 0.559 . . . . 0.0 112.348 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.499 ' O ' HD13 ' A' ' 148' ' ' ILE . . . -87.56 131.67 34.31 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.022 179.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' TYR . . . . . 0.539 ' C ' HD12 ' A' ' 148' ' ' ILE . 4.6 p90 -134.33 163.46 29.6 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.577 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 1.013 HG12 HG21 ' A' ' 148' ' ' ILE . 1.9 p . . . . . 0 CA--C 1.536 0.412 0 CA-C-O 120.77 0.319 . . . . 0.0 111.489 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.472 0.649 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.572 HG11 ' HG3' ' A' ' 150' ' ' GLN . 29.1 t -89.45 138.44 19.29 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.732 0 CA-C-O 121.287 0.565 . . . . 0.0 110.193 178.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.508 HG23 ' HB1' ' A' ' 232' ' ' ALA . 3.7 tp -121.5 -14.96 7.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.257 177.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.5 ' O ' ' HB3' ' A' ' 232' ' ' ALA . . . 165.11 88.56 0.07 OUTLIER Glycine 0 C--N 1.345 1.071 0 C-N-CA 120.131 -1.033 . . . . 0.0 112.864 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.572 ' HG3' HG11 ' A' ' 147' ' ' VAL . 3.0 mt-30 -90.05 142.22 27.91 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.441 ' CB ' ' HB2' ' A' ' 168' ' ' CYS . . . -150.93 174.99 12.47 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 120.107 -0.637 . . . . 0.0 112.148 -179.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.826 ' CG ' HG22 ' A' ' 229' ' ' VAL . 0.0 OUTLIER -120.42 123.72 43.72 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.054 179.81 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.7 ' HB ' HD11 ' A' ' 230' ' ' ILE . 2.4 p -55.79 127.77 15.14 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 CA-C-O 121.377 0.608 . . . . 0.0 111.522 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.416 ' CA ' ' NE ' ' A' ' 154' ' ' ARG . 0.0 OUTLIER -89.56 -57.49 2.86 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 105.025 -2.213 . . . . 0.0 105.025 176.209 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.433 ' HA ' ' H ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER -162.76 -163.61 0.9 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.257 -1.338 . . . . 0.0 110.262 174.735 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.597 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 16.7 p -144.42 158.92 43.51 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 177.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.657 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 2.4 m-85 -99.98 76.08 1.91 Allowed 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -176.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 7.7 tttt -85.93 63.58 8.11 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 122.071 0.938 . . . . 0.0 108.809 178.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.455 HG12 ' N ' ' A' ' 161' ' ' LYS . 55.0 t -89.89 155.53 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 CA-C-N 113.77 -1.559 . . . . 0.0 109.867 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 3.9 t -90.7 33.58 0.92 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.126 0.489 . . . . 0.0 110.153 178.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.455 ' N ' HG12 ' A' ' 159' ' ' VAL . 3.6 mttt -151.02 -29.67 0.19 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.712 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.489 HG12 ' N ' ' A' ' 163' ' ' GLY . 88.2 t -103.19 -101.79 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 O-C-N 122.195 -0.316 . . . . 0.0 110.275 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . 0.489 ' N ' HG12 ' A' ' 162' ' ' VAL . . . -158.5 -103.39 0.19 Allowed Glycine 0 N--CA 1.451 -0.363 0 N-CA-C 111.661 -0.576 . . . . 0.0 111.661 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 1.048 HG21 HG21 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -153.14 36.24 0.48 Allowed 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 114.362 -0.919 . . . . 0.0 108.968 178.458 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.657 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 4.9 mt -42.55 101.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.925 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.597 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . -83.62 121.88 27.85 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.004 -0.998 . . . . 0.0 112.871 -178.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -89.1 136.08 13.38 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 178.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.664 ' HB3' HD13 ' A' ' 230' ' ' ILE . 0.0 OUTLIER -138.14 131.49 30.52 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.898 0.349 . . . . 0.0 110.531 -178.523 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . 0.425 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 5.7 t80 -85.94 126.42 34.09 Favored 'General case' 0 C--O 1.219 -0.502 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 178.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.578 HG21 ' O ' ' A' ' 208' ' ' VAL . 45.3 t -85.22 145.37 8.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -175.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -133.9 10.52 3.93 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 114.646 -1.161 . . . . 0.0 112.337 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.428 ' O ' ' O ' ' A' ' 173' ' ' GLY . 3.0 t70 -150.12 -145.76 0.18 Allowed 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 118.91 -0.567 . . . . 0.0 109.613 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 172' ' ' ASP . . . -37.68 -108.11 0.0 OUTLIER Glycine 0 CA--C 1.537 1.444 0 N-CA-C 115.338 0.895 . . . . 0.0 115.338 -179.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.795 ' HG2' ' HB2' ' A' ' 209' ' ' ALA . 1.7 mtmm -151.51 135.52 16.58 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 122.311 -0.523 . . . . 0.0 111.84 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.624 ' HB ' HG23 ' A' ' 208' ' ' VAL . 2.6 mm -88.44 86.9 2.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 177.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.87 ' O ' HD13 ' A' ' 195' ' ' ILE . 0.0 OUTLIER -98.26 170.41 8.9 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.17 -177.767 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -69.02 -39.41 79.26 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.269 179.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -89.29 51.85 2.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.97 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . 0.842 ' O ' HD12 ' A' ' 195' ' ' ILE . 0.7 OUTLIER -142.94 159.49 42.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.75 179.795 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 2.8 mptp? -89.6 177.71 6.47 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.611 HG22 ' CA ' ' A' ' 194' ' ' GLU . 2.8 m -149.43 148.69 15.4 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.509 0 CA-C-O 121.535 0.683 . . . . 0.0 112.237 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 231' ' ' GLU . 23.0 ttp180 -153.83 102.45 2.52 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.671 -1.15 . . . . 0.0 111.678 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.616 ' C ' HD12 ' A' ' 184' ' ' ILE . 0.3 OUTLIER -98.16 169.13 9.81 Favored 'General case' 0 N--CA 1.438 -1.064 0 C-N-CA 120.564 -0.455 . . . . 0.0 111.246 179.869 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.738 HG23 ' O ' ' A' ' 188' ' ' ILE . 4.0 mp -151.01 139.83 14.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.048 -178.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.516 ' N ' HG22 ' A' ' 190' ' ' VAL . 0.0 OUTLIER -88.04 -150.73 0.18 Allowed 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.156 -0.929 . . . . 0.0 108.749 178.241 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -94.72 27.75 2.94 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 118.461 0.573 . . . . 0.0 111.454 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -153.11 -77.78 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.688 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.738 ' O ' HG23 ' A' ' 184' ' ' ILE . 0.5 OUTLIER -116.69 -154.34 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-N 115.514 -0.343 . . . . 0.0 110.43 -179.292 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.694 HG11 ' CG ' ' A' ' 192' ' ' GLU . 23.0 t -85.67 138.45 19.05 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 CA-C-O 121.517 0.675 . . . . 0.0 110.803 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.88 HG12 ' OD2' ' A' ' 223' ' ' ASP . 0.7 OUTLIER -87.86 -39.24 12.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 114.739 -1.119 . . . . 0.0 109.0 -179.86 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . 0.477 ' HB2' ' CE1' ' A' ' 221' ' ' PHE . 1.0 OUTLIER -172.17 157.67 4.32 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.63 -1.168 . . . . 0.0 110.411 -179.935 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . 0.694 ' CG ' HG11 ' A' ' 189' ' ' VAL . 34.1 mt-10 -144.79 157.16 44.28 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.205 0.526 . . . . 0.0 111.182 179.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 148.9 -129.82 3.19 Favored Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.524 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . 0.611 ' CA ' HG22 ' A' ' 181' ' ' VAL . 12.7 pt-20 -138.97 -175.78 4.27 Favored 'General case' 0 CA--C 1.497 -1.061 0 CA-C-O 121.292 0.567 . . . . 0.0 111.584 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.87 HD13 ' O ' ' A' ' 176' ' ' THR . 3.0 mp -88.13 143.35 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.379 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.405 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' ASP . . . . . 0.407 ' CB ' ' HB ' ' A' ' 217' ' ' THR . 0.6 OUTLIER -89.02 -56.92 3.09 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.164 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 3.0 m -151.61 150.54 30.4 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.942 179.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.428 HD21 ' HB3' ' A' ' 214' ' ' CYS . 1.3 tt -120.56 111.56 17.82 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 121.379 0.609 . . . . 0.0 111.169 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 62.2 mttt -150.62 122.55 8.17 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.286 179.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.602 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.509 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . 0.402 ' HA ' ' HA ' ' A' ' 199' ' ' LYS . 9.6 p-10 . . . . . 0 N--CA 1.454 -0.27 0 CA-C-O 120.725 0.298 . . . . 0.0 110.652 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 33.9 m -82.87 163.82 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.916 0 CA-C-O 121.481 0.658 . . . . 0.0 112.152 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . 0.474 ' O ' ' HB ' ' A' ' 176' ' ' THR . 0.2 OUTLIER -89.11 -36.79 15.53 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.939 -178.53 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.69 ' HB3' HG22 ' A' ' 176' ' ' THR . 1.9 mp0 -141.73 -178.08 5.49 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.343 0.592 . . . . 0.0 111.993 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.624 HG23 ' HB ' ' A' ' 175' ' ' ILE . 0.1 OUTLIER -151.08 91.73 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.681 178.946 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.795 ' HB2' ' HG2' ' A' ' 174' ' ' LYS . . . -112.89 165.87 11.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.022 0.439 . . . . 0.0 112.028 -179.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 34.1 tp60 82.26 -69.36 0.07 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.035 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 178.41 37.78 0.06 OUTLIER Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.355 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -97.45 136.05 38.45 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.863 0.363 . . . . 0.0 111.199 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -91.54 146.48 23.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.349 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' CYS . . . . . 0.428 ' HB3' HD21 ' A' ' 198' ' ' LEU . 1.8 m -150.95 142.7 23.74 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.532 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . 0.55 ' C ' HG23 ' A' ' 165' ' ' ILE . . . -89.64 103.77 3.04 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.608 -0.806 . . . . 0.0 111.978 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.526 HD12 ' CD1' ' A' ' 218' ' ' ILE . 0.4 OUTLIER -128.86 143.16 50.83 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.078 0.466 . . . . 0.0 111.467 -179.576 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . 0.407 ' HB ' ' CB ' ' A' ' 196' ' ' ASP . 1.2 m -83.93 143.49 29.81 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 177.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . 0.599 HG22 ' O ' ' A' ' 218' ' ' ILE . 1.5 mp -106.16 92.09 2.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.943 0.401 . . . . 0.0 110.247 -178.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 4.3 tttp 45.06 -144.24 0.17 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.894 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -87.18 61.33 6.66 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 121.024 0.44 . . . . 0.0 110.817 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . 0.477 ' CE1' ' HB2' ' A' ' 191' ' ' TYR . 0.1 OUTLIER -55.92 120.62 7.7 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 114.722 1.379 . . . . 0.0 114.722 179.128 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 21.4 t30 -82.32 -48.55 11.05 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 114.815 -1.084 . . . . 0.0 108.346 176.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . 0.88 ' OD2' HG12 ' A' ' 190' ' ' VAL . 0.0 OUTLIER -82.01 137.88 35.0 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 177.668 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 1.048 HG21 HG21 ' A' ' 164' ' ' THR . 0.2 OUTLIER -133.85 179.13 4.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -178.951 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.407 ' O ' ' C ' ' A' ' 226' ' ' GLU . 0.1 OUTLIER 57.09 117.28 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.107 -179.114 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . 0.433 ' H ' ' HA ' ' A' ' 155' ' ' GLN . 38.9 tt0 7.71 63.28 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 124.484 1.114 . . . . 0.0 113.758 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . 0.457 ' N ' HG11 ' A' ' 153' ' ' VAL . . . -63.49 -66.43 2.54 Favored Glycine 0 N--CA 1.431 -1.655 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.932 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.464 ' O ' HG12 ' A' ' 153' ' ' VAL . 0.7 OUTLIER -164.17 -150.2 0.14 Allowed 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 179.888 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . 0.826 HG22 ' CG ' ' A' ' 152' ' ' GLU . 69.2 t -88.49 130.68 37.59 Favored 'Isoleucine or valine' 0 C--N 1.345 0.38 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.208 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . 0.7 HD11 ' HB ' ' A' ' 153' ' ' VAL . 5.1 mp -100.37 157.72 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 O-C-N 123.618 0.574 . . . . 0.0 110.961 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' GLU . . . . . 0.453 ' HA ' ' HA ' ' A' ' 150' ' ' GLN . 33.6 tt0 -146.94 112.32 5.55 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 120.246 -0.582 . . . . 0.0 112.427 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.508 ' HB1' HG23 ' A' ' 148' ' ' ILE . . . -88.18 133.91 33.91 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.008 179.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' TYR . . . . . 0.405 ' O ' ' CG2' ' A' ' 234' ' ' VAL . 2.9 p90 -136.04 120.3 17.88 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.803 -178.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.405 ' CG2' ' O ' ' A' ' 233' ' ' TYR . 62.6 t . . . . . 0 N--CA 1.464 0.229 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.863 179.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.517 ' HG3' HG23 ' A' ' 147' ' ' VAL . 3.8 tppp? . . . . . 0 CA--C 1.529 0.169 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.517 HG23 ' HG3' ' A' ' 146' ' ' LYS . 6.7 t -99.5 140.71 18.23 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.758 0 CA-C-O 121.245 0.545 . . . . 0.0 110.699 179.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.472 HD13 ' N ' ' A' ' 149' ' ' GLY . 0.0 OUTLIER -131.33 -2.32 2.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.009 178.784 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.539 ' CA ' ' HB3' ' A' ' 232' ' ' ALA . . . -178.43 73.59 0.07 OUTLIER Glycine 0 C--N 1.342 0.889 0 C-N-CA 120.81 -0.71 . . . . 0.0 111.931 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.474 ' HB2' HG11 ' A' ' 147' ' ' VAL . 0.4 OUTLIER -91.67 134.77 34.41 Favored 'General case' 0 CA--C 1.505 -0.769 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.749 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.467 ' HB1' ' O ' ' A' ' 169' ' ' TYR . . . -151.62 175.03 12.76 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-O 121.52 0.676 . . . . 0.0 112.511 -178.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.738 ' HG2' HG22 ' A' ' 229' ' ' VAL . 2.4 mt-10 -120.37 127.02 51.91 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.107 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.713 ' HB ' HD11 ' A' ' 230' ' ' ILE . 2.6 p -57.68 128.22 17.92 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.354 0 CA-C-O 121.643 0.735 . . . . 0.0 111.887 -179.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.408 ' HD3' ' HB2' ' A' ' 169' ' ' TYR . 0.0 OUTLIER -90.17 -57.25 2.91 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 104.789 -2.3 . . . . 0.0 104.789 175.617 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.426 ' HA ' ' H ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER -163.3 -166.16 1.2 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.094 -1.412 . . . . 0.0 110.363 174.742 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.548 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 18.8 p -151.17 149.88 29.97 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.191 177.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.616 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 5.8 m-30 -94.83 72.11 3.51 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -178.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? -86.48 61.4 6.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.894 0.854 . . . . 0.0 108.924 178.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.405 HG12 ' H ' ' A' ' 161' ' ' LYS . 49.0 t -89.77 155.59 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-N 114.095 -1.411 . . . . 0.0 109.789 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.75 22.01 3.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.905 0.383 . . . . 0.0 111.177 178.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.405 ' H ' HG12 ' A' ' 159' ' ' VAL . 6.5 mttt -150.9 6.98 0.53 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.982 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 58.4 t -130.81 -99.6 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 CA-C-N 118.374 0.534 . . . . 0.0 110.017 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -158.46 -112.76 0.34 Allowed Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.494 HG22 ' CG2' ' A' ' 224' ' ' ILE . 0.0 OUTLIER -153.7 32.08 0.45 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.401 -0.899 . . . . 0.0 109.18 178.173 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.616 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 1.9 mm -41.09 94.32 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.473 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.604 ' HB3' HD13 ' A' ' 218' ' ' ILE . . . -86.48 113.93 22.81 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.689 -1.141 . . . . 0.0 111.993 -179.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -88.3 126.38 8.08 Favored Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 178.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.808 ' HB3' HD13 ' A' ' 230' ' ' ILE . 0.0 OUTLIER -129.79 134.48 47.6 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.83 0.315 . . . . 0.0 110.471 -178.088 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . 0.467 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 15.0 t80 -86.27 130.34 34.55 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.081 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.715 HG21 ' O ' ' A' ' 208' ' ' VAL . 42.3 t -85.78 148.57 4.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 113.404 0.891 . . . . 0.0 113.404 -175.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -141.87 15.79 2.12 Favored 'General case' 0 CA--C 1.527 0.076 0 CA-C-N 114.562 -1.199 . . . . 0.0 111.898 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.412 ' H ' HG12 ' A' ' 170' ' ' VAL . 6.6 t0 -150.24 -142.64 0.12 Allowed 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 -179.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -45.73 -109.89 0.01 OUTLIER Glycine 0 CA--C 1.533 1.193 0 N-CA-C 115.009 0.764 . . . . 0.0 115.009 -178.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.67 ' HG2' ' HB2' ' A' ' 209' ' ' ALA . 3.8 mttm -151.13 127.01 10.32 Favored 'General case' 0 CA--C 1.512 -0.496 0 O-C-N 122.451 -0.441 . . . . 0.0 111.107 -178.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.589 HD12 ' HB2' ' A' ' 232' ' ' ALA . 0.5 OUTLIER -89.03 113.85 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 C-N-CA 119.199 -1.0 . . . . 0.0 109.431 177.811 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.891 ' O ' HD13 ' A' ' 195' ' ' ILE . 0.1 OUTLIER -124.97 169.26 12.27 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.95 -177.376 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.402 ' HG3' ' HB2' ' A' ' 198' ' ' LEU . 0.2 OUTLIER -61.34 -38.74 88.01 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.299 179.414 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -89.28 52.74 2.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.156 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . 0.754 ' O ' HD12 ' A' ' 195' ' ' ILE . 29.4 m -150.46 157.04 42.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.341 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 0.0 OUTLIER -89.35 176.78 6.79 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.553 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.624 HG22 ' CA ' ' A' ' 194' ' ' GLU . 2.5 m -145.65 149.21 16.7 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.579 0 CA-C-O 121.473 0.654 . . . . 0.0 112.203 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . 0.436 ' N ' ' O ' ' A' ' 231' ' ' GLU . 26.8 ttm180 -154.36 102.34 2.43 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.851 -1.068 . . . . 0.0 112.236 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.521 ' CB ' ' HA ' ' A' ' 230' ' ' ILE . 0.3 OUTLIER -99.61 170.67 8.42 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-O 120.932 0.396 . . . . 0.0 110.649 179.363 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.683 HG23 ' O ' ' A' ' 188' ' ' ILE . 36.5 mt -155.5 139.94 9.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.855 -178.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.494 ' N ' HG22 ' A' ' 190' ' ' VAL . 6.9 ttm-85 -87.33 -152.64 0.2 Allowed 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.9 178.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 18.7 mp0 -94.69 28.67 2.57 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 118.141 0.428 . . . . 0.0 111.32 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -152.72 -79.14 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.487 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.683 ' O ' HG23 ' A' ' 184' ' ' ILE . 0.1 OUTLIER -114.4 -157.22 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 115.536 -0.332 . . . . 0.0 110.227 -179.6 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.779 HG11 ' CG ' ' A' ' 192' ' ' GLU . 22.3 t -86.22 139.54 17.22 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 CA-C-O 121.457 0.646 . . . . 0.0 110.739 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.585 HG23 ' CA ' ' A' ' 184' ' ' ILE . 0.4 OUTLIER -87.89 -35.53 8.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.13 -179.93 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . 0.475 ' HB2' ' CE1' ' A' ' 221' ' ' PHE . 22.5 t80 -178.54 146.4 0.36 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.901 179.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . 0.779 ' CG ' HG11 ' A' ' 189' ' ' VAL . 34.7 mt-10 -135.46 158.08 45.27 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.015 0.436 . . . . 0.0 110.858 179.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 147.23 -124.6 1.98 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.736 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . 0.624 ' CA ' HG22 ' A' ' 181' ' ' VAL . 13.7 pt-20 -144.15 -174.95 4.43 Favored 'General case' 0 CA--C 1.497 -1.087 0 CA-C-O 121.202 0.525 . . . . 0.0 111.437 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.891 HD13 ' O ' ' A' ' 176' ' ' THR . 3.8 mp -87.72 142.92 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.602 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.03 -52.37 5.12 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 1.2 m -151.47 145.62 25.33 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.724 178.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.529 HD13 ' HA ' ' A' ' 176' ' ' THR . 4.5 tt -124.06 114.15 19.34 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.394 0.616 . . . . 0.0 111.613 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 56.6 mttt -150.17 121.19 7.69 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.096 -0.957 . . . . 0.0 109.86 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.323 -0.573 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.285 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 22.0 p30 . . . . . 0 N--CA 1.451 -0.401 0 CA-C-O 121.088 0.471 . . . . 0.0 110.043 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 33.9 m -55.12 164.02 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.04 0 CA-C-O 121.47 0.652 . . . . 0.0 112.304 -179.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . 0.498 ' O ' ' HB ' ' A' ' 176' ' ' THR . 1.6 mtm180 -89.44 -41.34 12.14 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-N 114.715 -1.13 . . . . 0.0 111.34 -178.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.533 ' HB3' HG22 ' A' ' 176' ' ' THR . 0.9 OUTLIER -129.72 -178.59 4.76 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.458 0.647 . . . . 0.0 112.37 -179.131 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.715 ' O ' HG21 ' A' ' 170' ' ' VAL . 0.0 OUTLIER -151.17 81.44 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.269 178.631 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.67 ' HB2' ' HG2' ' A' ' 174' ' ' LYS . . . -100.76 171.79 7.47 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -178.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 8.9 tm0? 83.49 -72.67 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.016 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 177.93 37.18 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.345 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -98.21 141.61 30.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.925 0.393 . . . . 0.0 111.303 -179.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.5 131.15 43.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.339 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' CYS . . . . . 0.461 ' HB3' HG21 ' A' ' 208' ' ' VAL . 52.5 t -133.17 143.96 49.56 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.676 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -88.5 109.62 3.56 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.978 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.55 HD12 ' CD1' ' A' ' 218' ' ' ILE . 0.4 OUTLIER -135.75 141.77 44.88 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 120.924 0.393 . . . . 0.0 111.478 -179.305 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . 0.46 ' C ' HD12 ' A' ' 218' ' ' ILE . 0.0 OUTLIER -77.43 146.97 36.22 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 177.662 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . 0.607 HG22 ' O ' ' A' ' 218' ' ' ILE . 1.6 mp -112.61 87.83 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.144 0.497 . . . . 0.0 109.755 -179.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 6.5 tttp 46.71 -144.85 0.26 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.759 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -87.33 61.09 6.45 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 121.009 0.433 . . . . 0.0 111.135 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . 0.512 ' CZ ' HD21 ' A' ' 183' ' ' LEU . 0.1 OUTLIER -55.49 121.42 8.97 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 178.973 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 14.4 t30 -88.63 -45.15 10.08 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.483 176.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 223' ' ' ASP . 0.0 OUTLIER -81.72 134.7 35.48 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.215 177.604 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.634 HD13 ' H ' ' A' ' 224' ' ' ILE . 0.2 OUTLIER -133.82 -179.64 3.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -179.067 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.422 ' O ' ' C ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER 57.07 114.33 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.698 -178.367 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . 0.448 ' HA ' ' CG1' ' A' ' 153' ' ' VAL . 3.0 tt0 8.66 64.22 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 124.633 1.173 . . . . 0.0 113.555 -179.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . 0.413 ' N ' HG11 ' A' ' 153' ' ' VAL . . . -61.48 -66.86 2.39 Favored Glycine 0 N--CA 1.432 -1.59 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.468 179.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.458 ' O ' HG12 ' A' ' 153' ' ' VAL . 0.9 OUTLIER -164.9 -147.99 0.11 Allowed 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 179.435 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . 0.738 HG22 ' HG2' ' A' ' 152' ' ' GLU . 98.4 t -89.24 132.16 34.69 Favored 'Isoleucine or valine' 0 C--N 1.347 0.462 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . 0.808 HD13 ' HB3' ' A' ' 168' ' ' CYS . 4.5 mp -99.2 157.23 3.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 O-C-N 123.499 0.499 . . . . 0.0 111.196 -179.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' GLU . . . . . 0.436 ' O ' ' N ' ' A' ' 182' ' ' ARG . 1.9 tm-20 -147.63 110.24 4.68 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 120.159 -0.616 . . . . 0.0 112.633 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.589 ' HB2' HD12 ' A' ' 175' ' ' ILE . . . -87.8 134.39 33.69 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.472 178.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' TYR . . . . . 0.724 ' O ' HG23 ' A' ' 234' ' ' VAL . 6.3 p90 -131.58 147.07 52.5 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.935 0.398 . . . . 0.0 111.703 -179.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.724 HG23 ' O ' ' A' ' 233' ' ' TYR . 0.9 OUTLIER . . . . . 0 CA--C 1.536 0.41 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.417 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 1.1 tptp . . . . . 0 CA--C 1.53 0.181 0 N-CA-C 110.529 -0.174 . . . . 0.0 110.529 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.707 ' O ' HD13 ' A' ' 148' ' ' ILE . 5.8 t -58.62 142.42 14.32 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 CA-C-O 121.333 0.587 . . . . 0.0 111.381 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.707 HD13 ' O ' ' A' ' 147' ' ' VAL . 11.6 mm -134.41 13.16 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.57 178.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.719 ' HA3' ' HB3' ' A' ' 232' ' ' ALA . . . 175.46 65.68 0.06 OUTLIER Glycine 0 C--N 1.343 0.945 0 C-N-CA 121.329 -0.462 . . . . 0.0 112.181 179.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.682 ' HB2' HG11 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -89.61 131.19 35.74 Favored 'General case' 0 CA--C 1.507 -0.679 0 O-C-N 122.506 -0.408 . . . . 0.0 110.481 179.83 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.413 ' HA ' ' O ' ' A' ' 169' ' ' TYR . . . -152.18 174.21 14.02 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-O 121.42 0.629 . . . . 0.0 112.448 -178.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.739 ' HG2' HG22 ' A' ' 229' ' ' VAL . 7.2 mt-10 -120.63 121.73 38.97 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.487 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.499 HG13 ' HG2' ' A' ' 226' ' ' GLU . 3.1 p -51.45 131.07 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.416 ' HD2' ' HB2' ' A' ' 169' ' ' TYR . 5.1 mmp_? -90.07 -59.27 2.24 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 175.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.544 ' HA ' ' H ' ' A' ' 226' ' ' GLU . 0.3 OUTLIER -162.3 -164.32 1.03 Allowed 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 113.75 -1.568 . . . . 0.0 109.751 175.449 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.537 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 7.0 p -150.47 162.51 40.45 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 177.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.557 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 0.2 OUTLIER -115.53 78.41 1.17 Allowed 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -179.123 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 8.6 tttm -86.47 62.57 7.5 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 177.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.49 HG12 ' N ' ' A' ' 161' ' ' LYS . 71.3 t -93.04 156.19 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 CA-C-N 113.606 -1.633 . . . . 0.0 110.488 -178.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 46.0 p -91.29 34.64 0.94 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.234 0.54 . . . . 0.0 109.71 178.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.49 ' N ' HG12 ' A' ' 159' ' ' VAL . 0.1 OUTLIER -150.76 -32.92 0.17 Allowed 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.206 -179.721 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.514 HG12 ' N ' ' A' ' 163' ' ' GLY . 84.3 t -100.67 -103.05 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . 0.514 ' N ' HG12 ' A' ' 162' ' ' VAL . . . -159.35 -101.19 0.17 Allowed Glycine 0 N--CA 1.451 -0.353 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 178.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.468 ' CG2' HG21 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -154.14 33.94 0.43 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 114.115 -1.042 . . . . 0.0 108.51 177.812 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.626 HD12 HG23 ' A' ' 217' ' ' THR . 1.5 mp -42.91 95.26 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.522 -179.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.537 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . -89.93 120.51 31.21 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.722 -1.126 . . . . 0.0 112.179 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -88.15 148.0 20.55 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 178.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.572 ' HB3' HD12 ' A' ' 230' ' ' ILE . 0.0 OUTLIER -147.73 134.64 20.19 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 117.366 0.583 . . . . 0.0 110.694 -178.455 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . 0.416 ' HB2' ' HD2' ' A' ' 154' ' ' ARG . 78.4 t80 -86.53 124.47 32.87 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 177.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.665 HG21 ' O ' ' A' ' 208' ' ' VAL . 22.7 t -85.42 144.3 9.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 113.14 0.792 . . . . 0.0 113.14 -176.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.1 p -137.2 14.17 3.04 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 114.779 -1.1 . . . . 0.0 112.078 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.41 ' H ' HG12 ' A' ' 170' ' ' VAL . 5.9 t0 -150.56 -144.68 0.16 Allowed 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -40.27 -105.0 0.01 OUTLIER Glycine 0 CA--C 1.533 1.16 0 N-CA-C 115.264 0.865 . . . . 0.0 115.264 -178.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.438 ' HB2' ' HB3' ' A' ' 207' ' ' GLU . 0.0 OUTLIER -150.93 150.9 31.39 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.061 0.458 . . . . 0.0 111.442 -178.416 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.63 HG21 HD11 ' A' ' 216' ' ' LEU . 16.1 mm -103.67 82.72 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 176.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 0.0 OUTLIER -95.58 172.89 7.78 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.78 1.029 . . . . 0.0 113.78 -176.569 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.553 ' HB2' HD22 ' A' ' 198' ' ' LEU . 7.8 ttp180 -69.42 -48.68 60.28 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 114.1 -1.409 . . . . 0.0 110.792 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -89.45 61.61 5.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.28 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 1.8 m -148.3 157.62 43.6 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.343 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.481 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 1.1 mptt -88.56 173.7 8.5 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.628 HG22 ' CA ' ' A' ' 194' ' ' GLU . 2.9 m -142.49 150.35 18.54 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.568 0 CA-C-O 121.483 0.659 . . . . 0.0 112.595 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . 0.421 ' N ' ' O ' ' A' ' 231' ' ' GLU . 43.5 ttp180 -154.83 102.09 2.33 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.847 -1.069 . . . . 0.0 112.479 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.517 ' CB ' ' HA ' ' A' ' 230' ' ' ILE . 0.3 OUTLIER -100.56 170.57 8.29 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 120.426 -0.51 . . . . 0.0 111.004 179.235 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.683 HG23 ' O ' ' A' ' 188' ' ' ILE . 26.6 mt -154.18 140.15 11.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -178.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.5 ' N ' HG22 ' A' ' 190' ' ' VAL . 1.2 ttt180 -87.17 -154.18 0.24 Allowed 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.012 -0.995 . . . . 0.0 108.774 178.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -94.7 28.74 2.54 Favored 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 122.02 -0.425 . . . . 0.0 111.184 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -152.98 -75.81 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.45 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.683 ' O ' HG23 ' A' ' 184' ' ' ILE . 0.5 OUTLIER -117.75 -156.75 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 115.441 -0.379 . . . . 0.0 110.296 -179.359 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.713 HG11 ' CG ' ' A' ' 192' ' ' GLU . 21.3 t -86.48 139.49 17.28 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.393 0 CA-C-O 121.399 0.619 . . . . 0.0 110.916 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.563 HG23 ' CA ' ' A' ' 184' ' ' ILE . 0.3 OUTLIER -88.58 -35.84 8.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.468 -179.841 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . 0.466 ' HB2' ' CE1' ' A' ' 221' ' ' PHE . 31.1 t80 -178.34 144.31 0.3 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.997 179.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . 0.713 ' CG ' HG11 ' A' ' 189' ' ' VAL . 0.3 OUTLIER -131.87 159.03 39.77 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.937 0.398 . . . . 0.0 110.801 179.293 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 146.16 -126.05 2.41 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.852 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . 0.628 ' CA ' HG22 ' A' ' 181' ' ' VAL . 11.0 pt-20 -143.07 -176.37 4.89 Favored 'General case' 0 CA--C 1.499 -1.011 0 CA-C-O 121.289 0.566 . . . . 0.0 111.667 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.523 HG12 HG13 ' A' ' 181' ' ' VAL . 12.3 mm -87.42 143.41 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.485 -179.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.78 -57.1 3.03 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 1.2 m -151.59 152.94 33.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.282 178.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.597 HD11 ' C ' ' A' ' 206' ' ' ARG . 0.3 OUTLIER -134.87 119.05 17.62 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.694 0.759 . . . . 0.0 112.014 179.9 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.28 125.31 9.94 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 114.445 -1.252 . . . . 0.0 109.431 178.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . 0.639 ' NH1' HG11 ' A' ' 205' ' ' VAL . 1.2 ptp85 . . . . . 0 C--N 1.316 -0.859 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.244 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 . . . . . 0 N--CA 1.452 -0.35 0 CA-C-O 121.243 0.544 . . . . 0.0 110.066 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.639 HG11 ' NH1' ' A' ' 200' ' ' ARG . 35.3 m -56.55 158.16 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.962 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.796 -179.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . 0.597 ' C ' HD11 ' A' ' 198' ' ' LEU . 2.5 ttp-105 -89.07 -27.82 20.54 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.716 -178.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.438 ' HB3' ' HB2' ' A' ' 174' ' ' LYS . 1.5 mp0 -139.99 178.36 7.32 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.092 0.472 . . . . 0.0 111.162 179.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.665 ' O ' HG21 ' A' ' 170' ' ' VAL . 0.5 OUTLIER -151.02 75.74 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.854 179.121 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.431 ' HB2' ' HB3' ' A' ' 174' ' ' LYS . . . -97.27 175.18 6.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.081 0.467 . . . . 0.0 112.223 -178.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 83.88 -75.46 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.858 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 178.26 36.89 0.06 OUTLIER Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.372 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -98.32 144.06 28.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.901 0.382 . . . . 0.0 111.171 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.62 131.32 44.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.021 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' CYS . . . . . 0.53 ' HB3' HG21 ' A' ' 208' ' ' VAL . 50.8 t -134.22 149.86 51.01 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.753 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -88.99 116.54 4.69 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.568 -0.825 . . . . 0.0 111.621 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.63 HD11 HG21 ' A' ' 175' ' ' ILE . 0.1 OUTLIER -143.68 145.65 32.61 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 121.113 0.482 . . . . 0.0 111.386 -178.784 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . 0.626 HG23 HD12 ' A' ' 165' ' ' ILE . 0.0 OUTLIER -86.44 146.48 26.41 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.348 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . 0.623 HG23 HG21 ' A' ' 181' ' ' VAL . 1.6 mp -110.36 87.91 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 1.4 tttt 45.93 -144.44 0.23 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.018 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -87.17 62.03 7.06 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 121.097 0.475 . . . . 0.0 111.016 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . 0.51 ' CZ ' HD21 ' A' ' 183' ' ' LEU . 0.1 OUTLIER -55.59 122.23 10.86 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 114.423 1.268 . . . . 0.0 114.423 179.034 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -87.92 -45.69 10.03 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 114.899 -1.046 . . . . 0.0 108.422 176.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . 0.452 ' OD1' ' N ' ' A' ' 223' ' ' ASP . 0.0 OUTLIER -81.65 135.14 35.54 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.994 177.588 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.636 ' N ' HD13 ' A' ' 224' ' ' ILE . 0.2 OUTLIER -134.67 179.65 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.718 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.411 ' O ' ' C ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER 57.33 114.44 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 114.479 -1.237 . . . . 0.0 110.052 -178.96 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . 0.544 ' H ' ' HA ' ' A' ' 155' ' ' GLN . 5.2 tm-20 11.41 61.1 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 124.671 1.232 . . . . 0.0 112.919 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . 0.43 ' N ' HG11 ' A' ' 153' ' ' VAL . . . -60.19 -68.02 1.88 Allowed Glycine 0 N--CA 1.433 -1.541 0 CA-C-N 114.695 -1.139 . . . . 0.0 111.736 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.463 ' O ' HG12 ' A' ' 153' ' ' VAL . 0.8 OUTLIER -164.8 -148.93 0.12 Allowed 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 179.631 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . 0.739 HG22 ' HG2' ' A' ' 152' ' ' GLU . 92.1 t -88.44 129.61 39.32 Favored 'Isoleucine or valine' 0 C--N 1.346 0.453 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.517 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . 0.572 HD12 ' HB3' ' A' ' 168' ' ' CYS . 17.4 mt -98.94 157.17 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 O-C-N 123.689 0.618 . . . . 0.0 111.564 -179.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' GLU . . . . . 0.423 ' CG ' ' HG2' ' A' ' 150' ' ' GLN . 0.0 OUTLIER -146.46 109.97 4.82 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -179.673 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.719 ' HB3' ' HA3' ' A' ' 149' ' ' GLY . . . -88.96 131.14 35.29 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.397 178.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' TYR . . . . . 0.438 ' CE1' ' HB3' ' A' ' 180' ' ' LYS . 11.8 p90 -128.95 142.83 50.8 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.724 0.297 . . . . 0.0 110.962 -179.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.457 HG12 HG13 ' A' ' 148' ' ' ILE . 0.9 OUTLIER . . . . . 0 CA--C 1.536 0.431 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.607 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.555 ' HG3' HG23 ' A' ' 147' ' ' VAL . 17.4 tptt . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.584 0.23 . . . . 0.0 111.099 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.564 HG11 ' HB2' ' A' ' 150' ' ' GLN . 13.6 t -122.64 142.73 38.03 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.555 0 CA-C-O 121.507 0.67 . . . . 0.0 111.706 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.495 ' HB ' HG12 ' A' ' 234' ' ' VAL . 3.9 tp -118.01 -20.05 5.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.084 178.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.434 ' O ' ' HB3' ' A' ' 232' ' ' ALA . . . -178.02 85.17 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.445 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.564 ' HB2' HG11 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -93.72 132.98 37.56 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.764 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.439 ' CB ' ' HB2' ' A' ' 168' ' ' CYS . . . -152.14 175.88 12.12 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 119.736 -0.786 . . . . 0.0 113.059 -177.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.835 ' HG2' HG22 ' A' ' 229' ' ' VAL . 13.1 mt-10 -120.47 124.09 44.56 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.445 -1.252 . . . . 0.0 110.046 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.474 HG12 ' O ' ' A' ' 228' ' ' ASP . 3.6 p -50.52 134.46 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -178.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -89.46 -61.35 1.72 Allowed 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 175.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.528 ' HA ' ' H ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER -161.13 -160.46 0.73 Allowed 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 113.711 -1.586 . . . . 0.0 109.651 175.595 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.496 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 4.3 p -147.99 168.24 22.83 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 177.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.681 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 6.4 m-85 -118.11 75.58 1.02 Allowed 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -178.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.05 63.28 7.94 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 122.121 0.962 . . . . 0.0 108.481 178.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 83.9 t -90.9 157.75 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 CA-C-N 113.709 -1.587 . . . . 0.0 110.229 -178.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 1.2 m -92.5 34.57 1.05 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.217 0.532 . . . . 0.0 109.849 178.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 9.8 mttt -151.67 -32.97 0.15 Allowed 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.442 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.868 HG11 HD12 ' A' ' 165' ' ' ILE . 84.0 t -99.83 -103.21 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.278 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . 0.513 ' N ' HG12 ' A' ' 162' ' ' VAL . . . -159.12 -101.56 0.17 Allowed Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 111.481 -0.648 . . . . 0.0 111.481 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.598 ' CG2' HG22 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -153.83 36.18 0.44 Allowed 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 114.152 -1.024 . . . . 0.0 108.49 178.25 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.868 HD12 HG11 ' A' ' 162' ' ' VAL . 3.8 mt -42.14 98.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.441 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.591 ' HB3' HD13 ' A' ' 218' ' ' ILE . . . -91.71 121.05 33.0 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.006 -0.997 . . . . 0.0 112.298 -179.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -88.73 150.96 22.01 Favored Glycine 0 N--CA 1.441 -0.969 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 178.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.485 ' HB3' HD13 ' A' ' 230' ' ' ILE . 0.0 OUTLIER -145.92 136.05 23.74 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 117.377 0.588 . . . . 0.0 110.776 -178.409 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . 0.419 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 31.4 t80 -87.2 123.56 32.36 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 177.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.685 HG21 ' O ' ' A' ' 208' ' ' VAL . 38.8 t -85.13 148.08 5.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -175.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -138.86 16.86 2.67 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-N 114.298 -1.319 . . . . 0.0 111.81 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.543 ' H ' HG12 ' A' ' 170' ' ' VAL . 8.6 t0 -150.19 -147.42 0.23 Allowed 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -179.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -44.39 -104.47 0.01 OUTLIER Glycine 0 CA--C 1.53 1.025 0 N-CA-C 114.685 0.634 . . . . 0.0 114.685 -179.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.747 ' HG3' ' HB2' ' A' ' 209' ' ' ALA . 0.0 OUTLIER -151.1 126.61 10.11 Favored 'General case' 0 CA--C 1.513 -0.449 0 O-C-N 122.608 -0.348 . . . . 0.0 111.458 -179.04 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.656 ' O ' HG23 ' A' ' 175' ' ' ILE . 1.5 tp -88.82 83.76 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 CA-C-O 122.035 0.922 . . . . 0.0 109.238 177.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.518 HG22 ' HB3' ' A' ' 207' ' ' GLU . 0.0 OUTLIER -89.18 -177.91 5.53 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.384 -1.28 . . . . 0.0 112.932 -177.137 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 37.7 mtm180 -74.71 -44.11 51.71 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 114.669 -1.151 . . . . 0.0 110.839 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -89.04 57.68 4.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.75 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 3.3 m -148.22 163.33 37.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.401 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.479 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 2.7 mptm? -93.77 176.48 6.34 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.104 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.546 HG13 HD11 ' A' ' 195' ' ' ILE . 1.1 m -151.14 149.99 13.69 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.476 0 CA-C-O 121.598 0.713 . . . . 0.0 111.952 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . 0.449 ' N ' ' O ' ' A' ' 231' ' ' GLU . 41.3 ttp180 -153.39 104.36 2.75 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.108 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.595 HD21 ' CZ ' ' A' ' 221' ' ' PHE . 0.3 OUTLIER -99.49 170.88 8.31 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-O 120.976 0.417 . . . . 0.0 111.008 -179.75 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.759 HG23 ' O ' ' A' ' 188' ' ' ILE . 48.4 mt -152.92 141.64 14.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.194 -177.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.472 ' O ' HG22 ' A' ' 184' ' ' ILE . 7.1 ttp180 -86.49 -157.38 0.35 Allowed 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -94.17 27.14 2.97 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.724 178.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -154.25 -43.59 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.862 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.759 ' O ' HG23 ' A' ' 184' ' ' ILE . 0.4 OUTLIER -150.24 -160.52 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -178.098 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.658 HG11 ' CD ' ' A' ' 192' ' ' GLU . 35.5 t -85.41 134.98 25.87 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.397 0 CA-C-O 121.439 0.638 . . . . 0.0 110.386 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.486 HG23 ' HG ' ' A' ' 183' ' ' LEU . 0.2 OUTLIER -88.79 -32.54 5.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.619 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . 0.522 ' CB ' ' CE1' ' A' ' 221' ' ' PHE . 79.8 t80 179.9 158.41 0.72 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.673 178.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . 0.658 ' CD ' HG11 ' A' ' 189' ' ' VAL . 7.6 mp0 -143.87 154.28 43.21 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.969 0.414 . . . . 0.0 110.443 178.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 148.5 -129.33 3.08 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.843 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . 0.479 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 13.3 pt-20 -139.38 -174.38 3.86 Favored 'General case' 0 CA--C 1.498 -1.039 0 CA-C-O 121.27 0.557 . . . . 0.0 111.393 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.546 HD11 HG13 ' A' ' 181' ' ' VAL . 4.2 mp -88.0 143.84 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.009 -178.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -89.24 -53.29 4.63 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 18.3 p -151.2 143.22 23.95 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.308 178.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.727 ' CD1' HD22 ' A' ' 216' ' ' LEU . 0.5 OUTLIER -119.67 114.42 22.16 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.329 0.585 . . . . 0.0 111.681 -179.571 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 26.9 tttt -150.48 122.15 8.04 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.137 179.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.323 -0.563 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.968 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . 0.403 ' HA ' ' HA ' ' A' ' 199' ' ' LYS . 4.4 t70 . . . . . 0 N--CA 1.453 -0.292 0 CA-C-O 120.959 0.409 . . . . 0.0 110.189 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 32.9 m -61.07 160.06 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 CA-C-O 121.521 0.677 . . . . 0.0 112.242 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . 0.431 ' O ' ' HB ' ' A' ' 176' ' ' THR . 0.2 OUTLIER -89.43 -36.74 15.28 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 114.735 -1.121 . . . . 0.0 111.607 -178.616 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.518 ' HB3' HG22 ' A' ' 176' ' ' THR . 0.6 OUTLIER -137.53 177.23 8.02 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.301 0.572 . . . . 0.0 111.895 -179.799 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.685 ' O ' HG21 ' A' ' 170' ' ' VAL . 0.0 OUTLIER -150.86 82.64 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.074 -0.967 . . . . 0.0 109.46 179.058 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.747 ' HB2' ' HG3' ' A' ' 174' ' ' LYS . . . -101.5 171.67 7.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.093 0.473 . . . . 0.0 112.182 -178.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 83.22 -72.55 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.998 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 178.0 37.89 0.06 OUTLIER Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.404 179.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . 0.419 ' HB3' HG12 ' A' ' 208' ' ' VAL . 2.1 m-85 -98.09 142.93 29.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.95 0.405 . . . . 0.0 111.565 -179.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.67 160.71 16.47 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.482 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -150.41 -164.97 2.14 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.863 0.363 . . . . 0.0 111.04 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . 0.461 ' C ' HG23 ' A' ' 165' ' ' ILE . . . -148.64 96.23 0.17 Allowed Glycine 0 N--CA 1.451 -0.316 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.727 HD22 ' CD1' ' A' ' 198' ' ' LEU . 0.5 OUTLIER -131.17 143.6 50.73 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -177.642 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . 0.542 ' C ' HD12 ' A' ' 218' ' ' ILE . 0.0 OUTLIER -78.0 143.79 37.25 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 176.404 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . 0.591 HD13 ' HB3' ' A' ' 166' ' ' ALA . 1.6 mp -108.26 88.14 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.709 -178.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 9.8 tttt 47.16 -141.91 0.44 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.663 179.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -86.42 55.73 3.68 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.091 0.472 . . . . 0.0 110.99 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . 0.595 ' CZ ' HD21 ' A' ' 183' ' ' LEU . 0.1 OUTLIER -57.51 132.0 51.85 Favored 'General case' 0 C--N 1.339 0.126 0 N-CA-C 116.086 1.884 . . . . 0.0 116.086 178.964 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.42 -42.3 8.55 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 114.35 -1.296 . . . . 0.0 108.658 175.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . 0.542 ' HB3' ' CE1' ' A' ' 221' ' ' PHE . 0.0 OUTLIER -64.96 164.12 13.27 Favored 'General case' 0 C--N 1.351 0.65 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.794 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.609 ' N ' HD13 ' A' ' 224' ' ' ILE . 0.2 OUTLIER -155.36 -177.11 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 114.897 -1.047 . . . . 0.0 111.988 176.39 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.418 ' CG ' HG12 ' A' ' 224' ' ' ILE . 0.0 OUTLIER 34.12 103.92 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.752 1.221 . . . . 0.0 112.345 -179.611 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . 0.528 ' H ' ' HA ' ' A' ' 155' ' ' GLN . 18.5 tt0 20.35 59.49 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.228 0 O-C-N 124.487 1.117 . . . . 0.0 113.224 179.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -61.65 -61.73 6.5 Favored Glycine 0 N--CA 1.432 -1.574 0 CA-C-N 114.869 -1.06 . . . . 0.0 112.482 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.474 ' O ' HG12 ' A' ' 153' ' ' VAL . 0.6 OUTLIER -164.06 -152.02 0.18 Allowed 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -179.544 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . 0.835 HG22 ' HG2' ' A' ' 152' ' ' GLU . 92.2 t -90.02 134.41 29.13 Favored 'Isoleucine or valine' 0 C--N 1.35 0.604 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.945 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . 0.485 HD13 ' HB3' ' A' ' 168' ' ' CYS . 2.7 mp -103.39 158.69 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 O-C-N 123.544 0.528 . . . . 0.0 111.228 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' GLU . . . . . 0.449 ' O ' ' N ' ' A' ' 182' ' ' ARG . 9.2 tt0 -147.79 111.32 4.98 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.653 ' HB2' HD12 ' A' ' 175' ' ' ILE . . . -87.7 139.68 30.28 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.683 179.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' TYR . . . . . 0.495 ' CA ' HG22 ' A' ' 148' ' ' ILE . 30.3 p90 -139.03 135.01 33.79 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.146 -179.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.495 HG12 ' HB ' ' A' ' 148' ' ' ILE . 0.5 OUTLIER . . . . . 0 CA--C 1.54 0.593 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.668 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.814 0.34 . . . . 0.0 110.952 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.719 HG11 ' HB2' ' A' ' 150' ' ' GLN . 20.7 t -58.68 143.22 13.33 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.449 0 CA-C-O 121.415 0.626 . . . . 0.0 111.424 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.542 HG22 ' O ' ' A' ' 148' ' ' ILE . 16.1 mm -129.7 6.98 2.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.843 178.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.59 ' CA ' ' HB3' ' A' ' 232' ' ' ALA . . . 173.9 72.88 0.05 OUTLIER Glycine 0 C--N 1.343 0.936 0 C-N-CA 121.127 -0.559 . . . . 0.0 111.904 179.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.719 ' HB2' HG11 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -93.71 131.5 38.98 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 116.871 0.335 . . . . 0.0 110.305 179.855 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.499 ' O ' HG13 ' A' ' 229' ' ' VAL . . . -151.65 176.47 11.33 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -178.338 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.46 ' HA ' ' HA ' ' A' ' 229' ' ' VAL . 1.9 mt-10 -123.69 125.82 45.45 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.746 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.472 HG12 ' O ' ' A' ' 228' ' ' ASP . 1.8 p -55.16 127.21 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-O 121.569 0.699 . . . . 0.0 112.196 -179.221 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.485 ' O ' ' HB3' ' A' ' 226' ' ' GLU . 0.0 OUTLIER -89.87 -55.16 3.74 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 105.056 -2.201 . . . . 0.0 105.056 175.736 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.83 -164.07 0.86 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.861 174.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.554 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 26.3 p -143.41 -175.9 4.73 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 178.253 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.669 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 21.7 m-85 -144.11 76.53 1.51 Allowed 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.475 ' HG2' HG13 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -86.52 62.64 7.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 122.428 1.109 . . . . 0.0 108.498 178.285 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.483 HG12 ' N ' ' A' ' 161' ' ' LYS . 45.8 t -89.85 154.73 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 CA-C-N 113.236 -1.802 . . . . 0.0 110.226 -178.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 26.3 t -89.83 36.74 0.86 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.057 0.456 . . . . 0.0 110.006 178.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.483 ' N ' HG12 ' A' ' 159' ' ' VAL . 1.4 mttt -150.6 -34.18 0.16 Allowed 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.213 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.501 HG12 ' N ' ' A' ' 163' ' ' GLY . 84.9 t -101.65 -101.81 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . 0.501 ' N ' HG12 ' A' ' 162' ' ' VAL . . . -158.79 -101.74 0.18 Allowed Glycine 0 C--O 1.224 -0.498 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 178.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.455 ' C ' HG23 ' A' ' 217' ' ' THR . 0.0 OUTLIER -152.32 37.07 0.53 Allowed 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 177.48 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.669 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 2.2 mm -40.28 93.21 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.338 0.095 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.773 -179.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.554 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . -84.98 116.47 23.4 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.457 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -87.49 134.4 12.44 Favored Glycine 0 N--CA 1.438 -1.181 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 178.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.414 ' HB2' ' CB ' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -136.46 131.21 33.73 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.859 0.329 . . . . 0.0 110.374 -178.503 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . 0.416 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 41.1 t80 -85.64 126.8 34.2 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 177.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.801 HG21 ' O ' ' A' ' 208' ' ' VAL . 45.4 t -85.73 146.36 6.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -175.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.2 p -138.44 14.19 2.77 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 114.402 -1.272 . . . . 0.0 111.807 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.408 ' H ' HG12 ' A' ' 170' ' ' VAL . 4.6 t70 -150.46 -142.58 0.12 Allowed 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -44.54 -105.36 0.01 OUTLIER Glycine 0 CA--C 1.53 1.015 0 N-CA-C 114.455 0.542 . . . . 0.0 114.455 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.808 ' HG2' ' HB2' ' A' ' 209' ' ' ALA . 10.7 mttm -151.8 143.13 23.39 Favored 'General case' 0 CA--C 1.516 -0.347 0 O-C-N 122.301 -0.529 . . . . 0.0 111.995 -179.1 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.622 ' CG1' HG22 ' A' ' 170' ' ' VAL . 11.2 mm -93.23 90.52 3.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 176.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.459 HG22 ' HB3' ' A' ' 207' ' ' GLU . 0.1 OUTLIER -106.13 174.7 5.77 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.488 0.661 . . . . 0.0 112.677 -177.495 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.408 ' HG3' ' HB2' ' A' ' 198' ' ' LEU . 0.1 OUTLIER -72.96 -42.59 63.22 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.208 179.351 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -88.28 56.22 3.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.141 -179.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -150.2 161.51 42.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.418 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 0.0 OUTLIER -89.18 -177.45 5.41 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.5 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.661 HG11 HG13 ' A' ' 218' ' ' ILE . 1.4 m -146.07 157.29 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 CA-C-O 121.227 0.537 . . . . 0.0 111.638 179.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . 0.418 ' N ' ' O ' ' A' ' 231' ' ' GLU . 6.0 ttt85 -152.78 102.54 2.7 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.312 -0.858 . . . . 0.0 113.196 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.708 HD12 ' HB3' ' A' ' 191' ' ' TYR . 0.3 OUTLIER -86.36 154.12 21.43 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-O 121.701 0.763 . . . . 0.0 113.034 -179.937 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.476 ' N ' HG23 ' A' ' 190' ' ' VAL . 3.2 mp -148.5 121.24 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 113.989 -1.46 . . . . 0.0 112.27 178.124 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.419 ' N ' HG22 ' A' ' 190' ' ' VAL . 1.3 ttm180 -85.99 -150.44 0.14 Allowed 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 177.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -93.99 27.48 2.78 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 118.78 0.718 . . . . 0.0 110.766 178.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -154.81 -77.54 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.835 -0.697 . . . . 0.0 112.673 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -115.44 -155.28 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 115.277 -0.462 . . . . 0.0 110.734 -179.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.775 HG11 ' CG ' ' A' ' 192' ' ' GLU . 44.2 t -87.08 135.44 25.21 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.102 0 CA-C-O 121.565 0.698 . . . . 0.0 111.74 -179.181 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.793 HG12 ' OD2' ' A' ' 223' ' ' ASP . 0.2 OUTLIER -89.58 -34.51 6.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 114.665 -1.152 . . . . 0.0 108.961 178.637 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . 0.708 ' HB3' HD12 ' A' ' 183' ' ' LEU . 16.6 t80 -158.33 158.79 35.0 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.35 178.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . 0.775 ' CG ' HG11 ' A' ' 189' ' ' VAL . 14.3 mt-10 -150.33 155.81 40.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.112 178.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 134.7 -119.34 2.15 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.257 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . 0.628 ' CA ' HG22 ' A' ' 181' ' ' VAL . 17.6 pt-20 -150.32 -175.01 4.91 Favored 'General case' 0 CA--C 1.496 -1.097 0 CA-C-O 121.357 0.599 . . . . 0.0 111.675 -179.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.567 ' CD1' HG13 ' A' ' 181' ' ' VAL . 4.3 mp -88.48 143.38 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.322 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' ASP . . . . . 0.421 ' CB ' ' HB ' ' A' ' 217' ' ' THR . 0.4 OUTLIER -88.93 -57.47 2.89 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.412 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 35.2 t -151.53 153.03 33.78 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.222 179.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.564 HD21 ' O ' ' A' ' 175' ' ' ILE . 0.1 OUTLIER -123.0 119.22 29.73 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-O 121.37 0.605 . . . . 0.0 111.484 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.34 118.7 6.42 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.126 179.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 4.6 ptm85 . . . . . 0 C--N 1.321 -0.653 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.177 179.844 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 19.4 t70 . . . . . 0 N--CA 1.454 -0.26 0 CA-C-O 120.978 0.418 . . . . 0.0 110.078 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 36.0 m -72.12 166.33 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.921 0 CA-C-O 121.618 0.723 . . . . 0.0 112.562 -178.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . 0.443 ' O ' ' HA ' ' A' ' 176' ' ' THR . 16.6 ttp180 -89.07 -41.1 12.51 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 114.483 -1.235 . . . . 0.0 111.556 -178.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.459 ' HB3' HG22 ' A' ' 176' ' ' THR . 0.3 OUTLIER -138.09 -177.18 4.71 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.135 0.493 . . . . 0.0 111.684 -179.544 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.801 ' O ' HG21 ' A' ' 170' ' ' VAL . 0.2 OUTLIER -150.88 81.56 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.801 179.316 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.808 ' HB2' ' HG2' ' A' ' 174' ' ' LYS . . . -99.74 175.28 5.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.056 0.455 . . . . 0.0 112.154 -178.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 82.59 -75.0 0.03 OUTLIER 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.697 -179.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 178.47 37.31 0.06 OUTLIER Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.376 -0.916 . . . . 0.0 112.362 179.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -99.22 145.28 27.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.963 0.411 . . . . 0.0 111.196 -179.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.4 131.79 46.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.453 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' CYS . . . . . 0.566 ' HB3' HG21 ' A' ' 208' ' ' VAL . 50.0 t -134.96 144.45 47.42 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.399 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . 0.625 ' O ' HD12 ' A' ' 165' ' ' ILE . . . -88.58 108.15 3.42 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.494 -0.86 . . . . 0.0 111.995 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.574 HD12 ' CD1' ' A' ' 218' ' ' ILE . 0.3 OUTLIER -132.54 140.51 48.33 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 120.97 0.414 . . . . 0.0 111.436 -179.264 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . 0.455 HG23 ' C ' ' A' ' 164' ' ' THR . 0.2 OUTLIER -78.73 138.8 38.42 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 177.907 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . 0.661 HG13 HG11 ' A' ' 181' ' ' VAL . 1.4 mp -105.79 95.4 3.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 -178.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 44.04 -145.53 0.11 Allowed 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.928 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 -88.16 63.83 7.42 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-O 120.85 0.357 . . . . 0.0 111.2 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . 0.683 ' CZ ' HD13 ' A' ' 183' ' ' LEU . 0.1 OUTLIER -54.4 118.44 4.13 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 179.002 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -84.14 -43.43 15.01 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.755 176.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . 0.793 ' OD2' HG12 ' A' ' 190' ' ' VAL . 0.0 OUTLIER -87.74 132.26 34.2 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.97 178.455 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.475 HG13 ' HG2' ' A' ' 158' ' ' LYS . 0.1 OUTLIER -116.61 179.56 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 CA-C-O 121.09 0.471 . . . . 0.0 112.003 -179.646 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.421 ' O ' ' N ' ' A' ' 227' ' ' GLY . 0.0 OUTLIER 55.67 120.88 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.543 179.853 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . 0.485 ' HB3' ' O ' ' A' ' 154' ' ' ARG . 3.3 pt-20 -3.97 71.73 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . 0.439 ' N ' HG11 ' A' ' 153' ' ' VAL . . . -64.48 -63.42 4.3 Favored Glycine 0 N--CA 1.43 -1.722 0 CA-C-N 114.7 -1.136 . . . . 0.0 111.616 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.472 ' O ' HG12 ' A' ' 153' ' ' VAL . 1.0 OUTLIER -164.76 -148.49 0.11 Allowed 'General case' 0 C--O 1.22 -0.491 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 179.585 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . 0.499 HG13 ' O ' ' A' ' 151' ' ' ALA . 61.9 t -89.47 145.76 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.225 0 O-C-N 122.091 -0.381 . . . . 0.0 110.494 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . 0.419 HG13 ' CD2' ' A' ' 183' ' ' LEU . 2.6 mp -117.01 154.4 18.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.156 -179.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' GLU . . . . . 0.506 ' OE2' HG22 ' A' ' 147' ' ' VAL . 7.5 tt0 -143.27 113.96 7.56 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.403 0.62 . . . . 0.0 111.948 -179.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.59 ' HB3' ' CA ' ' A' ' 149' ' ' GLY . . . -88.45 128.45 35.53 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.497 178.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -130.5 129.48 42.95 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.869 -178.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 4.3 t . . . . . 0 C--N 1.328 -0.349 0 CA-C-O 120.982 0.42 . . . . 0.0 111.762 -179.835 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 2.0 tttm . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.663 0.268 . . . . 0.0 110.527 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.706 HG11 ' HB2' ' A' ' 150' ' ' GLN . 14.9 t -59.53 140.9 17.04 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.637 0 CA-C-O 121.308 0.575 . . . . 0.0 111.315 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.704 HD11 ' HB3' ' A' ' 179' ' ' SER . 1.8 pp -124.97 -1.78 5.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.048 178.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.568 ' CA ' ' HB3' ' A' ' 232' ' ' ALA . . . 179.51 73.95 0.06 OUTLIER Glycine 0 C--N 1.34 0.791 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.165 179.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.706 ' HB2' HG11 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -90.99 132.8 35.76 Favored 'General case' 0 CA--C 1.509 -0.61 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.249 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.417 ' CB ' ' HB2' ' A' ' 168' ' ' CYS . . . -151.57 174.71 13.12 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 121.457 0.646 . . . . 0.0 112.458 -178.124 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.752 ' CG ' HG22 ' A' ' 229' ' ' VAL . 0.8 OUTLIER -119.98 122.14 40.52 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.021 179.691 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.443 HG12 ' O ' ' A' ' 228' ' ' ASP . 2.6 p -50.05 134.13 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -89.29 -63.31 1.31 Allowed 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 175.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.469 ' HA ' ' H ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER -161.51 -162.03 0.85 Allowed 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 113.826 -1.534 . . . . 0.0 109.198 175.206 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.514 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 7.5 p -145.89 157.3 43.91 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 120.829 0.347 . . . . 0.0 110.392 177.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.681 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 2.3 m-85 -104.21 72.13 1.06 Allowed 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -177.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 16.7 tttt -85.67 63.72 8.22 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 122.125 0.964 . . . . 0.0 108.826 178.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 95.8 t -89.9 158.21 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 CA-C-N 113.673 -1.603 . . . . 0.0 109.906 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 25.2 p -92.62 32.97 1.16 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.224 0.535 . . . . 0.0 110.036 178.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 3.2 mtmt -152.02 -31.54 0.15 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.644 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.459 HG12 ' N ' ' A' ' 163' ' ' GLY . 98.5 t -98.98 -101.19 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 O-C-N 122.171 -0.331 . . . . 0.0 110.234 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . 0.459 ' N ' HG12 ' A' ' 162' ' ' VAL . . . -158.72 -105.95 0.22 Allowed Glycine 0 N--CA 1.451 -0.361 0 N-CA-C 111.644 -0.583 . . . . 0.0 111.644 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.504 HG21 HG21 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -153.7 34.85 0.45 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.378 -0.911 . . . . 0.0 108.944 178.391 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.681 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 3.8 mm -42.45 94.87 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.577 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.514 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . -87.77 117.8 26.85 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 114.748 -1.114 . . . . 0.0 111.189 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -88.39 153.97 24.72 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 179.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.417 ' HB2' ' CB ' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -148.29 136.12 20.88 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.922 0.361 . . . . 0.0 110.81 -178.268 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . 0.408 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 33.3 t80 -87.39 124.96 33.95 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 177.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.77 HG21 ' O ' ' A' ' 208' ' ' VAL . 24.5 t -85.08 144.51 9.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -175.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -136.41 14.3 3.23 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-N 114.544 -1.207 . . . . 0.0 112.013 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.457 ' H ' HG12 ' A' ' 170' ' ' VAL . 4.2 t0 -150.52 -144.16 0.15 Allowed 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -179.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -41.32 -106.0 0.01 OUTLIER Glycine 0 CA--C 1.533 1.188 0 N-CA-C 115.197 0.839 . . . . 0.0 115.197 -178.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.408 ' HB2' ' HB3' ' A' ' 207' ' ' GLU . 0.0 OUTLIER -150.69 146.74 26.66 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.014 0.435 . . . . 0.0 111.619 -178.399 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.599 HG13 HG22 ' A' ' 170' ' ' VAL . 10.6 mm -99.39 83.23 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 176.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.457 ' HA ' ' O ' ' A' ' 206' ' ' ARG . 0.1 OUTLIER -95.88 168.5 10.6 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -177.177 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.412 ' CG ' ' HB3' ' A' ' 198' ' ' LEU . 33.8 mtm180 -64.58 -45.07 88.58 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 114.546 -1.206 . . . . 0.0 110.743 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -89.4 59.99 5.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.743 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . 0.704 ' HB3' HD11 ' A' ' 148' ' ' ILE . 58.9 m -149.13 156.04 41.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.756 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 3.5 mptp? -89.18 -179.33 5.86 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.696 179.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.812 HG21 HD12 ' A' ' 218' ' ' ILE . 1.1 m -150.86 150.12 13.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.493 0.663 . . . . 0.0 111.953 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . 0.439 ' N ' ' O ' ' A' ' 231' ' ' GLU . 11.5 ttt85 -153.25 102.43 2.61 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.463 179.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.622 ' C ' HD12 ' A' ' 184' ' ' ILE . 0.3 OUTLIER -100.58 167.67 10.2 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-O 120.947 0.403 . . . . 0.0 111.382 -179.829 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.666 HG23 ' O ' ' A' ' 188' ' ' ILE . 4.7 mp -151.56 139.98 14.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.944 -177.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.504 ' N ' HG22 ' A' ' 190' ' ' VAL . 0.1 OUTLIER -87.16 -153.19 0.21 Allowed 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.022 -0.99 . . . . 0.0 108.86 178.117 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -94.71 28.02 2.83 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 118.092 0.405 . . . . 0.0 111.296 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -152.96 -76.75 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.556 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.666 ' O ' HG23 ' A' ' 184' ' ' ILE . 0.4 OUTLIER -116.12 -156.57 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 115.525 -0.338 . . . . 0.0 110.319 -179.54 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.759 HG11 ' CD ' ' A' ' 192' ' ' GLU . 31.0 t -86.16 138.84 18.32 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 CA-C-O 121.476 0.655 . . . . 0.0 110.702 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.577 HG23 ' CA ' ' A' ' 184' ' ' ILE . 0.6 OUTLIER -87.68 -37.11 10.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 114.913 -1.04 . . . . 0.0 108.89 179.847 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . 0.439 ' CE2' ' HA ' ' A' ' 221' ' ' PHE . 0.5 OUTLIER -178.69 150.49 0.52 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.354 179.617 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . 0.759 ' CD ' HG11 ' A' ' 189' ' ' VAL . 2.3 mp0 -137.13 158.35 44.63 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.935 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 144.53 -132.73 4.9 Favored Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.556 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . 0.736 ' O ' HG23 ' A' ' 218' ' ' ILE . 4.1 pt-20 -143.58 -179.34 6.37 Favored 'General case' 0 CA--C 1.498 -1.023 0 CA-C-O 121.186 0.517 . . . . 0.0 111.051 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.866 HG12 HD13 ' A' ' 216' ' ' LEU . 4.5 mp -88.73 143.05 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.877 -178.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -91.81 -43.79 9.33 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 48.8 m -151.29 145.56 25.43 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.09 179.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.536 HD12 ' HB3' ' A' ' 216' ' ' LEU . 16.7 tp -119.39 113.82 21.39 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.075 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 19.7 mtmm -149.56 122.86 8.98 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.368 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.322 -0.594 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.833 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . 0.404 ' HA ' ' HA ' ' A' ' 199' ' ' LYS . 19.2 m-20 . . . . . 0 N--CA 1.453 -0.308 0 CA-C-O 120.919 0.39 . . . . 0.0 110.317 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 33.1 m -64.52 159.45 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.878 0 CA-C-O 121.583 0.706 . . . . 0.0 112.313 -179.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . 0.457 ' O ' ' HA ' ' A' ' 176' ' ' THR . 1.9 ttt180 -89.3 -34.54 16.54 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.875 -178.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 176' ' ' THR . 1.6 mp0 -142.03 -179.01 5.97 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.156 0.503 . . . . 0.0 111.527 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.77 ' O ' HG21 ' A' ' 170' ' ' VAL . 1.9 t -150.79 73.03 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.848 179.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.401 ' HB2' ' HD2' ' A' ' 174' ' ' LYS . . . -96.25 171.01 8.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.087 0.47 . . . . 0.0 112.206 -178.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 83.11 -76.32 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.766 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 178.31 37.46 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.299 -0.953 . . . . 0.0 112.656 179.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -95.83 154.71 17.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.894 0.378 . . . . 0.0 111.2 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -89.55 162.43 15.68 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.355 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' CYS . . . . . 0.598 ' HB3' HG21 ' A' ' 208' ' ' VAL . 29.8 p -150.49 -171.65 3.98 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.874 0.369 . . . . 0.0 111.42 -179.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . 0.508 ' O ' HD12 ' A' ' 165' ' ' ILE . . . -150.2 98.58 0.19 Allowed Glycine 0 N--CA 1.451 -0.343 0 N-CA-C 111.505 -0.638 . . . . 0.0 111.505 179.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.866 HD13 HG12 ' A' ' 195' ' ' ILE . 0.5 OUTLIER -126.27 140.63 52.37 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-O 121.18 0.514 . . . . 0.0 112.242 -179.113 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -100.6 115.19 29.6 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.314 -0.857 . . . . 0.0 108.738 177.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . 0.812 HD12 HG21 ' A' ' 181' ' ' VAL . 15.6 mm -63.39 140.59 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-O 121.27 0.557 . . . . 0.0 110.626 -178.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . 0.409 ' HD3' ' HG2' ' A' ' 194' ' ' GLU . 6.1 ptmt -42.45 -28.64 0.22 Allowed 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 -177.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' ASN . . . . . 0.433 ' O ' ' CE2' ' A' ' 191' ' ' TYR . 6.1 t-20 -152.36 34.4 0.51 Allowed 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 -178.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . 0.518 ' CZ ' HD21 ' A' ' 183' ' ' LEU . 0.1 OUTLIER -58.25 121.41 10.68 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 178.872 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -89.52 -48.68 7.15 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 114.888 -1.051 . . . . 0.0 108.377 176.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . 0.451 ' O ' ' CD1' ' A' ' 221' ' ' PHE . 0.0 OUTLIER -77.14 140.22 40.16 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.292 177.496 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.637 ' N ' HD13 ' A' ' 224' ' ' ILE . 0.2 OUTLIER -134.67 178.01 6.06 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -178.85 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.413 ' O ' ' C ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER 56.61 115.54 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 114.391 -1.277 . . . . 0.0 110.182 -179.147 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . 0.469 ' H ' ' HA ' ' A' ' 155' ' ' GLN . 6.5 tt0 7.5 64.28 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 124.65 1.18 . . . . 0.0 113.55 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -61.18 -65.78 3.07 Favored Glycine 0 N--CA 1.431 -1.635 0 CA-C-N 114.694 -1.139 . . . . 0.0 111.764 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.443 ' O ' HG12 ' A' ' 153' ' ' VAL . 0.9 OUTLIER -164.98 -147.67 0.1 Allowed 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 179.859 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . 0.752 HG22 ' CG ' ' A' ' 152' ' ' GLU . 76.4 t -89.32 131.51 36.42 Favored 'Isoleucine or valine' 0 C--N 1.348 0.536 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.063 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . 0.481 ' HA ' ' CB ' ' A' ' 183' ' ' LEU . 3.7 mt -102.31 159.23 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 O-C-N 123.494 0.496 . . . . 0.0 111.487 -179.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' GLU . . . . . 0.448 ' N ' HG22 ' A' ' 230' ' ' ILE . 7.2 tt0 -145.25 110.42 5.22 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.568 ' HB3' ' CA ' ' A' ' 149' ' ' GLY . . . -88.26 129.5 35.35 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.668 178.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -130.82 141.5 50.34 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.803 -178.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.561 HG12 HG21 ' A' ' 148' ' ' ILE . 0.3 OUTLIER . . . . . 0 CA--C 1.535 0.38 0 CA-C-O 120.804 0.335 . . . . 0.0 111.135 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 11.6 mmtp . . . . . 0 CA--C 1.528 0.118 0 CA-C-O 120.667 0.27 . . . . 0.0 110.751 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.763 HG11 ' HB2' ' A' ' 150' ' ' GLN . 20.1 t -56.71 137.59 18.42 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.541 0 CA-C-O 121.135 0.493 . . . . 0.0 111.522 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.57 HD13 ' O ' ' A' ' 147' ' ' VAL . 25.7 mm -121.81 -4.31 8.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.27 178.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.476 ' O ' ' HB3' ' A' ' 232' ' ' ALA . . . -176.72 72.15 0.08 OUTLIER Glycine 0 C--N 1.343 0.926 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.044 179.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.763 ' HB2' HG11 ' A' ' 147' ' ' VAL . 2.3 tt0 -90.49 135.15 33.88 Favored 'General case' 0 CA--C 1.512 -0.501 0 O-C-N 122.678 -0.307 . . . . 0.0 110.369 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.436 ' CB ' ' HB2' ' A' ' 168' ' ' CYS . . . -152.56 171.08 18.68 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 120.095 -0.642 . . . . 0.0 112.674 -178.1 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.835 ' CG ' HG22 ' A' ' 229' ' ' VAL . 0.6 OUTLIER -119.84 124.09 45.25 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.031 179.453 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.443 ' HB ' ' O ' ' A' ' 228' ' ' ASP . 3.9 p -52.01 133.26 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -178.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -89.29 -60.28 1.99 Allowed 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 104.827 -2.286 . . . . 0.0 104.827 175.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.535 ' HA ' ' H ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER -161.28 -161.94 0.85 Allowed 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 113.04 -1.891 . . . . 0.0 108.773 175.252 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.585 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 1.6 p -150.96 155.56 39.35 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 176.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.696 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 2.8 m-85 -104.62 76.38 1.28 Allowed 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -178.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -86.07 62.99 7.77 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.486 HG12 ' N ' ' A' ' 161' ' ' LYS . 54.7 t -89.97 155.35 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 CA-C-N 113.749 -1.569 . . . . 0.0 110.12 -178.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 28.6 t -90.79 34.78 0.9 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.203 0.525 . . . . 0.0 109.973 178.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.486 ' N ' HG12 ' A' ' 159' ' ' VAL . 0.5 OUTLIER -150.71 -31.67 0.18 Allowed 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.316 -179.689 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.5 HG12 ' N ' ' A' ' 163' ' ' GLY . 90.5 t -102.71 -102.78 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . 0.5 ' N ' HG12 ' A' ' 162' ' ' VAL . . . -158.95 -105.9 0.22 Allowed Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 179.084 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.637 HG21 HG21 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -156.03 54.4 0.58 Allowed 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 178.124 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.696 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 0.1 OUTLIER -34.38 -27.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.214 -0.812 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 -177.003 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.585 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . 36.78 97.52 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 178.348 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -86.39 149.67 22.95 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 109.881 -1.287 . . . . 0.0 109.881 178.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.436 ' HB2' ' CB ' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -144.81 135.33 24.44 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 117.216 0.508 . . . . 0.0 110.467 -178.18 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . 0.433 ' O ' ' HA ' ' A' ' 151' ' ' ALA . 1.9 t80 -87.96 124.8 34.07 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 177.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.754 HG21 ' O ' ' A' ' 208' ' ' VAL . 41.0 t -85.16 137.92 19.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.635 0.731 . . . . 0.0 112.849 -176.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.3 p -129.42 12.0 5.9 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 114.627 -1.169 . . . . 0.0 112.096 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -145.76 -139.21 0.1 Allowed 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -50.84 -110.73 0.01 OUTLIER Glycine 0 CA--C 1.53 1.013 0 C-N-CA 121.058 -0.592 . . . . 0.0 114.151 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.68 ' CG ' ' HB2' ' A' ' 209' ' ' ALA . 0.0 OUTLIER -144.7 137.26 26.43 Favored 'General case' 0 CA--C 1.514 -0.423 0 O-C-N 122.349 -0.501 . . . . 0.0 110.834 -179.272 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.479 ' O ' HG23 ' A' ' 175' ' ' ILE . 0.6 OUTLIER -94.43 112.18 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 C-N-CA 119.556 -0.858 . . . . 0.0 109.165 177.371 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.52 ' HB ' ' O ' ' A' ' 206' ' ' ARG . 0.3 OUTLIER -125.03 177.76 5.89 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.37 0.605 . . . . 0.0 112.09 -177.373 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.411 ' N ' HD13 ' A' ' 198' ' ' LEU . 0.0 OUTLIER -74.8 -36.81 62.47 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.032 -0.986 . . . . 0.0 109.525 179.241 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -88.94 52.04 2.31 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.054 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . 0.477 ' O ' HD12 ' A' ' 195' ' ' ILE . 0.6 OUTLIER -150.72 159.59 44.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.987 179.799 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.486 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 0.0 OUTLIER -88.98 -177.84 5.56 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.172 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.664 HG21 HG23 ' A' ' 218' ' ' ILE . 2.3 m -142.13 160.39 20.22 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 CA-C-O 121.335 0.588 . . . . 0.0 111.82 179.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . 0.445 ' N ' ' O ' ' A' ' 231' ' ' GLU . 4.4 ttt-85 -152.66 97.81 2.28 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.099 -0.955 . . . . 0.0 112.806 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.687 HD13 ' CZ ' ' A' ' 221' ' ' PHE . 0.3 OUTLIER -86.25 153.79 21.75 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-O 121.748 0.785 . . . . 0.0 112.58 179.991 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.776 ' N ' HG23 ' A' ' 190' ' ' VAL . 17.8 mt -158.23 131.73 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 114.171 -1.377 . . . . 0.0 112.581 179.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.446 ' O ' HG22 ' A' ' 184' ' ' ILE . 0.0 OUTLIER -89.0 -151.74 0.22 Allowed 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.024 -1.472 . . . . 0.0 107.024 176.253 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -95.93 27.54 3.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 118.521 0.601 . . . . 0.0 110.516 178.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -153.96 -43.33 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.679 -0.772 . . . . 0.0 113.405 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.668 HG23 ' N ' ' A' ' 189' ' ' VAL . 0.4 OUTLIER -150.15 -158.33 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -177.953 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.668 ' N ' HG23 ' A' ' 188' ' ' ILE . 48.0 t -87.34 138.11 19.7 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 CA-C-O 121.624 0.726 . . . . 0.0 111.204 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.816 HG21 ' CB ' ' A' ' 228' ' ' ASP . 0.1 OUTLIER -98.12 -34.21 4.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 114.645 -1.161 . . . . 0.0 108.864 179.264 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . 0.629 ' HB3' HD12 ' A' ' 183' ' ' LEU . 19.1 t80 -158.58 159.75 35.83 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.18 179.096 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . 0.65 ' CG ' HG11 ' A' ' 189' ' ' VAL . 19.3 mt-10 -150.34 155.11 39.02 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.61 178.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 135.13 -121.48 2.59 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.485 -0.864 . . . . 0.0 112.382 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 12.4 pt-20 -150.01 -176.57 5.5 Favored 'General case' 0 CA--C 1.495 -1.143 0 CA-C-O 121.447 0.642 . . . . 0.0 112.031 -178.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.477 HD12 ' O ' ' A' ' 179' ' ' SER . 4.5 mp -89.06 150.28 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 CA-C-N 115.175 -0.921 . . . . 0.0 109.37 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -88.73 -67.98 0.8 Allowed 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -151.99 154.62 36.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.455 178.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.592 HD22 ' C ' ' A' ' 206' ' ' ARG . 0.2 OUTLIER -107.61 127.85 54.02 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.319 0.581 . . . . 0.0 111.711 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 43.8 tttt -150.63 113.46 4.75 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.388 179.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.516 0 CA-C-N 116.081 -0.508 . . . . 0.0 109.823 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . 0.422 ' HA ' ' HA ' ' A' ' 199' ' ' LYS . 4.5 p-10 . . . . . 0 N--CA 1.454 -0.267 0 CA-C-O 120.673 0.273 . . . . 0.0 110.44 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.499 HG23 HD23 ' A' ' 198' ' ' LEU . 35.0 m -74.34 176.66 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -0.986 0 CA-C-O 121.576 0.703 . . . . 0.0 112.366 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . 0.592 ' C ' HD22 ' A' ' 198' ' ' LEU . 2.1 ttt180 -103.74 -42.24 5.69 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 114.616 -1.175 . . . . 0.0 111.796 -179.01 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.481 ' CB ' HG22 ' A' ' 176' ' ' THR . 1.4 mp0 -131.03 -177.02 4.19 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.207 0.527 . . . . 0.0 112.052 -179.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.754 ' O ' HG21 ' A' ' 170' ' ' VAL . 0.9 OUTLIER -151.42 71.26 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.848 178.539 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.68 ' HB2' ' CG ' ' A' ' 174' ' ' LYS . . . -91.65 171.68 9.0 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.094 0.473 . . . . 0.0 112.174 -178.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 83.67 -76.87 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.9 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . 0.4 ' O ' ' CE1' ' A' ' 169' ' ' TYR . . . 178.04 36.95 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.338 -0.934 . . . . 0.0 112.563 179.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -100.45 153.01 19.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.023 0.439 . . . . 0.0 111.239 -179.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.2 133.05 45.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.971 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' CYS . . . . . 0.471 ' HB3' HG21 ' A' ' 208' ' ' VAL . 1.8 t -135.73 146.08 47.31 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.976 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -89.66 112.27 3.99 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.868 179.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.548 HD12 ' CD1' ' A' ' 218' ' ' ILE . 0.4 OUTLIER -139.95 131.67 27.37 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-O 120.937 0.398 . . . . 0.0 111.012 -179.909 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . 0.42 ' C ' HD12 ' A' ' 218' ' ' ILE . 0.0 OUTLIER -68.72 142.96 54.85 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.267 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . 0.664 HG23 HG21 ' A' ' 181' ' ' VAL . 1.7 mp -108.81 87.42 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 -178.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . 0.429 ' HB2' ' O ' ' A' ' 194' ' ' GLU . 2.7 tttt 45.3 -143.47 0.22 Allowed 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.519 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -88.44 63.69 7.18 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-O 120.732 0.301 . . . . 0.0 111.317 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . 0.687 ' CZ ' HD13 ' A' ' 183' ' ' LEU . 0.1 OUTLIER -54.91 119.04 4.82 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 178.705 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -82.75 -45.44 14.4 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.651 176.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . 0.619 ' OD2' HG12 ' A' ' 190' ' ' VAL . 0.0 OUTLIER -88.16 146.33 25.45 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.031 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.64 ' N ' HD13 ' A' ' 224' ' ' ILE . 0.2 OUTLIER -141.46 -179.18 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.146 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -178.527 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.409 ' O ' ' C ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER 54.87 111.1 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 114.184 -1.371 . . . . 0.0 110.376 -179.127 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . 0.535 ' H ' ' HA ' ' A' ' 155' ' ' GLN . 21.9 tt0 14.81 56.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 124.685 1.24 . . . . 0.0 112.504 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -67.45 -56.63 11.06 Favored Glycine 0 N--CA 1.422 -2.262 0 CA-C-N 114.224 -1.353 . . . . 0.0 113.323 -178.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.816 ' CB ' HG21 ' A' ' 190' ' ' VAL . 4.3 m-20 -161.25 -164.12 1.11 Allowed 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 115.124 1.527 . . . . 0.0 115.124 -177.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . 0.835 HG22 ' CG ' ' A' ' 152' ' ' GLU . 63.9 t -88.07 140.87 15.12 Favored 'Isoleucine or valine' 0 C--N 1.346 0.429 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . 0.412 HG13 ' HG ' ' A' ' 183' ' ' LEU . 2.7 mp -112.92 154.55 14.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.958 0.408 . . . . 0.0 111.372 -178.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' GLU . . . . . 0.445 ' HA ' ' HA ' ' A' ' 150' ' ' GLN . 5.0 tt0 -144.5 109.5 5.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.328 0.585 . . . . 0.0 111.684 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.476 ' HB3' ' O ' ' A' ' 149' ' ' GLY . . . -87.01 128.5 35.08 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.965 179.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' TYR . . . . . 0.423 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 8.8 p90 -131.63 141.22 49.58 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.551 -179.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.475 HG12 HG13 ' A' ' 148' ' ' ILE . 4.4 p . . . . . 0 C--N 1.329 -0.317 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.629 0.252 . . . . 0.0 110.479 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.541 HG11 ' HB2' ' A' ' 150' ' ' GLN . 15.7 t -55.38 144.77 6.26 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.526 0 CA-C-O 121.441 0.638 . . . . 0.0 111.483 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.66 HD13 ' OG ' ' A' ' 179' ' ' SER . 2.7 pp -124.63 -6.64 6.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.04 178.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.558 ' O ' HD11 ' A' ' 175' ' ' ILE . . . -179.32 76.99 0.06 OUTLIER Glycine 0 C--N 1.343 0.964 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.043 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.541 ' HB2' HG11 ' A' ' 147' ' ' VAL . 0.1 OUTLIER -89.9 135.21 33.77 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 179.715 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.506 ' HB1' ' HB2' ' A' ' 168' ' ' CYS . . . -151.35 167.68 27.16 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 120.102 -0.639 . . . . 0.0 112.522 -178.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.705 ' HG2' HG22 ' A' ' 229' ' ' VAL . 20.5 mt-10 -120.42 124.51 45.65 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.407 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.502 ' HB ' ' O ' ' A' ' 228' ' ' ASP . 3.1 p -51.17 132.63 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -178.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -89.44 -60.16 2.02 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 104.416 -2.439 . . . . 0.0 104.416 175.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.508 ' HA ' ' H ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER -161.45 -163.71 1.03 Allowed 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 113.025 -1.898 . . . . 0.0 108.613 174.786 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.564 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 1.5 p -151.91 143.02 23.21 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 176.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.655 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 5.7 m-30 -91.04 75.37 6.29 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.043 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.66 63.72 8.12 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.967 0.889 . . . . 0.0 108.847 178.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.475 HG12 ' N ' ' A' ' 161' ' ' LYS . 49.2 t -89.25 154.85 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-N 113.944 -1.48 . . . . 0.0 109.707 -179.39 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 47.4 t -89.74 33.49 0.85 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.074 0.464 . . . . 0.0 110.406 178.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.475 ' N ' HG12 ' A' ' 159' ' ' VAL . 0.3 OUTLIER -150.93 -29.3 0.2 Allowed 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.597 -179.875 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.474 HG12 ' N ' ' A' ' 163' ' ' GLY . 97.7 t -103.52 -101.53 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 O-C-N 122.132 -0.355 . . . . 0.0 110.15 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . 0.474 ' N ' HG12 ' A' ' 162' ' ' VAL . . . -158.51 -110.34 0.29 Allowed Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 111.543 -0.623 . . . . 0.0 111.543 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.595 HG21 HG21 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -155.15 58.96 0.65 Allowed 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 178.253 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.655 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 0.3 OUTLIER -38.7 -22.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.219 -0.54 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 -177.243 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.564 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . 31.02 98.36 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 178.163 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -87.59 150.76 22.72 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 178.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.563 ' SG ' HD11 ' A' ' 216' ' ' LEU . 0.0 OUTLIER -145.07 136.48 25.18 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 117.353 0.577 . . . . 0.0 110.725 -178.482 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . 0.445 ' O ' ' HA ' ' A' ' 151' ' ' ALA . 71.9 t80 -87.74 131.05 34.63 Favored 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 106.965 -1.495 . . . . 0.0 106.965 177.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.533 HG12 ' N ' ' A' ' 212' ' ' TYR . 4.7 p -86.25 144.84 8.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -176.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.4 p -138.53 11.91 2.74 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.416 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -151.48 -147.51 0.23 Allowed 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 119.52 -0.276 . . . . 0.0 110.263 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -39.53 -104.56 0.01 OUTLIER Glycine 0 CA--C 1.531 1.047 0 N-CA-C 115.188 0.835 . . . . 0.0 115.188 -178.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.456 ' HB3' ' HB2' ' A' ' 209' ' ' ALA . 0.0 OUTLIER -150.75 143.89 24.78 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.092 0.472 . . . . 0.0 111.88 -178.716 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.684 HG22 HD11 ' A' ' 198' ' ' LEU . 7.4 mm -99.68 87.15 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 N-CA-C 108.498 -0.926 . . . . 0.0 108.498 176.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.517 ' HB ' ' O ' ' A' ' 206' ' ' ARG . 0.2 OUTLIER -100.93 172.82 6.8 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.517 0.675 . . . . 0.0 112.106 -178.061 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -69.2 -43.02 74.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.711 -1.131 . . . . 0.0 111.067 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -88.56 58.59 4.74 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.17 -179.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . 0.66 ' OG ' HD13 ' A' ' 148' ' ' ILE . 1.1 m -149.08 162.69 39.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.797 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.531 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 26.4 mttp -89.0 -170.81 3.04 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.545 HG22 ' CA ' ' A' ' 194' ' ' GLU . 2.4 m -150.23 160.79 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.539 0 CA-C-O 121.398 0.618 . . . . 0.0 111.711 179.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . 0.458 ' N ' ' O ' ' A' ' 231' ' ' GLU . 43.3 ttm180 -153.58 98.75 2.26 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.136 -0.938 . . . . 0.0 113.215 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.559 HD13 ' CZ ' ' A' ' 221' ' ' PHE . 0.2 OUTLIER -86.68 148.33 25.5 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-O 121.745 0.783 . . . . 0.0 112.22 179.721 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.743 ' N ' HG23 ' A' ' 190' ' ' VAL . 22.2 mt -157.87 130.14 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 114.311 -1.313 . . . . 0.0 111.485 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -88.52 -151.94 0.21 Allowed 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 177.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -94.71 29.84 2.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 118.354 0.525 . . . . 0.0 110.533 179.05 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -154.04 -45.94 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.668 -0.777 . . . . 0.0 113.182 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.682 ' O ' HG23 ' A' ' 184' ' ' ILE . 0.4 OUTLIER -150.11 -160.56 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -178.106 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.721 HG11 ' CG ' ' A' ' 192' ' ' GLU . 96.1 t -87.09 135.76 24.51 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 CA-C-O 121.684 0.754 . . . . 0.0 110.845 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.873 HG21 ' HB2' ' A' ' 228' ' ' ASP . 0.0 OUTLIER -97.67 -35.44 5.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 114.562 -1.199 . . . . 0.0 108.959 179.343 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . 0.485 ' HB3' ' CD1' ' A' ' 183' ' ' LEU . 5.0 t80 -157.51 156.13 31.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.569 179.115 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . 0.721 ' CG ' HG11 ' A' ' 189' ' ' VAL . 23.8 mt-10 -151.0 155.39 38.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.218 178.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 134.85 -113.15 1.1 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.573 -0.823 . . . . 0.0 112.363 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . 0.545 ' CA ' HG22 ' A' ' 181' ' ' VAL . 0.0 OUTLIER -150.77 -176.16 5.4 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-O 121.303 0.573 . . . . 0.0 111.161 -179.051 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.725 HD11 HD12 ' A' ' 216' ' ' LEU . 0.3 OUTLIER -99.13 155.07 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.178 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.495 -179.074 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -89.42 -67.64 0.83 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 1.3 m -150.91 154.45 37.19 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.949 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.756 HD13 ' HB3' ' A' ' 216' ' ' LEU . 3.5 mm? -107.46 117.8 35.05 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.962 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 18.1 ttmt -138.13 115.14 10.85 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.812 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 7.6 ttm180 . . . . . 0 C--N 1.325 -0.493 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.846 179.688 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . 0.401 ' HA ' ' HA ' ' A' ' 199' ' ' LYS . 16.4 t70 . . . . . 0 N--CA 1.453 -0.293 0 CA-C-O 120.931 0.396 . . . . 0.0 110.279 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 32.7 m -59.28 159.86 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.934 0 CA-C-O 121.603 0.716 . . . . 0.0 112.317 -179.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . 0.517 ' O ' ' HB ' ' A' ' 176' ' ' THR . 7.6 ttm-85 -89.44 -36.51 15.4 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 114.651 -1.159 . . . . 0.0 111.795 -178.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -141.31 179.42 6.78 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.221 0.534 . . . . 0.0 111.682 -179.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.496 ' O ' HG21 ' A' ' 170' ' ' VAL . 0.6 OUTLIER -151.12 70.95 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.729 178.661 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.456 ' HB2' ' HB3' ' A' ' 174' ' ' LYS . . . -97.46 178.47 5.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.138 -178.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 81.97 -75.45 0.03 OUTLIER 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.538 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 178.41 38.12 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.401 -0.904 . . . . 0.0 112.286 179.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . 0.533 ' N ' HG12 ' A' ' 170' ' ' VAL . 0.2 OUTLIER -107.43 150.09 27.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.159 0.504 . . . . 0.0 112.025 -179.118 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -96.57 152.78 18.31 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.076 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' CYS . . . . . 0.472 ' HB3' HG21 ' A' ' 208' ' ' VAL . 18.5 t -150.64 154.34 37.31 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.004 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -89.53 110.24 3.7 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.116 179.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.756 ' HB3' HD13 ' A' ' 198' ' ' LEU . 0.2 OUTLIER -134.44 131.36 38.04 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 121.298 0.571 . . . . 0.0 111.59 -179.026 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . 0.402 ' O ' HD13 ' A' ' 195' ' ' ILE . 0.2 OUTLIER -84.35 130.38 34.8 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.93 179.872 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . 0.593 HG22 ' O ' ' A' ' 218' ' ' ILE . 1.5 mp -90.84 79.27 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 34.75 -85.99 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.998 0 O-C-N 124.134 0.896 . . . . 0.0 112.835 -178.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' ASN . . . . . 0.439 ' N ' ' O ' ' A' ' 218' ' ' ILE . 5.9 p30 -129.73 65.67 1.48 Allowed 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.589 -179.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . 0.559 ' CZ ' HD13 ' A' ' 183' ' ' LEU . 0.1 OUTLIER -58.58 119.38 6.94 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 177.883 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -77.91 -44.51 26.79 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 176.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . 0.829 ' OD2' HG12 ' A' ' 190' ' ' VAL . 0.0 OUTLIER -92.74 143.19 26.55 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.236 177.713 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.638 ' N ' HD13 ' A' ' 224' ' ' ILE . 0.2 OUTLIER -140.48 -179.4 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -178.706 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.414 ' O ' ' C ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER 55.26 110.56 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 114.319 -1.31 . . . . 0.0 110.067 -178.881 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . 0.508 ' H ' ' HA ' ' A' ' 155' ' ' GLN . 18.2 tt0 10.95 60.5 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 124.747 1.28 . . . . 0.0 112.948 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -71.59 -58.13 5.58 Favored Glycine 0 N--CA 1.421 -2.348 0 CA-C-N 114.115 -1.402 . . . . 0.0 113.144 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.873 ' HB2' HG21 ' A' ' 190' ' ' VAL . 25.8 m-20 -158.48 -160.62 0.9 Allowed 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -178.019 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . 0.705 HG22 ' HG2' ' A' ' 152' ' ' GLU . 42.9 t -88.65 152.98 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 CA-C-O 120.769 0.318 . . . . 0.0 110.15 178.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . 0.424 HD13 ' HB3' ' A' ' 168' ' ' CYS . 3.0 mp -120.92 153.93 24.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.753 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' GLU . . . . . 0.458 ' O ' ' N ' ' A' ' 182' ' ' ARG . 20.1 tt0 -147.12 111.58 5.23 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 119.839 -0.744 . . . . 0.0 112.676 -179.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.555 ' HB1' HD11 ' A' ' 148' ' ' ILE . . . -87.17 135.58 33.24 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.17 178.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' TYR . . . . . 0.63 ' O ' HG23 ' A' ' 234' ' ' VAL . 3.5 p90 -137.64 156.75 47.7 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.062 -178.45 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 233' ' ' TYR . 0.9 OUTLIER . . . . . 0 CA--C 1.536 0.435 0 CA-C-O 121.15 0.5 . . . . 0.0 110.743 179.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 4.5 ptpt . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.553 0.216 . . . . 0.0 110.767 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.481 HG11 ' HB2' ' A' ' 150' ' ' GLN . 12.1 t -58.58 139.99 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.611 0 CA-C-O 121.297 0.57 . . . . 0.0 111.506 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.557 HD11 ' HB3' ' A' ' 179' ' ' SER . 2.7 pp -127.06 -1.82 4.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.35 178.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.512 ' O ' ' HB3' ' A' ' 232' ' ' ALA . . . 178.08 75.34 0.06 OUTLIER Glycine 0 C--N 1.342 0.897 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.912 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.481 ' HB2' HG11 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -89.97 136.41 33.06 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 122.721 -0.282 . . . . 0.0 110.336 -179.969 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.503 ' O ' HG13 ' A' ' 229' ' ' VAL . . . -151.17 179.59 8.16 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-O 121.63 0.729 . . . . 0.0 112.871 -178.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.904 ' HG2' HG22 ' A' ' 229' ' ' VAL . 1.3 tt0 -126.96 120.37 28.94 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.814 -1.084 . . . . 0.0 110.445 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.464 HG12 ' O ' ' A' ' 228' ' ' ASP . 2.2 p -48.13 137.97 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -179.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.483 ' O ' ' HB3' ' A' ' 226' ' ' GLU . 3.2 mmp_? -97.44 -61.03 1.45 Allowed 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 105.963 -1.865 . . . . 0.0 105.963 176.093 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.75 -160.53 0.46 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 113.739 -1.573 . . . . 0.0 109.157 175.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.49 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 5.9 p -150.92 149.0 29.11 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 177.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.601 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 5.6 m-30 -92.6 72.1 5.03 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -178.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 15.6 tttt -85.95 62.21 7.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 122.002 0.906 . . . . 0.0 109.071 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 55.2 t -89.64 155.78 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 CA-C-N 113.919 -1.492 . . . . 0.0 109.535 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 9.0 m -89.72 22.41 3.09 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.049 178.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.71 5.66 0.52 Allowed 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.188 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 57.8 t -129.98 -99.17 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 CA-C-N 118.483 0.583 . . . . 0.0 110.14 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -158.02 -113.51 0.38 Allowed Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.415 ' CG2' ' CG2' ' A' ' 224' ' ' ILE . 0.0 OUTLIER -153.98 32.9 0.44 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.462 -0.869 . . . . 0.0 109.098 178.157 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.601 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 1.9 mm -40.27 93.78 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.715 -179.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.49 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . -88.25 118.45 27.85 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 114.729 -1.123 . . . . 0.0 111.967 -179.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -89.59 151.21 21.69 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.49 179.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -147.58 133.45 19.08 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -179.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . 0.451 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 11.1 t80 -86.8 131.28 34.17 Favored 'General case' 0 C--O 1.219 -0.512 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 178.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.508 HG12 ' N ' ' A' ' 212' ' ' TYR . 5.7 p -85.64 147.01 5.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -175.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.1 p -141.87 13.12 2.07 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.04 -0.982 . . . . 0.0 112.359 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.412 ' CB ' ' HB2' ' A' ' 150' ' ' GLN . 10.4 t0 -151.27 -145.87 0.18 Allowed 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -38.96 -103.53 0.01 OUTLIER Glycine 0 CA--C 1.531 1.05 0 N-CA-C 115.275 0.87 . . . . 0.0 115.275 -178.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.565 ' HG2' ' HB2' ' A' ' 209' ' ' ALA . 21.9 mttm -150.47 134.94 17.25 Favored 'General case' 0 CA--C 1.515 -0.402 0 O-C-N 122.591 -0.358 . . . . 0.0 111.871 -178.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.557 HG22 ' O ' ' A' ' 175' ' ' ILE . 3.5 mm -93.37 86.89 2.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 176.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.723 HG22 ' HB3' ' A' ' 207' ' ' GLU . 0.1 OUTLIER -100.79 172.24 7.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.523 -177.265 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -69.25 -42.1 76.05 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.347 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -88.75 56.32 3.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.415 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . 0.557 ' HB3' HD11 ' A' ' 148' ' ' ILE . 29.7 m -145.97 157.34 43.88 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.428 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 0.0 OUTLIER -89.25 -172.93 3.83 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.44 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.504 HG22 ' HA ' ' A' ' 194' ' ' GLU . 0.6 OUTLIER -150.1 156.76 6.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.385 0.612 . . . . 0.0 111.473 179.512 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . 0.425 ' N ' ' O ' ' A' ' 231' ' ' GLU . 60.2 ttt180 -152.03 101.83 2.76 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.113 -0.948 . . . . 0.0 112.581 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.724 HD12 ' HB3' ' A' ' 191' ' ' TYR . 0.3 OUTLIER -86.16 157.41 20.01 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-O 121.862 0.839 . . . . 0.0 112.918 -179.669 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.614 HD12 ' C ' ' A' ' 183' ' ' LEU . 3.1 mp -151.01 121.36 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 113.885 -1.507 . . . . 0.0 111.935 177.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.418 ' HB2' HG22 ' A' ' 190' ' ' VAL . 0.0 OUTLIER -85.45 -151.76 0.15 Allowed 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 177.504 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -93.97 28.57 2.38 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 118.539 0.608 . . . . 0.0 110.829 178.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -154.62 -76.96 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.619 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.452 ' H ' HD12 ' A' ' 188' ' ' ILE . 0.1 OUTLIER -116.47 -156.54 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 115.34 -0.43 . . . . 0.0 110.718 -179.039 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.749 HG11 ' CG ' ' A' ' 192' ' ' GLU . 46.3 t -87.37 133.96 28.9 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.101 0 CA-C-O 121.518 0.675 . . . . 0.0 111.771 -179.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.907 HG12 ' OD2' ' A' ' 223' ' ' ASP . 0.2 OUTLIER -89.61 -34.21 6.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 114.778 -1.101 . . . . 0.0 108.884 178.503 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . 0.724 ' HB3' HD12 ' A' ' 183' ' ' LEU . 41.5 t80 -157.6 155.87 30.88 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 178.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . 0.749 ' CG ' HG11 ' A' ' 189' ' ' VAL . 14.4 mt-10 -150.14 148.83 29.43 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.287 177.342 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 133.05 -127.75 4.85 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.068 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . 0.504 ' HA ' HG22 ' A' ' 181' ' ' VAL . 4.5 pt-20 -145.38 -178.88 6.3 Favored 'General case' 0 CA--C 1.499 -0.986 0 CA-C-O 121.662 0.744 . . . . 0.0 112.631 -178.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.778 HG12 HD13 ' A' ' 216' ' ' LEU . 4.7 mp -89.67 153.42 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.115 -179.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -93.95 -52.19 4.53 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 4.6 m -151.38 144.92 24.91 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.858 178.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.793 HD12 HD22 ' A' ' 216' ' ' LEU . 2.8 tt -120.49 118.01 29.14 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.427 0.632 . . . . 0.0 111.647 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 10.7 tttm -148.83 122.52 9.23 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.672 179.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 8.4 ttp85 . . . . . 0 C--N 1.321 -0.637 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.314 -179.52 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . 0.406 ' HA ' ' HA ' ' A' ' 199' ' ' LYS . 4.9 p-10 . . . . . 0 N--CA 1.451 -0.402 0 CA-C-O 121.025 0.441 . . . . 0.0 110.107 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.6 HG23 ' CD2' ' A' ' 198' ' ' LEU . 28.3 m -56.29 156.94 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.931 0 CA-C-O 121.515 0.674 . . . . 0.0 112.23 -179.107 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . 0.469 ' O ' ' HB ' ' A' ' 176' ' ' THR . 0.1 OUTLIER -89.51 -34.07 16.54 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.899 -178.447 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.723 ' HB3' HG22 ' A' ' 176' ' ' THR . 3.0 mt-10 -141.26 175.75 9.39 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.03 0.443 . . . . 0.0 111.161 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.803 HG12 ' HB3' ' A' ' 212' ' ' TYR . 0.1 OUTLIER -150.8 83.25 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.782 178.761 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.565 ' HB2' ' HG2' ' A' ' 174' ' ' LYS . . . -101.85 174.05 6.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.787 -179.187 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 80.63 -68.76 0.1 Allowed 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.725 -179.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 178.95 36.75 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.49 179.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . 0.803 ' HB3' HG12 ' A' ' 208' ' ' VAL . 2.7 m-85 -100.27 135.01 42.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.022 0.439 . . . . 0.0 111.747 -179.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . 0.407 ' HG2' ' HA ' ' A' ' 169' ' ' TYR . 6.7 mt-10 -89.73 152.25 21.42 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.22 179.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' CYS . . . . . 0.401 ' HB2' HG21 ' A' ' 208' ' ' VAL . 0.7 OUTLIER -150.57 139.89 21.33 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.095 179.967 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -89.08 115.92 4.57 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.662 -0.78 . . . . 0.0 111.733 179.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.793 HD22 HD12 ' A' ' 198' ' ' LEU . 0.4 OUTLIER -135.47 141.6 45.38 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 121.119 0.485 . . . . 0.0 111.609 -179.28 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . 0.403 ' N ' HD13 ' A' ' 165' ' ' ILE . 1.4 m -89.17 133.1 34.54 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.374 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . 0.621 ' CD1' HD12 ' A' ' 216' ' ' LEU . 1.6 mp -86.16 134.4 27.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 -179.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . 0.416 ' HG2' ' O ' ' A' ' 194' ' ' GLU . 5.5 ptmt -39.24 -31.75 0.09 Allowed 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 114.406 1.262 . . . . 0.0 114.406 -177.05 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -153.08 40.38 0.54 Allowed 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 -178.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . 0.689 ' CZ ' HD13 ' A' ' 183' ' ' LEU . 0.1 OUTLIER -59.16 115.98 3.55 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 178.626 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -83.67 -42.56 16.51 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.12 -0.946 . . . . 0.0 108.481 176.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . 0.907 ' OD2' HG12 ' A' ' 190' ' ' VAL . 0.0 OUTLIER -90.53 141.95 28.24 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.893 178.201 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.451 ' C ' HD12 ' A' ' 224' ' ' ILE . 2.5 pp -122.49 -177.97 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.36 0.6 . . . . 0.0 112.423 -179.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.461 ' O ' ' N ' ' A' ' 227' ' ' GLY . 11.4 mtpt 59.37 172.76 0.08 Allowed 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.289 -177.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . 0.483 ' HB3' ' O ' ' A' ' 154' ' ' ARG . 0.3 OUTLIER -58.61 84.09 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.036 0.446 . . . . 0.0 110.831 179.683 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 225' ' ' LYS . . . -71.65 -61.54 3.79 Favored Glycine 0 N--CA 1.427 -1.911 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 178.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.464 ' O ' HG12 ' A' ' 153' ' ' VAL . 0.9 OUTLIER -164.6 -148.3 0.11 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 178.669 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . 0.904 HG22 ' HG2' ' A' ' 152' ' ' GLU . 59.4 t -89.48 145.33 7.53 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 O-C-N 122.331 -0.231 . . . . 0.0 110.606 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . 0.415 HG13 ' CD2' ' A' ' 183' ' ' LEU . 2.9 mt -116.16 153.07 17.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.205 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' GLU . . . . . 0.479 ' HA ' ' HA ' ' A' ' 150' ' ' GLN . 23.9 tt0 -142.1 111.73 6.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.33 0.586 . . . . 0.0 112.369 -179.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' A' ' 149' ' ' GLY . . . -88.89 127.92 35.65 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.942 179.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -128.36 144.44 51.13 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.945 -179.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.553 HG12 HG12 ' A' ' 148' ' ' ILE . 0.3 OUTLIER . . . . . 0 CA--C 1.535 0.368 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.881 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 12.2 mttp . . . . . 0 CA--C 1.529 0.135 0 N-CA-C 110.417 -0.216 . . . . 0.0 110.417 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.782 ' O ' HD13 ' A' ' 148' ' ' ILE . 6.4 t -115.85 137.59 49.01 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.79 0 CA-C-O 121.356 0.598 . . . . 0.0 110.804 179.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.782 HD13 ' O ' ' A' ' 147' ' ' VAL . 31.0 mm -129.45 -3.93 3.01 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.693 178.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.522 ' O ' ' HB3' ' A' ' 232' ' ' ALA . . . -171.97 70.77 0.11 Allowed Glycine 0 C--N 1.341 0.806 0 N-CA-C 111.344 -0.703 . . . . 0.0 111.344 179.158 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.643 ' HB2' HG11 ' A' ' 147' ' ' VAL . 0.8 OUTLIER -91.31 136.25 33.23 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-O 120.734 0.302 . . . . 0.0 110.639 -179.643 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.428 ' HB1' ' HB2' ' A' ' 168' ' ' CYS . . . -151.76 175.79 12.06 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 121.537 0.684 . . . . 0.0 112.761 -178.293 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.761 ' HG2' HG22 ' A' ' 229' ' ' VAL . 31.3 mt-10 -126.15 121.64 33.4 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.5 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.474 HG11 ' N ' ' A' ' 227' ' ' GLY . 1.6 p -47.31 144.42 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 121.37 0.605 . . . . 0.0 112.595 -179.108 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.482 ' O ' ' HB3' ' A' ' 226' ' ' GLU . 3.8 mmp_? -109.86 -57.32 2.2 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 176.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.55 -162.88 0.61 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 113.755 -1.566 . . . . 0.0 109.776 175.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 8.0 p -150.79 163.88 37.55 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 177.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.547 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 0.2 OUTLIER -116.05 80.08 1.4 Allowed 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -179.033 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 6.5 tttt -86.53 62.77 7.61 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.434 HG12 ' N ' ' A' ' 161' ' ' LYS . 71.7 t -92.9 157.32 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 CA-C-N 113.659 -1.61 . . . . 0.0 110.528 -178.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 28.9 t -92.33 35.89 1.0 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 177.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.434 ' N ' HG12 ' A' ' 159' ' ' VAL . 0.0 OUTLIER -151.37 -35.22 0.14 Allowed 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.092 -179.592 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.766 HG11 HD12 ' A' ' 165' ' ' ILE . 88.7 t -98.96 -103.7 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . 0.524 ' N ' HG12 ' A' ' 162' ' ' VAL . . . -159.51 -99.99 0.16 Allowed Glycine 0 N--CA 1.452 -0.271 0 N-CA-C 111.194 -0.763 . . . . 0.0 111.194 178.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.477 HG22 HG22 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -153.72 33.83 0.45 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 113.958 -1.121 . . . . 0.0 108.278 177.732 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.766 HD12 HG11 ' A' ' 162' ' ' VAL . 3.6 mt -41.98 95.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.461 0.086 0 CA-C-N 115.155 -0.929 . . . . 0.0 111.664 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.532 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . -87.12 125.23 34.01 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.735 -1.12 . . . . 0.0 112.27 -179.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -88.99 144.39 18.02 Favored Glycine 0 N--CA 1.442 -0.951 0 N-CA-C 110.534 -1.027 . . . . 0.0 110.534 178.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.428 ' HB2' ' HB1' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -145.69 132.36 19.93 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 117.204 0.502 . . . . 0.0 110.271 -178.884 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . 0.421 ' O ' ' HA ' ' A' ' 151' ' ' ALA . 5.6 t80 -87.3 127.37 35.18 Favored 'General case' 0 C--O 1.222 -0.39 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 177.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.833 HG21 ' O ' ' A' ' 208' ' ' VAL . 44.3 t -85.44 142.16 13.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 -176.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.4 p -135.38 12.61 3.51 Favored 'General case' 0 C--O 1.231 0.084 0 CA-C-N 114.833 -1.076 . . . . 0.0 112.3 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.417 ' CB ' ' HB2' ' A' ' 150' ' ' GLN . 4.8 t70 -146.87 -144.01 0.15 Allowed 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -179.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -45.2 -107.03 0.01 OUTLIER Glycine 0 CA--C 1.532 1.149 0 N-CA-C 114.792 0.677 . . . . 0.0 114.792 -178.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.553 ' HB3' ' HB2' ' A' ' 209' ' ' ALA . 0.0 OUTLIER -150.76 135.0 16.94 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 122.562 -0.375 . . . . 0.0 111.039 -178.943 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.59 ' CG2' HG23 ' A' ' 208' ' ' VAL . 0.5 OUTLIER -92.31 111.45 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 176.47 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.504 ' HB ' ' O ' ' A' ' 206' ' ' ARG . 0.1 OUTLIER -118.54 169.47 9.76 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.458 0.647 . . . . 0.0 112.481 -176.327 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.491 ' HA ' HG21 ' A' ' 195' ' ' ILE . 0.5 OUTLIER -61.13 -40.86 95.41 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.478 179.667 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -95.91 63.64 2.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.251 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 4.8 m -148.8 161.43 41.82 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.92 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 0.0 OUTLIER -88.93 -175.29 4.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.722 179.493 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.549 HG21 HG23 ' A' ' 218' ' ' ILE . 1.6 m -147.93 156.09 9.58 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.478 0 CA-C-O 121.247 0.546 . . . . 0.0 111.731 179.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . 0.445 ' N ' ' O ' ' A' ' 231' ' ' GLU . 17.9 ttt180 -152.96 100.67 2.52 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.313 -0.858 . . . . 0.0 113.305 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.656 HD13 ' CZ ' ' A' ' 221' ' ' PHE . 0.3 OUTLIER -86.88 156.1 19.98 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-O 121.7 0.762 . . . . 0.0 112.839 -179.869 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.695 ' N ' HG23 ' A' ' 190' ' ' VAL . 28.9 mm -154.01 123.93 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 114.487 -1.233 . . . . 0.0 111.345 178.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.569 ' N ' HG22 ' A' ' 190' ' ' VAL . 4.6 ttp180 -85.68 -151.3 0.15 Allowed 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 177.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -93.84 25.8 3.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 118.509 0.595 . . . . 0.0 110.892 178.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -155.12 -67.57 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.498 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -121.16 -156.34 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-N 115.297 -0.452 . . . . 0.0 110.84 -178.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.807 HG11 ' CG ' ' A' ' 192' ' ' GLU . 58.3 t -87.39 136.28 23.41 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 CA-C-O 121.287 0.565 . . . . 0.0 111.632 -179.135 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.8 HG12 ' OD2' ' A' ' 223' ' ' ASP . 0.1 OUTLIER -89.57 -33.86 6.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.099 -0.955 . . . . 0.0 108.914 178.614 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . 0.612 ' HB3' HD12 ' A' ' 183' ' ' LEU . 16.0 t80 -162.5 157.04 21.73 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.386 -0.825 . . . . 0.0 112.273 178.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . 0.807 ' CG ' HG11 ' A' ' 189' ' ' VAL . 15.7 mt-10 -149.94 160.08 43.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.902 178.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 133.46 -115.4 1.52 Allowed Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.519 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . 0.51 ' CA ' HG22 ' A' ' 181' ' ' VAL . 17.1 pt-20 -150.4 -174.87 4.88 Favored 'General case' 0 CA--C 1.496 -1.1 0 CA-C-O 121.247 0.546 . . . . 0.0 111.342 -178.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.812 HD13 ' O ' ' A' ' 217' ' ' THR . 0.4 OUTLIER -88.52 142.84 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.024 -178.921 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.75 -55.35 3.74 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.03 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 17.2 p -152.6 164.68 37.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.051 178.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.782 ' CD1' HD22 ' A' ' 216' ' ' LEU . 21.2 tp -135.16 110.25 8.87 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.417 0.627 . . . . 0.0 111.419 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 45.4 mttt -137.79 126.91 24.36 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.308 179.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 27.8 ttm180 . . . . . 0 C--N 1.32 -0.71 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.274 -179.937 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . 0.417 ' HA ' ' HA ' ' A' ' 199' ' ' LYS . 7.1 p-10 . . . . . 0 N--CA 1.452 -0.337 0 CA-C-O 120.741 0.305 . . . . 0.0 110.338 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 28.4 m -59.32 158.7 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -1.011 0 CA-C-O 121.554 0.692 . . . . 0.0 112.001 -179.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . 0.504 ' O ' ' HB ' ' A' ' 176' ' ' THR . 4.0 ttp180 -89.43 -38.03 14.38 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.505 -178.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -141.2 177.46 8.07 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.073 0.463 . . . . 0.0 111.418 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.833 ' O ' HG21 ' A' ' 170' ' ' VAL . 0.1 OUTLIER -151.28 79.78 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.462 178.759 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.553 ' HB2' ' HB3' ' A' ' 174' ' ' LYS . . . -104.49 173.34 6.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.065 0.459 . . . . 0.0 112.204 -178.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 84.22 -71.61 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.104 -179.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 178.05 37.6 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.394 179.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -104.51 140.56 37.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.983 0.421 . . . . 0.0 111.233 -179.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -93.26 152.75 18.99 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.28 179.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' CYS . . . . . 0.491 ' HB2' HG21 ' A' ' 208' ' ' VAL . 2.3 m -150.54 145.55 26.02 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.767 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -88.26 106.35 3.23 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.484 -0.865 . . . . 0.0 110.998 179.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.782 HD22 ' CD1' ' A' ' 198' ' ' LEU . 0.2 OUTLIER -133.53 145.34 50.04 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 120.993 0.425 . . . . 0.0 111.789 -178.055 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . 0.812 ' O ' HD13 ' A' ' 195' ' ' ILE . 0.2 OUTLIER -86.64 140.79 29.48 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.488 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . 0.606 HG22 ' O ' ' A' ' 218' ' ' ILE . 1.6 mp -108.5 94.03 2.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 121.028 -0.269 . . . . 0.0 110.427 -179.158 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 6.1 tttp 42.16 -143.7 0.08 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.133 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 32.1 t30 -87.87 63.71 7.54 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 120.901 0.381 . . . . 0.0 110.9 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . 0.656 ' CZ ' HD13 ' A' ' 183' ' ' LEU . 0.1 OUTLIER -54.98 118.01 3.93 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 114.595 1.332 . . . . 0.0 114.595 178.835 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -83.07 -43.55 16.16 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.586 176.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . 0.8 ' OD2' HG12 ' A' ' 190' ' ' VAL . 0.0 OUTLIER -89.73 129.97 36.06 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.023 178.264 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.54 HD12 ' HG3' ' A' ' 225' ' ' LYS . 2.0 pt -114.67 178.95 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 CA-C-O 121.191 0.519 . . . . 0.0 111.551 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.54 ' HG3' HD12 ' A' ' 224' ' ' ILE . 11.2 mtpt 62.38 155.63 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.098 -178.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . 0.482 ' HB3' ' O ' ' A' ' 154' ' ' ARG . 0.6 OUTLIER -45.08 90.35 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 121.199 0.523 . . . . 0.0 111.77 -179.461 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . 0.474 ' N ' HG11 ' A' ' 153' ' ' VAL . . . -83.35 -57.97 2.39 Favored Glycine 0 N--CA 1.428 -1.885 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 178.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.453 ' O ' HG12 ' A' ' 153' ' ' VAL . 1.0 OUTLIER -163.83 -148.89 0.13 Allowed 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 179.014 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . 0.761 HG22 ' HG2' ' A' ' 152' ' ' GLU . 46.1 t -90.33 149.38 4.07 Favored 'Isoleucine or valine' 0 C--N 1.341 0.218 0 CA-C-O 120.75 0.31 . . . . 0.0 110.771 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 2.7 mp -120.17 153.41 23.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.77 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' GLU . . . . . 0.458 ' HA ' ' HA ' ' A' ' 150' ' ' GLN . 0.0 OUTLIER -144.14 109.97 5.31 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.357 0.598 . . . . 0.0 112.559 -179.053 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.522 ' HB3' ' O ' ' A' ' 149' ' ' GLY . . . -88.65 127.46 35.57 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.598 178.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' TYR . . . . . 0.423 ' CE1' ' HB3' ' A' ' 180' ' ' LYS . 26.1 p90 -123.02 140.59 52.87 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.013 0.435 . . . . 0.0 111.403 -178.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.538 0.496 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.04 179.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.132 0 CA-C-O 120.608 0.242 . . . . 0.0 110.583 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.698 HG11 ' HB2' ' A' ' 150' ' ' GLN . 19.5 t -58.77 141.53 15.62 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.559 0 CA-C-O 121.394 0.616 . . . . 0.0 111.559 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.818 HD13 HG12 ' A' ' 234' ' ' VAL . 1.3 pt -123.7 -8.38 7.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.074 178.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.504 ' CA ' ' HB3' ' A' ' 232' ' ' ALA . . . -174.63 74.56 0.08 OUTLIER Glycine 0 C--N 1.344 0.981 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.114 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.698 ' HB2' HG11 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -89.38 136.8 32.82 Favored 'General case' 0 CA--C 1.506 -0.725 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.255 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.486 ' HB1' ' HB2' ' A' ' 168' ' ' CYS . . . -151.35 169.15 22.69 Favored 'General case' 0 N--CA 1.435 -1.176 0 C-N-CA 120.164 -0.615 . . . . 0.0 112.387 -178.03 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.742 ' HG2' HG22 ' A' ' 229' ' ' VAL . 12.9 mt-10 -119.85 124.98 47.4 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.024 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.53 ' HB ' HD11 ' A' ' 230' ' ' ILE . 4.0 p -55.9 128.15 15.79 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 CA-C-O 121.325 0.583 . . . . 0.0 111.771 -179.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.414 ' CA ' ' NE ' ' A' ' 154' ' ' ARG . 0.0 OUTLIER -89.99 -53.54 4.44 Favored 'General case' 0 N--CA 1.429 -1.521 0 N-CA-C 105.175 -2.158 . . . . 0.0 105.175 175.982 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.542 ' HA ' ' H ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER -162.33 -163.36 0.91 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 114.016 -1.447 . . . . 0.0 110.482 175.233 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.595 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 6.0 p -148.09 -179.57 7.02 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 177.28 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.546 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 0.2 OUTLIER -133.29 79.41 1.83 Allowed 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -179.911 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.572 ' HG3' HD13 ' A' ' 224' ' ' ILE . 5.7 tmtt? -86.34 62.25 7.31 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 177.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.498 HG12 ' N ' ' A' ' 161' ' ' LYS . 54.6 t -92.31 156.05 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 CA-C-N 113.633 -1.622 . . . . 0.0 110.455 -178.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 52.3 m -90.86 34.81 0.9 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.125 0.488 . . . . 0.0 109.797 178.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.498 ' N ' HG12 ' A' ' 159' ' ' VAL . 0.0 OUTLIER -150.51 -32.76 0.18 Allowed 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.291 -179.713 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.509 HG12 ' N ' ' A' ' 163' ' ' GLY . 89.9 t -101.53 -104.02 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.26 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . 0.509 ' N ' HG12 ' A' ' 162' ' ' VAL . . . -159.7 -98.27 0.13 Allowed Glycine 0 N--CA 1.451 -0.347 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 178.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.558 ' CG2' HG22 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -153.92 34.83 0.44 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 113.996 -1.102 . . . . 0.0 108.246 177.692 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.565 HG22 ' O ' ' A' ' 165' ' ' ILE . 1.8 mm -41.56 94.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.44 -179.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.595 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . -84.06 117.57 23.51 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 114.767 -1.106 . . . . 0.0 112.416 -179.189 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -88.29 136.95 14.08 Favored Glycine 0 N--CA 1.439 -1.109 0 N-CA-C 109.934 -1.267 . . . . 0.0 109.934 178.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.7 ' SG ' HD11 ' A' ' 216' ' ' LEU . 0.0 OUTLIER -138.43 132.66 31.71 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.938 0.369 . . . . 0.0 110.838 -178.023 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . 0.408 ' O ' ' HA ' ' A' ' 151' ' ' ALA . 11.7 t80 -86.8 133.37 33.65 Favored 'General case' 0 C--O 1.222 -0.368 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 177.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.779 HG21 ' O ' ' A' ' 208' ' ' VAL . 44.2 t -85.73 143.55 11.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -176.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.1 p -135.28 13.57 3.53 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 114.719 -1.128 . . . . 0.0 112.041 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -150.01 -146.71 0.21 Allowed 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -179.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -42.12 -102.5 0.01 OUTLIER Glycine 0 CA--C 1.532 1.117 0 N-CA-C 114.777 0.671 . . . . 0.0 114.777 -179.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.798 ' HG2' ' HB2' ' A' ' 209' ' ' ALA . 6.3 mttt -150.75 134.61 16.65 Favored 'General case' 0 CA--C 1.514 -0.407 0 O-C-N 122.696 -0.297 . . . . 0.0 111.19 -178.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.666 ' O ' HG23 ' A' ' 175' ' ' ILE . 1.1 tp -95.18 83.51 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-O 122.195 0.997 . . . . 0.0 108.948 177.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.531 HG22 ' HB3' ' A' ' 207' ' ' GLU . 0.0 OUTLIER -90.97 -177.61 4.98 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.501 -1.227 . . . . 0.0 113.144 -176.565 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 46.9 mtm180 -76.58 -45.57 29.79 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 114.572 -1.194 . . . . 0.0 111.206 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -88.96 60.64 5.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.104 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . 0.646 ' HB3' HD11 ' A' ' 148' ' ' ILE . 74.7 m -147.81 160.08 43.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.828 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 0.0 OUTLIER -88.55 178.69 6.45 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.171 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.827 HG21 HG23 ' A' ' 218' ' ' ILE . 2.9 m -146.73 149.17 16.11 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.539 0 CA-C-O 121.449 0.642 . . . . 0.0 112.165 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . 0.457 ' N ' ' O ' ' A' ' 231' ' ' GLU . 2.7 ttt180 -154.11 100.28 2.31 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.822 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.494 HD11 ' HB ' ' A' ' 190' ' ' VAL . 0.6 OUTLIER -99.54 165.79 11.46 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-O 121.21 0.528 . . . . 0.0 110.8 179.767 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.853 HG23 ' O ' ' A' ' 188' ' ' ILE . 42.8 mt -157.5 141.32 7.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.467 -178.272 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.514 ' O ' HG22 ' A' ' 184' ' ' ILE . 30.8 ptt180 -87.75 -157.2 0.39 Allowed 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 177.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -93.72 30.6 1.75 Allowed 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.004 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -153.45 -45.47 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.7 -0.762 . . . . 0.0 113.053 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.853 ' O ' HG23 ' A' ' 184' ' ' ILE . 0.2 OUTLIER -150.49 -162.95 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-O 120.945 0.402 . . . . 0.0 112.022 -178.035 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.651 ' N ' HG23 ' A' ' 188' ' ' ILE . 21.9 t -85.85 133.2 30.17 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.531 0 CA-C-O 121.505 0.669 . . . . 0.0 109.842 179.011 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.598 HG23 ' CA ' ' A' ' 184' ' ' ILE . 0.5 OUTLIER -88.38 -35.08 7.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.738 -179.187 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . 0.49 ' CB ' HD21 ' A' ' 183' ' ' LEU . 0.4 OUTLIER -176.94 166.5 2.48 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.544 179.735 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . 0.463 ' OE2' HG11 ' A' ' 189' ' ' VAL . 37.6 mt-10 -151.11 158.5 44.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.924 0.392 . . . . 0.0 111.072 179.046 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 143.95 -131.47 4.45 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.917 -0.658 . . . . 0.0 111.687 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . 0.589 ' CA ' HG22 ' A' ' 181' ' ' VAL . 4.4 pt-20 -133.27 -177.6 4.6 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-O 121.237 0.541 . . . . 0.0 111.003 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.869 HD11 HD13 ' A' ' 216' ' ' LEU . 1.1 tt -88.08 149.07 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.293 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.959 -178.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.48 -60.35 1.97 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 179.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 9.7 t -152.02 151.1 30.72 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.532 178.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.991 HD13 HD23 ' A' ' 216' ' ' LEU . 10.9 tp -125.93 118.63 25.82 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.481 0.658 . . . . 0.0 111.644 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . 0.421 ' N ' HD12 ' A' ' 198' ' ' LEU . 0.5 OUTLIER -150.23 121.09 7.6 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.593 179.009 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . 0.432 ' NH1' ' CD1' ' A' ' 212' ' ' TYR . 3.5 ttm180 . . . . . 0 C--N 1.323 -0.578 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.342 -179.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 23.9 p30 . . . . . 0 N--CA 1.452 -0.331 0 CA-C-O 121.188 0.518 . . . . 0.0 109.817 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 33.1 m -55.45 160.8 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.925 0 CA-C-O 121.595 0.712 . . . . 0.0 112.549 -178.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . 0.447 ' O ' ' HB ' ' A' ' 176' ' ' THR . 4.8 ttm180 -89.3 -37.26 15.06 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 114.642 -1.163 . . . . 0.0 111.524 -178.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.531 ' HB3' HG22 ' A' ' 176' ' ' THR . 1.3 mp0 -138.04 179.41 6.45 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.159 0.504 . . . . 0.0 111.512 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.779 ' O ' HG21 ' A' ' 170' ' ' VAL . 0.2 OUTLIER -150.94 78.4 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.842 179.283 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.798 ' HB2' ' HG2' ' A' ' 174' ' ' LYS . . . -97.44 170.31 9.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.052 0.453 . . . . 0.0 112.151 -178.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 85.89 -74.99 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.155 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . 0.403 ' O ' ' CE2' ' A' ' 169' ' ' TYR . . . 177.86 37.7 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.219 -0.991 . . . . 0.0 112.494 179.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . 0.432 ' CD1' ' NH1' ' A' ' 200' ' ' ARG . 1.6 m-85 -95.17 148.62 22.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.966 0.413 . . . . 0.0 111.414 -179.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -89.54 159.12 17.37 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.095 179.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 10.3 p -150.95 -177.88 6.27 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.182 0.515 . . . . 0.0 111.642 -179.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -136.71 105.83 0.53 Allowed Glycine 0 N--CA 1.452 -0.3 0 N-CA-C 110.086 -1.205 . . . . 0.0 110.086 178.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.991 HD23 HD13 ' A' ' 198' ' ' LEU . 0.3 OUTLIER -138.86 144.68 39.32 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -177.685 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . 0.692 ' O ' HD13 ' A' ' 218' ' ' ILE . 0.0 OUTLIER -79.39 -179.06 6.58 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 176.661 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . 0.827 HG23 HG21 ' A' ' 181' ' ' VAL . 49.8 mm -141.11 81.66 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 120.024 -0.67 . . . . 0.0 112.737 -178.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 13.7 tttt 44.08 -134.95 0.57 Allowed 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 121.177 -0.209 . . . . 0.0 110.695 177.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -87.7 53.62 2.84 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.088 0.47 . . . . 0.0 110.645 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . 0.486 ' HA ' ' CE2' ' A' ' 191' ' ' TYR . 1.2 t80 -56.96 153.52 11.07 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 117.332 2.345 . . . . 0.0 117.332 179.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . 0.454 ' HB2' ' CE1' ' A' ' 191' ' ' TYR . 7.8 t-20 -122.52 -49.34 2.02 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 112.957 -1.928 . . . . 0.0 111.481 178.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . 0.454 ' OD1' ' N ' ' A' ' 224' ' ' ILE . 0.0 OUTLIER -61.28 163.82 6.05 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 -178.463 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.572 HD13 ' HG3' ' A' ' 158' ' ' LYS . 17.4 pt -154.13 -178.31 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 176.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 34.4 100.65 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 114.466 -1.243 . . . . 0.0 111.926 -179.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . 0.542 ' H ' ' HA ' ' A' ' 155' ' ' GLN . 38.1 tt0 25.95 57.44 0.06 Allowed 'General case' 0 N--CA 1.482 1.169 0 O-C-N 124.294 0.996 . . . . 0.0 112.277 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . 0.448 ' N ' HG11 ' A' ' 153' ' ' VAL . . . -57.83 -69.83 1.16 Allowed Glycine 0 N--CA 1.429 -1.775 0 CA-C-N 114.411 -1.268 . . . . 0.0 113.14 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.56 ' HB2' HG21 ' A' ' 190' ' ' VAL . 8.3 m-20 -157.58 -159.67 0.86 Allowed 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 -178.233 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . 0.742 HG22 ' HG2' ' A' ' 152' ' ' GLU . 69.7 t -88.21 136.09 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 O-C-N 122.142 -0.349 . . . . 0.0 110.308 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . 0.623 HD13 ' HB3' ' A' ' 168' ' ' CYS . 5.3 mp -102.64 158.52 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 O-C-N 123.639 0.587 . . . . 0.0 111.257 -179.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' GLU . . . . . 0.457 ' O ' ' N ' ' A' ' 182' ' ' ARG . 5.2 tm-20 -147.14 109.57 4.56 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.504 ' HB3' ' CA ' ' A' ' 149' ' ' GLY . . . -87.41 130.05 34.81 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.474 178.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -132.81 141.96 48.74 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.047 -178.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.818 HG12 HD13 ' A' ' 148' ' ' ILE . 0.3 OUTLIER . . . . . 0 CA--C 1.535 0.382 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.746 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 17.3 tttt . . . . . 0 N--CA 1.462 0.158 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 3.5 t -60.05 140.24 18.39 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.871 0 CA-C-O 121.254 0.55 . . . . 0.0 111.209 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.533 HG21 ' CG1' ' A' ' 234' ' ' VAL . 3.3 tp -132.61 -3.05 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.225 177.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.494 ' CA ' ' HB3' ' A' ' 232' ' ' ALA . . . -165.77 66.71 0.21 Allowed Glycine 0 C--N 1.341 0.825 0 C-N-CA 119.982 -1.104 . . . . 0.0 112.496 179.465 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.494 ' HA ' ' HA ' ' A' ' 231' ' ' GLU . 1.3 mt-30 -90.0 132.48 35.33 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.451 ' HB1' ' O ' ' A' ' 169' ' ' TYR . . . -152.54 178.33 9.69 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 -177.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.86 ' CG ' HG22 ' A' ' 229' ' ' VAL . 0.1 OUTLIER -123.7 124.18 42.17 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.693 -1.14 . . . . 0.0 110.373 179.904 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.492 ' CG1' ' HA ' ' A' ' 226' ' ' GLU . 2.7 p -49.5 133.06 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -179.209 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.509 ' O ' ' HB3' ' A' ' 226' ' ' GLU . 4.3 mmp_? -89.56 -62.16 1.54 Allowed 'General case' 0 N--CA 1.434 -1.248 0 N-CA-C 105.08 -2.193 . . . . 0.0 105.08 175.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.51 -160.08 0.5 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 113.671 -1.604 . . . . 0.0 108.698 174.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 7.6 p -148.97 159.3 44.33 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.871 0.367 . . . . 0.0 110.232 177.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.675 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 2.6 m-85 -104.42 73.95 1.14 Allowed 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -177.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -85.9 63.42 8.03 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 122.08 0.943 . . . . 0.0 108.794 178.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 93.1 t -90.09 158.1 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-N 113.752 -1.567 . . . . 0.0 110.02 -179.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 13.9 m -92.52 33.32 1.12 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.132 0.491 . . . . 0.0 110.004 178.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -151.84 -31.78 0.15 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.639 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.556 HG12 HD13 ' A' ' 165' ' ' ILE . 93.0 t -99.47 -101.94 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.203 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . 0.478 ' N ' HG12 ' A' ' 162' ' ' VAL . . . -158.79 -104.33 0.2 Allowed Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 111.728 -0.549 . . . . 0.0 111.728 179.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.552 HG21 HG21 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -153.78 35.63 0.44 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 114.299 -0.95 . . . . 0.0 108.771 178.355 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.675 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 1.7 mp -42.8 95.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-N 115.327 -0.852 . . . . 0.0 111.342 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.532 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . -87.19 120.79 28.84 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 114.649 -1.16 . . . . 0.0 111.859 -179.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -89.46 149.91 20.92 Favored Glycine 0 N--CA 1.442 -0.93 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 178.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.811 ' SG ' HD11 ' A' ' 216' ' ' LEU . 0.0 OUTLIER -144.55 133.78 22.96 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 117.061 0.431 . . . . 0.0 110.21 -179.279 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . 0.451 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 1.1 t80 -86.94 127.51 35.07 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 178.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.659 HG21 ' O ' ' A' ' 208' ' ' VAL . 36.7 t -85.21 142.97 12.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -175.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -132.76 9.16 4.21 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 114.289 -1.323 . . . . 0.0 111.921 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.41 ' CB ' ' HB2' ' A' ' 150' ' ' GLN . 5.5 t0 -142.67 -142.42 0.14 Allowed 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -48.26 -104.84 0.01 OUTLIER Glycine 0 CA--C 1.535 1.294 0 C-N-CA 120.636 -0.792 . . . . 0.0 114.387 -179.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.824 ' HG3' ' HB2' ' A' ' 209' ' ' ALA . 0.0 OUTLIER -145.45 133.91 21.94 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.003 0.521 . . . . 0.0 110.849 -179.276 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.652 ' O ' HG23 ' A' ' 175' ' ' ILE . 9.0 tp -88.5 84.12 2.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 122.26 1.029 . . . . 0.0 109.425 178.182 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.785 HG22 ' HB3' ' A' ' 207' ' ' GLU . 0.6 OUTLIER -85.99 -174.42 5.09 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.327 -1.306 . . . . 0.0 113.924 -176.585 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -84.71 -45.99 11.89 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 114.417 -1.265 . . . . 0.0 111.439 -179.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -88.72 52.89 2.54 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.589 -178.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -139.66 161.24 38.0 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.882 179.15 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 1.1 mptt -88.65 -172.21 3.64 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.506 HG22 ' CA ' ' A' ' 194' ' ' GLU . 3.0 m -141.35 161.03 22.22 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.647 0 CA-C-O 121.4 0.619 . . . . 0.0 111.883 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . 0.449 ' HB3' ' HB3' ' A' ' 231' ' ' GLU . 8.4 ttt85 -152.09 92.8 1.75 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.04 -0.982 . . . . 0.0 112.099 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.766 HD22 ' CZ ' ' A' ' 221' ' ' PHE . 5.7 mp -88.37 142.33 27.82 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -178.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.665 HD13 ' O ' ' A' ' 183' ' ' LEU . 17.3 mm -150.56 128.73 2.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 113.05 -1.886 . . . . 0.0 111.36 179.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.421 ' N ' HG22 ' A' ' 190' ' ' VAL . 4.0 ttp180 -88.83 -148.09 0.17 Allowed 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 177.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -95.79 28.33 3.11 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 118.473 0.579 . . . . 0.0 110.726 178.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.475 ' C ' HD13 ' A' ' 188' ' ' ILE . . . -153.87 -83.6 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.792 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.475 HD13 ' C ' ' A' ' 187' ' ' GLY . 0.2 OUTLIER -110.22 -157.78 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 115.427 -0.387 . . . . 0.0 110.657 -179.204 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.605 HG11 ' CG ' ' A' ' 192' ' ' GLU . 41.4 t -87.41 135.62 24.92 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 CA-C-O 121.751 0.786 . . . . 0.0 111.262 -179.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.878 HG12 ' OD2' ' A' ' 223' ' ' ASP . 0.1 OUTLIER -97.3 -34.04 4.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 114.426 -1.261 . . . . 0.0 109.411 179.76 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . 0.746 ' HB3' HD13 ' A' ' 183' ' ' LEU . 41.8 t80 -167.86 154.0 7.54 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.327 -0.852 . . . . 0.0 112.453 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . 0.605 ' CG ' HG11 ' A' ' 189' ' ' VAL . 50.7 mt-10 -150.16 158.28 43.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.067 178.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 133.97 -120.48 2.51 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.427 -0.892 . . . . 0.0 112.761 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . 0.506 ' CA ' HG22 ' A' ' 181' ' ' VAL . 0.0 OUTLIER -147.92 179.53 7.66 Favored 'General case' 0 CA--C 1.503 -0.857 0 CA-C-O 121.706 0.765 . . . . 0.0 111.797 -179.04 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.949 HD12 HD13 ' A' ' 216' ' ' LEU . 32.9 mm -92.57 153.06 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.308 0 CA-C-N 114.35 -1.295 . . . . 0.0 110.186 -179.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -89.97 -58.52 2.48 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 36.4 p -150.6 156.73 41.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.85 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.918 ' CD1' HD23 ' A' ' 216' ' ' LEU . 5.9 tp -127.88 115.78 19.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.172 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 5.1 ptpt -150.09 120.0 7.13 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.195 -0.912 . . . . 0.0 109.564 179.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.523 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.328 -179.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 22.7 t70 . . . . . 0 N--CA 1.453 -0.324 0 CA-C-O 121.247 0.546 . . . . 0.0 110.022 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.585 ' O ' HD23 ' A' ' 198' ' ' LEU . 31.9 m -53.91 160.87 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.969 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.352 -179.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . 0.476 ' O ' ' HB ' ' A' ' 176' ' ' THR . 0.0 OUTLIER -88.86 -36.73 15.83 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.321 -178.859 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.785 ' HB3' HG22 ' A' ' 176' ' ' THR . 0.6 OUTLIER -133.71 176.78 8.24 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.268 0.556 . . . . 0.0 111.821 179.926 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.659 ' O ' HG21 ' A' ' 170' ' ' VAL . 0.2 OUTLIER -150.38 84.24 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.759 179.129 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.824 ' HB2' ' HG3' ' A' ' 174' ' ' LYS . . . -99.99 178.82 4.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.096 0.474 . . . . 0.0 112.086 -178.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 81.9 -75.01 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.698 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . 0.405 ' O ' ' CE1' ' A' ' 169' ' ' TYR . . . 178.42 37.65 0.06 OUTLIER Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.347 179.033 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -101.75 143.2 31.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.917 0.389 . . . . 0.0 111.372 -179.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . 0.443 ' HG2' ' CD2' ' A' ' 169' ' ' TYR . 0.0 OUTLIER -98.56 131.5 44.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.454 179.943 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' CYS . . . . . 0.524 ' CB ' HG21 ' A' ' 208' ' ' VAL . 34.6 t -125.84 145.52 50.2 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.333 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -88.38 113.81 4.12 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.148 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.949 HD13 HD12 ' A' ' 195' ' ' ILE . 0.5 OUTLIER -133.81 147.35 51.23 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 120.839 0.352 . . . . 0.0 111.073 -179.26 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.01 138.45 31.97 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 177.038 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . 0.648 HG22 ' CE1' ' A' ' 191' ' ' TYR . 19.1 mm -91.33 52.61 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.086 0.469 . . . . 0.0 112.193 -177.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 4.6 tptm 61.48 -72.08 0.04 OUTLIER 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.642 178.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' ASN . . . . . 0.426 ' N ' ' O ' ' A' ' 218' ' ' ILE . 5.0 p-10 -145.43 51.45 1.2 Allowed 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.253 -179.089 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . 0.766 ' CZ ' HD22 ' A' ' 183' ' ' LEU . 0.1 OUTLIER -57.3 118.49 5.16 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 178.33 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -77.84 -46.3 21.88 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 176.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . 0.878 ' OD2' HG12 ' A' ' 190' ' ' VAL . 0.0 OUTLIER -88.09 130.39 35.02 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 177.48 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.637 HD13 ' H ' ' A' ' 224' ' ' ILE . 0.2 OUTLIER -117.31 176.77 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 CA-C-O 121.438 0.637 . . . . 0.0 112.466 -179.283 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.463 ' O ' ' N ' ' A' ' 227' ' ' GLY . 10.4 mtmt 62.06 154.28 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.231 -178.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . 0.509 ' HB3' ' O ' ' A' ' 154' ' ' ARG . 0.2 OUTLIER -39.99 90.77 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 122.235 1.017 . . . . 0.0 111.845 179.939 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 225' ' ' LYS . . . -106.66 -38.85 2.14 Favored Glycine 0 N--CA 1.429 -1.805 0 CA-C-N 114.356 -1.293 . . . . 0.0 112.207 -178.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.711 ' CB ' HG21 ' A' ' 190' ' ' VAL . 2.9 p30 -157.95 -166.7 2.03 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 115.736 1.754 . . . . 0.0 115.736 -178.166 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . 0.86 HG22 ' CG ' ' A' ' 152' ' ' GLU . 40.6 t -97.98 142.48 14.4 Favored 'Isoleucine or valine' 0 C--N 1.343 0.326 0 CA-C-N 114.441 -1.254 . . . . 0.0 108.075 177.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . 0.403 HG13 ' HG ' ' A' ' 183' ' ' LEU . 3.9 mp -115.48 150.89 17.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.091 0.472 . . . . 0.0 111.831 -178.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' GLU . . . . . 0.494 ' HA ' ' HA ' ' A' ' 150' ' ' GLN . 7.4 tt0 -137.69 108.73 6.75 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.271 0.558 . . . . 0.0 110.731 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.494 ' HB3' ' CA ' ' A' ' 149' ' ' GLY . . . -87.8 124.19 33.36 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.808 -179.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -123.62 166.97 14.57 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.709 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.533 ' CG1' HG21 ' A' ' 148' ' ' ILE . 9.8 p . . . . . 0 C--N 1.326 -0.444 0 C-N-CA 121.076 -0.249 . . . . 0.0 110.98 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.632 0.253 . . . . 0.0 110.57 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.566 HG11 ' HB2' ' A' ' 150' ' ' GLN . 15.0 t -60.13 139.84 19.03 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 CA-C-O 121.463 0.649 . . . . 0.0 111.356 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.56 ' HB ' HG12 ' A' ' 234' ' ' VAL . 6.9 tp -114.13 -18.97 7.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.231 178.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.406 ' O ' ' HB3' ' A' ' 232' ' ' ALA . . . 178.97 85.9 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.339 -179.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.566 ' HB2' HG11 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -91.44 135.05 34.12 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.664 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.461 ' HB1' ' O ' ' A' ' 169' ' ' TYR . . . -150.78 173.14 14.55 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 -177.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.834 ' CG ' HG22 ' A' ' 229' ' ' VAL . 0.4 OUTLIER -117.51 122.82 44.75 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.091 179.715 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.456 HG12 ' O ' ' A' ' 228' ' ' ASP . 2.7 p -55.65 128.92 16.52 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.338 0 CA-C-O 121.326 0.584 . . . . 0.0 111.65 -179.42 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.419 ' CA ' ' NE ' ' A' ' 154' ' ' ARG . 0.0 OUTLIER -89.2 -58.38 2.56 Favored 'General case' 0 N--CA 1.427 -1.606 0 N-CA-C 105.288 -2.115 . . . . 0.0 105.288 176.203 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.43 ' HA ' ' H ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER -163.1 -163.23 0.83 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.691 174.906 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.593 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 7.0 p -147.57 149.01 31.76 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.564 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 0.2 OUTLIER -94.4 80.3 3.92 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -177.984 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 13.8 tttm -85.88 63.69 8.18 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.42 HG12 ' N ' ' A' ' 161' ' ' LYS . 69.9 t -93.21 157.06 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-N 113.652 -1.613 . . . . 0.0 110.231 -178.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -92.07 35.45 0.99 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.208 0.528 . . . . 0.0 109.655 178.129 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.42 ' N ' HG12 ' A' ' 159' ' ' VAL . 5.0 mttt -151.47 -35.32 0.14 Allowed 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.084 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.49 HG12 HD13 ' A' ' 165' ' ' ILE . 95.5 t -97.85 -102.24 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . 0.471 ' N ' HG12 ' A' ' 162' ' ' VAL . . . -159.33 -102.8 0.18 Allowed Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 178.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 1.082 HG21 HG21 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -153.68 35.2 0.45 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.087 -1.056 . . . . 0.0 108.271 177.404 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.564 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 1.5 mp -42.92 96.02 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.541 -179.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.593 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . -80.39 118.67 22.23 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.697 -1.138 . . . . 0.0 112.194 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -88.75 141.86 16.73 Favored Glycine 0 N--CA 1.441 -1.022 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 178.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.465 ' HB3' HD12 ' A' ' 230' ' ' ILE . 0.0 OUTLIER -141.01 132.39 26.76 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.879 0.339 . . . . 0.0 110.488 -178.491 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . 0.461 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 47.5 t80 -85.59 129.36 34.84 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.247 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.69 HG21 ' O ' ' A' ' 208' ' ' VAL . 31.8 t -85.73 149.28 4.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -175.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -140.09 15.12 2.44 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 114.427 -1.261 . . . . 0.0 111.826 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.523 ' H ' HG12 ' A' ' 170' ' ' VAL . 9.3 t0 -150.6 -145.26 0.17 Allowed 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -179.346 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -43.48 -105.18 0.01 OUTLIER Glycine 0 CA--C 1.53 0.997 0 N-CA-C 114.84 0.696 . . . . 0.0 114.84 -179.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.814 ' HG2' ' HB2' ' A' ' 209' ' ' ALA . 7.6 mttt -151.44 144.28 24.44 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.999 0.428 . . . . 0.0 112.013 -178.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.445 ' CG1' HG22 ' A' ' 170' ' ' VAL . 10.3 mm -89.91 87.34 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 176.28 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.653 ' C ' HD11 ' A' ' 198' ' ' LEU . 0.1 OUTLIER -98.1 165.7 11.77 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -176.909 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 20.6 mtm105 -64.85 -44.45 89.75 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 114.55 -1.204 . . . . 0.0 111.083 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -89.3 60.15 5.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.752 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 46.6 m -149.2 159.54 44.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.652 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.538 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 14.9 mttp -89.62 -172.28 3.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.483 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.49 HG22 ' CA ' ' A' ' 194' ' ' GLU . 3.0 m -149.47 146.32 17.16 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.607 0 CA-C-O 121.554 0.692 . . . . 0.0 111.861 179.326 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . 0.448 ' N ' ' O ' ' A' ' 231' ' ' GLU . 6.0 ttm180 -154.45 98.83 2.14 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.722 -1.126 . . . . 0.0 112.002 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.628 ' C ' HD12 ' A' ' 184' ' ' ILE . 0.3 OUTLIER -100.88 168.53 9.58 Favored 'General case' 0 N--CA 1.437 -1.093 0 C-N-CA 120.358 -0.537 . . . . 0.0 111.026 179.597 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.771 HG23 ' O ' ' A' ' 188' ' ' ILE . 5.3 mp -151.15 140.07 14.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.156 -177.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.464 ' N ' HG22 ' A' ' 190' ' ' VAL . 8.0 ptp180 -87.16 -155.77 0.3 Allowed 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.172 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -93.6 27.23 2.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 118.327 0.512 . . . . 0.0 111.385 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -154.4 -43.87 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.966 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.771 ' O ' HG23 ' A' ' 184' ' ' ILE . 0.4 OUTLIER -150.14 -159.34 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 120.679 0.276 . . . . 0.0 111.711 -177.969 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.668 ' N ' HG23 ' A' ' 188' ' ' ILE . 39.8 t -85.13 135.13 25.49 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 CA-C-O 121.564 0.697 . . . . 0.0 110.349 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.498 ' HB ' HD11 ' A' ' 183' ' ' LEU . 0.3 OUTLIER -87.99 -35.04 7.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.347 -179.848 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . 0.48 ' HB2' ' CE1' ' A' ' 221' ' ' PHE . 0.6 OUTLIER -176.66 155.3 1.31 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.042 -179.994 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . 0.625 ' CG ' HG11 ' A' ' 189' ' ' VAL . 33.3 mt-10 -141.7 161.14 38.67 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.884 179.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 141.28 -137.31 8.03 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 111.377 -0.689 . . . . 0.0 111.377 -179.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . 0.707 ' O ' HG23 ' A' ' 218' ' ' ILE . 7.2 pt-20 -131.97 -176.07 3.94 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-O 121.011 0.434 . . . . 0.0 111.169 179.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.482 HG22 ' N ' ' A' ' 196' ' ' ASP . 5.8 mm -87.21 159.11 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.687 -178.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' ASP . . . . . 0.643 ' HB3' HG23 ' A' ' 217' ' ' THR . 4.0 t0 -103.16 -56.98 2.12 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 18.1 p -151.58 155.01 37.58 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.543 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.653 HD11 ' C ' ' A' ' 176' ' ' THR . 13.6 mt -117.11 128.22 54.92 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.927 179.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 10.8 ptpt -151.09 118.45 6.0 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.473 178.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 6.6 ttp180 . . . . . 0 C--N 1.321 -0.668 0 CA-C-O 121.433 0.635 . . . . 0.0 111.525 -178.778 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 . . . . . 0 N--CA 1.452 -0.341 0 CA-C-O 120.739 0.304 . . . . 0.0 110.731 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 27.6 m -66.48 155.42 7.19 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.915 0 CA-C-O 121.332 0.587 . . . . 0.0 111.671 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . 0.456 ' O ' ' HB ' ' A' ' 176' ' ' THR . 2.7 mtp180 -89.37 -32.74 17.16 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.388 -178.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -150.06 179.0 8.42 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.921 0.391 . . . . 0.0 110.713 179.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.69 ' O ' HG21 ' A' ' 170' ' ' VAL . 1.8 t -151.07 80.34 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.828 178.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.814 ' HB2' ' HG2' ' A' ' 174' ' ' LYS . . . -102.68 174.53 5.85 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 83.11 -74.33 0.03 OUTLIER 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.09 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 178.11 37.21 0.06 OUTLIER Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.392 -0.909 . . . . 0.0 112.385 179.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -98.17 144.69 27.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.919 0.39 . . . . 0.0 111.274 -179.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -96.77 130.11 44.08 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.872 179.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' CYS . . . . . 0.486 ' CB ' HG21 ' A' ' 208' ' ' VAL . 33.6 t -128.75 144.93 51.28 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.775 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -88.77 110.64 3.69 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.634 -0.793 . . . . 0.0 111.761 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.447 ' CD1' HD12 ' A' ' 195' ' ' ILE . 0.1 OUTLIER -129.0 144.37 51.16 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.116 0.484 . . . . 0.0 111.111 -179.229 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . 0.643 HG23 ' HB3' ' A' ' 196' ' ' ASP . 0.1 OUTLIER -107.09 141.69 37.92 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 178.147 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . 0.707 HG23 ' O ' ' A' ' 194' ' ' GLU . 18.4 mm -90.72 140.45 15.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.241 0.544 . . . . 0.0 110.571 -179.344 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt -42.0 -30.1 0.26 Allowed 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -177.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 220' ' ' ASN . . . . . 0.425 ' O ' ' CE2' ' A' ' 191' ' ' TYR . 5.0 t30 -152.46 35.08 0.51 Allowed 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -178.335 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . 0.5 ' HB2' ' HB ' ' A' ' 218' ' ' ILE . 0.1 OUTLIER -58.84 120.09 8.37 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 178.891 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -88.11 -46.97 8.85 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 176.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . 0.459 ' O ' ' CD1' ' A' ' 221' ' ' PHE . 0.0 OUTLIER -79.54 136.25 36.83 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.063 177.403 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 1.082 HG21 HG21 ' A' ' 164' ' ' THR . 0.2 OUTLIER -133.28 178.9 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -178.859 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.412 ' O ' ' C ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER 57.46 116.8 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.853 -178.862 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . 0.43 ' H ' ' HA ' ' A' ' 155' ' ' GLN . 0.5 OUTLIER 6.91 63.95 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 124.51 1.124 . . . . 0.0 113.814 -179.545 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . 0.437 ' N ' HG11 ' A' ' 153' ' ' VAL . . . -61.39 -66.73 2.48 Favored Glycine 0 N--CA 1.434 -1.497 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.739 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.456 ' O ' HG12 ' A' ' 153' ' ' VAL . 0.8 OUTLIER -165.07 -148.21 0.11 Allowed 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 114.279 1.215 . . . . 0.0 114.279 179.686 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . 0.834 HG22 ' CG ' ' A' ' 152' ' ' GLU . 73.0 t -89.14 130.2 38.89 Favored 'Isoleucine or valine' 0 C--N 1.345 0.381 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . 0.497 ' HA ' ' CB ' ' A' ' 183' ' ' LEU . 22.6 mt -101.04 158.32 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.119 0 O-C-N 123.66 0.6 . . . . 0.0 111.332 -179.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 231' ' ' GLU . . . . . 0.448 ' O ' ' N ' ' A' ' 182' ' ' ARG . 16.1 tt0 -144.85 111.0 5.51 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.3 0.572 . . . . 0.0 112.522 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.556 ' O ' HG22 ' A' ' 148' ' ' ILE . . . -87.67 122.83 31.85 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.948 178.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -123.84 141.27 52.18 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.022 -179.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.56 HG12 ' HB ' ' A' ' 148' ' ' ILE . 0.9 OUTLIER . . . . . 0 CA--C 1.54 0.593 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.017 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 33.2 mttp . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.665 0.269 . . . . 0.0 110.302 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.465 HG11 ' HB2' ' A' ' 150' ' ' GLN . 4.3 t -108.43 141.96 22.32 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.739 0 CA-C-O 121.435 0.636 . . . . 0.0 110.727 179.022 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.643 HG21 HG12 ' A' ' 234' ' ' VAL . 2.6 pp -128.99 -8.85 3.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.635 179.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.539 ' N ' HD12 ' A' ' 148' ' ' ILE . . . -174.04 75.0 0.09 OUTLIER Glycine 0 C--N 1.341 0.817 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.831 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.465 ' HB2' HG11 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -90.39 137.99 31.9 Favored 'General case' 0 CA--C 1.506 -0.728 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.852 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.534 ' HB1' ' HB2' ' A' ' 168' ' ' CYS . . . -151.66 174.85 12.99 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 120.093 -0.643 . . . . 0.0 112.339 -178.105 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.773 ' HG3' HG22 ' A' ' 229' ' ' VAL . 0.4 OUTLIER -125.12 119.37 28.4 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.507 179.92 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.464 HG11 ' N ' ' A' ' 227' ' ' GLY . 1.1 p -49.07 131.23 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -178.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.557 ' O ' ' HB3' ' A' ' 226' ' ' GLU . 4.0 mmp_? -91.48 -60.17 1.95 Allowed 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 105.249 -2.13 . . . . 0.0 105.249 175.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.73 -159.18 0.44 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 113.743 -1.571 . . . . 0.0 109.422 175.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.551 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 9.5 p -148.92 163.17 38.24 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 120.821 0.343 . . . . 0.0 110.647 177.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.656 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 3.7 m-85 -110.13 73.04 0.82 Allowed 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -178.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.588 ' HG3' HD13 ' A' ' 224' ' ' ILE . 8.2 tmtm? -85.94 64.36 8.55 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 92.4 t -92.25 158.22 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 CA-C-N 113.549 -1.66 . . . . 0.0 110.258 -178.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 71.5 m -93.06 34.46 1.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.225 0.535 . . . . 0.0 109.761 178.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.63 -33.09 0.15 Allowed 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.386 -179.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.516 HG12 ' N ' ' A' ' 163' ' ' GLY . 89.0 t -99.82 -102.19 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.19 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . 0.516 ' N ' HG12 ' A' ' 162' ' ' VAL . . . -158.85 -103.4 0.19 Allowed Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 111.522 -0.631 . . . . 0.0 111.522 179.268 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.458 HG21 ' CG2' ' A' ' 224' ' ' ILE . 0.0 OUTLIER -153.64 34.61 0.45 Allowed 'General case' 0 C--O 1.232 0.148 0 CA-C-N 114.311 -0.944 . . . . 0.0 108.801 178.259 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.656 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 1.6 mp -43.3 98.09 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.527 0.096 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.424 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.551 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . -87.08 122.89 31.52 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.854 -1.067 . . . . 0.0 111.698 -179.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -87.73 146.54 20.02 Favored Glycine 0 N--CA 1.442 -0.921 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 178.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.534 ' HB2' ' HB1' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -147.66 134.37 19.98 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 117.279 0.539 . . . . 0.0 110.771 -178.338 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . 0.427 ' O ' ' HA ' ' A' ' 151' ' ' ALA . 22.9 t80 -86.84 134.34 33.55 Favored 'General case' 0 C--O 1.221 -0.414 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 177.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.512 HG12 ' N ' ' A' ' 212' ' ' TYR . 9.2 p -86.43 146.63 6.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -176.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.2 p -140.95 12.01 2.23 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.557 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.425 ' CB ' ' HB2' ' A' ' 150' ' ' GLN . 9.1 t0 -150.79 -148.14 0.25 Allowed 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -41.48 -104.51 0.01 OUTLIER Glycine 0 CA--C 1.532 1.119 0 N-CA-C 115.09 0.796 . . . . 0.0 115.09 -178.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.707 ' HG3' ' HB2' ' A' ' 209' ' ' ALA . 0.0 OUTLIER -150.64 128.89 11.98 Favored 'General case' 0 CA--C 1.513 -0.457 0 O-C-N 122.722 -0.281 . . . . 0.0 111.368 -178.778 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.658 ' O ' HG23 ' A' ' 175' ' ' ILE . 1.1 tp -89.54 76.78 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 CA-C-O 122.27 1.033 . . . . 0.0 108.981 177.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.803 HG22 ' HB3' ' A' ' 207' ' ' GLU . 0.2 OUTLIER -84.03 173.01 11.49 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.015 -1.448 . . . . 0.0 113.543 -176.796 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 43.0 ttp85 -59.96 -51.6 68.98 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 114.2 -1.364 . . . . 0.0 111.536 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -89.55 61.92 5.72 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.68 -178.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . 0.622 ' HB3' HD13 ' A' ' 148' ' ' ILE . 0.9 OUTLIER -142.68 160.4 40.38 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.443 179.396 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.516 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 11.9 mttt -89.08 -174.39 4.43 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.698 HG21 HG23 ' A' ' 218' ' ' ILE . 2.4 m -150.7 145.51 16.77 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 CA-C-O 121.573 0.702 . . . . 0.0 112.111 179.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . 0.465 ' N ' ' O ' ' A' ' 231' ' ' GLU . 16.9 ttt180 -154.87 100.52 2.21 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.725 -1.125 . . . . 0.0 112.051 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.532 ' HA ' ' O ' ' A' ' 229' ' ' VAL . 0.3 OUTLIER -100.15 168.83 9.57 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 120.616 -0.433 . . . . 0.0 110.878 179.551 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.725 HG23 ' O ' ' A' ' 188' ' ' ILE . 27.2 mt -155.5 139.55 8.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.333 -0.394 . . . . 0.0 112.017 -178.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.492 ' N ' HG22 ' A' ' 190' ' ' VAL . 0.0 OUTLIER -86.57 -154.02 0.22 Allowed 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.081 178.174 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -94.27 29.11 2.29 Favored 'General case' 0 N--CA 1.455 -0.191 0 O-C-N 122.023 -0.423 . . . . 0.0 111.51 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -152.91 -77.41 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.319 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.725 ' O ' HG23 ' A' ' 184' ' ' ILE . 0.5 OUTLIER -115.49 -157.68 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-N 115.464 -0.368 . . . . 0.0 110.094 -179.765 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.732 HG11 ' CG ' ' A' ' 192' ' ' GLU . 23.4 t -86.83 139.97 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 CA-C-O 121.425 0.631 . . . . 0.0 110.889 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.611 HG23 ' CA ' ' A' ' 184' ' ' ILE . 0.4 OUTLIER -88.22 -35.44 8.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.011 179.883 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . 0.463 ' HB2' ' CE1' ' A' ' 221' ' ' PHE . 9.9 t80 -178.91 151.33 0.52 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.014 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . 0.732 ' CG ' HG11 ' A' ' 189' ' ' VAL . 34.0 mt-10 -143.47 159.34 42.59 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.68 179.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 150.33 -122.9 1.46 Allowed Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.825 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . 0.52 ' C ' HG22 ' A' ' 181' ' ' VAL . 8.8 pt-20 -139.31 -177.98 5.16 Favored 'General case' 0 CA--C 1.497 -1.065 0 CA-C-O 121.288 0.566 . . . . 0.0 111.207 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.815 HD11 ' CD1' ' A' ' 216' ' ' LEU . 0.3 OUTLIER -88.27 142.62 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.145 -178.485 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -88.7 -61.69 1.65 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -151.94 166.05 32.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.529 178.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.575 HD21 ' O ' ' A' ' 205' ' ' VAL . 1.3 pt? -139.3 122.41 16.86 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.69 0.757 . . . . 0.0 112.149 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -146.83 127.82 14.55 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 114.406 -1.27 . . . . 0.0 108.719 178.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 3.1 ttp85 . . . . . 0 C--N 1.32 -0.709 0 CA-C-O 121.51 0.671 . . . . 0.0 111.82 -178.321 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.45 -0.468 0 CA-C-O 120.695 0.283 . . . . 0.0 110.644 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.575 ' O ' HD21 ' A' ' 198' ' ' LEU . 30.4 m -56.15 173.47 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.068 0 CA-C-O 120.972 0.415 . . . . 0.0 111.361 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . 0.478 ' O ' ' HB ' ' A' ' 176' ' ' THR . 2.6 ttp180 -97.34 -40.07 8.91 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.787 -178.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.803 ' HB3' HG22 ' A' ' 176' ' ' THR . 1.1 mp0 -143.12 178.12 7.92 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.29 0.567 . . . . 0.0 111.938 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.569 HG23 HG23 ' A' ' 175' ' ' ILE . 0.1 OUTLIER -150.74 81.23 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.743 179.478 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.707 ' HB2' ' HG3' ' A' ' 174' ' ' LYS . . . -105.32 177.5 4.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.999 0.428 . . . . 0.0 112.043 -178.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 83.24 -72.06 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.942 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . 0.501 ' HA2' HG13 ' A' ' 170' ' ' VAL . . . 178.63 36.88 0.06 OUTLIER Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.537 -0.839 . . . . 0.0 112.369 179.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . 0.512 ' N ' HG12 ' A' ' 170' ' ' VAL . 0.5 OUTLIER -104.54 144.45 31.67 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.071 0.463 . . . . 0.0 111.746 -179.232 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -99.56 151.11 21.54 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.933 179.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 53.9 t -146.66 148.2 31.8 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.845 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -88.23 108.72 3.45 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.394 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.815 ' CD1' HD11 ' A' ' 195' ' ' ILE . 0.1 OUTLIER -138.27 147.6 43.81 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 121.12 0.486 . . . . 0.0 112.06 -178.208 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . 0.708 ' O ' HD13 ' A' ' 195' ' ' ILE . 0.0 OUTLIER -88.1 143.86 26.83 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.025 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . 0.698 HG23 HG21 ' A' ' 181' ' ' VAL . 1.5 mp -109.42 92.15 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 -179.335 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 1.8 ttpp 44.43 -146.1 0.11 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.852 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -87.67 62.66 7.14 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-O 121.319 0.58 . . . . 0.0 110.808 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . 0.49 ' CZ ' HD21 ' A' ' 183' ' ' LEU . 0.1 OUTLIER -54.37 121.6 8.63 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 179.14 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -84.06 -48.66 9.67 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.287 176.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 223' ' ' ASP . 0.0 OUTLIER -81.0 125.37 30.08 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.122 177.68 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.633 HD12 ' HG2' ' A' ' 225' ' ' LYS . 1.7 pt -115.89 176.86 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.603 0 CA-C-O 121.469 0.652 . . . . 0.0 111.884 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.633 ' HG2' HD12 ' A' ' 224' ' ' ILE . 0.1 OUTLIER 63.88 149.46 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.757 -1.111 . . . . 0.0 108.635 -178.627 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . 0.557 ' HB3' ' O ' ' A' ' 154' ' ' ARG . 5.5 pt-20 -36.92 86.5 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 121.986 0.898 . . . . 0.0 112.89 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 225' ' ' LYS . . . -78.5 -60.17 2.71 Favored Glycine 0 N--CA 1.426 -2.006 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.502 179.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.458 ' HB3' ' O ' ' A' ' 184' ' ' ILE . 1.1 t70 -165.21 -144.94 0.08 Allowed 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . 0.773 HG22 ' HG3' ' A' ' 152' ' ' GLU . 80.2 t -89.65 134.21 29.48 Favored 'Isoleucine or valine' 0 C--N 1.349 0.555 0 C-N-CA 122.937 0.495 . . . . 0.0 109.881 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . 0.501 ' HA ' ' CB ' ' A' ' 183' ' ' LEU . 5.5 mt -103.26 158.04 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 O-C-N 123.435 0.459 . . . . 0.0 110.951 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 231' ' ' GLU . . . . . 0.465 ' O ' ' N ' ' A' ' 182' ' ' ARG . 1.4 tm-20 -148.89 109.88 4.33 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.649 ' HB2' HD12 ' A' ' 175' ' ' ILE . . . -87.59 128.25 35.27 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.354 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' TYR . . . . . 0.456 ' HA ' HG13 ' A' ' 148' ' ' ILE . 11.5 p90 -124.97 143.17 51.03 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.625 -178.164 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.643 HG12 HG21 ' A' ' 148' ' ' ILE . 0.3 OUTLIER . . . . . 0 CA--C 1.534 0.332 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.855 178.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 8.7 p90 . . . . . 0 N--CA 1.487 1.424 0 CA-C-O 120.892 0.377 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -101.25 157.8 16.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.849 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -88.25 59.21 5.13 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.807 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -59.17 -169.13 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.938 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.661 HG11 ' HB2' ' A' ' 150' ' ' GLN . 17.0 t -61.69 141.06 18.12 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.595 0 CA-C-O 121.25 0.548 . . . . 0.0 111.53 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.735 HG21 HG12 ' A' ' 234' ' ' VAL . 0.3 OUTLIER -126.54 2.17 4.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.632 177.48 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.587 ' CA ' ' HB3' ' A' ' 232' ' ' ALA . . . 175.83 74.29 0.05 OUTLIER Glycine 0 C--N 1.341 0.847 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.356 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.661 ' HB2' HG11 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -91.71 132.86 36.08 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.177 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.424 ' O ' HG13 ' A' ' 229' ' ' VAL . . . -151.88 174.16 13.93 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-O 121.466 0.65 . . . . 0.0 112.438 -178.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.681 ' HG2' HG22 ' A' ' 229' ' ' VAL . 50.4 mt-10 -118.71 122.75 43.22 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.274 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.731 ' HB ' HD11 ' A' ' 230' ' ' ILE . 2.4 p -52.1 132.26 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 121.257 0.551 . . . . 0.0 112.436 -178.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.445 ' O ' ' HB3' ' A' ' 226' ' ' GLU . 4.7 mmp_? -89.33 -61.48 1.69 Allowed 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 175.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.435 ' HA ' ' H ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER -162.38 -163.83 0.96 Allowed 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 113.624 -1.625 . . . . 0.0 109.479 174.789 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.553 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 12.2 p -143.82 173.57 11.57 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 177.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.654 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 9.2 m-85 -125.5 75.5 1.48 Allowed 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -178.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -86.2 63.14 7.85 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 177.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.47 HG12 ' N ' ' A' ' 161' ' ' LYS . 66.5 t -91.71 156.02 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 CA-C-N 113.603 -1.635 . . . . 0.0 110.343 -178.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 49.1 p -91.36 34.71 0.94 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.217 0.532 . . . . 0.0 109.845 178.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.47 ' N ' HG12 ' A' ' 159' ' ' VAL . 1.6 mttt -150.84 -32.15 0.17 Allowed 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.358 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.792 HG11 HD12 ' A' ' 165' ' ' ILE . 91.9 t -102.11 -103.31 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . 0.512 ' N ' HG12 ' A' ' 162' ' ' VAL . . . -159.04 -100.44 0.16 Allowed Glycine 0 N--CA 1.451 -0.317 0 N-CA-C 111.438 -0.665 . . . . 0.0 111.438 179.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.437 ' CG2' ' CG2' ' A' ' 224' ' ' ILE . 0.0 OUTLIER -153.87 35.11 0.44 Allowed 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 114.209 -0.996 . . . . 0.0 108.709 178.266 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.792 HD12 HG11 ' A' ' 162' ' ' VAL . 4.2 mt -42.13 95.57 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.567 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.553 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . -88.07 119.01 28.03 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.744 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -88.07 146.82 19.94 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 178.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.639 ' HB3' HD13 ' A' ' 230' ' ' ILE . 0.0 OUTLIER -147.17 135.28 21.49 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 117.248 0.524 . . . . 0.0 110.833 -178.416 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . 0.4 ' O ' ' HA ' ' A' ' 151' ' ' ALA . 5.3 t80 -86.85 124.12 32.73 Favored 'General case' 0 C--O 1.223 -0.301 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 177.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.787 HG21 ' O ' ' A' ' 208' ' ' VAL . 26.9 t -85.53 147.13 5.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 -175.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.2 p -139.86 14.26 2.48 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.924 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.437 ' H ' HG12 ' A' ' 170' ' ' VAL . 3.9 t70 -150.85 -144.66 0.16 Allowed 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -40.3 -105.16 0.01 OUTLIER Glycine 0 CA--C 1.534 1.246 0 N-CA-C 115.208 0.843 . . . . 0.0 115.208 -179.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.817 ' HG2' ' HB2' ' A' ' 209' ' ' ALA . 6.8 mttt -151.04 143.25 24.1 Favored 'General case' 0 CA--C 1.517 -0.315 0 O-C-N 122.557 -0.378 . . . . 0.0 111.764 -178.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.628 HG13 HG22 ' A' ' 170' ' ' VAL . 14.6 mm -95.36 78.94 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 176.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.853 ' O ' HD13 ' A' ' 195' ' ' ILE . 0.0 OUTLIER -97.97 171.06 8.51 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -176.834 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.34 -39.54 74.63 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.28 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -88.58 55.14 3.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.815 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.812 ' O ' HD12 ' A' ' 195' ' ' ILE . 0.9 OUTLIER -150.18 159.65 44.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.603 -179.973 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 0.0 OUTLIER -89.06 -178.49 5.7 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 179.238 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.697 HG21 HG23 ' A' ' 218' ' ' ILE . 3.3 m -149.64 146.24 17.1 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.615 0 CA-C-O 121.599 0.714 . . . . 0.0 112.028 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 231' ' ' GLU . 7.8 ttt180 -154.54 101.93 2.37 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.748 -1.114 . . . . 0.0 112.198 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.643 ' C ' HD12 ' A' ' 184' ' ' ILE . 0.3 OUTLIER -97.46 170.54 8.98 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.636 179.234 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.791 HG23 ' O ' ' A' ' 188' ' ' ILE . 5.3 mp -152.08 141.32 14.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.021 -177.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.486 ' N ' HG22 ' A' ' 190' ' ' VAL . 3.6 ttm180 -86.37 -156.22 0.29 Allowed 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 178.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -93.62 26.5 3.03 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.915 179.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -154.07 -43.68 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.062 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.791 ' O ' HG23 ' A' ' 184' ' ' ILE . 0.4 OUTLIER -150.4 -159.74 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -178.001 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.663 ' N ' HG23 ' A' ' 188' ' ' ILE . 22.4 t -84.86 133.68 28.75 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 CA-C-O 121.572 0.701 . . . . 0.0 110.137 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.875 HG12 ' OD2' ' A' ' 223' ' ' ASP . 0.2 OUTLIER -88.32 -38.38 11.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 114.678 -1.147 . . . . 0.0 109.223 -179.213 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . 0.479 ' HB2' ' CE1' ' A' ' 221' ' ' PHE . 19.1 t80 -169.62 162.39 9.83 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.201 178.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . 0.654 ' CG ' HG11 ' A' ' 189' ' ' VAL . 28.1 mt-10 -150.1 157.97 43.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.041 0.448 . . . . 0.0 111.056 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 146.27 -126.42 2.49 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.077 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 0.597 ' CA ' HG22 ' A' ' 181' ' ' VAL . 3.9 pt-20 -139.92 -176.9 4.75 Favored 'General case' 0 CA--C 1.498 -1.038 0 CA-C-O 121.152 0.501 . . . . 0.0 111.3 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.853 HD13 ' O ' ' A' ' 176' ' ' THR . 3.1 mp -86.85 141.44 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.39 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.351 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.08 -47.48 8.07 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 40.4 m -151.24 163.42 38.92 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.086 179.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.69 HD22 ' HB3' ' A' ' 216' ' ' LEU . 0.1 OUTLIER -134.38 108.84 8.4 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 121.099 0.476 . . . . 0.0 111.073 -179.947 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 3.3 mtpm? -150.1 118.61 6.49 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.682 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . 0.551 HH12 HG11 ' A' ' 205' ' ' VAL . 0.0 OUTLIER -88.21 -160.5 0.64 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.946 179.896 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -87.35 -9.81 53.84 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 121.243 -0.183 . . . . 0.0 111.169 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.45 -57.7 2.03 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-O 120.632 0.253 . . . . 0.0 111.142 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 26.2 p-10 -152.32 -170.62 3.69 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 120.807 0.337 . . . . 0.0 111.049 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . 0.401 ' HA ' ' HA ' ' A' ' 199' ' ' LYS . 4.1 m-20 -89.71 72.62 7.69 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.334 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.551 HG11 HH12 ' A' ' 200' ' ' ARG . 32.6 m -64.38 154.83 6.61 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.905 0 CA-C-O 121.501 0.667 . . . . 0.0 112.038 -179.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . 0.456 ' O ' ' HB ' ' A' ' 176' ' ' THR . 4.3 ttm-85 -89.62 -29.7 18.66 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 114.868 -1.06 . . . . 0.0 112.052 -178.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.699 ' HB3' HG22 ' A' ' 176' ' ' THR . 1.5 mp0 -142.93 178.17 7.85 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.123 0.487 . . . . 0.0 111.078 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.787 ' O ' HG21 ' A' ' 170' ' ' VAL . 0.2 OUTLIER -151.18 75.83 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.882 179.054 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.817 ' HB2' ' HG2' ' A' ' 174' ' ' LYS . . . -98.24 172.81 7.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.053 0.454 . . . . 0.0 112.195 -178.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 83.94 -73.49 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.957 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 178.45 37.71 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.328 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -102.23 142.98 32.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.863 0.363 . . . . 0.0 111.237 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -100.17 131.72 45.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.337 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' CYS . . . . . 0.569 ' HB3' HG21 ' A' ' 208' ' ' VAL . 48.6 t -133.85 148.19 51.26 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.384 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -88.54 111.47 3.79 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.016 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.69 ' HB3' HD22 ' A' ' 198' ' ' LEU . 0.2 OUTLIER -135.73 144.76 46.06 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 120.946 0.403 . . . . 0.0 111.281 -179.141 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . 0.543 ' C ' HD12 ' A' ' 218' ' ' ILE . 0.2 OUTLIER -82.37 149.0 27.94 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.189 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . 0.697 HG23 HG21 ' A' ' 181' ' ' VAL . 1.7 mp -113.96 88.2 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 -179.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 2.3 tttt 45.51 -144.72 0.19 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.931 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -87.08 61.35 6.72 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 120.957 0.408 . . . . 0.0 110.889 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.523 ' CZ ' HD21 ' A' ' 183' ' ' LEU . 0.1 OUTLIER -55.23 118.85 4.74 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 179.081 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 21.8 t30 -81.56 -47.46 13.05 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 114.804 -1.089 . . . . 0.0 108.571 176.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . 0.875 ' OD2' HG12 ' A' ' 190' ' ' VAL . 0.0 OUTLIER -83.62 139.25 32.94 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.204 177.966 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.636 ' N ' HD13 ' A' ' 224' ' ' ILE . 0.2 OUTLIER -132.27 179.35 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 CA-C-O 121.276 0.56 . . . . 0.0 112.28 -179.542 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.403 ' O ' ' C ' ' A' ' 226' ' ' GLU . 0.3 OUTLIER 58.01 115.87 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.677 -178.756 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . 0.445 ' HB3' ' O ' ' A' ' 154' ' ' ARG . 2.6 pt-20 3.64 66.62 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 124.812 1.245 . . . . 0.0 113.931 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -63.35 -62.56 5.27 Favored Glycine 0 N--CA 1.43 -1.745 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.855 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.451 ' O ' HG12 ' A' ' 153' ' ' VAL . 0.8 OUTLIER -164.95 -148.38 0.11 Allowed 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -179.891 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . 0.681 HG22 ' HG2' ' A' ' 152' ' ' GLU . 96.4 t -90.37 132.23 35.54 Favored 'Isoleucine or valine' 0 C--N 1.347 0.46 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . 0.731 HD11 ' HB ' ' A' ' 153' ' ' VAL . 4.6 mp -98.61 158.8 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 O-C-N 123.477 0.486 . . . . 0.0 111.572 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' GLU . . . . . 0.44 ' O ' ' N ' ' A' ' 182' ' ' ARG . 7.8 tt0 -145.89 109.55 4.79 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.587 ' HB3' ' CA ' ' A' ' 149' ' ' GLY . . . -88.12 126.86 35.34 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.516 178.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -132.57 140.08 48.11 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.107 -178.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.735 HG12 HG21 ' A' ' 148' ' ' ILE . 0.4 OUTLIER -176.64 -162.33 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.937 179.807 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' MET . . . . . 0.652 ' N ' HG13 ' A' ' 234' ' ' VAL . 0.0 OUTLIER -89.46 -163.49 1.01 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.691 0.281 . . . . 0.0 110.63 179.739 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -96.48 36.82 1.32 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.911 0.386 . . . . 0.0 111.366 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -125.78 44.66 2.78 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.904 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.576 HG22 HG11 ' A' ' 234' ' ' VAL . 11.6 t -101.93 159.4 4.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.256 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . 0.476 ' N ' HG12 ' A' ' 238' ' ' VAL . . . 70.53 -62.73 0.43 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.354 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 3.4 ttp180 -89.19 -3.42 58.59 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.313 -1.015 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.11 179.983 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.808 0.337 . . . . 0.0 111.129 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -145.22 153.38 41.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.969 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.74 -72.57 0.55 Allowed 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 121.567 0.699 . . . . 0.0 111.147 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 12.7 tttt 64.57 168.14 0.17 Allowed 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.159 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.711 HG11 ' HB2' ' A' ' 150' ' ' GLN . 15.1 t -59.0 140.81 16.81 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.595 0 CA-C-O 121.209 0.528 . . . . 0.0 111.485 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.666 HG13 HG12 ' A' ' 234' ' ' VAL . 0.1 OUTLIER -125.96 -0.85 4.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.819 177.872 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.551 ' CA ' ' HB3' ' A' ' 232' ' ' ALA . . . -176.66 72.95 0.08 OUTLIER Glycine 0 C--N 1.341 0.848 0 C-N-CA 121.109 -0.567 . . . . 0.0 111.817 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.711 ' HB2' HG11 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -91.97 132.3 36.62 Favored 'General case' 0 CA--C 1.511 -0.532 0 O-C-N 122.514 -0.403 . . . . 0.0 110.217 179.899 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.493 ' O ' HG13 ' A' ' 229' ' ' VAL . . . -152.22 177.51 10.46 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -178.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.504 ' CD ' HG22 ' A' ' 229' ' ' VAL . 2.1 mm-40 -123.66 125.09 44.16 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.566 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.447 HG11 ' N ' ' A' ' 227' ' ' GLY . 1.4 p -49.82 132.43 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -179.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.554 ' O ' ' HB3' ' A' ' 226' ' ' GLU . 4.3 mmp_? -89.58 -61.88 1.6 Allowed 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 105.232 -2.136 . . . . 0.0 105.232 175.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.29 -159.05 0.46 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 113.555 -1.657 . . . . 0.0 108.945 175.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.525 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 17.4 p -146.04 175.16 10.67 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 110.34 -0.245 . . . . 0.0 110.34 177.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.662 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 12.0 m-85 -129.06 73.25 1.5 Allowed 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -179.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 163' ' ' GLY . 4.6 ptmt -85.81 64.38 8.57 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.491 HG12 ' N ' ' A' ' 161' ' ' LYS . 57.0 t -93.22 156.87 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 CA-C-N 113.294 -1.775 . . . . 0.0 110.527 -178.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 92.0 p -91.95 35.91 0.97 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.221 0.534 . . . . 0.0 109.584 178.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.491 ' N ' HG12 ' A' ' 159' ' ' VAL . 0.2 OUTLIER -150.85 -34.04 0.16 Allowed 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.165 -179.576 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.617 HG12 HD13 ' A' ' 165' ' ' ILE . 89.5 t -102.18 -102.04 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . 0.511 ' N ' HG12 ' A' ' 162' ' ' VAL . . . -158.54 -102.0 0.18 Allowed Glycine 0 C--O 1.226 -0.384 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.461 HG22 HG22 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -153.37 34.46 0.46 Allowed 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 124.482 1.113 . . . . 0.0 108.145 177.795 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.662 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 1.6 mp -42.15 95.2 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 CA-C-N 115.063 -0.971 . . . . 0.0 112.143 -178.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.525 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . -87.8 117.89 26.95 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.416 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -87.9 149.51 21.63 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.157 -1.02 . . . . 0.0 110.761 179.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.427 ' HB2' ' CB ' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -144.7 135.06 24.34 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.929 0.365 . . . . 0.0 110.537 -178.69 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . 0.408 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 91.0 t80 -86.94 124.69 33.43 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 177.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.716 HG21 ' O ' ' A' ' 208' ' ' VAL . 25.0 t -85.06 143.53 11.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -175.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -136.44 14.75 3.21 Favored 'General case' 0 CA--C 1.526 0.053 0 CA-C-N 114.475 -1.239 . . . . 0.0 111.851 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.421 ' H ' HG12 ' A' ' 170' ' ' VAL . 5.0 t0 -150.36 -144.28 0.15 Allowed 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -179.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -42.06 -105.06 0.01 OUTLIER Glycine 0 CA--C 1.532 1.107 0 N-CA-C 115.055 0.782 . . . . 0.0 115.055 -179.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.779 ' HG2' ' HB2' ' A' ' 209' ' ' ALA . 17.8 mttt -150.83 143.8 24.65 Favored 'General case' 0 N--CA 1.465 0.312 0 O-C-N 122.585 -0.362 . . . . 0.0 111.582 -178.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.61 ' CG1' HG22 ' A' ' 170' ' ' VAL . 13.2 mm -94.96 81.64 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 176.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.707 HG22 ' HB3' ' A' ' 207' ' ' GLU . 0.1 OUTLIER -95.47 169.23 10.2 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -177.028 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.406 ' CG ' ' HB3' ' A' ' 198' ' ' LEU . 24.7 mtm105 -65.5 -44.46 86.98 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.977 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.16 60.59 5.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.128 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.49 ' O ' HD12 ' A' ' 195' ' ' ILE . 23.8 m -149.98 161.49 42.22 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.682 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 13.5 mttt -91.46 -169.72 2.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.077 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.552 HG22 ' CA ' ' A' ' 194' ' ' GLU . 1.2 m -150.34 158.1 5.58 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.451 0 CA-C-O 121.235 0.541 . . . . 0.0 111.633 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . 0.632 ' NH1' HD11 ' A' ' 184' ' ' ILE . 1.6 ttt85 -152.73 100.53 2.54 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.377 -0.829 . . . . 0.0 112.88 -179.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.673 HD12 ' HB3' ' A' ' 191' ' ' TYR . 0.3 OUTLIER -85.99 156.32 20.5 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-O 121.793 0.806 . . . . 0.0 113.149 -179.608 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.699 ' N ' HG23 ' A' ' 190' ' ' VAL . 28.4 mm -154.3 123.96 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 114.254 -1.339 . . . . 0.0 111.296 178.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.571 ' N ' HG22 ' A' ' 190' ' ' VAL . 0.2 OUTLIER -85.74 -150.85 0.14 Allowed 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 177.976 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.84 25.74 3.48 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 118.531 0.605 . . . . 0.0 110.81 178.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -155.03 -68.11 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.478 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -120.61 -156.68 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 115.327 -0.437 . . . . 0.0 110.901 -178.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.761 HG11 ' CG ' ' A' ' 192' ' ' GLU . 59.0 t -87.22 135.85 24.35 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-O 121.303 0.573 . . . . 0.0 111.506 -179.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.781 HG12 ' OD2' ' A' ' 223' ' ' ASP . 0.1 OUTLIER -89.37 -33.95 6.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.165 -0.925 . . . . 0.0 108.911 178.764 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . 0.673 ' HB3' HD12 ' A' ' 183' ' ' LEU . 15.8 t80 -162.71 159.31 24.14 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.45 178.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . 0.761 ' CG ' HG11 ' A' ' 189' ' ' VAL . 19.8 mt-10 -150.17 158.08 43.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.862 178.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 133.02 -119.49 2.39 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.24 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 0.552 ' CA ' HG22 ' A' ' 181' ' ' VAL . 12.2 pt-20 -150.61 -175.17 5.0 Favored 'General case' 0 CA--C 1.5 -0.971 0 CA-C-O 121.179 0.514 . . . . 0.0 111.345 -179.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.49 HD12 ' O ' ' A' ' 179' ' ' SER . 4.9 mp -88.86 143.76 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.409 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' ASP . . . . . 0.57 ' HB3' HG23 ' A' ' 217' ' ' THR . 0.6 OUTLIER -88.91 -53.9 4.38 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.5 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -151.72 142.71 23.08 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.783 179.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.781 ' CD1' HD22 ' A' ' 216' ' ' LEU . 32.3 tp -115.73 117.51 30.44 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 121.466 0.65 . . . . 0.0 111.922 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 25.6 mttt -150.36 120.94 7.45 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.952 179.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 4.5 ttm180 -87.96 -157.99 0.44 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.991 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 33.9 p90 -86.44 -16.02 38.44 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.606 0.241 . . . . 0.0 110.919 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.51 -60.77 1.64 Allowed 'General case' 0 N--CA 1.441 -0.898 0 CA-C-O 120.594 0.235 . . . . 0.0 110.973 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.86 -164.52 1.96 Allowed 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 120.808 0.337 . . . . 0.0 110.983 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . 0.412 ' HA ' ' HA ' ' A' ' 199' ' ' LYS . 7.2 p-10 -89.68 73.16 7.68 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.061 179.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 28.3 m -60.96 157.77 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.884 0 CA-C-O 121.596 0.712 . . . . 0.0 112.376 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . 0.47 ' O ' ' HB ' ' A' ' 176' ' ' THR . 0.1 OUTLIER -89.31 -35.26 16.22 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 114.616 -1.175 . . . . 0.0 111.454 -178.741 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.707 ' HB3' HG22 ' A' ' 176' ' ' THR . 2.2 mp0 -144.32 178.49 7.88 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.9 0.381 . . . . 0.0 110.878 179.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.716 ' O ' HG21 ' A' ' 170' ' ' VAL . 1.3 t -150.93 77.0 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.109 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.779 ' HB2' ' HG2' ' A' ' 174' ' ' LYS . . . -96.85 170.84 8.89 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -178.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 85.77 -75.5 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.233 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 177.89 37.15 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.334 -0.936 . . . . 0.0 112.432 179.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -95.27 150.03 20.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.901 0.381 . . . . 0.0 111.333 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -89.76 159.53 17.0 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.215 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 5.1 p -150.71 -175.48 5.13 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.265 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . 0.448 ' C ' HG23 ' A' ' 165' ' ' ILE . . . -144.02 96.97 0.19 Allowed Glycine 0 N--CA 1.451 -0.335 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 179.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.781 HD22 ' CD1' ' A' ' 198' ' ' LEU . 0.4 OUTLIER -131.71 142.01 49.7 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 120.932 0.396 . . . . 0.0 111.992 -178.367 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . 0.57 HG23 ' HB3' ' A' ' 196' ' ' ASP . 0.1 OUTLIER -79.14 132.98 36.74 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 176.877 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . 0.578 HG22 ' O ' ' A' ' 218' ' ' ILE . 1.4 mp -98.35 97.49 6.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.459 -177.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 6.5 tttp 42.5 -144.33 0.08 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.978 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -87.66 64.14 7.88 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 120.871 0.367 . . . . 0.0 110.738 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.646 ' CZ ' HD13 ' A' ' 183' ' ' LEU . 0.1 OUTLIER -54.81 118.51 4.31 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 179.075 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -82.76 -43.82 16.31 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 114.691 -1.14 . . . . 0.0 108.548 176.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . 0.781 ' OD2' HG12 ' A' ' 190' ' ' VAL . 0.0 OUTLIER -89.57 130.7 35.85 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 178.171 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.617 HD13 ' H ' ' A' ' 224' ' ' ILE . 0.2 OUTLIER -114.96 175.89 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 CA-C-O 121.263 0.554 . . . . 0.0 111.511 179.562 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.469 ' O ' ' N ' ' A' ' 227' ' ' GLY . 5.9 mtmt 63.53 147.74 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.84 -1.073 . . . . 0.0 108.992 -178.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . 0.554 ' HB3' ' O ' ' A' ' 154' ' ' ARG . 3.3 pt-20 -36.58 87.98 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.931 0.872 . . . . 0.0 112.855 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 225' ' ' LYS . . . -81.46 -57.62 2.73 Favored Glycine 0 N--CA 1.427 -1.902 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.873 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.447 ' O ' HG12 ' A' ' 153' ' ' VAL . 1.0 OUTLIER -163.71 -146.91 0.11 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 179.365 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . 0.504 HG22 ' CD ' ' A' ' 152' ' ' GLU . 61.6 t -93.64 147.4 5.54 Favored 'Isoleucine or valine' 0 C--N 1.342 0.278 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.62 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . 0.409 HG13 ' HG ' ' A' ' 183' ' ' LEU . 2.8 mp -118.6 154.58 20.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.187 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' GLU . . . . . 0.46 ' HA ' ' HA ' ' A' ' 150' ' ' GLN . 10.2 tt0 -142.49 112.26 6.85 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.421 0.629 . . . . 0.0 111.965 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.551 ' HB3' ' CA ' ' A' ' 149' ' ' GLY . . . -86.9 129.81 34.72 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.195 178.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' TYR . . . . . 0.61 ' C ' HD12 ' A' ' 148' ' ' ILE . 6.0 p90 -130.2 144.0 51.11 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.289 -178.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.666 HG12 HG13 ' A' ' 148' ' ' ILE . 0.3 OUTLIER 178.46 -169.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.674 179.399 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' MET . . . . . 0.616 ' N ' HG13 ' A' ' 234' ' ' VAL . 0.8 OUTLIER -96.96 -162.85 0.99 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.068 179.209 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 29.2 mm100 -89.23 77.01 7.56 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.142 0.496 . . . . 0.0 110.784 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . 0.824 ' O ' ' HB3' ' A' ' 241' ' ' ALA . 59.3 mt-10 -150.61 40.16 0.74 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.142 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.433 ' O ' ' HB3' ' A' ' 239' ' ' ALA . 0.8 OUTLIER -104.46 163.44 4.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.014 179.751 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' A' ' 238' ' ' VAL . . . 71.25 -62.38 0.46 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.271 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.23 -3.76 58.44 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . 0.824 ' HB3' ' O ' ' A' ' 237' ' ' GLU . . . . . . . . 0 C--N 1.312 -1.05 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.041 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.868 0.366 . . . . 0.0 111.15 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -75.18 -168.5 0.79 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.928 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -89.64 50.87 1.97 Allowed 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.236 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 2.8 tttp -71.35 -168.05 0.29 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.548 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.81 HG11 ' HB2' ' A' ' 150' ' ' GLN . 14.4 t -61.72 139.27 20.93 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.628 0 CA-C-O 121.357 0.599 . . . . 0.0 111.226 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.727 HG21 HG12 ' A' ' 234' ' ' VAL . 1.1 pt -117.64 -11.87 11.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.145 178.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.527 ' O ' ' HB3' ' A' ' 232' ' ' ALA . . . -177.64 77.91 0.07 OUTLIER Glycine 0 C--N 1.34 0.799 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.81 ' HB2' HG11 ' A' ' 147' ' ' VAL . 0.7 OUTLIER -91.29 137.94 31.97 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 120.704 0.288 . . . . 0.0 110.56 -179.65 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.468 ' O ' HG13 ' A' ' 229' ' ' VAL . . . -152.01 178.13 9.75 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -178.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.724 ' HG2' HG22 ' A' ' 229' ' ' VAL . 40.4 mt-10 -124.34 124.93 43.45 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.334 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.543 ' HB ' HD11 ' A' ' 230' ' ' ILE . 2.2 p -51.04 133.84 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.403 ' HD2' ' HB2' ' A' ' 169' ' ' TYR . 4.2 mmp_? -89.52 -63.39 1.29 Allowed 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 104.943 -2.243 . . . . 0.0 104.943 175.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.418 ' HA ' ' H ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER -162.4 -162.29 0.8 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 113.664 -1.607 . . . . 0.0 108.839 174.721 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 4.9 p -147.19 143.95 28.58 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 177.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.527 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 0.4 OUTLIER -89.96 83.51 6.13 Favored 'General case' 0 CA--C 1.51 -0.583 0 N-CA-C 113.969 1.099 . . . . 0.0 113.969 -177.598 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 10.2 tttp -86.82 62.18 7.24 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 177.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.518 HG12 ' N ' ' A' ' 161' ' ' LYS . 40.9 t -93.32 156.02 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 CA-C-N 113.694 -1.593 . . . . 0.0 110.306 -178.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 12.4 t -90.15 35.68 0.86 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.13 0.491 . . . . 0.0 109.954 178.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.518 ' N ' HG12 ' A' ' 159' ' ' VAL . 0.9 OUTLIER -150.41 -32.4 0.18 Allowed 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.343 -179.671 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.523 HG12 ' N ' ' A' ' 163' ' ' GLY . 93.5 t -102.85 -103.23 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.226 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . 0.523 ' N ' HG12 ' A' ' 162' ' ' VAL . . . -159.07 -99.07 0.15 Allowed Glycine 0 N--CA 1.452 -0.25 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 178.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 1.118 HG21 HG21 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -153.49 34.65 0.45 Allowed 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.282 1.033 . . . . 0.0 108.275 177.72 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.529 HG22 ' O ' ' A' ' 165' ' ' ILE . 1.1 mm -40.86 98.11 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.587 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.672 ' HB3' HD13 ' A' ' 218' ' ' ILE . . . -85.78 119.47 26.13 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.914 -1.039 . . . . 0.0 112.368 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -88.32 151.65 22.86 Favored Glycine 0 N--CA 1.443 -0.892 0 N-CA-C 110.159 -1.176 . . . . 0.0 110.159 178.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.55 ' HB3' HD13 ' A' ' 230' ' ' ILE . 0.0 OUTLIER -145.62 133.74 21.56 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 117.181 0.491 . . . . 0.0 110.724 -178.563 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . 0.432 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 10.9 t80 -87.33 127.33 35.19 Favored 'General case' 0 C--O 1.221 -0.429 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 177.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.812 HG21 ' O ' ' A' ' 208' ' ' VAL . 44.2 t -85.23 143.29 11.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -176.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -135.99 15.35 3.3 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 114.563 -1.199 . . . . 0.0 111.99 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -150.07 -146.42 0.2 Allowed 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -42.7 -105.11 0.01 OUTLIER Glycine 0 CA--C 1.531 1.071 0 N-CA-C 114.986 0.754 . . . . 0.0 114.986 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.745 ' HG3' ' HB2' ' A' ' 209' ' ' ALA . 0.0 OUTLIER -151.05 135.56 17.04 Favored 'General case' 0 CA--C 1.513 -0.465 0 O-C-N 122.637 -0.331 . . . . 0.0 111.207 -178.864 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.61 ' CG2' HG23 ' A' ' 208' ' ' VAL . 0.5 OUTLIER -95.51 112.13 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 176.909 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.48 ' HB ' ' O ' ' A' ' 206' ' ' ARG . 0.1 OUTLIER -120.93 169.12 10.77 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.468 0.652 . . . . 0.0 112.219 -176.8 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.92 -43.58 98.41 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.931 179.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -89.73 61.16 5.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.964 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.702 ' HB3' HD11 ' A' ' 148' ' ' ILE . 57.9 m -148.06 159.23 44.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.819 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 0.0 OUTLIER -89.08 -176.95 5.31 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.344 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.886 ' CG1' HD12 ' A' ' 195' ' ' ILE . 1.4 m -146.15 156.75 12.06 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 CA-C-O 121.466 0.65 . . . . 0.0 112.278 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . 0.436 ' N ' ' O ' ' A' ' 231' ' ' GLU . 4.1 ttt180 -153.49 102.65 2.59 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.081 -0.963 . . . . 0.0 113.051 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.738 HD13 ' CZ ' ' A' ' 221' ' ' PHE . 0.3 OUTLIER -86.03 159.55 19.56 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-O 122.143 0.973 . . . . 0.0 113.255 -179.758 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.531 ' N ' HG23 ' A' ' 190' ' ' VAL . 16.2 mt -153.82 122.59 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 113.838 -1.528 . . . . 0.0 112.311 178.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.431 ' N ' HG22 ' A' ' 190' ' ' VAL . 0.2 OUTLIER -87.05 -147.93 0.14 Allowed 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 177.848 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 21.0 mm100 -95.47 27.36 3.41 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 118.651 0.659 . . . . 0.0 110.745 178.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.419 ' C ' HD13 ' A' ' 188' ' ' ILE . . . -154.57 -80.24 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.755 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.419 HD13 ' C ' ' A' ' 187' ' ' GLY . 0.3 OUTLIER -112.41 -155.37 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 115.342 -0.429 . . . . 0.0 110.716 -179.107 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.777 HG11 ' CG ' ' A' ' 192' ' ' GLU . 41.2 t -87.04 135.62 24.8 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.096 0 CA-C-O 121.45 0.643 . . . . 0.0 111.576 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.897 HG12 ' OD2' ' A' ' 223' ' ' ASP . 0.2 OUTLIER -89.88 -32.25 5.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.203 178.687 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . 0.698 ' HB3' HD12 ' A' ' 183' ' ' LEU . 17.4 t80 -160.06 158.35 30.26 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.496 178.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . 0.777 ' CG ' HG11 ' A' ' 189' ' ' VAL . 22.3 mt-10 -150.81 154.05 36.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.072 178.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 135.29 -119.75 2.18 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.054 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 0.624 ' CA ' HG22 ' A' ' 181' ' ' VAL . 0.0 OUTLIER -148.43 -178.47 6.34 Favored 'General case' 0 CA--C 1.501 -0.904 0 CA-C-O 121.523 0.678 . . . . 0.0 111.663 -179.446 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.886 HD12 ' CG1' ' A' ' 181' ' ' VAL . 0.0 OUTLIER -88.75 147.77 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 CA-C-N 114.64 -1.163 . . . . 0.0 110.257 -178.674 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.68 -54.68 3.96 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 179.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 64.2 p -150.93 160.05 44.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.5 179.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.895 ' CD1' HD22 ' A' ' 216' ' ' LEU . 27.2 tp -133.44 110.71 10.18 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.384 0.611 . . . . 0.0 111.205 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 9.7 ptmt -149.8 123.89 9.44 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.414 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 2.6 ttm-85 -87.98 -160.17 0.6 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.896 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -87.1 -12.21 47.82 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.46 0.172 . . . . 0.0 110.988 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.03 -59.13 1.91 Allowed 'General case' 0 N--CA 1.441 -0.916 0 CA-C-O 120.651 0.263 . . . . 0.0 110.876 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -152.49 -174.79 5.02 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 120.88 0.371 . . . . 0.0 111.171 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -89.98 66.61 6.9 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.239 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 33.3 m -58.68 161.3 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.949 0 CA-C-O 121.55 0.69 . . . . 0.0 112.21 -179.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . 0.48 ' O ' ' HB ' ' A' ' 176' ' ' THR . 4.4 ttp180 -89.39 -38.17 14.31 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 114.625 -1.17 . . . . 0.0 111.461 -178.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.421 ' OE2' ' HB2' ' A' ' 239' ' ' ALA . 4.1 mt-10 -138.01 177.06 8.16 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.132 0.492 . . . . 0.0 111.332 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.812 ' O ' HG21 ' A' ' 170' ' ' VAL . 0.0 OUTLIER -151.05 81.78 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.544 178.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.745 ' HB2' ' HG3' ' A' ' 174' ' ' LYS . . . -101.7 172.52 6.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.102 0.477 . . . . 0.0 112.281 -178.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 2.8 tp-100 83.9 -72.98 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.983 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 178.09 37.95 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.371 -0.918 . . . . 0.0 112.44 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -97.99 143.22 28.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.979 0.419 . . . . 0.0 111.471 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -89.63 158.13 17.73 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.352 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -150.48 -171.09 3.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.015 0.436 . . . . 0.0 111.289 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -137.98 106.36 0.53 Allowed Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 178.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.895 HD22 ' CD1' ' A' ' 198' ' ' LEU . 0.1 OUTLIER -135.17 147.84 49.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.452 0.644 . . . . 0.0 112.602 -177.377 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . 0.485 ' C ' HD12 ' A' ' 218' ' ' ILE . 0.0 OUTLIER -87.31 142.77 27.64 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 177.355 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . 0.672 HD13 ' HB3' ' A' ' 166' ' ' ALA . 1.5 mp -100.52 81.11 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.915 0.388 . . . . 0.0 110.817 -178.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 4.0 ttpt 42.34 -88.94 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.721 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . 0.401 ' N ' ' O ' ' A' ' 218' ' ' ILE . 13.0 t-20 -132.6 62.59 1.65 Allowed 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.118 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.738 ' CZ ' HD13 ' A' ' 183' ' ' LEU . 0.1 OUTLIER -59.23 119.55 7.58 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 179.443 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -81.58 -42.51 19.99 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 175.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . 0.897 ' OD2' HG12 ' A' ' 190' ' ' VAL . 0.0 OUTLIER -92.81 143.44 26.28 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.339 177.693 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 1.118 HG21 HG21 ' A' ' 164' ' ' THR . 0.2 OUTLIER -135.94 178.14 5.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -179.183 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.412 ' O ' ' C ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER 57.68 119.31 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 114.543 -1.208 . . . . 0.0 110.009 -178.953 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . 0.453 ' HA ' ' CG1' ' A' ' 153' ' ' VAL . 5.3 tt0 5.95 65.81 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 124.455 1.102 . . . . 0.0 113.62 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -66.34 -63.74 3.76 Favored Glycine 0 N--CA 1.429 -1.802 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.236 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.441 ' O ' ' HB ' ' A' ' 153' ' ' VAL . 1.0 OUTLIER -165.05 -147.17 0.1 Allowed 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 179.259 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . 0.724 HG22 ' HG2' ' A' ' 152' ' ' GLU . 52.6 t -89.8 146.92 5.59 Favored 'Isoleucine or valine' 0 C--N 1.34 0.181 0 CA-C-N 116.71 -0.223 . . . . 0.0 110.412 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . 0.55 HD13 ' HB3' ' A' ' 168' ' ' CYS . 4.4 mp -116.63 153.57 18.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.024 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' GLU . . . . . 0.436 ' O ' ' N ' ' A' ' 182' ' ' ARG . 0.1 OUTLIER -142.09 110.74 6.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.281 0.562 . . . . 0.0 111.949 -179.052 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.527 ' HB3' ' O ' ' A' ' 149' ' ' GLY . . . -87.93 127.97 35.37 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.312 178.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -129.3 139.41 51.78 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.349 -178.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.727 HG12 HG21 ' A' ' 148' ' ' ILE . 0.5 OUTLIER -177.56 -175.6 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.881 179.625 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' MET . . . . . 0.507 ' H ' HG22 ' A' ' 234' ' ' VAL . 1.3 mtm -89.13 -163.51 1.0 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.634 0.254 . . . . 0.0 110.709 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -90.22 66.64 6.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.433 0.635 . . . . 0.0 110.707 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . 0.725 ' O ' ' HB2' ' A' ' 241' ' ' ALA . 2.2 tt0 -150.97 56.28 0.9 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.091 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.457 ' O ' ' HB3' ' A' ' 239' ' ' ALA . 0.0 OUTLIER -109.51 174.85 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.793 179.607 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' A' ' 238' ' ' VAL . . . 73.13 -61.05 0.52 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.44 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.34 -5.09 57.79 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . 0.725 ' HB2' ' O ' ' A' ' 237' ' ' GLU . . . . . . . . 0 C--N 1.313 -0.984 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.043 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.772 0.32 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 63.34 127.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.088 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -95.16 39.21 1.12 Allowed 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.26 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 5.3 mmtm -112.55 -82.95 0.59 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.605 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 11.9 t -102.46 137.22 31.26 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.712 0 CA-C-O 121.36 0.6 . . . . 0.0 110.988 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.598 HG21 HG12 ' A' ' 234' ' ' VAL . 2.7 pp -131.9 6.85 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.245 178.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.547 ' CA ' ' HB3' ' A' ' 232' ' ' ALA . . . 171.77 73.91 0.04 OUTLIER Glycine 0 C--N 1.341 0.841 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.125 179.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.486 ' HA ' ' HA ' ' A' ' 231' ' ' GLU . 0.5 OUTLIER -93.04 132.09 37.46 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 122.551 -0.381 . . . . 0.0 110.613 -179.683 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.483 ' O ' HG13 ' A' ' 229' ' ' VAL . . . -151.22 172.92 15.08 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 121.377 0.608 . . . . 0.0 112.564 -178.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.43 ' HA ' ' HA ' ' A' ' 229' ' ' VAL . 1.8 mm-40 -121.6 126.21 48.54 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.438 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.48 ' CG1' ' HA ' ' A' ' 226' ' ' GLU . 1.9 p -52.39 131.32 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-O 121.344 0.592 . . . . 0.0 112.309 -179.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.497 ' O ' ' HB3' ' A' ' 226' ' ' GLU . 0.0 OUTLIER -90.47 -60.34 1.95 Allowed 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 105.142 -2.17 . . . . 0.0 105.142 175.444 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.49 -159.88 0.49 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 114.206 -1.361 . . . . 0.0 109.915 174.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.547 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 12.7 p -150.13 148.2 28.68 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.574 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 0.2 OUTLIER -90.72 82.47 5.75 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -177.723 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.401 ' CD ' HG13 ' A' ' 224' ' ' ILE . 1.6 tttt -86.44 62.29 7.33 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 177.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.478 HG12 ' N ' ' A' ' 161' ' ' LYS . 54.0 t -91.28 156.08 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 CA-C-N 113.771 -1.559 . . . . 0.0 110.059 -178.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 80.0 p -90.41 34.2 0.88 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.122 0.487 . . . . 0.0 110.161 178.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.478 ' N ' HG12 ' A' ' 159' ' ' VAL . 0.0 OUTLIER -150.75 -32.32 0.17 Allowed 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.471 -179.862 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.494 HG12 ' N ' ' A' ' 163' ' ' GLY . 87.4 t -100.17 -102.68 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.15 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . 0.494 ' N ' HG12 ' A' ' 162' ' ' VAL . . . -159.28 -101.51 0.17 Allowed Glycine 0 N--CA 1.451 -0.344 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 178.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 1.039 HG21 HG21 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -153.5 36.46 0.46 Allowed 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 177.822 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.696 HD12 ' O ' ' A' ' 215' ' ' GLY . 0.9 OUTLIER -42.31 95.3 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.26 -179.416 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.877 ' O ' HD12 ' A' ' 216' ' ' LEU . . . -82.08 118.68 23.22 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 114.495 -1.229 . . . . 0.0 112.482 -178.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -91.22 143.99 16.94 Favored Glycine 0 N--CA 1.442 -0.965 0 N-CA-C 111.001 -0.839 . . . . 0.0 111.001 178.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.656 ' SG ' HD11 ' A' ' 216' ' ' LEU . 0.0 OUTLIER -137.73 132.95 33.56 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 -179.728 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . 0.432 ' HB2' ' HD3' ' A' ' 154' ' ' ARG . 7.4 t80 -85.03 128.16 34.51 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 178.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.581 HG21 ' O ' ' A' ' 208' ' ' VAL . 44.4 t -85.96 147.79 5.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -176.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.6 p -140.78 14.83 2.31 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-N 114.474 -1.239 . . . . 0.0 111.841 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.406 ' CB ' ' HB2' ' A' ' 150' ' ' GLN . 11.3 t0 -150.8 -144.46 0.15 Allowed 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 -179.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -40.15 -104.22 0.01 OUTLIER Glycine 0 CA--C 1.532 1.11 0 N-CA-C 115.209 0.844 . . . . 0.0 115.209 -179.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.671 ' HG2' ' HB2' ' A' ' 209' ' ' ALA . 20.2 mttp -151.13 134.73 16.33 Favored 'General case' 0 CA--C 1.514 -0.427 0 O-C-N 122.517 -0.402 . . . . 0.0 111.839 -178.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.839 ' CG2' HD21 ' A' ' 216' ' ' LEU . 4.6 mm -91.2 83.87 2.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 176.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.967 HG21 HG12 ' A' ' 238' ' ' VAL . 0.0 OUTLIER -98.62 -178.16 3.9 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -176.704 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.59 -45.59 21.33 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-N 114.854 -1.066 . . . . 0.0 111.166 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -88.67 61.39 6.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.393 0.616 . . . . 0.0 110.338 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.533 ' HB3' HD11 ' A' ' 148' ' ' ILE . 16.4 m -149.32 157.74 43.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.986 -179.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 1.7 mptt -89.06 -178.17 5.62 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.655 HG22 ' CA ' ' A' ' 194' ' ' GLU . 1.9 m -142.71 161.79 18.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.336 0.589 . . . . 0.0 111.845 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . 0.428 ' N ' ' O ' ' A' ' 231' ' ' GLU . 15.1 ttt180 -151.74 98.95 2.54 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.113 -0.948 . . . . 0.0 112.323 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.89 HD13 ' HB3' ' A' ' 191' ' ' TYR . 5.4 mp -89.08 146.14 25.02 Favored 'General case' 0 CA--C 1.497 -1.09 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -178.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.465 ' CA ' HG23 ' A' ' 190' ' ' VAL . 17.8 mt -156.57 128.18 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-N 113.168 -1.833 . . . . 0.0 111.772 179.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.403 ' N ' ' CG2' ' A' ' 190' ' ' VAL . 0.1 OUTLIER -88.87 -148.44 0.17 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 177.943 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -94.94 29.69 2.32 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 118.604 0.638 . . . . 0.0 110.998 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -153.6 -83.34 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.869 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.47 ' H ' HD12 ' A' ' 188' ' ' ILE . 0.1 OUTLIER -111.6 -158.7 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 CA-C-N 115.455 -0.372 . . . . 0.0 110.621 -179.252 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.536 HG11 ' CG ' ' A' ' 192' ' ' GLU . 43.4 t -87.13 134.85 26.58 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 CA-C-O 121.68 0.752 . . . . 0.0 110.992 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.895 HG12 ' OD2' ' A' ' 223' ' ' ASP . 0.2 OUTLIER -94.79 -34.84 5.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 114.416 -1.265 . . . . 0.0 109.525 -179.909 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . 0.89 ' HB3' HD13 ' A' ' 183' ' ' LEU . 27.0 t80 -170.1 156.14 5.82 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.102 -0.953 . . . . 0.0 112.446 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . 0.536 ' CG ' HG11 ' A' ' 189' ' ' VAL . 32.2 mt-10 -151.13 162.12 41.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.634 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 134.76 -114.88 1.33 Allowed Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.558 -0.829 . . . . 0.0 112.343 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 0.655 ' CA ' HG22 ' A' ' 181' ' ' VAL . 0.0 OUTLIER -150.47 -178.43 6.53 Favored 'General case' 0 CA--C 1.503 -0.865 0 CA-C-O 121.323 0.583 . . . . 0.0 110.901 -179.407 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.683 ' CD1' HD22 ' A' ' 216' ' ' LEU . 0.0 OUTLIER -89.76 154.65 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.921 -179.431 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' ASP . . . . . 0.402 ' HB3' ' CB ' ' A' ' 217' ' ' THR . 26.3 t70 -89.8 -66.79 0.89 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 178.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -151.63 146.72 26.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.248 179.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.853 ' HG ' HD23 ' A' ' 216' ' ' LEU . 2.4 tt -110.96 119.52 39.34 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.519 0.676 . . . . 0.0 112.487 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . 0.558 ' N ' HD23 ' A' ' 198' ' ' LEU . 0.7 OUTLIER -151.55 116.52 5.22 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.491 178.55 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -88.06 -159.71 0.56 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -87.95 13.0 11.82 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.35 -62.11 1.46 Allowed 'General case' 0 N--CA 1.438 -1.04 0 CA-C-O 120.943 0.402 . . . . 0.0 110.384 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -151.97 -172.79 4.33 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.763 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -90.72 71.86 6.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.417 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 34.2 m -66.14 162.39 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.958 0 CA-C-O 121.414 0.626 . . . . 0.0 112.062 -179.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . 0.468 ' O ' ' HB ' ' A' ' 176' ' ' THR . 5.3 mtp180 -89.15 -37.32 15.14 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.565 -178.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.706 ' HB3' HG22 ' A' ' 176' ' ' THR . 0.5 OUTLIER -141.38 178.35 7.49 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.27 0.557 . . . . 0.0 111.746 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.581 ' O ' HG21 ' A' ' 170' ' ' VAL . 0.0 OUTLIER -151.05 80.59 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.588 179.034 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.671 ' HB2' ' HG2' ' A' ' 174' ' ' LYS . . . -96.47 172.02 8.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.072 0.463 . . . . 0.0 112.038 -178.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 84.83 -73.88 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.055 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 177.87 37.34 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.29 -0.957 . . . . 0.0 112.623 179.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -99.51 145.23 27.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.939 0.399 . . . . 0.0 111.568 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -89.77 161.38 16.06 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.528 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 27.1 p -150.55 -170.03 3.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.967 0.413 . . . . 0.0 111.209 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . 0.696 ' O ' HD12 ' A' ' 165' ' ' ILE . . . -139.74 98.68 0.24 Allowed Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 179.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.877 HD12 ' O ' ' A' ' 166' ' ' ALA . 0.2 OUTLIER -129.3 151.11 50.32 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 121.06 0.457 . . . . 0.0 110.782 -178.997 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . 0.402 ' CB ' ' HB3' ' A' ' 196' ' ' ASP . 0.0 OUTLIER -87.91 141.06 28.88 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 177.294 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . 0.606 HG22 ' O ' ' A' ' 218' ' ' ILE . 16.6 mm -98.2 74.39 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.77 -178.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 46.43 -136.0 0.8 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.295 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -87.03 58.07 4.86 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 120.793 0.33 . . . . 0.0 111.609 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.767 ' CZ ' HD22 ' A' ' 183' ' ' LEU . 0.1 OUTLIER -56.25 120.0 6.88 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 178.1 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -80.01 -45.23 18.76 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 176.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . 0.895 ' OD2' HG12 ' A' ' 190' ' ' VAL . 0.0 OUTLIER -91.35 131.44 36.84 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.761 178.109 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 1.039 HG21 HG21 ' A' ' 164' ' ' THR . 0.1 OUTLIER -121.29 177.61 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-O 121.17 0.51 . . . . 0.0 111.929 -179.877 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.473 ' O ' ' N ' ' A' ' 227' ' ' GLY . 2.3 mtpp 62.92 152.32 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.136 -178.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . 0.497 ' HB3' ' O ' ' A' ' 154' ' ' ARG . 0.4 OUTLIER -38.45 90.14 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 CA-C-O 122.186 0.993 . . . . 0.0 112.258 -179.947 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 225' ' ' LYS . . . -106.45 -39.28 2.1 Favored Glycine 0 N--CA 1.43 -1.741 0 CA-C-N 114.429 -1.26 . . . . 0.0 112.152 -178.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.738 ' CB ' HG21 ' A' ' 190' ' ' VAL . 2.9 p30 -158.23 -164.85 1.57 Allowed 'General case' 0 C--O 1.22 -0.466 0 N-CA-C 115.292 1.59 . . . . 0.0 115.292 -178.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . 0.483 HG13 ' O ' ' A' ' 151' ' ' ALA . 89.3 t -102.25 144.66 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 177.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . 0.402 HG13 ' HG ' ' A' ' 183' ' ' LEU . 3.7 mp -114.79 153.61 16.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.217 0.532 . . . . 0.0 112.103 -178.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' GLU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 150' ' ' GLN . 20.3 tt0 -140.85 111.88 7.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.374 0.606 . . . . 0.0 111.476 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.547 ' HB3' ' CA ' ' A' ' 149' ' ' GLY . . . -87.78 128.7 35.32 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.896 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -130.81 142.81 50.41 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.916 -179.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.598 HG12 HG21 ' A' ' 148' ' ' ILE . 0.3 OUTLIER -178.12 -177.36 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.111 -179.762 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' MET . . . . . 0.508 ' H ' HG22 ' A' ' 234' ' ' VAL . 0.7 OUTLIER -89.7 -157.71 0.48 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.976 179.33 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -88.26 70.82 9.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.442 0.639 . . . . 0.0 110.819 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -150.66 58.73 0.94 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.544 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.967 HG12 HG21 ' A' ' 176' ' ' THR . 0.2 OUTLIER -92.44 -164.35 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.727 -179.438 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . 0.454 ' HB2' ' HG3' ' A' ' 207' ' ' GLU . . . -49.62 -71.77 0.06 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.028 0.442 . . . . 0.0 111.243 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -89.83 -6.47 55.85 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.036 179.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.316 -0.85 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.168 179.961 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.819 0.342 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -119.66 119.59 34.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.972 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.83 36.03 1.46 Allowed 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.187 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 5.9 mmtm -147.48 -80.39 0.14 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.243 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 18.9 t -97.39 136.91 26.56 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.631 0 CA-C-O 121.17 0.509 . . . . 0.0 110.527 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.601 HG21 ' O ' ' A' ' 234' ' ' VAL . 2.7 pp -128.94 6.31 2.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.326 178.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.569 ' CA ' ' HB3' ' A' ' 232' ' ' ALA . . . 171.21 75.43 0.04 OUTLIER Glycine 0 C--N 1.341 0.843 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.003 179.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.462 ' HA ' ' HA ' ' A' ' 231' ' ' GLU . 0.7 OUTLIER -95.14 130.3 41.9 Favored 'General case' 0 CA--C 1.517 -0.317 0 O-C-N 122.551 -0.382 . . . . 0.0 110.419 -179.826 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.475 ' O ' HG13 ' A' ' 229' ' ' VAL . . . -151.04 171.21 17.69 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 120.32 -0.552 . . . . 0.0 112.25 -178.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 229' ' ' VAL . 1.6 mm-40 -119.01 128.0 53.97 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.536 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.489 ' CG1' ' HA ' ' A' ' 226' ' ' GLU . 2.0 p -49.65 142.61 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -178.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -100.77 -63.01 1.17 Allowed 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 104.379 -2.452 . . . . 0.0 104.379 174.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.92 -165.65 1.29 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 113.735 -1.575 . . . . 0.0 109.368 174.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.525 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 8.1 p -147.11 163.29 36.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.553 0.216 . . . . 0.0 110.425 177.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.549 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 0.2 OUTLIER -115.48 76.26 0.99 Allowed 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -179.475 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.876 ' CB ' HD13 ' A' ' 224' ' ' ILE . 7.2 tmtm? -86.27 62.97 7.75 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 177.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.403 HG12 ' N ' ' A' ' 161' ' ' LYS . 98.3 t -92.94 158.59 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 CA-C-N 113.589 -1.642 . . . . 0.0 110.538 -178.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 19.7 m -93.28 34.57 1.13 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.317 0.58 . . . . 0.0 109.552 177.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.403 ' N ' HG12 ' A' ' 159' ' ' VAL . 1.1 mtpt -151.49 -34.77 0.14 Allowed 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.164 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.76 ' CG1' HD12 ' A' ' 165' ' ' ILE . 86.0 t -97.65 -102.7 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 N-CA-C 109.703 -0.481 . . . . 0.0 109.703 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . 0.505 ' N ' HG12 ' A' ' 162' ' ' VAL . . . -159.46 -102.47 0.18 Allowed Glycine 0 N--CA 1.451 -0.326 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 178.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.532 ' CG2' HG21 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -154.21 32.61 0.43 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 113.976 -1.112 . . . . 0.0 108.543 177.611 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.76 HD12 ' CG1' ' A' ' 162' ' ' VAL . 1.8 mt -42.53 95.42 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.481 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.525 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . -90.45 122.94 33.75 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.82 -1.082 . . . . 0.0 112.052 -179.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -88.29 146.03 19.38 Favored Glycine 0 N--CA 1.44 -1.053 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 178.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.412 ' HB2' ' CB ' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -143.76 131.4 21.24 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 117.164 0.482 . . . . 0.0 110.072 -179.18 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . 0.41 ' O ' ' HA ' ' A' ' 151' ' ' ALA . 17.2 t80 -86.94 122.39 30.74 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 178.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.74 HG21 ' O ' ' A' ' 208' ' ' VAL . 38.7 t -85.38 145.17 8.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -176.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 2.0 p -138.19 14.92 2.82 Favored 'General case' 0 N--CA 1.457 -0.113 0 CA-C-N 114.662 -1.154 . . . . 0.0 111.912 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.408 ' H ' HG12 ' A' ' 170' ' ' VAL . 10.7 t0 -150.62 -144.36 0.15 Allowed 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -179.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -40.48 -105.52 0.01 OUTLIER Glycine 0 CA--C 1.532 1.103 0 N-CA-C 115.13 0.812 . . . . 0.0 115.13 -178.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.618 ' HG2' ' HB2' ' A' ' 209' ' ' ALA . 7.1 mttt -151.4 134.85 16.17 Favored 'General case' 0 CA--C 1.514 -0.417 0 O-C-N 122.526 -0.397 . . . . 0.0 111.957 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.674 ' O ' HD11 ' A' ' 198' ' ' LEU . 6.0 mm -91.81 83.23 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 176.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.78 ' O ' HD12 ' A' ' 195' ' ' ILE . 0.1 OUTLIER -98.59 176.22 5.73 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.54 0.686 . . . . 0.0 112.415 -177.557 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -71.58 -44.67 64.06 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.969 -1.014 . . . . 0.0 111.386 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -88.99 61.83 6.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.249 0.547 . . . . 0.0 110.756 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.42 ' HB3' HD11 ' A' ' 148' ' ' ILE . 20.3 m -150.09 157.95 43.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.048 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 2.1 mptt -88.68 177.27 6.79 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.661 HG22 ' CA ' ' A' ' 194' ' ' GLU . 2.0 m -141.68 163.71 19.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.399 0.619 . . . . 0.0 111.956 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . 0.43 ' N ' ' O ' ' A' ' 231' ' ' GLU . 7.4 ttt180 -151.51 100.09 2.68 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.037 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.852 HD13 ' HB3' ' A' ' 191' ' ' TYR . 5.4 mp -89.2 144.49 26.07 Favored 'General case' 0 CA--C 1.494 -1.184 0 CA-C-O 122.476 1.131 . . . . 0.0 113.868 -178.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.487 ' CA ' HG23 ' A' ' 190' ' ' VAL . 18.1 mt -156.65 129.28 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-N 113.007 -1.906 . . . . 0.0 111.754 179.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.413 ' N ' ' CG2' ' A' ' 190' ' ' VAL . 0.1 OUTLIER -88.54 -148.45 0.17 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.028 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -95.46 29.53 2.54 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 118.526 0.603 . . . . 0.0 110.818 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -153.23 -82.39 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.904 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -113.06 -158.26 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 115.519 -0.34 . . . . 0.0 110.704 -179.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.414 HG11 ' HG3' ' A' ' 192' ' ' GLU . 40.0 t -87.08 137.02 21.7 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 CA-C-O 121.741 0.781 . . . . 0.0 111.05 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.793 HG21 ' CB ' ' A' ' 228' ' ' ASP . 0.2 OUTLIER -98.88 -35.78 5.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 114.272 -1.331 . . . . 0.0 109.484 -179.462 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . 0.852 ' HB3' HD13 ' A' ' 183' ' ' LEU . 14.7 t80 -169.04 157.72 8.07 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.012 -0.994 . . . . 0.0 112.38 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . 0.414 ' HG3' HG11 ' A' ' 189' ' ' VAL . 60.9 mt-10 -151.5 162.06 41.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.748 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 135.38 -116.98 1.62 Allowed Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.169 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 0.661 ' CA ' HG22 ' A' ' 181' ' ' VAL . 17.0 pt-20 -149.98 -176.3 5.38 Favored 'General case' 0 CA--C 1.497 -1.085 0 CA-C-O 121.336 0.589 . . . . 0.0 111.432 -179.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.78 HD12 ' O ' ' A' ' 176' ' ' THR . 49.1 mt -89.43 146.99 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.352 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.552 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' ASP . . . . . 0.629 ' HB3' HG23 ' A' ' 217' ' ' THR . 0.5 OUTLIER -89.14 -59.87 2.11 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.87 0.366 . . . . 0.0 110.033 179.581 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 1.3 m -151.32 159.08 44.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.87 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.674 HD11 ' O ' ' A' ' 175' ' ' ILE . 0.2 OUTLIER -127.54 122.86 34.4 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 121.435 0.636 . . . . 0.0 112.093 -179.388 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 13.2 mtmm -150.61 118.15 6.11 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.96 179.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 7.5 ttp180 -88.15 -160.35 0.62 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.309 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -87.11 -13.92 42.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.775 -0.193 . . . . 0.0 110.889 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -97.18 -57.63 2.22 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-O 120.659 0.266 . . . . 0.0 111.024 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -152.46 -166.5 2.49 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 120.706 0.289 . . . . 0.0 110.854 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . 0.428 ' HA ' ' HA ' ' A' ' 199' ' ' LYS . 9.8 t70 -89.72 64.41 6.49 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 121.049 0.452 . . . . 0.0 110.209 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.482 HG23 ' CD2' ' A' ' 198' ' ' LEU . 32.6 m -57.71 158.62 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.961 0 CA-C-O 121.511 0.672 . . . . 0.0 112.179 -179.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . 0.426 ' O ' ' HA ' ' A' ' 176' ' ' THR . 1.7 ttp180 -89.44 -35.36 16.05 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 114.769 -1.105 . . . . 0.0 112.225 -178.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.48 ' HB3' HG22 ' A' ' 176' ' ' THR . 0.3 OUTLIER -140.11 177.55 7.9 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.343 0.592 . . . . 0.0 111.898 -179.456 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.74 ' O ' HG21 ' A' ' 170' ' ' VAL . 0.0 OUTLIER -151.07 77.86 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.167 178.517 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.618 ' HB2' ' HG2' ' A' ' 174' ' ' LYS . . . -98.55 174.35 6.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.168 0.508 . . . . 0.0 112.366 -178.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 81.75 -70.08 0.07 Allowed 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.867 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 178.2 37.23 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 120.431 -0.89 . . . . 0.0 112.248 179.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . 0.648 ' HB3' HG12 ' A' ' 208' ' ' VAL . 1.2 m-85 -104.11 140.49 37.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.966 0.412 . . . . 0.0 111.215 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -95.48 148.61 22.3 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.404 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' CYS . . . . . 0.519 ' HB3' HG21 ' A' ' 208' ' ' VAL . 45.5 t -150.51 146.14 26.42 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.371 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -88.11 112.49 3.89 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.943 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.656 HD12 HD11 ' A' ' 218' ' ' ILE . 0.3 OUTLIER -138.56 143.3 39.36 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 120.864 0.364 . . . . 0.0 111.149 -179.139 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . 0.629 HG23 ' HB3' ' A' ' 196' ' ' ASP . 0.2 OUTLIER -83.48 142.42 30.95 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 177.951 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . 0.656 HD11 HD12 ' A' ' 216' ' ' LEU . 1.6 mp -106.84 92.36 2.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 -178.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 2.5 tttp 45.77 -146.98 0.13 Allowed 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.511 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 -87.54 62.46 7.11 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-O 120.857 0.36 . . . . 0.0 110.984 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.762 ' CZ ' HD22 ' A' ' 183' ' ' LEU . 0.1 OUTLIER -54.71 119.86 5.93 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 179.31 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -84.19 -47.6 10.67 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 114.771 -1.104 . . . . 0.0 108.368 176.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . 0.527 ' OD2' HG12 ' A' ' 190' ' ' VAL . 0.0 OUTLIER -84.78 130.27 34.7 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 178.026 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.876 HD13 ' CB ' ' A' ' 158' ' ' LYS . 1.2 pt -126.46 176.48 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -179.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.815 ' HG2' HD12 ' A' ' 224' ' ' ILE . 0.0 OUTLIER 61.12 129.47 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.102 -179.057 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . 0.489 ' HA ' ' CG1' ' A' ' 153' ' ' VAL . 3.6 tt0 -11.67 77.97 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 124.249 1.02 . . . . 0.0 113.341 -179.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 225' ' ' LYS . . . -98.26 -40.16 3.55 Favored Glycine 0 N--CA 1.43 -1.759 0 CA-C-N 114.564 -1.198 . . . . 0.0 112.626 -178.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.793 ' CB ' HG21 ' A' ' 190' ' ' VAL . 2.7 p30 -159.03 -160.98 0.9 Allowed 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 115.375 1.62 . . . . 0.0 115.375 -177.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . 0.475 HG13 ' O ' ' A' ' 151' ' ' ALA . 91.9 t -108.3 143.88 17.9 Favored 'Isoleucine or valine' 0 C--N 1.343 0.292 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 177.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 3.7 mp -111.43 153.32 13.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.252 0.548 . . . . 0.0 112.097 -178.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' GLU . . . . . 0.462 ' HA ' ' HA ' ' A' ' 150' ' ' GLN . 15.1 tt0 -141.05 111.32 6.75 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.437 0.637 . . . . 0.0 111.598 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.569 ' HB3' ' CA ' ' A' ' 149' ' ' GLY . . . -87.34 134.21 33.6 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.412 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -138.58 139.27 38.56 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.081 -178.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.601 ' O ' HG21 ' A' ' 148' ' ' ILE . 0.5 OUTLIER -177.39 131.09 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-O 120.938 0.399 . . . . 0.0 111.881 -179.931 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 1.8 mpp? -89.5 56.69 3.67 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -127.48 -152.0 0.5 Allowed 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.67 -178.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . 0.686 ' O ' ' HB2' ' A' ' 241' ' ' ALA . 10.3 tt0 -136.86 69.78 1.41 Allowed 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.528 ' O ' ' HB3' ' A' ' 239' ' ' ALA . 4.6 t -83.65 161.07 3.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.216 -178.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' A' ' 238' ' ' VAL . . . 80.74 -56.64 0.32 Allowed 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.182 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 1.6 ttp85 -89.48 -5.42 57.34 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . 0.686 ' HB2' ' O ' ' A' ' 237' ' ' GLU . . . . . . . . 0 C--N 1.312 -1.034 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.12 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 12.2 p90 . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 120.653 0.263 . . . . 0.0 111.409 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 60.83 169.37 0.09 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.836 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.06 42.17 1.09 Allowed 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.406 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 6.3 tptt -97.37 -173.29 2.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.776 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.675 HG11 ' HB2' ' A' ' 150' ' ' GLN . 5.8 t -61.0 141.0 17.93 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.683 0 CA-C-O 121.294 0.569 . . . . 0.0 111.181 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 1.013 HG21 HG12 ' A' ' 234' ' ' VAL . 0.1 OUTLIER -123.56 -5.65 7.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.871 178.095 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.465 ' O ' ' HB3' ' A' ' 232' ' ' ALA . . . -174.38 74.41 0.08 OUTLIER Glycine 0 C--N 1.342 0.869 0 N-CA-C 111.683 -0.567 . . . . 0.0 111.683 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.675 ' HB2' HG11 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -89.49 136.11 33.22 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 179.591 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.498 ' HB1' ' HB2' ' A' ' 168' ' ' CYS . . . -151.93 173.2 15.12 Favored 'General case' 0 N--CA 1.435 -1.176 0 C-N-CA 120.009 -0.677 . . . . 0.0 112.478 -178.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.699 ' HG2' HG22 ' A' ' 229' ' ' VAL . 3.8 mt-10 -122.32 121.1 35.94 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.081 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.447 ' CG1' ' HA ' ' A' ' 226' ' ' GLU . 2.2 p -49.71 132.55 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -178.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -90.17 -61.56 1.66 Allowed 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 104.941 -2.244 . . . . 0.0 104.941 175.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.48 ' HA ' ' H ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER -162.28 -163.49 0.93 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 113.76 -1.563 . . . . 0.0 109.405 174.902 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.565 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 6.9 p -145.42 156.97 44.09 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 120.845 0.355 . . . . 0.0 110.079 177.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.685 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 2.4 m-85 -103.98 73.22 1.14 Allowed 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -177.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.95 63.93 8.31 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 88.2 t -91.4 157.87 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 CA-C-N 113.611 -1.631 . . . . 0.0 110.075 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 3.8 t -92.67 34.4 1.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.145 0.498 . . . . 0.0 109.784 178.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -151.45 -33.03 0.15 Allowed 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.445 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.508 HG12 ' N ' ' A' ' 163' ' ' GLY . 90.4 t -100.07 -101.95 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.169 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 -179.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . 0.508 ' N ' HG12 ' A' ' 162' ' ' VAL . . . -158.74 -103.69 0.2 Allowed Glycine 0 N--CA 1.451 -0.366 0 N-CA-C 111.706 -0.558 . . . . 0.0 111.706 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.515 ' CG2' HG21 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -153.63 34.82 0.45 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 114.406 -0.897 . . . . 0.0 108.932 178.483 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.685 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 2.9 mm -42.88 95.44 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.496 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.565 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . -86.19 119.17 26.18 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.706 -1.133 . . . . 0.0 111.247 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -87.95 150.63 22.37 Favored Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 178.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.675 ' SG ' HD11 ' A' ' 216' ' ' LEU . 0.0 OUTLIER -148.25 136.43 21.19 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 117.364 0.582 . . . . 0.0 111.102 -178.236 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . 0.42 ' O ' ' HA ' ' A' ' 151' ' ' ALA . 5.9 t80 -87.66 129.96 34.96 Favored 'General case' 0 C--O 1.221 -0.402 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 177.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.795 HG21 ' O ' ' A' ' 208' ' ' VAL . 38.3 t -85.67 145.09 8.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -176.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.2 p -138.25 13.18 2.82 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 114.788 -1.096 . . . . 0.0 112.164 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.408 ' CB ' ' HB2' ' A' ' 150' ' ' GLN . 10.4 t0 -149.98 -141.04 0.1 Allowed 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -48.67 -109.59 0.01 OUTLIER Glycine 0 CA--C 1.531 1.033 0 N-CA-C 114.527 0.571 . . . . 0.0 114.527 -179.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.659 ' HG2' ' HB2' ' A' ' 209' ' ' ALA . 5.6 mtmt -150.59 138.84 20.29 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 122.397 -0.472 . . . . 0.0 110.603 -179.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.431 ' O ' HG23 ' A' ' 175' ' ' ILE . 0.5 OUTLIER -94.38 112.29 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 C-N-CA 119.528 -0.869 . . . . 0.0 109.536 177.439 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.917 HG21 HG12 ' A' ' 238' ' ' VAL . 0.2 OUTLIER -120.36 173.05 7.38 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.654 0.74 . . . . 0.0 112.99 -177.009 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.02 -43.67 86.93 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 114.521 -1.218 . . . . 0.0 109.95 178.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -89.25 56.5 3.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.696 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.469 ' OG ' HG23 ' A' ' 176' ' ' THR . 5.4 m -150.33 161.39 42.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.86 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 7.6 tptt -89.32 177.62 6.55 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.036 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.782 HG21 HD12 ' A' ' 218' ' ' ILE . 1.5 m -146.13 146.9 18.73 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.548 0 CA-C-O 121.347 0.594 . . . . 0.0 111.04 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . 0.551 ' HD2' HD11 ' A' ' 184' ' ' ILE . 5.2 ttm-85 -155.37 99.34 2.05 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.177 -0.92 . . . . 0.0 112.539 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.625 ' C ' HD12 ' A' ' 184' ' ' ILE . 0.3 OUTLIER -97.51 166.59 11.45 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 120.186 -0.606 . . . . 0.0 110.908 179.302 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.756 HG23 ' O ' ' A' ' 188' ' ' ILE . 4.4 mp -151.87 140.08 14.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.143 -0.48 . . . . 0.0 112.057 -177.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.798 ' NH2' HG13 ' A' ' 190' ' ' VAL . 5.2 ptp180 -87.08 -152.67 0.19 Allowed 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.371 -0.832 . . . . 0.0 108.906 178.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -94.64 29.04 2.42 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 118.19 0.45 . . . . 0.0 111.489 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.61 ' C ' HD13 ' A' ' 188' ' ' ILE . . . -153.23 -76.12 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.39 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.756 ' O ' HG23 ' A' ' 184' ' ' ILE . 0.2 OUTLIER -117.9 -155.86 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 115.373 -0.414 . . . . 0.0 110.216 -179.522 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.714 HG11 ' CG ' ' A' ' 192' ' ' GLU . 35.1 t -85.95 139.53 17.26 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 CA-C-O 121.573 0.701 . . . . 0.0 110.758 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.831 HG12 ' OD2' ' A' ' 223' ' ' ASP . 0.7 OUTLIER -87.41 -40.76 14.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 114.693 -1.14 . . . . 0.0 108.409 179.898 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . 0.453 ' CE2' ' O ' ' A' ' 220' ' ' ASN . 0.6 OUTLIER -171.91 150.21 2.56 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.606 -1.179 . . . . 0.0 111.131 179.322 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . 0.714 ' CG ' HG11 ' A' ' 189' ' ' VAL . 32.3 mt-10 -135.53 164.45 27.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.081 0.467 . . . . 0.0 111.19 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 135.87 -160.26 24.52 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 0.541 ' O ' HG23 ' A' ' 218' ' ' ILE . 3.3 pt-20 -108.69 -178.1 3.5 Favored 'General case' 0 CA--C 1.498 -1.052 0 CA-C-N 117.656 0.728 . . . . 0.0 110.723 179.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.934 ' CD1' HD13 ' A' ' 216' ' ' LEU . 0.1 OUTLIER -88.39 148.92 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.881 -177.977 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -88.92 -54.94 3.9 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -151.47 152.86 33.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.088 179.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.717 HD22 ' HB3' ' A' ' 216' ' ' LEU . 0.2 OUTLIER -122.01 103.42 8.8 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.882 179.872 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 0.1 OUTLIER -135.96 122.72 21.11 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.428 179.618 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -88.37 -159.26 0.53 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.096 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -87.03 -10.81 52.15 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 121.295 -0.162 . . . . 0.0 111.101 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.72 -59.44 1.72 Allowed 'General case' 0 N--CA 1.441 -0.909 0 CA-C-O 120.699 0.285 . . . . 0.0 111.01 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -152.27 -169.34 3.32 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 120.804 0.335 . . . . 0.0 110.991 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . 0.401 ' HA ' ' HA ' ' A' ' 199' ' ' LYS . 17.4 m-20 -90.16 70.07 7.24 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.37 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 35.5 m -62.29 165.23 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.063 0 CA-C-O 121.538 0.685 . . . . 0.0 112.088 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . 0.504 ' O ' ' HB ' ' A' ' 176' ' ' THR . 1.6 ttm180 -89.18 -41.7 12.09 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-N 114.726 -1.125 . . . . 0.0 111.368 -178.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -136.2 178.6 6.94 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.249 0.547 . . . . 0.0 111.963 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.795 ' O ' HG21 ' A' ' 170' ' ' VAL . 0.2 OUTLIER -150.96 94.67 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.701 179.108 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.659 ' HB2' ' HG2' ' A' ' 174' ' ' LYS . . . -118.27 178.09 4.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.215 0.531 . . . . 0.0 112.36 -178.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 80.91 -71.8 0.07 Allowed 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.794 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 178.62 37.31 0.06 OUTLIER Glycine 0 N--CA 1.442 -0.933 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.2 179.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -104.48 139.11 39.87 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.962 0.41 . . . . 0.0 111.089 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.74 150.92 22.09 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.039 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' CYS . . . . . 0.51 ' CB ' HG21 ' A' ' 208' ' ' VAL . 7.5 t -150.15 146.13 26.71 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.679 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -89.1 115.41 4.47 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.043 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.934 HD13 ' CD1' ' A' ' 195' ' ' ILE . 0.3 OUTLIER -132.18 141.48 49.1 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 120.975 0.417 . . . . 0.0 110.742 -179.827 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . 0.512 ' OG1' HD13 ' A' ' 165' ' ' ILE . 1.6 m -105.67 140.08 39.29 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 177.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . 0.782 HD12 HG21 ' A' ' 181' ' ' VAL . 18.9 mm -89.19 144.32 9.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 120.449 -0.5 . . . . 0.0 109.747 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.78 -10.74 4.11 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -176.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . 0.453 ' O ' ' CE2' ' A' ' 191' ' ' TYR . 58.2 t30 -153.23 21.1 0.56 Allowed 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.485 ' HB2' ' HB ' ' A' ' 218' ' ' ILE . 0.1 OUTLIER -57.95 123.76 16.93 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 -179.681 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . 0.401 ' HB2' ' CE1' ' A' ' 191' ' ' TYR . 2.3 t-20 -96.59 -47.76 5.8 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 114.347 -1.297 . . . . 0.0 108.367 176.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . 0.831 ' OD2' HG12 ' A' ' 190' ' ' VAL . 0.0 OUTLIER -75.66 150.25 37.98 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.095 177.422 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.644 ' N ' HD13 ' A' ' 224' ' ' ILE . 0.2 OUTLIER -143.14 177.78 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -179.209 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.424 ' O ' ' C ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER 56.56 116.25 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 114.443 -1.253 . . . . 0.0 110.073 -179.046 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . 0.48 ' H ' ' HA ' ' A' ' 155' ' ' GLN . 3.2 tt0 8.78 63.88 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.523 1.129 . . . . 0.0 113.517 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -61.61 -65.48 3.22 Favored Glycine 0 N--CA 1.432 -1.613 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.4 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.439 ' O ' HG12 ' A' ' 153' ' ' VAL . 0.9 OUTLIER -165.38 -147.48 0.1 Allowed 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 114.236 1.199 . . . . 0.0 114.236 179.381 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . 0.699 HG22 ' HG2' ' A' ' 152' ' ' GLU . 91.7 t -89.17 135.09 26.75 Favored 'Isoleucine or valine' 0 C--N 1.346 0.437 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . 0.495 ' HA ' ' HA ' ' A' ' 183' ' ' LEU . 2.7 mp -102.93 159.04 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 O-C-N 123.378 0.424 . . . . 0.0 110.859 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' GLU . . . . . 0.46 ' O ' ' N ' ' A' ' 182' ' ' ARG . 5.7 tt0 -149.46 108.43 3.89 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.274 0.559 . . . . 0.0 112.348 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.499 ' O ' HD13 ' A' ' 148' ' ' ILE . . . -87.56 131.67 34.31 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.022 179.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' TYR . . . . . 0.539 ' C ' HD12 ' A' ' 148' ' ' ILE . 4.6 p90 -134.33 163.46 29.6 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.577 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 1.013 HG12 HG21 ' A' ' 148' ' ' ILE . 1.9 p -175.07 171.32 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-O 120.77 0.319 . . . . 0.0 111.489 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' MET . . . . . 0.507 ' H ' HG22 ' A' ' 234' ' ' VAL . 3.2 mtm -99.52 34.55 2.18 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.293 0.568 . . . . 0.0 110.631 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . 0.786 ' H ' HG13 ' A' ' 234' ' ' VAL . 1.0 OUTLIER -150.53 -158.91 0.96 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.827 -179.957 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -98.82 -90.45 0.29 Allowed 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 120.838 0.352 . . . . 0.0 110.331 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.917 HG12 HG21 ' A' ' 176' ' ' THR . 0.1 OUTLIER -154.2 -176.11 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.644 179.78 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . 0.443 ' H ' HG12 ' A' ' 238' ' ' VAL . . . 66.61 -72.3 0.09 Allowed 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.998 179.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.53 -1.23 57.97 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.153 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . 0.691 ' HB3' ' HB3' ' A' ' 236' ' ' GLN . . . . . . . . 0 C--N 1.317 -0.824 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.061 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.415 0 CA-C-O 120.778 0.323 . . . . 0.0 111.14 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 59.36 89.48 0.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.967 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.456 ' CA ' ' HA ' ' A' ' 235' ' ' MET . 0.6 OUTLIER -90.43 65.92 6.28 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-O 121.226 0.536 . . . . 0.0 111.773 -179.826 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -39.66 -65.6 0.37 Allowed 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.68 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.572 HG11 ' HG3' ' A' ' 150' ' ' GLN . 29.1 t -89.45 138.44 19.29 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.732 0 CA-C-O 121.287 0.565 . . . . 0.0 110.193 178.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.538 HD11 ' HB ' ' A' ' 238' ' ' VAL . 3.7 tp -121.5 -14.96 7.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.257 177.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.5 ' O ' ' HB3' ' A' ' 232' ' ' ALA . . . 165.11 88.56 0.07 OUTLIER Glycine 0 C--N 1.345 1.071 0 C-N-CA 120.131 -1.033 . . . . 0.0 112.864 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.572 ' HG3' HG11 ' A' ' 147' ' ' VAL . 3.0 mt-30 -90.05 142.22 27.91 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.441 ' CB ' ' HB2' ' A' ' 168' ' ' CYS . . . -150.93 174.99 12.47 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 120.107 -0.637 . . . . 0.0 112.148 -179.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.826 ' CG ' HG22 ' A' ' 229' ' ' VAL . 0.0 OUTLIER -120.42 123.72 43.72 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.054 179.81 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.7 ' HB ' HD11 ' A' ' 230' ' ' ILE . 2.4 p -55.79 127.77 15.14 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 CA-C-O 121.377 0.608 . . . . 0.0 111.522 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.416 ' CA ' ' NE ' ' A' ' 154' ' ' ARG . 0.0 OUTLIER -89.56 -57.49 2.86 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 105.025 -2.213 . . . . 0.0 105.025 176.209 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.433 ' HA ' ' H ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER -162.76 -163.61 0.9 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.257 -1.338 . . . . 0.0 110.262 174.735 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.597 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 16.7 p -144.42 158.92 43.51 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 177.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.657 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 2.4 m-85 -99.98 76.08 1.91 Allowed 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -176.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 7.7 tttt -85.93 63.58 8.11 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 122.071 0.938 . . . . 0.0 108.809 178.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.455 HG12 ' N ' ' A' ' 161' ' ' LYS . 55.0 t -89.89 155.53 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 CA-C-N 113.77 -1.559 . . . . 0.0 109.867 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 3.9 t -90.7 33.58 0.92 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.126 0.489 . . . . 0.0 110.153 178.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.455 ' N ' HG12 ' A' ' 159' ' ' VAL . 3.6 mttt -151.02 -29.67 0.19 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.712 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.489 HG12 ' N ' ' A' ' 163' ' ' GLY . 88.2 t -103.19 -101.79 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 O-C-N 122.195 -0.316 . . . . 0.0 110.275 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . 0.489 ' N ' HG12 ' A' ' 162' ' ' VAL . . . -158.5 -103.39 0.19 Allowed Glycine 0 N--CA 1.451 -0.363 0 N-CA-C 111.661 -0.576 . . . . 0.0 111.661 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 1.048 HG21 HG21 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -153.14 36.24 0.48 Allowed 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 114.362 -0.919 . . . . 0.0 108.968 178.458 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.657 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 4.9 mt -42.55 101.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.925 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.597 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . -83.62 121.88 27.85 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.004 -0.998 . . . . 0.0 112.871 -178.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -89.1 136.08 13.38 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 178.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.664 ' HB3' HD13 ' A' ' 230' ' ' ILE . 0.0 OUTLIER -138.14 131.49 30.52 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.898 0.349 . . . . 0.0 110.531 -178.523 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . 0.425 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 5.7 t80 -85.94 126.42 34.09 Favored 'General case' 0 C--O 1.219 -0.502 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 178.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.578 HG21 ' O ' ' A' ' 208' ' ' VAL . 45.3 t -85.22 145.37 8.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -175.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -133.9 10.52 3.93 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 114.646 -1.161 . . . . 0.0 112.337 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.428 ' O ' ' O ' ' A' ' 173' ' ' GLY . 3.0 t70 -150.12 -145.76 0.18 Allowed 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 118.91 -0.567 . . . . 0.0 109.613 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 172' ' ' ASP . . . -37.68 -108.11 0.0 OUTLIER Glycine 0 CA--C 1.537 1.444 0 N-CA-C 115.338 0.895 . . . . 0.0 115.338 -179.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.795 ' HG2' ' HB2' ' A' ' 209' ' ' ALA . 1.7 mtmm -151.51 135.52 16.58 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 122.311 -0.523 . . . . 0.0 111.84 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.624 ' HB ' HG23 ' A' ' 208' ' ' VAL . 2.6 mm -88.44 86.9 2.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 177.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.87 ' O ' HD13 ' A' ' 195' ' ' ILE . 0.0 OUTLIER -98.26 170.41 8.9 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.17 -177.767 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -69.02 -39.41 79.26 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.269 179.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . 0.408 ' O ' HG13 ' A' ' 238' ' ' VAL . 38.8 m-20 -89.29 51.85 2.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.97 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.842 ' O ' HD12 ' A' ' 195' ' ' ILE . 0.7 OUTLIER -142.94 159.49 42.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.75 179.795 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 2.8 mptp? -89.6 177.71 6.47 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.611 HG22 ' CA ' ' A' ' 194' ' ' GLU . 2.8 m -149.43 148.69 15.4 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.509 0 CA-C-O 121.535 0.683 . . . . 0.0 112.237 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 231' ' ' GLU . 23.0 ttp180 -153.83 102.45 2.52 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.671 -1.15 . . . . 0.0 111.678 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.616 ' C ' HD12 ' A' ' 184' ' ' ILE . 0.3 OUTLIER -98.16 169.13 9.81 Favored 'General case' 0 N--CA 1.438 -1.064 0 C-N-CA 120.564 -0.455 . . . . 0.0 111.246 179.869 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.738 HG23 ' O ' ' A' ' 188' ' ' ILE . 4.0 mp -151.01 139.83 14.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.048 -178.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.516 ' N ' HG22 ' A' ' 190' ' ' VAL . 0.0 OUTLIER -88.04 -150.73 0.18 Allowed 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.156 -0.929 . . . . 0.0 108.749 178.241 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -94.72 27.75 2.94 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 118.461 0.573 . . . . 0.0 111.454 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -153.11 -77.78 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.688 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.738 ' O ' HG23 ' A' ' 184' ' ' ILE . 0.5 OUTLIER -116.69 -154.34 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-N 115.514 -0.343 . . . . 0.0 110.43 -179.292 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.694 HG11 ' CG ' ' A' ' 192' ' ' GLU . 23.0 t -85.67 138.45 19.05 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 CA-C-O 121.517 0.675 . . . . 0.0 110.803 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.88 HG12 ' OD2' ' A' ' 223' ' ' ASP . 0.7 OUTLIER -87.86 -39.24 12.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 114.739 -1.119 . . . . 0.0 109.0 -179.86 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . 0.477 ' HB2' ' CE1' ' A' ' 221' ' ' PHE . 1.0 OUTLIER -172.17 157.67 4.32 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.63 -1.168 . . . . 0.0 110.411 -179.935 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . 0.694 ' CG ' HG11 ' A' ' 189' ' ' VAL . 34.1 mt-10 -144.79 157.16 44.28 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.205 0.526 . . . . 0.0 111.182 179.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 148.9 -129.82 3.19 Favored Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.524 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 0.611 ' CA ' HG22 ' A' ' 181' ' ' VAL . 12.7 pt-20 -138.97 -175.78 4.27 Favored 'General case' 0 CA--C 1.497 -1.061 0 CA-C-O 121.292 0.567 . . . . 0.0 111.584 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.87 HD13 ' O ' ' A' ' 176' ' ' THR . 3.0 mp -88.13 143.35 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.379 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.405 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' ASP . . . . . 0.407 ' CB ' ' HB ' ' A' ' 217' ' ' THR . 0.6 OUTLIER -89.02 -56.92 3.09 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.164 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 3.0 m -151.61 150.54 30.4 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.942 179.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.428 HD21 ' HB3' ' A' ' 214' ' ' CYS . 1.3 tt -120.56 111.56 17.82 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 121.379 0.609 . . . . 0.0 111.169 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 62.2 mttt -150.62 122.55 8.17 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.286 179.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.57 -160.8 0.64 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.509 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -87.27 -8.15 57.08 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 121.23 -0.188 . . . . 0.0 111.04 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.52 -58.74 1.82 Allowed 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 120.628 0.251 . . . . 0.0 111.006 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -152.23 -175.11 5.12 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-O 120.876 0.37 . . . . 0.0 111.095 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . 0.402 ' HA ' ' HA ' ' A' ' 199' ' ' LYS . 9.6 p-10 -94.84 92.06 6.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.652 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 33.9 m -82.87 163.82 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.916 0 CA-C-O 121.481 0.658 . . . . 0.0 112.152 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . 0.474 ' O ' ' HB ' ' A' ' 176' ' ' THR . 0.2 OUTLIER -89.11 -36.79 15.53 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.939 -178.53 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.69 ' HB3' HG22 ' A' ' 176' ' ' THR . 1.9 mp0 -141.73 -178.08 5.49 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.343 0.592 . . . . 0.0 111.993 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.624 HG23 ' HB ' ' A' ' 175' ' ' ILE . 0.1 OUTLIER -151.08 91.73 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.681 178.946 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.795 ' HB2' ' HG2' ' A' ' 174' ' ' LYS . . . -112.89 165.87 11.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.022 0.439 . . . . 0.0 112.028 -179.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 34.1 tp60 82.26 -69.36 0.07 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.035 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 178.41 37.78 0.06 OUTLIER Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.355 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -97.45 136.05 38.45 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.863 0.363 . . . . 0.0 111.199 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -91.54 146.48 23.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.349 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' CYS . . . . . 0.428 ' HB3' HD21 ' A' ' 198' ' ' LEU . 1.8 m -150.95 142.7 23.74 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.532 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . 0.55 ' C ' HG23 ' A' ' 165' ' ' ILE . . . -89.64 103.77 3.04 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.608 -0.806 . . . . 0.0 111.978 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.526 HD12 ' CD1' ' A' ' 218' ' ' ILE . 0.4 OUTLIER -128.86 143.16 50.83 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.078 0.466 . . . . 0.0 111.467 -179.576 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . 0.407 ' HB ' ' CB ' ' A' ' 196' ' ' ASP . 1.2 m -83.93 143.49 29.81 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 177.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . 0.599 HG22 ' O ' ' A' ' 218' ' ' ILE . 1.5 mp -106.16 92.09 2.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.943 0.401 . . . . 0.0 110.247 -178.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 4.3 tttp 45.06 -144.24 0.17 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.894 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -87.18 61.33 6.66 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 121.024 0.44 . . . . 0.0 110.817 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.477 ' CE1' ' HB2' ' A' ' 191' ' ' TYR . 0.1 OUTLIER -55.92 120.62 7.7 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 114.722 1.379 . . . . 0.0 114.722 179.128 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 21.4 t30 -82.32 -48.55 11.05 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 114.815 -1.084 . . . . 0.0 108.346 176.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . 0.88 ' OD2' HG12 ' A' ' 190' ' ' VAL . 0.0 OUTLIER -82.01 137.88 35.0 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 177.668 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 1.048 HG21 HG21 ' A' ' 164' ' ' THR . 0.2 OUTLIER -133.85 179.13 4.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -178.951 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.407 ' O ' ' C ' ' A' ' 226' ' ' GLU . 0.1 OUTLIER 57.09 117.28 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.107 -179.114 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . 0.433 ' H ' ' HA ' ' A' ' 155' ' ' GLN . 38.9 tt0 7.71 63.28 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 124.484 1.114 . . . . 0.0 113.758 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . 0.457 ' N ' HG11 ' A' ' 153' ' ' VAL . . . -63.49 -66.43 2.54 Favored Glycine 0 N--CA 1.431 -1.655 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.932 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.464 ' O ' HG12 ' A' ' 153' ' ' VAL . 0.7 OUTLIER -164.17 -150.2 0.14 Allowed 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 179.888 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . 0.826 HG22 ' CG ' ' A' ' 152' ' ' GLU . 69.2 t -88.49 130.68 37.59 Favored 'Isoleucine or valine' 0 C--N 1.345 0.38 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.208 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . 0.7 HD11 ' HB ' ' A' ' 153' ' ' VAL . 5.1 mp -100.37 157.72 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 O-C-N 123.618 0.574 . . . . 0.0 110.961 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' GLU . . . . . 0.453 ' HA ' ' HA ' ' A' ' 150' ' ' GLN . 33.6 tt0 -146.94 112.32 5.55 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 120.246 -0.582 . . . . 0.0 112.427 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.508 ' HB1' HG23 ' A' ' 148' ' ' ILE . . . -88.18 133.91 33.91 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.008 179.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' TYR . . . . . 0.405 ' O ' ' CG2' ' A' ' 234' ' ' VAL . 2.9 p90 -136.04 120.3 17.88 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.803 -178.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.405 ' CG2' ' O ' ' A' ' 233' ' ' TYR . 62.6 t -159.97 111.17 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.863 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' MET . . . . . 0.456 ' HA ' ' CA ' ' A' ' 145' ' ' GLU . 18.5 mtm -86.88 59.36 5.59 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 19.6 mm100 -132.06 -145.2 0.26 Allowed 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.426 -0.807 . . . . 0.0 111.485 -177.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . 0.762 ' O ' ' HB2' ' A' ' 241' ' ' ALA . 13.3 mm-40 -126.49 66.04 1.24 Allowed 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.559 0.695 . . . . 0.0 109.318 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.538 ' HB ' HD11 ' A' ' 148' ' ' ILE . 12.5 t -83.43 160.46 3.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.81 -178.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . 0.521 ' HB3' ' O ' ' A' ' 238' ' ' VAL . . . 80.64 -56.24 0.33 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 122.854 0.461 . . . . 0.0 111.215 -179.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.87 -6.2 56.06 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . 0.762 ' HB2' ' O ' ' A' ' 237' ' ' GLU . . . . . . . . 0 C--N 1.312 -1.03 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.064 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 . . . . . 0 N--CA 1.485 1.312 0 CA-C-O 120.756 0.312 . . . . 0.0 111.202 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -147.23 140.2 25.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.951 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.98 37.39 1.23 Allowed 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.35 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.517 ' HG3' HG23 ' A' ' 147' ' ' VAL . 3.8 tppp? -135.17 -82.68 0.42 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.251 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.517 HG23 ' HG3' ' A' ' 146' ' ' LYS . 6.7 t -99.5 140.71 18.23 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.758 0 CA-C-O 121.245 0.545 . . . . 0.0 110.699 179.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.472 HD13 ' N ' ' A' ' 149' ' ' GLY . 0.0 OUTLIER -131.33 -2.32 2.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.009 178.784 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.539 ' CA ' ' HB3' ' A' ' 232' ' ' ALA . . . -178.43 73.59 0.07 OUTLIER Glycine 0 C--N 1.342 0.889 0 C-N-CA 120.81 -0.71 . . . . 0.0 111.931 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.474 ' HB2' HG11 ' A' ' 147' ' ' VAL . 0.4 OUTLIER -91.67 134.77 34.41 Favored 'General case' 0 CA--C 1.505 -0.769 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.749 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.467 ' HB1' ' O ' ' A' ' 169' ' ' TYR . . . -151.62 175.03 12.76 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-O 121.52 0.676 . . . . 0.0 112.511 -178.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.738 ' HG2' HG22 ' A' ' 229' ' ' VAL . 2.4 mt-10 -120.37 127.02 51.91 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.107 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.713 ' HB ' HD11 ' A' ' 230' ' ' ILE . 2.6 p -57.68 128.22 17.92 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.354 0 CA-C-O 121.643 0.735 . . . . 0.0 111.887 -179.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.408 ' HD3' ' HB2' ' A' ' 169' ' ' TYR . 0.0 OUTLIER -90.17 -57.25 2.91 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 104.789 -2.3 . . . . 0.0 104.789 175.617 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.426 ' HA ' ' H ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER -163.3 -166.16 1.2 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.094 -1.412 . . . . 0.0 110.363 174.742 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.548 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 18.8 p -151.17 149.88 29.97 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.191 177.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.616 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 5.8 m-30 -94.83 72.11 3.51 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -178.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? -86.48 61.4 6.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.894 0.854 . . . . 0.0 108.924 178.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.405 HG12 ' H ' ' A' ' 161' ' ' LYS . 49.0 t -89.77 155.59 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-N 114.095 -1.411 . . . . 0.0 109.789 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.75 22.01 3.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.905 0.383 . . . . 0.0 111.177 178.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.405 ' H ' HG12 ' A' ' 159' ' ' VAL . 6.5 mttt -150.9 6.98 0.53 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.982 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 58.4 t -130.81 -99.6 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 CA-C-N 118.374 0.534 . . . . 0.0 110.017 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -158.46 -112.76 0.34 Allowed Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.494 HG22 ' CG2' ' A' ' 224' ' ' ILE . 0.0 OUTLIER -153.7 32.08 0.45 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.401 -0.899 . . . . 0.0 109.18 178.173 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.616 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 1.9 mm -41.09 94.32 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.473 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.604 ' HB3' HD13 ' A' ' 218' ' ' ILE . . . -86.48 113.93 22.81 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.689 -1.141 . . . . 0.0 111.993 -179.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -88.3 126.38 8.08 Favored Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 178.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.808 ' HB3' HD13 ' A' ' 230' ' ' ILE . 0.0 OUTLIER -129.79 134.48 47.6 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.83 0.315 . . . . 0.0 110.471 -178.088 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . 0.467 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 15.0 t80 -86.27 130.34 34.55 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.081 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.715 HG21 ' O ' ' A' ' 208' ' ' VAL . 42.3 t -85.78 148.57 4.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 113.404 0.891 . . . . 0.0 113.404 -175.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -141.87 15.79 2.12 Favored 'General case' 0 CA--C 1.527 0.076 0 CA-C-N 114.562 -1.199 . . . . 0.0 111.898 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.412 ' H ' HG12 ' A' ' 170' ' ' VAL . 6.6 t0 -150.24 -142.64 0.12 Allowed 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 -179.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -45.73 -109.89 0.01 OUTLIER Glycine 0 CA--C 1.533 1.193 0 N-CA-C 115.009 0.764 . . . . 0.0 115.009 -178.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.67 ' HG2' ' HB2' ' A' ' 209' ' ' ALA . 3.8 mttm -151.13 127.01 10.32 Favored 'General case' 0 CA--C 1.512 -0.496 0 O-C-N 122.451 -0.441 . . . . 0.0 111.107 -178.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.589 HD12 ' HB2' ' A' ' 232' ' ' ALA . 0.5 OUTLIER -89.03 113.85 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 C-N-CA 119.199 -1.0 . . . . 0.0 109.431 177.811 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.891 ' O ' HD13 ' A' ' 195' ' ' ILE . 0.1 OUTLIER -124.97 169.26 12.27 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.95 -177.376 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.402 ' HG3' ' HB2' ' A' ' 198' ' ' LEU . 0.2 OUTLIER -61.34 -38.74 88.01 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.299 179.414 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -89.28 52.74 2.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.156 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.754 ' O ' HD12 ' A' ' 195' ' ' ILE . 29.4 m -150.46 157.04 42.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.341 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 0.0 OUTLIER -89.35 176.78 6.79 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.553 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.624 HG22 ' CA ' ' A' ' 194' ' ' GLU . 2.5 m -145.65 149.21 16.7 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.579 0 CA-C-O 121.473 0.654 . . . . 0.0 112.203 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . 0.436 ' N ' ' O ' ' A' ' 231' ' ' GLU . 26.8 ttm180 -154.36 102.34 2.43 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.851 -1.068 . . . . 0.0 112.236 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.521 ' CB ' ' HA ' ' A' ' 230' ' ' ILE . 0.3 OUTLIER -99.61 170.67 8.42 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-O 120.932 0.396 . . . . 0.0 110.649 179.363 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.683 HG23 ' O ' ' A' ' 188' ' ' ILE . 36.5 mt -155.5 139.94 9.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.855 -178.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.494 ' N ' HG22 ' A' ' 190' ' ' VAL . 6.9 ttm-85 -87.33 -152.64 0.2 Allowed 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.9 178.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 18.7 mp0 -94.69 28.67 2.57 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 118.141 0.428 . . . . 0.0 111.32 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -152.72 -79.14 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.487 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.683 ' O ' HG23 ' A' ' 184' ' ' ILE . 0.1 OUTLIER -114.4 -157.22 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 115.536 -0.332 . . . . 0.0 110.227 -179.6 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.779 HG11 ' CG ' ' A' ' 192' ' ' GLU . 22.3 t -86.22 139.54 17.22 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 CA-C-O 121.457 0.646 . . . . 0.0 110.739 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.585 HG23 ' CA ' ' A' ' 184' ' ' ILE . 0.4 OUTLIER -87.89 -35.53 8.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.13 -179.93 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . 0.475 ' HB2' ' CE1' ' A' ' 221' ' ' PHE . 22.5 t80 -178.54 146.4 0.36 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.901 179.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . 0.779 ' CG ' HG11 ' A' ' 189' ' ' VAL . 34.7 mt-10 -135.46 158.08 45.27 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.015 0.436 . . . . 0.0 110.858 179.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 147.23 -124.6 1.98 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.736 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 0.624 ' CA ' HG22 ' A' ' 181' ' ' VAL . 13.7 pt-20 -144.15 -174.95 4.43 Favored 'General case' 0 CA--C 1.497 -1.087 0 CA-C-O 121.202 0.525 . . . . 0.0 111.437 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.891 HD13 ' O ' ' A' ' 176' ' ' THR . 3.8 mp -87.72 142.92 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.602 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.03 -52.37 5.12 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 1.2 m -151.47 145.62 25.33 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.724 178.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.529 HD13 ' HA ' ' A' ' 176' ' ' THR . 4.5 tt -124.06 114.15 19.34 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.394 0.616 . . . . 0.0 111.613 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 56.6 mttt -150.17 121.19 7.69 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.096 -0.957 . . . . 0.0 109.86 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.19 -160.03 0.6 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.285 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -86.74 -16.64 35.79 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.528 0.204 . . . . 0.0 110.778 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.96 -59.67 2.14 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-O 120.655 0.264 . . . . 0.0 110.617 179.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -152.96 -171.09 3.82 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 120.964 0.411 . . . . 0.0 111.083 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 22.0 p30 -89.95 57.83 3.96 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.043 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 33.9 m -55.12 164.02 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.04 0 CA-C-O 121.47 0.652 . . . . 0.0 112.304 -179.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . 0.498 ' O ' ' HB ' ' A' ' 176' ' ' THR . 1.6 mtm180 -89.44 -41.34 12.14 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-N 114.715 -1.13 . . . . 0.0 111.34 -178.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.545 ' HG3' ' HB2' ' A' ' 239' ' ' ALA . 0.9 OUTLIER -129.72 -178.59 4.76 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.458 0.647 . . . . 0.0 112.37 -179.131 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.715 ' O ' HG21 ' A' ' 170' ' ' VAL . 0.0 OUTLIER -151.17 81.44 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.269 178.631 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.67 ' HB2' ' HG2' ' A' ' 174' ' ' LYS . . . -100.76 171.79 7.47 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -178.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 8.9 tm0? 83.49 -72.67 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.016 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 177.93 37.18 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.345 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -98.21 141.61 30.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.925 0.393 . . . . 0.0 111.303 -179.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.5 131.15 43.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.339 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' CYS . . . . . 0.461 ' HB3' HG21 ' A' ' 208' ' ' VAL . 52.5 t -133.17 143.96 49.56 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.676 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -88.5 109.62 3.56 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.978 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.55 HD12 ' CD1' ' A' ' 218' ' ' ILE . 0.4 OUTLIER -135.75 141.77 44.88 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 120.924 0.393 . . . . 0.0 111.478 -179.305 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . 0.46 ' C ' HD12 ' A' ' 218' ' ' ILE . 0.0 OUTLIER -77.43 146.97 36.22 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 177.662 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . 0.607 HG22 ' O ' ' A' ' 218' ' ' ILE . 1.6 mp -112.61 87.83 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.144 0.497 . . . . 0.0 109.755 -179.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 6.5 tttp 46.71 -144.85 0.26 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.759 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -87.33 61.09 6.45 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 121.009 0.433 . . . . 0.0 111.135 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.512 ' CZ ' HD21 ' A' ' 183' ' ' LEU . 0.1 OUTLIER -55.49 121.42 8.97 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 178.973 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 14.4 t30 -88.63 -45.15 10.08 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.483 176.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 223' ' ' ASP . 0.0 OUTLIER -81.72 134.7 35.48 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.215 177.604 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.634 HD13 ' H ' ' A' ' 224' ' ' ILE . 0.2 OUTLIER -133.82 -179.64 3.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -179.067 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.422 ' O ' ' C ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER 57.07 114.33 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.698 -178.367 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . 0.448 ' HA ' ' CG1' ' A' ' 153' ' ' VAL . 3.0 tt0 8.66 64.22 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 124.633 1.173 . . . . 0.0 113.555 -179.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . 0.413 ' N ' HG11 ' A' ' 153' ' ' VAL . . . -61.48 -66.86 2.39 Favored Glycine 0 N--CA 1.432 -1.59 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.468 179.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.458 ' O ' HG12 ' A' ' 153' ' ' VAL . 0.9 OUTLIER -164.9 -147.99 0.11 Allowed 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 179.435 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . 0.738 HG22 ' HG2' ' A' ' 152' ' ' GLU . 98.4 t -89.24 132.16 34.69 Favored 'Isoleucine or valine' 0 C--N 1.347 0.462 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . 0.808 HD13 ' HB3' ' A' ' 168' ' ' CYS . 4.5 mp -99.2 157.23 3.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 O-C-N 123.499 0.499 . . . . 0.0 111.196 -179.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' GLU . . . . . 0.436 ' O ' ' N ' ' A' ' 182' ' ' ARG . 1.9 tm-20 -147.63 110.24 4.68 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 120.159 -0.616 . . . . 0.0 112.633 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.589 ' HB2' HD12 ' A' ' 175' ' ' ILE . . . -87.8 134.39 33.69 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.472 178.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' TYR . . . . . 0.724 ' O ' HG23 ' A' ' 234' ' ' VAL . 6.3 p90 -131.58 147.07 52.5 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.935 0.398 . . . . 0.0 111.703 -179.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.724 HG23 ' O ' ' A' ' 233' ' ' TYR . 0.9 OUTLIER -179.77 167.28 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.417 179.959 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' MET . . . . . 0.411 ' N ' ' CG1' ' A' ' 234' ' ' VAL . 1.9 mtm -88.88 -73.54 0.5 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.565 0.698 . . . . 0.0 110.527 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -150.03 73.2 1.15 Allowed 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.896 179.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -150.94 57.97 0.91 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.788 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.858 HG12 HG21 ' A' ' 176' ' ' THR . 0.2 OUTLIER -94.96 -165.52 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.682 -179.701 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . 0.545 ' HB2' ' HG3' ' A' ' 207' ' ' GLU . . . -55.05 -73.23 0.05 Allowed 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.942 0.401 . . . . 0.0 111.038 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.83 -5.49 58.0 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.261 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . 0.522 ' HB3' HG23 ' A' ' 238' ' ' VAL . . . . . . . . 0 C--N 1.313 -0.995 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.076 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 87.6 t80 . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.859 0.361 . . . . 0.0 111.204 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 59.96 28.92 18.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.018 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -89.86 49.39 1.71 Allowed 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.442 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 1.1 tptp -83.11 -162.68 0.63 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.529 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.707 ' O ' HD13 ' A' ' 148' ' ' ILE . 5.8 t -58.62 142.42 14.32 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 CA-C-O 121.333 0.587 . . . . 0.0 111.381 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.983 HG21 HG21 ' A' ' 238' ' ' VAL . 11.6 mm -134.41 13.16 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.57 178.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.719 ' HA3' ' HB3' ' A' ' 232' ' ' ALA . . . 175.46 65.68 0.06 OUTLIER Glycine 0 C--N 1.343 0.945 0 C-N-CA 121.329 -0.462 . . . . 0.0 112.181 179.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.682 ' HB2' HG11 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -89.61 131.19 35.74 Favored 'General case' 0 CA--C 1.507 -0.679 0 O-C-N 122.506 -0.408 . . . . 0.0 110.481 179.83 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.413 ' HA ' ' O ' ' A' ' 169' ' ' TYR . . . -152.18 174.21 14.02 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-O 121.42 0.629 . . . . 0.0 112.448 -178.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.739 ' HG2' HG22 ' A' ' 229' ' ' VAL . 7.2 mt-10 -120.63 121.73 38.97 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.487 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.499 HG13 ' HG2' ' A' ' 226' ' ' GLU . 3.1 p -51.45 131.07 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.416 ' HD2' ' HB2' ' A' ' 169' ' ' TYR . 5.1 mmp_? -90.07 -59.27 2.24 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 175.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.544 ' HA ' ' H ' ' A' ' 226' ' ' GLU . 0.3 OUTLIER -162.3 -164.32 1.03 Allowed 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 113.75 -1.568 . . . . 0.0 109.751 175.449 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.537 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 7.0 p -150.47 162.51 40.45 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 177.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.557 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 0.2 OUTLIER -115.53 78.41 1.17 Allowed 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -179.123 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 8.6 tttm -86.47 62.57 7.5 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 177.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.49 HG12 ' N ' ' A' ' 161' ' ' LYS . 71.3 t -93.04 156.19 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 CA-C-N 113.606 -1.633 . . . . 0.0 110.488 -178.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 46.0 p -91.29 34.64 0.94 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.234 0.54 . . . . 0.0 109.71 178.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.49 ' N ' HG12 ' A' ' 159' ' ' VAL . 0.1 OUTLIER -150.76 -32.92 0.17 Allowed 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.206 -179.721 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.514 HG12 ' N ' ' A' ' 163' ' ' GLY . 84.3 t -100.67 -103.05 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . 0.514 ' N ' HG12 ' A' ' 162' ' ' VAL . . . -159.35 -101.19 0.17 Allowed Glycine 0 N--CA 1.451 -0.353 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 178.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.468 ' CG2' HG21 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -154.14 33.94 0.43 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 114.115 -1.042 . . . . 0.0 108.51 177.812 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.626 HD12 HG23 ' A' ' 217' ' ' THR . 1.5 mp -42.91 95.26 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.522 -179.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.537 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . -89.93 120.51 31.21 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.722 -1.126 . . . . 0.0 112.179 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -88.15 148.0 20.55 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 178.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.572 ' HB3' HD12 ' A' ' 230' ' ' ILE . 0.0 OUTLIER -147.73 134.64 20.19 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 117.366 0.583 . . . . 0.0 110.694 -178.455 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . 0.416 ' HB2' ' HD2' ' A' ' 154' ' ' ARG . 78.4 t80 -86.53 124.47 32.87 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 177.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.665 HG21 ' O ' ' A' ' 208' ' ' VAL . 22.7 t -85.42 144.3 9.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 113.14 0.792 . . . . 0.0 113.14 -176.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.1 p -137.2 14.17 3.04 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 114.779 -1.1 . . . . 0.0 112.078 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.41 ' H ' HG12 ' A' ' 170' ' ' VAL . 5.9 t0 -150.56 -144.68 0.16 Allowed 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -40.27 -105.0 0.01 OUTLIER Glycine 0 CA--C 1.533 1.16 0 N-CA-C 115.264 0.865 . . . . 0.0 115.264 -178.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.438 ' HB2' ' HB3' ' A' ' 207' ' ' GLU . 0.0 OUTLIER -150.93 150.9 31.39 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.061 0.458 . . . . 0.0 111.442 -178.416 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.63 HG21 HD11 ' A' ' 216' ' ' LEU . 16.1 mm -103.67 82.72 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 176.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.525 HG21 HG12 ' A' ' 238' ' ' VAL . 0.0 OUTLIER -95.58 172.89 7.78 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.78 1.029 . . . . 0.0 113.78 -176.569 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.553 ' HB2' HD22 ' A' ' 198' ' ' LEU . 7.8 ttp180 -69.42 -48.68 60.28 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 114.1 -1.409 . . . . 0.0 110.792 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -89.45 61.61 5.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.28 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 1.8 m -148.3 157.62 43.6 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.343 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.481 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 1.1 mptt -88.56 173.7 8.5 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.628 HG22 ' CA ' ' A' ' 194' ' ' GLU . 2.9 m -142.49 150.35 18.54 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.568 0 CA-C-O 121.483 0.659 . . . . 0.0 112.595 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . 0.421 ' N ' ' O ' ' A' ' 231' ' ' GLU . 43.5 ttp180 -154.83 102.09 2.33 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.847 -1.069 . . . . 0.0 112.479 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.517 ' CB ' ' HA ' ' A' ' 230' ' ' ILE . 0.3 OUTLIER -100.56 170.57 8.29 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 120.426 -0.51 . . . . 0.0 111.004 179.235 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.683 HG23 ' O ' ' A' ' 188' ' ' ILE . 26.6 mt -154.18 140.15 11.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -178.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.5 ' N ' HG22 ' A' ' 190' ' ' VAL . 1.2 ttt180 -87.17 -154.18 0.24 Allowed 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.012 -0.995 . . . . 0.0 108.774 178.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -94.7 28.74 2.54 Favored 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 122.02 -0.425 . . . . 0.0 111.184 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -152.98 -75.81 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.45 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.683 ' O ' HG23 ' A' ' 184' ' ' ILE . 0.5 OUTLIER -117.75 -156.75 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 115.441 -0.379 . . . . 0.0 110.296 -179.359 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.713 HG11 ' CG ' ' A' ' 192' ' ' GLU . 21.3 t -86.48 139.49 17.28 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.393 0 CA-C-O 121.399 0.619 . . . . 0.0 110.916 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.563 HG23 ' CA ' ' A' ' 184' ' ' ILE . 0.3 OUTLIER -88.58 -35.84 8.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.468 -179.841 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . 0.466 ' HB2' ' CE1' ' A' ' 221' ' ' PHE . 31.1 t80 -178.34 144.31 0.3 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.997 179.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . 0.713 ' CG ' HG11 ' A' ' 189' ' ' VAL . 0.3 OUTLIER -131.87 159.03 39.77 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.937 0.398 . . . . 0.0 110.801 179.293 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 146.16 -126.05 2.41 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.852 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 0.628 ' CA ' HG22 ' A' ' 181' ' ' VAL . 11.0 pt-20 -143.07 -176.37 4.89 Favored 'General case' 0 CA--C 1.499 -1.011 0 CA-C-O 121.289 0.566 . . . . 0.0 111.667 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.523 HG12 HG13 ' A' ' 181' ' ' VAL . 12.3 mm -87.42 143.41 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.485 -179.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.78 -57.1 3.03 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 1.2 m -151.59 152.94 33.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.282 178.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.597 HD11 ' C ' ' A' ' 206' ' ' ARG . 0.3 OUTLIER -134.87 119.05 17.62 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.694 0.759 . . . . 0.0 112.014 179.9 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.28 125.31 9.94 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 114.445 -1.252 . . . . 0.0 109.431 178.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . 0.639 ' NH1' HG11 ' A' ' 205' ' ' VAL . 1.2 ptp85 -86.88 -145.98 0.12 Allowed 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.244 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -84.5 108.57 17.36 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 54.13 29.38 10.32 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.501 -179.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -150.61 116.43 5.54 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 120.933 0.397 . . . . 0.0 111.342 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -89.49 55.2 3.15 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.066 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.639 HG11 ' NH1' ' A' ' 200' ' ' ARG . 35.3 m -56.55 158.16 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.962 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.796 -179.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . 0.597 ' C ' HD11 ' A' ' 198' ' ' LEU . 2.5 ttp-105 -89.07 -27.82 20.54 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.716 -178.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.438 ' HB3' ' HB2' ' A' ' 174' ' ' LYS . 1.5 mp0 -139.99 178.36 7.32 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.092 0.472 . . . . 0.0 111.162 179.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.665 ' O ' HG21 ' A' ' 170' ' ' VAL . 0.5 OUTLIER -151.02 75.74 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.854 179.121 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.431 ' HB2' ' HB3' ' A' ' 174' ' ' LYS . . . -97.27 175.18 6.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.081 0.467 . . . . 0.0 112.223 -178.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 83.88 -75.46 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.858 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 178.26 36.89 0.06 OUTLIER Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.372 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -98.32 144.06 28.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.901 0.382 . . . . 0.0 111.171 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.62 131.32 44.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.021 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' CYS . . . . . 0.53 ' HB3' HG21 ' A' ' 208' ' ' VAL . 50.8 t -134.22 149.86 51.01 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.753 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -88.99 116.54 4.69 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.568 -0.825 . . . . 0.0 111.621 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.63 HD11 HG21 ' A' ' 175' ' ' ILE . 0.1 OUTLIER -143.68 145.65 32.61 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 121.113 0.482 . . . . 0.0 111.386 -178.784 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . 0.626 HG23 HD12 ' A' ' 165' ' ' ILE . 0.0 OUTLIER -86.44 146.48 26.41 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.348 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . 0.623 HG23 HG21 ' A' ' 181' ' ' VAL . 1.6 mp -110.36 87.91 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 1.4 tttt 45.93 -144.44 0.23 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.018 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -87.17 62.03 7.06 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 121.097 0.475 . . . . 0.0 111.016 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.51 ' CZ ' HD21 ' A' ' 183' ' ' LEU . 0.1 OUTLIER -55.59 122.23 10.86 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 114.423 1.268 . . . . 0.0 114.423 179.034 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -87.92 -45.69 10.03 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 114.899 -1.046 . . . . 0.0 108.422 176.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . 0.452 ' OD1' ' N ' ' A' ' 223' ' ' ASP . 0.0 OUTLIER -81.65 135.14 35.54 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.994 177.588 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.636 ' N ' HD13 ' A' ' 224' ' ' ILE . 0.2 OUTLIER -134.67 179.65 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.718 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.411 ' O ' ' C ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER 57.33 114.44 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 114.479 -1.237 . . . . 0.0 110.052 -178.96 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . 0.544 ' H ' ' HA ' ' A' ' 155' ' ' GLN . 5.2 tm-20 11.41 61.1 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 124.671 1.232 . . . . 0.0 112.919 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . 0.43 ' N ' HG11 ' A' ' 153' ' ' VAL . . . -60.19 -68.02 1.88 Allowed Glycine 0 N--CA 1.433 -1.541 0 CA-C-N 114.695 -1.139 . . . . 0.0 111.736 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.463 ' O ' HG12 ' A' ' 153' ' ' VAL . 0.8 OUTLIER -164.8 -148.93 0.12 Allowed 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 179.631 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . 0.739 HG22 ' HG2' ' A' ' 152' ' ' GLU . 92.1 t -88.44 129.61 39.32 Favored 'Isoleucine or valine' 0 C--N 1.346 0.453 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.517 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . 0.572 HD12 ' HB3' ' A' ' 168' ' ' CYS . 17.4 mt -98.94 157.17 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 O-C-N 123.689 0.618 . . . . 0.0 111.564 -179.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' GLU . . . . . 0.423 ' CG ' ' HG2' ' A' ' 150' ' ' GLN . 0.0 OUTLIER -146.46 109.97 4.82 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -179.673 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.719 ' HB3' ' HA3' ' A' ' 149' ' ' GLY . . . -88.96 131.14 35.29 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.397 178.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' TYR . . . . . 0.438 ' CE1' ' HB3' ' A' ' 180' ' ' LYS . 11.8 p90 -128.95 142.83 50.8 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.724 0.297 . . . . 0.0 110.962 -179.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.68 HG11 HG22 ' A' ' 238' ' ' VAL . 0.9 OUTLIER -175.62 -172.64 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.607 -179.906 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' MET . . . . . 0.55 ' H ' HG22 ' A' ' 234' ' ' VAL . 7.8 mtm -88.68 -162.74 0.88 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.671 0.272 . . . . 0.0 110.842 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 68.9 mm-40 -95.56 37.83 1.18 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.934 0.397 . . . . 0.0 111.361 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . 0.804 ' O ' ' HB3' ' A' ' 241' ' ' ALA . 1.6 mp0 -131.58 46.31 2.67 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.79 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.983 HG21 HG21 ' A' ' 148' ' ' ILE . 2.8 t -93.46 161.95 2.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.986 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' A' ' 238' ' ' VAL . . . 72.86 -60.86 0.52 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.517 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -89.19 -4.36 58.26 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . 0.804 ' HB3' ' O ' ' A' ' 237' ' ' GLU . . . . . . . . 0 C--N 1.312 -1.065 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.01 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.836 0.351 . . . . 0.0 111.307 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 59.25 85.61 0.1 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.033 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.56 40.69 1.15 Allowed 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.091 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.555 ' HG3' HG23 ' A' ' 147' ' ' VAL . 17.4 tptt -94.73 -76.59 0.48 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.099 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.564 HG11 ' HB2' ' A' ' 150' ' ' GLN . 13.6 t -122.64 142.73 38.03 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.555 0 CA-C-O 121.507 0.67 . . . . 0.0 111.706 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.706 ' CD1' HG21 ' A' ' 238' ' ' VAL . 3.9 tp -118.01 -20.05 5.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.084 178.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.434 ' O ' ' HB3' ' A' ' 232' ' ' ALA . . . -178.02 85.17 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.445 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.564 ' HB2' HG11 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -93.72 132.98 37.56 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.764 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.439 ' CB ' ' HB2' ' A' ' 168' ' ' CYS . . . -152.14 175.88 12.12 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 119.736 -0.786 . . . . 0.0 113.059 -177.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.835 ' HG2' HG22 ' A' ' 229' ' ' VAL . 13.1 mt-10 -120.47 124.09 44.56 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.445 -1.252 . . . . 0.0 110.046 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.474 HG12 ' O ' ' A' ' 228' ' ' ASP . 3.6 p -50.52 134.46 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -178.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -89.46 -61.35 1.72 Allowed 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 175.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.528 ' HA ' ' H ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER -161.13 -160.46 0.73 Allowed 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 113.711 -1.586 . . . . 0.0 109.651 175.595 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.496 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 4.3 p -147.99 168.24 22.83 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 177.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.681 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 6.4 m-85 -118.11 75.58 1.02 Allowed 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -178.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.05 63.28 7.94 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 122.121 0.962 . . . . 0.0 108.481 178.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 83.9 t -90.9 157.75 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 CA-C-N 113.709 -1.587 . . . . 0.0 110.229 -178.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 1.2 m -92.5 34.57 1.05 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.217 0.532 . . . . 0.0 109.849 178.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 9.8 mttt -151.67 -32.97 0.15 Allowed 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.442 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.868 HG11 HD12 ' A' ' 165' ' ' ILE . 84.0 t -99.83 -103.21 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.278 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . 0.513 ' N ' HG12 ' A' ' 162' ' ' VAL . . . -159.12 -101.56 0.17 Allowed Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 111.481 -0.648 . . . . 0.0 111.481 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.598 ' CG2' HG22 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -153.83 36.18 0.44 Allowed 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 114.152 -1.024 . . . . 0.0 108.49 178.25 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.868 HD12 HG11 ' A' ' 162' ' ' VAL . 3.8 mt -42.14 98.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.441 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.591 ' HB3' HD13 ' A' ' 218' ' ' ILE . . . -91.71 121.05 33.0 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.006 -0.997 . . . . 0.0 112.298 -179.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -88.73 150.96 22.01 Favored Glycine 0 N--CA 1.441 -0.969 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 178.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.485 ' HB3' HD13 ' A' ' 230' ' ' ILE . 0.0 OUTLIER -145.92 136.05 23.74 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 117.377 0.588 . . . . 0.0 110.776 -178.409 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . 0.419 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 31.4 t80 -87.2 123.56 32.36 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 177.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.685 HG21 ' O ' ' A' ' 208' ' ' VAL . 38.8 t -85.13 148.08 5.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -175.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -138.86 16.86 2.67 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-N 114.298 -1.319 . . . . 0.0 111.81 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.543 ' H ' HG12 ' A' ' 170' ' ' VAL . 8.6 t0 -150.19 -147.42 0.23 Allowed 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -179.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -44.39 -104.47 0.01 OUTLIER Glycine 0 CA--C 1.53 1.025 0 N-CA-C 114.685 0.634 . . . . 0.0 114.685 -179.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.747 ' HG3' ' HB2' ' A' ' 209' ' ' ALA . 0.0 OUTLIER -151.1 126.61 10.11 Favored 'General case' 0 CA--C 1.513 -0.449 0 O-C-N 122.608 -0.348 . . . . 0.0 111.458 -179.04 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.656 ' O ' HG23 ' A' ' 175' ' ' ILE . 1.5 tp -88.82 83.76 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 CA-C-O 122.035 0.922 . . . . 0.0 109.238 177.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.518 HG22 ' HB3' ' A' ' 207' ' ' GLU . 0.0 OUTLIER -89.18 -177.91 5.53 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.384 -1.28 . . . . 0.0 112.932 -177.137 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 37.7 mtm180 -74.71 -44.11 51.71 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 114.669 -1.151 . . . . 0.0 110.839 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . 0.531 ' O ' HG13 ' A' ' 238' ' ' VAL . 22.9 t70 -89.04 57.68 4.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.75 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.575 ' OG ' HG11 ' A' ' 238' ' ' VAL . 3.3 m -148.22 163.33 37.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.401 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.479 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 2.7 mptm? -93.77 176.48 6.34 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.104 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.546 HG13 HD11 ' A' ' 195' ' ' ILE . 1.1 m -151.14 149.99 13.69 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.476 0 CA-C-O 121.598 0.713 . . . . 0.0 111.952 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . 0.449 ' N ' ' O ' ' A' ' 231' ' ' GLU . 41.3 ttp180 -153.39 104.36 2.75 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.108 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.595 HD21 ' CZ ' ' A' ' 221' ' ' PHE . 0.3 OUTLIER -99.49 170.88 8.31 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-O 120.976 0.417 . . . . 0.0 111.008 -179.75 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.759 HG23 ' O ' ' A' ' 188' ' ' ILE . 48.4 mt -152.92 141.64 14.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.194 -177.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.472 ' O ' HG22 ' A' ' 184' ' ' ILE . 7.1 ttp180 -86.49 -157.38 0.35 Allowed 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -94.17 27.14 2.97 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.724 178.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -154.25 -43.59 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.862 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.759 ' O ' HG23 ' A' ' 184' ' ' ILE . 0.4 OUTLIER -150.24 -160.52 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -178.098 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.658 HG11 ' CD ' ' A' ' 192' ' ' GLU . 35.5 t -85.41 134.98 25.87 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.397 0 CA-C-O 121.439 0.638 . . . . 0.0 110.386 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.486 HG23 ' HG ' ' A' ' 183' ' ' LEU . 0.2 OUTLIER -88.79 -32.54 5.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.619 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . 0.522 ' CB ' ' CE1' ' A' ' 221' ' ' PHE . 79.8 t80 179.9 158.41 0.72 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.673 178.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . 0.658 ' CD ' HG11 ' A' ' 189' ' ' VAL . 7.6 mp0 -143.87 154.28 43.21 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.969 0.414 . . . . 0.0 110.443 178.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 148.5 -129.33 3.08 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.843 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 0.479 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 13.3 pt-20 -139.38 -174.38 3.86 Favored 'General case' 0 CA--C 1.498 -1.039 0 CA-C-O 121.27 0.557 . . . . 0.0 111.393 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.546 HD11 HG13 ' A' ' 181' ' ' VAL . 4.2 mp -88.0 143.84 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.009 -178.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -89.24 -53.29 4.63 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 18.3 p -151.2 143.22 23.95 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.308 178.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.727 ' CD1' HD22 ' A' ' 216' ' ' LEU . 0.5 OUTLIER -119.67 114.42 22.16 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.329 0.585 . . . . 0.0 111.681 -179.571 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 26.9 tttt -150.48 122.15 8.04 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.137 179.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -88.04 -160.16 0.6 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.968 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -87.03 -12.76 46.37 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.489 0.185 . . . . 0.0 110.931 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.97 -59.28 1.94 Allowed 'General case' 0 N--CA 1.44 -0.952 0 CA-C-O 120.633 0.254 . . . . 0.0 110.775 179.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -152.54 -169.29 3.3 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 120.907 0.384 . . . . 0.0 111.01 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . 0.403 ' HA ' ' HA ' ' A' ' 199' ' ' LYS . 4.4 t70 -93.07 66.31 4.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.189 179.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 32.9 m -61.07 160.06 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 CA-C-O 121.521 0.677 . . . . 0.0 112.242 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . 0.431 ' O ' ' HB ' ' A' ' 176' ' ' THR . 0.2 OUTLIER -89.43 -36.74 15.28 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 114.735 -1.121 . . . . 0.0 111.607 -178.616 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.518 ' HB3' HG22 ' A' ' 176' ' ' THR . 0.6 OUTLIER -137.53 177.23 8.02 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.301 0.572 . . . . 0.0 111.895 -179.799 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.685 ' O ' HG21 ' A' ' 170' ' ' VAL . 0.0 OUTLIER -150.86 82.64 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.074 -0.967 . . . . 0.0 109.46 179.058 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.747 ' HB2' ' HG3' ' A' ' 174' ' ' LYS . . . -101.5 171.67 7.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.093 0.473 . . . . 0.0 112.182 -178.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 83.22 -72.55 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.998 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 178.0 37.89 0.06 OUTLIER Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.404 179.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . 0.419 ' HB3' HG12 ' A' ' 208' ' ' VAL . 2.1 m-85 -98.09 142.93 29.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.95 0.405 . . . . 0.0 111.565 -179.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.67 160.71 16.47 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.482 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -150.41 -164.97 2.14 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.863 0.363 . . . . 0.0 111.04 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . 0.461 ' C ' HG23 ' A' ' 165' ' ' ILE . . . -148.64 96.23 0.17 Allowed Glycine 0 N--CA 1.451 -0.316 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.727 HD22 ' CD1' ' A' ' 198' ' ' LEU . 0.5 OUTLIER -131.17 143.6 50.73 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -177.642 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . 0.542 ' C ' HD12 ' A' ' 218' ' ' ILE . 0.0 OUTLIER -78.0 143.79 37.25 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 176.404 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . 0.591 HD13 ' HB3' ' A' ' 166' ' ' ALA . 1.6 mp -108.26 88.14 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.709 -178.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 9.8 tttt 47.16 -141.91 0.44 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.663 179.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -86.42 55.73 3.68 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.091 0.472 . . . . 0.0 110.99 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.595 ' CZ ' HD21 ' A' ' 183' ' ' LEU . 0.1 OUTLIER -57.51 132.0 51.85 Favored 'General case' 0 C--N 1.339 0.126 0 N-CA-C 116.086 1.884 . . . . 0.0 116.086 178.964 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.42 -42.3 8.55 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 114.35 -1.296 . . . . 0.0 108.658 175.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . 0.542 ' HB3' ' CE1' ' A' ' 221' ' ' PHE . 0.0 OUTLIER -64.96 164.12 13.27 Favored 'General case' 0 C--N 1.351 0.65 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.794 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.609 ' N ' HD13 ' A' ' 224' ' ' ILE . 0.2 OUTLIER -155.36 -177.11 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 114.897 -1.047 . . . . 0.0 111.988 176.39 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.418 ' CG ' HG12 ' A' ' 224' ' ' ILE . 0.0 OUTLIER 34.12 103.92 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.752 1.221 . . . . 0.0 112.345 -179.611 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . 0.528 ' H ' ' HA ' ' A' ' 155' ' ' GLN . 18.5 tt0 20.35 59.49 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.228 0 O-C-N 124.487 1.117 . . . . 0.0 113.224 179.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -61.65 -61.73 6.5 Favored Glycine 0 N--CA 1.432 -1.574 0 CA-C-N 114.869 -1.06 . . . . 0.0 112.482 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.474 ' O ' HG12 ' A' ' 153' ' ' VAL . 0.6 OUTLIER -164.06 -152.02 0.18 Allowed 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -179.544 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . 0.835 HG22 ' HG2' ' A' ' 152' ' ' GLU . 92.2 t -90.02 134.41 29.13 Favored 'Isoleucine or valine' 0 C--N 1.35 0.604 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.945 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . 0.485 HD13 ' HB3' ' A' ' 168' ' ' CYS . 2.7 mp -103.39 158.69 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 O-C-N 123.544 0.528 . . . . 0.0 111.228 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' GLU . . . . . 0.449 ' O ' ' N ' ' A' ' 182' ' ' ARG . 9.2 tt0 -147.79 111.32 4.98 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.653 ' HB2' HD12 ' A' ' 175' ' ' ILE . . . -87.7 139.68 30.28 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.683 179.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' TYR . . . . . 0.495 ' CA ' HG22 ' A' ' 148' ' ' ILE . 30.3 p90 -139.03 135.01 33.79 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.146 -179.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.635 HG13 ' N ' ' A' ' 235' ' ' MET . 0.5 OUTLIER -176.93 -161.05 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.668 179.716 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' MET . . . . . 0.635 ' N ' HG13 ' A' ' 234' ' ' VAL . 0.0 OUTLIER -95.94 -167.54 1.61 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.795 0.331 . . . . 0.0 110.687 -179.892 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.91 32.7 2.55 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.092 0.472 . . . . 0.0 111.334 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -118.84 43.04 2.65 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.023 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.706 HG21 ' CD1' ' A' ' 148' ' ' ILE . 0.6 OUTLIER -108.44 168.38 3.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.075 -179.137 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . 0.438 ' H ' HG12 ' A' ' 238' ' ' VAL . . . 69.84 -64.87 0.33 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.885 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.67 -3.95 57.99 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.313 -0.987 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.059 -179.995 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.765 0.317 . . . . 0.0 111.215 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -67.98 139.65 56.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.972 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -93.84 42.23 1.09 Allowed 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.389 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -94.3 -178.51 4.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.952 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.719 HG11 ' HB2' ' A' ' 150' ' ' GLN . 20.7 t -58.68 143.22 13.33 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.449 0 CA-C-O 121.415 0.626 . . . . 0.0 111.424 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.542 HG22 ' O ' ' A' ' 148' ' ' ILE . 16.1 mm -129.7 6.98 2.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.843 178.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.59 ' CA ' ' HB3' ' A' ' 232' ' ' ALA . . . 173.9 72.88 0.05 OUTLIER Glycine 0 C--N 1.343 0.936 0 C-N-CA 121.127 -0.559 . . . . 0.0 111.904 179.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.719 ' HB2' HG11 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -93.71 131.5 38.98 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 116.871 0.335 . . . . 0.0 110.305 179.855 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.499 ' O ' HG13 ' A' ' 229' ' ' VAL . . . -151.65 176.47 11.33 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -178.338 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.46 ' HA ' ' HA ' ' A' ' 229' ' ' VAL . 1.9 mt-10 -123.69 125.82 45.45 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.746 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.472 HG12 ' O ' ' A' ' 228' ' ' ASP . 1.8 p -55.16 127.21 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-O 121.569 0.699 . . . . 0.0 112.196 -179.221 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.485 ' O ' ' HB3' ' A' ' 226' ' ' GLU . 0.0 OUTLIER -89.87 -55.16 3.74 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 105.056 -2.201 . . . . 0.0 105.056 175.736 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.83 -164.07 0.86 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.861 174.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.554 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 26.3 p -143.41 -175.9 4.73 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 178.253 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.669 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 21.7 m-85 -144.11 76.53 1.51 Allowed 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.475 ' HG2' HG13 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -86.52 62.64 7.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 122.428 1.109 . . . . 0.0 108.498 178.285 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.483 HG12 ' N ' ' A' ' 161' ' ' LYS . 45.8 t -89.85 154.73 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 CA-C-N 113.236 -1.802 . . . . 0.0 110.226 -178.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 26.3 t -89.83 36.74 0.86 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.057 0.456 . . . . 0.0 110.006 178.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.483 ' N ' HG12 ' A' ' 159' ' ' VAL . 1.4 mttt -150.6 -34.18 0.16 Allowed 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.213 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.501 HG12 ' N ' ' A' ' 163' ' ' GLY . 84.9 t -101.65 -101.81 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . 0.501 ' N ' HG12 ' A' ' 162' ' ' VAL . . . -158.79 -101.74 0.18 Allowed Glycine 0 C--O 1.224 -0.498 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 178.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.455 ' C ' HG23 ' A' ' 217' ' ' THR . 0.0 OUTLIER -152.32 37.07 0.53 Allowed 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 177.48 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.669 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 2.2 mm -40.28 93.21 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.338 0.095 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.773 -179.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.554 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . -84.98 116.47 23.4 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.457 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -87.49 134.4 12.44 Favored Glycine 0 N--CA 1.438 -1.181 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 178.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.414 ' HB2' ' CB ' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -136.46 131.21 33.73 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.859 0.329 . . . . 0.0 110.374 -178.503 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . 0.416 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 41.1 t80 -85.64 126.8 34.2 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 177.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.801 HG21 ' O ' ' A' ' 208' ' ' VAL . 45.4 t -85.73 146.36 6.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -175.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.2 p -138.44 14.19 2.77 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 114.402 -1.272 . . . . 0.0 111.807 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.408 ' H ' HG12 ' A' ' 170' ' ' VAL . 4.6 t70 -150.46 -142.58 0.12 Allowed 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -44.54 -105.36 0.01 OUTLIER Glycine 0 CA--C 1.53 1.015 0 N-CA-C 114.455 0.542 . . . . 0.0 114.455 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.808 ' HG2' ' HB2' ' A' ' 209' ' ' ALA . 10.7 mttm -151.8 143.13 23.39 Favored 'General case' 0 CA--C 1.516 -0.347 0 O-C-N 122.301 -0.529 . . . . 0.0 111.995 -179.1 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.622 ' CG1' HG22 ' A' ' 170' ' ' VAL . 11.2 mm -93.23 90.52 3.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 176.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.459 HG22 ' HB3' ' A' ' 207' ' ' GLU . 0.1 OUTLIER -106.13 174.7 5.77 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.488 0.661 . . . . 0.0 112.677 -177.495 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.408 ' HG3' ' HB2' ' A' ' 198' ' ' LEU . 0.1 OUTLIER -72.96 -42.59 63.22 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.208 179.351 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -88.28 56.22 3.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.141 -179.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.495 ' OG ' HG21 ' A' ' 238' ' ' VAL . 0.5 OUTLIER -150.2 161.51 42.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.418 179.697 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 0.0 OUTLIER -89.18 -177.45 5.41 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.5 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.661 HG11 HG13 ' A' ' 218' ' ' ILE . 1.4 m -146.07 157.29 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 CA-C-O 121.227 0.537 . . . . 0.0 111.638 179.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . 0.418 ' N ' ' O ' ' A' ' 231' ' ' GLU . 6.0 ttt85 -152.78 102.54 2.7 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.312 -0.858 . . . . 0.0 113.196 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.708 HD12 ' HB3' ' A' ' 191' ' ' TYR . 0.3 OUTLIER -86.36 154.12 21.43 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-O 121.701 0.763 . . . . 0.0 113.034 -179.937 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.476 ' N ' HG23 ' A' ' 190' ' ' VAL . 3.2 mp -148.5 121.24 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 113.989 -1.46 . . . . 0.0 112.27 178.124 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.419 ' N ' HG22 ' A' ' 190' ' ' VAL . 1.3 ttm180 -85.99 -150.44 0.14 Allowed 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 177.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -93.99 27.48 2.78 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 118.78 0.718 . . . . 0.0 110.766 178.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -154.81 -77.54 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.835 -0.697 . . . . 0.0 112.673 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -115.44 -155.28 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 115.277 -0.462 . . . . 0.0 110.734 -179.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.775 HG11 ' CG ' ' A' ' 192' ' ' GLU . 44.2 t -87.08 135.44 25.21 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.102 0 CA-C-O 121.565 0.698 . . . . 0.0 111.74 -179.181 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.793 HG12 ' OD2' ' A' ' 223' ' ' ASP . 0.2 OUTLIER -89.58 -34.51 6.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 114.665 -1.152 . . . . 0.0 108.961 178.637 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . 0.708 ' HB3' HD12 ' A' ' 183' ' ' LEU . 16.6 t80 -158.33 158.79 35.0 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.35 178.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . 0.775 ' CG ' HG11 ' A' ' 189' ' ' VAL . 14.3 mt-10 -150.33 155.81 40.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.112 178.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 134.7 -119.34 2.15 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.257 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 0.628 ' CA ' HG22 ' A' ' 181' ' ' VAL . 17.6 pt-20 -150.32 -175.01 4.91 Favored 'General case' 0 CA--C 1.496 -1.097 0 CA-C-O 121.357 0.599 . . . . 0.0 111.675 -179.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.567 ' CD1' HG13 ' A' ' 181' ' ' VAL . 4.3 mp -88.48 143.38 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.322 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' ASP . . . . . 0.421 ' CB ' ' HB ' ' A' ' 217' ' ' THR . 0.4 OUTLIER -88.93 -57.47 2.89 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.412 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 35.2 t -151.53 153.03 33.78 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.222 179.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.564 HD21 ' O ' ' A' ' 175' ' ' ILE . 0.1 OUTLIER -123.0 119.22 29.73 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-O 121.37 0.605 . . . . 0.0 111.484 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.34 118.7 6.42 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.126 179.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 4.6 ptm85 -87.86 -144.27 0.13 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.177 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -84.57 109.32 17.87 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 53.0 29.25 7.65 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.767 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -150.85 130.31 12.94 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 120.947 0.403 . . . . 0.0 111.316 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -98.34 71.42 2.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.078 179.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 36.0 m -72.12 166.33 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.921 0 CA-C-O 121.618 0.723 . . . . 0.0 112.562 -178.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . 0.443 ' O ' ' HA ' ' A' ' 176' ' ' THR . 16.6 ttp180 -89.07 -41.1 12.51 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 114.483 -1.235 . . . . 0.0 111.556 -178.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.459 ' HB3' HG22 ' A' ' 176' ' ' THR . 0.3 OUTLIER -138.09 -177.18 4.71 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.135 0.493 . . . . 0.0 111.684 -179.544 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.801 ' O ' HG21 ' A' ' 170' ' ' VAL . 0.2 OUTLIER -150.88 81.56 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.801 179.316 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.808 ' HB2' ' HG2' ' A' ' 174' ' ' LYS . . . -99.74 175.28 5.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.056 0.455 . . . . 0.0 112.154 -178.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 82.59 -75.0 0.03 OUTLIER 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.697 -179.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 178.47 37.31 0.06 OUTLIER Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.376 -0.916 . . . . 0.0 112.362 179.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -99.22 145.28 27.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.963 0.411 . . . . 0.0 111.196 -179.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.4 131.79 46.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.453 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' CYS . . . . . 0.566 ' HB3' HG21 ' A' ' 208' ' ' VAL . 50.0 t -134.96 144.45 47.42 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.399 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . 0.625 ' O ' HD12 ' A' ' 165' ' ' ILE . . . -88.58 108.15 3.42 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.494 -0.86 . . . . 0.0 111.995 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.574 HD12 ' CD1' ' A' ' 218' ' ' ILE . 0.3 OUTLIER -132.54 140.51 48.33 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 120.97 0.414 . . . . 0.0 111.436 -179.264 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . 0.455 HG23 ' C ' ' A' ' 164' ' ' THR . 0.2 OUTLIER -78.73 138.8 38.42 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 177.907 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . 0.661 HG13 HG11 ' A' ' 181' ' ' VAL . 1.4 mp -105.79 95.4 3.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 -178.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 44.04 -145.53 0.11 Allowed 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.928 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 -88.16 63.83 7.42 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-O 120.85 0.357 . . . . 0.0 111.2 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.683 ' CZ ' HD13 ' A' ' 183' ' ' LEU . 0.1 OUTLIER -54.4 118.44 4.13 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 179.002 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -84.14 -43.43 15.01 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.755 176.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . 0.793 ' OD2' HG12 ' A' ' 190' ' ' VAL . 0.0 OUTLIER -87.74 132.26 34.2 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.97 178.455 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.475 HG13 ' HG2' ' A' ' 158' ' ' LYS . 0.1 OUTLIER -116.61 179.56 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 CA-C-O 121.09 0.471 . . . . 0.0 112.003 -179.646 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.421 ' O ' ' N ' ' A' ' 227' ' ' GLY . 0.0 OUTLIER 55.67 120.88 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.543 179.853 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . 0.485 ' HB3' ' O ' ' A' ' 154' ' ' ARG . 3.3 pt-20 -3.97 71.73 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . 0.439 ' N ' HG11 ' A' ' 153' ' ' VAL . . . -64.48 -63.42 4.3 Favored Glycine 0 N--CA 1.43 -1.722 0 CA-C-N 114.7 -1.136 . . . . 0.0 111.616 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.472 ' O ' HG12 ' A' ' 153' ' ' VAL . 1.0 OUTLIER -164.76 -148.49 0.11 Allowed 'General case' 0 C--O 1.22 -0.491 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 179.585 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . 0.499 HG13 ' O ' ' A' ' 151' ' ' ALA . 61.9 t -89.47 145.76 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.225 0 O-C-N 122.091 -0.381 . . . . 0.0 110.494 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . 0.419 HG13 ' CD2' ' A' ' 183' ' ' LEU . 2.6 mp -117.01 154.4 18.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.156 -179.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' GLU . . . . . 0.506 ' OE2' HG22 ' A' ' 147' ' ' VAL . 7.5 tt0 -143.27 113.96 7.56 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.403 0.62 . . . . 0.0 111.948 -179.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.59 ' HB3' ' CA ' ' A' ' 149' ' ' GLY . . . -88.45 128.45 35.53 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.497 178.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -130.5 129.48 42.95 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.869 -178.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.604 HG12 ' HG3' ' A' ' 236' ' ' GLN . 4.3 t -153.98 139.4 10.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.982 0.42 . . . . 0.0 111.762 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.59 37.25 1.96 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 178.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . 0.604 ' HG3' HG12 ' A' ' 234' ' ' VAL . 45.7 mt-30 -120.08 -143.54 0.35 Allowed 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.316 -178.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -137.31 72.77 1.42 Allowed 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.52 ' O ' ' HB3' ' A' ' 239' ' ' ALA . 2.1 t -82.72 160.64 3.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.862 -178.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' A' ' 238' ' ' VAL . . . 78.62 -59.77 0.41 Allowed 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.842 -179.253 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.8 -7.66 53.87 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.312 -1.031 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.038 179.998 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 2.8 t80 . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.888 0.375 . . . . 0.0 111.251 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 60.64 -175.47 0.11 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.97 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -93.7 42.46 1.1 Allowed 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.453 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 2.0 tttm -76.26 -166.33 0.6 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.527 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.706 HG11 ' HB2' ' A' ' 150' ' ' GLN . 14.9 t -59.53 140.9 17.04 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.637 0 CA-C-O 121.308 0.575 . . . . 0.0 111.315 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.704 HD11 ' HB3' ' A' ' 179' ' ' SER . 1.8 pp -124.97 -1.78 5.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.048 178.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.568 ' CA ' ' HB3' ' A' ' 232' ' ' ALA . . . 179.51 73.95 0.06 OUTLIER Glycine 0 C--N 1.34 0.791 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.165 179.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.706 ' HB2' HG11 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -90.99 132.8 35.76 Favored 'General case' 0 CA--C 1.509 -0.61 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.249 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.417 ' CB ' ' HB2' ' A' ' 168' ' ' CYS . . . -151.57 174.71 13.12 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 121.457 0.646 . . . . 0.0 112.458 -178.124 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.752 ' CG ' HG22 ' A' ' 229' ' ' VAL . 0.8 OUTLIER -119.98 122.14 40.52 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.021 179.691 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.443 HG12 ' O ' ' A' ' 228' ' ' ASP . 2.6 p -50.05 134.13 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -89.29 -63.31 1.31 Allowed 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 175.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.469 ' HA ' ' H ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER -161.51 -162.03 0.85 Allowed 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 113.826 -1.534 . . . . 0.0 109.198 175.206 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.514 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 7.5 p -145.89 157.3 43.91 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 120.829 0.347 . . . . 0.0 110.392 177.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.681 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 2.3 m-85 -104.21 72.13 1.06 Allowed 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -177.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 16.7 tttt -85.67 63.72 8.22 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 122.125 0.964 . . . . 0.0 108.826 178.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 95.8 t -89.9 158.21 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 CA-C-N 113.673 -1.603 . . . . 0.0 109.906 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 25.2 p -92.62 32.97 1.16 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.224 0.535 . . . . 0.0 110.036 178.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 3.2 mtmt -152.02 -31.54 0.15 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.644 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.459 HG12 ' N ' ' A' ' 163' ' ' GLY . 98.5 t -98.98 -101.19 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 O-C-N 122.171 -0.331 . . . . 0.0 110.234 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . 0.459 ' N ' HG12 ' A' ' 162' ' ' VAL . . . -158.72 -105.95 0.22 Allowed Glycine 0 N--CA 1.451 -0.361 0 N-CA-C 111.644 -0.583 . . . . 0.0 111.644 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.504 HG21 HG21 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -153.7 34.85 0.45 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.378 -0.911 . . . . 0.0 108.944 178.391 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.681 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 3.8 mm -42.45 94.87 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.577 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.514 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . -87.77 117.8 26.85 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 114.748 -1.114 . . . . 0.0 111.189 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -88.39 153.97 24.72 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 179.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.417 ' HB2' ' CB ' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -148.29 136.12 20.88 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.922 0.361 . . . . 0.0 110.81 -178.268 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . 0.408 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 33.3 t80 -87.39 124.96 33.95 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 177.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.77 HG21 ' O ' ' A' ' 208' ' ' VAL . 24.5 t -85.08 144.51 9.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -175.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -136.41 14.3 3.23 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-N 114.544 -1.207 . . . . 0.0 112.013 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.457 ' H ' HG12 ' A' ' 170' ' ' VAL . 4.2 t0 -150.52 -144.16 0.15 Allowed 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -179.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -41.32 -106.0 0.01 OUTLIER Glycine 0 CA--C 1.533 1.188 0 N-CA-C 115.197 0.839 . . . . 0.0 115.197 -178.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.408 ' HB2' ' HB3' ' A' ' 207' ' ' GLU . 0.0 OUTLIER -150.69 146.74 26.66 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.014 0.435 . . . . 0.0 111.619 -178.399 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.599 HG13 HG22 ' A' ' 170' ' ' VAL . 10.6 mm -99.39 83.23 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 176.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.561 HG21 ' HB ' ' A' ' 238' ' ' VAL . 0.1 OUTLIER -95.88 168.5 10.6 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -177.177 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.412 ' CG ' ' HB3' ' A' ' 198' ' ' LEU . 33.8 mtm180 -64.58 -45.07 88.58 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 114.546 -1.206 . . . . 0.0 110.743 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -89.4 59.99 5.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.743 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.704 ' HB3' HD11 ' A' ' 148' ' ' ILE . 58.9 m -149.13 156.04 41.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.756 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 3.5 mptp? -89.18 -179.33 5.86 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.696 179.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.812 HG21 HD12 ' A' ' 218' ' ' ILE . 1.1 m -150.86 150.12 13.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.493 0.663 . . . . 0.0 111.953 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . 0.439 ' N ' ' O ' ' A' ' 231' ' ' GLU . 11.5 ttt85 -153.25 102.43 2.61 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.463 179.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.622 ' C ' HD12 ' A' ' 184' ' ' ILE . 0.3 OUTLIER -100.58 167.67 10.2 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-O 120.947 0.403 . . . . 0.0 111.382 -179.829 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.666 HG23 ' O ' ' A' ' 188' ' ' ILE . 4.7 mp -151.56 139.98 14.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.944 -177.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.504 ' N ' HG22 ' A' ' 190' ' ' VAL . 0.1 OUTLIER -87.16 -153.19 0.21 Allowed 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.022 -0.99 . . . . 0.0 108.86 178.117 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -94.71 28.02 2.83 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 118.092 0.405 . . . . 0.0 111.296 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -152.96 -76.75 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.556 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.666 ' O ' HG23 ' A' ' 184' ' ' ILE . 0.4 OUTLIER -116.12 -156.57 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 115.525 -0.338 . . . . 0.0 110.319 -179.54 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.759 HG11 ' CD ' ' A' ' 192' ' ' GLU . 31.0 t -86.16 138.84 18.32 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 CA-C-O 121.476 0.655 . . . . 0.0 110.702 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.577 HG23 ' CA ' ' A' ' 184' ' ' ILE . 0.6 OUTLIER -87.68 -37.11 10.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 114.913 -1.04 . . . . 0.0 108.89 179.847 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . 0.439 ' CE2' ' HA ' ' A' ' 221' ' ' PHE . 0.5 OUTLIER -178.69 150.49 0.52 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.354 179.617 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . 0.759 ' CD ' HG11 ' A' ' 189' ' ' VAL . 2.3 mp0 -137.13 158.35 44.63 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.935 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 144.53 -132.73 4.9 Favored Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.556 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 0.736 ' O ' HG23 ' A' ' 218' ' ' ILE . 4.1 pt-20 -143.58 -179.34 6.37 Favored 'General case' 0 CA--C 1.498 -1.023 0 CA-C-O 121.186 0.517 . . . . 0.0 111.051 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.866 HG12 HD13 ' A' ' 216' ' ' LEU . 4.5 mp -88.73 143.05 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.877 -178.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -91.81 -43.79 9.33 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 48.8 m -151.29 145.56 25.43 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.09 179.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.536 HD12 ' HB3' ' A' ' 216' ' ' LEU . 16.7 tp -119.39 113.82 21.39 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.075 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 19.7 mtmm -149.56 122.86 8.98 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.368 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -87.76 -159.77 0.56 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.833 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -87.17 -7.77 57.61 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 121.097 -0.241 . . . . 0.0 111.295 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 10.4 tptt -102.86 -59.41 1.71 Allowed 'General case' 0 N--CA 1.441 -0.902 0 CA-C-O 120.712 0.291 . . . . 0.0 110.975 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 -152.46 -171.07 3.82 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 120.764 0.316 . . . . 0.0 111.021 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . 0.404 ' HA ' ' HA ' ' A' ' 199' ' ' LYS . 19.2 m-20 -89.61 75.07 7.53 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.317 179.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 33.1 m -64.52 159.45 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.878 0 CA-C-O 121.583 0.706 . . . . 0.0 112.313 -179.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . 0.457 ' O ' ' HA ' ' A' ' 176' ' ' THR . 1.9 ttt180 -89.3 -34.54 16.54 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.875 -178.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 176' ' ' THR . 1.6 mp0 -142.03 -179.01 5.97 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.156 0.503 . . . . 0.0 111.527 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.77 ' O ' HG21 ' A' ' 170' ' ' VAL . 1.9 t -150.79 73.03 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.848 179.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.401 ' HB2' ' HD2' ' A' ' 174' ' ' LYS . . . -96.25 171.01 8.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.087 0.47 . . . . 0.0 112.206 -178.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 83.11 -76.32 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.766 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 178.31 37.46 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.299 -0.953 . . . . 0.0 112.656 179.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -95.83 154.71 17.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.894 0.378 . . . . 0.0 111.2 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -89.55 162.43 15.68 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.355 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' CYS . . . . . 0.598 ' HB3' HG21 ' A' ' 208' ' ' VAL . 29.8 p -150.49 -171.65 3.98 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.874 0.369 . . . . 0.0 111.42 -179.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . 0.508 ' O ' HD12 ' A' ' 165' ' ' ILE . . . -150.2 98.58 0.19 Allowed Glycine 0 N--CA 1.451 -0.343 0 N-CA-C 111.505 -0.638 . . . . 0.0 111.505 179.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.866 HD13 HG12 ' A' ' 195' ' ' ILE . 0.5 OUTLIER -126.27 140.63 52.37 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-O 121.18 0.514 . . . . 0.0 112.242 -179.113 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -100.6 115.19 29.6 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.314 -0.857 . . . . 0.0 108.738 177.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . 0.812 HD12 HG21 ' A' ' 181' ' ' VAL . 15.6 mm -63.39 140.59 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-O 121.27 0.557 . . . . 0.0 110.626 -178.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . 0.409 ' HD3' ' HG2' ' A' ' 194' ' ' GLU . 6.1 ptmt -42.45 -28.64 0.22 Allowed 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 -177.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . 0.433 ' O ' ' CE2' ' A' ' 191' ' ' TYR . 6.1 t-20 -152.36 34.4 0.51 Allowed 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 -178.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.518 ' CZ ' HD21 ' A' ' 183' ' ' LEU . 0.1 OUTLIER -58.25 121.41 10.68 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 178.872 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -89.52 -48.68 7.15 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 114.888 -1.051 . . . . 0.0 108.377 176.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . 0.451 ' O ' ' CD1' ' A' ' 221' ' ' PHE . 0.0 OUTLIER -77.14 140.22 40.16 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.292 177.496 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.637 ' N ' HD13 ' A' ' 224' ' ' ILE . 0.2 OUTLIER -134.67 178.01 6.06 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -178.85 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.413 ' O ' ' C ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER 56.61 115.54 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 114.391 -1.277 . . . . 0.0 110.182 -179.147 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . 0.469 ' H ' ' HA ' ' A' ' 155' ' ' GLN . 6.5 tt0 7.5 64.28 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 124.65 1.18 . . . . 0.0 113.55 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -61.18 -65.78 3.07 Favored Glycine 0 N--CA 1.431 -1.635 0 CA-C-N 114.694 -1.139 . . . . 0.0 111.764 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.443 ' O ' HG12 ' A' ' 153' ' ' VAL . 0.9 OUTLIER -164.98 -147.67 0.1 Allowed 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 179.859 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . 0.752 HG22 ' CG ' ' A' ' 152' ' ' GLU . 76.4 t -89.32 131.51 36.42 Favored 'Isoleucine or valine' 0 C--N 1.348 0.536 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.063 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . 0.481 ' HA ' ' CB ' ' A' ' 183' ' ' LEU . 3.7 mt -102.31 159.23 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 O-C-N 123.494 0.496 . . . . 0.0 111.487 -179.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' GLU . . . . . 0.448 ' N ' HG22 ' A' ' 230' ' ' ILE . 7.2 tt0 -145.25 110.42 5.22 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.568 ' HB3' ' CA ' ' A' ' 149' ' ' GLY . . . -88.26 129.5 35.35 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.668 178.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -130.82 141.5 50.34 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.803 -178.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.561 HG12 HG21 ' A' ' 148' ' ' ILE . 0.3 OUTLIER -178.81 -173.78 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-O 120.804 0.335 . . . . 0.0 111.135 179.971 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' MET . . . . . 0.503 ' H ' HG22 ' A' ' 234' ' ' VAL . 0.0 OUTLIER -89.65 -163.73 1.05 Allowed 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.21 179.524 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 6.0 pm0 -90.06 77.25 6.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.107 0.479 . . . . 0.0 110.71 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -150.84 39.35 0.7 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.007 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.561 ' HB ' HG21 ' A' ' 176' ' ' THR . 3.0 m -109.64 148.01 13.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.555 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . 69.67 -63.65 0.38 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.168 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.4 -3.88 58.26 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 121.147 0.499 . . . . 0.0 112.326 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.314 -0.959 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.145 179.932 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.811 0.339 . . . . 0.0 111.202 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -131.12 126.27 35.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.885 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.54 40.63 1.09 Allowed 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.391 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 11.6 mmtp -123.79 -165.62 1.37 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.751 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.763 HG11 ' HB2' ' A' ' 150' ' ' GLN . 20.1 t -56.71 137.59 18.42 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.541 0 CA-C-O 121.135 0.493 . . . . 0.0 111.522 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.57 HD13 ' O ' ' A' ' 147' ' ' VAL . 25.7 mm -121.81 -4.31 8.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.27 178.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.476 ' O ' ' HB3' ' A' ' 232' ' ' ALA . . . -176.72 72.15 0.08 OUTLIER Glycine 0 C--N 1.343 0.926 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.044 179.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.763 ' HB2' HG11 ' A' ' 147' ' ' VAL . 2.3 tt0 -90.49 135.15 33.88 Favored 'General case' 0 CA--C 1.512 -0.501 0 O-C-N 122.678 -0.307 . . . . 0.0 110.369 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.436 ' CB ' ' HB2' ' A' ' 168' ' ' CYS . . . -152.56 171.08 18.68 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 120.095 -0.642 . . . . 0.0 112.674 -178.1 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.835 ' CG ' HG22 ' A' ' 229' ' ' VAL . 0.6 OUTLIER -119.84 124.09 45.25 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.031 179.453 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.443 ' HB ' ' O ' ' A' ' 228' ' ' ASP . 3.9 p -52.01 133.26 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -178.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -89.29 -60.28 1.99 Allowed 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 104.827 -2.286 . . . . 0.0 104.827 175.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.535 ' HA ' ' H ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER -161.28 -161.94 0.85 Allowed 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 113.04 -1.891 . . . . 0.0 108.773 175.252 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.585 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 1.6 p -150.96 155.56 39.35 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 176.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.696 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 2.8 m-85 -104.62 76.38 1.28 Allowed 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -178.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -86.07 62.99 7.77 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.486 HG12 ' N ' ' A' ' 161' ' ' LYS . 54.7 t -89.97 155.35 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 CA-C-N 113.749 -1.569 . . . . 0.0 110.12 -178.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 28.6 t -90.79 34.78 0.9 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.203 0.525 . . . . 0.0 109.973 178.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.486 ' N ' HG12 ' A' ' 159' ' ' VAL . 0.5 OUTLIER -150.71 -31.67 0.18 Allowed 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.316 -179.689 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.5 HG12 ' N ' ' A' ' 163' ' ' GLY . 90.5 t -102.71 -102.78 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . 0.5 ' N ' HG12 ' A' ' 162' ' ' VAL . . . -158.95 -105.9 0.22 Allowed Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 179.084 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.637 HG21 HG21 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -156.03 54.4 0.58 Allowed 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 178.124 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.696 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 0.1 OUTLIER -34.38 -27.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.214 -0.812 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 -177.003 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.585 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . 36.78 97.52 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 178.348 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -86.39 149.67 22.95 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 109.881 -1.287 . . . . 0.0 109.881 178.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.436 ' HB2' ' CB ' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -144.81 135.33 24.44 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 117.216 0.508 . . . . 0.0 110.467 -178.18 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . 0.433 ' O ' ' HA ' ' A' ' 151' ' ' ALA . 1.9 t80 -87.96 124.8 34.07 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 177.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.754 HG21 ' O ' ' A' ' 208' ' ' VAL . 41.0 t -85.16 137.92 19.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.635 0.731 . . . . 0.0 112.849 -176.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.3 p -129.42 12.0 5.9 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 114.627 -1.169 . . . . 0.0 112.096 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -145.76 -139.21 0.1 Allowed 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -50.84 -110.73 0.01 OUTLIER Glycine 0 CA--C 1.53 1.013 0 C-N-CA 121.058 -0.592 . . . . 0.0 114.151 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.68 ' CG ' ' HB2' ' A' ' 209' ' ' ALA . 0.0 OUTLIER -144.7 137.26 26.43 Favored 'General case' 0 CA--C 1.514 -0.423 0 O-C-N 122.349 -0.501 . . . . 0.0 110.834 -179.272 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.479 ' O ' HG23 ' A' ' 175' ' ' ILE . 0.6 OUTLIER -94.43 112.18 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 C-N-CA 119.556 -0.858 . . . . 0.0 109.165 177.371 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.52 ' HB ' ' O ' ' A' ' 206' ' ' ARG . 0.3 OUTLIER -125.03 177.76 5.89 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.37 0.605 . . . . 0.0 112.09 -177.373 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.411 ' N ' HD13 ' A' ' 198' ' ' LEU . 0.0 OUTLIER -74.8 -36.81 62.47 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.032 -0.986 . . . . 0.0 109.525 179.241 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . 0.446 ' O ' HG13 ' A' ' 238' ' ' VAL . 5.1 m-20 -88.94 52.04 2.31 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.054 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.477 ' O ' HD12 ' A' ' 195' ' ' ILE . 0.6 OUTLIER -150.72 159.59 44.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.987 179.799 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.486 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 0.0 OUTLIER -88.98 -177.84 5.56 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.172 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.664 HG21 HG23 ' A' ' 218' ' ' ILE . 2.3 m -142.13 160.39 20.22 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 CA-C-O 121.335 0.588 . . . . 0.0 111.82 179.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . 0.445 ' N ' ' O ' ' A' ' 231' ' ' GLU . 4.4 ttt-85 -152.66 97.81 2.28 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.099 -0.955 . . . . 0.0 112.806 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.687 HD13 ' CZ ' ' A' ' 221' ' ' PHE . 0.3 OUTLIER -86.25 153.79 21.75 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-O 121.748 0.785 . . . . 0.0 112.58 179.991 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.776 ' N ' HG23 ' A' ' 190' ' ' VAL . 17.8 mt -158.23 131.73 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 114.171 -1.377 . . . . 0.0 112.581 179.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.446 ' O ' HG22 ' A' ' 184' ' ' ILE . 0.0 OUTLIER -89.0 -151.74 0.22 Allowed 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.024 -1.472 . . . . 0.0 107.024 176.253 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -95.93 27.54 3.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 118.521 0.601 . . . . 0.0 110.516 178.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -153.96 -43.33 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.679 -0.772 . . . . 0.0 113.405 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.668 HG23 ' N ' ' A' ' 189' ' ' VAL . 0.4 OUTLIER -150.15 -158.33 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -177.953 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.668 ' N ' HG23 ' A' ' 188' ' ' ILE . 48.0 t -87.34 138.11 19.7 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 CA-C-O 121.624 0.726 . . . . 0.0 111.204 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.816 HG21 ' CB ' ' A' ' 228' ' ' ASP . 0.1 OUTLIER -98.12 -34.21 4.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 114.645 -1.161 . . . . 0.0 108.864 179.264 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . 0.629 ' HB3' HD12 ' A' ' 183' ' ' LEU . 19.1 t80 -158.58 159.75 35.83 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.18 179.096 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . 0.65 ' CG ' HG11 ' A' ' 189' ' ' VAL . 19.3 mt-10 -150.34 155.11 39.02 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.61 178.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 135.13 -121.48 2.59 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.485 -0.864 . . . . 0.0 112.382 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 12.4 pt-20 -150.01 -176.57 5.5 Favored 'General case' 0 CA--C 1.495 -1.143 0 CA-C-O 121.447 0.642 . . . . 0.0 112.031 -178.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.477 HD12 ' O ' ' A' ' 179' ' ' SER . 4.5 mp -89.06 150.28 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 CA-C-N 115.175 -0.921 . . . . 0.0 109.37 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -88.73 -67.98 0.8 Allowed 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -151.99 154.62 36.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.455 178.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.592 HD22 ' C ' ' A' ' 206' ' ' ARG . 0.2 OUTLIER -107.61 127.85 54.02 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.319 0.581 . . . . 0.0 111.711 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 43.8 tttt -150.63 113.46 4.75 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.388 179.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.18 -161.66 0.75 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.081 -0.508 . . . . 0.0 109.823 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -87.76 -13.23 42.91 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.474 0.178 . . . . 0.0 110.972 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.85 -55.07 2.74 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 120.569 0.223 . . . . 0.0 111.229 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -152.38 -173.41 4.54 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 120.858 0.361 . . . . 0.0 111.234 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . 0.422 ' HA ' ' HA ' ' A' ' 199' ' ' LYS . 4.5 p-10 -89.96 82.2 6.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.44 179.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.499 HG23 HD23 ' A' ' 198' ' ' LEU . 35.0 m -74.34 176.66 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -0.986 0 CA-C-O 121.576 0.703 . . . . 0.0 112.366 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . 0.592 ' C ' HD22 ' A' ' 198' ' ' LEU . 2.1 ttt180 -103.74 -42.24 5.69 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 114.616 -1.175 . . . . 0.0 111.796 -179.01 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.501 ' HG2' ' HB2' ' A' ' 239' ' ' ALA . 1.4 mp0 -131.03 -177.02 4.19 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.207 0.527 . . . . 0.0 112.052 -179.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.754 ' O ' HG21 ' A' ' 170' ' ' VAL . 0.9 OUTLIER -151.42 71.26 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.848 178.539 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.68 ' HB2' ' CG ' ' A' ' 174' ' ' LYS . . . -91.65 171.68 9.0 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.094 0.473 . . . . 0.0 112.174 -178.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 83.67 -76.87 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.9 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . 0.4 ' O ' ' CE1' ' A' ' 169' ' ' TYR . . . 178.04 36.95 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.338 -0.934 . . . . 0.0 112.563 179.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -100.45 153.01 19.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.023 0.439 . . . . 0.0 111.239 -179.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.2 133.05 45.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.971 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' CYS . . . . . 0.471 ' HB3' HG21 ' A' ' 208' ' ' VAL . 1.8 t -135.73 146.08 47.31 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.976 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -89.66 112.27 3.99 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.868 179.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.548 HD12 ' CD1' ' A' ' 218' ' ' ILE . 0.4 OUTLIER -139.95 131.67 27.37 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-O 120.937 0.398 . . . . 0.0 111.012 -179.909 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . 0.42 ' C ' HD12 ' A' ' 218' ' ' ILE . 0.0 OUTLIER -68.72 142.96 54.85 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.267 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . 0.664 HG23 HG21 ' A' ' 181' ' ' VAL . 1.7 mp -108.81 87.42 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 -178.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . 0.429 ' HB2' ' O ' ' A' ' 194' ' ' GLU . 2.7 tttt 45.3 -143.47 0.22 Allowed 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.519 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -88.44 63.69 7.18 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-O 120.732 0.301 . . . . 0.0 111.317 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.687 ' CZ ' HD13 ' A' ' 183' ' ' LEU . 0.1 OUTLIER -54.91 119.04 4.82 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 178.705 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -82.75 -45.44 14.4 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.651 176.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . 0.619 ' OD2' HG12 ' A' ' 190' ' ' VAL . 0.0 OUTLIER -88.16 146.33 25.45 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.031 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.64 ' N ' HD13 ' A' ' 224' ' ' ILE . 0.2 OUTLIER -141.46 -179.18 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.146 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -178.527 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.409 ' O ' ' C ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER 54.87 111.1 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 114.184 -1.371 . . . . 0.0 110.376 -179.127 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . 0.535 ' H ' ' HA ' ' A' ' 155' ' ' GLN . 21.9 tt0 14.81 56.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 124.685 1.24 . . . . 0.0 112.504 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -67.45 -56.63 11.06 Favored Glycine 0 N--CA 1.422 -2.262 0 CA-C-N 114.224 -1.353 . . . . 0.0 113.323 -178.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.816 ' CB ' HG21 ' A' ' 190' ' ' VAL . 4.3 m-20 -161.25 -164.12 1.11 Allowed 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 115.124 1.527 . . . . 0.0 115.124 -177.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . 0.835 HG22 ' CG ' ' A' ' 152' ' ' GLU . 63.9 t -88.07 140.87 15.12 Favored 'Isoleucine or valine' 0 C--N 1.346 0.429 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . 0.412 HG13 ' HG ' ' A' ' 183' ' ' LEU . 2.7 mp -112.92 154.55 14.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.958 0.408 . . . . 0.0 111.372 -178.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' GLU . . . . . 0.445 ' HA ' ' HA ' ' A' ' 150' ' ' GLN . 5.0 tt0 -144.5 109.5 5.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.328 0.585 . . . . 0.0 111.684 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.476 ' HB3' ' O ' ' A' ' 149' ' ' GLY . . . -87.01 128.5 35.08 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.965 179.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' TYR . . . . . 0.423 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 8.8 p90 -131.63 141.22 49.58 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.551 -179.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.475 HG12 HG13 ' A' ' 148' ' ' ILE . 4.4 p -175.97 137.76 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.29 67.31 1.56 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . 0.4 ' HG2' ' CG1' ' A' ' 234' ' ' VAL . 2.1 pt20 -142.79 -146.99 0.2 Allowed 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.741 -178.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -135.09 74.71 1.53 Allowed 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.507 ' O ' ' HB3' ' A' ' 239' ' ' ALA . 1.2 t -82.45 161.19 3.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.796 -178.348 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 238' ' ' VAL . . . 81.22 -56.66 0.28 Allowed 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.944 -179.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.82 -7.87 53.35 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.312 -1.022 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.153 179.951 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 120.881 0.372 . . . . 0.0 111.22 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -140.22 127.22 20.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.88 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -93.84 40.49 1.08 Allowed 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.592 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -127.55 -169.91 2.13 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.479 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.541 HG11 ' HB2' ' A' ' 150' ' ' GLN . 15.7 t -55.38 144.77 6.26 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.526 0 CA-C-O 121.441 0.638 . . . . 0.0 111.483 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.66 HD13 ' OG ' ' A' ' 179' ' ' SER . 2.7 pp -124.63 -6.64 6.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.04 178.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.558 ' O ' HD11 ' A' ' 175' ' ' ILE . . . -179.32 76.99 0.06 OUTLIER Glycine 0 C--N 1.343 0.964 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.043 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.541 ' HB2' HG11 ' A' ' 147' ' ' VAL . 0.1 OUTLIER -89.9 135.21 33.77 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 179.715 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.506 ' HB1' ' HB2' ' A' ' 168' ' ' CYS . . . -151.35 167.68 27.16 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 120.102 -0.639 . . . . 0.0 112.522 -178.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.705 ' HG2' HG22 ' A' ' 229' ' ' VAL . 20.5 mt-10 -120.42 124.51 45.65 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.407 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.502 ' HB ' ' O ' ' A' ' 228' ' ' ASP . 3.1 p -51.17 132.63 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -178.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -89.44 -60.16 2.02 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 104.416 -2.439 . . . . 0.0 104.416 175.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.508 ' HA ' ' H ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER -161.45 -163.71 1.03 Allowed 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 113.025 -1.898 . . . . 0.0 108.613 174.786 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.564 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 1.5 p -151.91 143.02 23.21 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 176.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.655 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 5.7 m-30 -91.04 75.37 6.29 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.043 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.66 63.72 8.12 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.967 0.889 . . . . 0.0 108.847 178.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.475 HG12 ' N ' ' A' ' 161' ' ' LYS . 49.2 t -89.25 154.85 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-N 113.944 -1.48 . . . . 0.0 109.707 -179.39 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 47.4 t -89.74 33.49 0.85 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.074 0.464 . . . . 0.0 110.406 178.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.475 ' N ' HG12 ' A' ' 159' ' ' VAL . 0.3 OUTLIER -150.93 -29.3 0.2 Allowed 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.597 -179.875 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.474 HG12 ' N ' ' A' ' 163' ' ' GLY . 97.7 t -103.52 -101.53 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 O-C-N 122.132 -0.355 . . . . 0.0 110.15 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . 0.474 ' N ' HG12 ' A' ' 162' ' ' VAL . . . -158.51 -110.34 0.29 Allowed Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 111.543 -0.623 . . . . 0.0 111.543 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.595 HG21 HG21 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -155.15 58.96 0.65 Allowed 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 178.253 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.655 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 0.3 OUTLIER -38.7 -22.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.219 -0.54 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 -177.243 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.564 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . 31.02 98.36 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 178.163 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -87.59 150.76 22.72 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 178.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.563 ' SG ' HD11 ' A' ' 216' ' ' LEU . 0.0 OUTLIER -145.07 136.48 25.18 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 117.353 0.577 . . . . 0.0 110.725 -178.482 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . 0.445 ' O ' ' HA ' ' A' ' 151' ' ' ALA . 71.9 t80 -87.74 131.05 34.63 Favored 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 106.965 -1.495 . . . . 0.0 106.965 177.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.533 HG12 ' N ' ' A' ' 212' ' ' TYR . 4.7 p -86.25 144.84 8.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -176.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.4 p -138.53 11.91 2.74 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.416 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -151.48 -147.51 0.23 Allowed 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 119.52 -0.276 . . . . 0.0 110.263 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -39.53 -104.56 0.01 OUTLIER Glycine 0 CA--C 1.531 1.047 0 N-CA-C 115.188 0.835 . . . . 0.0 115.188 -178.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.456 ' HB3' ' HB2' ' A' ' 209' ' ' ALA . 0.0 OUTLIER -150.75 143.89 24.78 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.092 0.472 . . . . 0.0 111.88 -178.716 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.684 HG22 HD11 ' A' ' 198' ' ' LEU . 7.4 mm -99.68 87.15 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 N-CA-C 108.498 -0.926 . . . . 0.0 108.498 176.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.517 ' HB ' ' O ' ' A' ' 206' ' ' ARG . 0.2 OUTLIER -100.93 172.82 6.8 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.517 0.675 . . . . 0.0 112.106 -178.061 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -69.2 -43.02 74.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.711 -1.131 . . . . 0.0 111.067 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . 0.482 ' O ' HG11 ' A' ' 238' ' ' VAL . 61.4 t0 -88.56 58.59 4.74 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.17 -179.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.66 ' OG ' HD13 ' A' ' 148' ' ' ILE . 1.1 m -149.08 162.69 39.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.797 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.531 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 26.4 mttp -89.0 -170.81 3.04 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.545 HG22 ' CA ' ' A' ' 194' ' ' GLU . 2.4 m -150.23 160.79 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.539 0 CA-C-O 121.398 0.618 . . . . 0.0 111.711 179.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . 0.458 ' N ' ' O ' ' A' ' 231' ' ' GLU . 43.3 ttm180 -153.58 98.75 2.26 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.136 -0.938 . . . . 0.0 113.215 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.559 HD13 ' CZ ' ' A' ' 221' ' ' PHE . 0.2 OUTLIER -86.68 148.33 25.5 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-O 121.745 0.783 . . . . 0.0 112.22 179.721 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.743 ' N ' HG23 ' A' ' 190' ' ' VAL . 22.2 mt -157.87 130.14 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 114.311 -1.313 . . . . 0.0 111.485 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -88.52 -151.94 0.21 Allowed 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 177.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -94.71 29.84 2.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 118.354 0.525 . . . . 0.0 110.533 179.05 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -154.04 -45.94 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.668 -0.777 . . . . 0.0 113.182 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.682 ' O ' HG23 ' A' ' 184' ' ' ILE . 0.4 OUTLIER -150.11 -160.56 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -178.106 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.721 HG11 ' CG ' ' A' ' 192' ' ' GLU . 96.1 t -87.09 135.76 24.51 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 CA-C-O 121.684 0.754 . . . . 0.0 110.845 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.873 HG21 ' HB2' ' A' ' 228' ' ' ASP . 0.0 OUTLIER -97.67 -35.44 5.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 114.562 -1.199 . . . . 0.0 108.959 179.343 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . 0.485 ' HB3' ' CD1' ' A' ' 183' ' ' LEU . 5.0 t80 -157.51 156.13 31.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.569 179.115 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . 0.721 ' CG ' HG11 ' A' ' 189' ' ' VAL . 23.8 mt-10 -151.0 155.39 38.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.218 178.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 134.85 -113.15 1.1 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.573 -0.823 . . . . 0.0 112.363 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 0.545 ' CA ' HG22 ' A' ' 181' ' ' VAL . 0.0 OUTLIER -150.77 -176.16 5.4 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-O 121.303 0.573 . . . . 0.0 111.161 -179.051 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.725 HD11 HD12 ' A' ' 216' ' ' LEU . 0.3 OUTLIER -99.13 155.07 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.178 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.495 -179.074 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -89.42 -67.64 0.83 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 1.3 m -150.91 154.45 37.19 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.949 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.756 HD13 ' HB3' ' A' ' 216' ' ' LEU . 3.5 mm? -107.46 117.8 35.05 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.962 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 18.1 ttmt -138.13 115.14 10.85 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.812 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 7.6 ttm180 -88.83 -158.7 0.51 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.846 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -87.11 -6.75 58.56 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 121.227 -0.189 . . . . 0.0 111.35 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -105.54 -59.71 1.73 Allowed 'General case' 0 N--CA 1.442 -0.87 0 CA-C-O 120.708 0.29 . . . . 0.0 111.154 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -151.82 -163.39 1.73 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.72 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . 0.401 ' HA ' ' HA ' ' A' ' 199' ' ' LYS . 16.4 t70 -89.06 75.4 7.94 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 120.931 0.396 . . . . 0.0 110.279 179.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 32.7 m -59.28 159.86 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.934 0 CA-C-O 121.603 0.716 . . . . 0.0 112.317 -179.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . 0.517 ' O ' ' HB ' ' A' ' 176' ' ' THR . 7.6 ttm-85 -89.44 -36.51 15.4 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 114.651 -1.159 . . . . 0.0 111.795 -178.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -141.31 179.42 6.78 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.221 0.534 . . . . 0.0 111.682 -179.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.496 ' O ' HG21 ' A' ' 170' ' ' VAL . 0.6 OUTLIER -151.12 70.95 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.729 178.661 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.456 ' HB2' ' HB3' ' A' ' 174' ' ' LYS . . . -97.46 178.47 5.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.138 -178.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 81.97 -75.45 0.03 OUTLIER 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.538 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 178.41 38.12 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.401 -0.904 . . . . 0.0 112.286 179.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . 0.533 ' N ' HG12 ' A' ' 170' ' ' VAL . 0.2 OUTLIER -107.43 150.09 27.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.159 0.504 . . . . 0.0 112.025 -179.118 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -96.57 152.78 18.31 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.076 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' CYS . . . . . 0.472 ' HB3' HG21 ' A' ' 208' ' ' VAL . 18.5 t -150.64 154.34 37.31 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.004 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -89.53 110.24 3.7 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.116 179.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.756 ' HB3' HD13 ' A' ' 198' ' ' LEU . 0.2 OUTLIER -134.44 131.36 38.04 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 121.298 0.571 . . . . 0.0 111.59 -179.026 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . 0.402 ' O ' HD13 ' A' ' 195' ' ' ILE . 0.2 OUTLIER -84.35 130.38 34.8 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.93 179.872 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . 0.593 HG22 ' O ' ' A' ' 218' ' ' ILE . 1.5 mp -90.84 79.27 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 34.75 -85.99 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.998 0 O-C-N 124.134 0.896 . . . . 0.0 112.835 -178.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . 0.439 ' N ' ' O ' ' A' ' 218' ' ' ILE . 5.9 p30 -129.73 65.67 1.48 Allowed 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.589 -179.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.559 ' CZ ' HD13 ' A' ' 183' ' ' LEU . 0.1 OUTLIER -58.58 119.38 6.94 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 177.883 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -77.91 -44.51 26.79 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 176.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . 0.829 ' OD2' HG12 ' A' ' 190' ' ' VAL . 0.0 OUTLIER -92.74 143.19 26.55 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.236 177.713 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.638 ' N ' HD13 ' A' ' 224' ' ' ILE . 0.2 OUTLIER -140.48 -179.4 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -178.706 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.414 ' O ' ' C ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER 55.26 110.56 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 114.319 -1.31 . . . . 0.0 110.067 -178.881 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . 0.508 ' H ' ' HA ' ' A' ' 155' ' ' GLN . 18.2 tt0 10.95 60.5 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 124.747 1.28 . . . . 0.0 112.948 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -71.59 -58.13 5.58 Favored Glycine 0 N--CA 1.421 -2.348 0 CA-C-N 114.115 -1.402 . . . . 0.0 113.144 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.873 ' HB2' HG21 ' A' ' 190' ' ' VAL . 25.8 m-20 -158.48 -160.62 0.9 Allowed 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -178.019 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . 0.705 HG22 ' HG2' ' A' ' 152' ' ' GLU . 42.9 t -88.65 152.98 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 CA-C-O 120.769 0.318 . . . . 0.0 110.15 178.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . 0.424 HD13 ' HB3' ' A' ' 168' ' ' CYS . 3.0 mp -120.92 153.93 24.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.753 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' GLU . . . . . 0.458 ' O ' ' N ' ' A' ' 182' ' ' ARG . 20.1 tt0 -147.12 111.58 5.23 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 119.839 -0.744 . . . . 0.0 112.676 -179.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.555 ' HB1' HD11 ' A' ' 148' ' ' ILE . . . -87.17 135.58 33.24 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.17 178.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' TYR . . . . . 0.63 ' O ' HG23 ' A' ' 234' ' ' VAL . 3.5 p90 -137.64 156.75 47.7 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.062 -178.45 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 233' ' ' TYR . 0.9 OUTLIER 171.55 149.68 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-O 121.15 0.5 . . . . 0.0 110.743 179.23 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.15 45.74 1.15 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.557 178.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . 0.43 ' H ' HG12 ' A' ' 234' ' ' VAL . 0.2 OUTLIER -133.15 -154.1 0.59 Allowed 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.216 -0.447 . . . . 0.0 112.158 -177.929 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -142.7 75.43 1.49 Allowed 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.508 ' O ' ' HB2' ' A' ' 239' ' ' ALA . 2.4 t -83.08 142.18 13.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 114.67 -1.15 . . . . 0.0 112.422 -176.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . 0.508 ' HB2' ' O ' ' A' ' 238' ' ' VAL . . . 152.74 -51.28 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 114.443 -1.253 . . . . 0.0 110.292 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.84 -7.51 54.13 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.312 -1.047 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.042 -179.977 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.847 0.356 . . . . 0.0 111.234 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -129.53 -167.64 1.83 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.856 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -93.48 42.21 1.09 Allowed 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.456 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 4.5 ptpt -61.6 -171.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.767 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.481 HG11 ' HB2' ' A' ' 150' ' ' GLN . 12.1 t -58.58 139.99 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.611 0 CA-C-O 121.297 0.57 . . . . 0.0 111.506 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.557 HD11 ' HB3' ' A' ' 179' ' ' SER . 2.7 pp -127.06 -1.82 4.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.35 178.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.512 ' O ' ' HB3' ' A' ' 232' ' ' ALA . . . 178.08 75.34 0.06 OUTLIER Glycine 0 C--N 1.342 0.897 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.912 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.481 ' HB2' HG11 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -89.97 136.41 33.06 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 122.721 -0.282 . . . . 0.0 110.336 -179.969 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.503 ' O ' HG13 ' A' ' 229' ' ' VAL . . . -151.17 179.59 8.16 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-O 121.63 0.729 . . . . 0.0 112.871 -178.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.904 ' HG2' HG22 ' A' ' 229' ' ' VAL . 1.3 tt0 -126.96 120.37 28.94 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.814 -1.084 . . . . 0.0 110.445 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.464 HG12 ' O ' ' A' ' 228' ' ' ASP . 2.2 p -48.13 137.97 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -179.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.483 ' O ' ' HB3' ' A' ' 226' ' ' GLU . 3.2 mmp_? -97.44 -61.03 1.45 Allowed 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 105.963 -1.865 . . . . 0.0 105.963 176.093 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.75 -160.53 0.46 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 113.739 -1.573 . . . . 0.0 109.157 175.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.49 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 5.9 p -150.92 149.0 29.11 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 177.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.601 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 5.6 m-30 -92.6 72.1 5.03 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -178.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 15.6 tttt -85.95 62.21 7.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 122.002 0.906 . . . . 0.0 109.071 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 55.2 t -89.64 155.78 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 CA-C-N 113.919 -1.492 . . . . 0.0 109.535 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 9.0 m -89.72 22.41 3.09 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.049 178.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.71 5.66 0.52 Allowed 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.188 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 57.8 t -129.98 -99.17 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 CA-C-N 118.483 0.583 . . . . 0.0 110.14 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -158.02 -113.51 0.38 Allowed Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.415 ' CG2' ' CG2' ' A' ' 224' ' ' ILE . 0.0 OUTLIER -153.98 32.9 0.44 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.462 -0.869 . . . . 0.0 109.098 178.157 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.601 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 1.9 mm -40.27 93.78 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.715 -179.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.49 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . -88.25 118.45 27.85 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 114.729 -1.123 . . . . 0.0 111.967 -179.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -89.59 151.21 21.69 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.49 179.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -147.58 133.45 19.08 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -179.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . 0.451 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 11.1 t80 -86.8 131.28 34.17 Favored 'General case' 0 C--O 1.219 -0.512 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 178.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.508 HG12 ' N ' ' A' ' 212' ' ' TYR . 5.7 p -85.64 147.01 5.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -175.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.1 p -141.87 13.12 2.07 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.04 -0.982 . . . . 0.0 112.359 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.412 ' CB ' ' HB2' ' A' ' 150' ' ' GLN . 10.4 t0 -151.27 -145.87 0.18 Allowed 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -38.96 -103.53 0.01 OUTLIER Glycine 0 CA--C 1.531 1.05 0 N-CA-C 115.275 0.87 . . . . 0.0 115.275 -178.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.565 ' HG2' ' HB2' ' A' ' 209' ' ' ALA . 21.9 mttm -150.47 134.94 17.25 Favored 'General case' 0 CA--C 1.515 -0.402 0 O-C-N 122.591 -0.358 . . . . 0.0 111.871 -178.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.557 HG22 ' O ' ' A' ' 175' ' ' ILE . 3.5 mm -93.37 86.89 2.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 176.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.723 HG22 ' HB3' ' A' ' 207' ' ' GLU . 0.1 OUTLIER -100.79 172.24 7.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.523 -177.265 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -69.25 -42.1 76.05 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.347 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -88.75 56.32 3.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.415 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.557 ' HB3' HD11 ' A' ' 148' ' ' ILE . 29.7 m -145.97 157.34 43.88 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.428 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 0.0 OUTLIER -89.25 -172.93 3.83 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.44 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.504 HG22 ' HA ' ' A' ' 194' ' ' GLU . 0.6 OUTLIER -150.1 156.76 6.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.385 0.612 . . . . 0.0 111.473 179.512 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . 0.425 ' N ' ' O ' ' A' ' 231' ' ' GLU . 60.2 ttt180 -152.03 101.83 2.76 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.113 -0.948 . . . . 0.0 112.581 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.724 HD12 ' HB3' ' A' ' 191' ' ' TYR . 0.3 OUTLIER -86.16 157.41 20.01 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-O 121.862 0.839 . . . . 0.0 112.918 -179.669 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.614 HD12 ' C ' ' A' ' 183' ' ' LEU . 3.1 mp -151.01 121.36 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 113.885 -1.507 . . . . 0.0 111.935 177.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.418 ' HB2' HG22 ' A' ' 190' ' ' VAL . 0.0 OUTLIER -85.45 -151.76 0.15 Allowed 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 177.504 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -93.97 28.57 2.38 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 118.539 0.608 . . . . 0.0 110.829 178.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -154.62 -76.96 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.619 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.452 ' H ' HD12 ' A' ' 188' ' ' ILE . 0.1 OUTLIER -116.47 -156.54 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 115.34 -0.43 . . . . 0.0 110.718 -179.039 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.749 HG11 ' CG ' ' A' ' 192' ' ' GLU . 46.3 t -87.37 133.96 28.9 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.101 0 CA-C-O 121.518 0.675 . . . . 0.0 111.771 -179.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.907 HG12 ' OD2' ' A' ' 223' ' ' ASP . 0.2 OUTLIER -89.61 -34.21 6.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 114.778 -1.101 . . . . 0.0 108.884 178.503 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . 0.724 ' HB3' HD12 ' A' ' 183' ' ' LEU . 41.5 t80 -157.6 155.87 30.88 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 178.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . 0.749 ' CG ' HG11 ' A' ' 189' ' ' VAL . 14.4 mt-10 -150.14 148.83 29.43 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.287 177.342 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 133.05 -127.75 4.85 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.068 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 0.504 ' HA ' HG22 ' A' ' 181' ' ' VAL . 4.5 pt-20 -145.38 -178.88 6.3 Favored 'General case' 0 CA--C 1.499 -0.986 0 CA-C-O 121.662 0.744 . . . . 0.0 112.631 -178.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.778 HG12 HD13 ' A' ' 216' ' ' LEU . 4.7 mp -89.67 153.42 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.115 -179.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -93.95 -52.19 4.53 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 4.6 m -151.38 144.92 24.91 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.858 178.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.793 HD12 HD22 ' A' ' 216' ' ' LEU . 2.8 tt -120.49 118.01 29.14 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.427 0.632 . . . . 0.0 111.647 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 10.7 tttm -148.83 122.52 9.23 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.672 179.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 8.4 ttp85 -87.81 -160.38 0.61 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.314 -179.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -86.89 -15.1 40.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.522 0.201 . . . . 0.0 110.902 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -93.56 -58.73 2.19 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-O 120.633 0.254 . . . . 0.0 110.698 179.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -152.83 -170.54 3.66 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 120.863 0.363 . . . . 0.0 111.164 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . 0.406 ' HA ' ' HA ' ' A' ' 199' ' ' LYS . 4.9 p-10 -90.0 63.35 5.91 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.107 179.24 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.6 HG23 ' CD2' ' A' ' 198' ' ' LEU . 28.3 m -56.29 156.94 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.931 0 CA-C-O 121.515 0.674 . . . . 0.0 112.23 -179.107 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . 0.469 ' O ' ' HB ' ' A' ' 176' ' ' THR . 0.1 OUTLIER -89.51 -34.07 16.54 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.899 -178.447 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.79 ' OE2' ' HB2' ' A' ' 239' ' ' ALA . 3.0 mt-10 -141.26 175.75 9.39 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.03 0.443 . . . . 0.0 111.161 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.803 HG12 ' HB3' ' A' ' 212' ' ' TYR . 0.1 OUTLIER -150.8 83.25 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.782 178.761 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.565 ' HB2' ' HG2' ' A' ' 174' ' ' LYS . . . -101.85 174.05 6.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.787 -179.187 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 80.63 -68.76 0.1 Allowed 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.725 -179.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 178.95 36.75 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.49 179.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . 0.803 ' HB3' HG12 ' A' ' 208' ' ' VAL . 2.7 m-85 -100.27 135.01 42.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.022 0.439 . . . . 0.0 111.747 -179.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . 0.407 ' HG2' ' HA ' ' A' ' 169' ' ' TYR . 6.7 mt-10 -89.73 152.25 21.42 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.22 179.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' CYS . . . . . 0.401 ' HB2' HG21 ' A' ' 208' ' ' VAL . 0.7 OUTLIER -150.57 139.89 21.33 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.095 179.967 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -89.08 115.92 4.57 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.662 -0.78 . . . . 0.0 111.733 179.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.793 HD22 HD12 ' A' ' 198' ' ' LEU . 0.4 OUTLIER -135.47 141.6 45.38 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 121.119 0.485 . . . . 0.0 111.609 -179.28 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . 0.403 ' N ' HD13 ' A' ' 165' ' ' ILE . 1.4 m -89.17 133.1 34.54 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.374 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . 0.621 ' CD1' HD12 ' A' ' 216' ' ' LEU . 1.6 mp -86.16 134.4 27.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 -179.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . 0.416 ' HG2' ' O ' ' A' ' 194' ' ' GLU . 5.5 ptmt -39.24 -31.75 0.09 Allowed 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 114.406 1.262 . . . . 0.0 114.406 -177.05 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -153.08 40.38 0.54 Allowed 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 -178.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.689 ' CZ ' HD13 ' A' ' 183' ' ' LEU . 0.1 OUTLIER -59.16 115.98 3.55 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 178.626 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -83.67 -42.56 16.51 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.12 -0.946 . . . . 0.0 108.481 176.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . 0.907 ' OD2' HG12 ' A' ' 190' ' ' VAL . 0.0 OUTLIER -90.53 141.95 28.24 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.893 178.201 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.451 ' C ' HD12 ' A' ' 224' ' ' ILE . 2.5 pp -122.49 -177.97 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.36 0.6 . . . . 0.0 112.423 -179.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.461 ' O ' ' N ' ' A' ' 227' ' ' GLY . 11.4 mtpt 59.37 172.76 0.08 Allowed 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.289 -177.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . 0.483 ' HB3' ' O ' ' A' ' 154' ' ' ARG . 0.3 OUTLIER -58.61 84.09 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.036 0.446 . . . . 0.0 110.831 179.683 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 225' ' ' LYS . . . -71.65 -61.54 3.79 Favored Glycine 0 N--CA 1.427 -1.911 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 178.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.464 ' O ' HG12 ' A' ' 153' ' ' VAL . 0.9 OUTLIER -164.6 -148.3 0.11 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 178.669 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . 0.904 HG22 ' HG2' ' A' ' 152' ' ' GLU . 59.4 t -89.48 145.33 7.53 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 O-C-N 122.331 -0.231 . . . . 0.0 110.606 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . 0.415 HG13 ' CD2' ' A' ' 183' ' ' LEU . 2.9 mt -116.16 153.07 17.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.205 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' GLU . . . . . 0.479 ' HA ' ' HA ' ' A' ' 150' ' ' GLN . 23.9 tt0 -142.1 111.73 6.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.33 0.586 . . . . 0.0 112.369 -179.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' A' ' 149' ' ' GLY . . . -88.89 127.92 35.65 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.942 179.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -128.36 144.44 51.13 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.945 -179.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.617 HG13 ' N ' ' A' ' 235' ' ' MET . 0.3 OUTLIER -178.95 -166.99 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.881 -179.891 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' MET . . . . . 0.617 ' N ' HG13 ' A' ' 234' ' ' VAL . 0.0 OUTLIER -99.58 -164.23 1.11 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.141 179.304 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 -89.72 75.27 7.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.152 0.501 . . . . 0.0 110.694 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -150.64 39.23 0.71 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.099 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.431 ' O ' ' HB3' ' A' ' 239' ' ' ALA . 0.3 OUTLIER -108.1 167.69 3.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.102 179.744 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . 0.79 ' HB2' ' OE2' ' A' ' 207' ' ' GLU . . . 70.91 -63.34 0.42 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.104 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -89.4 -4.26 58.1 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.313 -1.003 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.061 179.971 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 120.819 0.342 . . . . 0.0 111.13 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 60.34 99.6 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.903 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -94.95 38.86 1.11 Allowed 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.452 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 12.2 mttp -94.6 -83.5 0.34 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.417 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.782 ' O ' HD13 ' A' ' 148' ' ' ILE . 6.4 t -115.85 137.59 49.01 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.79 0 CA-C-O 121.356 0.598 . . . . 0.0 110.804 179.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.782 HD13 ' O ' ' A' ' 147' ' ' VAL . 31.0 mm -129.45 -3.93 3.01 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.693 178.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.522 ' O ' ' HB3' ' A' ' 232' ' ' ALA . . . -171.97 70.77 0.11 Allowed Glycine 0 C--N 1.341 0.806 0 N-CA-C 111.344 -0.703 . . . . 0.0 111.344 179.158 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.643 ' HB2' HG11 ' A' ' 147' ' ' VAL . 0.8 OUTLIER -91.31 136.25 33.23 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-O 120.734 0.302 . . . . 0.0 110.639 -179.643 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.428 ' HB1' ' HB2' ' A' ' 168' ' ' CYS . . . -151.76 175.79 12.06 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 121.537 0.684 . . . . 0.0 112.761 -178.293 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.761 ' HG2' HG22 ' A' ' 229' ' ' VAL . 31.3 mt-10 -126.15 121.64 33.4 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.5 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.474 HG11 ' N ' ' A' ' 227' ' ' GLY . 1.6 p -47.31 144.42 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 121.37 0.605 . . . . 0.0 112.595 -179.108 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.482 ' O ' ' HB3' ' A' ' 226' ' ' GLU . 3.8 mmp_? -109.86 -57.32 2.2 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 176.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.55 -162.88 0.61 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 113.755 -1.566 . . . . 0.0 109.776 175.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 8.0 p -150.79 163.88 37.55 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 177.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.547 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 0.2 OUTLIER -116.05 80.08 1.4 Allowed 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -179.033 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 6.5 tttt -86.53 62.77 7.61 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.434 HG12 ' N ' ' A' ' 161' ' ' LYS . 71.7 t -92.9 157.32 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 CA-C-N 113.659 -1.61 . . . . 0.0 110.528 -178.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 28.9 t -92.33 35.89 1.0 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 177.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.434 ' N ' HG12 ' A' ' 159' ' ' VAL . 0.0 OUTLIER -151.37 -35.22 0.14 Allowed 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.092 -179.592 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.766 HG11 HD12 ' A' ' 165' ' ' ILE . 88.7 t -98.96 -103.7 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . 0.524 ' N ' HG12 ' A' ' 162' ' ' VAL . . . -159.51 -99.99 0.16 Allowed Glycine 0 N--CA 1.452 -0.271 0 N-CA-C 111.194 -0.763 . . . . 0.0 111.194 178.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.477 HG22 HG22 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -153.72 33.83 0.45 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 113.958 -1.121 . . . . 0.0 108.278 177.732 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.766 HD12 HG11 ' A' ' 162' ' ' VAL . 3.6 mt -41.98 95.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.461 0.086 0 CA-C-N 115.155 -0.929 . . . . 0.0 111.664 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.532 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . -87.12 125.23 34.01 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.735 -1.12 . . . . 0.0 112.27 -179.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -88.99 144.39 18.02 Favored Glycine 0 N--CA 1.442 -0.951 0 N-CA-C 110.534 -1.027 . . . . 0.0 110.534 178.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.428 ' HB2' ' HB1' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -145.69 132.36 19.93 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 117.204 0.502 . . . . 0.0 110.271 -178.884 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . 0.421 ' O ' ' HA ' ' A' ' 151' ' ' ALA . 5.6 t80 -87.3 127.37 35.18 Favored 'General case' 0 C--O 1.222 -0.39 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 177.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.833 HG21 ' O ' ' A' ' 208' ' ' VAL . 44.3 t -85.44 142.16 13.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 -176.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.4 p -135.38 12.61 3.51 Favored 'General case' 0 C--O 1.231 0.084 0 CA-C-N 114.833 -1.076 . . . . 0.0 112.3 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.417 ' CB ' ' HB2' ' A' ' 150' ' ' GLN . 4.8 t70 -146.87 -144.01 0.15 Allowed 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -179.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -45.2 -107.03 0.01 OUTLIER Glycine 0 CA--C 1.532 1.149 0 N-CA-C 114.792 0.677 . . . . 0.0 114.792 -178.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.553 ' HB3' ' HB2' ' A' ' 209' ' ' ALA . 0.0 OUTLIER -150.76 135.0 16.94 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 122.562 -0.375 . . . . 0.0 111.039 -178.943 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.59 ' CG2' HG23 ' A' ' 208' ' ' VAL . 0.5 OUTLIER -92.31 111.45 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 176.47 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.504 ' HB ' ' O ' ' A' ' 206' ' ' ARG . 0.1 OUTLIER -118.54 169.47 9.76 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.458 0.647 . . . . 0.0 112.481 -176.327 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.491 ' HA ' HG21 ' A' ' 195' ' ' ILE . 0.5 OUTLIER -61.13 -40.86 95.41 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.478 179.667 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -95.91 63.64 2.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.251 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.457 ' OG ' HG11 ' A' ' 238' ' ' VAL . 4.8 m -148.8 161.43 41.82 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.92 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 0.0 OUTLIER -88.93 -175.29 4.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.722 179.493 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.549 HG21 HG23 ' A' ' 218' ' ' ILE . 1.6 m -147.93 156.09 9.58 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.478 0 CA-C-O 121.247 0.546 . . . . 0.0 111.731 179.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . 0.445 ' N ' ' O ' ' A' ' 231' ' ' GLU . 17.9 ttt180 -152.96 100.67 2.52 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.313 -0.858 . . . . 0.0 113.305 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.656 HD13 ' CZ ' ' A' ' 221' ' ' PHE . 0.3 OUTLIER -86.88 156.1 19.98 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-O 121.7 0.762 . . . . 0.0 112.839 -179.869 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.695 ' N ' HG23 ' A' ' 190' ' ' VAL . 28.9 mm -154.01 123.93 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 114.487 -1.233 . . . . 0.0 111.345 178.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.569 ' N ' HG22 ' A' ' 190' ' ' VAL . 4.6 ttp180 -85.68 -151.3 0.15 Allowed 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 177.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -93.84 25.8 3.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 118.509 0.595 . . . . 0.0 110.892 178.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -155.12 -67.57 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.498 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -121.16 -156.34 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-N 115.297 -0.452 . . . . 0.0 110.84 -178.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.807 HG11 ' CG ' ' A' ' 192' ' ' GLU . 58.3 t -87.39 136.28 23.41 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 CA-C-O 121.287 0.565 . . . . 0.0 111.632 -179.135 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.8 HG12 ' OD2' ' A' ' 223' ' ' ASP . 0.1 OUTLIER -89.57 -33.86 6.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.099 -0.955 . . . . 0.0 108.914 178.614 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . 0.612 ' HB3' HD12 ' A' ' 183' ' ' LEU . 16.0 t80 -162.5 157.04 21.73 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.386 -0.825 . . . . 0.0 112.273 178.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . 0.807 ' CG ' HG11 ' A' ' 189' ' ' VAL . 15.7 mt-10 -149.94 160.08 43.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.902 178.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 133.46 -115.4 1.52 Allowed Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.519 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 0.51 ' CA ' HG22 ' A' ' 181' ' ' VAL . 17.1 pt-20 -150.4 -174.87 4.88 Favored 'General case' 0 CA--C 1.496 -1.1 0 CA-C-O 121.247 0.546 . . . . 0.0 111.342 -178.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.812 HD13 ' O ' ' A' ' 217' ' ' THR . 0.4 OUTLIER -88.52 142.84 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.024 -178.921 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.75 -55.35 3.74 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.03 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 17.2 p -152.6 164.68 37.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.051 178.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.782 ' CD1' HD22 ' A' ' 216' ' ' LEU . 21.2 tp -135.16 110.25 8.87 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.417 0.627 . . . . 0.0 111.419 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 204' ' ' ASP . 45.4 mttt -137.79 126.91 24.36 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.308 179.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 27.8 ttm180 -87.56 -112.66 0.06 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.274 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -88.37 -79.23 0.31 Allowed 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 117.939 0.336 . . . . 0.0 110.463 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -115.31 20.78 14.63 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 111.728 0.27 . . . . 0.0 111.728 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -151.22 153.33 34.71 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 120.969 0.414 . . . . 0.0 111.612 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . 0.417 ' HA ' ' HA ' ' A' ' 199' ' ' LYS . 7.1 p-10 -89.86 79.34 6.67 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.338 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 28.4 m -59.32 158.7 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -1.011 0 CA-C-O 121.554 0.692 . . . . 0.0 112.001 -179.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . 0.504 ' O ' ' HB ' ' A' ' 176' ' ' THR . 4.0 ttp180 -89.43 -38.03 14.38 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.505 -178.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -141.2 177.46 8.07 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.073 0.463 . . . . 0.0 111.418 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.833 ' O ' HG21 ' A' ' 170' ' ' VAL . 0.1 OUTLIER -151.28 79.78 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.462 178.759 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.553 ' HB2' ' HB3' ' A' ' 174' ' ' LYS . . . -104.49 173.34 6.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.065 0.459 . . . . 0.0 112.204 -178.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 84.22 -71.61 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.104 -179.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 178.05 37.6 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.394 179.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -104.51 140.56 37.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.983 0.421 . . . . 0.0 111.233 -179.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -93.26 152.75 18.99 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.28 179.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' CYS . . . . . 0.491 ' HB2' HG21 ' A' ' 208' ' ' VAL . 2.3 m -150.54 145.55 26.02 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.767 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -88.26 106.35 3.23 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.484 -0.865 . . . . 0.0 110.998 179.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.782 HD22 ' CD1' ' A' ' 198' ' ' LEU . 0.2 OUTLIER -133.53 145.34 50.04 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 120.993 0.425 . . . . 0.0 111.789 -178.055 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . 0.812 ' O ' HD13 ' A' ' 195' ' ' ILE . 0.2 OUTLIER -86.64 140.79 29.48 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.488 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . 0.606 HG22 ' O ' ' A' ' 218' ' ' ILE . 1.6 mp -108.5 94.03 2.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 121.028 -0.269 . . . . 0.0 110.427 -179.158 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 6.1 tttp 42.16 -143.7 0.08 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.133 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 32.1 t30 -87.87 63.71 7.54 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 120.901 0.381 . . . . 0.0 110.9 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.656 ' CZ ' HD13 ' A' ' 183' ' ' LEU . 0.1 OUTLIER -54.98 118.01 3.93 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 114.595 1.332 . . . . 0.0 114.595 178.835 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -83.07 -43.55 16.16 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.586 176.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . 0.8 ' OD2' HG12 ' A' ' 190' ' ' VAL . 0.0 OUTLIER -89.73 129.97 36.06 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.023 178.264 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.54 HD12 ' HG3' ' A' ' 225' ' ' LYS . 2.0 pt -114.67 178.95 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 CA-C-O 121.191 0.519 . . . . 0.0 111.551 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.54 ' HG3' HD12 ' A' ' 224' ' ' ILE . 11.2 mtpt 62.38 155.63 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.098 -178.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . 0.482 ' HB3' ' O ' ' A' ' 154' ' ' ARG . 0.6 OUTLIER -45.08 90.35 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 121.199 0.523 . . . . 0.0 111.77 -179.461 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . 0.474 ' N ' HG11 ' A' ' 153' ' ' VAL . . . -83.35 -57.97 2.39 Favored Glycine 0 N--CA 1.428 -1.885 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 178.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.453 ' O ' HG12 ' A' ' 153' ' ' VAL . 1.0 OUTLIER -163.83 -148.89 0.13 Allowed 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 179.014 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . 0.761 HG22 ' HG2' ' A' ' 152' ' ' GLU . 46.1 t -90.33 149.38 4.07 Favored 'Isoleucine or valine' 0 C--N 1.341 0.218 0 CA-C-O 120.75 0.31 . . . . 0.0 110.771 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 2.7 mp -120.17 153.41 23.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.77 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' GLU . . . . . 0.458 ' HA ' ' HA ' ' A' ' 150' ' ' GLN . 0.0 OUTLIER -144.14 109.97 5.31 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.357 0.598 . . . . 0.0 112.559 -179.053 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.522 ' HB3' ' O ' ' A' ' 149' ' ' GLY . . . -88.65 127.46 35.57 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.598 178.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' TYR . . . . . 0.423 ' CE1' ' HB3' ' A' ' 180' ' ' LYS . 26.1 p90 -123.02 140.59 52.87 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.013 0.435 . . . . 0.0 111.403 -178.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.534 HG13 ' N ' ' A' ' 235' ' ' MET . 0.9 OUTLIER -176.14 -163.07 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.04 179.716 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' MET . . . . . 0.534 ' N ' HG13 ' A' ' 234' ' ' VAL . 0.0 OUTLIER -89.41 -171.12 3.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.708 0.289 . . . . 0.0 110.742 179.945 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -96.27 37.53 1.25 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.885 0.374 . . . . 0.0 111.364 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -137.67 50.33 1.95 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.047 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.724 HG21 HG21 ' A' ' 148' ' ' ILE . 0.2 OUTLIER -105.35 137.65 33.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.755 179.868 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . 0.52 ' HB2' ' O ' ' A' ' 238' ' ' VAL . . . 167.52 -81.03 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.738 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.98 -8.56 45.79 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.312 -1.041 0 CA-C-N 115.635 -0.712 . . . . 0.0 111.09 -179.962 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.798 0.332 . . . . 0.0 111.068 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -75.91 89.95 2.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.986 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.87 40.07 1.13 Allowed 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.24 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.55 -164.01 1.03 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.583 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.698 HG11 ' HB2' ' A' ' 150' ' ' GLN . 19.5 t -58.77 141.53 15.62 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.559 0 CA-C-O 121.394 0.616 . . . . 0.0 111.559 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.818 HD13 HG12 ' A' ' 234' ' ' VAL . 1.3 pt -123.7 -8.38 7.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.074 178.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.504 ' CA ' ' HB3' ' A' ' 232' ' ' ALA . . . -174.63 74.56 0.08 OUTLIER Glycine 0 C--N 1.344 0.981 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.114 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.698 ' HB2' HG11 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -89.38 136.8 32.82 Favored 'General case' 0 CA--C 1.506 -0.725 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.255 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.486 ' HB1' ' HB2' ' A' ' 168' ' ' CYS . . . -151.35 169.15 22.69 Favored 'General case' 0 N--CA 1.435 -1.176 0 C-N-CA 120.164 -0.615 . . . . 0.0 112.387 -178.03 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.742 ' HG2' HG22 ' A' ' 229' ' ' VAL . 12.9 mt-10 -119.85 124.98 47.4 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.024 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.53 ' HB ' HD11 ' A' ' 230' ' ' ILE . 4.0 p -55.9 128.15 15.79 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 CA-C-O 121.325 0.583 . . . . 0.0 111.771 -179.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.414 ' CA ' ' NE ' ' A' ' 154' ' ' ARG . 0.0 OUTLIER -89.99 -53.54 4.44 Favored 'General case' 0 N--CA 1.429 -1.521 0 N-CA-C 105.175 -2.158 . . . . 0.0 105.175 175.982 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.542 ' HA ' ' H ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER -162.33 -163.36 0.91 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 114.016 -1.447 . . . . 0.0 110.482 175.233 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.595 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 6.0 p -148.09 -179.57 7.02 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 177.28 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.546 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 0.2 OUTLIER -133.29 79.41 1.83 Allowed 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -179.911 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.572 ' HG3' HD13 ' A' ' 224' ' ' ILE . 5.7 tmtt? -86.34 62.25 7.31 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 177.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.498 HG12 ' N ' ' A' ' 161' ' ' LYS . 54.6 t -92.31 156.05 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 CA-C-N 113.633 -1.622 . . . . 0.0 110.455 -178.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 52.3 m -90.86 34.81 0.9 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.125 0.488 . . . . 0.0 109.797 178.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.498 ' N ' HG12 ' A' ' 159' ' ' VAL . 0.0 OUTLIER -150.51 -32.76 0.18 Allowed 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.291 -179.713 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.509 HG12 ' N ' ' A' ' 163' ' ' GLY . 89.9 t -101.53 -104.02 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.26 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . 0.509 ' N ' HG12 ' A' ' 162' ' ' VAL . . . -159.7 -98.27 0.13 Allowed Glycine 0 N--CA 1.451 -0.347 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 178.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.558 ' CG2' HG22 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -153.92 34.83 0.44 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 113.996 -1.102 . . . . 0.0 108.246 177.692 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.565 HG22 ' O ' ' A' ' 165' ' ' ILE . 1.8 mm -41.56 94.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.44 -179.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.595 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . -84.06 117.57 23.51 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 114.767 -1.106 . . . . 0.0 112.416 -179.189 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -88.29 136.95 14.08 Favored Glycine 0 N--CA 1.439 -1.109 0 N-CA-C 109.934 -1.267 . . . . 0.0 109.934 178.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.7 ' SG ' HD11 ' A' ' 216' ' ' LEU . 0.0 OUTLIER -138.43 132.66 31.71 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.938 0.369 . . . . 0.0 110.838 -178.023 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . 0.408 ' O ' ' HA ' ' A' ' 151' ' ' ALA . 11.7 t80 -86.8 133.37 33.65 Favored 'General case' 0 C--O 1.222 -0.368 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 177.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.779 HG21 ' O ' ' A' ' 208' ' ' VAL . 44.2 t -85.73 143.55 11.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -176.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.1 p -135.28 13.57 3.53 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 114.719 -1.128 . . . . 0.0 112.041 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -150.01 -146.71 0.21 Allowed 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -179.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -42.12 -102.5 0.01 OUTLIER Glycine 0 CA--C 1.532 1.117 0 N-CA-C 114.777 0.671 . . . . 0.0 114.777 -179.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.798 ' HG2' ' HB2' ' A' ' 209' ' ' ALA . 6.3 mttt -150.75 134.61 16.65 Favored 'General case' 0 CA--C 1.514 -0.407 0 O-C-N 122.696 -0.297 . . . . 0.0 111.19 -178.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.666 ' O ' HG23 ' A' ' 175' ' ' ILE . 1.1 tp -95.18 83.51 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-O 122.195 0.997 . . . . 0.0 108.948 177.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.531 HG22 ' HB3' ' A' ' 207' ' ' GLU . 0.0 OUTLIER -90.97 -177.61 4.98 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.501 -1.227 . . . . 0.0 113.144 -176.565 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 46.9 mtm180 -76.58 -45.57 29.79 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 114.572 -1.194 . . . . 0.0 111.206 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -88.96 60.64 5.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.104 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.646 ' HB3' HD11 ' A' ' 148' ' ' ILE . 74.7 m -147.81 160.08 43.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.828 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 0.0 OUTLIER -88.55 178.69 6.45 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.171 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.827 HG21 HG23 ' A' ' 218' ' ' ILE . 2.9 m -146.73 149.17 16.11 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.539 0 CA-C-O 121.449 0.642 . . . . 0.0 112.165 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . 0.457 ' N ' ' O ' ' A' ' 231' ' ' GLU . 2.7 ttt180 -154.11 100.28 2.31 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.822 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.494 HD11 ' HB ' ' A' ' 190' ' ' VAL . 0.6 OUTLIER -99.54 165.79 11.46 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-O 121.21 0.528 . . . . 0.0 110.8 179.767 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.853 HG23 ' O ' ' A' ' 188' ' ' ILE . 42.8 mt -157.5 141.32 7.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.467 -178.272 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.514 ' O ' HG22 ' A' ' 184' ' ' ILE . 30.8 ptt180 -87.75 -157.2 0.39 Allowed 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 177.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -93.72 30.6 1.75 Allowed 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.004 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -153.45 -45.47 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.7 -0.762 . . . . 0.0 113.053 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.853 ' O ' HG23 ' A' ' 184' ' ' ILE . 0.2 OUTLIER -150.49 -162.95 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-O 120.945 0.402 . . . . 0.0 112.022 -178.035 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.651 ' N ' HG23 ' A' ' 188' ' ' ILE . 21.9 t -85.85 133.2 30.17 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.531 0 CA-C-O 121.505 0.669 . . . . 0.0 109.842 179.011 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.598 HG23 ' CA ' ' A' ' 184' ' ' ILE . 0.5 OUTLIER -88.38 -35.08 7.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.738 -179.187 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . 0.49 ' CB ' HD21 ' A' ' 183' ' ' LEU . 0.4 OUTLIER -176.94 166.5 2.48 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.544 179.735 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . 0.463 ' OE2' HG11 ' A' ' 189' ' ' VAL . 37.6 mt-10 -151.11 158.5 44.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.924 0.392 . . . . 0.0 111.072 179.046 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 143.95 -131.47 4.45 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.917 -0.658 . . . . 0.0 111.687 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 0.589 ' CA ' HG22 ' A' ' 181' ' ' VAL . 4.4 pt-20 -133.27 -177.6 4.6 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-O 121.237 0.541 . . . . 0.0 111.003 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.869 HD11 HD13 ' A' ' 216' ' ' LEU . 1.1 tt -88.08 149.07 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.293 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.959 -178.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.48 -60.35 1.97 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 179.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 9.7 t -152.02 151.1 30.72 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.532 178.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.991 HD13 HD23 ' A' ' 216' ' ' LEU . 10.9 tp -125.93 118.63 25.82 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.481 0.658 . . . . 0.0 111.644 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . 0.421 ' N ' HD12 ' A' ' 198' ' ' LEU . 0.5 OUTLIER -150.23 121.09 7.6 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.593 179.009 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . 0.432 ' NH1' ' CD1' ' A' ' 212' ' ' TYR . 3.5 ttm180 -87.77 -159.88 0.57 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.342 -179.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -86.75 -11.66 50.44 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.475 0.178 . . . . 0.0 111.093 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.76 -60.34 1.67 Allowed 'General case' 0 N--CA 1.44 -0.94 0 CA-C-O 120.67 0.272 . . . . 0.0 110.641 179.338 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -152.8 -170.82 3.74 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.779 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 23.9 p30 -89.61 63.07 6.11 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.188 0.518 . . . . 0.0 109.817 179.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 33.1 m -55.45 160.8 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.925 0 CA-C-O 121.595 0.712 . . . . 0.0 112.549 -178.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . 0.447 ' O ' ' HB ' ' A' ' 176' ' ' THR . 4.8 ttm180 -89.3 -37.26 15.06 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 114.642 -1.163 . . . . 0.0 111.524 -178.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.531 ' HB3' HG22 ' A' ' 176' ' ' THR . 1.3 mp0 -138.04 179.41 6.45 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.159 0.504 . . . . 0.0 111.512 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.779 ' O ' HG21 ' A' ' 170' ' ' VAL . 0.2 OUTLIER -150.94 78.4 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.842 179.283 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.798 ' HB2' ' HG2' ' A' ' 174' ' ' LYS . . . -97.44 170.31 9.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.052 0.453 . . . . 0.0 112.151 -178.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 85.89 -74.99 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.155 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . 0.403 ' O ' ' CE2' ' A' ' 169' ' ' TYR . . . 177.86 37.7 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.219 -0.991 . . . . 0.0 112.494 179.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . 0.432 ' CD1' ' NH1' ' A' ' 200' ' ' ARG . 1.6 m-85 -95.17 148.62 22.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.966 0.413 . . . . 0.0 111.414 -179.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -89.54 159.12 17.37 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.095 179.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 10.3 p -150.95 -177.88 6.27 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.182 0.515 . . . . 0.0 111.642 -179.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -136.71 105.83 0.53 Allowed Glycine 0 N--CA 1.452 -0.3 0 N-CA-C 110.086 -1.205 . . . . 0.0 110.086 178.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.991 HD23 HD13 ' A' ' 198' ' ' LEU . 0.3 OUTLIER -138.86 144.68 39.32 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -177.685 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . 0.692 ' O ' HD13 ' A' ' 218' ' ' ILE . 0.0 OUTLIER -79.39 -179.06 6.58 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 176.661 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . 0.827 HG23 HG21 ' A' ' 181' ' ' VAL . 49.8 mm -141.11 81.66 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 120.024 -0.67 . . . . 0.0 112.737 -178.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 13.7 tttt 44.08 -134.95 0.57 Allowed 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 121.177 -0.209 . . . . 0.0 110.695 177.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -87.7 53.62 2.84 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.088 0.47 . . . . 0.0 110.645 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.486 ' HA ' ' CE2' ' A' ' 191' ' ' TYR . 1.2 t80 -56.96 153.52 11.07 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 117.332 2.345 . . . . 0.0 117.332 179.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . 0.454 ' HB2' ' CE1' ' A' ' 191' ' ' TYR . 7.8 t-20 -122.52 -49.34 2.02 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 112.957 -1.928 . . . . 0.0 111.481 178.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . 0.454 ' OD1' ' N ' ' A' ' 224' ' ' ILE . 0.0 OUTLIER -61.28 163.82 6.05 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 -178.463 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.572 HD13 ' HG3' ' A' ' 158' ' ' LYS . 17.4 pt -154.13 -178.31 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 176.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 34.4 100.65 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 114.466 -1.243 . . . . 0.0 111.926 -179.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . 0.542 ' H ' ' HA ' ' A' ' 155' ' ' GLN . 38.1 tt0 25.95 57.44 0.06 Allowed 'General case' 0 N--CA 1.482 1.169 0 O-C-N 124.294 0.996 . . . . 0.0 112.277 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . 0.448 ' N ' HG11 ' A' ' 153' ' ' VAL . . . -57.83 -69.83 1.16 Allowed Glycine 0 N--CA 1.429 -1.775 0 CA-C-N 114.411 -1.268 . . . . 0.0 113.14 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.56 ' HB2' HG21 ' A' ' 190' ' ' VAL . 8.3 m-20 -157.58 -159.67 0.86 Allowed 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 -178.233 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . 0.742 HG22 ' HG2' ' A' ' 152' ' ' GLU . 69.7 t -88.21 136.09 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 O-C-N 122.142 -0.349 . . . . 0.0 110.308 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . 0.623 HD13 ' HB3' ' A' ' 168' ' ' CYS . 5.3 mp -102.64 158.52 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 O-C-N 123.639 0.587 . . . . 0.0 111.257 -179.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' GLU . . . . . 0.457 ' O ' ' N ' ' A' ' 182' ' ' ARG . 5.2 tm-20 -147.14 109.57 4.56 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.504 ' HB3' ' CA ' ' A' ' 149' ' ' GLY . . . -87.41 130.05 34.81 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.474 178.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -132.81 141.96 48.74 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.047 -178.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.818 HG12 HD13 ' A' ' 148' ' ' ILE . 0.3 OUTLIER -179.6 -167.14 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.746 -179.832 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' MET . . . . . 0.621 ' N ' HG13 ' A' ' 234' ' ' VAL . 1.5 ttm -97.3 -163.47 1.05 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.009 179.13 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -89.5 77.26 7.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.157 0.503 . . . . 0.0 110.808 179.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -150.87 38.75 0.68 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.116 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.408 ' HB ' HG21 ' A' ' 176' ' ' THR . 2.0 m -106.14 161.14 5.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.266 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . 0.456 ' HB2' ' OE2' ' A' ' 207' ' ' GLU . . . 70.02 -64.39 0.36 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.023 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.73 -3.52 58.14 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.314 -0.966 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.046 179.957 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.842 0.353 . . . . 0.0 111.15 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -177.13 136.14 0.21 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.877 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.456 ' N ' ' HA ' ' A' ' 235' ' ' MET . 0.0 OUTLIER -98.66 34.6 2.01 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.437 179.775 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 17.3 tttt 68.06 166.94 0.25 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -178.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 3.5 t -60.05 140.24 18.39 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.871 0 CA-C-O 121.254 0.55 . . . . 0.0 111.209 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.533 HG21 ' CG1' ' A' ' 234' ' ' VAL . 3.3 tp -132.61 -3.05 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.225 177.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.494 ' CA ' ' HB3' ' A' ' 232' ' ' ALA . . . -165.77 66.71 0.21 Allowed Glycine 0 C--N 1.341 0.825 0 C-N-CA 119.982 -1.104 . . . . 0.0 112.496 179.465 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.494 ' HA ' ' HA ' ' A' ' 231' ' ' GLU . 1.3 mt-30 -90.0 132.48 35.33 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.451 ' HB1' ' O ' ' A' ' 169' ' ' TYR . . . -152.54 178.33 9.69 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 -177.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.86 ' CG ' HG22 ' A' ' 229' ' ' VAL . 0.1 OUTLIER -123.7 124.18 42.17 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.693 -1.14 . . . . 0.0 110.373 179.904 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.492 ' CG1' ' HA ' ' A' ' 226' ' ' GLU . 2.7 p -49.5 133.06 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -179.209 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.509 ' O ' ' HB3' ' A' ' 226' ' ' GLU . 4.3 mmp_? -89.56 -62.16 1.54 Allowed 'General case' 0 N--CA 1.434 -1.248 0 N-CA-C 105.08 -2.193 . . . . 0.0 105.08 175.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.51 -160.08 0.5 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 113.671 -1.604 . . . . 0.0 108.698 174.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 7.6 p -148.97 159.3 44.33 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.871 0.367 . . . . 0.0 110.232 177.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.675 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 2.6 m-85 -104.42 73.95 1.14 Allowed 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -177.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -85.9 63.42 8.03 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 122.08 0.943 . . . . 0.0 108.794 178.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 93.1 t -90.09 158.1 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-N 113.752 -1.567 . . . . 0.0 110.02 -179.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 13.9 m -92.52 33.32 1.12 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.132 0.491 . . . . 0.0 110.004 178.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -151.84 -31.78 0.15 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.639 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.556 HG12 HD13 ' A' ' 165' ' ' ILE . 93.0 t -99.47 -101.94 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.203 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . 0.478 ' N ' HG12 ' A' ' 162' ' ' VAL . . . -158.79 -104.33 0.2 Allowed Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 111.728 -0.549 . . . . 0.0 111.728 179.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.552 HG21 HG21 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -153.78 35.63 0.44 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 114.299 -0.95 . . . . 0.0 108.771 178.355 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.675 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 1.7 mp -42.8 95.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-N 115.327 -0.852 . . . . 0.0 111.342 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.532 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . -87.19 120.79 28.84 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 114.649 -1.16 . . . . 0.0 111.859 -179.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -89.46 149.91 20.92 Favored Glycine 0 N--CA 1.442 -0.93 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 178.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.811 ' SG ' HD11 ' A' ' 216' ' ' LEU . 0.0 OUTLIER -144.55 133.78 22.96 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 117.061 0.431 . . . . 0.0 110.21 -179.279 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . 0.451 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 1.1 t80 -86.94 127.51 35.07 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 178.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.659 HG21 ' O ' ' A' ' 208' ' ' VAL . 36.7 t -85.21 142.97 12.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -175.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -132.76 9.16 4.21 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 114.289 -1.323 . . . . 0.0 111.921 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.41 ' CB ' ' HB2' ' A' ' 150' ' ' GLN . 5.5 t0 -142.67 -142.42 0.14 Allowed 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -48.26 -104.84 0.01 OUTLIER Glycine 0 CA--C 1.535 1.294 0 C-N-CA 120.636 -0.792 . . . . 0.0 114.387 -179.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.916 ' HD3' HG11 ' A' ' 238' ' ' VAL . 0.0 OUTLIER -145.45 133.91 21.94 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.003 0.521 . . . . 0.0 110.849 -179.276 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.652 ' O ' HG23 ' A' ' 175' ' ' ILE . 9.0 tp -88.5 84.12 2.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 122.26 1.029 . . . . 0.0 109.425 178.182 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 1.003 HG21 HG12 ' A' ' 238' ' ' VAL . 0.6 OUTLIER -85.99 -174.42 5.09 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.327 -1.306 . . . . 0.0 113.924 -176.585 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -84.71 -45.99 11.89 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 114.417 -1.265 . . . . 0.0 111.439 -179.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -88.72 52.89 2.54 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.589 -178.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -139.66 161.24 38.0 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.882 179.15 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 1.1 mptt -88.65 -172.21 3.64 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.506 HG22 ' CA ' ' A' ' 194' ' ' GLU . 3.0 m -141.35 161.03 22.22 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.647 0 CA-C-O 121.4 0.619 . . . . 0.0 111.883 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . 0.449 ' HB3' ' HB3' ' A' ' 231' ' ' GLU . 8.4 ttt85 -152.09 92.8 1.75 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.04 -0.982 . . . . 0.0 112.099 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.766 HD22 ' CZ ' ' A' ' 221' ' ' PHE . 5.7 mp -88.37 142.33 27.82 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -178.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.665 HD13 ' O ' ' A' ' 183' ' ' LEU . 17.3 mm -150.56 128.73 2.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 113.05 -1.886 . . . . 0.0 111.36 179.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.421 ' N ' HG22 ' A' ' 190' ' ' VAL . 4.0 ttp180 -88.83 -148.09 0.17 Allowed 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 177.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -95.79 28.33 3.11 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 118.473 0.579 . . . . 0.0 110.726 178.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.475 ' C ' HD13 ' A' ' 188' ' ' ILE . . . -153.87 -83.6 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.792 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.475 HD13 ' C ' ' A' ' 187' ' ' GLY . 0.2 OUTLIER -110.22 -157.78 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 115.427 -0.387 . . . . 0.0 110.657 -179.204 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.605 HG11 ' CG ' ' A' ' 192' ' ' GLU . 41.4 t -87.41 135.62 24.92 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 CA-C-O 121.751 0.786 . . . . 0.0 111.262 -179.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.878 HG12 ' OD2' ' A' ' 223' ' ' ASP . 0.1 OUTLIER -97.3 -34.04 4.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 114.426 -1.261 . . . . 0.0 109.411 179.76 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . 0.746 ' HB3' HD13 ' A' ' 183' ' ' LEU . 41.8 t80 -167.86 154.0 7.54 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.327 -0.852 . . . . 0.0 112.453 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . 0.605 ' CG ' HG11 ' A' ' 189' ' ' VAL . 50.7 mt-10 -150.16 158.28 43.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.067 178.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 133.97 -120.48 2.51 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.427 -0.892 . . . . 0.0 112.761 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 0.506 ' CA ' HG22 ' A' ' 181' ' ' VAL . 0.0 OUTLIER -147.92 179.53 7.66 Favored 'General case' 0 CA--C 1.503 -0.857 0 CA-C-O 121.706 0.765 . . . . 0.0 111.797 -179.04 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.949 HD12 HD13 ' A' ' 216' ' ' LEU . 32.9 mm -92.57 153.06 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.308 0 CA-C-N 114.35 -1.295 . . . . 0.0 110.186 -179.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -89.97 -58.52 2.48 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 36.4 p -150.6 156.73 41.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.85 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.918 ' CD1' HD23 ' A' ' 216' ' ' LEU . 5.9 tp -127.88 115.78 19.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.172 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 5.1 ptpt -150.09 120.0 7.13 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.195 -0.912 . . . . 0.0 109.564 179.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.88 -159.79 0.56 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.328 -179.249 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -86.62 -11.09 52.4 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 120.533 0.206 . . . . 0.0 111.101 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -94.48 -60.39 1.73 Allowed 'General case' 0 N--CA 1.439 -0.993 0 CA-C-O 120.739 0.304 . . . . 0.0 110.641 179.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -152.66 -174.3 4.86 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.085 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -89.61 56.1 3.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.247 0.546 . . . . 0.0 110.022 179.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.585 ' O ' HD23 ' A' ' 198' ' ' LEU . 31.9 m -53.91 160.87 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.969 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.352 -179.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . 0.476 ' O ' ' HB ' ' A' ' 176' ' ' THR . 0.0 OUTLIER -88.86 -36.73 15.83 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.321 -178.859 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.785 ' HB3' HG22 ' A' ' 176' ' ' THR . 0.6 OUTLIER -133.71 176.78 8.24 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.268 0.556 . . . . 0.0 111.821 179.926 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.659 ' O ' HG21 ' A' ' 170' ' ' VAL . 0.2 OUTLIER -150.38 84.24 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.759 179.129 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.824 ' HB2' ' HG3' ' A' ' 174' ' ' LYS . . . -99.99 178.82 4.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.096 0.474 . . . . 0.0 112.086 -178.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 81.9 -75.01 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.698 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . 0.405 ' O ' ' CE1' ' A' ' 169' ' ' TYR . . . 178.42 37.65 0.06 OUTLIER Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.347 179.033 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -101.75 143.2 31.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.917 0.389 . . . . 0.0 111.372 -179.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . 0.443 ' HG2' ' CD2' ' A' ' 169' ' ' TYR . 0.0 OUTLIER -98.56 131.5 44.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.454 179.943 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' CYS . . . . . 0.524 ' CB ' HG21 ' A' ' 208' ' ' VAL . 34.6 t -125.84 145.52 50.2 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.333 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -88.38 113.81 4.12 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.148 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.949 HD13 HD12 ' A' ' 195' ' ' ILE . 0.5 OUTLIER -133.81 147.35 51.23 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 120.839 0.352 . . . . 0.0 111.073 -179.26 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.01 138.45 31.97 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 177.038 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . 0.648 HG22 ' CE1' ' A' ' 191' ' ' TYR . 19.1 mm -91.33 52.61 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.086 0.469 . . . . 0.0 112.193 -177.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 4.6 tptm 61.48 -72.08 0.04 OUTLIER 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.642 178.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . 0.426 ' N ' ' O ' ' A' ' 218' ' ' ILE . 5.0 p-10 -145.43 51.45 1.2 Allowed 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.253 -179.089 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.766 ' CZ ' HD22 ' A' ' 183' ' ' LEU . 0.1 OUTLIER -57.3 118.49 5.16 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 178.33 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -77.84 -46.3 21.88 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 176.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . 0.878 ' OD2' HG12 ' A' ' 190' ' ' VAL . 0.0 OUTLIER -88.09 130.39 35.02 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 177.48 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.637 HD13 ' H ' ' A' ' 224' ' ' ILE . 0.2 OUTLIER -117.31 176.77 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 CA-C-O 121.438 0.637 . . . . 0.0 112.466 -179.283 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.463 ' O ' ' N ' ' A' ' 227' ' ' GLY . 10.4 mtmt 62.06 154.28 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.231 -178.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . 0.509 ' HB3' ' O ' ' A' ' 154' ' ' ARG . 0.2 OUTLIER -39.99 90.77 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 122.235 1.017 . . . . 0.0 111.845 179.939 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 225' ' ' LYS . . . -106.66 -38.85 2.14 Favored Glycine 0 N--CA 1.429 -1.805 0 CA-C-N 114.356 -1.293 . . . . 0.0 112.207 -178.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.711 ' CB ' HG21 ' A' ' 190' ' ' VAL . 2.9 p30 -157.95 -166.7 2.03 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 115.736 1.754 . . . . 0.0 115.736 -178.166 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . 0.86 HG22 ' CG ' ' A' ' 152' ' ' GLU . 40.6 t -97.98 142.48 14.4 Favored 'Isoleucine or valine' 0 C--N 1.343 0.326 0 CA-C-N 114.441 -1.254 . . . . 0.0 108.075 177.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . 0.403 HG13 ' HG ' ' A' ' 183' ' ' LEU . 3.9 mp -115.48 150.89 17.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.091 0.472 . . . . 0.0 111.831 -178.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' GLU . . . . . 0.494 ' HA ' ' HA ' ' A' ' 150' ' ' GLN . 7.4 tt0 -137.69 108.73 6.75 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.271 0.558 . . . . 0.0 110.731 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.494 ' HB3' ' CA ' ' A' ' 149' ' ' GLY . . . -87.8 124.19 33.36 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.808 -179.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -123.62 166.97 14.57 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.709 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.533 ' CG1' HG21 ' A' ' 148' ' ' ILE . 9.8 p -176.19 150.49 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 121.076 -0.249 . . . . 0.0 110.98 -179.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' MET . . . . . 0.456 ' HA ' ' N ' ' A' ' 145' ' ' GLU . 0.0 OUTLIER -97.06 30.94 2.55 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.123 0.487 . . . . 0.0 109.695 178.798 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -133.72 -155.88 0.7 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -98.56 -99.57 0.21 Allowed 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 179.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 1.003 HG12 HG21 ' A' ' 176' ' ' THR . 0.6 OUTLIER -154.47 -158.05 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.159 -179.883 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . 0.561 ' H ' HG12 ' A' ' 238' ' ' VAL . . . -47.36 -78.62 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 122.97 0.508 . . . . 0.0 111.318 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -90.68 -5.22 56.07 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.953 179.273 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.314 -0.951 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.072 179.994 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 . . . . . 0 N--CA 1.487 1.424 0 N-CA-C 111.714 0.264 . . . . 0.0 111.714 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 179.46 138.76 0.11 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.768 0.318 . . . . 0.0 110.673 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.3 39.5 1.12 Allowed 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.392 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -76.91 -179.21 5.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.57 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.566 HG11 ' HB2' ' A' ' 150' ' ' GLN . 15.0 t -60.13 139.84 19.03 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 CA-C-O 121.463 0.649 . . . . 0.0 111.356 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.872 ' CD1' HG21 ' A' ' 238' ' ' VAL . 6.9 tp -114.13 -18.97 7.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.231 178.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.406 ' O ' ' HB3' ' A' ' 232' ' ' ALA . . . 178.97 85.9 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.339 -179.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.566 ' HB2' HG11 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -91.44 135.05 34.12 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.664 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.461 ' HB1' ' O ' ' A' ' 169' ' ' TYR . . . -150.78 173.14 14.55 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 -177.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.834 ' CG ' HG22 ' A' ' 229' ' ' VAL . 0.4 OUTLIER -117.51 122.82 44.75 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.091 179.715 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.456 HG12 ' O ' ' A' ' 228' ' ' ASP . 2.7 p -55.65 128.92 16.52 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.338 0 CA-C-O 121.326 0.584 . . . . 0.0 111.65 -179.42 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.419 ' CA ' ' NE ' ' A' ' 154' ' ' ARG . 0.0 OUTLIER -89.2 -58.38 2.56 Favored 'General case' 0 N--CA 1.427 -1.606 0 N-CA-C 105.288 -2.115 . . . . 0.0 105.288 176.203 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.43 ' HA ' ' H ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER -163.1 -163.23 0.83 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.691 174.906 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.593 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 7.0 p -147.57 149.01 31.76 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.564 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 0.2 OUTLIER -94.4 80.3 3.92 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -177.984 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 13.8 tttm -85.88 63.69 8.18 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.42 HG12 ' N ' ' A' ' 161' ' ' LYS . 69.9 t -93.21 157.06 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-N 113.652 -1.613 . . . . 0.0 110.231 -178.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -92.07 35.45 0.99 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.208 0.528 . . . . 0.0 109.655 178.129 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.42 ' N ' HG12 ' A' ' 159' ' ' VAL . 5.0 mttt -151.47 -35.32 0.14 Allowed 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.084 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.49 HG12 HD13 ' A' ' 165' ' ' ILE . 95.5 t -97.85 -102.24 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . 0.471 ' N ' HG12 ' A' ' 162' ' ' VAL . . . -159.33 -102.8 0.18 Allowed Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 178.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 1.082 HG21 HG21 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -153.68 35.2 0.45 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.087 -1.056 . . . . 0.0 108.271 177.404 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.564 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 1.5 mp -42.92 96.02 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.541 -179.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.593 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . -80.39 118.67 22.23 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.697 -1.138 . . . . 0.0 112.194 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -88.75 141.86 16.73 Favored Glycine 0 N--CA 1.441 -1.022 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 178.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.465 ' HB3' HD12 ' A' ' 230' ' ' ILE . 0.0 OUTLIER -141.01 132.39 26.76 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.879 0.339 . . . . 0.0 110.488 -178.491 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . 0.461 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 47.5 t80 -85.59 129.36 34.84 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.247 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.69 HG21 ' O ' ' A' ' 208' ' ' VAL . 31.8 t -85.73 149.28 4.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -175.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -140.09 15.12 2.44 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 114.427 -1.261 . . . . 0.0 111.826 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.523 ' H ' HG12 ' A' ' 170' ' ' VAL . 9.3 t0 -150.6 -145.26 0.17 Allowed 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -179.346 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -43.48 -105.18 0.01 OUTLIER Glycine 0 CA--C 1.53 0.997 0 N-CA-C 114.84 0.696 . . . . 0.0 114.84 -179.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.814 ' HG2' ' HB2' ' A' ' 209' ' ' ALA . 7.6 mttt -151.44 144.28 24.44 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.999 0.428 . . . . 0.0 112.013 -178.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.445 ' CG1' HG22 ' A' ' 170' ' ' VAL . 10.3 mm -89.91 87.34 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 176.28 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.653 ' C ' HD11 ' A' ' 198' ' ' LEU . 0.1 OUTLIER -98.1 165.7 11.77 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -176.909 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 20.6 mtm105 -64.85 -44.45 89.75 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 114.55 -1.204 . . . . 0.0 111.083 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -89.3 60.15 5.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.752 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 46.6 m -149.2 159.54 44.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.652 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.538 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 14.9 mttp -89.62 -172.28 3.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.483 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.49 HG22 ' CA ' ' A' ' 194' ' ' GLU . 3.0 m -149.47 146.32 17.16 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.607 0 CA-C-O 121.554 0.692 . . . . 0.0 111.861 179.326 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . 0.448 ' N ' ' O ' ' A' ' 231' ' ' GLU . 6.0 ttm180 -154.45 98.83 2.14 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.722 -1.126 . . . . 0.0 112.002 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.628 ' C ' HD12 ' A' ' 184' ' ' ILE . 0.3 OUTLIER -100.88 168.53 9.58 Favored 'General case' 0 N--CA 1.437 -1.093 0 C-N-CA 120.358 -0.537 . . . . 0.0 111.026 179.597 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.771 HG23 ' O ' ' A' ' 188' ' ' ILE . 5.3 mp -151.15 140.07 14.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.156 -177.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.464 ' N ' HG22 ' A' ' 190' ' ' VAL . 8.0 ptp180 -87.16 -155.77 0.3 Allowed 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.172 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -93.6 27.23 2.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 118.327 0.512 . . . . 0.0 111.385 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -154.4 -43.87 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.966 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.771 ' O ' HG23 ' A' ' 184' ' ' ILE . 0.4 OUTLIER -150.14 -159.34 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 120.679 0.276 . . . . 0.0 111.711 -177.969 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.668 ' N ' HG23 ' A' ' 188' ' ' ILE . 39.8 t -85.13 135.13 25.49 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 CA-C-O 121.564 0.697 . . . . 0.0 110.349 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.498 ' HB ' HD11 ' A' ' 183' ' ' LEU . 0.3 OUTLIER -87.99 -35.04 7.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.347 -179.848 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . 0.48 ' HB2' ' CE1' ' A' ' 221' ' ' PHE . 0.6 OUTLIER -176.66 155.3 1.31 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.042 -179.994 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . 0.625 ' CG ' HG11 ' A' ' 189' ' ' VAL . 33.3 mt-10 -141.7 161.14 38.67 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.884 179.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 141.28 -137.31 8.03 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 111.377 -0.689 . . . . 0.0 111.377 -179.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 0.707 ' O ' HG23 ' A' ' 218' ' ' ILE . 7.2 pt-20 -131.97 -176.07 3.94 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-O 121.011 0.434 . . . . 0.0 111.169 179.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.482 HG22 ' N ' ' A' ' 196' ' ' ASP . 5.8 mm -87.21 159.11 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.687 -178.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' ASP . . . . . 0.643 ' HB3' HG23 ' A' ' 217' ' ' THR . 4.0 t0 -103.16 -56.98 2.12 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 18.1 p -151.58 155.01 37.58 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.543 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.653 HD11 ' C ' ' A' ' 176' ' ' THR . 13.6 mt -117.11 128.22 54.92 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.927 179.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 10.8 ptpt -151.09 118.45 6.0 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.473 178.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 6.6 ttp180 -88.74 -39.11 14.19 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.433 0.635 . . . . 0.0 111.525 -178.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -151.61 -86.4 0.07 Allowed 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 114.979 -1.009 . . . . 0.0 110.782 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.19 22.76 11.68 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 116.733 -0.212 . . . . 0.0 111.154 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -150.49 155.37 39.38 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 120.896 0.379 . . . . 0.0 110.938 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -89.83 90.7 8.3 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.731 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 27.6 m -66.48 155.42 7.19 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.915 0 CA-C-O 121.332 0.587 . . . . 0.0 111.671 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . 0.456 ' O ' ' HB ' ' A' ' 176' ' ' THR . 2.7 mtp180 -89.37 -32.74 17.16 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.388 -178.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -150.06 179.0 8.42 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.921 0.391 . . . . 0.0 110.713 179.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.69 ' O ' HG21 ' A' ' 170' ' ' VAL . 1.8 t -151.07 80.34 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.828 178.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.814 ' HB2' ' HG2' ' A' ' 174' ' ' LYS . . . -102.68 174.53 5.85 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 83.11 -74.33 0.03 OUTLIER 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.09 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 178.11 37.21 0.06 OUTLIER Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.392 -0.909 . . . . 0.0 112.385 179.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -98.17 144.69 27.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.919 0.39 . . . . 0.0 111.274 -179.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -96.77 130.11 44.08 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.872 179.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' CYS . . . . . 0.486 ' CB ' HG21 ' A' ' 208' ' ' VAL . 33.6 t -128.75 144.93 51.28 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.775 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -88.77 110.64 3.69 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.634 -0.793 . . . . 0.0 111.761 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.447 ' CD1' HD12 ' A' ' 195' ' ' ILE . 0.1 OUTLIER -129.0 144.37 51.16 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.116 0.484 . . . . 0.0 111.111 -179.229 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . 0.643 HG23 ' HB3' ' A' ' 196' ' ' ASP . 0.1 OUTLIER -107.09 141.69 37.92 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 178.147 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . 0.707 HG23 ' O ' ' A' ' 194' ' ' GLU . 18.4 mm -90.72 140.45 15.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.241 0.544 . . . . 0.0 110.571 -179.344 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt -42.0 -30.1 0.26 Allowed 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -177.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . 0.425 ' O ' ' CE2' ' A' ' 191' ' ' TYR . 5.0 t30 -152.46 35.08 0.51 Allowed 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -178.335 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.5 ' HB2' ' HB ' ' A' ' 218' ' ' ILE . 0.1 OUTLIER -58.84 120.09 8.37 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 178.891 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -88.11 -46.97 8.85 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 176.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . 0.459 ' O ' ' CD1' ' A' ' 221' ' ' PHE . 0.0 OUTLIER -79.54 136.25 36.83 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.063 177.403 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 1.082 HG21 HG21 ' A' ' 164' ' ' THR . 0.2 OUTLIER -133.28 178.9 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -178.859 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.412 ' O ' ' C ' ' A' ' 226' ' ' GLU . 0.0 OUTLIER 57.46 116.8 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.853 -178.862 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . 0.43 ' H ' ' HA ' ' A' ' 155' ' ' GLN . 0.5 OUTLIER 6.91 63.95 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 124.51 1.124 . . . . 0.0 113.814 -179.545 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . 0.437 ' N ' HG11 ' A' ' 153' ' ' VAL . . . -61.39 -66.73 2.48 Favored Glycine 0 N--CA 1.434 -1.497 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.739 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.456 ' O ' HG12 ' A' ' 153' ' ' VAL . 0.8 OUTLIER -165.07 -148.21 0.11 Allowed 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 114.279 1.215 . . . . 0.0 114.279 179.686 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . 0.834 HG22 ' CG ' ' A' ' 152' ' ' GLU . 73.0 t -89.14 130.2 38.89 Favored 'Isoleucine or valine' 0 C--N 1.345 0.381 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . 0.497 ' HA ' ' CB ' ' A' ' 183' ' ' LEU . 22.6 mt -101.04 158.32 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.119 0 O-C-N 123.66 0.6 . . . . 0.0 111.332 -179.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' GLU . . . . . 0.448 ' O ' ' N ' ' A' ' 182' ' ' ARG . 16.1 tt0 -144.85 111.0 5.51 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.3 0.572 . . . . 0.0 112.522 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.556 ' O ' HG22 ' A' ' 148' ' ' ILE . . . -87.67 122.83 31.85 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.948 178.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -123.84 141.27 52.18 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.022 -179.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.583 HG22 ' H ' ' A' ' 235' ' ' MET . 0.9 OUTLIER -175.99 -175.71 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.017 179.837 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' MET . . . . . 0.583 ' H ' HG22 ' A' ' 234' ' ' VAL . 0.5 OUTLIER -89.43 -162.64 0.89 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.657 0.265 . . . . 0.0 111.106 -179.775 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.78 38.09 1.07 Allowed 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.874 0.369 . . . . 0.0 111.885 -179.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -123.62 46.41 2.23 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.167 0.508 . . . . 0.0 110.057 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.872 HG21 ' CD1' ' A' ' 148' ' ' ILE . 1.4 t -108.24 168.35 3.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.298 -178.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . 0.501 ' H ' HG12 ' A' ' 238' ' ' VAL . . . 69.71 -64.68 0.34 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.052 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.62 -3.21 58.37 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.314 -0.938 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.978 -179.994 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.415 ' CE1' ' HE3' ' A' ' 174' ' ' LYS . 25.4 m-85 . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.822 0.344 . . . . 0.0 111.24 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -140.81 179.16 6.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.867 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.11 37.08 1.26 Allowed 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.303 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 33.2 mttp -119.17 -80.26 0.61 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.302 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.465 HG11 ' HB2' ' A' ' 150' ' ' GLN . 4.3 t -108.43 141.96 22.32 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.739 0 CA-C-O 121.435 0.636 . . . . 0.0 110.727 179.022 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.643 HG21 HG12 ' A' ' 234' ' ' VAL . 2.6 pp -128.99 -8.85 3.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.635 179.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.539 ' N ' HD12 ' A' ' 148' ' ' ILE . . . -174.04 75.0 0.09 OUTLIER Glycine 0 C--N 1.341 0.817 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.831 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.465 ' HB2' HG11 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -90.39 137.99 31.9 Favored 'General case' 0 CA--C 1.506 -0.728 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.852 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.534 ' HB1' ' HB2' ' A' ' 168' ' ' CYS . . . -151.66 174.85 12.99 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 120.093 -0.643 . . . . 0.0 112.339 -178.105 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.773 ' HG3' HG22 ' A' ' 229' ' ' VAL . 0.4 OUTLIER -125.12 119.37 28.4 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.507 179.92 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.464 HG11 ' N ' ' A' ' 227' ' ' GLY . 1.1 p -49.07 131.23 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -178.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.557 ' O ' ' HB3' ' A' ' 226' ' ' GLU . 4.0 mmp_? -91.48 -60.17 1.95 Allowed 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 105.249 -2.13 . . . . 0.0 105.249 175.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.73 -159.18 0.44 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 113.743 -1.571 . . . . 0.0 109.422 175.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.551 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 9.5 p -148.92 163.17 38.24 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 120.821 0.343 . . . . 0.0 110.647 177.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.656 ' HB2' ' HB ' ' A' ' 165' ' ' ILE . 3.7 m-85 -110.13 73.04 0.82 Allowed 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -178.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.588 ' HG3' HD13 ' A' ' 224' ' ' ILE . 8.2 tmtm? -85.94 64.36 8.55 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 92.4 t -92.25 158.22 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 CA-C-N 113.549 -1.66 . . . . 0.0 110.258 -178.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 71.5 m -93.06 34.46 1.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.225 0.535 . . . . 0.0 109.761 178.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.63 -33.09 0.15 Allowed 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.386 -179.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.516 HG12 ' N ' ' A' ' 163' ' ' GLY . 89.0 t -99.82 -102.19 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.19 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . 0.516 ' N ' HG12 ' A' ' 162' ' ' VAL . . . -158.85 -103.4 0.19 Allowed Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 111.522 -0.631 . . . . 0.0 111.522 179.268 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.458 HG21 ' CG2' ' A' ' 224' ' ' ILE . 0.0 OUTLIER -153.64 34.61 0.45 Allowed 'General case' 0 C--O 1.232 0.148 0 CA-C-N 114.311 -0.944 . . . . 0.0 108.801 178.259 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.656 ' HB ' ' HB2' ' A' ' 157' ' ' PHE . 1.6 mp -43.3 98.09 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.527 0.096 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.424 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.551 ' HA ' ' HA ' ' A' ' 156' ' ' THR . . . -87.08 122.89 31.52 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.854 -1.067 . . . . 0.0 111.698 -179.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -87.73 146.54 20.02 Favored Glycine 0 N--CA 1.442 -0.921 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 178.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.534 ' HB2' ' HB1' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -147.66 134.37 19.98 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 117.279 0.539 . . . . 0.0 110.771 -178.338 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . 0.427 ' O ' ' HA ' ' A' ' 151' ' ' ALA . 22.9 t80 -86.84 134.34 33.55 Favored 'General case' 0 C--O 1.221 -0.414 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 177.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.512 HG12 ' N ' ' A' ' 212' ' ' TYR . 9.2 p -86.43 146.63 6.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -176.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.2 p -140.95 12.01 2.23 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.557 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.425 ' CB ' ' HB2' ' A' ' 150' ' ' GLN . 9.1 t0 -150.79 -148.14 0.25 Allowed 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -41.48 -104.51 0.01 OUTLIER Glycine 0 CA--C 1.532 1.119 0 N-CA-C 115.09 0.796 . . . . 0.0 115.09 -178.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.707 ' HG3' ' HB2' ' A' ' 209' ' ' ALA . 0.0 OUTLIER -150.64 128.89 11.98 Favored 'General case' 0 CA--C 1.513 -0.457 0 O-C-N 122.722 -0.281 . . . . 0.0 111.368 -178.778 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.658 ' O ' HG23 ' A' ' 175' ' ' ILE . 1.1 tp -89.54 76.78 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 CA-C-O 122.27 1.033 . . . . 0.0 108.981 177.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.803 HG22 ' HB3' ' A' ' 207' ' ' GLU . 0.2 OUTLIER -84.03 173.01 11.49 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.015 -1.448 . . . . 0.0 113.543 -176.796 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 43.0 ttp85 -59.96 -51.6 68.98 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 114.2 -1.364 . . . . 0.0 111.536 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -89.55 61.92 5.72 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.68 -178.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.622 ' HB3' HD13 ' A' ' 148' ' ' ILE . 0.9 OUTLIER -142.68 160.4 40.38 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.443 179.396 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.516 ' HA ' ' HA ' ' A' ' 194' ' ' GLU . 11.9 mttt -89.08 -174.39 4.43 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.698 HG21 HG23 ' A' ' 218' ' ' ILE . 2.4 m -150.7 145.51 16.77 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 CA-C-O 121.573 0.702 . . . . 0.0 112.111 179.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . 0.465 ' N ' ' O ' ' A' ' 231' ' ' GLU . 16.9 ttt180 -154.87 100.52 2.21 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.725 -1.125 . . . . 0.0 112.051 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.532 ' HA ' ' O ' ' A' ' 229' ' ' VAL . 0.3 OUTLIER -100.15 168.83 9.57 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 120.616 -0.433 . . . . 0.0 110.878 179.551 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.725 HG23 ' O ' ' A' ' 188' ' ' ILE . 27.2 mt -155.5 139.55 8.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.333 -0.394 . . . . 0.0 112.017 -178.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.492 ' N ' HG22 ' A' ' 190' ' ' VAL . 0.0 OUTLIER -86.57 -154.02 0.22 Allowed 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.081 178.174 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -94.27 29.11 2.29 Favored 'General case' 0 N--CA 1.455 -0.191 0 O-C-N 122.023 -0.423 . . . . 0.0 111.51 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -152.91 -77.41 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.319 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.725 ' O ' HG23 ' A' ' 184' ' ' ILE . 0.5 OUTLIER -115.49 -157.68 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-N 115.464 -0.368 . . . . 0.0 110.094 -179.765 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.732 HG11 ' CG ' ' A' ' 192' ' ' GLU . 23.4 t -86.83 139.97 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 CA-C-O 121.425 0.631 . . . . 0.0 110.889 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.611 HG23 ' CA ' ' A' ' 184' ' ' ILE . 0.4 OUTLIER -88.22 -35.44 8.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.011 179.883 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . 0.463 ' HB2' ' CE1' ' A' ' 221' ' ' PHE . 9.9 t80 -178.91 151.33 0.52 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.014 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . 0.732 ' CG ' HG11 ' A' ' 189' ' ' VAL . 34.0 mt-10 -143.47 159.34 42.59 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.68 179.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 150.33 -122.9 1.46 Allowed Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.825 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 0.52 ' C ' HG22 ' A' ' 181' ' ' VAL . 8.8 pt-20 -139.31 -177.98 5.16 Favored 'General case' 0 CA--C 1.497 -1.065 0 CA-C-O 121.288 0.566 . . . . 0.0 111.207 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.815 HD11 ' CD1' ' A' ' 216' ' ' LEU . 0.3 OUTLIER -88.27 142.62 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.145 -178.485 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -88.7 -61.69 1.65 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -151.94 166.05 32.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.529 178.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.575 HD21 ' O ' ' A' ' 205' ' ' VAL . 1.3 pt? -139.3 122.41 16.86 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.69 0.757 . . . . 0.0 112.149 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -146.83 127.82 14.55 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 114.406 -1.27 . . . . 0.0 108.719 178.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 3.1 ttp85 -88.8 -38.19 14.83 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.51 0.671 . . . . 0.0 111.82 -178.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.459 ' CD1' ' N ' ' A' ' 201' ' ' TYR . 0.0 OUTLIER -151.52 -96.32 0.06 Allowed 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.139 179.504 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 5.3 tttp -107.07 20.63 18.74 Favored 'General case' 0 N--CA 1.44 -0.97 0 O-C-N 122.33 -0.231 . . . . 0.0 110.908 179.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -150.82 144.11 24.85 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 120.864 0.364 . . . . 0.0 110.828 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.67 82.32 6.33 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.644 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.575 ' O ' HD21 ' A' ' 198' ' ' LEU . 30.4 m -56.15 173.47 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.068 0 CA-C-O 120.972 0.415 . . . . 0.0 111.361 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . 0.478 ' O ' ' HB ' ' A' ' 176' ' ' THR . 2.6 ttp180 -97.34 -40.07 8.91 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.787 -178.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.803 ' HB3' HG22 ' A' ' 176' ' ' THR . 1.1 mp0 -143.12 178.12 7.92 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.29 0.567 . . . . 0.0 111.938 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.569 HG23 HG23 ' A' ' 175' ' ' ILE . 0.1 OUTLIER -150.74 81.23 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.743 179.478 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.707 ' HB2' ' HG3' ' A' ' 174' ' ' LYS . . . -105.32 177.5 4.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.999 0.428 . . . . 0.0 112.043 -178.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 83.24 -72.06 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.942 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . 0.501 ' HA2' HG13 ' A' ' 170' ' ' VAL . . . 178.63 36.88 0.06 OUTLIER Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.537 -0.839 . . . . 0.0 112.369 179.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . 0.512 ' N ' HG12 ' A' ' 170' ' ' VAL . 0.5 OUTLIER -104.54 144.45 31.67 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.071 0.463 . . . . 0.0 111.746 -179.232 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -99.56 151.11 21.54 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.933 179.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 53.9 t -146.66 148.2 31.8 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.845 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -88.23 108.72 3.45 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.394 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.815 ' CD1' HD11 ' A' ' 195' ' ' ILE . 0.1 OUTLIER -138.27 147.6 43.81 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 121.12 0.486 . . . . 0.0 112.06 -178.208 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . 0.708 ' O ' HD13 ' A' ' 195' ' ' ILE . 0.0 OUTLIER -88.1 143.86 26.83 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.025 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . 0.698 HG23 HG21 ' A' ' 181' ' ' VAL . 1.5 mp -109.42 92.15 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 -179.335 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 1.8 ttpp 44.43 -146.1 0.11 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.852 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -87.67 62.66 7.14 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-O 121.319 0.58 . . . . 0.0 110.808 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.49 ' CZ ' HD21 ' A' ' 183' ' ' LEU . 0.1 OUTLIER -54.37 121.6 8.63 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 179.14 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -84.06 -48.66 9.67 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.287 176.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 223' ' ' ASP . 0.0 OUTLIER -81.0 125.37 30.08 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.122 177.68 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.633 HD12 ' HG2' ' A' ' 225' ' ' LYS . 1.7 pt -115.89 176.86 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.603 0 CA-C-O 121.469 0.652 . . . . 0.0 111.884 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.633 ' HG2' HD12 ' A' ' 224' ' ' ILE . 0.1 OUTLIER 63.88 149.46 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.757 -1.111 . . . . 0.0 108.635 -178.627 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . 0.557 ' HB3' ' O ' ' A' ' 154' ' ' ARG . 5.5 pt-20 -36.92 86.5 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 121.986 0.898 . . . . 0.0 112.89 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 225' ' ' LYS . . . -78.5 -60.17 2.71 Favored Glycine 0 N--CA 1.426 -2.006 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.502 179.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.458 ' HB3' ' O ' ' A' ' 184' ' ' ILE . 1.1 t70 -165.21 -144.94 0.08 Allowed 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . 0.773 HG22 ' HG3' ' A' ' 152' ' ' GLU . 80.2 t -89.65 134.21 29.48 Favored 'Isoleucine or valine' 0 C--N 1.349 0.555 0 C-N-CA 122.937 0.495 . . . . 0.0 109.881 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . 0.501 ' HA ' ' CB ' ' A' ' 183' ' ' LEU . 5.5 mt -103.26 158.04 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 O-C-N 123.435 0.459 . . . . 0.0 110.951 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' GLU . . . . . 0.465 ' O ' ' N ' ' A' ' 182' ' ' ARG . 1.4 tm-20 -148.89 109.88 4.33 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.649 ' HB2' HD12 ' A' ' 175' ' ' ILE . . . -87.59 128.25 35.27 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.354 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' TYR . . . . . 0.456 ' HA ' HG13 ' A' ' 148' ' ' ILE . 11.5 p90 -124.97 143.17 51.03 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.625 -178.164 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.643 HG12 HG21 ' A' ' 148' ' ' ILE . 0.3 OUTLIER 179.97 -173.83 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.855 178.909 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' MET . . . . . 0.586 ' N ' HG13 ' A' ' 234' ' ' VAL . 3.6 mmt -89.87 -162.38 0.88 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.437 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -89.52 53.64 2.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.243 0.544 . . . . 0.0 110.9 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -133.64 44.56 2.76 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.111 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.408 ' O ' ' HB3' ' A' ' 239' ' ' ALA . 1.7 m -104.05 166.91 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.98 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 238' ' ' VAL . . . 69.92 -64.54 0.35 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.923 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 3.5 ttp180 -89.68 -3.65 58.12 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.313 -1.012 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.114 179.967 . . . . . . . . 0 0 . 1 stop_ save_